data_7act_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 7act _Structure_validation_residue.Date_analyzed 2020-10-30 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 N--CA 1.483 0.901 0 CA-C-O 118.651 -0.645 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -71.05 113.61 8.26 Favored 'General case' 0 C--O 1.275 2.408 0 CA-C-O 124.423 2.059 . . . . 0.0 112.772 -174.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -70.98 -9.14 57.43 Favored 'General case' 0 CA--C 1.614 3.413 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -167.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.1 m 58.49 -31.62 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 1 C-N-CA 132.1 4.16 . . . . 0.0 115.192 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.54 157.69 21.18 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.167 2.987 . . . . 0.0 113.11 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.0 t -79.53 136.89 37.0 Favored 'General case' 0 N--CA 1.422 -1.875 0 O-C-N 120.225 -1.547 . . . . 0.0 110.584 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.88 -29.35 70.69 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 115.849 -2.024 . . . . 0.0 113.952 169.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -100.38 162.68 12.79 Favored 'General case' 0 C--N 1.377 1.788 0 O-C-N 127.552 3.033 . . . . 0.0 113.611 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.307 35.2 p -59.45 140.35 56.27 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 125.183 2.421 . . . . 0.0 113.162 166.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.05 143.91 32.58 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 111.151 -2.749 . . . . 0.0 109.623 -171.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.31 152.38 21.06 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.578 -1.326 . . . . 0.0 108.004 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -116.64 134.15 55.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 118.29 -2.756 . . . . 0.0 110.637 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -68.76 139.89 55.32 Favored 'General case' 0 CA--C 1.607 3.139 0 C-N-CA 126.58 1.952 . . . . 0.0 115.856 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -115.72 -48.04 2.78 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.23 -135.62 5.61 Favored Glycine 0 N--CA 1.508 3.458 0 C-N-CA 127.063 2.268 . . . . 0.0 110.959 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -147.39 -29.04 0.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.277 2.038 . . . . 0.0 114.143 -164.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.79 129.47 37.74 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 127.819 2.448 . . . . 0.0 114.773 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' HB2' ' HE3' ' A' ' 65' ' ' LYS . 82.0 m-20 -56.91 155.57 7.83 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 128.384 2.674 . . . . 0.0 108.067 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.16 57.32 0.84 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.504 -2.623 . . . . 0.0 110.029 -170.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.476 ' HE3' ' HB2' ' A' ' 63' ' ' ASP . 82.8 mttt -87.61 101.81 14.0 Favored 'General case' 0 CA--C 1.576 1.957 1 O-C-N 115.776 -4.327 . . . . 0.0 106.86 -164.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -68.25 149.61 98.03 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -55.78 154.59 25.62 Favored 'Trans proline' 1 C--N 1.417 4.139 0 O-C-N 118.291 -1.479 . . . . 0.0 108.568 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 54.63 -5.95 0.02 OUTLIER 'General case' 0 N--CA 1.539 3.977 1 N-CA-C 122.123 4.12 . . . . 0.0 122.123 152.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.78 7.37 71.32 Favored Glycine 0 CA--C 1.564 3.154 1 O-C-N 115.285 -4.634 . . . . 0.0 113.861 -168.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -86.72 104.6 16.27 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 117.803 -1.094 . . . . 0.0 109.0 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.25 21.54 0.04 OUTLIER Glycine 0 C--N 1.356 1.694 0 CA-C-N 122.326 2.33 . . . . 0.0 113.212 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.254 97.9 t -73.29 117.6 61.67 Favored Pre-proline 0 C--O 1.268 2.031 0 O-C-N 119.535 -2.156 . . . . 0.0 116.087 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -68.64 170.18 15.77 Favored 'Trans proline' 0 CA--C 1.552 1.387 1 C-N-CA 129.287 6.658 . . . . 0.0 109.534 -169.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.8 mt -105.13 141.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 O-C-N 117.772 -3.08 . . . . 0.0 112.381 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 127.481 2.312 . . . . 0.0 111.778 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.4 m -57.49 -43.99 84.57 Favored 'General case' 0 C--O 1.192 -1.929 0 O-C-N 124.054 0.846 . . . . 0.0 112.124 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -77.14 39.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 128.0 2.52 . . . . 0.0 111.907 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.2 p -146.57 144.62 29.69 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 125.551 1.54 . . . . 0.0 111.88 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -83.16 168.01 25.45 Favored Pre-proline 0 C--O 1.271 2.215 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -62.89 -33.76 74.11 Favored 'Trans proline' 0 C--O 1.203 -1.241 0 CA-C-O 117.554 -1.102 . . . . 0.0 114.511 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -58.02 -29.12 65.07 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 128.698 2.799 . . . . 0.0 111.21 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.318 33.9 m-20 -74.16 -11.67 60.36 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 129.036 2.935 . . . . 0.0 114.104 -172.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -88.39 66.37 8.3 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 117.149 -1.405 . . . . 0.0 111.229 -157.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.8 tt -154.62 144.23 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.671 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 178.89 -167.49 37.8 Favored Glycine 1 CA--C 1.58 4.137 0 C-N-CA 116.873 -2.584 . . . . 0.0 114.925 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -153.57 147.18 25.1 Favored 'General case' 0 C--O 1.202 -1.432 0 O-C-N 118.247 -2.913 . . . . 0.0 112.985 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -92.91 139.48 30.49 Favored 'General case' 0 C--O 1.246 0.896 0 O-C-N 128.736 3.773 . . . . 0.0 117.34 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -140.69 164.0 31.37 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 121.813 2.097 . . . . 0.0 110.865 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -83.92 154.68 23.25 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 117.78 2.511 . . . . 0.0 117.78 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.23 88.69 2.11 Favored 'General case' 0 C--O 1.182 -2.453 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.635 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.7 p -67.6 -27.8 67.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 116.07 -1.919 . . . . 0.0 111.729 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 52.88 56.05 8.13 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-N 120.189 1.359 . . . . 0.0 109.252 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -122.91 -12.0 8.06 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 130.395 3.478 . . . . 0.0 114.476 -160.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 mp 61.27 124.88 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.549 4.495 1 C-N-CA 131.82 4.048 . . . . 0.0 108.521 166.684 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 . . . . . 0 N--CA 1.518 2.954 0 C-N-CA 127.145 2.178 . . . . 0.0 107.368 169.507 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.7 tttt . . . . . 0 CA--C 1.6 2.872 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 55.99 -0.34 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 131.667 3.987 . . . . 0.0 116.141 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -67.56 169.34 9.43 Favored 'General case' 0 N--CA 1.53 3.555 0 CA-C-N 123.844 3.02 . . . . 0.0 109.667 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.9 m -56.83 163.06 3.05 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 127.27 3.414 . . . . 0.0 111.61 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -71.57 168.05 24.7 Favored 'Trans proline' 0 N--CA 1.427 -2.402 0 CA-C-O 124.844 1.935 . . . . 0.0 115.228 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -113.74 164.54 13.58 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 116.767 -3.708 . . . . 0.0 107.167 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -134.25 122.56 22.91 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 129.775 3.23 . . . . 0.0 112.051 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -107.84 147.61 30.68 Favored 'General case' 0 CA--C 1.597 2.769 0 CA-C-N 113.438 -1.71 . . . . 0.0 112.508 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -101.82 148.88 24.77 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.834 2.454 . . . . 0.0 110.16 166.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -134.05 145.2 49.2 Favored 'General case' 0 C--O 1.255 1.394 0 C-N-CA 125.267 1.427 . . . . 0.0 111.884 168.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -57.73 157.05 7.75 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 160.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.25 138.03 57.38 Favored 'General case' 0 C--N 1.384 2.095 0 O-C-N 123.982 0.801 . . . . 0.0 111.068 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.95 32.43 75.27 Favored Glycine 0 CA--C 1.564 3.129 0 CA-C-O 118.08 -1.4 . . . . 0.0 115.069 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -141.88 172.04 13.23 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 128.228 2.611 . . . . 0.0 112.206 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -163.98 45.93 Favored Glycine 1 C--O 1.298 4.126 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.879 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.57 -29.26 25.08 Favored 'Trans proline' 0 CA--C 1.578 2.708 1 C-N-CA 125.579 4.186 . . . . 0.0 111.378 -170.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -94.45 24.63 4.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.921 -2.362 . . . . 0.0 111.521 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 -29.59 41.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.062 1.745 . . . . 0.0 114.404 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.38 -10.38 84.66 Favored Glycine 0 C--N 1.388 3.42 0 CA-C-O 124.505 2.169 . . . . 0.0 117.668 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.9 mt -70.29 136.17 86.64 Favored Pre-proline 0 N--CA 1.522 3.155 1 O-C-N 115.776 -4.367 . . . . 0.0 110.179 168.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.18 174.26 13.11 Favored 'Trans proline' 0 C--N 1.376 1.986 0 O-C-N 123.689 1.363 . . . . 0.0 112.711 160.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.02 133.44 56.1 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 120.289 -1.507 . . . . 0.0 111.698 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.75 5.65 89.34 Favored Glycine 1 CA--C 1.621 6.663 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 168.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.98 151.37 4.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.596 1.665 . . . . 0.0 111.994 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -94.95 68.02 3.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -125.05 137.39 54.21 Favored 'General case' 0 C--O 1.258 1.542 0 C-N-CA 126.646 1.978 . . . . 0.0 113.745 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.259 3.2 t0 -57.39 124.05 17.57 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 112.194 -2.275 . . . . 0.0 112.296 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.84 -4.63 79.01 Favored Glycine 0 C--N 1.373 2.589 0 O-C-N 125.204 1.565 . . . . 0.0 114.115 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 mp -86.68 128.82 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.609 3.242 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 163.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.0 mm -109.75 109.62 29.09 Favored 'Isoleucine or valine' 0 C--O 1.254 1.332 1 O-C-N 129.179 4.049 . . . . 0.0 110.574 170.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.21 138.5 35.81 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.205 -0.935 . . . . 0.0 112.901 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.01 146.25 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 126.121 1.769 . . . . 0.0 114.029 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.85 153.57 35.62 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 130.153 3.381 . . . . 0.0 110.843 -175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.2 p -102.43 156.56 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 129.38 3.072 . . . . 0.0 105.096 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -52.7 -31.13 36.0 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.59 -27.31 10.68 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 127.892 2.663 . . . . 0.0 113.171 -163.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.53 157.98 8.28 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.302 1.441 . . . . 0.0 111.486 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.09 131.15 54.43 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 124.589 2.137 . . . . 0.0 110.939 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -64.53 24.42 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.369 0 O-C-N 117.971 -2.956 . . . . 0.0 118.272 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.3 p -87.36 150.76 49.82 Favored Pre-proline 0 C--N 1.362 1.119 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.31 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.4 148.77 49.28 Favored 'Trans proline' 0 CA--C 1.505 -0.949 0 CA-C-O 116.686 -1.464 . . . . 0.0 115.041 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -97.51 90.09 4.92 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 126.166 2.888 . . . . 0.0 109.868 -172.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -52.39 -59.54 4.3 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -64.44 -66.91 0.48 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.064 2.146 . . . . 0.0 106.758 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.0 mt -45.53 -27.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 119.223 -2.173 . . . . 0.0 116.394 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -92.9 -11.23 59.17 Favored Glycine 1 CA--C 1.579 4.035 0 O-C-N 117.785 -3.072 . . . . 0.0 115.834 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.3 p -125.56 -12.65 6.65 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 114.975 -2.441 . . . . 0.0 112.676 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -74.63 178.34 5.45 Favored 'General case' 0 CA--C 1.582 2.2 0 CA-C-O 113.115 -3.326 . . . . 0.0 115.733 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -109.6 97.47 27.82 Favored Pre-proline 0 N--CA 1.414 -2.262 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . 0.337 4.2 Cg_exo -57.86 -28.45 82.53 Favored 'Trans proline' 0 CA--C 1.581 2.827 0 C-N-CA 123.183 2.589 . . . . 0.0 113.882 171.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.7 -12.75 25.7 Favored 'General case' 0 CA--C 1.556 1.184 0 O-C-N 124.448 1.093 . . . . 0.0 113.195 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -61.81 -19.81 62.95 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -148.31 -176.55 5.34 Favored 'General case' 0 C--O 1.175 -2.831 0 CA-C-N 121.271 1.85 . . . . 0.0 110.345 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.24 156.24 0.6 Allowed 'General case' 0 C--N 1.386 2.153 0 CA-C-N 113.531 -1.668 . . . . 0.0 114.825 154.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.08 159.98 24.61 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.1 mt -81.46 130.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.722 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 p -63.35 121.2 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 124.497 2.094 . . . . 0.0 108.483 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 118.86 12.23 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 114.693 -5.005 . . . . 0.0 111.514 171.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -151.29 133.08 14.97 Favored 'General case' 0 C--O 1.251 1.136 0 O-C-N 126.87 2.606 . . . . 0.0 109.695 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.5 mt -75.21 165.63 52.2 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.52 145.97 92.68 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 119.509 0.86 . . . . 0.0 112.915 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 58.6 9.92 1.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.939 2.895 . . . . 0.0 113.098 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.29 30.17 73.45 Favored Glycine 0 CA--C 1.548 2.128 0 O-C-N 118.217 -2.802 . . . . 0.0 116.144 -168.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.7 m -55.0 125.65 21.31 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-N 112.737 -1.731 . . . . 0.0 111.889 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 87.0 m -69.51 125.82 27.86 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -164.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 mt -71.91 157.55 89.34 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 125.632 1.832 . . . . 0.0 106.168 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -44.02 124.84 5.04 Favored 'Trans proline' 0 N--CA 1.52 3.039 1 C-N-CA 129.195 6.597 . . . . 0.0 116.734 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -57.99 -25.41 61.03 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 128.579 2.751 . . . . 0.0 107.708 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.94 -15.25 9.38 Favored Glycine 1 CA--C 1.596 5.147 0 CA-C-N 120.781 1.628 . . . . 0.0 114.917 174.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -137.34 153.89 50.16 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 126.593 1.957 . . . . 0.0 113.188 -154.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -98.6 124.72 43.54 Favored 'General case' 0 C--O 1.199 -1.589 0 O-C-N 118.843 -2.411 . . . . 0.0 109.101 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -117.24 164.63 14.52 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 127.49 2.316 . . . . 0.0 113.988 168.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 CA--C 1.568 1.662 0 C-N-CA 127.471 2.309 . . . . 0.0 116.108 174.488 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo . . . . . 0 C--O 1.252 1.176 0 N-CA-C 118.687 2.534 . . . . 0.0 118.687 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -71.04 111.93 6.79 Favored 'General case' 0 N--CA 1.403 -2.778 0 O-C-N 119.878 -1.764 . . . . 0.0 112.395 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.439 ' C ' ' H ' ' A' ' 50' ' ' ALA 0.456 27.3 p30 -46.2 -32.8 3.22 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 119.72 -1.862 . . . . 0.0 115.742 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.3 m 64.96 -36.69 0.21 Allowed 'General case' 0 CA--C 1.609 3.219 0 C-N-CA 128.481 2.712 . . . . 0.0 106.974 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 48' ' ' ASN . . . -76.62 152.66 35.8 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 120.639 1.563 . . . . 0.0 113.766 -173.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -95.96 145.68 25.22 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 117.432 2.382 . . . . 0.0 117.432 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -83.03 -13.38 55.98 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -108.39 158.12 17.8 Favored 'General case' 0 N--CA 1.415 -2.18 0 O-C-N 127.965 3.291 . . . . 0.0 116.631 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.0 p -63.27 125.91 25.66 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.88 155.19 35.01 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 127.463 2.305 . . . . 0.0 111.783 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.97 164.09 12.5 Favored 'General case' 0 CA--C 1.593 2.63 0 C-N-CA 128.712 2.805 . . . . 0.0 109.043 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 67.4 m -132.51 130.65 40.7 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 118.878 -2.389 . . . . 0.0 110.616 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -67.49 137.4 55.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.269 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -125.58 -33.11 2.81 Favored 'General case' 0 CA--C 1.593 2.596 0 CA-C-N 120.874 1.67 . . . . 0.0 111.266 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.09 -134.66 0.65 Allowed Glycine 0 N--CA 1.514 3.842 0 N-CA-C 120.945 3.138 . . . . 0.0 120.945 170.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -133.82 -23.63 1.78 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 125.964 1.705 . . . . 0.0 113.444 167.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.92 146.96 25.97 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -72.21 159.47 34.04 Favored 'General case' 0 N--CA 1.409 -2.494 0 O-C-N 118.71 -2.494 . . . . 0.0 111.015 -168.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.1 tp -74.3 68.64 1.52 Allowed 'General case' 0 N--CA 1.534 3.73 0 CA-C-O 123.598 1.666 . . . . 0.0 111.543 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -91.87 158.99 16.0 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 125.114 2.387 . . . . 0.0 106.894 -168.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 61.8 m-85 -148.07 126.95 6.19 Favored Pre-proline 0 C--O 1.257 1.456 0 O-C-N 119.45 -2.031 . . . . 0.0 107.874 -167.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -57.96 106.95 0.28 Allowed 'Trans proline' 0 C--O 1.192 -1.779 1 C-N-CA 125.481 4.121 . . . . 0.0 113.117 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 38.77 36.34 0.14 Allowed 'General case' 0 C--N 1.387 2.235 0 C-N-CA 129.539 3.135 . . . . 0.0 115.244 -166.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.5 75.13 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 171.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.18 101.75 3.42 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.411 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.42 -1.26 0.04 OUTLIER Glycine 0 C--O 1.284 3.27 0 N-CA-C 122.952 3.941 . . . . 0.0 122.952 -167.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.76 144.26 68.55 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 121.797 -0.825 . . . . 0.0 113.138 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -82.95 163.67 15.68 Favored 'Trans proline' 0 CA--C 1.55 1.286 0 O-C-N 115.549 -2.921 . . . . 0.0 115.953 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.6 tt -78.55 144.35 11.29 Favored 'Isoleucine or valine' 0 C--O 1.277 2.534 0 CA-C-O 127.69 3.614 . . . . 0.0 112.026 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -150.06 144.46 25.77 Favored 'General case' 0 C--O 1.26 1.652 0 O-C-N 116.971 -3.58 . . . . 0.0 113.35 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.0 m -82.61 -36.29 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . 0.342 17.4 m120 -84.0 20.48 1.53 Allowed 'General case' 0 C--O 1.189 -2.084 0 C-N-CA 131.615 3.966 . . . . 0.0 116.124 -162.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 p -161.34 166.96 26.69 Favored 'General case' 0 C--N 1.388 2.248 0 C-N-CA 126.056 1.742 . . . . 0.0 112.538 171.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.0 p -94.44 169.6 9.47 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.131 0.972 . . . . 0.0 112.419 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -65.3 -23.69 58.87 Favored 'Trans proline' 0 CA--C 1.452 -3.589 0 O-C-N 116.908 -2.206 . . . . 0.0 116.908 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -68.01 -24.87 65.17 Favored 'General case' 0 C--O 1.274 2.348 0 C-N-CA 127.636 2.375 . . . . 0.0 107.751 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -78.64 -18.48 54.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 121.725 2.057 . . . . 0.0 115.205 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -84.3 74.04 10.38 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 125.228 2.442 . . . . 0.0 112.104 -162.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -156.04 141.66 10.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.753 1 C-N-CA 133.29 4.636 . . . . 0.0 112.859 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.02 -173.41 40.79 Favored Glycine 1 CA--C 1.581 4.186 0 CA-C-O 124.394 2.108 . . . . 0.0 116.321 -168.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -136.44 156.13 49.04 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 109.36 -3.42 . . . . 0.0 111.736 168.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 36.1 m-85 -99.86 143.32 30.22 Favored 'General case' 0 N--CA 1.391 -3.399 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 162.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -123.04 143.34 50.01 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 126.097 1.759 . . . . 0.0 112.299 165.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.97 166.06 1.63 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 165.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 133.406 4.682 . . . . 0.0 112.875 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.1 p -137.26 -13.72 1.56 Allowed 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 59.48 41.16 19.72 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 124.342 2.02 . . . . 0.0 112.203 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -120.37 3.55 10.79 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 118.138 -2.851 . . . . 0.0 116.589 -161.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.8 mm 65.56 92.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.16 -3.63 0 C-N-CA 130.806 3.643 . . . . 0.0 116.579 149.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 . . . . . 0 N--CA 1.418 -2.071 0 O-C-N 124.144 0.902 . . . . 0.0 109.981 161.916 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 CA--C 1.57 1.714 0 CA-C-O 114.258 -2.782 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.27 27.24 15.42 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.235 1.834 . . . . 0.0 112.134 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.59 167.67 17.1 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 122.747 1.26 . . . . 0.0 107.872 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -65.67 146.22 98.99 Favored Pre-proline 0 C--N 1.405 2.983 0 CA-C-N 112.215 -2.266 . . . . 0.0 116.761 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.02 155.41 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 1 C-N-CA 127.993 5.795 . . . . 0.0 111.872 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -114.83 172.34 7.1 Favored 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -140.82 147.1 38.49 Favored 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 126.936 2.094 . . . . 0.0 113.237 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 55.6 m-85 -132.14 145.71 51.55 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 130.409 3.484 . . . . 0.0 116.717 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -98.83 141.25 31.85 Favored 'General case' 0 C--O 1.262 1.734 0 O-C-N 118.198 -2.814 . . . . 0.0 109.544 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -142.41 122.82 13.99 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 127.669 2.388 . . . . 0.0 110.09 172.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -45.82 151.54 0.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 111.082 171.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.305 69.1 tp -52.84 132.63 37.14 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 125.886 2.755 . . . . 0.0 112.456 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.34 42.18 98.74 Favored Glycine 0 C--O 1.263 1.94 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.898 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -149.55 173.01 14.09 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 114.14 -1.03 . . . . 0.0 112.03 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 54.71 -159.51 5.59 Favored Glycine 0 C--O 1.255 1.421 0 O-C-N 119.727 -1.858 . . . . 0.0 115.186 -163.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.1 -19.34 63.18 Favored 'Trans proline' 0 N--CA 1.5 1.9 1 C-N-CA 125.638 4.225 . . . . 0.0 117.794 -166.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -117.45 35.32 4.72 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 124.645 1.178 . . . . 0.0 111.547 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.59 -5.65 1.32 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 119.967 -1.708 . . . . 0.0 114.159 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.31 -36.66 44.23 Favored Glycine 0 N--CA 1.417 -2.622 0 CA-C-O 114.729 -3.262 . . . . 0.0 113.928 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.6 mt -69.22 125.65 92.13 Favored Pre-proline 0 C--O 1.262 1.737 0 CA-C-N 121.228 2.514 . . . . 0.0 116.768 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.57 171.93 2.34 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 121.868 1.712 . . . . 0.0 114.485 160.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -68.22 138.37 55.52 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.16 74.8 Favored Glycine 1 CA--C 1.585 4.459 0 C-N-CA 117.225 -2.417 . . . . 0.0 116.811 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.34 82.2 8.38 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 171.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.49 126.72 29.17 Favored 'General case' 0 C--O 1.207 -1.163 0 O-C-N 118.044 -2.91 . . . . 0.0 113.126 -167.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -148.1 159.2 44.17 Favored 'General case' 0 C--O 1.182 -2.495 0 C-N-CA 126.714 2.006 . . . . 0.0 110.558 -170.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.1 133.84 46.56 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.8 -2.31 72.59 Favored Glycine 1 CA--C 1.621 6.658 0 O-C-N 119.636 -1.915 . . . . 0.0 114.377 169.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.8 mt -131.3 142.08 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 1 C-N-CA 131.952 4.101 . . . . 0.0 104.62 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.9 mm -137.73 112.96 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.759 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -76.47 128.58 35.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.288 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 m -133.05 142.92 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 127.465 3.507 . . . . 0.0 114.889 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.18 173.57 12.1 Favored 'General case' 0 CA--C 1.478 -1.81 0 O-C-N 118.159 -2.838 . . . . 0.0 112.571 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 37.2 p -127.61 157.11 41.11 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 129.539 3.136 . . . . 0.0 109.916 173.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -64.67 -35.82 82.27 Favored 'General case' 0 CA--C 1.582 2.18 0 C-N-CA 123.964 0.906 . . . . 0.0 112.694 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.79 -22.19 72.65 Favored Glycine 1 CA--C 1.595 5.076 0 O-C-N 119.592 -1.943 . . . . 0.0 114.361 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.69 165.71 4.89 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-N 120.319 2.06 . . . . 0.0 113.197 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.3 mt -126.88 147.44 50.06 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.655 2.782 . . . . 0.0 112.424 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -75.51 -2.68 30.07 Favored 'General case' 1 CA--C 1.63 4.042 0 C-N-CA 126.926 2.091 . . . . 0.0 114.311 -175.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -71.62 148.48 92.85 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 126.22 1.808 . . . . 0.0 111.26 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.6 142.98 9.52 Favored 'Trans proline' 0 CA--C 1.467 -2.872 0 C-N-CA 123.929 3.086 . . . . 0.0 109.931 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -94.08 65.12 3.39 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 117.574 -3.204 . . . . 0.0 108.155 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.52 -34.35 75.72 Favored 'General case' 0 CA--C 1.61 3.254 0 CA-C-O 113.214 -3.279 . . . . 0.0 115.624 -161.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.268 41.0 m80 -62.05 -44.49 96.57 Favored 'General case' 1 CA--C 1.645 4.629 0 O-C-N 126.019 2.074 . . . . 0.0 110.292 171.698 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.4 mt -64.49 -31.87 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.02 -2.03 88.29 Favored Glycine 0 CA--C 1.496 -1.134 0 CA-C-O 116.392 -2.338 . . . . 0.0 117.185 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.5 p -128.88 -27.19 2.56 Favored 'General case' 0 CA--C 1.596 2.724 0 CA-C-N 122.141 2.97 . . . . 0.0 113.251 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -49.4 154.58 0.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 122.292 2.315 . . . . 0.0 111.18 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -67.02 121.0 76.19 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 129.284 3.034 . . . . 0.0 113.595 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -33.79 84.76 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 N-CA-C 118.293 2.382 . . . . 0.0 118.293 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.13 0.41 36.35 Favored 'General case' 0 C--O 1.254 1.341 0 C-N-CA 127.058 2.143 . . . . 0.0 114.579 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -72.93 -16.73 61.54 Favored 'General case' 0 C--O 1.172 -3.015 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -146.36 146.31 30.61 Favored 'General case' 0 CA--C 1.609 3.226 0 CA-C-N 113.074 -1.876 . . . . 0.0 113.363 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.77 152.89 44.64 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 118.706 -2.496 . . . . 0.0 117.135 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.27 116.02 6.18 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 119.747 -1.846 . . . . 0.0 114.771 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.49 120.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.62 0 C-N-CA 127.922 2.489 . . . . 0.0 108.596 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.3 109.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 166.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.6 116.93 6.69 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -172.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -153.52 142.47 21.19 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 116.432 -3.917 . . . . 0.0 108.406 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.54 140.29 22.1 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 116.511 -1.709 . . . . 0.0 114.633 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -37.72 169.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 123.205 2.604 . . . . 0.0 115.325 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 54.64 19.14 2.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.636 2.374 . . . . 0.0 112.318 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.14 13.65 60.25 Favored Glycine 0 CA--C 1.562 3.021 0 O-C-N 116.682 -3.761 . . . . 0.0 116.458 -169.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -60.82 116.22 4.27 Favored 'General case' 0 C--O 1.165 -3.39 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.995 -167.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 m -70.18 146.92 50.43 Favored 'General case' 1 N--CA 1.539 4.016 0 C-N-CA 125.611 1.564 . . . . 0.0 113.534 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.56 157.03 77.79 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 122.47 1.129 . . . . 0.0 111.773 175.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.95 120.42 7.88 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 125.038 3.825 . . . . 0.0 112.56 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -60.44 -20.32 59.44 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -168.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.13 4.12 Favored Glycine 0 CA--C 1.54 1.609 1 O-C-N 116.071 -4.143 . . . . 0.0 117.51 161.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.61 125.8 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 123.256 3.528 . . . . 0.0 115.528 171.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -66.71 131.04 45.12 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 115.583 -2.151 . . . . 0.0 109.085 167.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.51 141.86 37.31 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 123.459 2.845 . . . . 0.0 112.301 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 . . . . . 0 CA--C 1.577 2.01 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -171.333 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 N--CA 1.501 1.962 0 CA-C-O 129.255 3.773 . . . . 0.0 106.663 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -54.99 141.61 33.27 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 109.953 -3.294 . . . . 0.0 113.548 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -96.47 -35.28 11.19 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 m 61.25 -21.82 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 129.985 3.314 . . . . 0.0 118.261 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.42 151.75 26.45 Favored 'General case' 0 CA--C 1.618 3.56 0 O-C-N 118.247 -2.783 . . . . 0.0 113.818 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -77.78 153.25 33.03 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 118.862 -2.399 . . . . 0.0 112.576 167.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -76.07 -27.34 57.19 Favored 'General case' 0 C--O 1.281 2.717 0 C-N-CA 125.616 1.567 . . . . 0.0 114.06 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.64 164.96 11.78 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 124.582 2.134 . . . . 0.0 111.171 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -67.0 159.62 28.22 Favored 'General case' 0 C--O 1.288 3.088 0 CA-C-N 111.206 -2.724 . . . . 0.0 111.02 167.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.0 147.13 28.14 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 127.284 3.421 . . . . 0.0 114.282 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -76.21 162.17 28.18 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.467 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.7 m -122.03 125.41 46.2 Favored 'General case' 0 C--N 1.38 1.916 0 C-N-CA 124.423 1.089 . . . . 0.0 109.047 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -69.41 129.36 39.54 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 125.95 1.7 . . . . 0.0 109.462 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -123.78 -7.29 7.92 Favored 'General case' 0 C--O 1.203 -1.381 0 C-N-CA 128.522 2.729 . . . . 0.0 110.475 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.8 -139.79 10.58 Favored Glycine 0 CA--C 1.566 3.269 0 O-C-N 119.333 -2.104 . . . . 0.0 109.463 159.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -147.98 -17.69 0.35 Allowed 'General case' 0 C--O 1.189 -2.116 0 C-N-CA 128.957 2.903 . . . . 0.0 109.952 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.06 132.72 49.94 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -60.19 161.57 6.88 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.048 1.739 . . . . 0.0 111.55 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.15 69.75 9.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 119.433 -2.042 . . . . 0.0 110.067 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -67.32 149.47 50.3 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.402 170.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.06 141.33 41.06 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 126.025 1.73 . . . . 0.0 113.146 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.48 129.69 24.55 Favored 'Trans proline' 0 C--N 1.381 2.271 0 N-CA-C 106.438 -2.178 . . . . 0.0 106.438 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 55.59 21.62 4.63 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 126.909 2.084 . . . . 0.0 115.583 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.01 27.81 72.73 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 124.573 1.082 . . . . 0.0 115.608 -170.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.258 20.1 tt0 -84.85 84.74 7.6 Favored 'General case' 1 CA--C 1.638 4.33 0 C-N-CA 128.463 2.705 . . . . 0.0 106.258 -175.241 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.11 0.08 OUTLIER Glycine 0 C--O 1.206 -1.648 2 CA-C-O 128.64 4.466 . . . . 0.0 123.615 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.1 t -69.96 126.88 92.66 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.975 -3.662 . . . . 0.0 111.004 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.63 160.86 4.86 Favored 'Trans proline' 0 CA--C 1.58 2.782 1 C-N-CA 128.518 6.145 . . . . 0.0 114.582 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.3 tt -85.28 142.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 159.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -157.54 104.82 2.01 Favored 'General case' 0 C--O 1.272 2.266 0 C-N-CA 126.955 2.102 . . . . 0.0 110.898 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.6 m -59.17 -32.71 70.15 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 125.389 1.68 . . . . 0.0 113.434 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -83.43 2.7 35.31 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.8 p -114.63 147.66 39.23 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 129.549 3.139 . . . . 0.0 110.287 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.2 t -72.35 155.65 91.18 Favored Pre-proline 0 CA--C 1.609 3.247 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -36.3 -31.87 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.682 1 C-N-CA 126.769 4.979 . . . . 0.0 114.45 152.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -82.58 -22.2 34.94 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 120.043 1.292 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -83.89 -14.57 50.75 Favored 'General case' 0 C--O 1.213 -0.861 0 O-C-N 119.369 -2.082 . . . . 0.0 114.367 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -68.9 59.11 0.09 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -167.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 tt -156.25 139.59 7.45 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.06 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.72 -160.71 30.96 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.034 -1.425 . . . . 0.0 114.921 -172.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -148.85 145.67 27.6 Favored 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 119.63 1.715 . . . . 0.0 110.169 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -85.4 161.22 19.53 Favored 'General case' 0 C--N 1.396 2.62 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 164.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -125.58 157.73 36.4 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 118.878 -2.389 . . . . 0.0 109.041 161.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.461 HH22 ' CG ' ' A' ' 128' ' ' ASP . 26.9 ptt180 -77.81 159.81 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.664 1.585 . . . . 0.0 107.815 169.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.04 136.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.449 1.9 . . . . 0.0 110.671 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -133.97 -16.22 2.25 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -168.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 55.26 60.03 3.63 Favored 'General case' 0 N--CA 1.538 3.944 0 O-C-N 119.568 -1.958 . . . . 0.0 107.051 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -128.18 -8.61 5.34 Favored 'General case' 0 C--O 1.193 -1.914 0 O-C-N 119.408 -2.057 . . . . 0.0 109.125 -160.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.337 1.1 mp 68.39 136.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 171.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 . . . . . 0 C--O 1.272 2.241 0 C-N-CA 127.503 2.321 . . . . 0.0 114.231 167.13 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.4 tttt . . . . . 1 C--O 1.309 4.234 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.5 0.4 OUTLIER 73.68 -10.67 1.04 Allowed 'General case' 0 C--N 1.363 1.164 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 177.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.7 mt -68.91 153.73 43.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 129.395 3.078 . . . . 0.0 111.698 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.8 m -66.86 167.64 13.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 114.761 -2.542 . . . . 0.0 111.544 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.259 59.3 Cg_exo -65.28 164.72 24.55 Favored 'Trans proline' 0 CA--C 1.584 3.011 0 C-N-CA 124.504 3.469 . . . . 0.0 114.348 -176.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -131.53 168.63 17.33 Favored 'General case' 0 C--N 1.386 2.173 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -128.7 127.63 42.5 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 128.113 3.383 . . . . 0.0 112.283 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -108.04 144.5 35.29 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 128.336 3.523 . . . . 0.0 111.194 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.6 144.1 31.88 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -140.36 151.34 44.91 Favored 'General case' 0 N--CA 1.514 2.765 0 O-C-N 118.635 -2.541 . . . . 0.0 109.83 176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.4 ' CD1' HG21 ' A' ' 146' ' ' ILE . 27.5 m-85 -90.46 161.29 15.6 Favored 'General case' 0 CA--C 1.595 2.708 0 CA-C-O 125.887 2.756 . . . . 0.0 112.586 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.3 tp -57.77 116.12 3.24 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 117.809 -3.057 . . . . 0.0 109.608 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.74 17.9 50.1 Favored Glycine 0 N--CA 1.501 3.0 0 O-C-N 118.584 -2.572 . . . . 0.0 115.259 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -133.55 165.37 25.05 Favored 'General case' 0 CA--C 1.504 -0.827 1 C-N-CA 132.841 4.456 . . . . 0.0 112.815 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.23 -165.69 52.09 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 125.683 1.611 . . . . 0.0 110.176 171.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.65 -28.54 52.41 Favored 'Trans proline' 0 N--CA 1.427 -2.393 1 C-N-CA 127.195 5.264 . . . . 0.0 111.422 -171.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -96.01 17.58 15.16 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 117.976 -2.952 . . . . 0.0 114.607 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.94 -12.21 0.3 Allowed 'General case' 0 C--N 1.39 2.366 0 O-C-N 118.869 -2.395 . . . . 0.0 116.095 -168.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.17 -34.63 57.99 Favored Glycine 0 C--N 1.287 -2.156 0 C-N-CA 128.461 2.934 . . . . 0.0 114.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.64 142.08 83.26 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.982 2.113 . . . . 0.0 115.044 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -77.4 163.91 29.36 Favored 'Trans proline' 0 C--N 1.397 3.111 1 C-N-CA 126.58 4.853 . . . . 0.0 115.118 161.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.42 151.18 41.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 117.374 -1.73 . . . . 0.0 115.124 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.91 8.12 5.49 Favored Glycine 0 CA--C 1.56 2.886 0 N-CA-C 120.903 3.121 . . . . 0.0 120.903 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.72 137.67 49.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 121.062 2.431 . . . . 0.0 113.458 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -78.89 142.79 36.49 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-O 116.307 -1.806 . . . . 0.0 114.227 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.06 142.41 7.35 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 129.672 3.189 . . . . 0.0 111.132 159.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.461 ' CG ' HH22 ' A' ' 89' ' ' ARG . 13.6 t0 -65.34 121.56 15.11 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 126.46 1.904 . . . . 0.0 115.222 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.94 74.72 Favored Glycine 0 CA--C 1.568 3.383 1 C-N-CA 130.957 4.122 . . . . 0.0 122.435 -169.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.1 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 O-C-N 128.199 2.941 . . . . 0.0 108.813 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.9 mm -120.9 119.89 60.77 Favored 'Isoleucine or valine' 0 C--N 1.385 2.112 0 CA-C-O 123.154 1.454 . . . . 0.0 112.491 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -73.63 138.99 45.16 Favored 'General case' 0 C--N 1.372 1.56 0 O-C-N 119.08 -2.262 . . . . 0.0 109.117 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.95 147.51 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.577 0 C-N-CA 123.635 0.774 . . . . 0.0 111.998 159.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.71 169.78 17.81 Favored 'General case' 0 N--CA 1.395 -3.193 0 C-N-CA 126.848 2.059 . . . . 0.0 113.455 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.255 81.8 p -98.93 170.03 9.02 Favored 'General case' 0 C--O 1.248 0.994 0 O-C-N 120.242 -1.536 . . . . 0.0 113.631 152.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -60.05 -45.78 91.73 Favored 'General case' 0 C--O 1.283 2.863 0 CA-C-O 116.932 -1.508 . . . . 0.0 112.483 160.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.31 -34.45 67.86 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.89 153.78 41.08 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.967 1.365 . . . . 0.0 111.598 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.43 145.21 31.14 Favored 'General case' 0 C--O 1.259 1.581 0 C-N-CA 130.043 3.337 . . . . 0.0 113.792 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -65.49 4.37 0.56 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 p -85.74 142.51 36.99 Favored Pre-proline 0 CA--C 1.479 -1.761 0 C-N-CA 128.832 2.853 . . . . 0.0 109.934 -166.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -59.29 117.21 3.91 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 124.306 3.338 . . . . 0.0 109.845 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -68.17 52.86 0.07 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 126.385 1.874 . . . . 0.0 113.317 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.56 -24.35 67.48 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -171.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -74.14 -35.82 64.12 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.4 HG21 ' CD1' ' A' ' 112' ' ' TYR . 80.4 mt -67.72 -18.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 O-C-N 119.927 -1.733 . . . . 0.0 110.76 164.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.49 -11.7 65.97 Favored Glycine 0 CA--C 1.569 3.435 0 O-C-N 124.44 1.088 . . . . 0.0 115.738 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 24.7 p -130.5 -33.18 1.67 Allowed 'General case' 0 C--N 1.373 1.626 0 O-C-N 124.672 0.866 . . . . 0.0 111.441 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -66.2 142.05 57.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.642 1.564 . . . . 0.0 110.715 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -81.96 114.01 47.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 119.817 -1.802 . . . . 0.0 111.127 -149.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 -4.37 15.24 Favored 'Trans proline' 0 N--CA 1.425 -2.508 0 C-N-CA 124.069 3.179 . . . . 0.0 111.124 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.69 19.12 15.47 Favored 'General case' 0 C--O 1.193 -1.87 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -71.62 -54.95 8.75 Favored 'General case' 0 C--O 1.293 3.379 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.542 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.51 177.92 7.59 Favored 'General case' 0 CA--C 1.598 2.795 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.265 164.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.81 19.88 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 127.32 2.248 . . . . 0.0 107.206 170.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.24 136.55 58.0 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 113.973 -2.917 . . . . 0.0 117.775 169.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.5 mt -58.53 121.4 6.05 Favored 'Isoleucine or valine' 0 C--N 1.381 1.958 0 O-C-N 128.882 3.864 . . . . 0.0 108.242 165.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.19 103.8 2.0 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 O-C-N 120.086 -1.634 . . . . 0.0 110.664 172.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.52 106.74 0.58 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.551 1.941 . . . . 0.0 111.209 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -119.6 160.3 22.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-O 122.995 1.379 . . . . 0.0 109.773 156.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 83.7 mt -74.75 162.3 74.16 Favored Pre-proline 1 N--CA 1.54 4.042 0 C-N-CA 126.313 1.845 . . . . 0.0 110.528 163.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.27 164.39 10.73 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.182 1.921 . . . . 0.0 116.442 161.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 40.76 41.47 1.18 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 125.79 1.636 . . . . 0.0 113.472 -170.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.73 21.02 1.32 Allowed Glycine 0 CA--C 1.562 3.015 0 O-C-N 125.86 1.975 . . . . 0.0 117.076 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 84.9 m -58.17 131.72 51.4 Favored 'General case' 0 C--N 1.394 2.534 0 O-C-N 117.85 -3.147 . . . . 0.0 115.14 -165.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . 0.267 27.6 m -77.09 116.83 18.08 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 127.646 3.091 . . . . 0.0 114.161 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.36 154.63 83.0 Favored Pre-proline 0 CA--C 1.586 2.352 0 C-N-CA 130.804 3.642 . . . . 0.0 110.107 -169.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.96 149.44 7.98 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.673 2.249 . . . . 0.0 117.586 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.34 -16.66 62.45 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.319 1.448 . . . . 0.0 114.667 -163.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.18 -0.96 78.99 Favored Glycine 0 CA--C 1.572 3.621 0 CA-C-O 117.24 -1.867 . . . . 0.0 116.978 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -120.74 135.84 55.03 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.092 2.446 . . . . 0.0 111.368 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -83.89 154.3 23.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 127.266 2.854 . . . . 0.0 107.884 164.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . 0.292 . . -156.72 154.03 29.38 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 126.153 2.883 . . . . 0.0 112.649 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 . . . . . 0 N--CA 1.43 -1.427 0 CA-C-N 112.348 -2.206 . . . . 0.0 112.134 159.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 CA--C 1.574 2.508 0 CA-C-O 122.91 1.129 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -71.49 133.73 46.05 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.55 -18.34 45.26 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -171.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m 59.27 -43.95 0.07 Allowed 'General case' 0 CA--C 1.589 2.445 0 C-N-CA 129.603 3.161 . . . . 0.0 118.295 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 39.19 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.976 2.11 . . . . 0.0 114.725 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.464 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 47.6 t -85.46 139.13 31.75 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 125.655 1.582 . . . . 0.0 113.429 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -79.86 -9.27 59.65 Favored 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 125.362 1.465 . . . . 0.0 113.892 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -109.85 157.09 19.56 Favored 'General case' 0 CA--C 1.581 2.163 0 CA-C-O 124.294 1.997 . . . . 0.0 110.717 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 p -68.2 165.37 18.48 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -111.61 136.92 50.16 Favored 'General case' 0 C--O 1.259 1.586 0 O-C-N 119.566 -1.959 . . . . 0.0 109.736 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.9 mt -75.08 160.86 29.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 126.634 1.973 . . . . 0.0 110.781 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.5 m -126.31 139.29 53.42 Favored 'General case' 0 N--CA 1.493 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 110.652 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.62 141.1 55.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.766 2.426 . . . . 0.0 109.055 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -125.59 -34.19 2.69 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 161.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.01 -126.85 0.02 OUTLIER Glycine 0 C--N 1.305 -1.15 1 CA-C-O 127.99 4.106 . . . . 0.0 113.948 168.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -154.45 -28.01 0.12 Allowed 'General case' 0 C--N 1.292 -1.911 2 O-C-N 114.434 -5.156 . . . . 0.0 111.381 163.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.35 145.89 53.77 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.71 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -54.23 167.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 117.534 -3.229 . . . . 0.0 112.349 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.1 tp -74.26 64.72 1.12 Allowed 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 125.31 2.481 . . . . 0.0 114.362 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -75.55 140.29 42.63 Favored 'General case' 0 C--O 1.287 3.027 0 O-C-N 119.166 -2.209 . . . . 0.0 111.043 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -127.06 156.81 73.79 Favored Pre-proline 0 C--N 1.397 2.658 0 O-C-N 119.256 -2.152 . . . . 0.0 111.319 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -79.86 141.18 14.97 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 42.92 16.46 0.01 OUTLIER 'General case' 0 CA--C 1.584 2.262 0 O-C-N 126.3 2.25 . . . . 0.0 116.207 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.49 73.24 Favored Glycine 0 CA--C 1.557 2.68 1 C-N-CA 130.95 4.119 . . . . 0.0 116.359 -164.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -85.42 108.23 17.77 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 117.39 -1.291 . . . . 0.0 110.319 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.91 10.85 0.03 OUTLIER Glycine 1 CA--C 1.601 5.431 0 CA-C-O 114.655 -3.303 . . . . 0.0 117.46 -170.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.18 125.81 59.0 Favored Pre-proline 0 CA--C 1.587 2.387 0 CA-C-N 122.752 3.276 . . . . 0.0 113.482 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.22 153.18 24.4 Favored 'Trans proline' 0 N--CA 1.421 -2.739 0 C-N-CA 122.762 2.308 . . . . 0.0 111.806 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -70.84 146.0 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 O-C-N 128.407 3.567 . . . . 0.0 109.972 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -145.91 111.05 5.3 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 118.291 -0.861 . . . . 0.0 109.695 162.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -67.17 -15.69 63.86 Favored 'General case' 0 C--N 1.378 1.833 0 CA-C-N 123.099 2.681 . . . . 0.0 111.604 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -89.43 12.16 17.2 Favored 'General case' 0 CA--C 1.608 3.2 0 C-N-CA 128.761 2.824 . . . . 0.0 110.719 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -120.93 163.23 18.55 Favored 'General case' 0 C--O 1.256 1.412 0 O-C-N 125.147 1.529 . . . . 0.0 111.407 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.8 p -101.76 163.25 18.17 Favored Pre-proline 0 C--O 1.256 1.403 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -59.37 -26.18 81.03 Favored 'Trans proline' 0 CA--C 1.563 1.954 0 CA-C-N 122.666 1.988 . . . . 0.0 110.485 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.47 -30.65 63.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 120.711 1.596 . . . . 0.0 113.91 173.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -79.99 -16.32 55.43 Favored 'General case' 0 C--O 1.186 -2.272 0 C-N-CA 127.643 2.377 . . . . 0.0 115.292 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -73.41 61.8 0.69 Allowed 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 129.32 3.048 . . . . 0.0 116.05 -167.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.264 13.3 tt -153.53 138.27 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 127.953 3.283 . . . . 0.0 108.363 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.46 -152.73 11.31 Favored Glycine 0 CA--C 1.489 -1.555 0 O-C-N 116.887 -3.633 . . . . 0.0 114.796 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -149.96 138.37 20.59 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 127.136 2.174 . . . . 0.0 110.493 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -89.35 155.71 19.18 Favored 'General case' 0 C--N 1.286 -2.18 0 O-C-N 127.85 3.219 . . . . 0.0 109.75 159.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -145.39 148.94 33.89 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.554 -1.341 . . . . 0.0 108.677 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -86.95 -177.72 6.13 Favored 'General case' 0 CA--C 1.61 3.263 0 CA-C-N 121.827 2.103 . . . . 0.0 114.906 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 136.9 9.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 118.878 -2.389 . . . . 0.0 110.592 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.9 p -145.4 -17.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 113.814 -2.993 . . . . 0.0 113.724 -164.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 47.47 48.72 16.54 Favored 'General case' 0 CA--C 1.602 2.956 0 O-C-N 125.39 1.681 . . . . 0.0 111.603 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -105.65 -9.57 17.27 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 119.939 -1.726 . . . . 0.0 112.444 170.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 mp 70.85 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.27 2.173 0 C-N-CA 127.051 2.14 . . . . 0.0 110.76 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 . . . . . 0 CA--C 1.586 2.334 1 C-N-CA 133.205 4.602 . . . . 0.0 110.296 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.239 0.509 0 CA-C-O 118.218 -0.896 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.95 37.85 22.13 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 126.101 1.76 . . . . 0.0 112.986 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.76 169.6 18.0 Favored 'General case' 0 C--O 1.289 3.144 0 C-N-CA 125.578 1.551 . . . . 0.0 110.621 167.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . 0.278 52.6 m -62.32 145.5 94.05 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 123.29 1.519 . . . . 0.0 114.992 170.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.263 15.1 Cg_exo -42.67 155.96 0.1 Allowed 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 121.709 1.606 . . . . 0.0 113.247 164.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -121.4 159.4 26.25 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.601 2.361 . . . . 0.0 115.545 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -129.92 139.94 51.03 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 126.72 2.512 . . . . 0.0 115.631 161.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -121.36 154.19 36.77 Favored 'General case' 0 CA--C 1.592 2.593 0 C-N-CA 126.464 1.905 . . . . 0.0 109.957 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -111.19 141.18 45.04 Favored 'General case' 0 N--CA 1.535 3.801 0 CA-C-N 122.929 2.604 . . . . 0.0 113.906 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 51' ' ' SER . 8.2 m-85 -141.66 150.92 42.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 125.021 2.343 . . . . 0.0 110.063 170.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -87.59 156.01 19.7 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-N 114.085 -1.416 . . . . 0.0 113.207 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.3 tp -51.47 127.62 20.55 Favored 'General case' 0 C--O 1.271 2.23 0 C-N-CA 124.072 0.949 . . . . 0.0 112.961 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.56 73.83 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.6 p -142.59 -178.51 5.81 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 119.709 1.754 . . . . 0.0 109.616 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.38 -154.1 45.4 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -73.73 -43.08 0.67 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.325 2.017 . . . . 0.0 115.203 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.327 2.5 mm-40 -81.94 27.74 0.45 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 131.431 3.892 . . . . 0.0 110.481 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.76 -19.52 50.83 Favored 'General case' 0 C--O 1.159 -3.706 0 O-C-N 118.188 -2.82 . . . . 0.0 113.096 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.29 -34.5 54.65 Favored Glycine 0 C--O 1.253 1.337 0 O-C-N 124.752 1.282 . . . . 0.0 113.809 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 mt -65.36 139.29 97.34 Favored Pre-proline 0 CA--C 1.607 3.143 0 CA-C-N 120.772 2.286 . . . . 0.0 113.297 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -61.92 166.17 12.79 Favored 'Trans proline' 0 C--O 1.272 2.178 0 O-C-N 124.42 1.747 . . . . 0.0 113.983 155.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -65.09 123.43 19.49 Favored 'General case' 0 C--N 1.365 1.261 0 CA-C-N 110.27 -3.15 . . . . 0.0 116.6 170.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 20.22 62.86 Favored Glycine 0 CA--C 1.576 3.904 0 CA-C-O 124.128 1.96 . . . . 0.0 111.148 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.34 135.69 47.46 Favored 'General case' 0 C--O 1.25 1.094 0 O-C-N 117.534 -3.333 . . . . 0.0 108.793 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.73 11.94 1.5 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -161.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . 0.291 66.7 tttt -72.31 126.03 28.82 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 124.32 2.009 . . . . 0.0 111.238 -167.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -53.8 138.74 35.1 Favored 'General case' 0 C--O 1.271 2.226 0 O-C-N 117.588 -3.195 . . . . 0.0 108.038 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.15 -11.42 63.81 Favored Glycine 0 N--CA 1.502 3.076 0 CA-C-O 116.147 -2.474 . . . . 0.0 117.367 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -108.97 134.7 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.616 3.517 0 C-N-CA 130.618 3.567 . . . . 0.0 110.91 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.88 124.11 71.63 Favored 'Isoleucine or valine' 0 C--O 1.291 3.28 0 O-C-N 125.694 1.871 . . . . 0.0 109.323 171.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.68 134.8 33.59 Favored 'General case' 0 CA--C 1.587 2.396 0 CA-C-O 125.418 2.532 . . . . 0.0 111.516 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.28 141.42 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 O-C-N 119.323 -2.11 . . . . 0.0 111.152 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.96 170.96 14.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 p -131.79 157.62 43.39 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 113.492 -1.685 . . . . 0.0 114.893 158.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -72.0 -27.24 62.61 Favored 'General case' 0 C--N 1.365 1.28 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.95 -18.25 63.64 Favored Glycine 0 CA--C 1.565 3.189 0 C-N-CA 127.792 2.615 . . . . 0.0 118.143 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.22 147.32 53.19 Favored 'General case' 0 C--O 1.286 3.017 0 C-N-CA 127.152 2.181 . . . . 0.0 110.202 162.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.88 142.1 30.05 Favored 'General case' 0 C--O 1.285 2.94 0 CA-C-O 125.122 2.391 . . . . 0.0 108.024 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -48.03 -12.46 0.03 OUTLIER 'General case' 0 CA--C 1.6 2.867 0 CA-C-O 114.014 -2.898 . . . . 0.0 116.012 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -55.34 139.42 66.21 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 130.841 3.656 . . . . 0.0 114.025 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -64.28 140.25 69.76 Favored 'Trans proline' 0 N--CA 1.528 3.503 0 C-N-CA 122.831 2.354 . . . . 0.0 106.369 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -91.53 60.84 4.17 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -23.12 66.09 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.816 -165.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -61.81 -55.51 29.22 Favored 'General case' 0 CA--C 1.61 3.287 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 6.4 mt -60.81 -25.26 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.623 0 C-N-CA 116.781 -1.968 . . . . 0.0 111.567 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.51 -12.03 83.44 Favored Glycine 1 CA--C 1.587 4.567 0 C-N-CA 128.696 3.046 . . . . 0.0 116.695 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.6 p -126.88 -24.96 3.41 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.3 158.71 28.78 Favored 'General case' 0 C--O 1.266 1.931 0 O-C-N 117.153 -3.467 . . . . 0.0 106.511 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.5 118.43 47.42 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.835 -2.507 . . . . 0.0 112.432 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -73.4 -25.31 15.51 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.95 2.433 . . . . 0.0 115.93 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.32 -4.27 35.24 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 120.699 -1.25 . . . . 0.0 109.705 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.82 -28.92 70.19 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 121.407 1.912 . . . . 0.0 113.64 -165.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.57 159.93 29.55 Favored 'General case' 0 C--O 1.25 1.119 1 C-N-CA 131.99 4.116 . . . . 0.0 110.847 160.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -53.94 160.74 1.37 Allowed 'General case' 1 N--CA 1.54 4.029 0 C-N-CA 128.441 2.696 . . . . 0.0 111.996 172.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.35 130.97 49.28 Favored 'General case' 0 CA--C 1.584 2.283 0 O-C-N 118.276 -2.765 . . . . 0.0 112.546 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.81 126.77 32.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 124.215 1.959 . . . . 0.0 107.193 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.0 126.8 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.608 0 O-C-N 120.157 -1.589 . . . . 0.0 111.827 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.73 116.7 7.21 Favored 'General case' 0 CA--C 1.604 3.035 0 O-C-N 126.589 2.431 . . . . 0.0 114.373 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -141.23 152.9 44.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 116.304 -3.997 . . . . 0.0 111.399 164.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -113.81 155.26 45.4 Favored Pre-proline 0 C--N 1.256 -3.498 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.469 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -48.92 159.67 0.88 Allowed 'Trans proline' 0 C--O 1.272 2.222 1 C-N-CA 132.108 8.539 . . . . 0.0 120.656 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.323 24.4 mt-30 46.52 31.72 1.42 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.62 72.28 Favored Glycine 0 CA--C 1.55 2.243 0 O-C-N 116.568 -3.832 . . . . 0.0 112.009 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.5 m -63.52 122.39 16.17 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-O 116.192 -1.861 . . . . 0.0 110.248 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 81.5 m -58.77 134.3 56.72 Favored 'General case' 0 C--N 1.382 2.015 0 CA-C-O 115.578 -2.154 . . . . 0.0 113.286 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.62 152.89 32.78 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 125.476 3.762 . . . . 0.0 111.344 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -62.94 145.09 94.31 Favored 'Trans proline' 1 CA--C 1.62 4.777 0 C-N-CA 125.06 3.84 . . . . 0.0 112.801 -161.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -69.11 -18.87 64.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 117.763 -3.086 . . . . 0.0 116.459 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.73 -17.95 10.07 Favored Glycine 0 CA--C 1.542 1.753 0 O-C-N 118.302 -2.749 . . . . 0.0 114.773 164.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.8 145.04 48.0 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 121.359 2.579 . . . . 0.0 115.829 -165.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -87.16 142.48 27.88 Favored 'General case' 0 CA--C 1.604 3.022 0 C-N-CA 131.006 3.722 . . . . 0.0 107.071 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.43 170.04 16.47 Favored 'General case' 0 CA--C 1.576 1.97 0 O-C-N 125.589 1.805 . . . . 0.0 113.517 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.555 1.147 0 O-C-N 124.556 1.16 . . . . 0.0 112.837 169.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 N--CA 1.53 3.669 0 CA-C-O 114.172 -2.512 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -69.08 123.89 22.28 Favored 'General case' 0 CA--C 1.582 2.2 0 O-C-N 126.168 2.167 . . . . 0.0 110.51 161.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -80.7 -13.24 59.18 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 127.586 2.355 . . . . 0.0 114.869 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.3 m 57.24 -29.77 0.03 OUTLIER 'General case' 1 CA--C 1.644 4.561 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 171.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.326 . . -91.3 169.54 10.73 Favored 'General case' 0 C--O 1.188 -2.169 0 C-N-CA 127.011 2.125 . . . . 0.0 111.592 -174.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.1 t -84.81 130.4 34.68 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 128.325 2.65 . . . . 0.0 114.625 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -71.3 -15.01 62.39 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 127.627 2.371 . . . . 0.0 113.66 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.444 ' CD1' ' HB ' ' A' ' 157' ' ' ILE . 15.5 m-85 -118.02 173.26 6.88 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 127.378 2.271 . . . . 0.0 116.403 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p -61.27 153.01 27.55 Favored 'General case' 0 C--O 1.287 3.068 0 O-C-N 128.831 3.832 . . . . 0.0 110.851 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.59 154.43 19.95 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 129.766 3.227 . . . . 0.0 112.408 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.09 156.32 20.73 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.744 1.218 . . . . 0.0 108.711 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.4 m -139.46 121.9 16.12 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 131.486 3.914 . . . . 0.0 114.296 -168.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.262 4.5 tp-100 -77.42 142.32 39.3 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.244 1.497 . . . . 0.0 113.501 -167.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -135.77 -22.55 1.43 Allowed 'General case' 0 CA--C 1.601 2.93 0 CA-C-O 113.272 -3.251 . . . . 0.0 111.319 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.32 -130.92 0.61 Allowed Glycine 1 CA--C 1.61 6.012 0 O-C-N 126.47 2.356 . . . . 0.0 111.051 153.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -149.31 -20.93 0.29 Allowed 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 131.122 3.769 . . . . 0.0 113.053 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.94 147.84 48.32 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 124.893 1.371 . . . . 0.0 114.195 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.9 158.59 21.77 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.263 -2.148 . . . . 0.0 115.401 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.8 tp -75.36 51.52 0.56 Allowed 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 129.21 3.004 . . . . 0.0 111.818 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -76.44 139.26 40.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -129.7 88.01 50.8 Favored Pre-proline 0 CA--C 1.591 2.556 1 C-N-CA 132.611 4.365 . . . . 0.0 111.137 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.25 148.08 33.49 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.542 2.161 . . . . 0.0 115.978 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 45.34 20.68 0.05 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 131.119 3.768 . . . . 0.0 113.789 -165.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.7 22.25 69.8 Favored Glycine 0 N--CA 1.499 2.86 0 CA-C-O 116.351 -2.36 . . . . 0.0 108.43 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -84.08 106.37 15.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 128.091 2.877 . . . . 0.0 108.982 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.84 13.68 0.02 OUTLIER Glycine 0 CA--C 1.574 3.749 0 C-N-CA 128.702 3.049 . . . . 0.0 116.422 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.33 122.4 81.4 Favored Pre-proline 0 CA--C 1.56 1.351 0 O-C-N 117.96 -3.082 . . . . 0.0 112.537 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -75.16 177.36 8.71 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 121.69 1.593 . . . . 0.0 114.972 -168.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.99 129.89 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 112.378 -2.192 . . . . 0.0 111.016 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -167.38 104.4 0.53 Allowed 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 125.205 1.566 . . . . 0.0 114.312 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.9 m -70.06 -17.54 63.25 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-O 114.198 -2.81 . . . . 0.0 110.516 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -63.7 -11.96 30.43 Favored 'General case' 0 C--O 1.188 -2.136 0 CA-C-N 124.185 3.175 . . . . 0.0 112.536 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 p -125.37 136.88 53.9 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 126.994 2.118 . . . . 0.0 110.4 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 p -85.15 165.97 33.76 Favored Pre-proline 0 C--N 1.269 -2.935 0 C-N-CA 126.231 1.812 . . . . 0.0 112.328 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . 0.302 81.8 Cg_exo -52.87 -24.09 22.98 Favored 'Trans proline' 0 CA--C 1.574 2.521 1 C-N-CA 125.557 4.171 . . . . 0.0 115.684 168.388 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.05 -29.3 43.41 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 121.178 1.808 . . . . 0.0 112.636 171.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.75 -16.7 61.17 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -68.58 61.52 0.09 Allowed 'General case' 0 CA--C 1.595 2.697 0 C-N-CA 131.263 3.825 . . . . 0.0 110.367 -162.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 tt -156.05 138.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.906 0 C-N-CA 126.762 2.025 . . . . 0.0 113.383 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.4 -174.18 46.8 Favored Glycine 0 CA--C 1.557 2.68 0 O-C-N 119.829 -1.794 . . . . 0.0 114.13 -154.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -148.19 145.39 28.27 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 126.733 2.013 . . . . 0.0 112.21 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -92.63 137.15 32.62 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -126.74 139.78 52.87 Favored 'General case' 1 N--CA 1.548 4.457 0 C-N-CA 129.981 3.312 . . . . 0.0 112.555 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -71.51 166.96 20.69 Favored 'General case' 0 C--O 1.291 3.273 0 O-C-N 120.052 -1.655 . . . . 0.0 110.847 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.92 132.85 18.11 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 130.268 3.427 . . . . 0.0 108.182 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -140.8 -17.37 0.86 Allowed 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 130.018 3.327 . . . . 0.0 110.009 -163.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 47.58 60.92 3.19 Favored 'General case' 0 CA--C 1.589 2.447 0 O-C-N 125.909 2.005 . . . . 0.0 116.209 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -99.22 -23.69 15.12 Favored 'General case' 0 C--O 1.259 1.574 0 C-N-CA 129.201 3.0 . . . . 0.0 116.413 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 mp 60.18 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 CA-C-O 126.132 2.873 . . . . 0.0 111.805 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 . . . . . 0 N--CA 1.511 2.598 1 O-C-N 115.34 -4.6 . . . . 0.0 107.619 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt . . . . . 0 N--CA 1.508 2.437 0 CA-C-O 127.262 3.41 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 50.2 30.56 4.41 Favored 'General case' 0 C--N 1.39 2.328 0 O-C-N 117.745 -3.097 . . . . 0.0 117.888 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -122.07 170.37 9.91 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 126.72 2.512 . . . . 0.0 116.422 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.8 m -56.35 164.5 1.93 Allowed Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -49.5 164.03 0.38 Allowed 'Trans proline' 1 CA--C 1.622 4.91 1 C-N-CA 125.771 4.314 . . . . 0.0 112.178 166.48 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -141.78 168.57 19.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 110.851 -2.886 . . . . 0.0 109.028 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -140.66 149.87 42.8 Favored 'General case' 0 C--N 1.276 -2.601 0 O-C-N 118.926 -2.359 . . . . 0.0 108.925 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -130.63 162.8 28.57 Favored 'General case' 0 C--O 1.184 -2.361 0 C-N-CA 127.96 2.504 . . . . 0.0 108.217 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -119.87 145.27 46.83 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 128.919 2.888 . . . . 0.0 113.96 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -147.61 141.59 25.92 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 127.218 2.207 . . . . 0.0 110.712 -171.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -70.45 163.8 25.99 Favored 'General case' 0 CA--C 1.605 3.08 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.18 127.73 32.61 Favored 'General case' 0 CA--C 1.573 1.86 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.839 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.13 20.77 79.01 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 117.979 -2.058 . . . . 0.0 118.151 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.281 3.8 p -134.66 167.63 20.47 Favored 'General case' 0 C--O 1.263 1.775 0 C-N-CA 127.046 2.138 . . . . 0.0 111.539 -174.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.18 -156.36 37.84 Favored Glycine 1 CA--C 1.585 4.407 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.945 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -71.53 -43.16 1.49 Allowed 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 124.036 3.157 . . . . 0.0 114.151 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -82.8 31.96 0.42 Allowed 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 116.802 -1.571 . . . . 0.0 110.599 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.23 -24.86 66.68 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 122.682 2.492 . . . . 0.0 112.37 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.35 -36.73 70.67 Favored Glycine 1 CA--C 1.582 4.225 0 O-C-N 125.242 1.589 . . . . 0.0 116.314 167.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.93 124.78 89.72 Favored Pre-proline 0 CA--C 1.586 2.353 0 CA-C-O 116.509 -1.71 . . . . 0.0 109.971 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -63.05 166.73 13.71 Favored 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 125.237 3.958 . . . . 0.0 113.107 161.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -65.57 127.45 31.93 Favored 'General case' 0 CA--C 1.549 0.907 1 O-C-N 115.481 -4.512 . . . . 0.0 114.241 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.98 -2.63 79.83 Favored Glycine 0 CA--C 1.554 2.469 0 CA-C-N 113.081 -1.872 . . . . 0.0 116.825 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.51 129.83 42.4 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 116.936 -3.685 . . . . 0.0 110.541 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -82.46 25.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.372 -3.33 . . . . 0.0 117.634 -154.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.82 126.97 30.15 Favored 'General case' 0 CA--C 1.593 2.601 0 O-C-N 117.29 -3.381 . . . . 0.0 110.238 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.26 147.35 46.51 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 113.01 -1.904 . . . . 0.0 111.642 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.57 -18.59 54.64 Favored Glycine 1 N--CA 1.525 4.606 0 O-C-N 119.11 -2.243 . . . . 0.0 116.55 -163.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.65 119.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 129.496 3.118 . . . . 0.0 109.189 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.87 102.46 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.152 0 C-N-CA 127.752 2.421 . . . . 0.0 106.092 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -71.97 129.81 39.46 Favored 'General case' 0 CA--C 1.588 2.412 0 C-N-CA 125.736 1.615 . . . . 0.0 113.04 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.77 150.12 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 C-N-CA 126.872 2.069 . . . . 0.0 108.623 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.89 19.36 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.415 -173.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.1 p -122.32 155.32 36.22 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 115.84 -2.029 . . . . 0.0 112.5 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.22 -47.71 62.26 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 124.869 3.486 . . . . 0.0 111.515 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.24 -2.61 90.63 Favored Glycine 2 CA--C 1.599 5.341 0 C-N-CA 129.549 3.452 . . . . 0.0 117.061 -172.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.27 33.49 Favored 'General case' 0 CA--C 1.614 3.408 0 CA-C-N 119.487 1.643 . . . . 0.0 111.961 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.3 mt -88.98 146.61 24.77 Favored 'General case' 0 CA--C 1.596 2.747 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 160.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -90.0 29.79 1.16 Allowed 'General case' 0 CA--C 1.6 2.873 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.448 ' O ' ' HE2' ' A' ' 143' ' ' LYS . 25.6 p -72.06 148.52 91.7 Favored Pre-proline 0 N--CA 1.508 2.464 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.825 168.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.43 136.07 35.64 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-O 116.875 -1.385 . . . . 0.0 112.862 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 141' ' ' THR . 53.3 mmtt -88.55 52.15 2.36 Favored 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 128.649 2.78 . . . . 0.0 110.565 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.41 -20.11 0.64 Allowed 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -81.01 -44.17 18.5 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 119.133 -2.23 . . . . 0.0 110.432 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.251 9.3 mt -55.84 -32.33 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-O 116.665 -1.636 . . . . 0.0 113.674 158.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.72 -14.62 81.22 Favored Glycine 0 N--CA 1.514 3.863 0 O-C-N 127.867 3.229 . . . . 0.0 119.352 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.4 p -133.43 -25.79 1.69 Allowed 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -54.91 142.64 28.87 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 125.979 1.712 . . . . 0.0 110.085 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -77.95 101.97 0.82 Allowed Pre-proline 0 CA--C 1.497 -1.08 0 O-C-N 124.343 1.027 . . . . 0.0 110.969 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.38 -21.81 71.48 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 125.136 3.891 . . . . 0.0 116.038 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.79 -9.76 55.85 Favored 'General case' 0 C--O 1.276 2.499 0 C-N-CA 128.279 2.632 . . . . 0.0 112.444 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -59.22 -27.09 65.42 Favored 'General case' 0 CA--C 1.568 1.662 1 N-CA-C 122.638 4.31 . . . . 0.0 122.638 166.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.04 157.76 45.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 118.699 -2.501 . . . . 0.0 114.441 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -32.53 150.34 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.733 1 C-N-CA 131.757 4.023 . . . . 0.0 111.69 160.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.5 137.29 50.1 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 125.563 2.601 . . . . 0.0 114.546 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.444 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 7.3 mt -73.14 129.02 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 118.746 -2.471 . . . . 0.0 111.58 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.15 116.26 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 126.866 2.604 . . . . 0.0 113.165 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.9 tt -88.04 119.48 28.46 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 124.27 1.028 . . . . 0.0 110.175 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.21 151.73 12.12 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 126.669 1.988 . . . . 0.0 105.869 -157.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.2 mt -110.44 145.35 32.05 Favored Pre-proline 0 CA--C 1.564 1.517 0 O-C-N 124.136 0.897 . . . . 0.0 112.666 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.56 167.07 13.97 Favored 'Trans proline' 1 CA--C 1.605 4.056 0 C-N-CA 121.961 1.774 . . . . 0.0 110.155 170.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 53.89 25.91 5.73 Favored 'General case' 0 N--CA 1.531 3.582 0 O-C-N 127.132 2.77 . . . . 0.0 111.874 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.88 29.56 6.34 Favored Glycine 1 N--CA 1.516 4.004 0 O-C-N 127.187 2.805 . . . . 0.0 111.272 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.2 m -58.99 141.99 52.36 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 122.36 3.08 . . . . 0.0 110.459 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m -106.07 119.53 39.46 Favored 'General case' 0 CA--C 1.587 2.395 0 O-C-N 119.596 -1.94 . . . . 0.0 108.75 -162.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.94 145.72 62.74 Favored Pre-proline 0 N--CA 1.389 -3.493 0 O-C-N 118.491 -2.63 . . . . 0.0 114.756 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -50.13 123.73 11.51 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 121.944 3.786 . . . . 0.0 121.944 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -50.13 -30.69 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 126.071 2.107 . . . . 0.0 116.569 -172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.4 -32.5 84.37 Favored Glycine 0 C--O 1.195 -2.296 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 171.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -91.48 127.92 37.11 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-N 118.323 1.062 . . . . 0.0 109.354 171.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -65.06 152.11 44.33 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 155.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -169.67 146.82 3.36 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 124.894 2.283 . . . . 0.0 107.687 -168.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.057 2.143 . . . . 0.0 112.814 -178.365 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 N--CA 1.503 2.08 0 CA-C-O 121.655 0.606 . . . . 0.0 112.14 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -67.68 100.98 0.96 Allowed 'General case' 0 CA--C 1.588 2.408 0 C-N-CA 130.706 3.602 . . . . 0.0 110.249 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.279 34.4 p30 -54.6 -22.5 13.57 Favored 'General case' 0 CA--C 1.591 2.546 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.1 m 64.84 -47.09 0.34 Allowed 'General case' 0 N--CA 1.517 2.892 0 C-N-CA 126.823 2.049 . . . . 0.0 114.495 165.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.26 143.47 52.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 128.08 3.8 . . . . 0.0 111.109 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.3 t -81.65 135.29 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 109.897 -3.319 . . . . 0.0 115.18 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -77.96 -3.21 40.78 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.004 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.23 147.48 51.07 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 129.013 2.925 . . . . 0.0 115.102 -163.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.261 79.8 p -61.21 135.86 57.87 Favored 'General case' 0 C--O 1.185 -2.293 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.256 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.77 129.91 34.7 Favored 'General case' 0 CA--C 1.613 3.385 0 CA-C-O 113.974 -2.917 . . . . 0.0 111.493 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.1 175.75 1.97 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 125.263 1.602 . . . . 0.0 109.671 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -146.79 128.2 14.94 Favored 'General case' 0 C--N 1.309 -1.19 1 O-C-N 114.03 -5.419 . . . . 0.0 106.616 170.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -61.27 121.54 12.83 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 125.716 1.607 . . . . 0.0 112.523 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -100.31 -54.66 2.81 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.02 -126.89 0.1 OUTLIER Glycine 0 C--N 1.37 2.419 0 O-C-N 124.764 1.29 . . . . 0.0 116.131 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -144.38 -28.79 0.49 Allowed 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.836 3.207 . . . . 0.0 112.555 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -72.28 131.43 42.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 130.976 3.71 . . . . 0.0 111.721 -171.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.92 160.94 5.36 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 123.85 1.786 . . . . 0.0 110.939 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -65.69 42.91 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 126.309 1.844 . . . . 0.0 113.506 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -61.51 137.58 58.25 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 121.473 1.942 . . . . 0.0 111.386 -164.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.11 107.47 17.91 Favored Pre-proline 0 CA--C 1.562 1.406 0 O-C-N 117.996 -2.94 . . . . 0.0 112.623 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . 0.268 14.9 Cg_exo -57.7 144.62 92.67 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.671 2.247 . . . . 0.0 113.284 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 40.83 37.03 0.46 Allowed 'General case' 0 N--CA 1.516 2.865 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.05 15.44 5.15 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 127.006 2.691 . . . . 0.0 119.086 -168.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -71.54 109.42 5.48 Favored 'General case' 0 N--CA 1.415 -2.188 1 CA-C-N 125.013 4.406 . . . . 0.0 114.287 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.11 34.96 0.03 OUTLIER Glycine 0 CA--C 1.54 1.615 1 O-C-N 113.725 -5.609 . . . . 0.0 116.877 167.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.0 t -70.99 133.75 85.88 Favored Pre-proline 0 CA--C 1.614 3.427 1 CA-C-N 124.559 4.18 . . . . 0.0 115.159 169.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.22 164.09 36.69 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.499 2.133 . . . . 0.0 116.256 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.68 151.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.18 0 O-C-N 125.903 2.002 . . . . 0.0 111.724 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -166.69 106.2 0.62 Allowed 'General case' 0 N--CA 1.529 3.524 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.017 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -60.66 -28.55 68.68 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -80.3 18.57 0.87 Allowed 'General case' 0 CA--C 1.589 2.45 0 C-N-CA 127.606 2.362 . . . . 0.0 114.377 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 87.6 p -141.51 143.89 34.04 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 127.298 2.239 . . . . 0.0 106.262 -171.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 p -72.39 158.19 87.89 Favored Pre-proline 0 CA--C 1.599 2.837 0 CA-C-N 120.974 1.715 . . . . 0.0 108.49 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.69 -28.24 65.2 Favored 'Trans proline' 0 N--CA 1.524 3.302 0 C-N-CA 124.985 3.79 . . . . 0.0 116.181 167.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.21 -18.38 62.47 Favored 'General case' 0 C--O 1.178 -2.668 0 C-N-CA 126.36 1.864 . . . . 0.0 110.994 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.447 ' HA ' ' HE3' ' A' ' 143' ' ' LYS 0.286 65.4 m-20 -73.86 -21.74 60.0 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 124.409 1.083 . . . . 0.0 111.807 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -79.66 60.55 3.38 Favored 'General case' 0 CA--C 1.599 2.831 0 O-C-N 125.23 1.581 . . . . 0.0 110.972 -153.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.03 139.24 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 126.544 1.938 . . . . 0.0 108.736 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.84 -167.24 40.25 Favored Glycine 0 N--CA 1.493 2.493 1 CA-C-O 127.831 4.017 . . . . 0.0 110.621 -163.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.422 ' HB3' ' CE3' ' A' ' 132' ' ' TRP . 9.5 p90 -144.04 138.82 28.6 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 111.113 -2.543 . . . . 0.0 113.524 -170.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.45 145.52 27.4 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.343 1.068 . . . . 0.0 111.21 153.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -136.95 127.97 27.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 120.1 3.37 . . . . 0.0 120.1 170.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.404 HH22 ' CG ' ' A' ' 128' ' ' ASP . 11.4 ptt180 -50.34 161.06 0.33 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 129.47 3.108 . . . . 0.0 113.204 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.67 143.28 19.58 Favored 'General case' 0 C--N 1.394 2.525 0 O-C-N 117.426 -3.296 . . . . 0.0 113.89 169.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -145.75 -16.35 0.47 Allowed 'General case' 0 N--CA 1.535 3.822 0 C-N-CA 129.122 2.969 . . . . 0.0 112.433 -166.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 46.19 26.72 0.47 Allowed 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -69.78 -14.0 62.56 Favored 'General case' 0 C--O 1.169 -3.134 0 C-N-CA 129.709 3.204 . . . . 0.0 113.141 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.8 mt 70.52 144.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 C-N-CA 129.045 2.938 . . . . 0.0 110.509 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 . . . . . 1 N--CA 1.558 4.949 0 C-N-CA 128.173 2.589 . . . . 0.0 110.615 166.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt . . . . . 0 CA--C 1.566 1.561 0 CA-C-O 115.719 -2.086 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.34 0.3 OUTLIER 70.26 38.0 1.51 Allowed 'General case' 0 C--N 1.371 1.526 0 N-CA-C 118.798 2.888 . . . . 0.0 118.798 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.76 164.41 11.8 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.472 -1.392 . . . . 0.0 107.734 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.1 m -44.67 138.77 3.84 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 168.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.39 162.6 1.33 Allowed 'Trans proline' 0 C--O 1.303 3.728 0 C-N-CA 123.582 2.855 . . . . 0.0 114.222 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -135.05 163.1 30.65 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 128.676 2.791 . . . . 0.0 111.942 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -134.24 139.07 45.52 Favored 'General case' 0 C--O 1.272 2.255 0 O-C-N 117.842 -3.036 . . . . 0.0 108.747 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.55 150.15 41.32 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 126.778 2.031 . . . . 0.0 113.595 173.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -102.49 149.46 24.37 Favored 'General case' 0 C--N 1.364 1.228 0 O-C-N 119.686 -1.884 . . . . 0.0 111.889 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -153.01 147.3 25.74 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 118.823 -2.423 . . . . 0.0 110.945 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -65.51 160.35 22.49 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 127.171 3.367 . . . . 0.0 112.373 170.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.02 123.87 18.04 Favored 'General case' 0 N--CA 1.504 2.248 1 O-C-N 114.951 -4.843 . . . . 0.0 110.674 172.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.1 79.14 Favored Glycine 0 C--O 1.194 -2.387 0 C-N-CA 128.024 2.726 . . . . 0.0 115.853 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.2 p -131.78 160.16 36.37 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 129.325 3.603 . . . . 0.0 109.736 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.42 -167.3 53.97 Favored Glycine 0 CA--C 1.566 3.231 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.33 -38.79 34.75 Favored 'Trans proline' 0 CA--C 1.545 1.075 1 C-N-CA 127.595 5.53 . . . . 0.0 113.089 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -106.56 19.55 20.33 Favored 'General case' 0 C--O 1.276 2.45 0 O-C-N 118.398 -2.689 . . . . 0.0 112.425 -167.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.83 -17.79 2.71 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 116.962 -3.586 . . . . 0.0 115.332 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.77 -20.97 77.59 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 120.782 3.073 . . . . 0.0 120.782 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.55 151.69 68.86 Favored Pre-proline 0 C--O 1.181 -2.511 0 C-N-CA 129.225 3.01 . . . . 0.0 112.72 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -85.31 155.02 10.84 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 CA-C-O 124.569 1.82 . . . . 0.0 108.605 162.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -48.54 136.81 12.52 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 111.945 -2.389 . . . . 0.0 115.889 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.65 5.61 9.38 Favored Glycine 0 CA--C 1.568 3.351 0 C-N-CA 130.691 3.996 . . . . 0.0 118.877 -173.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -43.18 112.4 0.37 Allowed 'General case' 0 C--N 1.416 3.459 0 O-C-N 121.241 -1.152 . . . . 0.0 113.102 162.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -82.06 35.07 0.42 Allowed 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -157.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -71.07 142.92 50.83 Favored 'General case' 0 C--O 1.276 2.482 0 CA-C-N 113.298 -1.774 . . . . 0.0 115.092 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.404 ' CG ' HH22 ' A' ' 89' ' ' ARG . 18.9 t0 -63.28 134.15 55.36 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 127.332 2.253 . . . . 0.0 112.723 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.68 -1.31 88.94 Favored Glycine 0 C--N 1.302 -1.327 0 N-CA-C 119.492 2.557 . . . . 0.0 119.492 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.64 137.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 123.32 3.56 . . . . 0.0 114.518 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.52 116.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 86' ' ' TYR . 83.3 m95 -87.66 138.52 31.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.734 1.73 . . . . 0.0 113.172 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.23 139.96 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 O-C-N 120.577 -1.327 . . . . 0.0 114.166 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -156.18 152.72 28.2 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 115.692 -2.099 . . . . 0.0 116.139 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.3 p -101.51 142.82 32.32 Favored 'General case' 0 C--O 1.28 2.686 0 C-N-CA 125.537 1.535 . . . . 0.0 110.85 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.88 -25.62 68.24 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.439 -2.038 . . . . 0.0 113.709 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.77 -31.12 30.27 Favored Glycine 0 N--CA 1.512 3.701 1 O-C-N 115.813 -4.305 . . . . 0.0 119.638 161.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.89 151.03 27.47 Favored 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 127.729 2.411 . . . . 0.0 111.346 -170.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.16 148.98 22.14 Favored 'General case' 0 CA--C 1.59 2.518 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -61.87 -18.2 59.27 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 114.973 -2.441 . . . . 0.0 114.361 -166.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.4 p -66.56 146.16 99.03 Favored Pre-proline 0 C--O 1.261 1.701 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.48 132.5 27.42 Favored 'Trans proline' 0 CA--C 1.584 2.995 0 CA-C-N 122.992 2.104 . . . . 0.0 110.995 165.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 57.6 mmtt -80.75 54.6 2.17 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.982 1.713 . . . . 0.0 112.637 -168.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.73 -18.76 56.53 Favored 'General case' 0 N--CA 1.53 3.526 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -58.02 -59.8 4.72 Favored 'General case' 0 C--N 1.377 1.785 0 O-C-N 117.394 -3.316 . . . . 0.0 114.638 160.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.4 -19.26 24.66 Favored 'Isoleucine or valine' 0 C--N 1.364 1.207 0 O-C-N 123.996 0.81 . . . . 0.0 112.562 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.19 -0.75 84.86 Favored Glycine 0 N--CA 1.497 2.717 1 CA-C-O 112.843 -4.309 . . . . 0.0 117.634 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.0 p -131.3 -18.55 2.87 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 122.571 3.186 . . . . 0.0 118.396 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -64.74 -176.32 0.25 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.372 0.987 . . . . 0.0 112.608 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -92.89 113.89 61.06 Favored Pre-proline 0 C--N 1.382 1.995 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.856 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -81.3 4.77 6.73 Favored 'Trans proline' 0 C--N 1.385 2.482 0 O-C-N 123.15 1.079 . . . . 0.0 113.908 -170.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.83 19.46 2.49 Favored 'General case' 0 CA--C 1.6 2.882 0 O-C-N 127.367 2.917 . . . . 0.0 113.286 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.15 -38.62 35.52 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 126.447 1.899 . . . . 0.0 107.93 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.1 152.83 24.0 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.295 -1.321 . . . . 0.0 114.416 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.92 140.93 56.49 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 125.549 1.539 . . . . 0.0 113.816 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.3 152.28 29.64 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 125.013 2.339 . . . . 0.0 115.568 -166.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.42 127.6 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.1 t -52.83 106.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.183 -2.399 0 O-C-N 118.634 -2.542 . . . . 0.0 112.574 151.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.99 118.51 9.87 Favored 'General case' 0 C--N 1.362 1.112 0 O-C-N 128.365 3.541 . . . . 0.0 116.376 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -146.56 164.06 33.8 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.018 1.727 . . . . 0.0 107.035 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.06 160.56 30.56 Favored Pre-proline 0 N--CA 1.505 2.291 0 C-N-CA 126.83 2.052 . . . . 0.0 112.478 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -68.37 166.08 26.68 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 118.1 2.308 . . . . 0.0 118.1 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 54.74 31.72 15.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.019 1.728 . . . . 0.0 112.053 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.01 10.86 78.48 Favored Glycine 1 C--N 1.401 4.191 0 CA-C-O 118.996 -0.891 . . . . 0.0 112.381 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.6 m -57.37 119.88 7.23 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 128.478 2.711 . . . . 0.0 109.52 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -81.47 142.43 32.94 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.412 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.93 171.62 2.35 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 128.913 2.885 . . . . 0.0 111.105 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.84 147.15 96.18 Favored 'Trans proline' 0 C--N 1.384 2.418 0 CA-C-O 113.849 -2.646 . . . . 0.0 115.526 172.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -72.36 -16.22 61.86 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 128.757 3.786 . . . . 0.0 114.933 158.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.49 -14.55 9.39 Favored Glycine 0 C--N 1.358 1.786 0 CA-C-O 117.518 -1.712 . . . . 0.0 115.804 160.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -136.97 108.08 6.76 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.084 1.942 . . . . 0.0 111.381 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -59.46 144.61 46.6 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.89 1.805 . . . . 0.0 114.241 164.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.05 175.63 11.56 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 128.483 3.992 . . . . 0.0 112.635 -167.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.408 -2.549 0 O-C-N 117.386 -3.321 . . . . 0.0 110.129 158.248 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.526 3.394 0 CA-C-O 123.319 1.299 . . . . 0.0 115.378 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.63 129.24 39.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 116.974 -1.488 . . . . 0.0 110.828 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -82.87 -15.74 50.3 Favored 'General case' 0 CA--C 1.604 3.029 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m 63.24 -52.8 0.2 Allowed 'General case' 0 C--O 1.251 1.139 0 C-N-CA 128.079 2.552 . . . . 0.0 113.619 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.0 170.29 3.67 Favored 'General case' 0 CA--C 1.592 2.588 0 CA-C-N 123.52 2.873 . . . . 0.0 111.469 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.3 t -77.55 144.55 37.52 Favored 'General case' 0 CA--C 1.58 2.105 0 CA-C-O 113.577 -3.106 . . . . 0.0 113.515 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -95.15 -4.41 46.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 125.76 3.891 . . . . 0.0 113.296 172.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -120.93 164.64 16.39 Favored 'General case' 0 N--CA 1.513 2.689 0 O-C-N 119.069 -2.27 . . . . 0.0 109.34 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.9 p -56.43 146.88 23.08 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 126.392 2.307 . . . . 0.0 110.244 157.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.04 162.56 24.28 Favored 'General case' 0 CA--C 1.567 1.61 0 O-C-N 116.308 -3.995 . . . . 0.0 112.914 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.37 107.32 18.16 Favored 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.028 2.131 . . . . 0.0 114.676 -153.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.4 m -65.2 118.74 9.68 Favored 'General case' 0 C--O 1.18 -2.57 0 O-C-N 126.554 2.409 . . . . 0.0 111.194 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -55.55 124.53 17.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 129.732 3.213 . . . . 0.0 115.627 165.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.19 -7.09 4.84 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 128.538 2.735 . . . . 0.0 111.885 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.43 -141.77 12.55 Favored Glycine 0 N--CA 1.507 3.411 0 O-C-N 120.024 -1.672 . . . . 0.0 112.801 165.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -137.61 -34.56 0.69 Allowed 'General case' 0 C--O 1.177 -2.712 0 O-C-N 116.68 -3.835 . . . . 0.0 110.041 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -58.27 138.0 56.68 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.72 2.408 . . . . 0.0 109.495 173.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -80.08 168.97 18.48 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 124.346 2.022 . . . . 0.0 111.309 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -72.62 61.88 0.53 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 118.677 -2.514 . . . . 0.0 112.281 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.43 149.26 36.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.549 -1.969 . . . . 0.0 114.032 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.08 91.65 23.42 Favored Pre-proline 0 CA--C 1.587 2.374 0 O-C-N 126.176 2.173 . . . . 0.0 110.479 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.09 148.17 18.28 Favored 'Trans proline' 0 C--O 1.195 -1.628 0 C-N-CA 123.697 2.931 . . . . 0.0 110.187 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 53.14 6.46 0.06 Allowed 'General case' 0 C--N 1.372 1.558 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.66 23.08 42.36 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 129.94 3.638 . . . . 0.0 113.589 -169.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -69.31 107.15 3.16 Favored 'General case' 0 CA--C 1.573 1.841 0 O-C-N 120.116 -1.814 . . . . 0.0 108.378 159.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.86 25.69 0.03 OUTLIER Glycine 0 C--N 1.385 3.277 0 C-N-CA 127.131 2.301 . . . . 0.0 113.626 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.49 123.25 78.95 Favored Pre-proline 0 C--N 1.374 1.674 1 O-C-N 114.518 -5.107 . . . . 0.0 110.775 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.63 173.47 12.19 Favored 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.84 2.36 . . . . 0.0 111.66 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -69.24 138.29 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 O-C-N 118.812 -2.43 . . . . 0.0 117.476 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.56 103.06 1.74 Allowed 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 116.938 -1.506 . . . . 0.0 111.144 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 m -71.95 -16.44 62.1 Favored 'General case' 0 CA--C 1.563 1.456 1 C-N-CA 133.009 4.524 . . . . 0.0 112.835 -175.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -83.84 17.08 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 115.139 -2.362 . . . . 0.0 113.137 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.8 p -146.79 176.7 9.67 Favored 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.291 22.0 p -130.18 -174.08 0.36 Allowed Pre-proline 0 C--N 1.289 -2.03 0 O-C-N 118.999 -2.313 . . . . 0.0 111.18 -166.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -73.25 -28.95 11.99 Favored 'Trans proline' 0 C--O 1.196 -1.585 0 CA-C-N 120.739 1.3 . . . . 0.0 113.428 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.45 -24.07 64.93 Favored 'General case' 0 CA--C 1.608 3.191 0 CA-C-O 123.141 1.448 . . . . 0.0 113.428 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.263 69.6 m-20 -92.12 -15.17 28.07 Favored 'General case' 0 C--O 1.187 -2.193 0 O-C-N 118.121 -2.862 . . . . 0.0 113.702 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -74.63 54.64 0.62 Allowed 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 118.144 2.646 . . . . 0.0 118.144 -169.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.07 148.3 17.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.4 -158.47 28.83 Favored Glycine 0 CA--C 1.543 1.82 0 O-C-N 118.558 -2.589 . . . . 0.0 111.585 -173.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -147.13 160.54 42.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.676 2.391 . . . . 0.0 116.981 -172.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -104.52 155.24 18.99 Favored 'General case' 0 CA--C 1.585 2.317 0 C-N-CA 130.327 3.451 . . . . 0.0 110.841 160.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -145.38 146.95 31.77 Favored 'General case' 0 C--O 1.191 -2.02 0 O-C-N 125.804 1.94 . . . . 0.0 109.49 171.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -62.35 154.69 27.25 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.081 1.752 . . . . 0.0 115.595 171.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.18 124.24 30.23 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 129.019 2.928 . . . . 0.0 111.606 158.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -110.36 -18.76 13.18 Favored 'General case' 0 N--CA 1.514 2.736 0 C-N-CA 128.56 2.744 . . . . 0.0 114.811 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 48.0 41.89 15.74 Favored 'General case' 0 C--N 1.382 2.021 0 C-N-CA 124.417 1.087 . . . . 0.0 112.368 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -91.09 -26.38 19.17 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 131.646 3.978 . . . . 0.0 107.652 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.282 1.7 mp 68.05 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 O-C-N 128.319 3.512 . . . . 0.0 114.084 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 . . . . . 0 C--O 1.276 2.482 0 C-N-CA 127.754 2.421 . . . . 0.0 107.507 -179.258 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mttt . . . . . 0 N--CA 1.522 3.14 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 60.2 65.99 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.36 1.864 . . . . 0.0 107.22 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -115.49 157.95 23.28 Favored 'General case' 0 C--O 1.278 2.598 0 C-N-CA 127.79 2.436 . . . . 0.0 112.027 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 t -60.35 158.59 27.83 Favored Pre-proline 0 C--O 1.263 1.804 0 O-C-N 125.891 1.994 . . . . 0.0 114.589 163.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.38 159.2 45.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 123.387 2.724 . . . . 0.0 114.494 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -135.56 152.03 50.89 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -126.08 136.09 52.5 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.358 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.81 130.94 53.49 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 127.763 3.165 . . . . 0.0 112.174 -164.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -102.36 147.18 27.02 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -145.57 153.06 40.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 127.42 2.95 . . . . 0.0 114.639 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -89.26 166.95 13.46 Favored 'General case' 0 CA--C 1.617 3.52 1 CA-C-N 126.64 4.291 . . . . 0.0 112.697 170.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -54.99 123.49 13.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.002 -1.454 . . . . 0.0 113.31 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.09 25.44 68.91 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 126.354 2.284 . . . . 0.0 111.558 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.6 p -132.56 169.39 16.68 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 118.757 -2.614 . . . . 0.0 107.049 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.06 -168.8 49.27 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 112.357 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.5 -26.12 12.29 Favored 'Trans proline' 0 N--CA 1.437 -1.848 1 C-N-CA 127.428 5.419 . . . . 0.0 112.675 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -101.04 31.99 3.4 Favored 'General case' 1 N--CA 1.561 5.117 0 C-N-CA 127.436 2.294 . . . . 0.0 109.47 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.28 -22.91 33.17 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.73 79.18 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.408 1.956 . . . . 0.0 115.281 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.59 125.96 81.62 Favored Pre-proline 0 CA--C 1.499 -1.007 0 CA-C-O 114.663 -2.589 . . . . 0.0 111.005 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 176.69 4.86 Favored 'Trans proline' 0 C--O 1.193 -1.755 0 CA-C-N 124.135 2.512 . . . . 0.0 109.367 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.97 137.17 55.94 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 125.051 1.34 . . . . 0.0 112.172 173.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.08 5.26 65.21 Favored Glycine 0 C--N 1.379 2.918 0 CA-C-O 125.028 2.46 . . . . 0.0 117.56 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.77 47.28 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 117.391 -3.417 . . . . 0.0 111.647 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -74.32 107.37 6.44 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 111.44 -2.618 . . . . 0.0 110.897 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -136.81 124.06 21.84 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.219 1.007 . . . . 0.0 110.175 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.26 107.76 0.7 Allowed 'General case' 0 CA--C 1.596 2.735 0 C-N-CA 128.108 2.563 . . . . 0.0 109.686 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.52 26.78 Favored Glycine 0 N--CA 1.503 3.123 0 C-N-CA 128.581 2.991 . . . . 0.0 111.175 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.25 119.03 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 124.184 0.994 . . . . 0.0 108.893 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.2 mm -101.39 120.54 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-O 124.261 1.981 . . . . 0.0 115.491 164.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -80.76 136.68 36.18 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 116.305 -3.997 . . . . 0.0 118.152 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -139.54 128.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.262 1.743 0 CA-C-N 123.813 3.006 . . . . 0.0 113.425 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.3 23.21 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 128.038 2.535 . . . . 0.0 109.54 -166.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.1 p -137.3 153.38 50.3 Favored 'General case' 0 C--O 1.277 2.504 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.42 -28.55 65.15 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 118.672 -2.517 . . . . 0.0 111.225 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.58 -0.28 89.86 Favored Glycine 1 N--CA 1.517 4.041 0 C-N-CA 128.412 2.911 . . . . 0.0 112.852 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.47 156.03 24.29 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 120.356 2.078 . . . . 0.0 109.009 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.3 mt -95.41 144.1 26.21 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 124.49 2.091 . . . . 0.0 109.054 167.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . 0.328 1.4 p-10 -75.73 26.9 0.11 Allowed 'General case' 0 C--N 1.389 2.283 0 O-C-N 117.934 -2.979 . . . . 0.0 113.601 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.0 p -91.62 158.92 39.66 Favored Pre-proline 0 CA--C 1.554 1.134 0 O-C-N 117.511 -3.243 . . . . 0.0 104.088 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -80.21 142.55 15.22 Favored 'Trans proline' 0 C--N 1.37 1.683 0 N-CA-C 105.087 -2.697 . . . . 0.0 105.087 173.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -88.19 74.64 8.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 117.0 -3.563 . . . . 0.0 107.419 -174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.12 -39.31 92.12 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 122.464 2.393 . . . . 0.0 114.436 -166.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -64.78 -59.32 4.36 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.2 mt -61.11 -23.93 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.088 0 C-N-CA 127.852 2.461 . . . . 0.0 115.633 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.57 -2.74 89.99 Favored Glycine 0 C--O 1.255 1.43 0 N-CA-C 120.163 2.825 . . . . 0.0 120.163 164.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.8 p -130.66 -35.18 1.49 Allowed 'General case' 0 C--O 1.179 -2.641 0 CA-C-N 122.803 3.301 . . . . 0.0 111.504 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -69.03 147.6 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 118.729 -2.482 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -44.21 121.15 3.89 Favored Pre-proline 1 N--CA 1.545 4.297 0 CA-C-O 115.197 -2.335 . . . . 0.0 111.562 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.56 -14.88 5.36 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 123.905 3.07 . . . . 0.0 116.504 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.22 9.8 9.88 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -163.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -69.31 -14.88 63.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 118.577 -2.577 . . . . 0.0 115.504 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.47 171.87 10.68 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 124.915 1.384 . . . . 0.0 108.367 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.13 143.85 5.53 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 118.279 -2.763 . . . . 0.0 114.191 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.51 109.11 1.85 Allowed 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 127.257 2.223 . . . . 0.0 110.529 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.67 132.23 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 128.137 2.575 . . . . 0.0 107.562 -160.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.51 97.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.7 114.79 12.37 Favored 'General case' 0 C--O 1.255 1.389 0 O-C-N 121.118 -0.989 . . . . 0.0 109.086 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -147.63 146.15 29.24 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 128.528 2.731 . . . . 0.0 107.56 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.16 153.01 53.82 Favored Pre-proline 0 CA--C 1.592 2.592 0 O-C-N 118.827 -2.421 . . . . 0.0 113.186 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -43.33 160.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.392 2.819 0 N-CA-C 119.029 2.665 . . . . 0.0 119.029 161.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 56.15 18.32 3.18 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 127.073 2.149 . . . . 0.0 109.733 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.21 19.35 70.19 Favored Glycine 0 C--O 1.187 -2.804 0 CA-C-N 119.764 1.165 . . . . 0.0 113.037 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.5 m -65.27 123.83 20.6 Favored 'General case' 0 C--O 1.262 1.729 0 CA-C-N 118.9 1.35 . . . . 0.0 108.005 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.6 m -74.86 138.26 42.36 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 124.463 2.078 . . . . 0.0 108.058 -165.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.5 mt -66.16 154.15 90.6 Favored Pre-proline 1 N--CA 1.553 4.716 1 CA-C-O 111.205 -4.236 . . . . 0.0 110.314 170.799 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -55.41 137.02 76.35 Favored 'Trans proline' 0 CA--C 1.559 1.752 1 C-N-CA 129.05 6.5 . . . . 0.0 113.718 -172.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -75.66 -16.64 60.17 Favored 'General case' 0 N--CA 1.481 1.117 1 O-C-N 115.67 -4.394 . . . . 0.0 112.688 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.46 -9.65 13.41 Favored Glycine 0 N--CA 1.512 3.701 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 166.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -119.39 157.54 27.97 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.141 2.97 . . . . 0.0 111.376 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -104.51 136.31 44.31 Favored 'General case' 0 CA--C 1.605 3.077 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.264 165.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.29 -173.17 4.3 Favored 'General case' 0 C--N 1.384 2.108 0 C-N-CA 127.964 2.506 . . . . 0.0 111.106 -158.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.519 3.021 0 C-N-CA 126.542 1.937 . . . . 0.0 109.891 158.542 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 N--CA 1.512 2.57 0 N-CA-C 118.439 2.438 . . . . 0.0 118.439 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.64 111.56 2.13 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 127.247 3.403 . . . . 0.0 109.553 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -58.81 -11.8 3.64 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 118.804 -2.435 . . . . 0.0 110.758 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m 46.22 -50.22 0.0 OUTLIER 'General case' 0 C--N 1.364 1.23 1 C-N-CA 133.036 4.534 . . . . 0.0 119.942 -170.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.18 154.24 23.87 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 131.808 4.043 . . . . 0.0 112.052 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.0 t -82.5 137.57 34.58 Favored 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 127.385 2.274 . . . . 0.0 115.64 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -76.13 -21.05 57.05 Favored 'General case' 0 CA--C 1.615 3.461 0 CA-C-O 122.797 1.284 . . . . 0.0 110.56 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -88.29 173.01 9.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 118.389 -2.695 . . . . 0.0 113.952 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p -71.98 172.23 10.38 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 119.25 -2.156 . . . . 0.0 110.84 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . 0.309 . . -117.18 132.73 56.58 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 119.666 -1.896 . . . . 0.0 114.764 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.7 mt -70.25 163.42 26.51 Favored 'General case' 0 N--CA 1.513 2.677 0 C-N-CA 129.74 3.216 . . . . 0.0 111.643 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.9 m -128.15 131.12 48.95 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 168.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -66.92 149.95 49.89 Favored 'General case' 0 CA--C 1.6 2.893 0 C-N-CA 124.259 1.024 . . . . 0.0 112.083 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -151.53 -19.81 0.2 Allowed 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.611 -1.931 . . . . 0.0 113.43 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.94 -125.65 0.83 Allowed Glycine 0 CA--C 1.548 2.153 0 C-N-CA 128.107 2.765 . . . . 0.0 113.748 160.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -156.68 -22.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -69.32 139.68 54.3 Favored 'General case' 0 C--O 1.279 2.654 0 C-N-CA 126.272 1.829 . . . . 0.0 115.638 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.77 164.72 9.51 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 128.507 2.723 . . . . 0.0 115.816 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.8 tp -82.7 52.34 2.09 Favored 'General case' 0 CA--C 1.569 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 113.823 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -55.23 138.47 44.93 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 118.984 -2.323 . . . . 0.0 109.604 -171.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 50.5 m-85 -128.47 129.29 23.57 Favored Pre-proline 0 C--O 1.187 -2.221 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -84.11 137.75 7.48 Favored 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.315 4.01 . . . . 0.0 109.477 -170.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 45.81 23.82 0.18 Allowed 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.88 7.38 65.9 Favored Glycine 0 CA--C 1.567 3.325 0 CA-C-O 117.242 -1.865 . . . . 0.0 112.044 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -65.42 72.37 0.05 OUTLIER 'General case' 0 C--O 1.19 -2.052 0 CA-C-N 119.847 1.824 . . . . 0.0 111.892 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.16 33.96 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.206 0 CA-C-N 122.968 2.622 . . . . 0.0 119.398 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -74.43 119.36 76.14 Favored Pre-proline 0 C--O 1.257 1.453 0 O-C-N 118.708 -2.642 . . . . 0.0 110.593 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.51 161.49 20.56 Favored 'Trans proline' 0 CA--C 1.601 3.835 0 N-CA-C 119.035 2.667 . . . . 0.0 119.035 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.19 131.17 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 O-C-N 126.139 2.149 . . . . 0.0 108.922 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -165.12 91.96 0.55 Allowed 'General case' 0 N--CA 1.536 3.84 0 C-N-CA 128.65 2.78 . . . . 0.0 106.031 172.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -67.61 -21.22 65.41 Favored 'General case' 0 C--O 1.185 -2.315 0 CA-C-O 123.676 1.703 . . . . 0.0 113.607 -174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -55.41 -50.25 70.27 Favored 'General case' 0 N--CA 1.421 -1.889 1 O-C-N 115.342 -4.599 . . . . 0.0 114.897 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.2 p -58.36 153.86 14.72 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 119.069 2.988 . . . . 0.0 119.069 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.2 t -78.31 145.73 69.02 Favored Pre-proline 0 C--O 1.17 -3.128 0 O-C-N 125.241 1.588 . . . . 0.0 108.767 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.91 -34.72 16.86 Favored 'Trans proline' 0 CA--C 1.587 3.139 1 C-N-CA 125.755 4.303 . . . . 0.0 113.086 162.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.31 -38.77 92.45 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.646 1.178 . . . . 0.0 108.954 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.25 -19.66 66.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-O 116.201 -1.857 . . . . 0.0 114.629 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -84.62 81.18 8.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 123.523 2.874 . . . . 0.0 114.094 -151.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 tt -163.52 130.83 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.926 0 C-N-CA 126.999 2.12 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 -157.7 15.51 Favored Glycine 0 CA--C 1.557 2.702 0 CA-C-O 124.289 2.049 . . . . 0.0 115.902 -166.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -161.05 146.85 14.46 Favored 'General case' 0 C--O 1.284 2.897 0 CA-C-O 122.624 1.202 . . . . 0.0 112.547 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 4.2 m-85 -97.78 141.33 30.91 Favored 'General case' 0 C--O 1.171 -3.061 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.221 162.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -125.47 143.45 50.99 Favored 'General case' 0 C--O 1.202 -1.407 0 C-N-CA 125.668 1.587 . . . . 0.0 108.016 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.459 HH22 ' CG ' ' A' ' 128' ' ' ASP . 1.2 ptt180 -54.8 174.19 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 126.015 2.072 . . . . 0.0 116.348 163.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.29 139.59 13.38 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 115.181 -2.342 . . . . 0.0 108.999 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.5 p -127.11 -21.16 4.0 Favored 'General case' 0 C--O 1.262 1.747 0 C-N-CA 127.395 2.278 . . . . 0.0 113.297 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 46.01 49.14 12.28 Favored 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 125.512 1.525 . . . . 0.0 108.597 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -97.8 -9.71 26.04 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 127.248 2.219 . . . . 0.0 110.158 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.303 2.1 mp 64.57 157.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.592 2.59 0 O-C-N 120.398 -1.439 . . . . 0.0 114.478 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 . . . . . 0 C--N 1.301 -1.52 0 CA-C-O 122.914 1.34 . . . . 0.0 107.394 169.177 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.6 tttt . . . . . 0 C--O 1.205 -1.284 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 56.1 40.31 30.22 Favored 'General case' 0 CA--C 1.583 2.232 1 CA-C-O 129.032 4.253 . . . . 0.0 116.367 167.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.61 165.38 13.33 Favored 'General case' 0 C--N 1.375 1.704 0 O-C-N 117.897 -3.002 . . . . 0.0 116.048 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.0 t -60.03 147.78 79.24 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 121.988 0.899 . . . . 0.0 112.367 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -53.56 132.65 49.98 Favored 'Trans proline' 0 C--N 1.408 3.68 1 C-N-CA 125.939 4.426 . . . . 0.0 115.18 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -94.53 171.71 8.64 Favored 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 125.882 1.673 . . . . 0.0 114.601 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -146.03 139.5 26.14 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 119.571 -1.955 . . . . 0.0 113.228 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -128.86 170.23 13.64 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.262 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -114.14 136.3 53.09 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 127.809 2.443 . . . . 0.0 114.664 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.69 144.14 48.98 Favored 'General case' 0 CA--C 1.603 2.997 0 C-N-CA 126.496 1.918 . . . . 0.0 111.277 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.68 167.92 13.45 Favored 'General case' 0 N--CA 1.515 2.786 0 CA-C-O 123.603 1.668 . . . . 0.0 107.83 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.65 137.32 57.75 Favored 'General case' 0 C--O 1.199 -1.59 0 CA-C-O 115.671 -2.109 . . . . 0.0 109.599 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.63 -13.7 60.0 Favored Glycine 0 CA--C 1.569 3.446 0 CA-C-O 126.399 3.222 . . . . 0.0 114.815 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -119.31 171.94 7.96 Favored 'General case' 0 C--O 1.196 -1.716 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.01 -168.75 37.61 Favored Glycine 0 CA--C 1.566 3.252 0 O-C-N 129.001 3.938 . . . . 0.0 111.227 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -59.57 -39.81 71.48 Favored 'Trans proline' 0 N--CA 1.515 2.744 0 C-N-CA 122.56 2.174 . . . . 0.0 112.854 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -95.58 42.14 1.09 Allowed 'General case' 0 CA--C 1.588 2.408 0 O-C-N 119.854 -1.779 . . . . 0.0 112.486 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.53 -25.75 18.15 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 129.438 3.095 . . . . 0.0 114.863 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -87.62 -15.63 61.41 Favored Glycine 0 N--CA 1.478 1.499 0 C-N-CA 126.184 1.849 . . . . 0.0 115.434 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.22 135.56 84.61 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 120.01 1.905 . . . . 0.0 113.773 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -89.16 156.81 5.67 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 124.438 1.757 . . . . 0.0 113.685 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.72 128.15 34.87 Favored 'General case' 0 C--O 1.273 2.342 0 CA-C-O 115.811 -2.042 . . . . 0.0 113.089 -169.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.82 21.05 66.82 Favored Glycine 0 N--CA 1.406 -3.306 0 CA-C-N 122.765 2.529 . . . . 0.0 118.791 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.88 155.34 38.65 Favored 'General case' 0 C--O 1.268 2.071 0 O-C-N 120.817 -1.402 . . . . 0.0 114.29 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.89 43.99 1.04 Allowed 'General case' 0 C--O 1.269 2.084 0 CA-C-N 121.881 2.128 . . . . 0.0 109.81 -174.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -59.45 137.32 58.04 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-N 122.606 2.457 . . . . 0.0 113.009 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.459 ' CG ' HH22 ' A' ' 89' ' ' ARG . 49.6 t0 -57.44 118.38 5.11 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 128.032 2.533 . . . . 0.0 113.422 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.09 19.17 54.17 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 126.351 2.282 . . . . 0.0 117.697 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.49 121.83 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 131.301 3.84 . . . . 0.0 106.79 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.97 119.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 O-C-N 125.726 1.891 . . . . 0.0 114.017 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -76.47 141.48 41.3 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.67 149.7 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 118.242 -2.786 . . . . 0.0 112.811 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.36 -179.48 6.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.786 -2.007 . . . . 0.0 115.64 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -144.37 160.06 41.68 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 127.496 2.318 . . . . 0.0 111.927 163.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -61.48 -51.55 68.21 Favored 'General case' 0 CA--C 1.561 1.383 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.72 -6.14 54.21 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.969 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.61 158.58 29.72 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 126.549 1.94 . . . . 0.0 115.602 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.48 134.89 39.1 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 122.263 2.301 . . . . 0.0 114.004 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -64.52 59.59 0.02 OUTLIER 'General case' 0 CA--C 1.593 2.602 0 C-N-CA 129.538 3.135 . . . . 0.0 109.658 170.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.5 p -150.39 153.16 34.29 Favored Pre-proline 0 N--CA 1.509 2.5 0 C-N-CA 125.061 1.344 . . . . 0.0 113.135 -170.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.45 146.43 50.07 Favored 'Trans proline' 0 CA--C 1.555 1.539 1 C-N-CA 125.416 4.077 . . . . 0.0 112.928 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -114.6 47.02 1.29 Allowed 'General case' 0 C--O 1.264 1.847 0 CA-C-O 125.614 2.626 . . . . 0.0 104.385 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -52.81 -29.63 28.71 Favored 'General case' 0 N--CA 1.489 1.494 1 O-C-N 116.189 -4.069 . . . . 0.0 114.145 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -60.89 -51.51 68.96 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 122.138 2.245 . . . . 0.0 111.115 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.63 -26.81 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 CA-C-O 123.753 1.74 . . . . 0.0 112.058 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -69.68 -12.13 66.77 Favored Glycine 1 CA--C 1.6 5.406 0 CA-C-N 112.676 -2.056 . . . . 0.0 114.041 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 66.9 p -148.29 -29.56 0.3 Allowed 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 123.787 3.794 . . . . 0.0 113.789 -159.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.81 168.14 19.45 Favored 'General case' 0 C--O 1.201 -1.448 1 O-C-N 116.111 -4.118 . . . . 0.0 112.157 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . 0.3 54.7 t-20 -75.44 110.5 10.62 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 128.746 3.779 . . . . 0.0 109.377 -156.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.53 -9.94 18.7 Favored 'Trans proline' 0 C--N 1.396 3.04 1 C-N-CA 128.909 6.406 . . . . 0.0 109.879 -164.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.9 44.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.324 -1.485 . . . . 0.0 114.174 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -68.41 -62.95 1.17 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.164 0.586 . . . . 0.0 110.89 155.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -81.96 153.86 26.04 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 117.17 -1.395 . . . . 0.0 112.461 160.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.29 160.24 22.1 Favored 'General case' 0 CA--C 1.595 2.697 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -36.84 125.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -75.57 134.59 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 O-C-N 126.104 2.128 . . . . 0.0 110.766 172.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.11 125.83 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 O-C-N 118.332 -2.73 . . . . 0.0 107.541 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.42 97.1 6.24 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.315 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -148.53 146.68 28.42 Favored 'General case' 0 C--N 1.375 1.717 0 CA-C-O 126.706 3.146 . . . . 0.0 108.041 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 92.9 mt -85.76 146.19 43.15 Favored Pre-proline 0 C--O 1.255 1.348 0 C-N-CA 128.705 2.802 . . . . 0.0 118.109 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -49.24 164.62 0.27 Allowed 'Trans proline' 0 CA--C 1.57 2.321 1 C-N-CA 125.92 4.413 . . . . 0.0 113.092 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 56.49 32.41 20.71 Favored 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 127.974 2.509 . . . . 0.0 112.949 166.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.45 44.97 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 117.053 -1.971 . . . . 0.0 116.471 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.5 m -59.8 131.02 49.62 Favored 'General case' 0 C--N 1.379 1.89 0 O-C-N 125.583 1.402 . . . . 0.0 108.875 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 94.1 m -90.96 141.86 28.39 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.085 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.5 154.57 93.3 Favored Pre-proline 0 C--O 1.276 2.485 0 CA-C-N 123.529 2.877 . . . . 0.0 110.203 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.22 130.6 28.95 Favored 'Trans proline' 0 C--N 1.402 3.387 0 C-N-CA 124.259 3.306 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -64.56 -4.64 4.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.243 1.817 . . . . 0.0 113.872 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.76 -11.39 49.54 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 116.442 -2.31 . . . . 0.0 113.899 164.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.43 143.38 43.66 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 128.826 2.851 . . . . 0.0 116.1 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.88 154.14 38.35 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 123.801 1.762 . . . . 0.0 113.191 148.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.0 -179.26 7.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 127.125 3.345 . . . . 0.0 108.447 -162.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 CA--C 1.567 1.625 1 O-C-N 114.135 -5.353 . . . . 0.0 111.531 154.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.514 2.731 0 CA-C-O 123.708 1.462 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -84.44 123.23 30.01 Favored 'General case' 0 C--O 1.272 2.276 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.239 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -70.25 -13.97 62.41 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 117.838 -3.039 . . . . 0.0 113.86 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m 58.53 -29.31 0.03 OUTLIER 'General case' 0 CA--C 1.588 2.406 0 N-CA-C 118.648 2.832 . . . . 0.0 118.648 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.53 150.04 23.98 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 126.224 1.809 . . . . 0.0 112.335 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -87.68 136.24 33.03 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 118.718 -2.489 . . . . 0.0 113.755 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -80.31 -2.18 44.13 Favored 'General case' 0 C--O 1.185 -2.303 0 C-N-CA 124.959 1.304 . . . . 0.0 109.136 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -123.16 156.42 35.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 119.433 -2.042 . . . . 0.0 113.169 -168.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.8 p -64.87 142.98 58.25 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.56 164.49 21.89 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 127.287 2.867 . . . . 0.0 114.518 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.37 153.06 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.201 0.938 . . . . 0.0 112.308 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -119.22 128.23 54.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.14 -2.85 . . . . 0.0 106.534 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.95 150.36 29.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 108.205 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -138.01 -19.79 1.13 Allowed 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 122.097 0.951 . . . . 0.0 111.881 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.0 -128.12 6.2 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 123.558 1.643 . . . . 0.0 112.392 166.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -142.04 -24.72 0.68 Allowed 'General case' 0 CA--C 1.588 2.407 0 C-N-CA 125.023 1.329 . . . . 0.0 113.572 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.295 25.4 tp10 -60.49 138.85 57.95 Favored 'General case' 0 CA--C 1.609 3.226 0 O-C-N 118.671 -2.518 . . . . 0.0 114.859 173.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.97 163.69 11.72 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 122.742 1.258 . . . . 0.0 114.288 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tp -73.82 54.75 0.51 Allowed 'General case' 0 C--O 1.288 3.112 0 CA-C-N 112.36 -2.2 . . . . 0.0 114.45 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -59.81 159.54 8.78 Favored 'General case' 0 N--CA 1.406 -2.628 0 C-N-CA 127.102 2.161 . . . . 0.0 116.327 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.464 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 77.1 m-85 -145.47 125.37 7.04 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -47.18 117.28 2.14 Favored 'Trans proline' 0 N--CA 1.452 -0.945 1 C-N-CA 125.492 4.128 . . . . 0.0 115.169 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 43.56 23.86 0.05 Allowed 'General case' 1 N--CA 1.557 4.92 1 C-N-CA 131.8 4.04 . . . . 0.0 110.898 -171.41 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.33 17.45 62.47 Favored Glycine 0 CA--C 1.551 2.326 0 O-C-N 117.444 -3.285 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -88.87 111.45 22.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 121.086 2.443 . . . . 0.0 109.796 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.15 38.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-O 116.634 -2.204 . . . . 0.0 118.118 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.35 126.75 92.61 Favored Pre-proline 0 CA--C 1.505 -0.753 0 O-C-N 127.583 2.578 . . . . 0.0 109.601 158.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.93 170.24 20.22 Favored 'Trans proline' 0 N--CA 1.516 2.794 0 C-N-CA 125.221 3.947 . . . . 0.0 113.102 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.4 mt -79.26 126.08 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 117.962 -2.961 . . . . 0.0 110.621 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -138.34 116.1 11.47 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 127.124 3.345 . . . . 0.0 106.82 163.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 m -74.24 -21.86 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 112.27 -2.241 . . . . 0.0 106.249 -168.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.96 39.19 1.51 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 127.669 2.388 . . . . 0.0 114.056 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.7 p -140.94 149.62 42.07 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 121.323 -0.861 . . . . 0.0 112.752 151.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.9 p -75.9 163.7 65.17 Favored Pre-proline 0 CA--C 1.581 2.165 0 CA-C-O 116.3 -1.809 . . . . 0.0 113.519 -170.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.35 -28.75 73.91 Favored 'Trans proline' 0 CA--C 1.569 2.263 0 CA-C-N 124.137 2.513 . . . . 0.0 112.627 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -69.58 -13.81 62.52 Favored 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.41 -10.57 34.71 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 127.795 2.438 . . . . 0.0 111.051 -163.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -86.01 64.7 8.73 Favored 'General case' 0 C--O 1.277 2.528 0 C-N-CA 127.131 2.172 . . . . 0.0 113.749 -160.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.5 tt -158.1 139.31 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-N 112.955 -1.929 . . . . 0.0 107.168 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.04 -165.53 39.0 Favored Glycine 0 CA--C 1.568 3.388 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -165.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -145.37 156.14 43.6 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 125.966 1.706 . . . . 0.0 115.43 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 14.9 m-85 -94.1 148.22 22.39 Favored 'General case' 0 C--O 1.277 2.53 0 C-N-CA 124.064 0.945 . . . . 0.0 109.285 157.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -122.78 138.77 54.54 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 126.22 1.808 . . . . 0.0 112.962 171.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -71.77 143.02 49.7 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 118.608 -2.557 . . . . 0.0 116.828 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . 0.252 . . -124.29 83.45 2.15 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.958 1.703 . . . . 0.0 111.498 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.9 p -80.57 -15.44 56.64 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 120.102 1.319 . . . . 0.0 113.294 -165.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 47.5 35.5 4.28 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -89.84 -9.68 48.19 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.262 1.7 mp 65.85 143.69 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.553 4.701 0 C-N-CA 130.283 3.433 . . . . 0.0 116.216 172.98 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 . . . . . 0 CA--C 1.58 2.126 0 C-N-CA 127.488 2.315 . . . . 0.0 111.901 172.623 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 CA--C 1.595 2.678 0 CA-C-O 122.713 1.244 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 50.16 31.33 4.94 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 116.771 2.138 . . . . 0.0 116.771 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.43 156.29 17.87 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 117.98 -2.95 . . . . 0.0 108.508 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.8 t -58.24 144.23 77.58 Favored Pre-proline 0 N--CA 1.52 3.072 0 C-N-CA 129.23 3.012 . . . . 0.0 108.616 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -47.1 139.47 15.22 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 124.681 3.587 . . . . 0.0 115.288 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -102.37 170.62 7.95 Favored 'General case' 0 CA--C 1.572 1.812 0 O-C-N 127.122 2.764 . . . . 0.0 106.659 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -155.91 144.02 19.86 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 118.537 -2.602 . . . . 0.0 109.176 -174.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.01 147.57 44.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 128.975 2.91 . . . . 0.0 117.186 -172.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -92.92 155.87 17.3 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -148.22 139.25 23.22 Favored 'General case' 0 N--CA 1.532 3.642 1 C-N-CA 132.652 4.381 . . . . 0.0 113.721 169.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -75.04 158.63 32.87 Favored 'General case' 0 CA--C 1.606 3.12 0 O-C-N 125.454 1.721 . . . . 0.0 114.186 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.5 tp -53.65 127.21 24.65 Favored 'General case' 0 CA--C 1.582 2.176 0 O-C-N 117.377 -3.327 . . . . 0.0 114.711 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.28 15.69 76.01 Favored Glycine 0 CA--C 1.552 2.381 0 C-N-CA 123.82 0.724 . . . . 0.0 111.98 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -151.66 163.38 39.24 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-O 124.63 2.157 . . . . 0.0 111.993 -166.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.98 -163.25 54.47 Favored Glycine 1 CA--C 1.581 4.167 0 O-C-N 118.384 -2.697 . . . . 0.0 111.558 -164.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -70.59 -26.8 23.27 Favored 'Trans proline' 1 CA--C 1.607 4.157 0 CA-C-O 117.975 -0.927 . . . . 0.0 111.981 -168.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.28 37.53 1.87 Allowed 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.257 1.389 . . . . 0.0 112.901 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -25.89 67.92 Favored 'General case' 0 C--N 1.373 1.623 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.33 -12.93 77.75 Favored Glycine 1 CA--C 1.587 4.559 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.8 mt -53.65 145.8 28.36 Favored Pre-proline 0 CA--C 1.584 2.256 0 CA-C-N 119.385 1.592 . . . . 0.0 110.992 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -85.23 169.02 10.1 Favored 'Trans proline' 0 N--CA 1.412 -3.273 0 O-C-N 123.689 1.362 . . . . 0.0 113.467 155.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -57.47 136.17 56.65 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 125.503 1.752 . . . . 0.0 115.28 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.99 -4.73 56.85 Favored Glycine 1 CA--C 1.582 4.221 0 CA-C-O 115.379 -2.901 . . . . 0.0 114.047 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.73 153.99 12.59 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -82.42 100.84 10.26 Favored 'General case' 0 C--O 1.276 2.492 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.718 -165.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.11 127.95 4.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 126.442 2.339 . . . . 0.0 109.658 167.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.05 155.99 36.64 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 125.994 1.718 . . . . 0.0 110.26 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.14 7.47 87.67 Favored Glycine 0 N--CA 1.488 2.165 0 O-C-N 125.79 1.931 . . . . 0.0 113.634 -165.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.7 132.59 62.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 C-N-CA 127.026 2.13 . . . . 0.0 109.525 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.3 mm -121.99 121.14 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 C-N-CA 126.422 1.889 . . . . 0.0 106.826 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -99.03 140.7 32.79 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.8 1.24 . . . . 0.0 109.56 -170.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.02 158.64 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-O 117.654 -1.165 . . . . 0.0 113.339 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -151.56 176.75 11.02 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 127.561 3.038 . . . . 0.0 111.508 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.8 p -123.17 158.49 30.66 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 128.916 2.887 . . . . 0.0 109.379 155.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -49.94 -44.43 50.52 Favored 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 128.521 2.728 . . . . 0.0 113.892 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.11 -17.11 75.46 Favored Glycine 1 CA--C 1.59 4.758 0 CA-C-N 111.91 -2.405 . . . . 0.0 114.169 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . 0.268 . . -76.73 136.3 39.04 Favored 'General case' 0 C--O 1.292 3.324 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.2 mt -84.94 152.3 23.61 Favored 'General case' 0 C--N 1.383 2.022 0 CA-C-N 113.063 -1.881 . . . . 0.0 106.412 170.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -72.66 6.81 2.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.013 -1.449 . . . . 0.0 113.204 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.3 p -70.81 140.47 86.44 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.25 134.24 26.5 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 121.429 1.419 . . . . 0.0 109.408 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . 0.259 49.7 mmtt -77.84 41.87 0.36 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 116.417 -1.754 . . . . 0.0 109.602 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -46.02 -29.12 1.35 Allowed 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 113.365 -3.207 . . . . 0.0 114.425 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -60.74 -46.56 89.98 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 123.684 2.947 . . . . 0.0 113.253 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.7 mt -81.93 -17.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 126.126 1.77 . . . . 0.0 108.698 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.37 -23.07 55.39 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 129.772 3.558 . . . . 0.0 113.427 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.7 p -127.33 -11.71 5.72 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-O 125.89 2.757 . . . . 0.0 116.238 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -81.25 154.74 26.44 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 111.469 -2.605 . . . . 0.0 106.156 166.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -92.07 124.45 59.91 Favored Pre-proline 0 CA--C 1.581 2.162 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -52.94 -29.57 44.44 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.992 3.128 . . . . 0.0 115.642 169.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.4 -16.41 62.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -67.62 -17.45 64.62 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.929 3.059 . . . . 0.0 114.917 -170.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -135.04 178.01 7.36 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 122.696 1.236 . . . . 0.0 111.16 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.64 151.39 34.35 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 116.642 -1.647 . . . . 0.0 109.366 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.05 147.08 1.5 Allowed 'General case' 0 C--O 1.26 1.651 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.98 118.66 21.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 170.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.72 112.28 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 114.403 -2.713 . . . . 0.0 106.27 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 tt -80.1 137.82 36.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -156.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -157.02 145.95 20.02 Favored 'General case' 0 CA--C 1.611 3.31 0 C-N-CA 130.087 3.355 . . . . 0.0 107.956 -172.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.73 153.31 42.26 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 126.737 2.523 . . . . 0.0 111.744 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.72 171.77 12.73 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.398 3.398 . . . . 0.0 108.949 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.262 69.3 mt-30 64.69 12.78 7.87 Favored 'General case' 0 CA--C 1.589 2.455 0 C-N-CA 127.122 2.169 . . . . 0.0 112.419 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.99 19.32 44.34 Favored Glycine 0 CA--C 1.549 2.176 1 C-N-CA 132.881 5.038 . . . . 0.0 121.533 -163.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.0 m -61.43 137.74 58.25 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 124.068 0.947 . . . . 0.0 113.467 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 85.0 m -77.21 141.82 39.87 Favored 'General case' 0 CA--C 1.597 2.784 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.8 159.01 84.07 Favored Pre-proline 0 CA--C 1.572 1.794 0 C-N-CA 126.629 1.972 . . . . 0.0 113.273 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.13 136.96 25.47 Favored 'Trans proline' 0 CA--C 1.477 -2.333 0 CA-C-O 124.302 1.709 . . . . 0.0 112.392 -172.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -51.39 -19.92 1.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.254 166.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.43 17.26 44.74 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 125.006 3.548 . . . . 0.0 114.597 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -133.54 155.31 49.84 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-O 124.358 2.028 . . . . 0.0 110.537 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -100.57 143.38 30.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.591 -2.549 . . . . 0.0 107.369 160.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -155.42 -175.81 5.62 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 127.501 2.32 . . . . 0.0 112.641 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 . . . . . 0 N--CA 1.524 3.237 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 178.522 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 CA--C 1.561 1.837 0 N-CA-C 116.414 1.659 . . . . 0.0 116.414 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -62.42 126.58 27.81 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.209 -2.182 . . . . 0.0 113.104 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -79.7 -8.63 59.35 Favored 'General case' 0 CA--C 1.574 1.9 0 O-C-N 119.172 -2.205 . . . . 0.0 115.689 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m 57.94 -39.23 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 130.375 3.47 . . . . 0.0 119.322 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 165.47 25.09 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 110.788 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -89.79 139.51 30.51 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-N 113.767 -1.561 . . . . 0.0 115.001 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -78.92 -5.79 54.57 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 127.707 2.403 . . . . 0.0 110.866 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 156.4 48.96 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.323 1.535 . . . . 0.0 113.528 -165.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.0 p -56.6 163.06 1.95 Allowed 'General case' 0 CA--C 1.575 1.915 0 CA-C-O 124.253 1.978 . . . . 0.0 108.157 165.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.97 166.11 16.18 Favored 'General case' 0 CA--C 1.626 3.903 0 CA-C-N 110.562 -3.017 . . . . 0.0 117.643 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.53 168.83 10.45 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 144.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -126.93 132.53 50.84 Favored 'General case' 0 CA--C 1.579 2.059 0 C-N-CA 126.415 1.886 . . . . 0.0 111.728 158.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.27 128.7 26.01 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 119.521 -1.987 . . . . 0.0 109.101 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -124.16 -24.66 4.3 Favored 'General case' 0 C--O 1.278 2.585 0 O-C-N 128.194 3.434 . . . . 0.0 116.802 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.08 -133.53 4.31 Favored Glycine 0 CA--C 1.578 3.974 0 N-CA-C 119.755 2.662 . . . . 0.0 119.755 154.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -133.04 -29.58 1.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 CA-C-N 119.63 1.715 . . . . 0.0 114.728 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.72 139.28 51.11 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 125.384 1.678 . . . . 0.0 111.254 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -65.74 171.37 4.32 Favored 'General case' 0 CA--C 1.48 -1.747 0 C-N-CA 126.093 1.757 . . . . 0.0 112.759 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.18 37.83 0.17 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.091 -165.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -63.77 109.11 1.61 Allowed 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 127.845 2.458 . . . . 0.0 110.971 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.68 158.71 42.17 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 118.676 -2.515 . . . . 0.0 112.958 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.85 133.45 21.84 Favored 'Trans proline' 0 C--O 1.274 2.32 0 N-CA-C 107.401 -1.807 . . . . 0.0 107.401 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 61.56 7.24 1.76 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 130.055 3.342 . . . . 0.0 114.699 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.19 33.24 85.3 Favored Glycine 0 N--CA 1.492 2.431 0 CA-C-O 123.958 1.865 . . . . 0.0 112.835 -160.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -94.89 118.41 31.75 Favored 'General case' 0 CA--C 1.58 2.097 0 CA-C-N 113.762 -1.219 . . . . 0.0 109.934 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.19 28.93 0.02 OUTLIER Glycine 0 CA--C 1.57 3.494 0 O-C-N 116.882 -3.636 . . . . 0.0 114.329 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.73 128.44 88.28 Favored Pre-proline 0 C--O 1.26 1.654 0 CA-C-N 121.212 2.506 . . . . 0.0 114.62 167.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.44 171.25 18.49 Favored 'Trans proline' 0 N--CA 1.443 -1.487 1 C-N-CA 126.624 4.882 . . . . 0.0 114.477 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.28 135.7 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 128.354 2.662 . . . . 0.0 113.32 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -168.49 121.49 0.85 Allowed 'General case' 0 C--O 1.258 1.519 0 O-C-N 119.172 -2.205 . . . . 0.0 110.072 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.27 9.0 m -75.54 -24.18 56.71 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 118.434 -2.666 . . . . 0.0 112.095 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -75.43 5.58 5.63 Favored 'General case' 0 C--N 1.37 1.483 0 O-C-N 117.506 -3.246 . . . . 0.0 111.992 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -112.83 165.23 12.5 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.261 1.846 . . . . 0.0 112.235 158.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -120.27 175.84 2.11 Favored Pre-proline 0 C--O 1.281 2.74 0 C-N-CA 128.611 2.764 . . . . 0.0 113.506 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.37 -41.48 49.37 Favored 'Trans proline' 0 CA--C 1.591 3.365 0 C-N-CA 122.031 1.821 . . . . 0.0 114.077 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -52.2 -23.01 4.88 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 122.505 2.411 . . . . 0.0 112.414 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.13 -21.02 15.08 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 118.043 -2.911 . . . . 0.0 108.846 -161.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.01 73.8 0.04 OUTLIER 'General case' 0 CA--C 1.613 3.4 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.294 7.1 tt -158.1 137.34 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 C-N-CA 130.786 3.634 . . . . 0.0 104.702 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.36 -165.1 32.51 Favored Glycine 1 CA--C 1.588 4.611 0 CA-C-O 123.194 1.441 . . . . 0.0 111.717 -175.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -151.39 152.96 33.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 127.03 3.3 . . . . 0.0 116.446 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 110' ' ' PHE . 71.8 m-85 -92.88 147.3 22.96 Favored 'General case' 0 CA--C 1.606 3.11 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.179 164.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -125.68 136.79 53.61 Favored 'General case' 0 C--O 1.267 2.026 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -57.24 163.2 2.29 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.511 -1.368 . . . . 0.0 113.591 160.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.4 77.15 1.34 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.226 1.81 . . . . 0.0 111.209 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -71.25 -38.34 71.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.481 2.712 . . . . 0.0 112.538 -161.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 62.78 56.87 1.84 Allowed 'General case' 0 C--N 1.373 1.601 0 CA-C-O 126.988 3.28 . . . . 0.0 109.022 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 mtm180 -118.14 2.19 12.0 Favored 'General case' 0 CA--C 1.6 2.876 0 CA-C-O 113.493 -3.146 . . . . 0.0 107.681 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 mp 57.85 145.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 1 C-N-CA 132.23 4.212 . . . . 0.0 113.05 165.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 . . . . . 0 C--O 1.28 2.682 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 167.368 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.1 mttm . . . . . 0 CA--C 1.576 1.967 0 CA-C-O 115.623 -2.132 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.1 8.04 3.79 Favored 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 122.408 2.367 . . . . 0.0 116.596 -164.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.3 mt -101.37 167.23 10.3 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 123.415 1.579 . . . . 0.0 107.072 -171.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.9 m -72.9 159.77 84.52 Favored Pre-proline 0 C--N 1.368 1.393 0 CA-C-O 115.127 -2.368 . . . . 0.0 114.669 -171.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -49.18 134.86 30.78 Favored 'Trans proline' 0 CA--C 1.556 1.609 1 C-N-CA 130.636 7.557 . . . . 0.0 108.187 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -78.87 158.48 28.09 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.667 156.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -134.85 127.41 30.71 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 117.991 -2.943 . . . . 0.0 112.991 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.04 140.43 49.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.006 1.322 . . . . 0.0 113.652 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 65.1 t80 -92.45 151.57 20.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.698 3.592 . . . . 0.0 120.698 169.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.402 ' N ' ' CG ' ' A' ' 110' ' ' PHE . 24.6 m-85 -156.16 150.99 26.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.752 2.215 . . . . 0.0 108.455 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -71.08 150.03 45.91 Favored 'General case' 0 N--CA 1.524 3.266 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.796 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.4 tp -43.2 128.38 4.6 Favored 'General case' 0 C--O 1.257 1.49 0 CA-C-N 122.907 2.594 . . . . 0.0 117.161 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.42 18.54 75.4 Favored Glycine 0 CA--C 1.491 -1.462 0 CA-C-O 117.727 -1.596 . . . . 0.0 115.838 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 p -124.25 -164.14 1.22 Allowed 'General case' 0 C--O 1.282 2.773 0 CA-C-N 120.29 2.045 . . . . 0.0 112.428 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 -157.22 53.52 Favored Glycine 0 CA--C 1.547 2.088 0 CA-C-O 116.341 -2.366 . . . . 0.0 114.795 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -65.47 -22.52 59.04 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 N-CA-C 117.771 2.181 . . . . 0.0 117.771 168.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -115.31 33.51 5.4 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.918 0.887 . . . . 0.0 110.419 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.59 -12.22 56.92 Favored 'General case' 1 C--O 1.307 4.083 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.895 -166.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.11 -35.8 37.34 Favored Glycine 0 C--N 1.347 1.144 1 CA-C-O 109.029 -6.428 . . . . 0.0 107.375 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.79 135.93 94.63 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-N 123.553 3.676 . . . . 0.0 115.176 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.17 162.77 41.44 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 N-CA-C 119.927 3.011 . . . . 0.0 119.927 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -62.42 134.9 57.09 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 117.657 -3.152 . . . . 0.0 115.106 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.32 71.51 Favored Glycine 0 N--CA 1.499 2.891 0 CA-C-O 115.995 -2.558 . . . . 0.0 110.416 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.69 140.42 41.59 Favored 'General case' 0 C--N 1.389 2.3 0 O-C-N 126.747 2.087 . . . . 0.0 114.283 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -104.98 41.72 1.31 Allowed 'General case' 0 C--O 1.268 2.034 0 CA-C-N 123.397 2.817 . . . . 0.0 111.193 -147.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -74.51 116.42 15.17 Favored 'General case' 0 N--CA 1.521 3.108 0 O-C-N 126.856 2.598 . . . . 0.0 112.166 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.66 152.38 3.76 Favored 'General case' 0 C--O 1.285 2.923 0 CA-C-O 125.414 2.53 . . . . 0.0 114.181 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.33 -10.7 58.1 Favored Glycine 0 CA--C 1.575 3.812 0 CA-C-N 111.953 -2.385 . . . . 0.0 115.952 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -101.62 143.33 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.806 2.442 . . . . 0.0 110.269 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.5 mm -126.18 111.03 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 127.134 2.174 . . . . 0.0 110.322 162.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -65.61 152.2 44.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.97 138.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 O-C-N 118.12 -2.862 . . . . 0.0 113.6 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.63 179.98 7.73 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 118.661 -2.524 . . . . 0.0 113.395 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.4 p -152.59 151.09 30.24 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.422 1.489 . . . . 0.0 108.903 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.79 -27.7 65.27 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 114.566 -2.635 . . . . 0.0 113.023 -170.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.88 -16.73 50.56 Favored Glycine 0 C--O 1.189 -2.664 1 O-C-N 130.369 4.793 . . . . 0.0 117.24 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.39 150.09 28.56 Favored 'General case' 0 C--N 1.409 3.158 0 CA-C-N 121.277 2.538 . . . . 0.0 108.263 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.86 146.48 23.61 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.66 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -76.07 7.89 3.71 Favored 'General case' 1 CA--C 1.648 4.742 0 O-C-N 117.766 -3.084 . . . . 0.0 113.974 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.417 ' O ' ' HE2' ' A' ' 143' ' ' LYS . 20.9 p -70.57 145.54 92.77 Favored Pre-proline 0 N--CA 1.48 1.066 0 O-C-N 118.137 -2.852 . . . . 0.0 110.597 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.59 137.52 33.1 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 125.041 3.828 . . . . 0.0 112.995 160.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 141' ' ' THR . 39.5 mmtt -101.52 67.0 1.11 Allowed 'General case' 0 C--O 1.263 1.784 0 C-N-CA 128.578 2.751 . . . . 0.0 108.987 175.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -73.22 -12.12 60.75 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.978 -161.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -82.45 -47.85 11.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 113.608 -3.091 . . . . 0.0 114.526 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.47 -32.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 O-C-N 126.641 2.463 . . . . 0.0 113.409 156.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.74 -15.53 62.27 Favored Glycine 0 CA--C 1.553 2.448 0 C-N-CA 126.468 1.985 . . . . 0.0 115.459 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 81.2 p -145.12 -30.08 0.44 Allowed 'General case' 1 CA--C 1.635 4.213 0 C-N-CA 130.105 3.362 . . . . 0.0 117.836 -160.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.97 149.6 46.94 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.042 1.737 . . . . 0.0 110.334 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -74.62 111.03 11.28 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.067 -170.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.31 -35.73 39.02 Favored 'Trans proline' 0 N--CA 1.51 2.494 0 CA-C-O 122.81 1.087 . . . . 0.0 109.488 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.26 2.52 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 117.114 -3.491 . . . . 0.0 114.498 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . 0.265 27.9 t-20 -69.51 -22.5 63.58 Favored 'General case' 0 CA--C 1.588 2.43 0 CA-C-N 120.264 1.393 . . . . 0.0 113.786 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -138.26 177.81 7.6 Favored 'General case' 0 C--O 1.177 -2.725 0 C-N-CA 127.669 2.388 . . . . 0.0 109.005 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.07 156.16 38.0 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 114.912 -2.471 . . . . 0.0 114.986 162.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.85 146.32 37.79 Favored 'General case' 0 C--O 1.175 -2.867 0 CA-C-N 121.837 2.108 . . . . 0.0 113.098 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.8 mt -61.11 143.69 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.612 1.096 . . . . 0.0 111.265 160.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.6 p -74.46 126.13 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.9 tp -58.46 118.91 6.1 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -138.27 141.49 39.87 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.7 154.79 50.66 Favored Pre-proline 0 C--O 1.198 -1.609 0 CA-C-N 122.889 2.586 . . . . 0.0 113.296 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -56.71 177.06 0.18 Allowed 'Trans proline' 0 CA--C 1.558 1.687 1 C-N-CA 130.404 7.403 . . . . 0.0 117.479 166.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 48.37 32.12 3.08 Favored 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 131.787 4.035 . . . . 0.0 114.502 172.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.48 11.9 54.41 Favored Glycine 0 CA--C 1.556 2.597 0 O-C-N 117.661 -3.149 . . . . 0.0 118.005 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . 0.253 5.9 m -63.13 119.81 10.26 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -161.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 46.9 m -63.69 131.22 47.26 Favored 'General case' 0 C--N 1.381 1.948 0 O-C-N 124.521 1.138 . . . . 0.0 108.436 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 44.2 mt -66.81 156.89 85.84 Favored Pre-proline 0 C--O 1.268 2.031 0 C-N-CA 127.162 2.185 . . . . 0.0 106.206 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -57.96 131.34 43.04 Favored 'Trans proline' 0 CA--C 1.571 2.333 0 C-N-CA 123.495 2.797 . . . . 0.0 113.905 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -60.77 -39.29 88.23 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.038 1.735 . . . . 0.0 109.992 -161.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.91 41.43 3.04 Favored Glycine 0 C--N 1.38 2.982 0 O-C-N 117.777 -3.077 . . . . 0.0 112.124 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.68 144.6 37.67 Favored 'General case' 0 C--O 1.204 -1.311 0 O-C-N 119.325 -2.279 . . . . 0.0 113.528 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -72.05 145.38 48.3 Favored 'General case' 0 C--O 1.284 2.884 0 CA-C-O 116.208 -1.853 . . . . 0.0 111.206 157.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -160.92 170.75 19.99 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 126.708 2.003 . . . . 0.0 110.297 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 . . . . . 0 CA--C 1.571 1.77 0 O-C-N 119.364 -2.085 . . . . 0.0 113.196 171.139 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 105.1 -3.2 . . . . 0.0 105.1 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.61 161.7 10.51 Favored Pre-proline 0 CA--C 1.613 3.369 0 CA-C-N 119.103 1.451 . . . . 0.0 112.801 162.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -78.13 166.53 24.59 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 O-C-N 124.275 1.671 . . . . 0.0 111.14 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -71.05 113.61 8.26 Favored 'General case' 0 C--O 1.275 2.408 0 CA-C-O 124.423 2.059 . . . . 0.0 112.772 -174.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -70.98 -9.14 57.43 Favored 'General case' 0 CA--C 1.614 3.413 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -167.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.1 m 58.49 -31.62 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 1 C-N-CA 132.1 4.16 . . . . 0.0 115.192 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.54 157.69 21.18 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.167 2.987 . . . . 0.0 113.11 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.0 t -79.53 136.89 37.0 Favored 'General case' 0 N--CA 1.422 -1.875 0 O-C-N 120.225 -1.547 . . . . 0.0 110.584 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.88 -29.35 70.69 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 115.849 -2.024 . . . . 0.0 113.952 169.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -100.38 162.68 12.79 Favored 'General case' 0 C--N 1.377 1.788 0 O-C-N 127.552 3.033 . . . . 0.0 113.611 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.307 35.2 p -59.45 140.35 56.27 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 125.183 2.421 . . . . 0.0 113.162 166.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.05 143.91 32.58 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 111.151 -2.749 . . . . 0.0 109.623 -171.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.31 152.38 21.06 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.578 -1.326 . . . . 0.0 108.004 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -116.64 134.15 55.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 118.29 -2.756 . . . . 0.0 110.637 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -68.76 139.89 55.32 Favored 'General case' 0 CA--C 1.607 3.139 0 C-N-CA 126.58 1.952 . . . . 0.0 115.856 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -115.72 -48.04 2.78 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.23 -135.62 5.61 Favored Glycine 0 N--CA 1.508 3.458 0 C-N-CA 127.063 2.268 . . . . 0.0 110.959 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -147.39 -29.04 0.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.277 2.038 . . . . 0.0 114.143 -164.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.79 129.47 37.74 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 127.819 2.448 . . . . 0.0 114.773 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' HB2' ' HE3' ' A' ' 65' ' ' LYS . 82.0 m-20 -56.91 155.57 7.83 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 128.384 2.674 . . . . 0.0 108.067 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.16 57.32 0.84 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.504 -2.623 . . . . 0.0 110.029 -170.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.476 ' HE3' ' HB2' ' A' ' 63' ' ' ASP . 82.8 mttt -87.61 101.81 14.0 Favored 'General case' 0 CA--C 1.576 1.957 1 O-C-N 115.776 -4.327 . . . . 0.0 106.86 -164.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -68.25 149.61 98.03 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -55.78 154.59 25.62 Favored 'Trans proline' 1 C--N 1.417 4.139 0 O-C-N 118.291 -1.479 . . . . 0.0 108.568 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 54.63 -5.95 0.02 OUTLIER 'General case' 0 N--CA 1.539 3.977 1 N-CA-C 122.123 4.12 . . . . 0.0 122.123 152.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.78 7.37 71.32 Favored Glycine 0 CA--C 1.564 3.154 1 O-C-N 115.285 -4.634 . . . . 0.0 113.861 -168.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -86.72 104.6 16.27 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 117.803 -1.094 . . . . 0.0 109.0 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.25 21.54 0.04 OUTLIER Glycine 0 C--N 1.356 1.694 0 CA-C-N 122.326 2.33 . . . . 0.0 113.212 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.254 97.9 t -73.29 117.6 61.67 Favored Pre-proline 0 C--O 1.268 2.031 0 O-C-N 119.535 -2.156 . . . . 0.0 116.087 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -68.64 170.18 15.77 Favored 'Trans proline' 0 CA--C 1.552 1.387 1 C-N-CA 129.287 6.658 . . . . 0.0 109.534 -169.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.8 mt -105.13 141.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 O-C-N 117.772 -3.08 . . . . 0.0 112.381 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 127.481 2.312 . . . . 0.0 111.778 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.4 m -57.49 -43.99 84.57 Favored 'General case' 0 C--O 1.192 -1.929 0 O-C-N 124.054 0.846 . . . . 0.0 112.124 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -77.14 39.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 128.0 2.52 . . . . 0.0 111.907 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.2 p -146.57 144.62 29.69 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 125.551 1.54 . . . . 0.0 111.88 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -83.16 168.01 25.45 Favored Pre-proline 0 C--O 1.271 2.215 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -62.89 -33.76 74.11 Favored 'Trans proline' 0 C--O 1.203 -1.241 0 CA-C-O 117.554 -1.102 . . . . 0.0 114.511 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -58.02 -29.12 65.07 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 128.698 2.799 . . . . 0.0 111.21 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.318 33.9 m-20 -74.16 -11.67 60.36 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 129.036 2.935 . . . . 0.0 114.104 -172.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -88.39 66.37 8.3 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 117.149 -1.405 . . . . 0.0 111.229 -157.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.8 tt -154.62 144.23 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.671 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 178.89 -167.49 37.8 Favored Glycine 1 CA--C 1.58 4.137 0 C-N-CA 116.873 -2.584 . . . . 0.0 114.925 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -153.57 147.18 25.1 Favored 'General case' 0 C--O 1.202 -1.432 0 O-C-N 118.247 -2.913 . . . . 0.0 112.985 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -92.91 139.48 30.49 Favored 'General case' 0 C--O 1.246 0.896 0 O-C-N 128.736 3.773 . . . . 0.0 117.34 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -140.69 164.0 31.37 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 121.813 2.097 . . . . 0.0 110.865 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -83.92 154.68 23.25 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 117.78 2.511 . . . . 0.0 117.78 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.23 88.69 2.11 Favored 'General case' 0 C--O 1.182 -2.453 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.635 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.7 p -67.6 -27.8 67.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 116.07 -1.919 . . . . 0.0 111.729 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 52.88 56.05 8.13 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-N 120.189 1.359 . . . . 0.0 109.252 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -122.91 -12.0 8.06 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 130.395 3.478 . . . . 0.0 114.476 -160.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 mp 61.27 124.88 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.549 4.495 1 C-N-CA 131.82 4.048 . . . . 0.0 108.521 166.684 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -86.08 -25.16 26.0 Favored 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 127.145 2.178 . . . . 0.0 107.368 169.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.6 127.56 1.45 Allowed Glycine 0 CA--C 1.553 2.417 0 C-N-CA 127.095 2.283 . . . . 0.0 109.344 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.15 139.24 1.38 Allowed Glycine 0 C--O 1.274 2.613 0 O-C-N 119.47 -2.194 . . . . 0.0 116.23 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.292 32.7 m-20 72.33 54.92 0.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 125.482 1.513 . . . . 0.0 111.331 162.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.43 155.55 10.03 Favored Glycine 0 CA--C 1.546 2.026 0 CA-C-O 115.905 -2.609 . . . . 0.0 113.46 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -116.65 114.76 24.53 Favored 'General case' 0 C--O 1.273 2.318 0 CA-C-N 123.152 3.476 . . . . 0.0 103.921 -171.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 84.8 mmm -47.86 137.02 10.31 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 125.79 2.709 . . . . 0.0 108.844 153.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -140.04 -4.63 1.34 Allowed 'General case' 0 CA--C 1.6 2.872 1 C-N-CA 133.607 4.763 . . . . 0.0 115.772 -176.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 55.99 -0.34 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 131.667 3.987 . . . . 0.0 116.141 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -67.56 169.34 9.43 Favored 'General case' 0 N--CA 1.53 3.555 0 CA-C-N 123.844 3.02 . . . . 0.0 109.667 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.9 m -56.83 163.06 3.05 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 127.27 3.414 . . . . 0.0 111.61 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -71.57 168.05 24.7 Favored 'Trans proline' 0 N--CA 1.427 -2.402 0 CA-C-O 124.844 1.935 . . . . 0.0 115.228 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -113.74 164.54 13.58 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 116.767 -3.708 . . . . 0.0 107.167 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -134.25 122.56 22.91 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 129.775 3.23 . . . . 0.0 112.051 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -107.84 147.61 30.68 Favored 'General case' 0 CA--C 1.597 2.769 0 CA-C-N 113.438 -1.71 . . . . 0.0 112.508 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -101.82 148.88 24.77 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.834 2.454 . . . . 0.0 110.16 166.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -134.05 145.2 49.2 Favored 'General case' 0 C--O 1.255 1.394 0 C-N-CA 125.267 1.427 . . . . 0.0 111.884 168.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -57.73 157.05 7.75 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 160.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.25 138.03 57.38 Favored 'General case' 0 C--N 1.384 2.095 0 O-C-N 123.982 0.801 . . . . 0.0 111.068 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.95 32.43 75.27 Favored Glycine 0 CA--C 1.564 3.129 0 CA-C-O 118.08 -1.4 . . . . 0.0 115.069 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -141.88 172.04 13.23 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 128.228 2.611 . . . . 0.0 112.206 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -163.98 45.93 Favored Glycine 1 C--O 1.298 4.126 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.879 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.57 -29.26 25.08 Favored 'Trans proline' 0 CA--C 1.578 2.708 1 C-N-CA 125.579 4.186 . . . . 0.0 111.378 -170.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -94.45 24.63 4.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.921 -2.362 . . . . 0.0 111.521 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 -29.59 41.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.062 1.745 . . . . 0.0 114.404 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.38 -10.38 84.66 Favored Glycine 0 C--N 1.388 3.42 0 CA-C-O 124.505 2.169 . . . . 0.0 117.668 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.9 mt -70.29 136.17 86.64 Favored Pre-proline 0 N--CA 1.522 3.155 1 O-C-N 115.776 -4.367 . . . . 0.0 110.179 168.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.18 174.26 13.11 Favored 'Trans proline' 0 C--N 1.376 1.986 0 O-C-N 123.689 1.363 . . . . 0.0 112.711 160.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.02 133.44 56.1 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 120.289 -1.507 . . . . 0.0 111.698 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.75 5.65 89.34 Favored Glycine 1 CA--C 1.621 6.663 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 168.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.98 151.37 4.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.596 1.665 . . . . 0.0 111.994 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -94.95 68.02 3.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -125.05 137.39 54.21 Favored 'General case' 0 C--O 1.258 1.542 0 C-N-CA 126.646 1.978 . . . . 0.0 113.745 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.259 3.2 t0 -57.39 124.05 17.57 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 112.194 -2.275 . . . . 0.0 112.296 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.84 -4.63 79.01 Favored Glycine 0 C--N 1.373 2.589 0 O-C-N 125.204 1.565 . . . . 0.0 114.115 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 mp -86.68 128.82 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.609 3.242 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 163.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.0 mm -109.75 109.62 29.09 Favored 'Isoleucine or valine' 0 C--O 1.254 1.332 1 O-C-N 129.179 4.049 . . . . 0.0 110.574 170.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.21 138.5 35.81 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.205 -0.935 . . . . 0.0 112.901 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.01 146.25 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 126.121 1.769 . . . . 0.0 114.029 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.85 153.57 35.62 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 130.153 3.381 . . . . 0.0 110.843 -175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.2 p -102.43 156.56 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 129.38 3.072 . . . . 0.0 105.096 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -52.7 -31.13 36.0 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.59 -27.31 10.68 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 127.892 2.663 . . . . 0.0 113.171 -163.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.53 157.98 8.28 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.302 1.441 . . . . 0.0 111.486 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.09 131.15 54.43 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 124.589 2.137 . . . . 0.0 110.939 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -64.53 24.42 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.369 0 O-C-N 117.971 -2.956 . . . . 0.0 118.272 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.3 p -87.36 150.76 49.82 Favored Pre-proline 0 C--N 1.362 1.119 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.31 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.4 148.77 49.28 Favored 'Trans proline' 0 CA--C 1.505 -0.949 0 CA-C-O 116.686 -1.464 . . . . 0.0 115.041 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -97.51 90.09 4.92 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 126.166 2.888 . . . . 0.0 109.868 -172.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -52.39 -59.54 4.3 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -64.44 -66.91 0.48 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.064 2.146 . . . . 0.0 106.758 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.0 mt -45.53 -27.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 119.223 -2.173 . . . . 0.0 116.394 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -92.9 -11.23 59.17 Favored Glycine 1 CA--C 1.579 4.035 0 O-C-N 117.785 -3.072 . . . . 0.0 115.834 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.3 p -125.56 -12.65 6.65 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 114.975 -2.441 . . . . 0.0 112.676 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -74.63 178.34 5.45 Favored 'General case' 0 CA--C 1.582 2.2 0 CA-C-O 113.115 -3.326 . . . . 0.0 115.733 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -109.6 97.47 27.82 Favored Pre-proline 0 N--CA 1.414 -2.262 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . 0.337 4.2 Cg_exo -57.86 -28.45 82.53 Favored 'Trans proline' 0 CA--C 1.581 2.827 0 C-N-CA 123.183 2.589 . . . . 0.0 113.882 171.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.7 -12.75 25.7 Favored 'General case' 0 CA--C 1.556 1.184 0 O-C-N 124.448 1.093 . . . . 0.0 113.195 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -61.81 -19.81 62.95 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -148.31 -176.55 5.34 Favored 'General case' 0 C--O 1.175 -2.831 0 CA-C-N 121.271 1.85 . . . . 0.0 110.345 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.24 156.24 0.6 Allowed 'General case' 0 C--N 1.386 2.153 0 CA-C-N 113.531 -1.668 . . . . 0.0 114.825 154.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.08 159.98 24.61 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.1 mt -81.46 130.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.722 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 p -63.35 121.2 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 124.497 2.094 . . . . 0.0 108.483 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 118.86 12.23 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 114.693 -5.005 . . . . 0.0 111.514 171.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -151.29 133.08 14.97 Favored 'General case' 0 C--O 1.251 1.136 0 O-C-N 126.87 2.606 . . . . 0.0 109.695 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.5 mt -75.21 165.63 52.2 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.52 145.97 92.68 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 119.509 0.86 . . . . 0.0 112.915 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 58.6 9.92 1.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.939 2.895 . . . . 0.0 113.098 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.29 30.17 73.45 Favored Glycine 0 CA--C 1.548 2.128 0 O-C-N 118.217 -2.802 . . . . 0.0 116.144 -168.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.7 m -55.0 125.65 21.31 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-N 112.737 -1.731 . . . . 0.0 111.889 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 87.0 m -69.51 125.82 27.86 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -164.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 mt -71.91 157.55 89.34 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 125.632 1.832 . . . . 0.0 106.168 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -44.02 124.84 5.04 Favored 'Trans proline' 0 N--CA 1.52 3.039 1 C-N-CA 129.195 6.597 . . . . 0.0 116.734 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -57.99 -25.41 61.03 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 128.579 2.751 . . . . 0.0 107.708 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.94 -15.25 9.38 Favored Glycine 1 CA--C 1.596 5.147 0 CA-C-N 120.781 1.628 . . . . 0.0 114.917 174.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -137.34 153.89 50.16 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 126.593 1.957 . . . . 0.0 113.188 -154.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -98.6 124.72 43.54 Favored 'General case' 0 C--O 1.199 -1.589 0 O-C-N 118.843 -2.411 . . . . 0.0 109.101 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -117.24 164.63 14.52 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 127.49 2.316 . . . . 0.0 113.988 168.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -62.63 -25.01 67.9 Favored 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 127.471 2.309 . . . . 0.0 116.108 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -90.22 179.87 43.86 Favored Glycine 0 CA--C 1.55 2.228 0 O-C-N 127.23 2.831 . . . . 0.0 114.326 170.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 51.0 m 53.67 53.16 11.87 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -96.15 159.13 15.12 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 126.565 1.946 . . . . 0.0 112.082 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.76 178.78 37.99 Favored Glycine 0 C--N 1.39 3.565 0 C-N-CA 126.134 1.826 . . . . 0.0 114.135 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -152.23 178.64 29.34 Favored Glycine 0 N--CA 1.475 1.271 0 O-C-N 117.148 -3.56 . . . . 0.0 111.63 -160.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . 0.255 16.2 m . . . . . 0 C--O 1.251 1.149 0 CA-C-O 125.273 2.463 . . . . 0.0 111.155 -10.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.352 -5.072 4 O4'-C1'-N19 114.42 6.22 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.651 5.762 2 C1'-O4'-C4' 105.051 -5.054 . 0.174 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C3'--C2' 1.605 7.311 0 C4'-C3'-C2' 99.313 -3.387 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 4 P--O3' 1.509 -8.184 2 O5'-C5'-C4' 121.59 8.136 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.45 -6.779 1 O4'-C1'-N19 112.254 4.054 . 0.498 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 3 O4'--C4' 1.352 -8.427 3 O4'-C1'-N19 114.791 6.591 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O3' 1.542 -5.437 4 O5'-C5'-C4' 116.88 4.772 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.454 -6.329 1 O5'-C5'-C4' 119.594 6.71 . 0.052 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C3'--C2' 1.559 3.105 3 C3'-C2'-C1' 107.392 6.546 OUTLIER-DELTA 0.018 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.658 6.499 2 P-O3'-C3' 129.596 8.247 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 3.524 0 CA-C-O 125.876 2.931 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 mt -87.74 142.86 32.89 Favored Pre-proline 0 C--N 1.369 1.455 0 O-C-N 117.897 -3.119 . . . . 0.0 112.9 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -56.02 154.1 29.13 Favored 'Trans proline' 0 C--O 1.252 1.176 1 C-N-CA 126.514 4.809 . . . . 0.0 118.687 169.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -71.04 111.93 6.79 Favored 'General case' 0 N--CA 1.403 -2.778 0 O-C-N 119.878 -1.764 . . . . 0.0 112.395 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.439 ' C ' ' H ' ' A' ' 50' ' ' ALA 0.456 27.3 p30 -46.2 -32.8 3.22 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 119.72 -1.862 . . . . 0.0 115.742 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.3 m 64.96 -36.69 0.21 Allowed 'General case' 0 CA--C 1.609 3.219 0 C-N-CA 128.481 2.712 . . . . 0.0 106.974 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 48' ' ' ASN . . . -76.62 152.66 35.8 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 120.639 1.563 . . . . 0.0 113.766 -173.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -95.96 145.68 25.22 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 117.432 2.382 . . . . 0.0 117.432 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -83.03 -13.38 55.98 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -108.39 158.12 17.8 Favored 'General case' 0 N--CA 1.415 -2.18 0 O-C-N 127.965 3.291 . . . . 0.0 116.631 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.0 p -63.27 125.91 25.66 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.88 155.19 35.01 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 127.463 2.305 . . . . 0.0 111.783 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.97 164.09 12.5 Favored 'General case' 0 CA--C 1.593 2.63 0 C-N-CA 128.712 2.805 . . . . 0.0 109.043 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 67.4 m -132.51 130.65 40.7 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 118.878 -2.389 . . . . 0.0 110.616 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -67.49 137.4 55.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.269 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -125.58 -33.11 2.81 Favored 'General case' 0 CA--C 1.593 2.596 0 CA-C-N 120.874 1.67 . . . . 0.0 111.266 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.09 -134.66 0.65 Allowed Glycine 0 N--CA 1.514 3.842 0 N-CA-C 120.945 3.138 . . . . 0.0 120.945 170.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -133.82 -23.63 1.78 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 125.964 1.705 . . . . 0.0 113.444 167.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.92 146.96 25.97 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -72.21 159.47 34.04 Favored 'General case' 0 N--CA 1.409 -2.494 0 O-C-N 118.71 -2.494 . . . . 0.0 111.015 -168.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.1 tp -74.3 68.64 1.52 Allowed 'General case' 0 N--CA 1.534 3.73 0 CA-C-O 123.598 1.666 . . . . 0.0 111.543 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -91.87 158.99 16.0 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 125.114 2.387 . . . . 0.0 106.894 -168.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 61.8 m-85 -148.07 126.95 6.19 Favored Pre-proline 0 C--O 1.257 1.456 0 O-C-N 119.45 -2.031 . . . . 0.0 107.874 -167.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -57.96 106.95 0.28 Allowed 'Trans proline' 0 C--O 1.192 -1.779 1 C-N-CA 125.481 4.121 . . . . 0.0 113.117 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 38.77 36.34 0.14 Allowed 'General case' 0 C--N 1.387 2.235 0 C-N-CA 129.539 3.135 . . . . 0.0 115.244 -166.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.5 75.13 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 171.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.18 101.75 3.42 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.411 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.42 -1.26 0.04 OUTLIER Glycine 0 C--O 1.284 3.27 0 N-CA-C 122.952 3.941 . . . . 0.0 122.952 -167.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.76 144.26 68.55 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 121.797 -0.825 . . . . 0.0 113.138 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -82.95 163.67 15.68 Favored 'Trans proline' 0 CA--C 1.55 1.286 0 O-C-N 115.549 -2.921 . . . . 0.0 115.953 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.6 tt -78.55 144.35 11.29 Favored 'Isoleucine or valine' 0 C--O 1.277 2.534 0 CA-C-O 127.69 3.614 . . . . 0.0 112.026 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -150.06 144.46 25.77 Favored 'General case' 0 C--O 1.26 1.652 0 O-C-N 116.971 -3.58 . . . . 0.0 113.35 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.0 m -82.61 -36.29 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . 0.342 17.4 m120 -84.0 20.48 1.53 Allowed 'General case' 0 C--O 1.189 -2.084 0 C-N-CA 131.615 3.966 . . . . 0.0 116.124 -162.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 p -161.34 166.96 26.69 Favored 'General case' 0 C--N 1.388 2.248 0 C-N-CA 126.056 1.742 . . . . 0.0 112.538 171.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.0 p -94.44 169.6 9.47 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.131 0.972 . . . . 0.0 112.419 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -65.3 -23.69 58.87 Favored 'Trans proline' 0 CA--C 1.452 -3.589 0 O-C-N 116.908 -2.206 . . . . 0.0 116.908 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -68.01 -24.87 65.17 Favored 'General case' 0 C--O 1.274 2.348 0 C-N-CA 127.636 2.375 . . . . 0.0 107.751 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -78.64 -18.48 54.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 121.725 2.057 . . . . 0.0 115.205 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -84.3 74.04 10.38 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 125.228 2.442 . . . . 0.0 112.104 -162.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -156.04 141.66 10.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.753 1 C-N-CA 133.29 4.636 . . . . 0.0 112.859 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.02 -173.41 40.79 Favored Glycine 1 CA--C 1.581 4.186 0 CA-C-O 124.394 2.108 . . . . 0.0 116.321 -168.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -136.44 156.13 49.04 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 109.36 -3.42 . . . . 0.0 111.736 168.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 36.1 m-85 -99.86 143.32 30.22 Favored 'General case' 0 N--CA 1.391 -3.399 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 162.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -123.04 143.34 50.01 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 126.097 1.759 . . . . 0.0 112.299 165.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.97 166.06 1.63 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 165.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 133.406 4.682 . . . . 0.0 112.875 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.1 p -137.26 -13.72 1.56 Allowed 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 59.48 41.16 19.72 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 124.342 2.02 . . . . 0.0 112.203 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -120.37 3.55 10.79 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 118.138 -2.851 . . . . 0.0 116.589 -161.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.8 mm 65.56 92.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.16 -3.63 0 C-N-CA 130.806 3.643 . . . . 0.0 116.579 149.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -74.44 135.17 42.32 Favored 'General case' 0 N--CA 1.418 -2.071 0 O-C-N 124.144 0.902 . . . . 0.0 109.981 161.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.12 -142.4 16.0 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 125.475 1.735 . . . . 0.0 110.58 -170.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -135.17 174.41 21.19 Favored Glycine 0 C--N 1.291 -1.923 0 CA-C-O 126.2 3.111 . . . . 0.0 110.01 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 56.63 48.98 15.4 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 129.736 3.214 . . . . 0.0 116.1 171.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -136.76 136.46 8.36 Favored Glycine 0 CA--C 1.564 3.128 0 CA-C-O 118.635 -1.091 . . . . 0.0 112.159 166.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -67.86 128.61 37.12 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 126.177 1.791 . . . . 0.0 111.354 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -87.47 163.04 16.92 Favored 'General case' 0 N--CA 1.527 3.403 0 CA-C-N 121.157 1.799 . . . . 0.0 108.127 167.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -111.78 -18.79 12.64 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 127.818 3.198 . . . . 0.0 110.86 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.27 27.24 15.42 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.235 1.834 . . . . 0.0 112.134 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.59 167.67 17.1 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 122.747 1.26 . . . . 0.0 107.872 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -65.67 146.22 98.99 Favored Pre-proline 0 C--N 1.405 2.983 0 CA-C-N 112.215 -2.266 . . . . 0.0 116.761 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.02 155.41 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 1 C-N-CA 127.993 5.795 . . . . 0.0 111.872 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -114.83 172.34 7.1 Favored 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -140.82 147.1 38.49 Favored 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 126.936 2.094 . . . . 0.0 113.237 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 55.6 m-85 -132.14 145.71 51.55 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 130.409 3.484 . . . . 0.0 116.717 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -98.83 141.25 31.85 Favored 'General case' 0 C--O 1.262 1.734 0 O-C-N 118.198 -2.814 . . . . 0.0 109.544 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -142.41 122.82 13.99 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 127.669 2.388 . . . . 0.0 110.09 172.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -45.82 151.54 0.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 111.082 171.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.305 69.1 tp -52.84 132.63 37.14 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 125.886 2.755 . . . . 0.0 112.456 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.34 42.18 98.74 Favored Glycine 0 C--O 1.263 1.94 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.898 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -149.55 173.01 14.09 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 114.14 -1.03 . . . . 0.0 112.03 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 54.71 -159.51 5.59 Favored Glycine 0 C--O 1.255 1.421 0 O-C-N 119.727 -1.858 . . . . 0.0 115.186 -163.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.1 -19.34 63.18 Favored 'Trans proline' 0 N--CA 1.5 1.9 1 C-N-CA 125.638 4.225 . . . . 0.0 117.794 -166.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -117.45 35.32 4.72 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 124.645 1.178 . . . . 0.0 111.547 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.59 -5.65 1.32 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 119.967 -1.708 . . . . 0.0 114.159 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.31 -36.66 44.23 Favored Glycine 0 N--CA 1.417 -2.622 0 CA-C-O 114.729 -3.262 . . . . 0.0 113.928 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.6 mt -69.22 125.65 92.13 Favored Pre-proline 0 C--O 1.262 1.737 0 CA-C-N 121.228 2.514 . . . . 0.0 116.768 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.57 171.93 2.34 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 121.868 1.712 . . . . 0.0 114.485 160.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -68.22 138.37 55.52 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.16 74.8 Favored Glycine 1 CA--C 1.585 4.459 0 C-N-CA 117.225 -2.417 . . . . 0.0 116.811 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.34 82.2 8.38 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 171.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.49 126.72 29.17 Favored 'General case' 0 C--O 1.207 -1.163 0 O-C-N 118.044 -2.91 . . . . 0.0 113.126 -167.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -148.1 159.2 44.17 Favored 'General case' 0 C--O 1.182 -2.495 0 C-N-CA 126.714 2.006 . . . . 0.0 110.558 -170.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.1 133.84 46.56 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.8 -2.31 72.59 Favored Glycine 1 CA--C 1.621 6.658 0 O-C-N 119.636 -1.915 . . . . 0.0 114.377 169.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.8 mt -131.3 142.08 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 1 C-N-CA 131.952 4.101 . . . . 0.0 104.62 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.9 mm -137.73 112.96 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.759 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -76.47 128.58 35.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.288 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 m -133.05 142.92 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 127.465 3.507 . . . . 0.0 114.889 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.18 173.57 12.1 Favored 'General case' 0 CA--C 1.478 -1.81 0 O-C-N 118.159 -2.838 . . . . 0.0 112.571 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 37.2 p -127.61 157.11 41.11 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 129.539 3.136 . . . . 0.0 109.916 173.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -64.67 -35.82 82.27 Favored 'General case' 0 CA--C 1.582 2.18 0 C-N-CA 123.964 0.906 . . . . 0.0 112.694 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.79 -22.19 72.65 Favored Glycine 1 CA--C 1.595 5.076 0 O-C-N 119.592 -1.943 . . . . 0.0 114.361 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.69 165.71 4.89 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-N 120.319 2.06 . . . . 0.0 113.197 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.3 mt -126.88 147.44 50.06 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.655 2.782 . . . . 0.0 112.424 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -75.51 -2.68 30.07 Favored 'General case' 1 CA--C 1.63 4.042 0 C-N-CA 126.926 2.091 . . . . 0.0 114.311 -175.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -71.62 148.48 92.85 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 126.22 1.808 . . . . 0.0 111.26 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.6 142.98 9.52 Favored 'Trans proline' 0 CA--C 1.467 -2.872 0 C-N-CA 123.929 3.086 . . . . 0.0 109.931 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -94.08 65.12 3.39 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 117.574 -3.204 . . . . 0.0 108.155 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.52 -34.35 75.72 Favored 'General case' 0 CA--C 1.61 3.254 0 CA-C-O 113.214 -3.279 . . . . 0.0 115.624 -161.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.268 41.0 m80 -62.05 -44.49 96.57 Favored 'General case' 1 CA--C 1.645 4.629 0 O-C-N 126.019 2.074 . . . . 0.0 110.292 171.698 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.4 mt -64.49 -31.87 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.02 -2.03 88.29 Favored Glycine 0 CA--C 1.496 -1.134 0 CA-C-O 116.392 -2.338 . . . . 0.0 117.185 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.5 p -128.88 -27.19 2.56 Favored 'General case' 0 CA--C 1.596 2.724 0 CA-C-N 122.141 2.97 . . . . 0.0 113.251 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -49.4 154.58 0.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 122.292 2.315 . . . . 0.0 111.18 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -67.02 121.0 76.19 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 129.284 3.034 . . . . 0.0 113.595 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -33.79 84.76 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 N-CA-C 118.293 2.382 . . . . 0.0 118.293 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.13 0.41 36.35 Favored 'General case' 0 C--O 1.254 1.341 0 C-N-CA 127.058 2.143 . . . . 0.0 114.579 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -72.93 -16.73 61.54 Favored 'General case' 0 C--O 1.172 -3.015 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -146.36 146.31 30.61 Favored 'General case' 0 CA--C 1.609 3.226 0 CA-C-N 113.074 -1.876 . . . . 0.0 113.363 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.77 152.89 44.64 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 118.706 -2.496 . . . . 0.0 117.135 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.27 116.02 6.18 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 119.747 -1.846 . . . . 0.0 114.771 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.49 120.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.62 0 C-N-CA 127.922 2.489 . . . . 0.0 108.596 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.3 109.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 166.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.6 116.93 6.69 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -172.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -153.52 142.47 21.19 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 116.432 -3.917 . . . . 0.0 108.406 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.54 140.29 22.1 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 116.511 -1.709 . . . . 0.0 114.633 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -37.72 169.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 123.205 2.604 . . . . 0.0 115.325 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 54.64 19.14 2.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.636 2.374 . . . . 0.0 112.318 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.14 13.65 60.25 Favored Glycine 0 CA--C 1.562 3.021 0 O-C-N 116.682 -3.761 . . . . 0.0 116.458 -169.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -60.82 116.22 4.27 Favored 'General case' 0 C--O 1.165 -3.39 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.995 -167.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 m -70.18 146.92 50.43 Favored 'General case' 1 N--CA 1.539 4.016 0 C-N-CA 125.611 1.564 . . . . 0.0 113.534 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.56 157.03 77.79 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 122.47 1.129 . . . . 0.0 111.773 175.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.95 120.42 7.88 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 125.038 3.825 . . . . 0.0 112.56 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -60.44 -20.32 59.44 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -168.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.13 4.12 Favored Glycine 0 CA--C 1.54 1.609 1 O-C-N 116.071 -4.143 . . . . 0.0 117.51 161.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.61 125.8 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 123.256 3.528 . . . . 0.0 115.528 171.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -66.71 131.04 45.12 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 115.583 -2.151 . . . . 0.0 109.085 167.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.51 141.86 37.31 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 123.459 2.845 . . . . 0.0 112.301 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -55.37 153.85 6.82 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 101.41 174.59 28.58 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 127.841 2.639 . . . . 0.0 108.43 163.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.3 m 55.72 36.0 26.4 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -71.17 -20.78 62.25 Favored 'General case' 0 N--CA 1.491 1.603 1 C-N-CA 131.832 4.053 . . . . 0.0 112.935 -167.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.46 177.76 51.28 Favored Glycine 0 C--N 1.361 1.918 0 O-C-N 116.391 -3.943 . . . . 0.0 112.197 -166.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.44 -154.97 52.07 Favored Glycine 0 CA--C 1.544 1.867 0 O-C-N 118.353 -2.851 . . . . 0.0 114.591 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 125.777 2.703 . . . . 0.0 117.415 -1.012 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.371 -4.3 5 C1'-O4'-C4' 102.656 -7.715 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O4'--C1' 1.474 5.023 4 C1'-O4'-C4' 99.503 -11.218 . 0.235 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.461 -5.729 2 O4'-C1'-N19 114.207 6.007 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.122 5 O4'-C1'-N19 116.586 8.386 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C2'--C1' 1.593 6.462 0 C4'-C3'-C2' 99.78 -2.92 . 0.03 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.614 7.976 2 C3'-C2'-C1' 107.376 6.528 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O3'--C3' 1.369 -3.843 3 C4'-C3'-C2' 93.359 -9.341 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O3' 1.55 -4.778 1 C1'-O4'-C4' 105.116 -4.982 . 0.114 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.461 3.895 3 C3'-C2'-C1' 107.584 6.76 . 0.187 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.547 -5.016 4 O4'-C1'-N19 115.891 7.691 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.072 0 N-CA-C 105.778 -2.929 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.1 mt -87.48 155.0 54.15 Favored Pre-proline 0 CA--C 1.58 2.131 0 CA-C-N 121.894 2.847 . . . . 0.0 114.629 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.69 166.38 29.63 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 CA-C-O 129.255 3.773 . . . . 0.0 106.663 172.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -54.99 141.61 33.27 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 109.953 -3.294 . . . . 0.0 113.548 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -96.47 -35.28 11.19 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 m 61.25 -21.82 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 129.985 3.314 . . . . 0.0 118.261 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.42 151.75 26.45 Favored 'General case' 0 CA--C 1.618 3.56 0 O-C-N 118.247 -2.783 . . . . 0.0 113.818 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -77.78 153.25 33.03 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 118.862 -2.399 . . . . 0.0 112.576 167.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -76.07 -27.34 57.19 Favored 'General case' 0 C--O 1.281 2.717 0 C-N-CA 125.616 1.567 . . . . 0.0 114.06 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.64 164.96 11.78 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 124.582 2.134 . . . . 0.0 111.171 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -67.0 159.62 28.22 Favored 'General case' 0 C--O 1.288 3.088 0 CA-C-N 111.206 -2.724 . . . . 0.0 111.02 167.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.0 147.13 28.14 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 127.284 3.421 . . . . 0.0 114.282 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -76.21 162.17 28.18 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.467 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.7 m -122.03 125.41 46.2 Favored 'General case' 0 C--N 1.38 1.916 0 C-N-CA 124.423 1.089 . . . . 0.0 109.047 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -69.41 129.36 39.54 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 125.95 1.7 . . . . 0.0 109.462 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -123.78 -7.29 7.92 Favored 'General case' 0 C--O 1.203 -1.381 0 C-N-CA 128.522 2.729 . . . . 0.0 110.475 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.8 -139.79 10.58 Favored Glycine 0 CA--C 1.566 3.269 0 O-C-N 119.333 -2.104 . . . . 0.0 109.463 159.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -147.98 -17.69 0.35 Allowed 'General case' 0 C--O 1.189 -2.116 0 C-N-CA 128.957 2.903 . . . . 0.0 109.952 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.06 132.72 49.94 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -60.19 161.57 6.88 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.048 1.739 . . . . 0.0 111.55 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.15 69.75 9.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 119.433 -2.042 . . . . 0.0 110.067 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -67.32 149.47 50.3 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.402 170.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.06 141.33 41.06 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 126.025 1.73 . . . . 0.0 113.146 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.48 129.69 24.55 Favored 'Trans proline' 0 C--N 1.381 2.271 0 N-CA-C 106.438 -2.178 . . . . 0.0 106.438 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 55.59 21.62 4.63 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 126.909 2.084 . . . . 0.0 115.583 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.01 27.81 72.73 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 124.573 1.082 . . . . 0.0 115.608 -170.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.258 20.1 tt0 -84.85 84.74 7.6 Favored 'General case' 1 CA--C 1.638 4.33 0 C-N-CA 128.463 2.705 . . . . 0.0 106.258 -175.241 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.11 0.08 OUTLIER Glycine 0 C--O 1.206 -1.648 2 CA-C-O 128.64 4.466 . . . . 0.0 123.615 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.1 t -69.96 126.88 92.66 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.975 -3.662 . . . . 0.0 111.004 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.63 160.86 4.86 Favored 'Trans proline' 0 CA--C 1.58 2.782 1 C-N-CA 128.518 6.145 . . . . 0.0 114.582 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.3 tt -85.28 142.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 159.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -157.54 104.82 2.01 Favored 'General case' 0 C--O 1.272 2.266 0 C-N-CA 126.955 2.102 . . . . 0.0 110.898 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.6 m -59.17 -32.71 70.15 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 125.389 1.68 . . . . 0.0 113.434 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -83.43 2.7 35.31 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.8 p -114.63 147.66 39.23 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 129.549 3.139 . . . . 0.0 110.287 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.2 t -72.35 155.65 91.18 Favored Pre-proline 0 CA--C 1.609 3.247 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -36.3 -31.87 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.682 1 C-N-CA 126.769 4.979 . . . . 0.0 114.45 152.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -82.58 -22.2 34.94 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 120.043 1.292 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -83.89 -14.57 50.75 Favored 'General case' 0 C--O 1.213 -0.861 0 O-C-N 119.369 -2.082 . . . . 0.0 114.367 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -68.9 59.11 0.09 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -167.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 tt -156.25 139.59 7.45 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.06 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.72 -160.71 30.96 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.034 -1.425 . . . . 0.0 114.921 -172.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -148.85 145.67 27.6 Favored 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 119.63 1.715 . . . . 0.0 110.169 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -85.4 161.22 19.53 Favored 'General case' 0 C--N 1.396 2.62 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 164.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -125.58 157.73 36.4 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 118.878 -2.389 . . . . 0.0 109.041 161.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.461 HH22 ' CG ' ' A' ' 128' ' ' ASP . 26.9 ptt180 -77.81 159.81 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.664 1.585 . . . . 0.0 107.815 169.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.04 136.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.449 1.9 . . . . 0.0 110.671 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -133.97 -16.22 2.25 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -168.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 55.26 60.03 3.63 Favored 'General case' 0 N--CA 1.538 3.944 0 O-C-N 119.568 -1.958 . . . . 0.0 107.051 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -128.18 -8.61 5.34 Favored 'General case' 0 C--O 1.193 -1.914 0 O-C-N 119.408 -2.057 . . . . 0.0 109.125 -160.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.337 1.1 mp 68.39 136.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 171.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -145.54 -0.47 0.84 Allowed 'General case' 0 C--O 1.272 2.241 0 C-N-CA 127.503 2.321 . . . . 0.0 114.231 167.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -140.22 -149.07 5.26 Favored Glycine 0 C--N 1.39 3.531 0 C-N-CA 125.688 1.613 . . . . 0.0 113.701 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.43 -131.37 1.84 Allowed Glycine 0 N--CA 1.514 3.874 0 O-C-N 118.775 -2.603 . . . . 0.0 113.492 162.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 45.06 24.0 0.11 Allowed 'General case' 0 N--CA 1.502 2.151 1 C-N-CA 133.415 4.686 . . . . 0.0 116.145 168.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.67 166.81 34.88 Favored Glycine 0 N--CA 1.501 3.011 0 O-C-N 125.177 1.548 . . . . 0.0 115.613 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -128.7 134.57 48.52 Favored 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 114.642 -2.599 . . . . 0.0 114.192 -170.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 31.9 mtp -68.5 142.67 55.22 Favored 'General case' 0 N--CA 1.518 2.931 0 CA-C-N 122.381 2.355 . . . . 0.0 111.265 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.488 ' HE2' ' N3 ' ' B' ' 7' ' ' ' A' . 61.4 tttt -120.03 -4.15 10.09 Favored 'General case' 1 C--O 1.309 4.234 0 C-N-CA 129.644 3.178 . . . . 0.0 116.945 176.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.5 0.4 OUTLIER 73.68 -10.67 1.04 Allowed 'General case' 0 C--N 1.363 1.164 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 177.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.7 mt -68.91 153.73 43.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 129.395 3.078 . . . . 0.0 111.698 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.8 m -66.86 167.64 13.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 114.761 -2.542 . . . . 0.0 111.544 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.259 59.3 Cg_exo -65.28 164.72 24.55 Favored 'Trans proline' 0 CA--C 1.584 3.011 0 C-N-CA 124.504 3.469 . . . . 0.0 114.348 -176.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -131.53 168.63 17.33 Favored 'General case' 0 C--N 1.386 2.173 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -128.7 127.63 42.5 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 128.113 3.383 . . . . 0.0 112.283 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -108.04 144.5 35.29 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 128.336 3.523 . . . . 0.0 111.194 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.6 144.1 31.88 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -140.36 151.34 44.91 Favored 'General case' 0 N--CA 1.514 2.765 0 O-C-N 118.635 -2.541 . . . . 0.0 109.83 176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.4 ' CD1' HG21 ' A' ' 146' ' ' ILE . 27.5 m-85 -90.46 161.29 15.6 Favored 'General case' 0 CA--C 1.595 2.708 0 CA-C-O 125.887 2.756 . . . . 0.0 112.586 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.3 tp -57.77 116.12 3.24 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 117.809 -3.057 . . . . 0.0 109.608 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.74 17.9 50.1 Favored Glycine 0 N--CA 1.501 3.0 0 O-C-N 118.584 -2.572 . . . . 0.0 115.259 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -133.55 165.37 25.05 Favored 'General case' 0 CA--C 1.504 -0.827 1 C-N-CA 132.841 4.456 . . . . 0.0 112.815 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.23 -165.69 52.09 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 125.683 1.611 . . . . 0.0 110.176 171.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.65 -28.54 52.41 Favored 'Trans proline' 0 N--CA 1.427 -2.393 1 C-N-CA 127.195 5.264 . . . . 0.0 111.422 -171.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -96.01 17.58 15.16 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 117.976 -2.952 . . . . 0.0 114.607 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.94 -12.21 0.3 Allowed 'General case' 0 C--N 1.39 2.366 0 O-C-N 118.869 -2.395 . . . . 0.0 116.095 -168.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.17 -34.63 57.99 Favored Glycine 0 C--N 1.287 -2.156 0 C-N-CA 128.461 2.934 . . . . 0.0 114.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.64 142.08 83.26 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.982 2.113 . . . . 0.0 115.044 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -77.4 163.91 29.36 Favored 'Trans proline' 0 C--N 1.397 3.111 1 C-N-CA 126.58 4.853 . . . . 0.0 115.118 161.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.42 151.18 41.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 117.374 -1.73 . . . . 0.0 115.124 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.91 8.12 5.49 Favored Glycine 0 CA--C 1.56 2.886 0 N-CA-C 120.903 3.121 . . . . 0.0 120.903 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.72 137.67 49.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 121.062 2.431 . . . . 0.0 113.458 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -78.89 142.79 36.49 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-O 116.307 -1.806 . . . . 0.0 114.227 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.06 142.41 7.35 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 129.672 3.189 . . . . 0.0 111.132 159.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.461 ' CG ' HH22 ' A' ' 89' ' ' ARG . 13.6 t0 -65.34 121.56 15.11 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 126.46 1.904 . . . . 0.0 115.222 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.94 74.72 Favored Glycine 0 CA--C 1.568 3.383 1 C-N-CA 130.957 4.122 . . . . 0.0 122.435 -169.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.1 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 O-C-N 128.199 2.941 . . . . 0.0 108.813 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.9 mm -120.9 119.89 60.77 Favored 'Isoleucine or valine' 0 C--N 1.385 2.112 0 CA-C-O 123.154 1.454 . . . . 0.0 112.491 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -73.63 138.99 45.16 Favored 'General case' 0 C--N 1.372 1.56 0 O-C-N 119.08 -2.262 . . . . 0.0 109.117 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.95 147.51 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.577 0 C-N-CA 123.635 0.774 . . . . 0.0 111.998 159.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.71 169.78 17.81 Favored 'General case' 0 N--CA 1.395 -3.193 0 C-N-CA 126.848 2.059 . . . . 0.0 113.455 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.255 81.8 p -98.93 170.03 9.02 Favored 'General case' 0 C--O 1.248 0.994 0 O-C-N 120.242 -1.536 . . . . 0.0 113.631 152.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -60.05 -45.78 91.73 Favored 'General case' 0 C--O 1.283 2.863 0 CA-C-O 116.932 -1.508 . . . . 0.0 112.483 160.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.31 -34.45 67.86 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.89 153.78 41.08 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.967 1.365 . . . . 0.0 111.598 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.43 145.21 31.14 Favored 'General case' 0 C--O 1.259 1.581 0 C-N-CA 130.043 3.337 . . . . 0.0 113.792 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -65.49 4.37 0.56 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 p -85.74 142.51 36.99 Favored Pre-proline 0 CA--C 1.479 -1.761 0 C-N-CA 128.832 2.853 . . . . 0.0 109.934 -166.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -59.29 117.21 3.91 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 124.306 3.338 . . . . 0.0 109.845 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -68.17 52.86 0.07 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 126.385 1.874 . . . . 0.0 113.317 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.56 -24.35 67.48 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -171.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -74.14 -35.82 64.12 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.4 HG21 ' CD1' ' A' ' 112' ' ' TYR . 80.4 mt -67.72 -18.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 O-C-N 119.927 -1.733 . . . . 0.0 110.76 164.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.49 -11.7 65.97 Favored Glycine 0 CA--C 1.569 3.435 0 O-C-N 124.44 1.088 . . . . 0.0 115.738 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 24.7 p -130.5 -33.18 1.67 Allowed 'General case' 0 C--N 1.373 1.626 0 O-C-N 124.672 0.866 . . . . 0.0 111.441 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -66.2 142.05 57.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.642 1.564 . . . . 0.0 110.715 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -81.96 114.01 47.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 119.817 -1.802 . . . . 0.0 111.127 -149.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 -4.37 15.24 Favored 'Trans proline' 0 N--CA 1.425 -2.508 0 C-N-CA 124.069 3.179 . . . . 0.0 111.124 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.69 19.12 15.47 Favored 'General case' 0 C--O 1.193 -1.87 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -71.62 -54.95 8.75 Favored 'General case' 0 C--O 1.293 3.379 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.542 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.51 177.92 7.59 Favored 'General case' 0 CA--C 1.598 2.795 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.265 164.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.81 19.88 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 127.32 2.248 . . . . 0.0 107.206 170.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.24 136.55 58.0 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 113.973 -2.917 . . . . 0.0 117.775 169.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.5 mt -58.53 121.4 6.05 Favored 'Isoleucine or valine' 0 C--N 1.381 1.958 0 O-C-N 128.882 3.864 . . . . 0.0 108.242 165.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.19 103.8 2.0 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 O-C-N 120.086 -1.634 . . . . 0.0 110.664 172.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.52 106.74 0.58 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.551 1.941 . . . . 0.0 111.209 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -119.6 160.3 22.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-O 122.995 1.379 . . . . 0.0 109.773 156.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 83.7 mt -74.75 162.3 74.16 Favored Pre-proline 1 N--CA 1.54 4.042 0 C-N-CA 126.313 1.845 . . . . 0.0 110.528 163.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.27 164.39 10.73 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.182 1.921 . . . . 0.0 116.442 161.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 40.76 41.47 1.18 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 125.79 1.636 . . . . 0.0 113.472 -170.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.73 21.02 1.32 Allowed Glycine 0 CA--C 1.562 3.015 0 O-C-N 125.86 1.975 . . . . 0.0 117.076 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 84.9 m -58.17 131.72 51.4 Favored 'General case' 0 C--N 1.394 2.534 0 O-C-N 117.85 -3.147 . . . . 0.0 115.14 -165.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . 0.267 27.6 m -77.09 116.83 18.08 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 127.646 3.091 . . . . 0.0 114.161 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.36 154.63 83.0 Favored Pre-proline 0 CA--C 1.586 2.352 0 C-N-CA 130.804 3.642 . . . . 0.0 110.107 -169.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.96 149.44 7.98 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.673 2.249 . . . . 0.0 117.586 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.34 -16.66 62.45 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.319 1.448 . . . . 0.0 114.667 -163.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.18 -0.96 78.99 Favored Glycine 0 CA--C 1.572 3.621 0 CA-C-O 117.24 -1.867 . . . . 0.0 116.978 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -120.74 135.84 55.03 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.092 2.446 . . . . 0.0 111.368 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -83.89 154.3 23.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 127.266 2.854 . . . . 0.0 107.884 164.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . 0.292 . . -156.72 154.03 29.38 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 126.153 2.883 . . . . 0.0 112.649 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -62.97 140.11 58.83 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 112.348 -2.206 . . . . 0.0 112.134 159.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.7 -166.82 54.61 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 127.876 2.655 . . . . 0.0 111.468 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m 47.64 35.08 4.09 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 124.023 0.929 . . . . 0.0 110.002 -162.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.93 -10.44 59.72 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 129.395 3.078 . . . . 0.0 110.86 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.97 -118.34 5.93 Favored Glycine 0 C--O 1.268 2.251 0 O-C-N 118.973 -2.329 . . . . 0.0 110.154 169.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 68.56 -153.24 52.86 Favored Glycine 0 C--N 1.301 -1.413 0 O-C-N 119.238 -2.331 . . . . 0.0 118.819 167.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 1 N--CA 1.546 4.36 0 C-N-CA 125.418 1.487 . . . . 0.0 107.802 -7.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.515 -7.792 2 O4'-C1'-N19 114.073 5.873 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.465 -6.347 3 C3'-C2'-C1' 106.545 5.606 . 0.01 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.543 1 C4'-C3'-C2' 98.366 -4.334 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.671 7.763 3 O4'-C1'-N19 115.965 7.765 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C5'--C4' 1.582 5.554 2 P-O3'-C3' 127.733 6.695 . 0.376 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.685 9.241 2 C5'-C4'-C3' 104.827 -7.115 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ' A' . . . . . 0.488 ' N3 ' ' HE2' ' A' ' 102' ' ' LYS . . . . . . . . 1 O4'--C4' 1.402 -4.26 1 O4'-C1'-N19 103.841 -4.359 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C2'--O2' 1.36 -4.095 3 C4'-C3'-C2' 95.779 -6.921 . 0.151 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O4'--C4' 1.391 -5.197 2 P-O3'-C3' 125.991 5.242 . 0.09 &a . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 P--O5' 1.55 -4.288 1 O3'-P-O5' 95.887 -4.27 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.217 0 N-CA-C 106.545 -2.622 . . . . 0.0 106.545 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.49 156.66 88.09 Favored Pre-proline 0 C--N 1.369 1.414 0 O-C-N 119.314 -2.286 . . . . 0.0 116.77 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.92 127.32 25.78 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 124.647 3.565 . . . . 0.0 111.389 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -71.49 133.73 46.05 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.55 -18.34 45.26 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -171.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m 59.27 -43.95 0.07 Allowed 'General case' 0 CA--C 1.589 2.445 0 C-N-CA 129.603 3.161 . . . . 0.0 118.295 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 39.19 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.976 2.11 . . . . 0.0 114.725 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.464 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 47.6 t -85.46 139.13 31.75 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 125.655 1.582 . . . . 0.0 113.429 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -79.86 -9.27 59.65 Favored 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 125.362 1.465 . . . . 0.0 113.892 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -109.85 157.09 19.56 Favored 'General case' 0 CA--C 1.581 2.163 0 CA-C-O 124.294 1.997 . . . . 0.0 110.717 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 p -68.2 165.37 18.48 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -111.61 136.92 50.16 Favored 'General case' 0 C--O 1.259 1.586 0 O-C-N 119.566 -1.959 . . . . 0.0 109.736 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.9 mt -75.08 160.86 29.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 126.634 1.973 . . . . 0.0 110.781 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.5 m -126.31 139.29 53.42 Favored 'General case' 0 N--CA 1.493 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 110.652 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.62 141.1 55.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.766 2.426 . . . . 0.0 109.055 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -125.59 -34.19 2.69 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 161.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.01 -126.85 0.02 OUTLIER Glycine 0 C--N 1.305 -1.15 1 CA-C-O 127.99 4.106 . . . . 0.0 113.948 168.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -154.45 -28.01 0.12 Allowed 'General case' 0 C--N 1.292 -1.911 2 O-C-N 114.434 -5.156 . . . . 0.0 111.381 163.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.35 145.89 53.77 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.71 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -54.23 167.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 117.534 -3.229 . . . . 0.0 112.349 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.1 tp -74.26 64.72 1.12 Allowed 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 125.31 2.481 . . . . 0.0 114.362 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -75.55 140.29 42.63 Favored 'General case' 0 C--O 1.287 3.027 0 O-C-N 119.166 -2.209 . . . . 0.0 111.043 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -127.06 156.81 73.79 Favored Pre-proline 0 C--N 1.397 2.658 0 O-C-N 119.256 -2.152 . . . . 0.0 111.319 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -79.86 141.18 14.97 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 42.92 16.46 0.01 OUTLIER 'General case' 0 CA--C 1.584 2.262 0 O-C-N 126.3 2.25 . . . . 0.0 116.207 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.49 73.24 Favored Glycine 0 CA--C 1.557 2.68 1 C-N-CA 130.95 4.119 . . . . 0.0 116.359 -164.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -85.42 108.23 17.77 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 117.39 -1.291 . . . . 0.0 110.319 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.91 10.85 0.03 OUTLIER Glycine 1 CA--C 1.601 5.431 0 CA-C-O 114.655 -3.303 . . . . 0.0 117.46 -170.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.18 125.81 59.0 Favored Pre-proline 0 CA--C 1.587 2.387 0 CA-C-N 122.752 3.276 . . . . 0.0 113.482 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.22 153.18 24.4 Favored 'Trans proline' 0 N--CA 1.421 -2.739 0 C-N-CA 122.762 2.308 . . . . 0.0 111.806 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -70.84 146.0 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 O-C-N 128.407 3.567 . . . . 0.0 109.972 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -145.91 111.05 5.3 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 118.291 -0.861 . . . . 0.0 109.695 162.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -67.17 -15.69 63.86 Favored 'General case' 0 C--N 1.378 1.833 0 CA-C-N 123.099 2.681 . . . . 0.0 111.604 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -89.43 12.16 17.2 Favored 'General case' 0 CA--C 1.608 3.2 0 C-N-CA 128.761 2.824 . . . . 0.0 110.719 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -120.93 163.23 18.55 Favored 'General case' 0 C--O 1.256 1.412 0 O-C-N 125.147 1.529 . . . . 0.0 111.407 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.8 p -101.76 163.25 18.17 Favored Pre-proline 0 C--O 1.256 1.403 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -59.37 -26.18 81.03 Favored 'Trans proline' 0 CA--C 1.563 1.954 0 CA-C-N 122.666 1.988 . . . . 0.0 110.485 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.47 -30.65 63.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 120.711 1.596 . . . . 0.0 113.91 173.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -79.99 -16.32 55.43 Favored 'General case' 0 C--O 1.186 -2.272 0 C-N-CA 127.643 2.377 . . . . 0.0 115.292 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -73.41 61.8 0.69 Allowed 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 129.32 3.048 . . . . 0.0 116.05 -167.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.264 13.3 tt -153.53 138.27 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 127.953 3.283 . . . . 0.0 108.363 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.46 -152.73 11.31 Favored Glycine 0 CA--C 1.489 -1.555 0 O-C-N 116.887 -3.633 . . . . 0.0 114.796 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -149.96 138.37 20.59 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 127.136 2.174 . . . . 0.0 110.493 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -89.35 155.71 19.18 Favored 'General case' 0 C--N 1.286 -2.18 0 O-C-N 127.85 3.219 . . . . 0.0 109.75 159.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -145.39 148.94 33.89 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.554 -1.341 . . . . 0.0 108.677 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -86.95 -177.72 6.13 Favored 'General case' 0 CA--C 1.61 3.263 0 CA-C-N 121.827 2.103 . . . . 0.0 114.906 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 136.9 9.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 118.878 -2.389 . . . . 0.0 110.592 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.9 p -145.4 -17.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 113.814 -2.993 . . . . 0.0 113.724 -164.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 47.47 48.72 16.54 Favored 'General case' 0 CA--C 1.602 2.956 0 O-C-N 125.39 1.681 . . . . 0.0 111.603 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -105.65 -9.57 17.27 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 119.939 -1.726 . . . . 0.0 112.444 170.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' HA ' ' N3 ' ' B' ' 4' ' ' ' C' . 1.3 mp 70.85 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.27 2.173 0 C-N-CA 127.051 2.14 . . . . 0.0 110.76 172.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -123.35 -24.19 4.68 Favored 'General case' 0 CA--C 1.586 2.334 1 C-N-CA 133.205 4.602 . . . . 0.0 110.296 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.13 102.58 0.17 Allowed Glycine 0 C--O 1.2 -1.972 0 O-C-N 118.678 -2.514 . . . . 0.0 108.084 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.65 -155.39 51.09 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 124.459 2.144 . . . . 0.0 108.176 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 53.56 14.68 0.62 Allowed 'General case' 0 C--O 1.266 1.941 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.79 -172.49 45.07 Favored Glycine 0 C--N 1.285 -2.297 0 O-C-N 118.055 -2.903 . . . . 0.0 117.968 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -135.29 154.89 51.39 Favored 'General case' 0 N--CA 1.489 1.507 1 C-N-CA 133.374 4.669 . . . . 0.0 112.409 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -105.22 163.57 12.49 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 127.864 2.466 . . . . 0.0 111.795 -172.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -154.88 -7.27 0.14 Allowed 'General case' 0 C--O 1.239 0.509 0 O-C-N 120.908 -1.12 . . . . 0.0 112.244 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.95 37.85 22.13 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 126.101 1.76 . . . . 0.0 112.986 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.76 169.6 18.0 Favored 'General case' 0 C--O 1.289 3.144 0 C-N-CA 125.578 1.551 . . . . 0.0 110.621 167.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . 0.278 52.6 m -62.32 145.5 94.05 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 123.29 1.519 . . . . 0.0 114.992 170.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.263 15.1 Cg_exo -42.67 155.96 0.1 Allowed 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 121.709 1.606 . . . . 0.0 113.247 164.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -121.4 159.4 26.25 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.601 2.361 . . . . 0.0 115.545 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -129.92 139.94 51.03 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 126.72 2.512 . . . . 0.0 115.631 161.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -121.36 154.19 36.77 Favored 'General case' 0 CA--C 1.592 2.593 0 C-N-CA 126.464 1.905 . . . . 0.0 109.957 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -111.19 141.18 45.04 Favored 'General case' 0 N--CA 1.535 3.801 0 CA-C-N 122.929 2.604 . . . . 0.0 113.906 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 51' ' ' SER . 8.2 m-85 -141.66 150.92 42.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 125.021 2.343 . . . . 0.0 110.063 170.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -87.59 156.01 19.7 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-N 114.085 -1.416 . . . . 0.0 113.207 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.3 tp -51.47 127.62 20.55 Favored 'General case' 0 C--O 1.271 2.23 0 C-N-CA 124.072 0.949 . . . . 0.0 112.961 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.56 73.83 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.6 p -142.59 -178.51 5.81 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 119.709 1.754 . . . . 0.0 109.616 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.38 -154.1 45.4 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -73.73 -43.08 0.67 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.325 2.017 . . . . 0.0 115.203 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.327 2.5 mm-40 -81.94 27.74 0.45 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 131.431 3.892 . . . . 0.0 110.481 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.76 -19.52 50.83 Favored 'General case' 0 C--O 1.159 -3.706 0 O-C-N 118.188 -2.82 . . . . 0.0 113.096 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.29 -34.5 54.65 Favored Glycine 0 C--O 1.253 1.337 0 O-C-N 124.752 1.282 . . . . 0.0 113.809 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 mt -65.36 139.29 97.34 Favored Pre-proline 0 CA--C 1.607 3.143 0 CA-C-N 120.772 2.286 . . . . 0.0 113.297 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -61.92 166.17 12.79 Favored 'Trans proline' 0 C--O 1.272 2.178 0 O-C-N 124.42 1.747 . . . . 0.0 113.983 155.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -65.09 123.43 19.49 Favored 'General case' 0 C--N 1.365 1.261 0 CA-C-N 110.27 -3.15 . . . . 0.0 116.6 170.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 20.22 62.86 Favored Glycine 0 CA--C 1.576 3.904 0 CA-C-O 124.128 1.96 . . . . 0.0 111.148 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.34 135.69 47.46 Favored 'General case' 0 C--O 1.25 1.094 0 O-C-N 117.534 -3.333 . . . . 0.0 108.793 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.73 11.94 1.5 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -161.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . 0.291 66.7 tttt -72.31 126.03 28.82 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 124.32 2.009 . . . . 0.0 111.238 -167.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -53.8 138.74 35.1 Favored 'General case' 0 C--O 1.271 2.226 0 O-C-N 117.588 -3.195 . . . . 0.0 108.038 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.15 -11.42 63.81 Favored Glycine 0 N--CA 1.502 3.076 0 CA-C-O 116.147 -2.474 . . . . 0.0 117.367 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -108.97 134.7 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.616 3.517 0 C-N-CA 130.618 3.567 . . . . 0.0 110.91 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.88 124.11 71.63 Favored 'Isoleucine or valine' 0 C--O 1.291 3.28 0 O-C-N 125.694 1.871 . . . . 0.0 109.323 171.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.68 134.8 33.59 Favored 'General case' 0 CA--C 1.587 2.396 0 CA-C-O 125.418 2.532 . . . . 0.0 111.516 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.28 141.42 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 O-C-N 119.323 -2.11 . . . . 0.0 111.152 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.96 170.96 14.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 p -131.79 157.62 43.39 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 113.492 -1.685 . . . . 0.0 114.893 158.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -72.0 -27.24 62.61 Favored 'General case' 0 C--N 1.365 1.28 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.95 -18.25 63.64 Favored Glycine 0 CA--C 1.565 3.189 0 C-N-CA 127.792 2.615 . . . . 0.0 118.143 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.22 147.32 53.19 Favored 'General case' 0 C--O 1.286 3.017 0 C-N-CA 127.152 2.181 . . . . 0.0 110.202 162.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.88 142.1 30.05 Favored 'General case' 0 C--O 1.285 2.94 0 CA-C-O 125.122 2.391 . . . . 0.0 108.024 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -48.03 -12.46 0.03 OUTLIER 'General case' 0 CA--C 1.6 2.867 0 CA-C-O 114.014 -2.898 . . . . 0.0 116.012 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -55.34 139.42 66.21 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 130.841 3.656 . . . . 0.0 114.025 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -64.28 140.25 69.76 Favored 'Trans proline' 0 N--CA 1.528 3.503 0 C-N-CA 122.831 2.354 . . . . 0.0 106.369 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -91.53 60.84 4.17 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -23.12 66.09 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.816 -165.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -61.81 -55.51 29.22 Favored 'General case' 0 CA--C 1.61 3.287 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 6.4 mt -60.81 -25.26 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.623 0 C-N-CA 116.781 -1.968 . . . . 0.0 111.567 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.51 -12.03 83.44 Favored Glycine 1 CA--C 1.587 4.567 0 C-N-CA 128.696 3.046 . . . . 0.0 116.695 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.6 p -126.88 -24.96 3.41 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.3 158.71 28.78 Favored 'General case' 0 C--O 1.266 1.931 0 O-C-N 117.153 -3.467 . . . . 0.0 106.511 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.5 118.43 47.42 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.835 -2.507 . . . . 0.0 112.432 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -73.4 -25.31 15.51 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.95 2.433 . . . . 0.0 115.93 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.32 -4.27 35.24 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 120.699 -1.25 . . . . 0.0 109.705 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.82 -28.92 70.19 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 121.407 1.912 . . . . 0.0 113.64 -165.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.57 159.93 29.55 Favored 'General case' 0 C--O 1.25 1.119 1 C-N-CA 131.99 4.116 . . . . 0.0 110.847 160.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -53.94 160.74 1.37 Allowed 'General case' 1 N--CA 1.54 4.029 0 C-N-CA 128.441 2.696 . . . . 0.0 111.996 172.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.35 130.97 49.28 Favored 'General case' 0 CA--C 1.584 2.283 0 O-C-N 118.276 -2.765 . . . . 0.0 112.546 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.81 126.77 32.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 124.215 1.959 . . . . 0.0 107.193 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.0 126.8 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.608 0 O-C-N 120.157 -1.589 . . . . 0.0 111.827 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.73 116.7 7.21 Favored 'General case' 0 CA--C 1.604 3.035 0 O-C-N 126.589 2.431 . . . . 0.0 114.373 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -141.23 152.9 44.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 116.304 -3.997 . . . . 0.0 111.399 164.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -113.81 155.26 45.4 Favored Pre-proline 0 C--N 1.256 -3.498 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.469 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -48.92 159.67 0.88 Allowed 'Trans proline' 0 C--O 1.272 2.222 1 C-N-CA 132.108 8.539 . . . . 0.0 120.656 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.323 24.4 mt-30 46.52 31.72 1.42 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.62 72.28 Favored Glycine 0 CA--C 1.55 2.243 0 O-C-N 116.568 -3.832 . . . . 0.0 112.009 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.5 m -63.52 122.39 16.17 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-O 116.192 -1.861 . . . . 0.0 110.248 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 81.5 m -58.77 134.3 56.72 Favored 'General case' 0 C--N 1.382 2.015 0 CA-C-O 115.578 -2.154 . . . . 0.0 113.286 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.62 152.89 32.78 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 125.476 3.762 . . . . 0.0 111.344 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -62.94 145.09 94.31 Favored 'Trans proline' 1 CA--C 1.62 4.777 0 C-N-CA 125.06 3.84 . . . . 0.0 112.801 -161.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -69.11 -18.87 64.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 117.763 -3.086 . . . . 0.0 116.459 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.73 -17.95 10.07 Favored Glycine 0 CA--C 1.542 1.753 0 O-C-N 118.302 -2.749 . . . . 0.0 114.773 164.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.8 145.04 48.0 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 121.359 2.579 . . . . 0.0 115.829 -165.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -87.16 142.48 27.88 Favored 'General case' 0 CA--C 1.604 3.022 0 C-N-CA 131.006 3.722 . . . . 0.0 107.071 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.43 170.04 16.47 Favored 'General case' 0 CA--C 1.576 1.97 0 O-C-N 125.589 1.805 . . . . 0.0 113.517 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.0 162.65 14.63 Favored 'General case' 0 CA--C 1.555 1.147 0 O-C-N 124.556 1.16 . . . . 0.0 112.837 169.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 86.33 141.41 6.29 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-O 117.838 -1.534 . . . . 0.0 111.906 -170.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.7 m 60.46 41.94 15.16 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 125.215 1.185 . . . . 0.0 113.915 174.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -93.63 -1.58 55.14 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 -174.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 69.29 154.23 0.81 Allowed Glycine 0 N--CA 1.515 3.965 0 C-N-CA 128.224 2.821 . . . . 0.0 110.944 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.45 -168.42 38.81 Favored Glycine 0 CA--C 1.57 3.526 0 CA-C-O 116.411 -2.327 . . . . 0.0 114.056 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 CA--C 1.578 2.02 0 C-N-CA 128.372 2.669 . . . . 0.0 108.491 -9.055 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.558 HO2' " H5'" ' B' ' 2' ' ' ' C' . . . . . . . . 2 P--O5' 1.527 -6.611 4 C5'-C4'-C3' 106.693 -5.872 . 0.0 '__' . 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.558 " H5'" HO2' ' B' ' 1' ' ' ' U' . . . . . . . . 2 O5'--C5' 1.365 -4.716 2 P-O3'-C3' 124.79 4.241 . 0.642 1b . 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.624 3.107 2 O4'-C1'-N19 113.138 4.938 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.401 ' N3 ' ' HA ' ' A' ' 94' ' ' ILE . . . . . . . . 0 P--O3' 1.565 -3.5 4 O5'-C5'-C4' 119.717 6.798 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.515 -7.778 3 C4'-C3'-C2' 95.298 -7.402 . 0.114 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 3 P--O5' 1.54 -5.288 5 C3'-C2'-C1' 108.328 7.587 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.469 -5.033 1 C5'-C4'-C3' 122.188 4.459 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.429 HO2' " C5'" ' B' ' 9' ' ' ' C' . . . . . . . . 3 C4'--C3' 1.581 5.184 1 N19-C1'-C2' 120.003 4.127 . 0.199 &a . 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ' C' . . . . . 0.429 " C5'" HO2' ' B' ' 8' ' ' ' A' . . . . . . . . 1 C5'--C4' 1.623 8.684 5 C3'-C2'-C1' 107.36 6.511 . 0.067 1a . 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C4'--C3' 1.562 3.466 2 O4'-C1'-C2' 113.074 4.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt -115.8 141.6 27.76 Favored Pre-proline 0 C--O 1.281 2.72 0 O-C-N 118.234 -2.921 . . . . 0.0 105.827 166.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -67.83 154.45 73.0 Favored 'Trans proline' 0 N--CA 1.53 3.669 0 CA-C-O 114.172 -2.512 . . . . 0.0 112.479 -169.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -69.08 123.89 22.28 Favored 'General case' 0 CA--C 1.582 2.2 0 O-C-N 126.168 2.167 . . . . 0.0 110.51 161.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -80.7 -13.24 59.18 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 127.586 2.355 . . . . 0.0 114.869 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.3 m 57.24 -29.77 0.03 OUTLIER 'General case' 1 CA--C 1.644 4.561 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 171.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.326 . . -91.3 169.54 10.73 Favored 'General case' 0 C--O 1.188 -2.169 0 C-N-CA 127.011 2.125 . . . . 0.0 111.592 -174.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.1 t -84.81 130.4 34.68 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 128.325 2.65 . . . . 0.0 114.625 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -71.3 -15.01 62.39 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 127.627 2.371 . . . . 0.0 113.66 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.444 ' CD1' ' HB ' ' A' ' 157' ' ' ILE . 15.5 m-85 -118.02 173.26 6.88 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 127.378 2.271 . . . . 0.0 116.403 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p -61.27 153.01 27.55 Favored 'General case' 0 C--O 1.287 3.068 0 O-C-N 128.831 3.832 . . . . 0.0 110.851 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.59 154.43 19.95 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 129.766 3.227 . . . . 0.0 112.408 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.09 156.32 20.73 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.744 1.218 . . . . 0.0 108.711 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.4 m -139.46 121.9 16.12 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 131.486 3.914 . . . . 0.0 114.296 -168.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.262 4.5 tp-100 -77.42 142.32 39.3 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.244 1.497 . . . . 0.0 113.501 -167.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -135.77 -22.55 1.43 Allowed 'General case' 0 CA--C 1.601 2.93 0 CA-C-O 113.272 -3.251 . . . . 0.0 111.319 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.32 -130.92 0.61 Allowed Glycine 1 CA--C 1.61 6.012 0 O-C-N 126.47 2.356 . . . . 0.0 111.051 153.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -149.31 -20.93 0.29 Allowed 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 131.122 3.769 . . . . 0.0 113.053 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.94 147.84 48.32 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 124.893 1.371 . . . . 0.0 114.195 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.9 158.59 21.77 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.263 -2.148 . . . . 0.0 115.401 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.8 tp -75.36 51.52 0.56 Allowed 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 129.21 3.004 . . . . 0.0 111.818 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -76.44 139.26 40.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -129.7 88.01 50.8 Favored Pre-proline 0 CA--C 1.591 2.556 1 C-N-CA 132.611 4.365 . . . . 0.0 111.137 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.25 148.08 33.49 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.542 2.161 . . . . 0.0 115.978 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 45.34 20.68 0.05 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 131.119 3.768 . . . . 0.0 113.789 -165.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.7 22.25 69.8 Favored Glycine 0 N--CA 1.499 2.86 0 CA-C-O 116.351 -2.36 . . . . 0.0 108.43 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -84.08 106.37 15.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 128.091 2.877 . . . . 0.0 108.982 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.84 13.68 0.02 OUTLIER Glycine 0 CA--C 1.574 3.749 0 C-N-CA 128.702 3.049 . . . . 0.0 116.422 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.33 122.4 81.4 Favored Pre-proline 0 CA--C 1.56 1.351 0 O-C-N 117.96 -3.082 . . . . 0.0 112.537 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -75.16 177.36 8.71 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 121.69 1.593 . . . . 0.0 114.972 -168.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.99 129.89 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 112.378 -2.192 . . . . 0.0 111.016 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -167.38 104.4 0.53 Allowed 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 125.205 1.566 . . . . 0.0 114.312 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.9 m -70.06 -17.54 63.25 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-O 114.198 -2.81 . . . . 0.0 110.516 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -63.7 -11.96 30.43 Favored 'General case' 0 C--O 1.188 -2.136 0 CA-C-N 124.185 3.175 . . . . 0.0 112.536 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 p -125.37 136.88 53.9 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 126.994 2.118 . . . . 0.0 110.4 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 p -85.15 165.97 33.76 Favored Pre-proline 0 C--N 1.269 -2.935 0 C-N-CA 126.231 1.812 . . . . 0.0 112.328 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . 0.302 81.8 Cg_exo -52.87 -24.09 22.98 Favored 'Trans proline' 0 CA--C 1.574 2.521 1 C-N-CA 125.557 4.171 . . . . 0.0 115.684 168.388 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.05 -29.3 43.41 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 121.178 1.808 . . . . 0.0 112.636 171.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.75 -16.7 61.17 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -68.58 61.52 0.09 Allowed 'General case' 0 CA--C 1.595 2.697 0 C-N-CA 131.263 3.825 . . . . 0.0 110.367 -162.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 tt -156.05 138.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.906 0 C-N-CA 126.762 2.025 . . . . 0.0 113.383 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.4 -174.18 46.8 Favored Glycine 0 CA--C 1.557 2.68 0 O-C-N 119.829 -1.794 . . . . 0.0 114.13 -154.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -148.19 145.39 28.27 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 126.733 2.013 . . . . 0.0 112.21 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -92.63 137.15 32.62 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -126.74 139.78 52.87 Favored 'General case' 1 N--CA 1.548 4.457 0 C-N-CA 129.981 3.312 . . . . 0.0 112.555 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -71.51 166.96 20.69 Favored 'General case' 0 C--O 1.291 3.273 0 O-C-N 120.052 -1.655 . . . . 0.0 110.847 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.92 132.85 18.11 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 130.268 3.427 . . . . 0.0 108.182 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -140.8 -17.37 0.86 Allowed 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 130.018 3.327 . . . . 0.0 110.009 -163.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 47.58 60.92 3.19 Favored 'General case' 0 CA--C 1.589 2.447 0 O-C-N 125.909 2.005 . . . . 0.0 116.209 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -99.22 -23.69 15.12 Favored 'General case' 0 C--O 1.259 1.574 0 C-N-CA 129.201 3.0 . . . . 0.0 116.413 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 mp 60.18 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 CA-C-O 126.132 2.873 . . . . 0.0 111.805 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -82.65 55.42 2.98 Favored 'General case' 0 N--CA 1.511 2.598 1 O-C-N 115.34 -4.6 . . . . 0.0 107.619 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.87 117.45 0.02 OUTLIER Glycine 0 N--CA 1.422 -2.289 0 C-N-CA 124.746 1.165 . . . . 0.0 114.846 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.34 161.64 18.67 Favored Glycine 0 CA--C 1.574 3.732 0 C-N-CA 128.828 3.109 . . . . 0.0 116.505 165.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.447 0.0 OUTLIER 60.52 27.68 17.34 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 119.692 3.219 . . . . 0.0 119.692 -176.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.24 177.03 47.3 Favored Glycine 0 CA--C 1.56 2.859 0 CA-C-O 117.579 -1.678 . . . . 0.0 114.879 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -149.37 138.48 21.32 Favored 'General case' 0 C--N 1.399 2.757 0 C-N-CA 129.472 3.109 . . . . 0.0 109.07 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 45.3 mtm -67.97 149.49 49.68 Favored 'General case' 0 CA--C 1.58 2.119 0 C-N-CA 125.082 1.353 . . . . 0.0 113.251 171.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -114.42 -3.24 13.06 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 127.262 3.41 . . . . 0.0 114.218 -174.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 50.2 30.56 4.41 Favored 'General case' 0 C--N 1.39 2.328 0 O-C-N 117.745 -3.097 . . . . 0.0 117.888 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -122.07 170.37 9.91 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 126.72 2.512 . . . . 0.0 116.422 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.8 m -56.35 164.5 1.93 Allowed Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -49.5 164.03 0.38 Allowed 'Trans proline' 1 CA--C 1.622 4.91 1 C-N-CA 125.771 4.314 . . . . 0.0 112.178 166.48 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -141.78 168.57 19.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 110.851 -2.886 . . . . 0.0 109.028 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -140.66 149.87 42.8 Favored 'General case' 0 C--N 1.276 -2.601 0 O-C-N 118.926 -2.359 . . . . 0.0 108.925 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -130.63 162.8 28.57 Favored 'General case' 0 C--O 1.184 -2.361 0 C-N-CA 127.96 2.504 . . . . 0.0 108.217 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -119.87 145.27 46.83 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 128.919 2.888 . . . . 0.0 113.96 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -147.61 141.59 25.92 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 127.218 2.207 . . . . 0.0 110.712 -171.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -70.45 163.8 25.99 Favored 'General case' 0 CA--C 1.605 3.08 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.18 127.73 32.61 Favored 'General case' 0 CA--C 1.573 1.86 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.839 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.13 20.77 79.01 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 117.979 -2.058 . . . . 0.0 118.151 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.281 3.8 p -134.66 167.63 20.47 Favored 'General case' 0 C--O 1.263 1.775 0 C-N-CA 127.046 2.138 . . . . 0.0 111.539 -174.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.18 -156.36 37.84 Favored Glycine 1 CA--C 1.585 4.407 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.945 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -71.53 -43.16 1.49 Allowed 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 124.036 3.157 . . . . 0.0 114.151 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -82.8 31.96 0.42 Allowed 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 116.802 -1.571 . . . . 0.0 110.599 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.23 -24.86 66.68 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 122.682 2.492 . . . . 0.0 112.37 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.35 -36.73 70.67 Favored Glycine 1 CA--C 1.582 4.225 0 O-C-N 125.242 1.589 . . . . 0.0 116.314 167.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.93 124.78 89.72 Favored Pre-proline 0 CA--C 1.586 2.353 0 CA-C-O 116.509 -1.71 . . . . 0.0 109.971 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -63.05 166.73 13.71 Favored 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 125.237 3.958 . . . . 0.0 113.107 161.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -65.57 127.45 31.93 Favored 'General case' 0 CA--C 1.549 0.907 1 O-C-N 115.481 -4.512 . . . . 0.0 114.241 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.98 -2.63 79.83 Favored Glycine 0 CA--C 1.554 2.469 0 CA-C-N 113.081 -1.872 . . . . 0.0 116.825 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.51 129.83 42.4 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 116.936 -3.685 . . . . 0.0 110.541 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -82.46 25.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.372 -3.33 . . . . 0.0 117.634 -154.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.82 126.97 30.15 Favored 'General case' 0 CA--C 1.593 2.601 0 O-C-N 117.29 -3.381 . . . . 0.0 110.238 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.26 147.35 46.51 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 113.01 -1.904 . . . . 0.0 111.642 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.57 -18.59 54.64 Favored Glycine 1 N--CA 1.525 4.606 0 O-C-N 119.11 -2.243 . . . . 0.0 116.55 -163.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.65 119.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 129.496 3.118 . . . . 0.0 109.189 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.87 102.46 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.152 0 C-N-CA 127.752 2.421 . . . . 0.0 106.092 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -71.97 129.81 39.46 Favored 'General case' 0 CA--C 1.588 2.412 0 C-N-CA 125.736 1.615 . . . . 0.0 113.04 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.77 150.12 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 C-N-CA 126.872 2.069 . . . . 0.0 108.623 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.89 19.36 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.415 -173.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.1 p -122.32 155.32 36.22 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 115.84 -2.029 . . . . 0.0 112.5 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.22 -47.71 62.26 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 124.869 3.486 . . . . 0.0 111.515 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.24 -2.61 90.63 Favored Glycine 2 CA--C 1.599 5.341 0 C-N-CA 129.549 3.452 . . . . 0.0 117.061 -172.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.27 33.49 Favored 'General case' 0 CA--C 1.614 3.408 0 CA-C-N 119.487 1.643 . . . . 0.0 111.961 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.3 mt -88.98 146.61 24.77 Favored 'General case' 0 CA--C 1.596 2.747 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 160.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -90.0 29.79 1.16 Allowed 'General case' 0 CA--C 1.6 2.873 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.448 ' O ' ' HE2' ' A' ' 143' ' ' LYS . 25.6 p -72.06 148.52 91.7 Favored Pre-proline 0 N--CA 1.508 2.464 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.825 168.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.43 136.07 35.64 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-O 116.875 -1.385 . . . . 0.0 112.862 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 141' ' ' THR . 53.3 mmtt -88.55 52.15 2.36 Favored 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 128.649 2.78 . . . . 0.0 110.565 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.41 -20.11 0.64 Allowed 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -81.01 -44.17 18.5 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 119.133 -2.23 . . . . 0.0 110.432 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.251 9.3 mt -55.84 -32.33 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-O 116.665 -1.636 . . . . 0.0 113.674 158.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.72 -14.62 81.22 Favored Glycine 0 N--CA 1.514 3.863 0 O-C-N 127.867 3.229 . . . . 0.0 119.352 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.4 p -133.43 -25.79 1.69 Allowed 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -54.91 142.64 28.87 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 125.979 1.712 . . . . 0.0 110.085 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -77.95 101.97 0.82 Allowed Pre-proline 0 CA--C 1.497 -1.08 0 O-C-N 124.343 1.027 . . . . 0.0 110.969 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.38 -21.81 71.48 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 125.136 3.891 . . . . 0.0 116.038 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.79 -9.76 55.85 Favored 'General case' 0 C--O 1.276 2.499 0 C-N-CA 128.279 2.632 . . . . 0.0 112.444 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -59.22 -27.09 65.42 Favored 'General case' 0 CA--C 1.568 1.662 1 N-CA-C 122.638 4.31 . . . . 0.0 122.638 166.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.04 157.76 45.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 118.699 -2.501 . . . . 0.0 114.441 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -32.53 150.34 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.733 1 C-N-CA 131.757 4.023 . . . . 0.0 111.69 160.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.5 137.29 50.1 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 125.563 2.601 . . . . 0.0 114.546 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.444 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 7.3 mt -73.14 129.02 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 118.746 -2.471 . . . . 0.0 111.58 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.15 116.26 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 126.866 2.604 . . . . 0.0 113.165 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.9 tt -88.04 119.48 28.46 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 124.27 1.028 . . . . 0.0 110.175 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.21 151.73 12.12 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 126.669 1.988 . . . . 0.0 105.869 -157.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.2 mt -110.44 145.35 32.05 Favored Pre-proline 0 CA--C 1.564 1.517 0 O-C-N 124.136 0.897 . . . . 0.0 112.666 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.56 167.07 13.97 Favored 'Trans proline' 1 CA--C 1.605 4.056 0 C-N-CA 121.961 1.774 . . . . 0.0 110.155 170.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 53.89 25.91 5.73 Favored 'General case' 0 N--CA 1.531 3.582 0 O-C-N 127.132 2.77 . . . . 0.0 111.874 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.88 29.56 6.34 Favored Glycine 1 N--CA 1.516 4.004 0 O-C-N 127.187 2.805 . . . . 0.0 111.272 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.2 m -58.99 141.99 52.36 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 122.36 3.08 . . . . 0.0 110.459 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m -106.07 119.53 39.46 Favored 'General case' 0 CA--C 1.587 2.395 0 O-C-N 119.596 -1.94 . . . . 0.0 108.75 -162.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.94 145.72 62.74 Favored Pre-proline 0 N--CA 1.389 -3.493 0 O-C-N 118.491 -2.63 . . . . 0.0 114.756 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -50.13 123.73 11.51 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 121.944 3.786 . . . . 0.0 121.944 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -50.13 -30.69 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 126.071 2.107 . . . . 0.0 116.569 -172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.4 -32.5 84.37 Favored Glycine 0 C--O 1.195 -2.296 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 171.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -91.48 127.92 37.11 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-N 118.323 1.062 . . . . 0.0 109.354 171.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -65.06 152.11 44.33 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 155.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -169.67 146.82 3.36 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 124.894 2.283 . . . . 0.0 107.687 -168.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.83 134.64 49.96 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 127.057 2.143 . . . . 0.0 112.814 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.15 -178.67 48.95 Favored Glycine 1 CA--C 1.587 4.546 0 CA-C-O 118.17 -1.35 . . . . 0.0 113.707 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.0 m 63.48 14.48 8.03 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 126.825 2.132 . . . . 0.0 113.711 -171.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -64.88 -6.14 7.65 Favored 'General case' 0 C--N 1.369 1.413 0 CA-C-N 125.406 3.73 . . . . 0.0 120.642 -169.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.61 177.52 45.48 Favored Glycine 0 C--N 1.273 -2.964 0 C-N-CA 127.744 2.592 . . . . 0.0 113.243 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.53 -146.92 5.58 Favored Glycine 0 CA--C 1.554 2.515 0 C-N-CA 124.18 0.895 . . . . 0.0 112.635 169.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.6 m . . . . . 0 C--N 1.383 2.043 0 O-C-N 117.564 -3.316 . . . . 0.0 113.368 -2.821 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.564 4.179 2 C3'-C2'-C1' 106.216 5.24 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C5'--C4' 1.58 5.405 4 O4'-C1'-N19 113.134 4.934 . 0.707 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C2'--C1' 1.593 6.525 3 C3'-C2'-C1' 93.468 -8.924 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 C3'--C2' 1.587 5.672 3 C1'-O4'-C4' 104.911 -5.21 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.399 -4.48 3 C1'-O4'-C4' 114.442 5.38 . 0.38 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.453 -7.52 0 O3'-P-O5' 97.504 -3.419 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.645 5.157 0 OP1-P-OP2 115.245 -2.903 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C3'--C2' 1.564 3.541 3 C5'-C4'-C3' 106.388 -6.075 . 0.588 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.346 -8.883 4 C3'-C2'-C1' 93.015 -9.428 . 0.123 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.516 -7.581 1 C1'-O4'-C4' 105.087 -5.014 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.599 0 N-CA-C 105.588 -3.005 . . . . 0.0 105.588 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -72.1 158.49 87.53 Favored Pre-proline 0 CA--C 1.572 1.8 0 O-C-N 124.047 0.498 . . . . 0.0 111.228 168.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.13 166.37 18.62 Favored 'Trans proline' 0 N--CA 1.503 2.08 1 C-N-CA 127.767 5.645 . . . . 0.0 112.14 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -67.68 100.98 0.96 Allowed 'General case' 0 CA--C 1.588 2.408 0 C-N-CA 130.706 3.602 . . . . 0.0 110.249 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.279 34.4 p30 -54.6 -22.5 13.57 Favored 'General case' 0 CA--C 1.591 2.546 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.1 m 64.84 -47.09 0.34 Allowed 'General case' 0 N--CA 1.517 2.892 0 C-N-CA 126.823 2.049 . . . . 0.0 114.495 165.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.26 143.47 52.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 128.08 3.8 . . . . 0.0 111.109 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.3 t -81.65 135.29 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 109.897 -3.319 . . . . 0.0 115.18 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -77.96 -3.21 40.78 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.004 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.23 147.48 51.07 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 129.013 2.925 . . . . 0.0 115.102 -163.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.261 79.8 p -61.21 135.86 57.87 Favored 'General case' 0 C--O 1.185 -2.293 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.256 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.77 129.91 34.7 Favored 'General case' 0 CA--C 1.613 3.385 0 CA-C-O 113.974 -2.917 . . . . 0.0 111.493 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.1 175.75 1.97 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 125.263 1.602 . . . . 0.0 109.671 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -146.79 128.2 14.94 Favored 'General case' 0 C--N 1.309 -1.19 1 O-C-N 114.03 -5.419 . . . . 0.0 106.616 170.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -61.27 121.54 12.83 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 125.716 1.607 . . . . 0.0 112.523 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -100.31 -54.66 2.81 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.02 -126.89 0.1 OUTLIER Glycine 0 C--N 1.37 2.419 0 O-C-N 124.764 1.29 . . . . 0.0 116.131 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -144.38 -28.79 0.49 Allowed 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.836 3.207 . . . . 0.0 112.555 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -72.28 131.43 42.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 130.976 3.71 . . . . 0.0 111.721 -171.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.92 160.94 5.36 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 123.85 1.786 . . . . 0.0 110.939 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -65.69 42.91 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 126.309 1.844 . . . . 0.0 113.506 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -61.51 137.58 58.25 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 121.473 1.942 . . . . 0.0 111.386 -164.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.11 107.47 17.91 Favored Pre-proline 0 CA--C 1.562 1.406 0 O-C-N 117.996 -2.94 . . . . 0.0 112.623 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . 0.268 14.9 Cg_exo -57.7 144.62 92.67 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.671 2.247 . . . . 0.0 113.284 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 40.83 37.03 0.46 Allowed 'General case' 0 N--CA 1.516 2.865 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.05 15.44 5.15 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 127.006 2.691 . . . . 0.0 119.086 -168.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -71.54 109.42 5.48 Favored 'General case' 0 N--CA 1.415 -2.188 1 CA-C-N 125.013 4.406 . . . . 0.0 114.287 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.11 34.96 0.03 OUTLIER Glycine 0 CA--C 1.54 1.615 1 O-C-N 113.725 -5.609 . . . . 0.0 116.877 167.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.0 t -70.99 133.75 85.88 Favored Pre-proline 0 CA--C 1.614 3.427 1 CA-C-N 124.559 4.18 . . . . 0.0 115.159 169.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.22 164.09 36.69 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.499 2.133 . . . . 0.0 116.256 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.68 151.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.18 0 O-C-N 125.903 2.002 . . . . 0.0 111.724 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -166.69 106.2 0.62 Allowed 'General case' 0 N--CA 1.529 3.524 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.017 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -60.66 -28.55 68.68 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -80.3 18.57 0.87 Allowed 'General case' 0 CA--C 1.589 2.45 0 C-N-CA 127.606 2.362 . . . . 0.0 114.377 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 87.6 p -141.51 143.89 34.04 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 127.298 2.239 . . . . 0.0 106.262 -171.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 p -72.39 158.19 87.89 Favored Pre-proline 0 CA--C 1.599 2.837 0 CA-C-N 120.974 1.715 . . . . 0.0 108.49 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.69 -28.24 65.2 Favored 'Trans proline' 0 N--CA 1.524 3.302 0 C-N-CA 124.985 3.79 . . . . 0.0 116.181 167.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.21 -18.38 62.47 Favored 'General case' 0 C--O 1.178 -2.668 0 C-N-CA 126.36 1.864 . . . . 0.0 110.994 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.447 ' HA ' ' HE3' ' A' ' 143' ' ' LYS 0.286 65.4 m-20 -73.86 -21.74 60.0 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 124.409 1.083 . . . . 0.0 111.807 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -79.66 60.55 3.38 Favored 'General case' 0 CA--C 1.599 2.831 0 O-C-N 125.23 1.581 . . . . 0.0 110.972 -153.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.03 139.24 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 126.544 1.938 . . . . 0.0 108.736 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.84 -167.24 40.25 Favored Glycine 0 N--CA 1.493 2.493 1 CA-C-O 127.831 4.017 . . . . 0.0 110.621 -163.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.422 ' HB3' ' CE3' ' A' ' 132' ' ' TRP . 9.5 p90 -144.04 138.82 28.6 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 111.113 -2.543 . . . . 0.0 113.524 -170.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.45 145.52 27.4 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.343 1.068 . . . . 0.0 111.21 153.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.424 ' CZ ' " H5'" ' B' ' 4' ' ' ' C' . 7.6 ttp180 -136.95 127.97 27.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 120.1 3.37 . . . . 0.0 120.1 170.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.404 HH22 ' CG ' ' A' ' 128' ' ' ASP . 11.4 ptt180 -50.34 161.06 0.33 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 129.47 3.108 . . . . 0.0 113.204 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.67 143.28 19.58 Favored 'General case' 0 C--N 1.394 2.525 0 O-C-N 117.426 -3.296 . . . . 0.0 113.89 169.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -145.75 -16.35 0.47 Allowed 'General case' 0 N--CA 1.535 3.822 0 C-N-CA 129.122 2.969 . . . . 0.0 112.433 -166.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 46.19 26.72 0.47 Allowed 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -69.78 -14.0 62.56 Favored 'General case' 0 C--O 1.169 -3.134 0 C-N-CA 129.709 3.204 . . . . 0.0 113.141 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.8 mt 70.52 144.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 C-N-CA 129.045 2.938 . . . . 0.0 110.509 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -118.74 -20.48 8.25 Favored 'General case' 1 N--CA 1.558 4.949 0 C-N-CA 128.173 2.589 . . . . 0.0 110.615 166.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.17 85.73 0.06 OUTLIER Glycine 0 N--CA 1.432 -1.617 0 CA-C-N 121.932 2.151 . . . . 0.0 113.723 174.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.73 -140.02 41.9 Favored Glycine 0 CA--C 1.553 2.425 0 C-N-CA 129.507 3.432 . . . . 0.0 109.501 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 55.33 10.63 0.47 Allowed 'General case' 0 N--CA 1.514 2.754 0 C-N-CA 129.177 2.991 . . . . 0.0 114.395 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.68 177.35 47.48 Favored Glycine 0 CA--C 1.476 -2.384 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -132.86 165.37 24.78 Favored 'General case' 0 CA--C 1.59 2.485 0 O-C-N 118.561 -2.729 . . . . 0.0 106.279 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.7 mtm -105.25 141.01 37.53 Favored 'General case' 0 C--O 1.197 -1.659 0 O-C-N 126.564 2.415 . . . . 0.0 106.315 -166.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -106.52 -16.69 14.46 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 115.719 -2.086 . . . . 0.0 111.756 165.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.34 0.3 OUTLIER 70.26 38.0 1.51 Allowed 'General case' 0 C--N 1.371 1.526 0 N-CA-C 118.798 2.888 . . . . 0.0 118.798 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.76 164.41 11.8 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.472 -1.392 . . . . 0.0 107.734 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.1 m -44.67 138.77 3.84 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 168.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.39 162.6 1.33 Allowed 'Trans proline' 0 C--O 1.303 3.728 0 C-N-CA 123.582 2.855 . . . . 0.0 114.222 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -135.05 163.1 30.65 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 128.676 2.791 . . . . 0.0 111.942 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -134.24 139.07 45.52 Favored 'General case' 0 C--O 1.272 2.255 0 O-C-N 117.842 -3.036 . . . . 0.0 108.747 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.55 150.15 41.32 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 126.778 2.031 . . . . 0.0 113.595 173.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -102.49 149.46 24.37 Favored 'General case' 0 C--N 1.364 1.228 0 O-C-N 119.686 -1.884 . . . . 0.0 111.889 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -153.01 147.3 25.74 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 118.823 -2.423 . . . . 0.0 110.945 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -65.51 160.35 22.49 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 127.171 3.367 . . . . 0.0 112.373 170.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.02 123.87 18.04 Favored 'General case' 0 N--CA 1.504 2.248 1 O-C-N 114.951 -4.843 . . . . 0.0 110.674 172.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.1 79.14 Favored Glycine 0 C--O 1.194 -2.387 0 C-N-CA 128.024 2.726 . . . . 0.0 115.853 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.2 p -131.78 160.16 36.37 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 129.325 3.603 . . . . 0.0 109.736 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.42 -167.3 53.97 Favored Glycine 0 CA--C 1.566 3.231 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.33 -38.79 34.75 Favored 'Trans proline' 0 CA--C 1.545 1.075 1 C-N-CA 127.595 5.53 . . . . 0.0 113.089 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -106.56 19.55 20.33 Favored 'General case' 0 C--O 1.276 2.45 0 O-C-N 118.398 -2.689 . . . . 0.0 112.425 -167.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.83 -17.79 2.71 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 116.962 -3.586 . . . . 0.0 115.332 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.77 -20.97 77.59 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 120.782 3.073 . . . . 0.0 120.782 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.55 151.69 68.86 Favored Pre-proline 0 C--O 1.181 -2.511 0 C-N-CA 129.225 3.01 . . . . 0.0 112.72 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -85.31 155.02 10.84 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 CA-C-O 124.569 1.82 . . . . 0.0 108.605 162.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -48.54 136.81 12.52 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 111.945 -2.389 . . . . 0.0 115.889 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.65 5.61 9.38 Favored Glycine 0 CA--C 1.568 3.351 0 C-N-CA 130.691 3.996 . . . . 0.0 118.877 -173.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -43.18 112.4 0.37 Allowed 'General case' 0 C--N 1.416 3.459 0 O-C-N 121.241 -1.152 . . . . 0.0 113.102 162.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -82.06 35.07 0.42 Allowed 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -157.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -71.07 142.92 50.83 Favored 'General case' 0 C--O 1.276 2.482 0 CA-C-N 113.298 -1.774 . . . . 0.0 115.092 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.404 ' CG ' HH22 ' A' ' 89' ' ' ARG . 18.9 t0 -63.28 134.15 55.36 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 127.332 2.253 . . . . 0.0 112.723 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.68 -1.31 88.94 Favored Glycine 0 C--N 1.302 -1.327 0 N-CA-C 119.492 2.557 . . . . 0.0 119.492 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.64 137.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 123.32 3.56 . . . . 0.0 114.518 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.52 116.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 86' ' ' TYR . 83.3 m95 -87.66 138.52 31.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.734 1.73 . . . . 0.0 113.172 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.23 139.96 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 O-C-N 120.577 -1.327 . . . . 0.0 114.166 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -156.18 152.72 28.2 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 115.692 -2.099 . . . . 0.0 116.139 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.3 p -101.51 142.82 32.32 Favored 'General case' 0 C--O 1.28 2.686 0 C-N-CA 125.537 1.535 . . . . 0.0 110.85 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.88 -25.62 68.24 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.439 -2.038 . . . . 0.0 113.709 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.77 -31.12 30.27 Favored Glycine 0 N--CA 1.512 3.701 1 O-C-N 115.813 -4.305 . . . . 0.0 119.638 161.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.89 151.03 27.47 Favored 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 127.729 2.411 . . . . 0.0 111.346 -170.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.16 148.98 22.14 Favored 'General case' 0 CA--C 1.59 2.518 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -61.87 -18.2 59.27 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 114.973 -2.441 . . . . 0.0 114.361 -166.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.4 p -66.56 146.16 99.03 Favored Pre-proline 0 C--O 1.261 1.701 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.48 132.5 27.42 Favored 'Trans proline' 0 CA--C 1.584 2.995 0 CA-C-N 122.992 2.104 . . . . 0.0 110.995 165.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 57.6 mmtt -80.75 54.6 2.17 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.982 1.713 . . . . 0.0 112.637 -168.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.73 -18.76 56.53 Favored 'General case' 0 N--CA 1.53 3.526 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -58.02 -59.8 4.72 Favored 'General case' 0 C--N 1.377 1.785 0 O-C-N 117.394 -3.316 . . . . 0.0 114.638 160.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.4 -19.26 24.66 Favored 'Isoleucine or valine' 0 C--N 1.364 1.207 0 O-C-N 123.996 0.81 . . . . 0.0 112.562 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.19 -0.75 84.86 Favored Glycine 0 N--CA 1.497 2.717 1 CA-C-O 112.843 -4.309 . . . . 0.0 117.634 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.0 p -131.3 -18.55 2.87 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 122.571 3.186 . . . . 0.0 118.396 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -64.74 -176.32 0.25 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.372 0.987 . . . . 0.0 112.608 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -92.89 113.89 61.06 Favored Pre-proline 0 C--N 1.382 1.995 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.856 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -81.3 4.77 6.73 Favored 'Trans proline' 0 C--N 1.385 2.482 0 O-C-N 123.15 1.079 . . . . 0.0 113.908 -170.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.83 19.46 2.49 Favored 'General case' 0 CA--C 1.6 2.882 0 O-C-N 127.367 2.917 . . . . 0.0 113.286 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.15 -38.62 35.52 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 126.447 1.899 . . . . 0.0 107.93 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.1 152.83 24.0 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.295 -1.321 . . . . 0.0 114.416 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.92 140.93 56.49 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 125.549 1.539 . . . . 0.0 113.816 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.3 152.28 29.64 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 125.013 2.339 . . . . 0.0 115.568 -166.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.42 127.6 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.1 t -52.83 106.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.183 -2.399 0 O-C-N 118.634 -2.542 . . . . 0.0 112.574 151.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.99 118.51 9.87 Favored 'General case' 0 C--N 1.362 1.112 0 O-C-N 128.365 3.541 . . . . 0.0 116.376 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -146.56 164.06 33.8 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.018 1.727 . . . . 0.0 107.035 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.06 160.56 30.56 Favored Pre-proline 0 N--CA 1.505 2.291 0 C-N-CA 126.83 2.052 . . . . 0.0 112.478 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -68.37 166.08 26.68 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 118.1 2.308 . . . . 0.0 118.1 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 54.74 31.72 15.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.019 1.728 . . . . 0.0 112.053 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.01 10.86 78.48 Favored Glycine 1 C--N 1.401 4.191 0 CA-C-O 118.996 -0.891 . . . . 0.0 112.381 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.6 m -57.37 119.88 7.23 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 128.478 2.711 . . . . 0.0 109.52 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -81.47 142.43 32.94 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.412 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.93 171.62 2.35 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 128.913 2.885 . . . . 0.0 111.105 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.84 147.15 96.18 Favored 'Trans proline' 0 C--N 1.384 2.418 0 CA-C-O 113.849 -2.646 . . . . 0.0 115.526 172.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -72.36 -16.22 61.86 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 128.757 3.786 . . . . 0.0 114.933 158.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.49 -14.55 9.39 Favored Glycine 0 C--N 1.358 1.786 0 CA-C-O 117.518 -1.712 . . . . 0.0 115.804 160.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -136.97 108.08 6.76 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.084 1.942 . . . . 0.0 111.381 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -59.46 144.61 46.6 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.89 1.805 . . . . 0.0 114.241 164.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.05 175.63 11.56 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 128.483 3.992 . . . . 0.0 112.635 -167.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.48 139.72 51.75 Favored 'General case' 0 N--CA 1.408 -2.549 0 O-C-N 117.386 -3.321 . . . . 0.0 110.129 158.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 96.35 175.88 35.89 Favored Glycine 0 N--CA 1.509 3.556 0 C-N-CA 130.214 3.769 . . . . 0.0 113.23 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.3 m 49.16 39.71 16.0 Favored 'General case' 0 N--CA 1.517 2.897 0 O-C-N 121.059 -1.26 . . . . 0.0 112.646 -176.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.0 mmm-85 -85.73 -5.81 59.21 Favored 'General case' 1 CA--C 1.636 4.278 0 CA-C-N 121.312 1.869 . . . . 0.0 113.765 174.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.22 9.75 84.22 Favored Glycine 0 C--O 1.218 -0.884 0 C-N-CA 128.526 2.965 . . . . 0.0 117.948 169.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.03 -166.25 42.44 Favored Glycine 0 N--CA 1.504 3.225 0 O-C-N 116.948 -3.678 . . . . 0.0 108.808 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.499 2.007 0 CA-C-O 116.233 -1.842 . . . . 0.0 114.887 -0.16 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C2'--C1' 1.48 -4.811 1 OP1-P-OP2 108.609 -7.327 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.599 6.863 4 O4'-C1'-N19 118.131 9.931 . 0.855 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O4'--C1' 1.486 5.985 4 O4'-C1'-N19 121.626 13.426 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.424 " H5'" ' CZ ' ' A' ' 88' ' ' ARG . . . . . . . . 1 C2'--O2' 1.47 4.399 1 O4'-C1'-C2' 112.033 4.024 . 0.01 4n . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.466 -5.242 1 O4'-C1'-N19 114.93 6.73 . 0.417 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 3 O4'--C1' 1.501 7.263 1 O5'-C5'-C4' 116.806 4.718 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.567 4.383 0 C4'-C3'-C2' 98.77 -3.93 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.449 HO2' " C5'" ' B' ' 9' ' ' ' C' . . . . . . . . 2 P--O5' 1.673 8.017 1 C5'-C4'-O4' 121.863 9.045 . 0.01 1a . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ' C' . . . . . 0.449 " C5'" HO2' ' B' ' 8' ' ' ' A' . . . . . . . . 3 C2'--C1' 1.449 -7.88 0 O4'-C1'-N19 111.416 3.216 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 C2'--O2' 1.515 7.819 2 N19-C1'-C2' 106.498 -4.314 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.128 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.09 150.06 94.7 Favored Pre-proline 0 CA--C 1.592 2.593 0 O-C-N 119.036 -2.449 . . . . 0.0 113.11 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.96 -172.19 1.36 Allowed 'Trans proline' 0 N--CA 1.526 3.394 0 CA-C-O 123.319 1.299 . . . . 0.0 115.378 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.63 129.24 39.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 116.974 -1.488 . . . . 0.0 110.828 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -82.87 -15.74 50.3 Favored 'General case' 0 CA--C 1.604 3.029 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m 63.24 -52.8 0.2 Allowed 'General case' 0 C--O 1.251 1.139 0 C-N-CA 128.079 2.552 . . . . 0.0 113.619 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.0 170.29 3.67 Favored 'General case' 0 CA--C 1.592 2.588 0 CA-C-N 123.52 2.873 . . . . 0.0 111.469 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.3 t -77.55 144.55 37.52 Favored 'General case' 0 CA--C 1.58 2.105 0 CA-C-O 113.577 -3.106 . . . . 0.0 113.515 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -95.15 -4.41 46.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 125.76 3.891 . . . . 0.0 113.296 172.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -120.93 164.64 16.39 Favored 'General case' 0 N--CA 1.513 2.689 0 O-C-N 119.069 -2.27 . . . . 0.0 109.34 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.9 p -56.43 146.88 23.08 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 126.392 2.307 . . . . 0.0 110.244 157.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.04 162.56 24.28 Favored 'General case' 0 CA--C 1.567 1.61 0 O-C-N 116.308 -3.995 . . . . 0.0 112.914 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.37 107.32 18.16 Favored 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.028 2.131 . . . . 0.0 114.676 -153.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.4 m -65.2 118.74 9.68 Favored 'General case' 0 C--O 1.18 -2.57 0 O-C-N 126.554 2.409 . . . . 0.0 111.194 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -55.55 124.53 17.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 129.732 3.213 . . . . 0.0 115.627 165.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.19 -7.09 4.84 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 128.538 2.735 . . . . 0.0 111.885 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.43 -141.77 12.55 Favored Glycine 0 N--CA 1.507 3.411 0 O-C-N 120.024 -1.672 . . . . 0.0 112.801 165.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -137.61 -34.56 0.69 Allowed 'General case' 0 C--O 1.177 -2.712 0 O-C-N 116.68 -3.835 . . . . 0.0 110.041 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -58.27 138.0 56.68 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.72 2.408 . . . . 0.0 109.495 173.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -80.08 168.97 18.48 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 124.346 2.022 . . . . 0.0 111.309 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -72.62 61.88 0.53 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 118.677 -2.514 . . . . 0.0 112.281 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.43 149.26 36.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.549 -1.969 . . . . 0.0 114.032 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.08 91.65 23.42 Favored Pre-proline 0 CA--C 1.587 2.374 0 O-C-N 126.176 2.173 . . . . 0.0 110.479 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.09 148.17 18.28 Favored 'Trans proline' 0 C--O 1.195 -1.628 0 C-N-CA 123.697 2.931 . . . . 0.0 110.187 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 53.14 6.46 0.06 Allowed 'General case' 0 C--N 1.372 1.558 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.66 23.08 42.36 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 129.94 3.638 . . . . 0.0 113.589 -169.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -69.31 107.15 3.16 Favored 'General case' 0 CA--C 1.573 1.841 0 O-C-N 120.116 -1.814 . . . . 0.0 108.378 159.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.86 25.69 0.03 OUTLIER Glycine 0 C--N 1.385 3.277 0 C-N-CA 127.131 2.301 . . . . 0.0 113.626 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.49 123.25 78.95 Favored Pre-proline 0 C--N 1.374 1.674 1 O-C-N 114.518 -5.107 . . . . 0.0 110.775 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.63 173.47 12.19 Favored 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.84 2.36 . . . . 0.0 111.66 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -69.24 138.29 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 O-C-N 118.812 -2.43 . . . . 0.0 117.476 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.56 103.06 1.74 Allowed 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 116.938 -1.506 . . . . 0.0 111.144 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 m -71.95 -16.44 62.1 Favored 'General case' 0 CA--C 1.563 1.456 1 C-N-CA 133.009 4.524 . . . . 0.0 112.835 -175.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -83.84 17.08 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 115.139 -2.362 . . . . 0.0 113.137 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.8 p -146.79 176.7 9.67 Favored 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.291 22.0 p -130.18 -174.08 0.36 Allowed Pre-proline 0 C--N 1.289 -2.03 0 O-C-N 118.999 -2.313 . . . . 0.0 111.18 -166.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -73.25 -28.95 11.99 Favored 'Trans proline' 0 C--O 1.196 -1.585 0 CA-C-N 120.739 1.3 . . . . 0.0 113.428 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.45 -24.07 64.93 Favored 'General case' 0 CA--C 1.608 3.191 0 CA-C-O 123.141 1.448 . . . . 0.0 113.428 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.263 69.6 m-20 -92.12 -15.17 28.07 Favored 'General case' 0 C--O 1.187 -2.193 0 O-C-N 118.121 -2.862 . . . . 0.0 113.702 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -74.63 54.64 0.62 Allowed 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 118.144 2.646 . . . . 0.0 118.144 -169.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.07 148.3 17.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.4 -158.47 28.83 Favored Glycine 0 CA--C 1.543 1.82 0 O-C-N 118.558 -2.589 . . . . 0.0 111.585 -173.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -147.13 160.54 42.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.676 2.391 . . . . 0.0 116.981 -172.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -104.52 155.24 18.99 Favored 'General case' 0 CA--C 1.585 2.317 0 C-N-CA 130.327 3.451 . . . . 0.0 110.841 160.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.541 HH21 ' P ' ' B' ' 5' ' ' ' U' . 18.2 ttp180 -145.38 146.95 31.77 Favored 'General case' 0 C--O 1.191 -2.02 0 O-C-N 125.804 1.94 . . . . 0.0 109.49 171.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -62.35 154.69 27.25 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.081 1.752 . . . . 0.0 115.595 171.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.18 124.24 30.23 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 129.019 2.928 . . . . 0.0 111.606 158.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -110.36 -18.76 13.18 Favored 'General case' 0 N--CA 1.514 2.736 0 C-N-CA 128.56 2.744 . . . . 0.0 114.811 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 48.0 41.89 15.74 Favored 'General case' 0 C--N 1.382 2.021 0 C-N-CA 124.417 1.087 . . . . 0.0 112.368 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -91.09 -26.38 19.17 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 131.646 3.978 . . . . 0.0 107.652 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.282 1.7 mp 68.05 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 O-C-N 128.319 3.512 . . . . 0.0 114.084 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -136.31 81.77 1.9 Allowed 'General case' 0 C--O 1.276 2.482 0 C-N-CA 127.754 2.421 . . . . 0.0 107.507 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.21 47.63 43.55 Favored Glycine 0 N--CA 1.48 1.62 0 C-N-CA 126.771 2.129 . . . . 0.0 113.786 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.68 -155.95 47.35 Favored Glycine 1 CA--C 1.578 4.013 0 CA-C-N 113.889 -1.155 . . . . 0.0 112.165 -171.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 67.37 -1.48 1.52 Allowed 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 130.234 3.414 . . . . 0.0 114.387 -159.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.35 154.28 25.39 Favored Glycine 0 CA--C 1.571 3.564 0 O-C-N 118.103 -2.873 . . . . 0.0 118.681 170.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -71.91 128.63 36.34 Favored 'General case' 0 N--CA 1.52 3.056 0 O-C-N 119.503 -2.175 . . . . 0.0 114.606 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.3 mtp -84.57 127.72 34.21 Favored 'General case' 0 C--O 1.268 2.027 0 O-C-N 118.707 -2.496 . . . . 0.0 106.461 165.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -119.85 -6.94 10.05 Favored 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 127.637 2.375 . . . . 0.0 112.365 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 60.2 65.99 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.36 1.864 . . . . 0.0 107.22 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -115.49 157.95 23.28 Favored 'General case' 0 C--O 1.278 2.598 0 C-N-CA 127.79 2.436 . . . . 0.0 112.027 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 t -60.35 158.59 27.83 Favored Pre-proline 0 C--O 1.263 1.804 0 O-C-N 125.891 1.994 . . . . 0.0 114.589 163.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.38 159.2 45.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 123.387 2.724 . . . . 0.0 114.494 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -135.56 152.03 50.89 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -126.08 136.09 52.5 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.358 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.81 130.94 53.49 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 127.763 3.165 . . . . 0.0 112.174 -164.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -102.36 147.18 27.02 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -145.57 153.06 40.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 127.42 2.95 . . . . 0.0 114.639 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -89.26 166.95 13.46 Favored 'General case' 0 CA--C 1.617 3.52 1 CA-C-N 126.64 4.291 . . . . 0.0 112.697 170.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -54.99 123.49 13.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.002 -1.454 . . . . 0.0 113.31 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.09 25.44 68.91 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 126.354 2.284 . . . . 0.0 111.558 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.6 p -132.56 169.39 16.68 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 118.757 -2.614 . . . . 0.0 107.049 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.06 -168.8 49.27 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 112.357 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.5 -26.12 12.29 Favored 'Trans proline' 0 N--CA 1.437 -1.848 1 C-N-CA 127.428 5.419 . . . . 0.0 112.675 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -101.04 31.99 3.4 Favored 'General case' 1 N--CA 1.561 5.117 0 C-N-CA 127.436 2.294 . . . . 0.0 109.47 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.28 -22.91 33.17 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.73 79.18 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.408 1.956 . . . . 0.0 115.281 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.59 125.96 81.62 Favored Pre-proline 0 CA--C 1.499 -1.007 0 CA-C-O 114.663 -2.589 . . . . 0.0 111.005 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 176.69 4.86 Favored 'Trans proline' 0 C--O 1.193 -1.755 0 CA-C-N 124.135 2.512 . . . . 0.0 109.367 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.97 137.17 55.94 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 125.051 1.34 . . . . 0.0 112.172 173.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.08 5.26 65.21 Favored Glycine 0 C--N 1.379 2.918 0 CA-C-O 125.028 2.46 . . . . 0.0 117.56 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.77 47.28 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 117.391 -3.417 . . . . 0.0 111.647 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -74.32 107.37 6.44 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 111.44 -2.618 . . . . 0.0 110.897 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -136.81 124.06 21.84 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.219 1.007 . . . . 0.0 110.175 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.26 107.76 0.7 Allowed 'General case' 0 CA--C 1.596 2.735 0 C-N-CA 128.108 2.563 . . . . 0.0 109.686 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.52 26.78 Favored Glycine 0 N--CA 1.503 3.123 0 C-N-CA 128.581 2.991 . . . . 0.0 111.175 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.25 119.03 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 124.184 0.994 . . . . 0.0 108.893 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.2 mm -101.39 120.54 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-O 124.261 1.981 . . . . 0.0 115.491 164.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -80.76 136.68 36.18 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 116.305 -3.997 . . . . 0.0 118.152 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -139.54 128.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.262 1.743 0 CA-C-N 123.813 3.006 . . . . 0.0 113.425 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.3 23.21 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 128.038 2.535 . . . . 0.0 109.54 -166.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.1 p -137.3 153.38 50.3 Favored 'General case' 0 C--O 1.277 2.504 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.42 -28.55 65.15 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 118.672 -2.517 . . . . 0.0 111.225 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.58 -0.28 89.86 Favored Glycine 1 N--CA 1.517 4.041 0 C-N-CA 128.412 2.911 . . . . 0.0 112.852 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.47 156.03 24.29 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 120.356 2.078 . . . . 0.0 109.009 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.3 mt -95.41 144.1 26.21 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 124.49 2.091 . . . . 0.0 109.054 167.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . 0.328 1.4 p-10 -75.73 26.9 0.11 Allowed 'General case' 0 C--N 1.389 2.283 0 O-C-N 117.934 -2.979 . . . . 0.0 113.601 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.0 p -91.62 158.92 39.66 Favored Pre-proline 0 CA--C 1.554 1.134 0 O-C-N 117.511 -3.243 . . . . 0.0 104.088 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -80.21 142.55 15.22 Favored 'Trans proline' 0 C--N 1.37 1.683 0 N-CA-C 105.087 -2.697 . . . . 0.0 105.087 173.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -88.19 74.64 8.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 117.0 -3.563 . . . . 0.0 107.419 -174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.12 -39.31 92.12 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 122.464 2.393 . . . . 0.0 114.436 -166.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -64.78 -59.32 4.36 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.2 mt -61.11 -23.93 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.088 0 C-N-CA 127.852 2.461 . . . . 0.0 115.633 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.57 -2.74 89.99 Favored Glycine 0 C--O 1.255 1.43 0 N-CA-C 120.163 2.825 . . . . 0.0 120.163 164.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.8 p -130.66 -35.18 1.49 Allowed 'General case' 0 C--O 1.179 -2.641 0 CA-C-N 122.803 3.301 . . . . 0.0 111.504 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -69.03 147.6 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 118.729 -2.482 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -44.21 121.15 3.89 Favored Pre-proline 1 N--CA 1.545 4.297 0 CA-C-O 115.197 -2.335 . . . . 0.0 111.562 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.56 -14.88 5.36 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 123.905 3.07 . . . . 0.0 116.504 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.22 9.8 9.88 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -163.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -69.31 -14.88 63.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 118.577 -2.577 . . . . 0.0 115.504 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.47 171.87 10.68 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 124.915 1.384 . . . . 0.0 108.367 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.13 143.85 5.53 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 118.279 -2.763 . . . . 0.0 114.191 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.51 109.11 1.85 Allowed 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 127.257 2.223 . . . . 0.0 110.529 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.67 132.23 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 128.137 2.575 . . . . 0.0 107.562 -160.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.51 97.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.7 114.79 12.37 Favored 'General case' 0 C--O 1.255 1.389 0 O-C-N 121.118 -0.989 . . . . 0.0 109.086 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -147.63 146.15 29.24 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 128.528 2.731 . . . . 0.0 107.56 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.16 153.01 53.82 Favored Pre-proline 0 CA--C 1.592 2.592 0 O-C-N 118.827 -2.421 . . . . 0.0 113.186 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -43.33 160.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.392 2.819 0 N-CA-C 119.029 2.665 . . . . 0.0 119.029 161.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 56.15 18.32 3.18 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 127.073 2.149 . . . . 0.0 109.733 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.21 19.35 70.19 Favored Glycine 0 C--O 1.187 -2.804 0 CA-C-N 119.764 1.165 . . . . 0.0 113.037 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.5 m -65.27 123.83 20.6 Favored 'General case' 0 C--O 1.262 1.729 0 CA-C-N 118.9 1.35 . . . . 0.0 108.005 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.6 m -74.86 138.26 42.36 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 124.463 2.078 . . . . 0.0 108.058 -165.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.5 mt -66.16 154.15 90.6 Favored Pre-proline 1 N--CA 1.553 4.716 1 CA-C-O 111.205 -4.236 . . . . 0.0 110.314 170.799 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -55.41 137.02 76.35 Favored 'Trans proline' 0 CA--C 1.559 1.752 1 C-N-CA 129.05 6.5 . . . . 0.0 113.718 -172.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -75.66 -16.64 60.17 Favored 'General case' 0 N--CA 1.481 1.117 1 O-C-N 115.67 -4.394 . . . . 0.0 112.688 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.46 -9.65 13.41 Favored Glycine 0 N--CA 1.512 3.701 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 166.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -119.39 157.54 27.97 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.141 2.97 . . . . 0.0 111.376 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -104.51 136.31 44.31 Favored 'General case' 0 CA--C 1.605 3.077 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.264 165.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.29 -173.17 4.3 Favored 'General case' 0 C--N 1.384 2.108 0 C-N-CA 127.964 2.506 . . . . 0.0 111.106 -158.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -73.99 152.34 40.07 Favored 'General case' 0 N--CA 1.519 3.021 0 C-N-CA 126.542 1.937 . . . . 0.0 109.891 158.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 71.55 174.85 21.53 Favored Glycine 0 CA--C 1.568 3.378 0 O-C-N 127.201 2.813 . . . . 0.0 116.567 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.9 m 57.66 37.74 27.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 125.291 2.472 . . . . 0.0 109.343 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -69.78 -17.27 63.41 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 54.78 -162.51 4.27 Favored Glycine 1 N--CA 1.527 4.742 1 C-N-CA 132.849 5.023 . . . . 0.0 110.522 -170.105 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.14 -164.12 25.82 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 118.471 -1.183 . . . . 0.0 112.922 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.27 2.156 2 CA-C-N 124.835 4.318 . . . . 0.0 112.401 -18.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C5'--C4' 1.627 8.969 2 OP1-P-OP2 110.472 -6.085 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 5 P--O3' 1.496 -9.285 1 O4'-C1'-N19 113.78 5.58 . 0.01 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.444 HO2' ' P ' ' B' ' 4' ' ' ' C' . . . . . . . . 1 O4'--C1' 1.476 5.13 1 O4'-C1'-N19 115.413 7.213 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.444 ' P ' HO2' ' B' ' 3' ' ' ' U' . . . . . . . . 1 C5'--C4' 1.571 4.688 6 C5'-C4'-O4' 120.205 7.861 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.541 ' P ' HH21 ' A' ' 88' ' ' ARG . . . . . . . . 2 P--O3' 1.541 -5.518 3 O4'-C1'-N19 112.896 4.696 . 0.432 1t . 0.0 . . . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.39 -5.255 2 O4'-C1'-N19 113.238 5.038 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.692 9.851 3 O4'-C1'-N19 116.088 7.888 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.452 3.188 3 C1'-O4'-C4' 104.814 -5.318 . 0.374 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 4 C2'--O2' 1.487 5.704 0 O5'-C5'-C4' 106.279 -2.801 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.395 4 O4'-C1'-N19 114.35 6.15 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.259 0 CA-C-O 123.283 1.491 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.83 159.36 54.69 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.78 151.8 74.21 Favored 'Trans proline' 0 N--CA 1.512 2.57 0 N-CA-C 118.439 2.438 . . . . 0.0 118.439 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.64 111.56 2.13 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 127.247 3.403 . . . . 0.0 109.553 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -58.81 -11.8 3.64 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 118.804 -2.435 . . . . 0.0 110.758 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m 46.22 -50.22 0.0 OUTLIER 'General case' 0 C--N 1.364 1.23 1 C-N-CA 133.036 4.534 . . . . 0.0 119.942 -170.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.18 154.24 23.87 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 131.808 4.043 . . . . 0.0 112.052 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.0 t -82.5 137.57 34.58 Favored 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 127.385 2.274 . . . . 0.0 115.64 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -76.13 -21.05 57.05 Favored 'General case' 0 CA--C 1.615 3.461 0 CA-C-O 122.797 1.284 . . . . 0.0 110.56 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -88.29 173.01 9.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 118.389 -2.695 . . . . 0.0 113.952 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p -71.98 172.23 10.38 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 119.25 -2.156 . . . . 0.0 110.84 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . 0.309 . . -117.18 132.73 56.58 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 119.666 -1.896 . . . . 0.0 114.764 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.7 mt -70.25 163.42 26.51 Favored 'General case' 0 N--CA 1.513 2.677 0 C-N-CA 129.74 3.216 . . . . 0.0 111.643 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.9 m -128.15 131.12 48.95 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 168.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -66.92 149.95 49.89 Favored 'General case' 0 CA--C 1.6 2.893 0 C-N-CA 124.259 1.024 . . . . 0.0 112.083 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -151.53 -19.81 0.2 Allowed 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.611 -1.931 . . . . 0.0 113.43 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.94 -125.65 0.83 Allowed Glycine 0 CA--C 1.548 2.153 0 C-N-CA 128.107 2.765 . . . . 0.0 113.748 160.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -156.68 -22.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -69.32 139.68 54.3 Favored 'General case' 0 C--O 1.279 2.654 0 C-N-CA 126.272 1.829 . . . . 0.0 115.638 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.77 164.72 9.51 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 128.507 2.723 . . . . 0.0 115.816 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.8 tp -82.7 52.34 2.09 Favored 'General case' 0 CA--C 1.569 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 113.823 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -55.23 138.47 44.93 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 118.984 -2.323 . . . . 0.0 109.604 -171.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 50.5 m-85 -128.47 129.29 23.57 Favored Pre-proline 0 C--O 1.187 -2.221 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -84.11 137.75 7.48 Favored 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.315 4.01 . . . . 0.0 109.477 -170.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 45.81 23.82 0.18 Allowed 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.88 7.38 65.9 Favored Glycine 0 CA--C 1.567 3.325 0 CA-C-O 117.242 -1.865 . . . . 0.0 112.044 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -65.42 72.37 0.05 OUTLIER 'General case' 0 C--O 1.19 -2.052 0 CA-C-N 119.847 1.824 . . . . 0.0 111.892 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.16 33.96 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.206 0 CA-C-N 122.968 2.622 . . . . 0.0 119.398 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -74.43 119.36 76.14 Favored Pre-proline 0 C--O 1.257 1.453 0 O-C-N 118.708 -2.642 . . . . 0.0 110.593 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.51 161.49 20.56 Favored 'Trans proline' 0 CA--C 1.601 3.835 0 N-CA-C 119.035 2.667 . . . . 0.0 119.035 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.19 131.17 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 O-C-N 126.139 2.149 . . . . 0.0 108.922 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -165.12 91.96 0.55 Allowed 'General case' 0 N--CA 1.536 3.84 0 C-N-CA 128.65 2.78 . . . . 0.0 106.031 172.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -67.61 -21.22 65.41 Favored 'General case' 0 C--O 1.185 -2.315 0 CA-C-O 123.676 1.703 . . . . 0.0 113.607 -174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -55.41 -50.25 70.27 Favored 'General case' 0 N--CA 1.421 -1.889 1 O-C-N 115.342 -4.599 . . . . 0.0 114.897 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.2 p -58.36 153.86 14.72 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 119.069 2.988 . . . . 0.0 119.069 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.2 t -78.31 145.73 69.02 Favored Pre-proline 0 C--O 1.17 -3.128 0 O-C-N 125.241 1.588 . . . . 0.0 108.767 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.91 -34.72 16.86 Favored 'Trans proline' 0 CA--C 1.587 3.139 1 C-N-CA 125.755 4.303 . . . . 0.0 113.086 162.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.31 -38.77 92.45 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.646 1.178 . . . . 0.0 108.954 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.25 -19.66 66.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-O 116.201 -1.857 . . . . 0.0 114.629 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -84.62 81.18 8.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 123.523 2.874 . . . . 0.0 114.094 -151.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 tt -163.52 130.83 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.926 0 C-N-CA 126.999 2.12 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 -157.7 15.51 Favored Glycine 0 CA--C 1.557 2.702 0 CA-C-O 124.289 2.049 . . . . 0.0 115.902 -166.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -161.05 146.85 14.46 Favored 'General case' 0 C--O 1.284 2.897 0 CA-C-O 122.624 1.202 . . . . 0.0 112.547 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 4.2 m-85 -97.78 141.33 30.91 Favored 'General case' 0 C--O 1.171 -3.061 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.221 162.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -125.47 143.45 50.99 Favored 'General case' 0 C--O 1.202 -1.407 0 C-N-CA 125.668 1.587 . . . . 0.0 108.016 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.459 HH22 ' CG ' ' A' ' 128' ' ' ASP . 1.2 ptt180 -54.8 174.19 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 126.015 2.072 . . . . 0.0 116.348 163.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.29 139.59 13.38 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 115.181 -2.342 . . . . 0.0 108.999 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.5 p -127.11 -21.16 4.0 Favored 'General case' 0 C--O 1.262 1.747 0 C-N-CA 127.395 2.278 . . . . 0.0 113.297 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 46.01 49.14 12.28 Favored 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 125.512 1.525 . . . . 0.0 108.597 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -97.8 -9.71 26.04 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 127.248 2.219 . . . . 0.0 110.158 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.303 2.1 mp 64.57 157.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.592 2.59 0 O-C-N 120.398 -1.439 . . . . 0.0 114.478 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -139.61 55.28 1.67 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.914 1.34 . . . . 0.0 107.394 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.22 -3.12 47.31 Favored Glycine 0 C--N 1.349 1.285 0 C-N-CA 127.334 2.397 . . . . 0.0 116.034 166.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.35 -172.73 45.74 Favored Glycine 0 C--N 1.358 1.805 0 O-C-N 119.038 -2.448 . . . . 0.0 113.756 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 55.54 12.29 0.75 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 112.418 -1.891 . . . . 0.0 116.086 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.54 -178.66 42.82 Favored Glycine 0 N--CA 1.49 2.288 0 CA-C-N 114.302 -1.317 . . . . 0.0 114.037 172.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -116.46 146.71 42.35 Favored 'General case' 0 N--CA 1.503 2.189 1 CA-C-N 107.909 -4.146 . . . . 0.0 111.872 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 20.4 mtt -86.66 150.28 24.31 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 115.49 -2.195 . . . . 0.0 112.701 174.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -138.91 -7.01 1.42 Allowed 'General case' 0 C--O 1.205 -1.284 0 O-C-N 127.705 3.128 . . . . 0.0 115.593 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 56.1 40.31 30.22 Favored 'General case' 0 CA--C 1.583 2.232 1 CA-C-O 129.032 4.253 . . . . 0.0 116.367 167.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.61 165.38 13.33 Favored 'General case' 0 C--N 1.375 1.704 0 O-C-N 117.897 -3.002 . . . . 0.0 116.048 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.0 t -60.03 147.78 79.24 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 121.988 0.899 . . . . 0.0 112.367 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -53.56 132.65 49.98 Favored 'Trans proline' 0 C--N 1.408 3.68 1 C-N-CA 125.939 4.426 . . . . 0.0 115.18 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -94.53 171.71 8.64 Favored 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 125.882 1.673 . . . . 0.0 114.601 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -146.03 139.5 26.14 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 119.571 -1.955 . . . . 0.0 113.228 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -128.86 170.23 13.64 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.262 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -114.14 136.3 53.09 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 127.809 2.443 . . . . 0.0 114.664 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.69 144.14 48.98 Favored 'General case' 0 CA--C 1.603 2.997 0 C-N-CA 126.496 1.918 . . . . 0.0 111.277 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.68 167.92 13.45 Favored 'General case' 0 N--CA 1.515 2.786 0 CA-C-O 123.603 1.668 . . . . 0.0 107.83 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.65 137.32 57.75 Favored 'General case' 0 C--O 1.199 -1.59 0 CA-C-O 115.671 -2.109 . . . . 0.0 109.599 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.63 -13.7 60.0 Favored Glycine 0 CA--C 1.569 3.446 0 CA-C-O 126.399 3.222 . . . . 0.0 114.815 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -119.31 171.94 7.96 Favored 'General case' 0 C--O 1.196 -1.716 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.01 -168.75 37.61 Favored Glycine 0 CA--C 1.566 3.252 0 O-C-N 129.001 3.938 . . . . 0.0 111.227 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -59.57 -39.81 71.48 Favored 'Trans proline' 0 N--CA 1.515 2.744 0 C-N-CA 122.56 2.174 . . . . 0.0 112.854 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -95.58 42.14 1.09 Allowed 'General case' 0 CA--C 1.588 2.408 0 O-C-N 119.854 -1.779 . . . . 0.0 112.486 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.53 -25.75 18.15 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 129.438 3.095 . . . . 0.0 114.863 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -87.62 -15.63 61.41 Favored Glycine 0 N--CA 1.478 1.499 0 C-N-CA 126.184 1.849 . . . . 0.0 115.434 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.22 135.56 84.61 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 120.01 1.905 . . . . 0.0 113.773 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -89.16 156.81 5.67 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 124.438 1.757 . . . . 0.0 113.685 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.72 128.15 34.87 Favored 'General case' 0 C--O 1.273 2.342 0 CA-C-O 115.811 -2.042 . . . . 0.0 113.089 -169.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.82 21.05 66.82 Favored Glycine 0 N--CA 1.406 -3.306 0 CA-C-N 122.765 2.529 . . . . 0.0 118.791 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.88 155.34 38.65 Favored 'General case' 0 C--O 1.268 2.071 0 O-C-N 120.817 -1.402 . . . . 0.0 114.29 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.89 43.99 1.04 Allowed 'General case' 0 C--O 1.269 2.084 0 CA-C-N 121.881 2.128 . . . . 0.0 109.81 -174.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -59.45 137.32 58.04 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-N 122.606 2.457 . . . . 0.0 113.009 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.459 ' CG ' HH22 ' A' ' 89' ' ' ARG . 49.6 t0 -57.44 118.38 5.11 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 128.032 2.533 . . . . 0.0 113.422 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.09 19.17 54.17 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 126.351 2.282 . . . . 0.0 117.697 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.49 121.83 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 131.301 3.84 . . . . 0.0 106.79 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.97 119.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 O-C-N 125.726 1.891 . . . . 0.0 114.017 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -76.47 141.48 41.3 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.67 149.7 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 118.242 -2.786 . . . . 0.0 112.811 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.36 -179.48 6.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.786 -2.007 . . . . 0.0 115.64 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -144.37 160.06 41.68 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 127.496 2.318 . . . . 0.0 111.927 163.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -61.48 -51.55 68.21 Favored 'General case' 0 CA--C 1.561 1.383 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.72 -6.14 54.21 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.969 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.61 158.58 29.72 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 126.549 1.94 . . . . 0.0 115.602 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.48 134.89 39.1 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 122.263 2.301 . . . . 0.0 114.004 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -64.52 59.59 0.02 OUTLIER 'General case' 0 CA--C 1.593 2.602 0 C-N-CA 129.538 3.135 . . . . 0.0 109.658 170.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.5 p -150.39 153.16 34.29 Favored Pre-proline 0 N--CA 1.509 2.5 0 C-N-CA 125.061 1.344 . . . . 0.0 113.135 -170.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.45 146.43 50.07 Favored 'Trans proline' 0 CA--C 1.555 1.539 1 C-N-CA 125.416 4.077 . . . . 0.0 112.928 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -114.6 47.02 1.29 Allowed 'General case' 0 C--O 1.264 1.847 0 CA-C-O 125.614 2.626 . . . . 0.0 104.385 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -52.81 -29.63 28.71 Favored 'General case' 0 N--CA 1.489 1.494 1 O-C-N 116.189 -4.069 . . . . 0.0 114.145 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -60.89 -51.51 68.96 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 122.138 2.245 . . . . 0.0 111.115 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.63 -26.81 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 CA-C-O 123.753 1.74 . . . . 0.0 112.058 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -69.68 -12.13 66.77 Favored Glycine 1 CA--C 1.6 5.406 0 CA-C-N 112.676 -2.056 . . . . 0.0 114.041 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 66.9 p -148.29 -29.56 0.3 Allowed 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 123.787 3.794 . . . . 0.0 113.789 -159.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.81 168.14 19.45 Favored 'General case' 0 C--O 1.201 -1.448 1 O-C-N 116.111 -4.118 . . . . 0.0 112.157 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . 0.3 54.7 t-20 -75.44 110.5 10.62 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 128.746 3.779 . . . . 0.0 109.377 -156.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.53 -9.94 18.7 Favored 'Trans proline' 0 C--N 1.396 3.04 1 C-N-CA 128.909 6.406 . . . . 0.0 109.879 -164.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.9 44.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.324 -1.485 . . . . 0.0 114.174 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -68.41 -62.95 1.17 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.164 0.586 . . . . 0.0 110.89 155.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -81.96 153.86 26.04 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 117.17 -1.395 . . . . 0.0 112.461 160.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.29 160.24 22.1 Favored 'General case' 0 CA--C 1.595 2.697 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -36.84 125.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -75.57 134.59 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 O-C-N 126.104 2.128 . . . . 0.0 110.766 172.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.11 125.83 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 O-C-N 118.332 -2.73 . . . . 0.0 107.541 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.42 97.1 6.24 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.315 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -148.53 146.68 28.42 Favored 'General case' 0 C--N 1.375 1.717 0 CA-C-O 126.706 3.146 . . . . 0.0 108.041 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 92.9 mt -85.76 146.19 43.15 Favored Pre-proline 0 C--O 1.255 1.348 0 C-N-CA 128.705 2.802 . . . . 0.0 118.109 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -49.24 164.62 0.27 Allowed 'Trans proline' 0 CA--C 1.57 2.321 1 C-N-CA 125.92 4.413 . . . . 0.0 113.092 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 56.49 32.41 20.71 Favored 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 127.974 2.509 . . . . 0.0 112.949 166.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.45 44.97 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 117.053 -1.971 . . . . 0.0 116.471 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.5 m -59.8 131.02 49.62 Favored 'General case' 0 C--N 1.379 1.89 0 O-C-N 125.583 1.402 . . . . 0.0 108.875 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 94.1 m -90.96 141.86 28.39 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.085 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.5 154.57 93.3 Favored Pre-proline 0 C--O 1.276 2.485 0 CA-C-N 123.529 2.877 . . . . 0.0 110.203 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.22 130.6 28.95 Favored 'Trans proline' 0 C--N 1.402 3.387 0 C-N-CA 124.259 3.306 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -64.56 -4.64 4.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.243 1.817 . . . . 0.0 113.872 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.76 -11.39 49.54 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 116.442 -2.31 . . . . 0.0 113.899 164.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.43 143.38 43.66 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 128.826 2.851 . . . . 0.0 116.1 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.88 154.14 38.35 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 123.801 1.762 . . . . 0.0 113.191 148.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.0 -179.26 7.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 127.125 3.345 . . . . 0.0 108.447 -162.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.77 160.34 30.1 Favored 'General case' 0 CA--C 1.567 1.625 1 O-C-N 114.135 -5.353 . . . . 0.0 111.531 154.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.49 -173.28 46.9 Favored Glycine 0 C--O 1.258 1.645 0 C-N-CA 126.047 1.784 . . . . 0.0 112.72 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 17.5 m 62.73 34.09 14.97 Favored 'General case' 0 CA--C 1.603 3.012 0 C-N-CA 126.061 1.744 . . . . 0.0 113.041 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.508 HH22 ' P ' ' B' ' 9' ' ' ' C' . 3.6 mmm180 -94.2 -8.39 39.46 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 118.899 2.926 . . . . 0.0 118.899 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.92 -166.91 54.31 Favored Glycine 0 C--N 1.302 -1.36 0 O-C-N 126.971 2.67 . . . . 0.0 113.941 -157.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.25 176.02 37.57 Favored Glycine 0 CA--C 1.556 2.6 0 CA-C-N 117.802 0.801 . . . . 0.0 112.082 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 CA--C 1.579 2.069 1 O-C-N 115.588 -4.478 . . . . 0.0 110.801 3.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.549 3.003 1 O4'-C1'-N19 113.906 5.706 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O3'--C3' 1.471 3.409 2 O4'-C1'-N19 114.839 6.639 . 0.522 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.608 7.526 1 O3'-P-O5' 112.844 4.654 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--OP2 1.429 -3.284 5 O4'-C1'-N19 115.35 7.15 . 0.01 4n . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.586 5.765 4 O4'-C1'-N19 118.234 10.034 . 0.547 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.549 3.006 2 C3'-C2'-C1' 107.494 6.66 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.512 -8.103 2 C4'-C3'-C2' 94.958 -7.742 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.586 5.605 3 O4'-C1'-N19 116.227 8.027 . 0.01 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ' C' . . . . . 0.508 ' P ' HH22 ' A' ' 177' ' ' ARG . . . . . . . . 0 C2'--O2' 1.458 3.498 3 O4'-C1'-C2' 115.718 6.656 . 0.513 &a . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O4'--C4' 1.404 -4.054 2 O4'-C1'-N19 117.082 8.882 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.882 0 N-CA-C 116.526 1.37 . . . . 0.0 116.526 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.0 mt -60.08 150.86 68.74 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 120.588 -1.536 . . . . 0.0 109.686 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.3 179.93 5.36 Favored 'Trans proline' 0 N--CA 1.514 2.731 0 CA-C-O 123.708 1.462 . . . . 0.0 110.402 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -84.44 123.23 30.01 Favored 'General case' 0 C--O 1.272 2.276 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.239 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -70.25 -13.97 62.41 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 117.838 -3.039 . . . . 0.0 113.86 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m 58.53 -29.31 0.03 OUTLIER 'General case' 0 CA--C 1.588 2.406 0 N-CA-C 118.648 2.832 . . . . 0.0 118.648 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.53 150.04 23.98 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 126.224 1.809 . . . . 0.0 112.335 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -87.68 136.24 33.03 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 118.718 -2.489 . . . . 0.0 113.755 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -80.31 -2.18 44.13 Favored 'General case' 0 C--O 1.185 -2.303 0 C-N-CA 124.959 1.304 . . . . 0.0 109.136 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -123.16 156.42 35.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 119.433 -2.042 . . . . 0.0 113.169 -168.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.8 p -64.87 142.98 58.25 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.56 164.49 21.89 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 127.287 2.867 . . . . 0.0 114.518 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.37 153.06 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.201 0.938 . . . . 0.0 112.308 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -119.22 128.23 54.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.14 -2.85 . . . . 0.0 106.534 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.95 150.36 29.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 108.205 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -138.01 -19.79 1.13 Allowed 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 122.097 0.951 . . . . 0.0 111.881 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.0 -128.12 6.2 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 123.558 1.643 . . . . 0.0 112.392 166.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -142.04 -24.72 0.68 Allowed 'General case' 0 CA--C 1.588 2.407 0 C-N-CA 125.023 1.329 . . . . 0.0 113.572 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.295 25.4 tp10 -60.49 138.85 57.95 Favored 'General case' 0 CA--C 1.609 3.226 0 O-C-N 118.671 -2.518 . . . . 0.0 114.859 173.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.97 163.69 11.72 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 122.742 1.258 . . . . 0.0 114.288 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tp -73.82 54.75 0.51 Allowed 'General case' 0 C--O 1.288 3.112 0 CA-C-N 112.36 -2.2 . . . . 0.0 114.45 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -59.81 159.54 8.78 Favored 'General case' 0 N--CA 1.406 -2.628 0 C-N-CA 127.102 2.161 . . . . 0.0 116.327 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.464 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 77.1 m-85 -145.47 125.37 7.04 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -47.18 117.28 2.14 Favored 'Trans proline' 0 N--CA 1.452 -0.945 1 C-N-CA 125.492 4.128 . . . . 0.0 115.169 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 43.56 23.86 0.05 Allowed 'General case' 1 N--CA 1.557 4.92 1 C-N-CA 131.8 4.04 . . . . 0.0 110.898 -171.41 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.33 17.45 62.47 Favored Glycine 0 CA--C 1.551 2.326 0 O-C-N 117.444 -3.285 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -88.87 111.45 22.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 121.086 2.443 . . . . 0.0 109.796 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.15 38.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-O 116.634 -2.204 . . . . 0.0 118.118 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.35 126.75 92.61 Favored Pre-proline 0 CA--C 1.505 -0.753 0 O-C-N 127.583 2.578 . . . . 0.0 109.601 158.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.93 170.24 20.22 Favored 'Trans proline' 0 N--CA 1.516 2.794 0 C-N-CA 125.221 3.947 . . . . 0.0 113.102 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.4 mt -79.26 126.08 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 117.962 -2.961 . . . . 0.0 110.621 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -138.34 116.1 11.47 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 127.124 3.345 . . . . 0.0 106.82 163.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 m -74.24 -21.86 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 112.27 -2.241 . . . . 0.0 106.249 -168.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.96 39.19 1.51 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 127.669 2.388 . . . . 0.0 114.056 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.7 p -140.94 149.62 42.07 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 121.323 -0.861 . . . . 0.0 112.752 151.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.9 p -75.9 163.7 65.17 Favored Pre-proline 0 CA--C 1.581 2.165 0 CA-C-O 116.3 -1.809 . . . . 0.0 113.519 -170.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.35 -28.75 73.91 Favored 'Trans proline' 0 CA--C 1.569 2.263 0 CA-C-N 124.137 2.513 . . . . 0.0 112.627 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -69.58 -13.81 62.52 Favored 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.41 -10.57 34.71 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 127.795 2.438 . . . . 0.0 111.051 -163.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -86.01 64.7 8.73 Favored 'General case' 0 C--O 1.277 2.528 0 C-N-CA 127.131 2.172 . . . . 0.0 113.749 -160.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.5 tt -158.1 139.31 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-N 112.955 -1.929 . . . . 0.0 107.168 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.04 -165.53 39.0 Favored Glycine 0 CA--C 1.568 3.388 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -165.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -145.37 156.14 43.6 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 125.966 1.706 . . . . 0.0 115.43 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 14.9 m-85 -94.1 148.22 22.39 Favored 'General case' 0 C--O 1.277 2.53 0 C-N-CA 124.064 0.945 . . . . 0.0 109.285 157.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -122.78 138.77 54.54 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 126.22 1.808 . . . . 0.0 112.962 171.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -71.77 143.02 49.7 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 118.608 -2.557 . . . . 0.0 116.828 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . 0.252 . . -124.29 83.45 2.15 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.958 1.703 . . . . 0.0 111.498 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.9 p -80.57 -15.44 56.64 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 120.102 1.319 . . . . 0.0 113.294 -165.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 47.5 35.5 4.28 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.481 ' HB3' ' C2 ' ' B' ' 3' ' ' ' U' . 13.0 ttm180 -89.84 -9.68 48.19 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.262 1.7 mp 65.85 143.69 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.553 4.701 0 C-N-CA 130.283 3.433 . . . . 0.0 116.216 172.98 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -123.6 -9.1 7.94 Favored 'General case' 0 CA--C 1.58 2.126 0 C-N-CA 127.488 2.315 . . . . 0.0 111.901 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.27 -137.85 2.3 Favored Glycine 0 C--N 1.358 1.772 0 CA-C-O 114.676 -3.291 . . . . 0.0 113.289 -174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.77 -140.54 0.69 Allowed Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 120.56 2.18 . . . . 0.0 116.559 160.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 51.21 13.59 0.18 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 128.527 2.731 . . . . 0.0 117.804 -171.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 164.98 -171.23 40.32 Favored Glycine 0 C--O 1.191 -2.581 0 O-C-N 118.374 -2.704 . . . . 0.0 111.993 161.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -131.82 152.29 51.09 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 118.524 -2.75 . . . . 0.0 111.236 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 27.0 mtp -52.42 155.08 2.22 Favored 'General case' 0 CA--C 1.585 2.308 0 CA-C-N 119.349 0.977 . . . . 0.0 111.549 169.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -139.37 6.74 2.34 Favored 'General case' 0 CA--C 1.595 2.678 0 C-N-CA 128.658 2.783 . . . . 0.0 109.141 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 50.16 31.33 4.94 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 116.771 2.138 . . . . 0.0 116.771 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.43 156.29 17.87 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 117.98 -2.95 . . . . 0.0 108.508 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.8 t -58.24 144.23 77.58 Favored Pre-proline 0 N--CA 1.52 3.072 0 C-N-CA 129.23 3.012 . . . . 0.0 108.616 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -47.1 139.47 15.22 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 124.681 3.587 . . . . 0.0 115.288 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -102.37 170.62 7.95 Favored 'General case' 0 CA--C 1.572 1.812 0 O-C-N 127.122 2.764 . . . . 0.0 106.659 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -155.91 144.02 19.86 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 118.537 -2.602 . . . . 0.0 109.176 -174.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.01 147.57 44.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 128.975 2.91 . . . . 0.0 117.186 -172.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -92.92 155.87 17.3 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -148.22 139.25 23.22 Favored 'General case' 0 N--CA 1.532 3.642 1 C-N-CA 132.652 4.381 . . . . 0.0 113.721 169.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -75.04 158.63 32.87 Favored 'General case' 0 CA--C 1.606 3.12 0 O-C-N 125.454 1.721 . . . . 0.0 114.186 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.5 tp -53.65 127.21 24.65 Favored 'General case' 0 CA--C 1.582 2.176 0 O-C-N 117.377 -3.327 . . . . 0.0 114.711 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.28 15.69 76.01 Favored Glycine 0 CA--C 1.552 2.381 0 C-N-CA 123.82 0.724 . . . . 0.0 111.98 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -151.66 163.38 39.24 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-O 124.63 2.157 . . . . 0.0 111.993 -166.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.98 -163.25 54.47 Favored Glycine 1 CA--C 1.581 4.167 0 O-C-N 118.384 -2.697 . . . . 0.0 111.558 -164.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -70.59 -26.8 23.27 Favored 'Trans proline' 1 CA--C 1.607 4.157 0 CA-C-O 117.975 -0.927 . . . . 0.0 111.981 -168.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.28 37.53 1.87 Allowed 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.257 1.389 . . . . 0.0 112.901 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -25.89 67.92 Favored 'General case' 0 C--N 1.373 1.623 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.33 -12.93 77.75 Favored Glycine 1 CA--C 1.587 4.559 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.8 mt -53.65 145.8 28.36 Favored Pre-proline 0 CA--C 1.584 2.256 0 CA-C-N 119.385 1.592 . . . . 0.0 110.992 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -85.23 169.02 10.1 Favored 'Trans proline' 0 N--CA 1.412 -3.273 0 O-C-N 123.689 1.362 . . . . 0.0 113.467 155.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -57.47 136.17 56.65 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 125.503 1.752 . . . . 0.0 115.28 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.99 -4.73 56.85 Favored Glycine 1 CA--C 1.582 4.221 0 CA-C-O 115.379 -2.901 . . . . 0.0 114.047 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.73 153.99 12.59 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -82.42 100.84 10.26 Favored 'General case' 0 C--O 1.276 2.492 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.718 -165.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.11 127.95 4.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 126.442 2.339 . . . . 0.0 109.658 167.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.05 155.99 36.64 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 125.994 1.718 . . . . 0.0 110.26 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.14 7.47 87.67 Favored Glycine 0 N--CA 1.488 2.165 0 O-C-N 125.79 1.931 . . . . 0.0 113.634 -165.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.7 132.59 62.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 C-N-CA 127.026 2.13 . . . . 0.0 109.525 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.3 mm -121.99 121.14 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 C-N-CA 126.422 1.889 . . . . 0.0 106.826 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -99.03 140.7 32.79 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.8 1.24 . . . . 0.0 109.56 -170.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.02 158.64 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-O 117.654 -1.165 . . . . 0.0 113.339 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -151.56 176.75 11.02 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 127.561 3.038 . . . . 0.0 111.508 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.8 p -123.17 158.49 30.66 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 128.916 2.887 . . . . 0.0 109.379 155.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -49.94 -44.43 50.52 Favored 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 128.521 2.728 . . . . 0.0 113.892 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.11 -17.11 75.46 Favored Glycine 1 CA--C 1.59 4.758 0 CA-C-N 111.91 -2.405 . . . . 0.0 114.169 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . 0.268 . . -76.73 136.3 39.04 Favored 'General case' 0 C--O 1.292 3.324 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.2 mt -84.94 152.3 23.61 Favored 'General case' 0 C--N 1.383 2.022 0 CA-C-N 113.063 -1.881 . . . . 0.0 106.412 170.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -72.66 6.81 2.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.013 -1.449 . . . . 0.0 113.204 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.3 p -70.81 140.47 86.44 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.25 134.24 26.5 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 121.429 1.419 . . . . 0.0 109.408 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . 0.259 49.7 mmtt -77.84 41.87 0.36 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 116.417 -1.754 . . . . 0.0 109.602 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -46.02 -29.12 1.35 Allowed 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 113.365 -3.207 . . . . 0.0 114.425 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -60.74 -46.56 89.98 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 123.684 2.947 . . . . 0.0 113.253 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.7 mt -81.93 -17.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 126.126 1.77 . . . . 0.0 108.698 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.37 -23.07 55.39 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 129.772 3.558 . . . . 0.0 113.427 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.7 p -127.33 -11.71 5.72 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-O 125.89 2.757 . . . . 0.0 116.238 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -81.25 154.74 26.44 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 111.469 -2.605 . . . . 0.0 106.156 166.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -92.07 124.45 59.91 Favored Pre-proline 0 CA--C 1.581 2.162 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -52.94 -29.57 44.44 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.992 3.128 . . . . 0.0 115.642 169.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.4 -16.41 62.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -67.62 -17.45 64.62 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.929 3.059 . . . . 0.0 114.917 -170.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -135.04 178.01 7.36 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 122.696 1.236 . . . . 0.0 111.16 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.64 151.39 34.35 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 116.642 -1.647 . . . . 0.0 109.366 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.05 147.08 1.5 Allowed 'General case' 0 C--O 1.26 1.651 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.98 118.66 21.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 170.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.72 112.28 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 114.403 -2.713 . . . . 0.0 106.27 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 tt -80.1 137.82 36.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -156.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -157.02 145.95 20.02 Favored 'General case' 0 CA--C 1.611 3.31 0 C-N-CA 130.087 3.355 . . . . 0.0 107.956 -172.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.73 153.31 42.26 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 126.737 2.523 . . . . 0.0 111.744 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.72 171.77 12.73 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.398 3.398 . . . . 0.0 108.949 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.262 69.3 mt-30 64.69 12.78 7.87 Favored 'General case' 0 CA--C 1.589 2.455 0 C-N-CA 127.122 2.169 . . . . 0.0 112.419 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.99 19.32 44.34 Favored Glycine 0 CA--C 1.549 2.176 1 C-N-CA 132.881 5.038 . . . . 0.0 121.533 -163.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.0 m -61.43 137.74 58.25 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 124.068 0.947 . . . . 0.0 113.467 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 85.0 m -77.21 141.82 39.87 Favored 'General case' 0 CA--C 1.597 2.784 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.8 159.01 84.07 Favored Pre-proline 0 CA--C 1.572 1.794 0 C-N-CA 126.629 1.972 . . . . 0.0 113.273 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.13 136.96 25.47 Favored 'Trans proline' 0 CA--C 1.477 -2.333 0 CA-C-O 124.302 1.709 . . . . 0.0 112.392 -172.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -51.39 -19.92 1.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.254 166.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.43 17.26 44.74 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 125.006 3.548 . . . . 0.0 114.597 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -133.54 155.31 49.84 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-O 124.358 2.028 . . . . 0.0 110.537 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -100.57 143.38 30.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.591 -2.549 . . . . 0.0 107.369 160.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -155.42 -175.81 5.62 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 127.501 2.32 . . . . 0.0 112.641 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -88.2 -7.69 56.46 Favored 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -96.58 -171.13 34.55 Favored Glycine 0 CA--C 1.56 2.854 0 C-N-CA 130.533 3.921 . . . . 0.0 116.94 166.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . 0.265 3.4 m 56.07 14.47 1.47 Allowed 'General case' 0 CA--C 1.606 3.098 0 C-N-CA 130.743 3.617 . . . . 0.0 114.525 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -71.45 -34.61 70.39 Favored 'General case' 0 C--O 1.173 -2.968 0 C-N-CA 129.468 3.107 . . . . 0.0 117.69 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 68.1 -144.56 43.23 Favored Glycine 0 N--CA 1.413 -2.869 0 CA-C-O 113.567 -3.907 . . . . 0.0 109.958 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 62.96 -144.34 49.41 Favored Glycine 0 C--O 1.188 -2.774 0 CA-C-N 122.896 3.348 . . . . 0.0 117.014 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.255 1.369 0 C-N-CA 131.152 3.781 . . . . 0.0 110.077 -13.014 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 5 C2'--O2' 1.492 6.108 2 C5'-C4'-O4' 114.894 4.067 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.468 -5.073 5 C1'-O4'-C4' 102.326 -8.082 . 0.494 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.481 ' C2 ' ' HB3' ' A' ' 93' ' ' ARG . . . . . . . . 0 O4'--C1' 1.459 3.737 2 O4'-C1'-N19 118.685 10.485 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.359 -4.59 3 C5'-C4'-C3' 104.141 -7.572 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.381 -6.041 1 O4'-C1'-N19 114.368 6.168 . 0.58 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.583 5.598 3 N19-C1'-C2' 121.649 5.156 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.504 6.986 4 C5'-C4'-O4' 117.484 5.917 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 4 C5'--C4' 1.576 5.056 3 O4'-C1'-N19 114.444 6.244 . 0.082 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.496 -3.17 4 C5'-C4'-C3' 122.786 4.857 . 0.171 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C1' 1.499 7.049 8 C5'-C4'-O4' 98.595 -7.575 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.378 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.2 mt -69.49 170.92 7.91 Favored Pre-proline 0 C--O 1.193 -1.896 0 CA-C-O 121.815 0.817 . . . . 0.0 111.466 166.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -69.85 161.07 47.34 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 N-CA-C 116.414 1.659 . . . . 0.0 116.414 166.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -62.42 126.58 27.81 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.209 -2.182 . . . . 0.0 113.104 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -79.7 -8.63 59.35 Favored 'General case' 0 CA--C 1.574 1.9 0 O-C-N 119.172 -2.205 . . . . 0.0 115.689 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m 57.94 -39.23 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 130.375 3.47 . . . . 0.0 119.322 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 165.47 25.09 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 110.788 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -89.79 139.51 30.51 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-N 113.767 -1.561 . . . . 0.0 115.001 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -78.92 -5.79 54.57 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 127.707 2.403 . . . . 0.0 110.866 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 156.4 48.96 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.323 1.535 . . . . 0.0 113.528 -165.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.0 p -56.6 163.06 1.95 Allowed 'General case' 0 CA--C 1.575 1.915 0 CA-C-O 124.253 1.978 . . . . 0.0 108.157 165.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.97 166.11 16.18 Favored 'General case' 0 CA--C 1.626 3.903 0 CA-C-N 110.562 -3.017 . . . . 0.0 117.643 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.53 168.83 10.45 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 144.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -126.93 132.53 50.84 Favored 'General case' 0 CA--C 1.579 2.059 0 C-N-CA 126.415 1.886 . . . . 0.0 111.728 158.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.27 128.7 26.01 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 119.521 -1.987 . . . . 0.0 109.101 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -124.16 -24.66 4.3 Favored 'General case' 0 C--O 1.278 2.585 0 O-C-N 128.194 3.434 . . . . 0.0 116.802 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.08 -133.53 4.31 Favored Glycine 0 CA--C 1.578 3.974 0 N-CA-C 119.755 2.662 . . . . 0.0 119.755 154.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -133.04 -29.58 1.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 CA-C-N 119.63 1.715 . . . . 0.0 114.728 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.72 139.28 51.11 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 125.384 1.678 . . . . 0.0 111.254 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -65.74 171.37 4.32 Favored 'General case' 0 CA--C 1.48 -1.747 0 C-N-CA 126.093 1.757 . . . . 0.0 112.759 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.18 37.83 0.17 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.091 -165.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -63.77 109.11 1.61 Allowed 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 127.845 2.458 . . . . 0.0 110.971 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.68 158.71 42.17 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 118.676 -2.515 . . . . 0.0 112.958 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.85 133.45 21.84 Favored 'Trans proline' 0 C--O 1.274 2.32 0 N-CA-C 107.401 -1.807 . . . . 0.0 107.401 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 61.56 7.24 1.76 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 130.055 3.342 . . . . 0.0 114.699 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.19 33.24 85.3 Favored Glycine 0 N--CA 1.492 2.431 0 CA-C-O 123.958 1.865 . . . . 0.0 112.835 -160.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -94.89 118.41 31.75 Favored 'General case' 0 CA--C 1.58 2.097 0 CA-C-N 113.762 -1.219 . . . . 0.0 109.934 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.19 28.93 0.02 OUTLIER Glycine 0 CA--C 1.57 3.494 0 O-C-N 116.882 -3.636 . . . . 0.0 114.329 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.73 128.44 88.28 Favored Pre-proline 0 C--O 1.26 1.654 0 CA-C-N 121.212 2.506 . . . . 0.0 114.62 167.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.44 171.25 18.49 Favored 'Trans proline' 0 N--CA 1.443 -1.487 1 C-N-CA 126.624 4.882 . . . . 0.0 114.477 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.28 135.7 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 128.354 2.662 . . . . 0.0 113.32 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -168.49 121.49 0.85 Allowed 'General case' 0 C--O 1.258 1.519 0 O-C-N 119.172 -2.205 . . . . 0.0 110.072 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.27 9.0 m -75.54 -24.18 56.71 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 118.434 -2.666 . . . . 0.0 112.095 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -75.43 5.58 5.63 Favored 'General case' 0 C--N 1.37 1.483 0 O-C-N 117.506 -3.246 . . . . 0.0 111.992 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -112.83 165.23 12.5 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.261 1.846 . . . . 0.0 112.235 158.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -120.27 175.84 2.11 Favored Pre-proline 0 C--O 1.281 2.74 0 C-N-CA 128.611 2.764 . . . . 0.0 113.506 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.37 -41.48 49.37 Favored 'Trans proline' 0 CA--C 1.591 3.365 0 C-N-CA 122.031 1.821 . . . . 0.0 114.077 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -52.2 -23.01 4.88 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 122.505 2.411 . . . . 0.0 112.414 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.13 -21.02 15.08 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 118.043 -2.911 . . . . 0.0 108.846 -161.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.01 73.8 0.04 OUTLIER 'General case' 0 CA--C 1.613 3.4 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.294 7.1 tt -158.1 137.34 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 C-N-CA 130.786 3.634 . . . . 0.0 104.702 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.36 -165.1 32.51 Favored Glycine 1 CA--C 1.588 4.611 0 CA-C-O 123.194 1.441 . . . . 0.0 111.717 -175.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -151.39 152.96 33.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 127.03 3.3 . . . . 0.0 116.446 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 110' ' ' PHE . 71.8 m-85 -92.88 147.3 22.96 Favored 'General case' 0 CA--C 1.606 3.11 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.179 164.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -125.68 136.79 53.61 Favored 'General case' 0 C--O 1.267 2.026 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -57.24 163.2 2.29 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.511 -1.368 . . . . 0.0 113.591 160.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.4 77.15 1.34 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.226 1.81 . . . . 0.0 111.209 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -71.25 -38.34 71.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.481 2.712 . . . . 0.0 112.538 -161.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 62.78 56.87 1.84 Allowed 'General case' 0 C--N 1.373 1.601 0 CA-C-O 126.988 3.28 . . . . 0.0 109.022 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 mtm180 -118.14 2.19 12.0 Favored 'General case' 0 CA--C 1.6 2.876 0 CA-C-O 113.493 -3.146 . . . . 0.0 107.681 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 mp 57.85 145.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 1 C-N-CA 132.23 4.212 . . . . 0.0 113.05 165.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -92.26 -23.33 19.35 Favored 'General case' 0 C--O 1.28 2.682 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 167.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.54 124.7 1.6 Allowed Glycine 0 CA--C 1.54 1.604 0 O-C-N 125.356 1.66 . . . . 0.0 109.551 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.4 -162.09 54.22 Favored Glycine 0 CA--C 1.547 2.068 0 CA-C-O 127.644 3.914 . . . . 0.0 110.404 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.272 4.7 m-20 51.45 15.37 0.32 Allowed 'General case' 0 C--O 1.191 -2.02 0 O-C-N 116.53 -3.924 . . . . 0.0 119.705 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.52 173.62 39.91 Favored Glycine 0 N--CA 1.504 3.207 0 O-C-N 118.841 -2.412 . . . . 0.0 115.121 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -130.62 144.91 51.74 Favored 'General case' 0 N--CA 1.514 2.76 0 C-N-CA 128.216 2.606 . . . . 0.0 107.382 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.8 mtp -111.18 157.49 20.01 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 130.826 3.651 . . . . 0.0 111.526 -171.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -132.78 -12.72 2.94 Favored 'General case' 0 CA--C 1.576 1.967 0 CA-C-O 115.623 -2.132 . . . . 0.0 111.615 -165.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.1 8.04 3.79 Favored 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 122.408 2.367 . . . . 0.0 116.596 -164.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.3 mt -101.37 167.23 10.3 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 123.415 1.579 . . . . 0.0 107.072 -171.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.9 m -72.9 159.77 84.52 Favored Pre-proline 0 C--N 1.368 1.393 0 CA-C-O 115.127 -2.368 . . . . 0.0 114.669 -171.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -49.18 134.86 30.78 Favored 'Trans proline' 0 CA--C 1.556 1.609 1 C-N-CA 130.636 7.557 . . . . 0.0 108.187 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -78.87 158.48 28.09 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.667 156.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -134.85 127.41 30.71 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 117.991 -2.943 . . . . 0.0 112.991 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.04 140.43 49.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.006 1.322 . . . . 0.0 113.652 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 65.1 t80 -92.45 151.57 20.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.698 3.592 . . . . 0.0 120.698 169.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.402 ' N ' ' CG ' ' A' ' 110' ' ' PHE . 24.6 m-85 -156.16 150.99 26.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.752 2.215 . . . . 0.0 108.455 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -71.08 150.03 45.91 Favored 'General case' 0 N--CA 1.524 3.266 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.796 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.4 tp -43.2 128.38 4.6 Favored 'General case' 0 C--O 1.257 1.49 0 CA-C-N 122.907 2.594 . . . . 0.0 117.161 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.42 18.54 75.4 Favored Glycine 0 CA--C 1.491 -1.462 0 CA-C-O 117.727 -1.596 . . . . 0.0 115.838 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 p -124.25 -164.14 1.22 Allowed 'General case' 0 C--O 1.282 2.773 0 CA-C-N 120.29 2.045 . . . . 0.0 112.428 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 -157.22 53.52 Favored Glycine 0 CA--C 1.547 2.088 0 CA-C-O 116.341 -2.366 . . . . 0.0 114.795 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -65.47 -22.52 59.04 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 N-CA-C 117.771 2.181 . . . . 0.0 117.771 168.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -115.31 33.51 5.4 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.918 0.887 . . . . 0.0 110.419 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.59 -12.22 56.92 Favored 'General case' 1 C--O 1.307 4.083 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.895 -166.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.11 -35.8 37.34 Favored Glycine 0 C--N 1.347 1.144 1 CA-C-O 109.029 -6.428 . . . . 0.0 107.375 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.79 135.93 94.63 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-N 123.553 3.676 . . . . 0.0 115.176 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.17 162.77 41.44 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 N-CA-C 119.927 3.011 . . . . 0.0 119.927 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -62.42 134.9 57.09 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 117.657 -3.152 . . . . 0.0 115.106 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.32 71.51 Favored Glycine 0 N--CA 1.499 2.891 0 CA-C-O 115.995 -2.558 . . . . 0.0 110.416 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.69 140.42 41.59 Favored 'General case' 0 C--N 1.389 2.3 0 O-C-N 126.747 2.087 . . . . 0.0 114.283 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -104.98 41.72 1.31 Allowed 'General case' 0 C--O 1.268 2.034 0 CA-C-N 123.397 2.817 . . . . 0.0 111.193 -147.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -74.51 116.42 15.17 Favored 'General case' 0 N--CA 1.521 3.108 0 O-C-N 126.856 2.598 . . . . 0.0 112.166 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.66 152.38 3.76 Favored 'General case' 0 C--O 1.285 2.923 0 CA-C-O 125.414 2.53 . . . . 0.0 114.181 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.33 -10.7 58.1 Favored Glycine 0 CA--C 1.575 3.812 0 CA-C-N 111.953 -2.385 . . . . 0.0 115.952 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -101.62 143.33 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.806 2.442 . . . . 0.0 110.269 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.5 mm -126.18 111.03 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 127.134 2.174 . . . . 0.0 110.322 162.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -65.61 152.2 44.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.97 138.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 O-C-N 118.12 -2.862 . . . . 0.0 113.6 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.63 179.98 7.73 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 118.661 -2.524 . . . . 0.0 113.395 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.4 p -152.59 151.09 30.24 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.422 1.489 . . . . 0.0 108.903 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.79 -27.7 65.27 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 114.566 -2.635 . . . . 0.0 113.023 -170.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.88 -16.73 50.56 Favored Glycine 0 C--O 1.189 -2.664 1 O-C-N 130.369 4.793 . . . . 0.0 117.24 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.39 150.09 28.56 Favored 'General case' 0 C--N 1.409 3.158 0 CA-C-N 121.277 2.538 . . . . 0.0 108.263 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.86 146.48 23.61 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.66 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -76.07 7.89 3.71 Favored 'General case' 1 CA--C 1.648 4.742 0 O-C-N 117.766 -3.084 . . . . 0.0 113.974 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.417 ' O ' ' HE2' ' A' ' 143' ' ' LYS . 20.9 p -70.57 145.54 92.77 Favored Pre-proline 0 N--CA 1.48 1.066 0 O-C-N 118.137 -2.852 . . . . 0.0 110.597 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.59 137.52 33.1 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 125.041 3.828 . . . . 0.0 112.995 160.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 141' ' ' THR . 39.5 mmtt -101.52 67.0 1.11 Allowed 'General case' 0 C--O 1.263 1.784 0 C-N-CA 128.578 2.751 . . . . 0.0 108.987 175.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -73.22 -12.12 60.75 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.978 -161.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -82.45 -47.85 11.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 113.608 -3.091 . . . . 0.0 114.526 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.47 -32.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 O-C-N 126.641 2.463 . . . . 0.0 113.409 156.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.74 -15.53 62.27 Favored Glycine 0 CA--C 1.553 2.448 0 C-N-CA 126.468 1.985 . . . . 0.0 115.459 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 81.2 p -145.12 -30.08 0.44 Allowed 'General case' 1 CA--C 1.635 4.213 0 C-N-CA 130.105 3.362 . . . . 0.0 117.836 -160.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.97 149.6 46.94 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.042 1.737 . . . . 0.0 110.334 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -74.62 111.03 11.28 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.067 -170.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.31 -35.73 39.02 Favored 'Trans proline' 0 N--CA 1.51 2.494 0 CA-C-O 122.81 1.087 . . . . 0.0 109.488 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.26 2.52 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 117.114 -3.491 . . . . 0.0 114.498 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . 0.265 27.9 t-20 -69.51 -22.5 63.58 Favored 'General case' 0 CA--C 1.588 2.43 0 CA-C-N 120.264 1.393 . . . . 0.0 113.786 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -138.26 177.81 7.6 Favored 'General case' 0 C--O 1.177 -2.725 0 C-N-CA 127.669 2.388 . . . . 0.0 109.005 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.07 156.16 38.0 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 114.912 -2.471 . . . . 0.0 114.986 162.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.85 146.32 37.79 Favored 'General case' 0 C--O 1.175 -2.867 0 CA-C-N 121.837 2.108 . . . . 0.0 113.098 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.8 mt -61.11 143.69 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.612 1.096 . . . . 0.0 111.265 160.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.6 p -74.46 126.13 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.9 tp -58.46 118.91 6.1 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -138.27 141.49 39.87 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.7 154.79 50.66 Favored Pre-proline 0 C--O 1.198 -1.609 0 CA-C-N 122.889 2.586 . . . . 0.0 113.296 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -56.71 177.06 0.18 Allowed 'Trans proline' 0 CA--C 1.558 1.687 1 C-N-CA 130.404 7.403 . . . . 0.0 117.479 166.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 48.37 32.12 3.08 Favored 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 131.787 4.035 . . . . 0.0 114.502 172.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.48 11.9 54.41 Favored Glycine 0 CA--C 1.556 2.597 0 O-C-N 117.661 -3.149 . . . . 0.0 118.005 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . 0.253 5.9 m -63.13 119.81 10.26 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -161.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 46.9 m -63.69 131.22 47.26 Favored 'General case' 0 C--N 1.381 1.948 0 O-C-N 124.521 1.138 . . . . 0.0 108.436 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 44.2 mt -66.81 156.89 85.84 Favored Pre-proline 0 C--O 1.268 2.031 0 C-N-CA 127.162 2.185 . . . . 0.0 106.206 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -57.96 131.34 43.04 Favored 'Trans proline' 0 CA--C 1.571 2.333 0 C-N-CA 123.495 2.797 . . . . 0.0 113.905 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -60.77 -39.29 88.23 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.038 1.735 . . . . 0.0 109.992 -161.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.91 41.43 3.04 Favored Glycine 0 C--N 1.38 2.982 0 O-C-N 117.777 -3.077 . . . . 0.0 112.124 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.68 144.6 37.67 Favored 'General case' 0 C--O 1.204 -1.311 0 O-C-N 119.325 -2.279 . . . . 0.0 113.528 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -72.05 145.38 48.3 Favored 'General case' 0 C--O 1.284 2.884 0 CA-C-O 116.208 -1.853 . . . . 0.0 111.206 157.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -160.92 170.75 19.99 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 126.708 2.003 . . . . 0.0 110.297 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -79.48 59.1 2.84 Favored 'General case' 0 CA--C 1.571 1.77 0 O-C-N 119.364 -2.085 . . . . 0.0 113.196 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -159.86 176.94 36.53 Favored Glycine 0 CA--C 1.575 3.812 0 C-N-CA 127.839 2.638 . . . . 0.0 109.638 -168.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . 0.26 64.2 m 41.2 35.82 0.43 Allowed 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 127.252 2.221 . . . . 0.0 113.974 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -91.43 -3.53 56.56 Favored 'General case' 0 CA--C 1.603 2.993 0 C-N-CA 127.8 2.44 . . . . 0.0 110.494 -174.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 71.51 -157.69 53.34 Favored Glycine 0 C--N 1.357 1.702 0 N-CA-C 116.898 1.519 . . . . 0.0 116.898 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.85 -166.9 36.37 Favored Glycine 0 C--N 1.377 2.835 0 CA-C-O 124.855 2.364 . . . . 0.0 117.978 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.273 2.314 1 O-C-N 113.781 -5.541 . . . . 0.0 115.075 -2.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.474 4 OP1-P-OP2 110.3 -6.2 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O4'--C1' 1.463 4.125 2 O3'-P-O5' 116.512 6.585 . 0.531 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.55 -4.713 4 O5'-C5'-C4' 120.909 7.65 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.559 3.12 3 C5'-C4'-C3' 107.527 -5.315 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O3'--C3' 1.466 3.079 1 C5'-C4'-C3' 108.744 -4.504 . 0.547 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.394 -4.892 2 O5'-C5'-C4' 117.895 5.496 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.61 8.165 3 C1'-O4'-C4' 104.245 -5.95 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.465 HO2' " C5'" ' B' ' 9' ' ' ' C' . . . . . . . . 2 C3'--C2' 1.582 5.202 3 C3'-C2'-C1' 108.812 8.124 . 0.46 1a . 0.0 . . . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ' C' . . . . . 0.465 " C5'" HO2' ' B' ' 8' ' ' ' A' . . . . . . . . 2 P--O5' 1.525 -6.798 2 C1'-O4'-C4' 104.205 -5.995 . 0.366 1b . 0.0 . . . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.569 4.555 2 O4'-C1'-N19 118.024 9.824 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 N--CA 1.483 0.901 0 CA-C-O 118.651 -0.645 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -71.05 113.61 8.26 Favored 'General case' 0 C--O 1.275 2.408 0 CA-C-O 124.423 2.059 . . . . 0.0 112.772 -174.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -70.98 -9.14 57.43 Favored 'General case' 0 CA--C 1.614 3.413 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -167.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.1 m 58.49 -31.62 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 1 C-N-CA 132.1 4.16 . . . . 0.0 115.192 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.54 157.69 21.18 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.167 2.987 . . . . 0.0 113.11 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.0 t -79.53 136.89 37.0 Favored 'General case' 0 N--CA 1.422 -1.875 0 O-C-N 120.225 -1.547 . . . . 0.0 110.584 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.88 -29.35 70.69 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 115.849 -2.024 . . . . 0.0 113.952 169.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -100.38 162.68 12.79 Favored 'General case' 0 C--N 1.377 1.788 0 O-C-N 127.552 3.033 . . . . 0.0 113.611 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.307 35.2 p -59.45 140.35 56.27 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 125.183 2.421 . . . . 0.0 113.162 166.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.05 143.91 32.58 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 111.151 -2.749 . . . . 0.0 109.623 -171.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.31 152.38 21.06 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.578 -1.326 . . . . 0.0 108.004 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -116.64 134.15 55.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 118.29 -2.756 . . . . 0.0 110.637 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -68.76 139.89 55.32 Favored 'General case' 0 CA--C 1.607 3.139 0 C-N-CA 126.58 1.952 . . . . 0.0 115.856 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -115.72 -48.04 2.78 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.23 -135.62 5.61 Favored Glycine 0 N--CA 1.508 3.458 0 C-N-CA 127.063 2.268 . . . . 0.0 110.959 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -147.39 -29.04 0.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.277 2.038 . . . . 0.0 114.143 -164.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.79 129.47 37.74 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 127.819 2.448 . . . . 0.0 114.773 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.527 ' HB2' ' HE3' ' A' ' 65' ' ' LYS . 82.0 m-20 -56.91 155.57 7.83 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 128.384 2.674 . . . . 0.0 108.067 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.16 57.32 0.84 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.504 -2.623 . . . . 0.0 110.029 -170.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.527 ' HE3' ' HB2' ' A' ' 63' ' ' ASP . 82.8 mttt -87.61 101.81 14.0 Favored 'General case' 0 CA--C 1.576 1.957 1 O-C-N 115.776 -4.327 . . . . 0.0 106.86 -164.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -68.25 149.61 98.03 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -55.78 154.59 25.62 Favored 'Trans proline' 1 C--N 1.417 4.139 0 O-C-N 118.291 -1.479 . . . . 0.0 108.568 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 54.63 -5.95 0.02 OUTLIER 'General case' 0 N--CA 1.539 3.977 1 N-CA-C 122.123 4.12 . . . . 0.0 122.123 152.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.78 7.37 71.32 Favored Glycine 0 CA--C 1.564 3.154 1 O-C-N 115.285 -4.634 . . . . 0.0 113.861 -168.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -86.72 104.6 16.27 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 117.803 -1.094 . . . . 0.0 109.0 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.25 21.54 0.04 OUTLIER Glycine 0 C--N 1.356 1.694 0 CA-C-N 122.326 2.33 . . . . 0.0 113.212 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.254 97.9 t -73.29 117.6 61.67 Favored Pre-proline 0 C--O 1.268 2.031 0 O-C-N 119.535 -2.156 . . . . 0.0 116.087 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -68.64 170.18 15.77 Favored 'Trans proline' 0 CA--C 1.552 1.387 1 C-N-CA 129.287 6.658 . . . . 0.0 109.534 -169.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.8 mt -105.13 141.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 O-C-N 117.772 -3.08 . . . . 0.0 112.381 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 127.481 2.312 . . . . 0.0 111.778 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.4 m -57.49 -43.99 84.57 Favored 'General case' 0 C--O 1.192 -1.929 0 O-C-N 124.054 0.846 . . . . 0.0 112.124 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -77.14 39.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 128.0 2.52 . . . . 0.0 111.907 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.2 p -146.57 144.62 29.69 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 125.551 1.54 . . . . 0.0 111.88 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -83.16 168.01 25.45 Favored Pre-proline 0 C--O 1.271 2.215 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -62.89 -33.76 74.11 Favored 'Trans proline' 0 C--O 1.203 -1.241 0 CA-C-O 117.554 -1.102 . . . . 0.0 114.511 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -58.02 -29.12 65.07 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 128.698 2.799 . . . . 0.0 111.21 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.318 33.9 m-20 -74.16 -11.67 60.36 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 129.036 2.935 . . . . 0.0 114.104 -172.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -88.39 66.37 8.3 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 117.149 -1.405 . . . . 0.0 111.229 -157.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.8 tt -154.62 144.23 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.671 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 178.89 -167.49 37.8 Favored Glycine 1 CA--C 1.58 4.137 0 C-N-CA 116.873 -2.584 . . . . 0.0 114.925 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -153.57 147.18 25.1 Favored 'General case' 0 C--O 1.202 -1.432 0 O-C-N 118.247 -2.913 . . . . 0.0 112.985 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -92.91 139.48 30.49 Favored 'General case' 0 C--O 1.246 0.896 0 O-C-N 128.736 3.773 . . . . 0.0 117.34 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -140.69 164.0 31.37 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 121.813 2.097 . . . . 0.0 110.865 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -83.92 154.68 23.25 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 117.78 2.511 . . . . 0.0 117.78 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.23 88.69 2.11 Favored 'General case' 0 C--O 1.182 -2.453 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.635 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.7 p -67.6 -27.8 67.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 116.07 -1.919 . . . . 0.0 111.729 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 52.88 56.05 8.13 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-N 120.189 1.359 . . . . 0.0 109.252 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -122.91 -12.0 8.06 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 130.395 3.478 . . . . 0.0 114.476 -160.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 mp 61.27 124.88 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.549 4.495 1 C-N-CA 131.82 4.048 . . . . 0.0 108.521 166.684 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 . . . . . 0 N--CA 1.518 2.954 0 C-N-CA 127.145 2.178 . . . . 0.0 107.368 169.507 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.7 tttt . . . . . 0 CA--C 1.6 2.872 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 55.99 -0.34 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 131.667 3.987 . . . . 0.0 116.141 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -67.56 169.34 9.43 Favored 'General case' 0 N--CA 1.53 3.555 0 CA-C-N 123.844 3.02 . . . . 0.0 109.667 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.9 m -56.83 163.06 3.05 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 127.27 3.414 . . . . 0.0 111.61 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -71.57 168.05 24.7 Favored 'Trans proline' 0 N--CA 1.427 -2.402 0 CA-C-O 124.844 1.935 . . . . 0.0 115.228 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -113.74 164.54 13.58 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 116.767 -3.708 . . . . 0.0 107.167 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -134.25 122.56 22.91 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 129.775 3.23 . . . . 0.0 112.051 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -107.84 147.61 30.68 Favored 'General case' 0 CA--C 1.597 2.769 0 CA-C-N 113.438 -1.71 . . . . 0.0 112.508 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -101.82 148.88 24.77 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.834 2.454 . . . . 0.0 110.16 166.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -134.05 145.2 49.2 Favored 'General case' 0 C--O 1.255 1.394 0 C-N-CA 125.267 1.427 . . . . 0.0 111.884 168.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -57.73 157.05 7.75 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 160.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 114' ' ' GLY . 33.9 tp -66.25 138.03 57.38 Favored 'General case' 0 C--N 1.384 2.095 0 O-C-N 123.982 0.801 . . . . 0.0 111.068 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.456 ' H ' HD12 ' A' ' 113' ' ' LEU . . . 59.95 32.43 75.27 Favored Glycine 0 CA--C 1.564 3.129 0 CA-C-O 118.08 -1.4 . . . . 0.0 115.069 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -141.88 172.04 13.23 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 128.228 2.611 . . . . 0.0 112.206 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -163.98 45.93 Favored Glycine 1 C--O 1.298 4.126 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.879 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.57 -29.26 25.08 Favored 'Trans proline' 0 CA--C 1.578 2.708 1 C-N-CA 125.579 4.186 . . . . 0.0 111.378 -170.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -94.45 24.63 4.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.921 -2.362 . . . . 0.0 111.521 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 -29.59 41.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.062 1.745 . . . . 0.0 114.404 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.38 -10.38 84.66 Favored Glycine 0 C--N 1.388 3.42 0 CA-C-O 124.505 2.169 . . . . 0.0 117.668 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.9 mt -70.29 136.17 86.64 Favored Pre-proline 0 N--CA 1.522 3.155 1 O-C-N 115.776 -4.367 . . . . 0.0 110.179 168.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.18 174.26 13.11 Favored 'Trans proline' 0 C--N 1.376 1.986 0 O-C-N 123.689 1.363 . . . . 0.0 112.711 160.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.02 133.44 56.1 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 120.289 -1.507 . . . . 0.0 111.698 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.75 5.65 89.34 Favored Glycine 1 CA--C 1.621 6.663 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 168.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.98 151.37 4.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.596 1.665 . . . . 0.0 111.994 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -94.95 68.02 3.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -125.05 137.39 54.21 Favored 'General case' 0 C--O 1.258 1.542 0 C-N-CA 126.646 1.978 . . . . 0.0 113.745 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.259 3.2 t0 -57.39 124.05 17.57 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 112.194 -2.275 . . . . 0.0 112.296 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.84 -4.63 79.01 Favored Glycine 0 C--N 1.373 2.589 0 O-C-N 125.204 1.565 . . . . 0.0 114.115 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 mp -86.68 128.82 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.609 3.242 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 163.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.0 mm -109.75 109.62 29.09 Favored 'Isoleucine or valine' 0 C--O 1.254 1.332 1 O-C-N 129.179 4.049 . . . . 0.0 110.574 170.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.21 138.5 35.81 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.205 -0.935 . . . . 0.0 112.901 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.01 146.25 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 126.121 1.769 . . . . 0.0 114.029 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.85 153.57 35.62 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 130.153 3.381 . . . . 0.0 110.843 -175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.2 p -102.43 156.56 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 129.38 3.072 . . . . 0.0 105.096 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -52.7 -31.13 36.0 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.59 -27.31 10.68 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 127.892 2.663 . . . . 0.0 113.171 -163.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.53 157.98 8.28 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.302 1.441 . . . . 0.0 111.486 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.09 131.15 54.43 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 124.589 2.137 . . . . 0.0 110.939 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -64.53 24.42 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.369 0 O-C-N 117.971 -2.956 . . . . 0.0 118.272 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.3 p -87.36 150.76 49.82 Favored Pre-proline 0 C--N 1.362 1.119 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.31 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.4 148.77 49.28 Favored 'Trans proline' 0 CA--C 1.505 -0.949 0 CA-C-O 116.686 -1.464 . . . . 0.0 115.041 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -97.51 90.09 4.92 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 126.166 2.888 . . . . 0.0 109.868 -172.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -52.39 -59.54 4.3 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -64.44 -66.91 0.48 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.064 2.146 . . . . 0.0 106.758 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.0 mt -45.53 -27.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 119.223 -2.173 . . . . 0.0 116.394 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -92.9 -11.23 59.17 Favored Glycine 1 CA--C 1.579 4.035 0 O-C-N 117.785 -3.072 . . . . 0.0 115.834 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.3 p -125.56 -12.65 6.65 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 114.975 -2.441 . . . . 0.0 112.676 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -74.63 178.34 5.45 Favored 'General case' 0 CA--C 1.582 2.2 0 CA-C-O 113.115 -3.326 . . . . 0.0 115.733 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -109.6 97.47 27.82 Favored Pre-proline 0 N--CA 1.414 -2.262 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . 0.337 4.2 Cg_exo -57.86 -28.45 82.53 Favored 'Trans proline' 0 CA--C 1.581 2.827 0 C-N-CA 123.183 2.589 . . . . 0.0 113.882 171.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.7 -12.75 25.7 Favored 'General case' 0 CA--C 1.556 1.184 0 O-C-N 124.448 1.093 . . . . 0.0 113.195 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -61.81 -19.81 62.95 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -148.31 -176.55 5.34 Favored 'General case' 0 C--O 1.175 -2.831 0 CA-C-N 121.271 1.85 . . . . 0.0 110.345 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.24 156.24 0.6 Allowed 'General case' 0 C--N 1.386 2.153 0 CA-C-N 113.531 -1.668 . . . . 0.0 114.825 154.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.08 159.98 24.61 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.1 mt -81.46 130.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.722 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 p -63.35 121.2 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 124.497 2.094 . . . . 0.0 108.483 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 118.86 12.23 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 114.693 -5.005 . . . . 0.0 111.514 171.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -151.29 133.08 14.97 Favored 'General case' 0 C--O 1.251 1.136 0 O-C-N 126.87 2.606 . . . . 0.0 109.695 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.5 mt -75.21 165.63 52.2 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.52 145.97 92.68 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 119.509 0.86 . . . . 0.0 112.915 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 58.6 9.92 1.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.939 2.895 . . . . 0.0 113.098 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.29 30.17 73.45 Favored Glycine 0 CA--C 1.548 2.128 0 O-C-N 118.217 -2.802 . . . . 0.0 116.144 -168.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.7 m -55.0 125.65 21.31 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-N 112.737 -1.731 . . . . 0.0 111.889 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 87.0 m -69.51 125.82 27.86 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -164.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 mt -71.91 157.55 89.34 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 125.632 1.832 . . . . 0.0 106.168 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -44.02 124.84 5.04 Favored 'Trans proline' 0 N--CA 1.52 3.039 1 C-N-CA 129.195 6.597 . . . . 0.0 116.734 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -57.99 -25.41 61.03 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 128.579 2.751 . . . . 0.0 107.708 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.94 -15.25 9.38 Favored Glycine 1 CA--C 1.596 5.147 0 CA-C-N 120.781 1.628 . . . . 0.0 114.917 174.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -137.34 153.89 50.16 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 126.593 1.957 . . . . 0.0 113.188 -154.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -98.6 124.72 43.54 Favored 'General case' 0 C--O 1.199 -1.589 0 O-C-N 118.843 -2.411 . . . . 0.0 109.101 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -117.24 164.63 14.52 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 127.49 2.316 . . . . 0.0 113.988 168.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 CA--C 1.568 1.662 0 C-N-CA 127.471 2.309 . . . . 0.0 116.108 174.488 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo . . . . . 0 C--O 1.252 1.176 0 N-CA-C 118.687 2.534 . . . . 0.0 118.687 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -71.04 111.93 6.79 Favored 'General case' 0 N--CA 1.403 -2.778 0 O-C-N 119.878 -1.764 . . . . 0.0 112.395 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 50' ' ' ALA 0.456 27.3 p30 -46.2 -32.8 3.22 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 119.72 -1.862 . . . . 0.0 115.742 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.3 m 64.96 -36.69 0.21 Allowed 'General case' 0 CA--C 1.609 3.219 0 C-N-CA 128.481 2.712 . . . . 0.0 106.974 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 48' ' ' ASN . . . -76.62 152.66 35.8 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 120.639 1.563 . . . . 0.0 113.766 -173.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -95.96 145.68 25.22 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 117.432 2.382 . . . . 0.0 117.432 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -83.03 -13.38 55.98 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -108.39 158.12 17.8 Favored 'General case' 0 N--CA 1.415 -2.18 0 O-C-N 127.965 3.291 . . . . 0.0 116.631 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.0 p -63.27 125.91 25.66 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.88 155.19 35.01 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 127.463 2.305 . . . . 0.0 111.783 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.97 164.09 12.5 Favored 'General case' 0 CA--C 1.593 2.63 0 C-N-CA 128.712 2.805 . . . . 0.0 109.043 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 67.4 m -132.51 130.65 40.7 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 118.878 -2.389 . . . . 0.0 110.616 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -67.49 137.4 55.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.269 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -125.58 -33.11 2.81 Favored 'General case' 0 CA--C 1.593 2.596 0 CA-C-N 120.874 1.67 . . . . 0.0 111.266 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.09 -134.66 0.65 Allowed Glycine 0 N--CA 1.514 3.842 0 N-CA-C 120.945 3.138 . . . . 0.0 120.945 170.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -133.82 -23.63 1.78 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 125.964 1.705 . . . . 0.0 113.444 167.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.92 146.96 25.97 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -72.21 159.47 34.04 Favored 'General case' 0 N--CA 1.409 -2.494 0 O-C-N 118.71 -2.494 . . . . 0.0 111.015 -168.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.1 tp -74.3 68.64 1.52 Allowed 'General case' 0 N--CA 1.534 3.73 0 CA-C-O 123.598 1.666 . . . . 0.0 111.543 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -91.87 158.99 16.0 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 125.114 2.387 . . . . 0.0 106.894 -168.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 61.8 m-85 -148.07 126.95 6.19 Favored Pre-proline 0 C--O 1.257 1.456 0 O-C-N 119.45 -2.031 . . . . 0.0 107.874 -167.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -57.96 106.95 0.28 Allowed 'Trans proline' 0 C--O 1.192 -1.779 1 C-N-CA 125.481 4.121 . . . . 0.0 113.117 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 38.77 36.34 0.14 Allowed 'General case' 0 C--N 1.387 2.235 0 C-N-CA 129.539 3.135 . . . . 0.0 115.244 -166.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.5 75.13 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 171.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.18 101.75 3.42 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.411 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.42 -1.26 0.04 OUTLIER Glycine 0 C--O 1.284 3.27 0 N-CA-C 122.952 3.941 . . . . 0.0 122.952 -167.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.76 144.26 68.55 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 121.797 -0.825 . . . . 0.0 113.138 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -82.95 163.67 15.68 Favored 'Trans proline' 0 CA--C 1.55 1.286 0 O-C-N 115.549 -2.921 . . . . 0.0 115.953 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.6 tt -78.55 144.35 11.29 Favored 'Isoleucine or valine' 0 C--O 1.277 2.534 0 CA-C-O 127.69 3.614 . . . . 0.0 112.026 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -150.06 144.46 25.77 Favored 'General case' 0 C--O 1.26 1.652 0 O-C-N 116.971 -3.58 . . . . 0.0 113.35 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.0 m -82.61 -36.29 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . 0.342 17.4 m120 -84.0 20.48 1.53 Allowed 'General case' 0 C--O 1.189 -2.084 0 C-N-CA 131.615 3.966 . . . . 0.0 116.124 -162.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 p -161.34 166.96 26.69 Favored 'General case' 0 C--N 1.388 2.248 0 C-N-CA 126.056 1.742 . . . . 0.0 112.538 171.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.0 p -94.44 169.6 9.47 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.131 0.972 . . . . 0.0 112.419 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 83' ' ' GLN . 49.5 Cg_exo -65.3 -23.69 58.87 Favored 'Trans proline' 0 CA--C 1.452 -3.589 0 O-C-N 116.908 -2.206 . . . . 0.0 116.908 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -68.01 -24.87 65.17 Favored 'General case' 0 C--O 1.274 2.348 0 C-N-CA 127.636 2.375 . . . . 0.0 107.751 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -78.64 -18.48 54.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 121.725 2.057 . . . . 0.0 115.205 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 80' ' ' PRO . 63.0 mm-40 -84.3 74.04 10.38 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 125.228 2.442 . . . . 0.0 112.104 -162.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -156.04 141.66 10.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.753 1 C-N-CA 133.29 4.636 . . . . 0.0 112.859 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.02 -173.41 40.79 Favored Glycine 1 CA--C 1.581 4.186 0 CA-C-O 124.394 2.108 . . . . 0.0 116.321 -168.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -136.44 156.13 49.04 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 109.36 -3.42 . . . . 0.0 111.736 168.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.408 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 36.1 m-85 -99.86 143.32 30.22 Favored 'General case' 0 N--CA 1.391 -3.399 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 162.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -123.04 143.34 50.01 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 126.097 1.759 . . . . 0.0 112.299 165.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.97 166.06 1.63 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 165.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 133.406 4.682 . . . . 0.0 112.875 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.1 p -137.26 -13.72 1.56 Allowed 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 59.48 41.16 19.72 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 124.342 2.02 . . . . 0.0 112.203 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -120.37 3.55 10.79 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 118.138 -2.851 . . . . 0.0 116.589 -161.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.8 mm 65.56 92.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.16 -3.63 0 C-N-CA 130.806 3.643 . . . . 0.0 116.579 149.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 . . . . . 0 N--CA 1.418 -2.071 0 O-C-N 124.144 0.902 . . . . 0.0 109.981 161.916 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 CA--C 1.57 1.714 0 CA-C-O 114.258 -2.782 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.27 27.24 15.42 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.235 1.834 . . . . 0.0 112.134 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.59 167.67 17.1 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 122.747 1.26 . . . . 0.0 107.872 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -65.67 146.22 98.99 Favored Pre-proline 0 C--N 1.405 2.983 0 CA-C-N 112.215 -2.266 . . . . 0.0 116.761 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.02 155.41 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 1 C-N-CA 127.993 5.795 . . . . 0.0 111.872 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -114.83 172.34 7.1 Favored 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -140.82 147.1 38.49 Favored 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 126.936 2.094 . . . . 0.0 113.237 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 55.6 m-85 -132.14 145.71 51.55 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 130.409 3.484 . . . . 0.0 116.717 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -98.83 141.25 31.85 Favored 'General case' 0 C--O 1.262 1.734 0 O-C-N 118.198 -2.814 . . . . 0.0 109.544 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -142.41 122.82 13.99 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 127.669 2.388 . . . . 0.0 110.09 172.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -45.82 151.54 0.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 111.082 171.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.305 69.1 tp -52.84 132.63 37.14 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 125.886 2.755 . . . . 0.0 112.456 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.34 42.18 98.74 Favored Glycine 0 C--O 1.263 1.94 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.898 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -149.55 173.01 14.09 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 114.14 -1.03 . . . . 0.0 112.03 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 54.71 -159.51 5.59 Favored Glycine 0 C--O 1.255 1.421 0 O-C-N 119.727 -1.858 . . . . 0.0 115.186 -163.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.1 -19.34 63.18 Favored 'Trans proline' 0 N--CA 1.5 1.9 1 C-N-CA 125.638 4.225 . . . . 0.0 117.794 -166.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -117.45 35.32 4.72 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 124.645 1.178 . . . . 0.0 111.547 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.59 -5.65 1.32 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 119.967 -1.708 . . . . 0.0 114.159 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.31 -36.66 44.23 Favored Glycine 0 N--CA 1.417 -2.622 0 CA-C-O 114.729 -3.262 . . . . 0.0 113.928 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.6 mt -69.22 125.65 92.13 Favored Pre-proline 0 C--O 1.262 1.737 0 CA-C-N 121.228 2.514 . . . . 0.0 116.768 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.57 171.93 2.34 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 121.868 1.712 . . . . 0.0 114.485 160.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -68.22 138.37 55.52 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.16 74.8 Favored Glycine 1 CA--C 1.585 4.459 0 C-N-CA 117.225 -2.417 . . . . 0.0 116.811 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.34 82.2 8.38 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 171.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.49 126.72 29.17 Favored 'General case' 0 C--O 1.207 -1.163 0 O-C-N 118.044 -2.91 . . . . 0.0 113.126 -167.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -148.1 159.2 44.17 Favored 'General case' 0 C--O 1.182 -2.495 0 C-N-CA 126.714 2.006 . . . . 0.0 110.558 -170.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.1 133.84 46.56 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.8 -2.31 72.59 Favored Glycine 1 CA--C 1.621 6.658 0 O-C-N 119.636 -1.915 . . . . 0.0 114.377 169.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.8 mt -131.3 142.08 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 1 C-N-CA 131.952 4.101 . . . . 0.0 104.62 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.9 mm -137.73 112.96 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.759 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -76.47 128.58 35.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.288 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 m -133.05 142.92 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 127.465 3.507 . . . . 0.0 114.889 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.18 173.57 12.1 Favored 'General case' 0 CA--C 1.478 -1.81 0 O-C-N 118.159 -2.838 . . . . 0.0 112.571 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 37.2 p -127.61 157.11 41.11 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 129.539 3.136 . . . . 0.0 109.916 173.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -64.67 -35.82 82.27 Favored 'General case' 0 CA--C 1.582 2.18 0 C-N-CA 123.964 0.906 . . . . 0.0 112.694 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.79 -22.19 72.65 Favored Glycine 1 CA--C 1.595 5.076 0 O-C-N 119.592 -1.943 . . . . 0.0 114.361 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.69 165.71 4.89 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-N 120.319 2.06 . . . . 0.0 113.197 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.3 mt -126.88 147.44 50.06 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.655 2.782 . . . . 0.0 112.424 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -75.51 -2.68 30.07 Favored 'General case' 1 CA--C 1.63 4.042 0 C-N-CA 126.926 2.091 . . . . 0.0 114.311 -175.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -71.62 148.48 92.85 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 126.22 1.808 . . . . 0.0 111.26 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.6 142.98 9.52 Favored 'Trans proline' 0 CA--C 1.467 -2.872 0 C-N-CA 123.929 3.086 . . . . 0.0 109.931 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -94.08 65.12 3.39 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 117.574 -3.204 . . . . 0.0 108.155 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.52 -34.35 75.72 Favored 'General case' 0 CA--C 1.61 3.254 0 CA-C-O 113.214 -3.279 . . . . 0.0 115.624 -161.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.268 41.0 m80 -62.05 -44.49 96.57 Favored 'General case' 1 CA--C 1.645 4.629 0 O-C-N 126.019 2.074 . . . . 0.0 110.292 171.698 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.4 mt -64.49 -31.87 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.02 -2.03 88.29 Favored Glycine 0 CA--C 1.496 -1.134 0 CA-C-O 116.392 -2.338 . . . . 0.0 117.185 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.5 p -128.88 -27.19 2.56 Favored 'General case' 0 CA--C 1.596 2.724 0 CA-C-N 122.141 2.97 . . . . 0.0 113.251 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -49.4 154.58 0.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 122.292 2.315 . . . . 0.0 111.18 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -67.02 121.0 76.19 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 129.284 3.034 . . . . 0.0 113.595 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -33.79 84.76 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 N-CA-C 118.293 2.382 . . . . 0.0 118.293 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.13 0.41 36.35 Favored 'General case' 0 C--O 1.254 1.341 0 C-N-CA 127.058 2.143 . . . . 0.0 114.579 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -72.93 -16.73 61.54 Favored 'General case' 0 C--O 1.172 -3.015 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -146.36 146.31 30.61 Favored 'General case' 0 CA--C 1.609 3.226 0 CA-C-N 113.074 -1.876 . . . . 0.0 113.363 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.77 152.89 44.64 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 118.706 -2.496 . . . . 0.0 117.135 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.27 116.02 6.18 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 119.747 -1.846 . . . . 0.0 114.771 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.49 120.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.62 0 C-N-CA 127.922 2.489 . . . . 0.0 108.596 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.3 109.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 166.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.6 116.93 6.69 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -172.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -153.52 142.47 21.19 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 116.432 -3.917 . . . . 0.0 108.406 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.54 140.29 22.1 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 116.511 -1.709 . . . . 0.0 114.633 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -37.72 169.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 123.205 2.604 . . . . 0.0 115.325 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 54.64 19.14 2.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.636 2.374 . . . . 0.0 112.318 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.14 13.65 60.25 Favored Glycine 0 CA--C 1.562 3.021 0 O-C-N 116.682 -3.761 . . . . 0.0 116.458 -169.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -60.82 116.22 4.27 Favored 'General case' 0 C--O 1.165 -3.39 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.995 -167.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 m -70.18 146.92 50.43 Favored 'General case' 1 N--CA 1.539 4.016 0 C-N-CA 125.611 1.564 . . . . 0.0 113.534 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.56 157.03 77.79 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 122.47 1.129 . . . . 0.0 111.773 175.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.95 120.42 7.88 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 125.038 3.825 . . . . 0.0 112.56 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -60.44 -20.32 59.44 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -168.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.13 4.12 Favored Glycine 0 CA--C 1.54 1.609 1 O-C-N 116.071 -4.143 . . . . 0.0 117.51 161.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.61 125.8 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 123.256 3.528 . . . . 0.0 115.528 171.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -66.71 131.04 45.12 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 115.583 -2.151 . . . . 0.0 109.085 167.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.51 141.86 37.31 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 123.459 2.845 . . . . 0.0 112.301 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 . . . . . 0 CA--C 1.577 2.01 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -171.333 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 N--CA 1.501 1.962 0 CA-C-O 129.255 3.773 . . . . 0.0 106.663 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -54.99 141.61 33.27 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 109.953 -3.294 . . . . 0.0 113.548 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -96.47 -35.28 11.19 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 m 61.25 -21.82 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 129.985 3.314 . . . . 0.0 118.261 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.42 151.75 26.45 Favored 'General case' 0 CA--C 1.618 3.56 0 O-C-N 118.247 -2.783 . . . . 0.0 113.818 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -77.78 153.25 33.03 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 118.862 -2.399 . . . . 0.0 112.576 167.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -76.07 -27.34 57.19 Favored 'General case' 0 C--O 1.281 2.717 0 C-N-CA 125.616 1.567 . . . . 0.0 114.06 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.64 164.96 11.78 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 124.582 2.134 . . . . 0.0 111.171 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -67.0 159.62 28.22 Favored 'General case' 0 C--O 1.288 3.088 0 CA-C-N 111.206 -2.724 . . . . 0.0 111.02 167.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.0 147.13 28.14 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 127.284 3.421 . . . . 0.0 114.282 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -76.21 162.17 28.18 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.467 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.7 m -122.03 125.41 46.2 Favored 'General case' 0 C--N 1.38 1.916 0 C-N-CA 124.423 1.089 . . . . 0.0 109.047 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -69.41 129.36 39.54 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 125.95 1.7 . . . . 0.0 109.462 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -123.78 -7.29 7.92 Favored 'General case' 0 C--O 1.203 -1.381 0 C-N-CA 128.522 2.729 . . . . 0.0 110.475 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.8 -139.79 10.58 Favored Glycine 0 CA--C 1.566 3.269 0 O-C-N 119.333 -2.104 . . . . 0.0 109.463 159.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -147.98 -17.69 0.35 Allowed 'General case' 0 C--O 1.189 -2.116 0 C-N-CA 128.957 2.903 . . . . 0.0 109.952 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.06 132.72 49.94 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -60.19 161.57 6.88 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.048 1.739 . . . . 0.0 111.55 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.15 69.75 9.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 119.433 -2.042 . . . . 0.0 110.067 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -67.32 149.47 50.3 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.402 170.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.06 141.33 41.06 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 126.025 1.73 . . . . 0.0 113.146 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.48 129.69 24.55 Favored 'Trans proline' 0 C--N 1.381 2.271 0 N-CA-C 106.438 -2.178 . . . . 0.0 106.438 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 55.59 21.62 4.63 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 126.909 2.084 . . . . 0.0 115.583 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.01 27.81 72.73 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 124.573 1.082 . . . . 0.0 115.608 -170.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.258 20.1 tt0 -84.85 84.74 7.6 Favored 'General case' 1 CA--C 1.638 4.33 0 C-N-CA 128.463 2.705 . . . . 0.0 106.258 -175.241 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.11 0.08 OUTLIER Glycine 0 C--O 1.206 -1.648 2 CA-C-O 128.64 4.466 . . . . 0.0 123.615 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 133' ' ' VAL . 93.1 t -69.96 126.88 92.66 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.975 -3.662 . . . . 0.0 111.004 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.63 160.86 4.86 Favored 'Trans proline' 0 CA--C 1.58 2.782 1 C-N-CA 128.518 6.145 . . . . 0.0 114.582 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.3 tt -85.28 142.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 159.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -157.54 104.82 2.01 Favored 'General case' 0 C--O 1.272 2.266 0 C-N-CA 126.955 2.102 . . . . 0.0 110.898 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.6 m -59.17 -32.71 70.15 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 125.389 1.68 . . . . 0.0 113.434 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -83.43 2.7 35.31 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.8 p -114.63 147.66 39.23 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 129.549 3.139 . . . . 0.0 110.287 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.2 t -72.35 155.65 91.18 Favored Pre-proline 0 CA--C 1.609 3.247 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -36.3 -31.87 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.682 1 C-N-CA 126.769 4.979 . . . . 0.0 114.45 152.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -82.58 -22.2 34.94 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 120.043 1.292 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -83.89 -14.57 50.75 Favored 'General case' 0 C--O 1.213 -0.861 0 O-C-N 119.369 -2.082 . . . . 0.0 114.367 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -68.9 59.11 0.09 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -167.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 tt -156.25 139.59 7.45 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.06 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.72 -160.71 30.96 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.034 -1.425 . . . . 0.0 114.921 -172.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -148.85 145.67 27.6 Favored 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 119.63 1.715 . . . . 0.0 110.169 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 88.7 m-85 -85.4 161.22 19.53 Favored 'General case' 0 C--N 1.396 2.62 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 164.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -125.58 157.73 36.4 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 118.878 -2.389 . . . . 0.0 109.041 161.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.463 HH22 ' CG ' ' A' ' 128' ' ' ASP . 26.9 ptt180 -77.81 159.81 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.664 1.585 . . . . 0.0 107.815 169.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.04 136.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.449 1.9 . . . . 0.0 110.671 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -133.97 -16.22 2.25 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -168.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 55.26 60.03 3.63 Favored 'General case' 0 N--CA 1.538 3.944 0 O-C-N 119.568 -1.958 . . . . 0.0 107.051 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -128.18 -8.61 5.34 Favored 'General case' 0 C--O 1.193 -1.914 0 O-C-N 119.408 -2.057 . . . . 0.0 109.125 -160.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.337 1.1 mp 68.39 136.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 171.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 . . . . . 0 C--O 1.272 2.241 0 C-N-CA 127.503 2.321 . . . . 0.0 114.231 167.13 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.4 tttt . . . . . 1 C--O 1.309 4.234 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.5 0.4 OUTLIER 73.68 -10.67 1.04 Allowed 'General case' 0 C--N 1.363 1.164 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 177.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.7 mt -68.91 153.73 43.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 129.395 3.078 . . . . 0.0 111.698 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.8 m -66.86 167.64 13.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 114.761 -2.542 . . . . 0.0 111.544 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.259 59.3 Cg_exo -65.28 164.72 24.55 Favored 'Trans proline' 0 CA--C 1.584 3.011 0 C-N-CA 124.504 3.469 . . . . 0.0 114.348 -176.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -131.53 168.63 17.33 Favored 'General case' 0 C--N 1.386 2.173 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -128.7 127.63 42.5 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 128.113 3.383 . . . . 0.0 112.283 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 60.6 m-85 -108.04 144.5 35.29 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 128.336 3.523 . . . . 0.0 111.194 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.6 144.1 31.88 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -140.36 151.34 44.91 Favored 'General case' 0 N--CA 1.514 2.765 0 O-C-N 118.635 -2.541 . . . . 0.0 109.83 176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.446 ' CD1' HG21 ' A' ' 146' ' ' ILE . 27.5 m-85 -90.46 161.29 15.6 Favored 'General case' 0 CA--C 1.595 2.708 0 CA-C-O 125.887 2.756 . . . . 0.0 112.586 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.3 tp -57.77 116.12 3.24 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 117.809 -3.057 . . . . 0.0 109.608 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.74 17.9 50.1 Favored Glycine 0 N--CA 1.501 3.0 0 O-C-N 118.584 -2.572 . . . . 0.0 115.259 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -133.55 165.37 25.05 Favored 'General case' 0 CA--C 1.504 -0.827 1 C-N-CA 132.841 4.456 . . . . 0.0 112.815 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.23 -165.69 52.09 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 125.683 1.611 . . . . 0.0 110.176 171.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.65 -28.54 52.41 Favored 'Trans proline' 0 N--CA 1.427 -2.393 1 C-N-CA 127.195 5.264 . . . . 0.0 111.422 -171.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -96.01 17.58 15.16 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 117.976 -2.952 . . . . 0.0 114.607 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.94 -12.21 0.3 Allowed 'General case' 0 C--N 1.39 2.366 0 O-C-N 118.869 -2.395 . . . . 0.0 116.095 -168.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.17 -34.63 57.99 Favored Glycine 0 C--N 1.287 -2.156 0 C-N-CA 128.461 2.934 . . . . 0.0 114.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.64 142.08 83.26 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.982 2.113 . . . . 0.0 115.044 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -77.4 163.91 29.36 Favored 'Trans proline' 0 C--N 1.397 3.111 1 C-N-CA 126.58 4.853 . . . . 0.0 115.118 161.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.42 151.18 41.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 117.374 -1.73 . . . . 0.0 115.124 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.91 8.12 5.49 Favored Glycine 0 CA--C 1.56 2.886 0 N-CA-C 120.903 3.121 . . . . 0.0 120.903 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.72 137.67 49.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 121.062 2.431 . . . . 0.0 113.458 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -78.89 142.79 36.49 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-O 116.307 -1.806 . . . . 0.0 114.227 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.06 142.41 7.35 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 129.672 3.189 . . . . 0.0 111.132 159.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.463 ' CG ' HH22 ' A' ' 89' ' ' ARG . 13.6 t0 -65.34 121.56 15.11 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 126.46 1.904 . . . . 0.0 115.222 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.94 74.72 Favored Glycine 0 CA--C 1.568 3.383 1 C-N-CA 130.957 4.122 . . . . 0.0 122.435 -169.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.1 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 O-C-N 128.199 2.941 . . . . 0.0 108.813 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.9 mm -120.9 119.89 60.77 Favored 'Isoleucine or valine' 0 C--N 1.385 2.112 0 CA-C-O 123.154 1.454 . . . . 0.0 112.491 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -73.63 138.99 45.16 Favored 'General case' 0 C--N 1.372 1.56 0 O-C-N 119.08 -2.262 . . . . 0.0 109.117 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 72' ' ' VAL . 3.0 m -134.95 147.51 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.577 0 C-N-CA 123.635 0.774 . . . . 0.0 111.998 159.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.71 169.78 17.81 Favored 'General case' 0 N--CA 1.395 -3.193 0 C-N-CA 126.848 2.059 . . . . 0.0 113.455 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.255 81.8 p -98.93 170.03 9.02 Favored 'General case' 0 C--O 1.248 0.994 0 O-C-N 120.242 -1.536 . . . . 0.0 113.631 152.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -60.05 -45.78 91.73 Favored 'General case' 0 C--O 1.283 2.863 0 CA-C-O 116.932 -1.508 . . . . 0.0 112.483 160.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.31 -34.45 67.86 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.89 153.78 41.08 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.967 1.365 . . . . 0.0 111.598 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.43 145.21 31.14 Favored 'General case' 0 C--O 1.259 1.581 0 C-N-CA 130.043 3.337 . . . . 0.0 113.792 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -65.49 4.37 0.56 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 p -85.74 142.51 36.99 Favored Pre-proline 0 CA--C 1.479 -1.761 0 C-N-CA 128.832 2.853 . . . . 0.0 109.934 -166.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -59.29 117.21 3.91 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 124.306 3.338 . . . . 0.0 109.845 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -68.17 52.86 0.07 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 126.385 1.874 . . . . 0.0 113.317 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.56 -24.35 67.48 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -171.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -74.14 -35.82 64.12 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.446 HG21 ' CD1' ' A' ' 112' ' ' TYR . 80.4 mt -67.72 -18.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 O-C-N 119.927 -1.733 . . . . 0.0 110.76 164.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.49 -11.7 65.97 Favored Glycine 0 CA--C 1.569 3.435 0 O-C-N 124.44 1.088 . . . . 0.0 115.738 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 24.7 p -130.5 -33.18 1.67 Allowed 'General case' 0 C--N 1.373 1.626 0 O-C-N 124.672 0.866 . . . . 0.0 111.441 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -66.2 142.05 57.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.642 1.564 . . . . 0.0 110.715 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -81.96 114.01 47.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 119.817 -1.802 . . . . 0.0 111.127 -149.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 -4.37 15.24 Favored 'Trans proline' 0 N--CA 1.425 -2.508 0 C-N-CA 124.069 3.179 . . . . 0.0 111.124 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.69 19.12 15.47 Favored 'General case' 0 C--O 1.193 -1.87 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -71.62 -54.95 8.75 Favored 'General case' 0 C--O 1.293 3.379 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.542 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.51 177.92 7.59 Favored 'General case' 0 CA--C 1.598 2.795 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.265 164.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.81 19.88 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 127.32 2.248 . . . . 0.0 107.206 170.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.24 136.55 58.0 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 113.973 -2.917 . . . . 0.0 117.775 169.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.5 mt -58.53 121.4 6.05 Favored 'Isoleucine or valine' 0 C--N 1.381 1.958 0 O-C-N 128.882 3.864 . . . . 0.0 108.242 165.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.19 103.8 2.0 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 O-C-N 120.086 -1.634 . . . . 0.0 110.664 172.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.52 106.74 0.58 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.551 1.941 . . . . 0.0 111.209 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -119.6 160.3 22.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-O 122.995 1.379 . . . . 0.0 109.773 156.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 83.7 mt -74.75 162.3 74.16 Favored Pre-proline 1 N--CA 1.54 4.042 0 C-N-CA 126.313 1.845 . . . . 0.0 110.528 163.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.27 164.39 10.73 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.182 1.921 . . . . 0.0 116.442 161.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 40.76 41.47 1.18 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 125.79 1.636 . . . . 0.0 113.472 -170.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.73 21.02 1.32 Allowed Glycine 0 CA--C 1.562 3.015 0 O-C-N 125.86 1.975 . . . . 0.0 117.076 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 84.9 m -58.17 131.72 51.4 Favored 'General case' 0 C--N 1.394 2.534 0 O-C-N 117.85 -3.147 . . . . 0.0 115.14 -165.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . 0.267 27.6 m -77.09 116.83 18.08 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 127.646 3.091 . . . . 0.0 114.161 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.36 154.63 83.0 Favored Pre-proline 0 CA--C 1.586 2.352 0 C-N-CA 130.804 3.642 . . . . 0.0 110.107 -169.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.96 149.44 7.98 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.673 2.249 . . . . 0.0 117.586 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.34 -16.66 62.45 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.319 1.448 . . . . 0.0 114.667 -163.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.18 -0.96 78.99 Favored Glycine 0 CA--C 1.572 3.621 0 CA-C-O 117.24 -1.867 . . . . 0.0 116.978 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -120.74 135.84 55.03 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.092 2.446 . . . . 0.0 111.368 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -83.89 154.3 23.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 127.266 2.854 . . . . 0.0 107.884 164.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . 0.292 . . -156.72 154.03 29.38 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 126.153 2.883 . . . . 0.0 112.649 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 . . . . . 0 N--CA 1.43 -1.427 0 CA-C-N 112.348 -2.206 . . . . 0.0 112.134 159.974 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 CA--C 1.574 2.508 0 CA-C-O 122.91 1.129 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -71.49 133.73 46.05 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.55 -18.34 45.26 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -171.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m 59.27 -43.95 0.07 Allowed 'General case' 0 CA--C 1.589 2.445 0 C-N-CA 129.603 3.161 . . . . 0.0 118.295 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 39.19 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.976 2.11 . . . . 0.0 114.725 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.447 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 47.6 t -85.46 139.13 31.75 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 125.655 1.582 . . . . 0.0 113.429 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -79.86 -9.27 59.65 Favored 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 125.362 1.465 . . . . 0.0 113.892 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -109.85 157.09 19.56 Favored 'General case' 0 CA--C 1.581 2.163 0 CA-C-O 124.294 1.997 . . . . 0.0 110.717 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 p -68.2 165.37 18.48 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -111.61 136.92 50.16 Favored 'General case' 0 C--O 1.259 1.586 0 O-C-N 119.566 -1.959 . . . . 0.0 109.736 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.9 mt -75.08 160.86 29.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 126.634 1.973 . . . . 0.0 110.781 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.5 m -126.31 139.29 53.42 Favored 'General case' 0 N--CA 1.493 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 110.652 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.62 141.1 55.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.766 2.426 . . . . 0.0 109.055 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -125.59 -34.19 2.69 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 161.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.01 -126.85 0.02 OUTLIER Glycine 0 C--N 1.305 -1.15 1 CA-C-O 127.99 4.106 . . . . 0.0 113.948 168.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -154.45 -28.01 0.12 Allowed 'General case' 0 C--N 1.292 -1.911 2 O-C-N 114.434 -5.156 . . . . 0.0 111.381 163.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.35 145.89 53.77 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.71 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -54.23 167.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 117.534 -3.229 . . . . 0.0 112.349 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.1 tp -74.26 64.72 1.12 Allowed 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 125.31 2.481 . . . . 0.0 114.362 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -75.55 140.29 42.63 Favored 'General case' 0 C--O 1.287 3.027 0 O-C-N 119.166 -2.209 . . . . 0.0 111.043 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -127.06 156.81 73.79 Favored Pre-proline 0 C--N 1.397 2.658 0 O-C-N 119.256 -2.152 . . . . 0.0 111.319 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -79.86 141.18 14.97 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 42.92 16.46 0.01 OUTLIER 'General case' 0 CA--C 1.584 2.262 0 O-C-N 126.3 2.25 . . . . 0.0 116.207 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.49 73.24 Favored Glycine 0 CA--C 1.557 2.68 1 C-N-CA 130.95 4.119 . . . . 0.0 116.359 -164.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -85.42 108.23 17.77 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 117.39 -1.291 . . . . 0.0 110.319 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.91 10.85 0.03 OUTLIER Glycine 1 CA--C 1.601 5.431 0 CA-C-O 114.655 -3.303 . . . . 0.0 117.46 -170.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.18 125.81 59.0 Favored Pre-proline 0 CA--C 1.587 2.387 0 CA-C-N 122.752 3.276 . . . . 0.0 113.482 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.22 153.18 24.4 Favored 'Trans proline' 0 N--CA 1.421 -2.739 0 C-N-CA 122.762 2.308 . . . . 0.0 111.806 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -70.84 146.0 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 O-C-N 128.407 3.567 . . . . 0.0 109.972 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -145.91 111.05 5.3 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 118.291 -0.861 . . . . 0.0 109.695 162.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -67.17 -15.69 63.86 Favored 'General case' 0 C--N 1.378 1.833 0 CA-C-N 123.099 2.681 . . . . 0.0 111.604 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -89.43 12.16 17.2 Favored 'General case' 0 CA--C 1.608 3.2 0 C-N-CA 128.761 2.824 . . . . 0.0 110.719 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -120.93 163.23 18.55 Favored 'General case' 0 C--O 1.256 1.412 0 O-C-N 125.147 1.529 . . . . 0.0 111.407 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.8 p -101.76 163.25 18.17 Favored Pre-proline 0 C--O 1.256 1.403 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -59.37 -26.18 81.03 Favored 'Trans proline' 0 CA--C 1.563 1.954 0 CA-C-N 122.666 1.988 . . . . 0.0 110.485 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.47 -30.65 63.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 120.711 1.596 . . . . 0.0 113.91 173.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -79.99 -16.32 55.43 Favored 'General case' 0 C--O 1.186 -2.272 0 C-N-CA 127.643 2.377 . . . . 0.0 115.292 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -73.41 61.8 0.69 Allowed 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 129.32 3.048 . . . . 0.0 116.05 -167.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.264 13.3 tt -153.53 138.27 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 127.953 3.283 . . . . 0.0 108.363 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.46 -152.73 11.31 Favored Glycine 0 CA--C 1.489 -1.555 0 O-C-N 116.887 -3.633 . . . . 0.0 114.796 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -149.96 138.37 20.59 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 127.136 2.174 . . . . 0.0 110.493 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -89.35 155.71 19.18 Favored 'General case' 0 C--N 1.286 -2.18 0 O-C-N 127.85 3.219 . . . . 0.0 109.75 159.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -145.39 148.94 33.89 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.554 -1.341 . . . . 0.0 108.677 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.419 HH22 ' CG ' ' A' ' 128' ' ' ASP . 21.5 ptt180 -86.95 -177.72 6.13 Favored 'General case' 0 CA--C 1.61 3.263 0 CA-C-N 121.827 2.103 . . . . 0.0 114.906 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 136.9 9.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 118.878 -2.389 . . . . 0.0 110.592 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.9 p -145.4 -17.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 113.814 -2.993 . . . . 0.0 113.724 -164.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 47.47 48.72 16.54 Favored 'General case' 0 CA--C 1.602 2.956 0 O-C-N 125.39 1.681 . . . . 0.0 111.603 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -105.65 -9.57 17.27 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 119.939 -1.726 . . . . 0.0 112.444 170.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 mp 70.85 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.27 2.173 0 C-N-CA 127.051 2.14 . . . . 0.0 110.76 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 . . . . . 0 CA--C 1.586 2.334 1 C-N-CA 133.205 4.602 . . . . 0.0 110.296 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.239 0.509 0 CA-C-O 118.218 -0.896 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.95 37.85 22.13 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 126.101 1.76 . . . . 0.0 112.986 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.76 169.6 18.0 Favored 'General case' 0 C--O 1.289 3.144 0 C-N-CA 125.578 1.551 . . . . 0.0 110.621 167.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . 0.278 52.6 m -62.32 145.5 94.05 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 123.29 1.519 . . . . 0.0 114.992 170.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.263 15.1 Cg_exo -42.67 155.96 0.1 Allowed 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 121.709 1.606 . . . . 0.0 113.247 164.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -121.4 159.4 26.25 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.601 2.361 . . . . 0.0 115.545 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -129.92 139.94 51.03 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 126.72 2.512 . . . . 0.0 115.631 161.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -121.36 154.19 36.77 Favored 'General case' 0 CA--C 1.592 2.593 0 C-N-CA 126.464 1.905 . . . . 0.0 109.957 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -111.19 141.18 45.04 Favored 'General case' 0 N--CA 1.535 3.801 0 CA-C-N 122.929 2.604 . . . . 0.0 113.906 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.47 ' CD2' ' HA3' ' A' ' 116' ' ' GLY . 8.2 m-85 -141.66 150.92 42.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 125.021 2.343 . . . . 0.0 110.063 170.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -87.59 156.01 19.7 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-N 114.085 -1.416 . . . . 0.0 113.207 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.3 tp -51.47 127.62 20.55 Favored 'General case' 0 C--O 1.271 2.23 0 C-N-CA 124.072 0.949 . . . . 0.0 112.961 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.56 73.83 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.6 p -142.59 -178.51 5.81 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 119.709 1.754 . . . . 0.0 109.616 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 111' ' ' TYR . . . 63.38 -154.1 45.4 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -73.73 -43.08 0.67 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.325 2.017 . . . . 0.0 115.203 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.327 2.5 mm-40 -81.94 27.74 0.45 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 131.431 3.892 . . . . 0.0 110.481 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.76 -19.52 50.83 Favored 'General case' 0 C--O 1.159 -3.706 0 O-C-N 118.188 -2.82 . . . . 0.0 113.096 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.29 -34.5 54.65 Favored Glycine 0 C--O 1.253 1.337 0 O-C-N 124.752 1.282 . . . . 0.0 113.809 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 mt -65.36 139.29 97.34 Favored Pre-proline 0 CA--C 1.607 3.143 0 CA-C-N 120.772 2.286 . . . . 0.0 113.297 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -61.92 166.17 12.79 Favored 'Trans proline' 0 C--O 1.272 2.178 0 O-C-N 124.42 1.747 . . . . 0.0 113.983 155.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -65.09 123.43 19.49 Favored 'General case' 0 C--N 1.365 1.261 0 CA-C-N 110.27 -3.15 . . . . 0.0 116.6 170.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 20.22 62.86 Favored Glycine 0 CA--C 1.576 3.904 0 CA-C-O 124.128 1.96 . . . . 0.0 111.148 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.34 135.69 47.46 Favored 'General case' 0 C--O 1.25 1.094 0 O-C-N 117.534 -3.333 . . . . 0.0 108.793 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.73 11.94 1.5 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -161.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . 0.291 66.7 tttt -72.31 126.03 28.82 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 124.32 2.009 . . . . 0.0 111.238 -167.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.419 ' CG ' HH22 ' A' ' 89' ' ' ARG . 13.8 t0 -53.8 138.74 35.1 Favored 'General case' 0 C--O 1.271 2.226 0 O-C-N 117.588 -3.195 . . . . 0.0 108.038 -175.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.15 -11.42 63.81 Favored Glycine 0 N--CA 1.502 3.076 0 CA-C-O 116.147 -2.474 . . . . 0.0 117.367 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -108.97 134.7 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.616 3.517 0 C-N-CA 130.618 3.567 . . . . 0.0 110.91 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.88 124.11 71.63 Favored 'Isoleucine or valine' 0 C--O 1.291 3.28 0 O-C-N 125.694 1.871 . . . . 0.0 109.323 171.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.68 134.8 33.59 Favored 'General case' 0 CA--C 1.587 2.396 0 CA-C-O 125.418 2.532 . . . . 0.0 111.516 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.28 141.42 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 O-C-N 119.323 -2.11 . . . . 0.0 111.152 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.96 170.96 14.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 p -131.79 157.62 43.39 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 113.492 -1.685 . . . . 0.0 114.893 158.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -72.0 -27.24 62.61 Favored 'General case' 0 C--N 1.365 1.28 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.95 -18.25 63.64 Favored Glycine 0 CA--C 1.565 3.189 0 C-N-CA 127.792 2.615 . . . . 0.0 118.143 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.22 147.32 53.19 Favored 'General case' 0 C--O 1.286 3.017 0 C-N-CA 127.152 2.181 . . . . 0.0 110.202 162.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.88 142.1 30.05 Favored 'General case' 0 C--O 1.285 2.94 0 CA-C-O 125.122 2.391 . . . . 0.0 108.024 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -48.03 -12.46 0.03 OUTLIER 'General case' 0 CA--C 1.6 2.867 0 CA-C-O 114.014 -2.898 . . . . 0.0 116.012 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -55.34 139.42 66.21 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 130.841 3.656 . . . . 0.0 114.025 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -64.28 140.25 69.76 Favored 'Trans proline' 0 N--CA 1.528 3.503 0 C-N-CA 122.831 2.354 . . . . 0.0 106.369 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -91.53 60.84 4.17 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -23.12 66.09 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.816 -165.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -61.81 -55.51 29.22 Favored 'General case' 0 CA--C 1.61 3.287 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 6.4 mt -60.81 -25.26 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.623 0 C-N-CA 116.781 -1.968 . . . . 0.0 111.567 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.51 -12.03 83.44 Favored Glycine 1 CA--C 1.587 4.567 0 C-N-CA 128.696 3.046 . . . . 0.0 116.695 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.6 p -126.88 -24.96 3.41 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.3 158.71 28.78 Favored 'General case' 0 C--O 1.266 1.931 0 O-C-N 117.153 -3.467 . . . . 0.0 106.511 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.5 118.43 47.42 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.835 -2.507 . . . . 0.0 112.432 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -73.4 -25.31 15.51 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.95 2.433 . . . . 0.0 115.93 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.32 -4.27 35.24 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 120.699 -1.25 . . . . 0.0 109.705 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.82 -28.92 70.19 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 121.407 1.912 . . . . 0.0 113.64 -165.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.57 159.93 29.55 Favored 'General case' 0 C--O 1.25 1.119 1 C-N-CA 131.99 4.116 . . . . 0.0 110.847 160.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -53.94 160.74 1.37 Allowed 'General case' 1 N--CA 1.54 4.029 0 C-N-CA 128.441 2.696 . . . . 0.0 111.996 172.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.35 130.97 49.28 Favored 'General case' 0 CA--C 1.584 2.283 0 O-C-N 118.276 -2.765 . . . . 0.0 112.546 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.81 126.77 32.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 124.215 1.959 . . . . 0.0 107.193 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.0 126.8 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.608 0 O-C-N 120.157 -1.589 . . . . 0.0 111.827 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.73 116.7 7.21 Favored 'General case' 0 CA--C 1.604 3.035 0 O-C-N 126.589 2.431 . . . . 0.0 114.373 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -141.23 152.9 44.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 116.304 -3.997 . . . . 0.0 111.399 164.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -113.81 155.26 45.4 Favored Pre-proline 0 C--N 1.256 -3.498 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.469 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -48.92 159.67 0.88 Allowed 'Trans proline' 0 C--O 1.272 2.222 1 C-N-CA 132.108 8.539 . . . . 0.0 120.656 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.323 24.4 mt-30 46.52 31.72 1.42 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.62 72.28 Favored Glycine 0 CA--C 1.55 2.243 0 O-C-N 116.568 -3.832 . . . . 0.0 112.009 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.5 m -63.52 122.39 16.17 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-O 116.192 -1.861 . . . . 0.0 110.248 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 81.5 m -58.77 134.3 56.72 Favored 'General case' 0 C--N 1.382 2.015 0 CA-C-O 115.578 -2.154 . . . . 0.0 113.286 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.62 152.89 32.78 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 125.476 3.762 . . . . 0.0 111.344 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -62.94 145.09 94.31 Favored 'Trans proline' 1 CA--C 1.62 4.777 0 C-N-CA 125.06 3.84 . . . . 0.0 112.801 -161.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -69.11 -18.87 64.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 117.763 -3.086 . . . . 0.0 116.459 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.73 -17.95 10.07 Favored Glycine 0 CA--C 1.542 1.753 0 O-C-N 118.302 -2.749 . . . . 0.0 114.773 164.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.8 145.04 48.0 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 121.359 2.579 . . . . 0.0 115.829 -165.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -87.16 142.48 27.88 Favored 'General case' 0 CA--C 1.604 3.022 0 C-N-CA 131.006 3.722 . . . . 0.0 107.071 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.43 170.04 16.47 Favored 'General case' 0 CA--C 1.576 1.97 0 O-C-N 125.589 1.805 . . . . 0.0 113.517 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.555 1.147 0 O-C-N 124.556 1.16 . . . . 0.0 112.837 169.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 N--CA 1.53 3.669 0 CA-C-O 114.172 -2.512 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -69.08 123.89 22.28 Favored 'General case' 0 CA--C 1.582 2.2 0 O-C-N 126.168 2.167 . . . . 0.0 110.51 161.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -80.7 -13.24 59.18 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 127.586 2.355 . . . . 0.0 114.869 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.3 m 57.24 -29.77 0.03 OUTLIER 'General case' 1 CA--C 1.644 4.561 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 171.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.326 . . -91.3 169.54 10.73 Favored 'General case' 0 C--O 1.188 -2.169 0 C-N-CA 127.011 2.125 . . . . 0.0 111.592 -174.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.1 t -84.81 130.4 34.68 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 128.325 2.65 . . . . 0.0 114.625 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -71.3 -15.01 62.39 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 127.627 2.371 . . . . 0.0 113.66 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 157' ' ' ILE . 15.5 m-85 -118.02 173.26 6.88 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 127.378 2.271 . . . . 0.0 116.403 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p -61.27 153.01 27.55 Favored 'General case' 0 C--O 1.287 3.068 0 O-C-N 128.831 3.832 . . . . 0.0 110.851 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.59 154.43 19.95 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 129.766 3.227 . . . . 0.0 112.408 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.09 156.32 20.73 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.744 1.218 . . . . 0.0 108.711 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 107' ' ' ARG . 57.4 m -139.46 121.9 16.12 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 131.486 3.914 . . . . 0.0 114.296 -168.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.262 4.5 tp-100 -77.42 142.32 39.3 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.244 1.497 . . . . 0.0 113.501 -167.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -135.77 -22.55 1.43 Allowed 'General case' 0 CA--C 1.601 2.93 0 CA-C-O 113.272 -3.251 . . . . 0.0 111.319 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.32 -130.92 0.61 Allowed Glycine 1 CA--C 1.61 6.012 0 O-C-N 126.47 2.356 . . . . 0.0 111.051 153.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -149.31 -20.93 0.29 Allowed 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 131.122 3.769 . . . . 0.0 113.053 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.94 147.84 48.32 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 124.893 1.371 . . . . 0.0 114.195 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.9 158.59 21.77 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.263 -2.148 . . . . 0.0 115.401 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.8 tp -75.36 51.52 0.56 Allowed 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 129.21 3.004 . . . . 0.0 111.818 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -76.44 139.26 40.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -129.7 88.01 50.8 Favored Pre-proline 0 CA--C 1.591 2.556 1 C-N-CA 132.611 4.365 . . . . 0.0 111.137 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.25 148.08 33.49 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.542 2.161 . . . . 0.0 115.978 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 45.34 20.68 0.05 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 131.119 3.768 . . . . 0.0 113.789 -165.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.7 22.25 69.8 Favored Glycine 0 N--CA 1.499 2.86 0 CA-C-O 116.351 -2.36 . . . . 0.0 108.43 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -84.08 106.37 15.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 128.091 2.877 . . . . 0.0 108.982 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.84 13.68 0.02 OUTLIER Glycine 0 CA--C 1.574 3.749 0 C-N-CA 128.702 3.049 . . . . 0.0 116.422 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.33 122.4 81.4 Favored Pre-proline 0 CA--C 1.56 1.351 0 O-C-N 117.96 -3.082 . . . . 0.0 112.537 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.401 ' HD2' ' CZ ' ' A' ' 110' ' ' PHE . 13.8 Cg_endo -75.16 177.36 8.71 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 121.69 1.593 . . . . 0.0 114.972 -168.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.99 129.89 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 112.378 -2.192 . . . . 0.0 111.016 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -167.38 104.4 0.53 Allowed 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 125.205 1.566 . . . . 0.0 114.312 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.9 m -70.06 -17.54 63.25 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-O 114.198 -2.81 . . . . 0.0 110.516 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -63.7 -11.96 30.43 Favored 'General case' 0 C--O 1.188 -2.136 0 CA-C-N 124.185 3.175 . . . . 0.0 112.536 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 p -125.37 136.88 53.9 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 126.994 2.118 . . . . 0.0 110.4 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 p -85.15 165.97 33.76 Favored Pre-proline 0 C--N 1.269 -2.935 0 C-N-CA 126.231 1.812 . . . . 0.0 112.328 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . 0.302 81.8 Cg_exo -52.87 -24.09 22.98 Favored 'Trans proline' 0 CA--C 1.574 2.521 1 C-N-CA 125.557 4.171 . . . . 0.0 115.684 168.388 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.05 -29.3 43.41 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 121.178 1.808 . . . . 0.0 112.636 171.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.75 -16.7 61.17 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -68.58 61.52 0.09 Allowed 'General case' 0 CA--C 1.595 2.697 0 C-N-CA 131.263 3.825 . . . . 0.0 110.367 -162.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 tt -156.05 138.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.906 0 C-N-CA 126.762 2.025 . . . . 0.0 113.383 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.4 -174.18 46.8 Favored Glycine 0 CA--C 1.557 2.68 0 O-C-N 119.829 -1.794 . . . . 0.0 114.13 -154.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -148.19 145.39 28.27 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 126.733 2.013 . . . . 0.0 112.21 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -92.63 137.15 32.62 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -126.74 139.78 52.87 Favored 'General case' 1 N--CA 1.548 4.457 0 C-N-CA 129.981 3.312 . . . . 0.0 112.555 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -71.51 166.96 20.69 Favored 'General case' 0 C--O 1.291 3.273 0 O-C-N 120.052 -1.655 . . . . 0.0 110.847 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.92 132.85 18.11 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 130.268 3.427 . . . . 0.0 108.182 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -140.8 -17.37 0.86 Allowed 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 130.018 3.327 . . . . 0.0 110.009 -163.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 47.58 60.92 3.19 Favored 'General case' 0 CA--C 1.589 2.447 0 O-C-N 125.909 2.005 . . . . 0.0 116.209 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -99.22 -23.69 15.12 Favored 'General case' 0 C--O 1.259 1.574 0 C-N-CA 129.201 3.0 . . . . 0.0 116.413 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 mp 60.18 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 CA-C-O 126.132 2.873 . . . . 0.0 111.805 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 . . . . . 0 N--CA 1.511 2.598 1 O-C-N 115.34 -4.6 . . . . 0.0 107.619 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt . . . . . 0 N--CA 1.508 2.437 0 CA-C-O 127.262 3.41 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 50.2 30.56 4.41 Favored 'General case' 0 C--N 1.39 2.328 0 O-C-N 117.745 -3.097 . . . . 0.0 117.888 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -122.07 170.37 9.91 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 126.72 2.512 . . . . 0.0 116.422 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.8 m -56.35 164.5 1.93 Allowed Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -49.5 164.03 0.38 Allowed 'Trans proline' 1 CA--C 1.622 4.91 1 C-N-CA 125.771 4.314 . . . . 0.0 112.178 166.48 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HG2' HG23 ' A' ' 57' ' ' THR . 79.3 mtp180 -141.78 168.57 19.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 110.851 -2.886 . . . . 0.0 109.028 174.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -140.66 149.87 42.8 Favored 'General case' 0 C--N 1.276 -2.601 0 O-C-N 118.926 -2.359 . . . . 0.0 108.925 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -130.63 162.8 28.57 Favored 'General case' 0 C--O 1.184 -2.361 0 C-N-CA 127.96 2.504 . . . . 0.0 108.217 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 73' ' ' PRO . 54.4 t80 -119.87 145.27 46.83 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 128.919 2.888 . . . . 0.0 113.96 173.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -147.61 141.59 25.92 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 127.218 2.207 . . . . 0.0 110.712 -171.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -70.45 163.8 25.99 Favored 'General case' 0 CA--C 1.605 3.08 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.18 127.73 32.61 Favored 'General case' 0 CA--C 1.573 1.86 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.839 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.13 20.77 79.01 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 117.979 -2.058 . . . . 0.0 118.151 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.281 3.8 p -134.66 167.63 20.47 Favored 'General case' 0 C--O 1.263 1.775 0 C-N-CA 127.046 2.138 . . . . 0.0 111.539 -174.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.18 -156.36 37.84 Favored Glycine 1 CA--C 1.585 4.407 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.945 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -71.53 -43.16 1.49 Allowed 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 124.036 3.157 . . . . 0.0 114.151 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -82.8 31.96 0.42 Allowed 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 116.802 -1.571 . . . . 0.0 110.599 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.23 -24.86 66.68 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 122.682 2.492 . . . . 0.0 112.37 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.35 -36.73 70.67 Favored Glycine 1 CA--C 1.582 4.225 0 O-C-N 125.242 1.589 . . . . 0.0 116.314 167.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.93 124.78 89.72 Favored Pre-proline 0 CA--C 1.586 2.353 0 CA-C-O 116.509 -1.71 . . . . 0.0 109.971 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -63.05 166.73 13.71 Favored 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 125.237 3.958 . . . . 0.0 113.107 161.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -65.57 127.45 31.93 Favored 'General case' 0 CA--C 1.549 0.907 1 O-C-N 115.481 -4.512 . . . . 0.0 114.241 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.98 -2.63 79.83 Favored Glycine 0 CA--C 1.554 2.469 0 CA-C-N 113.081 -1.872 . . . . 0.0 116.825 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.51 129.83 42.4 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 116.936 -3.685 . . . . 0.0 110.541 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -82.46 25.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.372 -3.33 . . . . 0.0 117.634 -154.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.82 126.97 30.15 Favored 'General case' 0 CA--C 1.593 2.601 0 O-C-N 117.29 -3.381 . . . . 0.0 110.238 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.26 147.35 46.51 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 113.01 -1.904 . . . . 0.0 111.642 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.57 -18.59 54.64 Favored Glycine 1 N--CA 1.525 4.606 0 O-C-N 119.11 -2.243 . . . . 0.0 116.55 -163.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 130' ' ' ILE . 1.5 mp -101.65 119.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 129.496 3.118 . . . . 0.0 109.189 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.87 102.46 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.152 0 C-N-CA 127.752 2.421 . . . . 0.0 106.092 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -71.97 129.81 39.46 Favored 'General case' 0 CA--C 1.588 2.412 0 C-N-CA 125.736 1.615 . . . . 0.0 113.04 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.77 150.12 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 C-N-CA 126.872 2.069 . . . . 0.0 108.623 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.89 19.36 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.415 -173.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.1 p -122.32 155.32 36.22 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 115.84 -2.029 . . . . 0.0 112.5 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.22 -47.71 62.26 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 124.869 3.486 . . . . 0.0 111.515 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.24 -2.61 90.63 Favored Glycine 2 CA--C 1.599 5.341 0 C-N-CA 129.549 3.452 . . . . 0.0 117.061 -172.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.27 33.49 Favored 'General case' 0 CA--C 1.614 3.408 0 CA-C-N 119.487 1.643 . . . . 0.0 111.961 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.3 mt -88.98 146.61 24.77 Favored 'General case' 0 CA--C 1.596 2.747 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 160.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -90.0 29.79 1.16 Allowed 'General case' 0 CA--C 1.6 2.873 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.419 ' O ' ' HE2' ' A' ' 143' ' ' LYS . 25.6 p -72.06 148.52 91.7 Favored Pre-proline 0 N--CA 1.508 2.464 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.825 168.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.43 136.07 35.64 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-O 116.875 -1.385 . . . . 0.0 112.862 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 141' ' ' THR . 53.3 mmtt -88.55 52.15 2.36 Favored 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 128.649 2.78 . . . . 0.0 110.565 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.41 -20.11 0.64 Allowed 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -81.01 -44.17 18.5 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 119.133 -2.23 . . . . 0.0 110.432 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.251 9.3 mt -55.84 -32.33 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-O 116.665 -1.636 . . . . 0.0 113.674 158.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.72 -14.62 81.22 Favored Glycine 0 N--CA 1.514 3.863 0 O-C-N 127.867 3.229 . . . . 0.0 119.352 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.4 p -133.43 -25.79 1.69 Allowed 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -54.91 142.64 28.87 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 125.979 1.712 . . . . 0.0 110.085 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -77.95 101.97 0.82 Allowed Pre-proline 0 CA--C 1.497 -1.08 0 O-C-N 124.343 1.027 . . . . 0.0 110.969 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.38 -21.81 71.48 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 125.136 3.891 . . . . 0.0 116.038 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.79 -9.76 55.85 Favored 'General case' 0 C--O 1.276 2.499 0 C-N-CA 128.279 2.632 . . . . 0.0 112.444 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -59.22 -27.09 65.42 Favored 'General case' 0 CA--C 1.568 1.662 1 N-CA-C 122.638 4.31 . . . . 0.0 122.638 166.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.04 157.76 45.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 118.699 -2.501 . . . . 0.0 114.441 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -32.53 150.34 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.733 1 C-N-CA 131.757 4.023 . . . . 0.0 111.69 160.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.5 137.29 50.1 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 125.563 2.601 . . . . 0.0 114.546 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.476 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 7.3 mt -73.14 129.02 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 118.746 -2.471 . . . . 0.0 111.58 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.15 116.26 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 126.866 2.604 . . . . 0.0 113.165 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.9 tt -88.04 119.48 28.46 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 124.27 1.028 . . . . 0.0 110.175 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.21 151.73 12.12 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 126.669 1.988 . . . . 0.0 105.869 -157.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.2 mt -110.44 145.35 32.05 Favored Pre-proline 0 CA--C 1.564 1.517 0 O-C-N 124.136 0.897 . . . . 0.0 112.666 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.56 167.07 13.97 Favored 'Trans proline' 1 CA--C 1.605 4.056 0 C-N-CA 121.961 1.774 . . . . 0.0 110.155 170.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 53.89 25.91 5.73 Favored 'General case' 0 N--CA 1.531 3.582 0 O-C-N 127.132 2.77 . . . . 0.0 111.874 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.88 29.56 6.34 Favored Glycine 1 N--CA 1.516 4.004 0 O-C-N 127.187 2.805 . . . . 0.0 111.272 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.2 m -58.99 141.99 52.36 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 122.36 3.08 . . . . 0.0 110.459 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m -106.07 119.53 39.46 Favored 'General case' 0 CA--C 1.587 2.395 0 O-C-N 119.596 -1.94 . . . . 0.0 108.75 -162.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.94 145.72 62.74 Favored Pre-proline 0 N--CA 1.389 -3.493 0 O-C-N 118.491 -2.63 . . . . 0.0 114.756 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -50.13 123.73 11.51 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 121.944 3.786 . . . . 0.0 121.944 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -50.13 -30.69 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 126.071 2.107 . . . . 0.0 116.569 -172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.4 -32.5 84.37 Favored Glycine 0 C--O 1.195 -2.296 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 171.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -91.48 127.92 37.11 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-N 118.323 1.062 . . . . 0.0 109.354 171.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -65.06 152.11 44.33 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 155.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -169.67 146.82 3.36 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 124.894 2.283 . . . . 0.0 107.687 -168.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.057 2.143 . . . . 0.0 112.814 -178.365 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 N--CA 1.503 2.08 0 CA-C-O 121.655 0.606 . . . . 0.0 112.14 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -67.68 100.98 0.96 Allowed 'General case' 0 CA--C 1.588 2.408 0 C-N-CA 130.706 3.602 . . . . 0.0 110.249 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.279 34.4 p30 -54.6 -22.5 13.57 Favored 'General case' 0 CA--C 1.591 2.546 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.1 m 64.84 -47.09 0.34 Allowed 'General case' 0 N--CA 1.517 2.892 0 C-N-CA 126.823 2.049 . . . . 0.0 114.495 165.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.26 143.47 52.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 128.08 3.8 . . . . 0.0 111.109 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.3 t -81.65 135.29 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 109.897 -3.319 . . . . 0.0 115.18 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -77.96 -3.21 40.78 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.004 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.23 147.48 51.07 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 129.013 2.925 . . . . 0.0 115.102 -163.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.261 79.8 p -61.21 135.86 57.87 Favored 'General case' 0 C--O 1.185 -2.293 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.256 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.77 129.91 34.7 Favored 'General case' 0 CA--C 1.613 3.385 0 CA-C-O 113.974 -2.917 . . . . 0.0 111.493 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.1 175.75 1.97 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 125.263 1.602 . . . . 0.0 109.671 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -146.79 128.2 14.94 Favored 'General case' 0 C--N 1.309 -1.19 1 O-C-N 114.03 -5.419 . . . . 0.0 106.616 170.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -61.27 121.54 12.83 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 125.716 1.607 . . . . 0.0 112.523 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -100.31 -54.66 2.81 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.02 -126.89 0.1 OUTLIER Glycine 0 C--N 1.37 2.419 0 O-C-N 124.764 1.29 . . . . 0.0 116.131 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -144.38 -28.79 0.49 Allowed 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.836 3.207 . . . . 0.0 112.555 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -72.28 131.43 42.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 130.976 3.71 . . . . 0.0 111.721 -171.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.92 160.94 5.36 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 123.85 1.786 . . . . 0.0 110.939 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -65.69 42.91 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 126.309 1.844 . . . . 0.0 113.506 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -61.51 137.58 58.25 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 121.473 1.942 . . . . 0.0 111.386 -164.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.11 107.47 17.91 Favored Pre-proline 0 CA--C 1.562 1.406 0 O-C-N 117.996 -2.94 . . . . 0.0 112.623 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . 0.268 14.9 Cg_exo -57.7 144.62 92.67 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.671 2.247 . . . . 0.0 113.284 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 40.83 37.03 0.46 Allowed 'General case' 0 N--CA 1.516 2.865 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.05 15.44 5.15 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 127.006 2.691 . . . . 0.0 119.086 -168.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -71.54 109.42 5.48 Favored 'General case' 0 N--CA 1.415 -2.188 1 CA-C-N 125.013 4.406 . . . . 0.0 114.287 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.11 34.96 0.03 OUTLIER Glycine 0 CA--C 1.54 1.615 1 O-C-N 113.725 -5.609 . . . . 0.0 116.877 167.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.0 t -70.99 133.75 85.88 Favored Pre-proline 0 CA--C 1.614 3.427 1 CA-C-N 124.559 4.18 . . . . 0.0 115.159 169.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.22 164.09 36.69 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.499 2.133 . . . . 0.0 116.256 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.68 151.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.18 0 O-C-N 125.903 2.002 . . . . 0.0 111.724 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -166.69 106.2 0.62 Allowed 'General case' 0 N--CA 1.529 3.524 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.017 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -60.66 -28.55 68.68 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -80.3 18.57 0.87 Allowed 'General case' 0 CA--C 1.589 2.45 0 C-N-CA 127.606 2.362 . . . . 0.0 114.377 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 87.6 p -141.51 143.89 34.04 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 127.298 2.239 . . . . 0.0 106.262 -171.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 p -72.39 158.19 87.89 Favored Pre-proline 0 CA--C 1.599 2.837 0 CA-C-N 120.974 1.715 . . . . 0.0 108.49 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.69 -28.24 65.2 Favored 'Trans proline' 0 N--CA 1.524 3.302 0 C-N-CA 124.985 3.79 . . . . 0.0 116.181 167.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.21 -18.38 62.47 Favored 'General case' 0 C--O 1.178 -2.668 0 C-N-CA 126.36 1.864 . . . . 0.0 110.994 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.479 ' HA ' ' HE3' ' A' ' 143' ' ' LYS 0.286 65.4 m-20 -73.86 -21.74 60.0 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 124.409 1.083 . . . . 0.0 111.807 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -79.66 60.55 3.38 Favored 'General case' 0 CA--C 1.599 2.831 0 O-C-N 125.23 1.581 . . . . 0.0 110.972 -153.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.03 139.24 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 126.544 1.938 . . . . 0.0 108.736 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.84 -167.24 40.25 Favored Glycine 0 N--CA 1.493 2.493 1 CA-C-O 127.831 4.017 . . . . 0.0 110.621 -163.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB3' ' CE3' ' A' ' 132' ' ' TRP . 9.5 p90 -144.04 138.82 28.6 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 111.113 -2.543 . . . . 0.0 113.524 -170.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.45 145.52 27.4 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.343 1.068 . . . . 0.0 111.21 153.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -136.95 127.97 27.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 120.1 3.37 . . . . 0.0 120.1 170.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.465 HH22 ' CG ' ' A' ' 128' ' ' ASP . 11.4 ptt180 -50.34 161.06 0.33 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 129.47 3.108 . . . . 0.0 113.204 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.67 143.28 19.58 Favored 'General case' 0 C--N 1.394 2.525 0 O-C-N 117.426 -3.296 . . . . 0.0 113.89 169.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -145.75 -16.35 0.47 Allowed 'General case' 0 N--CA 1.535 3.822 0 C-N-CA 129.122 2.969 . . . . 0.0 112.433 -166.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 46.19 26.72 0.47 Allowed 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -69.78 -14.0 62.56 Favored 'General case' 0 C--O 1.169 -3.134 0 C-N-CA 129.709 3.204 . . . . 0.0 113.141 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.8 mt 70.52 144.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 C-N-CA 129.045 2.938 . . . . 0.0 110.509 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 . . . . . 1 N--CA 1.558 4.949 0 C-N-CA 128.173 2.589 . . . . 0.0 110.615 166.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt . . . . . 0 CA--C 1.566 1.561 0 CA-C-O 115.719 -2.086 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.34 0.3 OUTLIER 70.26 38.0 1.51 Allowed 'General case' 0 C--N 1.371 1.526 0 N-CA-C 118.798 2.888 . . . . 0.0 118.798 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.76 164.41 11.8 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.472 -1.392 . . . . 0.0 107.734 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.1 m -44.67 138.77 3.84 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 168.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.39 162.6 1.33 Allowed 'Trans proline' 0 C--O 1.303 3.728 0 C-N-CA 123.582 2.855 . . . . 0.0 114.222 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -135.05 163.1 30.65 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 128.676 2.791 . . . . 0.0 111.942 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -134.24 139.07 45.52 Favored 'General case' 0 C--O 1.272 2.255 0 O-C-N 117.842 -3.036 . . . . 0.0 108.747 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.55 150.15 41.32 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 126.778 2.031 . . . . 0.0 113.595 173.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -102.49 149.46 24.37 Favored 'General case' 0 C--N 1.364 1.228 0 O-C-N 119.686 -1.884 . . . . 0.0 111.889 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -153.01 147.3 25.74 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 118.823 -2.423 . . . . 0.0 110.945 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -65.51 160.35 22.49 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 127.171 3.367 . . . . 0.0 112.373 170.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.02 123.87 18.04 Favored 'General case' 0 N--CA 1.504 2.248 1 O-C-N 114.951 -4.843 . . . . 0.0 110.674 172.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.1 79.14 Favored Glycine 0 C--O 1.194 -2.387 0 C-N-CA 128.024 2.726 . . . . 0.0 115.853 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.2 p -131.78 160.16 36.37 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 129.325 3.603 . . . . 0.0 109.736 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.42 -167.3 53.97 Favored Glycine 0 CA--C 1.566 3.231 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.33 -38.79 34.75 Favored 'Trans proline' 0 CA--C 1.545 1.075 1 C-N-CA 127.595 5.53 . . . . 0.0 113.089 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -106.56 19.55 20.33 Favored 'General case' 0 C--O 1.276 2.45 0 O-C-N 118.398 -2.689 . . . . 0.0 112.425 -167.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.83 -17.79 2.71 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 116.962 -3.586 . . . . 0.0 115.332 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.77 -20.97 77.59 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 120.782 3.073 . . . . 0.0 120.782 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.55 151.69 68.86 Favored Pre-proline 0 C--O 1.181 -2.511 0 C-N-CA 129.225 3.01 . . . . 0.0 112.72 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -85.31 155.02 10.84 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 CA-C-O 124.569 1.82 . . . . 0.0 108.605 162.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -48.54 136.81 12.52 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 111.945 -2.389 . . . . 0.0 115.889 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.65 5.61 9.38 Favored Glycine 0 CA--C 1.568 3.351 0 C-N-CA 130.691 3.996 . . . . 0.0 118.877 -173.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -43.18 112.4 0.37 Allowed 'General case' 0 C--N 1.416 3.459 0 O-C-N 121.241 -1.152 . . . . 0.0 113.102 162.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -82.06 35.07 0.42 Allowed 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -157.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -71.07 142.92 50.83 Favored 'General case' 0 C--O 1.276 2.482 0 CA-C-N 113.298 -1.774 . . . . 0.0 115.092 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.465 ' CG ' HH22 ' A' ' 89' ' ' ARG . 18.9 t0 -63.28 134.15 55.36 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 127.332 2.253 . . . . 0.0 112.723 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.68 -1.31 88.94 Favored Glycine 0 C--N 1.302 -1.327 0 N-CA-C 119.492 2.557 . . . . 0.0 119.492 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.64 137.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 123.32 3.56 . . . . 0.0 114.518 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.52 116.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.414 ' CE3' ' HB3' ' A' ' 86' ' ' TYR . 83.3 m95 -87.66 138.52 31.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.734 1.73 . . . . 0.0 113.172 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.23 139.96 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 O-C-N 120.577 -1.327 . . . . 0.0 114.166 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -156.18 152.72 28.2 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 115.692 -2.099 . . . . 0.0 116.139 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.3 p -101.51 142.82 32.32 Favored 'General case' 0 C--O 1.28 2.686 0 C-N-CA 125.537 1.535 . . . . 0.0 110.85 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.88 -25.62 68.24 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.439 -2.038 . . . . 0.0 113.709 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.77 -31.12 30.27 Favored Glycine 0 N--CA 1.512 3.701 1 O-C-N 115.813 -4.305 . . . . 0.0 119.638 161.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.89 151.03 27.47 Favored 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 127.729 2.411 . . . . 0.0 111.346 -170.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.16 148.98 22.14 Favored 'General case' 0 CA--C 1.59 2.518 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -61.87 -18.2 59.27 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 114.973 -2.441 . . . . 0.0 114.361 -166.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.4 p -66.56 146.16 99.03 Favored Pre-proline 0 C--O 1.261 1.701 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.48 132.5 27.42 Favored 'Trans proline' 0 CA--C 1.584 2.995 0 CA-C-N 122.992 2.104 . . . . 0.0 110.995 165.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 57.6 mmtt -80.75 54.6 2.17 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.982 1.713 . . . . 0.0 112.637 -168.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.73 -18.76 56.53 Favored 'General case' 0 N--CA 1.53 3.526 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -58.02 -59.8 4.72 Favored 'General case' 0 C--N 1.377 1.785 0 O-C-N 117.394 -3.316 . . . . 0.0 114.638 160.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.4 -19.26 24.66 Favored 'Isoleucine or valine' 0 C--N 1.364 1.207 0 O-C-N 123.996 0.81 . . . . 0.0 112.562 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.19 -0.75 84.86 Favored Glycine 0 N--CA 1.497 2.717 1 CA-C-O 112.843 -4.309 . . . . 0.0 117.634 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.0 p -131.3 -18.55 2.87 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 122.571 3.186 . . . . 0.0 118.396 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -64.74 -176.32 0.25 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.372 0.987 . . . . 0.0 112.608 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -92.89 113.89 61.06 Favored Pre-proline 0 C--N 1.382 1.995 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.856 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -81.3 4.77 6.73 Favored 'Trans proline' 0 C--N 1.385 2.482 0 O-C-N 123.15 1.079 . . . . 0.0 113.908 -170.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.83 19.46 2.49 Favored 'General case' 0 CA--C 1.6 2.882 0 O-C-N 127.367 2.917 . . . . 0.0 113.286 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.15 -38.62 35.52 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 126.447 1.899 . . . . 0.0 107.93 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.1 152.83 24.0 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.295 -1.321 . . . . 0.0 114.416 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.92 140.93 56.49 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 125.549 1.539 . . . . 0.0 113.816 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.3 152.28 29.64 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 125.013 2.339 . . . . 0.0 115.568 -166.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.42 127.6 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.1 t -52.83 106.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.183 -2.399 0 O-C-N 118.634 -2.542 . . . . 0.0 112.574 151.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.99 118.51 9.87 Favored 'General case' 0 C--N 1.362 1.112 0 O-C-N 128.365 3.541 . . . . 0.0 116.376 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -146.56 164.06 33.8 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.018 1.727 . . . . 0.0 107.035 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.06 160.56 30.56 Favored Pre-proline 0 N--CA 1.505 2.291 0 C-N-CA 126.83 2.052 . . . . 0.0 112.478 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -68.37 166.08 26.68 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 118.1 2.308 . . . . 0.0 118.1 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 54.74 31.72 15.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.019 1.728 . . . . 0.0 112.053 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.01 10.86 78.48 Favored Glycine 1 C--N 1.401 4.191 0 CA-C-O 118.996 -0.891 . . . . 0.0 112.381 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.6 m -57.37 119.88 7.23 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 128.478 2.711 . . . . 0.0 109.52 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -81.47 142.43 32.94 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.412 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.93 171.62 2.35 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 128.913 2.885 . . . . 0.0 111.105 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.84 147.15 96.18 Favored 'Trans proline' 0 C--N 1.384 2.418 0 CA-C-O 113.849 -2.646 . . . . 0.0 115.526 172.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -72.36 -16.22 61.86 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 128.757 3.786 . . . . 0.0 114.933 158.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.49 -14.55 9.39 Favored Glycine 0 C--N 1.358 1.786 0 CA-C-O 117.518 -1.712 . . . . 0.0 115.804 160.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -136.97 108.08 6.76 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.084 1.942 . . . . 0.0 111.381 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -59.46 144.61 46.6 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.89 1.805 . . . . 0.0 114.241 164.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.05 175.63 11.56 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 128.483 3.992 . . . . 0.0 112.635 -167.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.408 -2.549 0 O-C-N 117.386 -3.321 . . . . 0.0 110.129 158.248 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.526 3.394 0 CA-C-O 123.319 1.299 . . . . 0.0 115.378 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.63 129.24 39.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 116.974 -1.488 . . . . 0.0 110.828 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -82.87 -15.74 50.3 Favored 'General case' 0 CA--C 1.604 3.029 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m 63.24 -52.8 0.2 Allowed 'General case' 0 C--O 1.251 1.139 0 C-N-CA 128.079 2.552 . . . . 0.0 113.619 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.0 170.29 3.67 Favored 'General case' 0 CA--C 1.592 2.588 0 CA-C-N 123.52 2.873 . . . . 0.0 111.469 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.3 t -77.55 144.55 37.52 Favored 'General case' 0 CA--C 1.58 2.105 0 CA-C-O 113.577 -3.106 . . . . 0.0 113.515 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -95.15 -4.41 46.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 125.76 3.891 . . . . 0.0 113.296 172.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -120.93 164.64 16.39 Favored 'General case' 0 N--CA 1.513 2.689 0 O-C-N 119.069 -2.27 . . . . 0.0 109.34 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.9 p -56.43 146.88 23.08 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 126.392 2.307 . . . . 0.0 110.244 157.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.04 162.56 24.28 Favored 'General case' 0 CA--C 1.567 1.61 0 O-C-N 116.308 -3.995 . . . . 0.0 112.914 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.37 107.32 18.16 Favored 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.028 2.131 . . . . 0.0 114.676 -153.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.4 m -65.2 118.74 9.68 Favored 'General case' 0 C--O 1.18 -2.57 0 O-C-N 126.554 2.409 . . . . 0.0 111.194 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -55.55 124.53 17.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 129.732 3.213 . . . . 0.0 115.627 165.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.19 -7.09 4.84 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 128.538 2.735 . . . . 0.0 111.885 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.43 -141.77 12.55 Favored Glycine 0 N--CA 1.507 3.411 0 O-C-N 120.024 -1.672 . . . . 0.0 112.801 165.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -137.61 -34.56 0.69 Allowed 'General case' 0 C--O 1.177 -2.712 0 O-C-N 116.68 -3.835 . . . . 0.0 110.041 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -58.27 138.0 56.68 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.72 2.408 . . . . 0.0 109.495 173.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -80.08 168.97 18.48 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 124.346 2.022 . . . . 0.0 111.309 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -72.62 61.88 0.53 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 118.677 -2.514 . . . . 0.0 112.281 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.43 149.26 36.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.549 -1.969 . . . . 0.0 114.032 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.08 91.65 23.42 Favored Pre-proline 0 CA--C 1.587 2.374 0 O-C-N 126.176 2.173 . . . . 0.0 110.479 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.09 148.17 18.28 Favored 'Trans proline' 0 C--O 1.195 -1.628 0 C-N-CA 123.697 2.931 . . . . 0.0 110.187 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 53.14 6.46 0.06 Allowed 'General case' 0 C--N 1.372 1.558 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.66 23.08 42.36 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 129.94 3.638 . . . . 0.0 113.589 -169.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -69.31 107.15 3.16 Favored 'General case' 0 CA--C 1.573 1.841 0 O-C-N 120.116 -1.814 . . . . 0.0 108.378 159.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.86 25.69 0.03 OUTLIER Glycine 0 C--N 1.385 3.277 0 C-N-CA 127.131 2.301 . . . . 0.0 113.626 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.49 123.25 78.95 Favored Pre-proline 0 C--N 1.374 1.674 1 O-C-N 114.518 -5.107 . . . . 0.0 110.775 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.63 173.47 12.19 Favored 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.84 2.36 . . . . 0.0 111.66 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -69.24 138.29 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 O-C-N 118.812 -2.43 . . . . 0.0 117.476 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.56 103.06 1.74 Allowed 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 116.938 -1.506 . . . . 0.0 111.144 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 m -71.95 -16.44 62.1 Favored 'General case' 0 CA--C 1.563 1.456 1 C-N-CA 133.009 4.524 . . . . 0.0 112.835 -175.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -83.84 17.08 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 115.139 -2.362 . . . . 0.0 113.137 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.8 p -146.79 176.7 9.67 Favored 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.291 22.0 p -130.18 -174.08 0.36 Allowed Pre-proline 0 C--N 1.289 -2.03 0 O-C-N 118.999 -2.313 . . . . 0.0 111.18 -166.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -73.25 -28.95 11.99 Favored 'Trans proline' 0 C--O 1.196 -1.585 0 CA-C-N 120.739 1.3 . . . . 0.0 113.428 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.45 -24.07 64.93 Favored 'General case' 0 CA--C 1.608 3.191 0 CA-C-O 123.141 1.448 . . . . 0.0 113.428 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.263 69.6 m-20 -92.12 -15.17 28.07 Favored 'General case' 0 C--O 1.187 -2.193 0 O-C-N 118.121 -2.862 . . . . 0.0 113.702 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -74.63 54.64 0.62 Allowed 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 118.144 2.646 . . . . 0.0 118.144 -169.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.07 148.3 17.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.4 -158.47 28.83 Favored Glycine 0 CA--C 1.543 1.82 0 O-C-N 118.558 -2.589 . . . . 0.0 111.585 -173.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -147.13 160.54 42.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.676 2.391 . . . . 0.0 116.981 -172.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -104.52 155.24 18.99 Favored 'General case' 0 CA--C 1.585 2.317 0 C-N-CA 130.327 3.451 . . . . 0.0 110.841 160.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -145.38 146.95 31.77 Favored 'General case' 0 C--O 1.191 -2.02 0 O-C-N 125.804 1.94 . . . . 0.0 109.49 171.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -62.35 154.69 27.25 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.081 1.752 . . . . 0.0 115.595 171.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.18 124.24 30.23 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 129.019 2.928 . . . . 0.0 111.606 158.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -110.36 -18.76 13.18 Favored 'General case' 0 N--CA 1.514 2.736 0 C-N-CA 128.56 2.744 . . . . 0.0 114.811 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 48.0 41.89 15.74 Favored 'General case' 0 C--N 1.382 2.021 0 C-N-CA 124.417 1.087 . . . . 0.0 112.368 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -91.09 -26.38 19.17 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 131.646 3.978 . . . . 0.0 107.652 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.282 1.7 mp 68.05 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 O-C-N 128.319 3.512 . . . . 0.0 114.084 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 . . . . . 0 C--O 1.276 2.482 0 C-N-CA 127.754 2.421 . . . . 0.0 107.507 -179.258 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mttt . . . . . 0 N--CA 1.522 3.14 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 60.2 65.99 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.36 1.864 . . . . 0.0 107.22 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -115.49 157.95 23.28 Favored 'General case' 0 C--O 1.278 2.598 0 C-N-CA 127.79 2.436 . . . . 0.0 112.027 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 t -60.35 158.59 27.83 Favored Pre-proline 0 C--O 1.263 1.804 0 O-C-N 125.891 1.994 . . . . 0.0 114.589 163.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.38 159.2 45.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 123.387 2.724 . . . . 0.0 114.494 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -135.56 152.03 50.89 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -126.08 136.09 52.5 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.358 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.81 130.94 53.49 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 127.763 3.165 . . . . 0.0 112.174 -164.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -102.36 147.18 27.02 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -145.57 153.06 40.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 127.42 2.95 . . . . 0.0 114.639 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -89.26 166.95 13.46 Favored 'General case' 0 CA--C 1.617 3.52 1 CA-C-N 126.64 4.291 . . . . 0.0 112.697 170.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -54.99 123.49 13.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.002 -1.454 . . . . 0.0 113.31 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.09 25.44 68.91 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 126.354 2.284 . . . . 0.0 111.558 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.6 p -132.56 169.39 16.68 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 118.757 -2.614 . . . . 0.0 107.049 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.06 -168.8 49.27 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 112.357 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.5 -26.12 12.29 Favored 'Trans proline' 0 N--CA 1.437 -1.848 1 C-N-CA 127.428 5.419 . . . . 0.0 112.675 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -101.04 31.99 3.4 Favored 'General case' 1 N--CA 1.561 5.117 0 C-N-CA 127.436 2.294 . . . . 0.0 109.47 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.28 -22.91 33.17 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.73 79.18 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.408 1.956 . . . . 0.0 115.281 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.59 125.96 81.62 Favored Pre-proline 0 CA--C 1.499 -1.007 0 CA-C-O 114.663 -2.589 . . . . 0.0 111.005 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 176.69 4.86 Favored 'Trans proline' 0 C--O 1.193 -1.755 0 CA-C-N 124.135 2.512 . . . . 0.0 109.367 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.97 137.17 55.94 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 125.051 1.34 . . . . 0.0 112.172 173.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.08 5.26 65.21 Favored Glycine 0 C--N 1.379 2.918 0 CA-C-O 125.028 2.46 . . . . 0.0 117.56 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.77 47.28 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 117.391 -3.417 . . . . 0.0 111.647 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -74.32 107.37 6.44 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 111.44 -2.618 . . . . 0.0 110.897 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -136.81 124.06 21.84 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.219 1.007 . . . . 0.0 110.175 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.26 107.76 0.7 Allowed 'General case' 0 CA--C 1.596 2.735 0 C-N-CA 128.108 2.563 . . . . 0.0 109.686 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.52 26.78 Favored Glycine 0 N--CA 1.503 3.123 0 C-N-CA 128.581 2.991 . . . . 0.0 111.175 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.25 119.03 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 124.184 0.994 . . . . 0.0 108.893 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.2 mm -101.39 120.54 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-O 124.261 1.981 . . . . 0.0 115.491 164.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -80.76 136.68 36.18 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 116.305 -3.997 . . . . 0.0 118.152 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -139.54 128.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.262 1.743 0 CA-C-N 123.813 3.006 . . . . 0.0 113.425 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.3 23.21 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 128.038 2.535 . . . . 0.0 109.54 -166.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.1 p -137.3 153.38 50.3 Favored 'General case' 0 C--O 1.277 2.504 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.42 -28.55 65.15 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 118.672 -2.517 . . . . 0.0 111.225 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.58 -0.28 89.86 Favored Glycine 1 N--CA 1.517 4.041 0 C-N-CA 128.412 2.911 . . . . 0.0 112.852 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.47 156.03 24.29 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 120.356 2.078 . . . . 0.0 109.009 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.3 mt -95.41 144.1 26.21 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 124.49 2.091 . . . . 0.0 109.054 167.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . 0.328 1.4 p-10 -75.73 26.9 0.11 Allowed 'General case' 0 C--N 1.389 2.283 0 O-C-N 117.934 -2.979 . . . . 0.0 113.601 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.0 p -91.62 158.92 39.66 Favored Pre-proline 0 CA--C 1.554 1.134 0 O-C-N 117.511 -3.243 . . . . 0.0 104.088 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -80.21 142.55 15.22 Favored 'Trans proline' 0 C--N 1.37 1.683 0 N-CA-C 105.087 -2.697 . . . . 0.0 105.087 173.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -88.19 74.64 8.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 117.0 -3.563 . . . . 0.0 107.419 -174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.12 -39.31 92.12 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 122.464 2.393 . . . . 0.0 114.436 -166.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -64.78 -59.32 4.36 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.2 mt -61.11 -23.93 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.088 0 C-N-CA 127.852 2.461 . . . . 0.0 115.633 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.57 -2.74 89.99 Favored Glycine 0 C--O 1.255 1.43 0 N-CA-C 120.163 2.825 . . . . 0.0 120.163 164.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.8 p -130.66 -35.18 1.49 Allowed 'General case' 0 C--O 1.179 -2.641 0 CA-C-N 122.803 3.301 . . . . 0.0 111.504 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -69.03 147.6 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 118.729 -2.482 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -44.21 121.15 3.89 Favored Pre-proline 1 N--CA 1.545 4.297 0 CA-C-O 115.197 -2.335 . . . . 0.0 111.562 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.56 -14.88 5.36 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 123.905 3.07 . . . . 0.0 116.504 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.22 9.8 9.88 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -163.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -69.31 -14.88 63.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 118.577 -2.577 . . . . 0.0 115.504 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.47 171.87 10.68 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 124.915 1.384 . . . . 0.0 108.367 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.13 143.85 5.53 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 118.279 -2.763 . . . . 0.0 114.191 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.51 109.11 1.85 Allowed 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 127.257 2.223 . . . . 0.0 110.529 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.67 132.23 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 128.137 2.575 . . . . 0.0 107.562 -160.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.51 97.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.7 114.79 12.37 Favored 'General case' 0 C--O 1.255 1.389 0 O-C-N 121.118 -0.989 . . . . 0.0 109.086 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -147.63 146.15 29.24 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 128.528 2.731 . . . . 0.0 107.56 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.16 153.01 53.82 Favored Pre-proline 0 CA--C 1.592 2.592 0 O-C-N 118.827 -2.421 . . . . 0.0 113.186 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -43.33 160.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.392 2.819 0 N-CA-C 119.029 2.665 . . . . 0.0 119.029 161.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 56.15 18.32 3.18 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 127.073 2.149 . . . . 0.0 109.733 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.21 19.35 70.19 Favored Glycine 0 C--O 1.187 -2.804 0 CA-C-N 119.764 1.165 . . . . 0.0 113.037 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.5 m -65.27 123.83 20.6 Favored 'General case' 0 C--O 1.262 1.729 0 CA-C-N 118.9 1.35 . . . . 0.0 108.005 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.6 m -74.86 138.26 42.36 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 124.463 2.078 . . . . 0.0 108.058 -165.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.5 mt -66.16 154.15 90.6 Favored Pre-proline 1 N--CA 1.553 4.716 1 CA-C-O 111.205 -4.236 . . . . 0.0 110.314 170.799 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -55.41 137.02 76.35 Favored 'Trans proline' 0 CA--C 1.559 1.752 1 C-N-CA 129.05 6.5 . . . . 0.0 113.718 -172.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -75.66 -16.64 60.17 Favored 'General case' 0 N--CA 1.481 1.117 1 O-C-N 115.67 -4.394 . . . . 0.0 112.688 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.46 -9.65 13.41 Favored Glycine 0 N--CA 1.512 3.701 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 166.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -119.39 157.54 27.97 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.141 2.97 . . . . 0.0 111.376 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -104.51 136.31 44.31 Favored 'General case' 0 CA--C 1.605 3.077 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.264 165.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.29 -173.17 4.3 Favored 'General case' 0 C--N 1.384 2.108 0 C-N-CA 127.964 2.506 . . . . 0.0 111.106 -158.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.519 3.021 0 C-N-CA 126.542 1.937 . . . . 0.0 109.891 158.542 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 N--CA 1.512 2.57 0 N-CA-C 118.439 2.438 . . . . 0.0 118.439 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.64 111.56 2.13 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 127.247 3.403 . . . . 0.0 109.553 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -58.81 -11.8 3.64 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 118.804 -2.435 . . . . 0.0 110.758 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m 46.22 -50.22 0.0 OUTLIER 'General case' 0 C--N 1.364 1.23 1 C-N-CA 133.036 4.534 . . . . 0.0 119.942 -170.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.18 154.24 23.87 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 131.808 4.043 . . . . 0.0 112.052 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.0 t -82.5 137.57 34.58 Favored 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 127.385 2.274 . . . . 0.0 115.64 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -76.13 -21.05 57.05 Favored 'General case' 0 CA--C 1.615 3.461 0 CA-C-O 122.797 1.284 . . . . 0.0 110.56 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -88.29 173.01 9.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 118.389 -2.695 . . . . 0.0 113.952 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p -71.98 172.23 10.38 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 119.25 -2.156 . . . . 0.0 110.84 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . 0.309 . . -117.18 132.73 56.58 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 119.666 -1.896 . . . . 0.0 114.764 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.7 mt -70.25 163.42 26.51 Favored 'General case' 0 N--CA 1.513 2.677 0 C-N-CA 129.74 3.216 . . . . 0.0 111.643 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.9 m -128.15 131.12 48.95 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 168.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -66.92 149.95 49.89 Favored 'General case' 0 CA--C 1.6 2.893 0 C-N-CA 124.259 1.024 . . . . 0.0 112.083 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -151.53 -19.81 0.2 Allowed 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.611 -1.931 . . . . 0.0 113.43 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.94 -125.65 0.83 Allowed Glycine 0 CA--C 1.548 2.153 0 C-N-CA 128.107 2.765 . . . . 0.0 113.748 160.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -156.68 -22.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -69.32 139.68 54.3 Favored 'General case' 0 C--O 1.279 2.654 0 C-N-CA 126.272 1.829 . . . . 0.0 115.638 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.77 164.72 9.51 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 128.507 2.723 . . . . 0.0 115.816 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.8 tp -82.7 52.34 2.09 Favored 'General case' 0 CA--C 1.569 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 113.823 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -55.23 138.47 44.93 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 118.984 -2.323 . . . . 0.0 109.604 -171.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 50.5 m-85 -128.47 129.29 23.57 Favored Pre-proline 0 C--O 1.187 -2.221 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -84.11 137.75 7.48 Favored 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.315 4.01 . . . . 0.0 109.477 -170.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 45.81 23.82 0.18 Allowed 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.88 7.38 65.9 Favored Glycine 0 CA--C 1.567 3.325 0 CA-C-O 117.242 -1.865 . . . . 0.0 112.044 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -65.42 72.37 0.05 OUTLIER 'General case' 0 C--O 1.19 -2.052 0 CA-C-N 119.847 1.824 . . . . 0.0 111.892 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.16 33.96 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.206 0 CA-C-N 122.968 2.622 . . . . 0.0 119.398 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -74.43 119.36 76.14 Favored Pre-proline 0 C--O 1.257 1.453 0 O-C-N 118.708 -2.642 . . . . 0.0 110.593 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.51 161.49 20.56 Favored 'Trans proline' 0 CA--C 1.601 3.835 0 N-CA-C 119.035 2.667 . . . . 0.0 119.035 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.19 131.17 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 O-C-N 126.139 2.149 . . . . 0.0 108.922 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -165.12 91.96 0.55 Allowed 'General case' 0 N--CA 1.536 3.84 0 C-N-CA 128.65 2.78 . . . . 0.0 106.031 172.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -67.61 -21.22 65.41 Favored 'General case' 0 C--O 1.185 -2.315 0 CA-C-O 123.676 1.703 . . . . 0.0 113.607 -174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -55.41 -50.25 70.27 Favored 'General case' 0 N--CA 1.421 -1.889 1 O-C-N 115.342 -4.599 . . . . 0.0 114.897 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.2 p -58.36 153.86 14.72 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 119.069 2.988 . . . . 0.0 119.069 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.2 t -78.31 145.73 69.02 Favored Pre-proline 0 C--O 1.17 -3.128 0 O-C-N 125.241 1.588 . . . . 0.0 108.767 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.91 -34.72 16.86 Favored 'Trans proline' 0 CA--C 1.587 3.139 1 C-N-CA 125.755 4.303 . . . . 0.0 113.086 162.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.31 -38.77 92.45 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.646 1.178 . . . . 0.0 108.954 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.25 -19.66 66.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-O 116.201 -1.857 . . . . 0.0 114.629 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -84.62 81.18 8.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 123.523 2.874 . . . . 0.0 114.094 -151.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 tt -163.52 130.83 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.926 0 C-N-CA 126.999 2.12 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 -157.7 15.51 Favored Glycine 0 CA--C 1.557 2.702 0 CA-C-O 124.289 2.049 . . . . 0.0 115.902 -166.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -161.05 146.85 14.46 Favored 'General case' 0 C--O 1.284 2.897 0 CA-C-O 122.624 1.202 . . . . 0.0 112.547 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 4.2 m-85 -97.78 141.33 30.91 Favored 'General case' 0 C--O 1.171 -3.061 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.221 162.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -125.47 143.45 50.99 Favored 'General case' 0 C--O 1.202 -1.407 0 C-N-CA 125.668 1.587 . . . . 0.0 108.016 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.501 HH22 ' CG ' ' A' ' 128' ' ' ASP . 1.2 ptt180 -54.8 174.19 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 126.015 2.072 . . . . 0.0 116.348 163.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.29 139.59 13.38 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 115.181 -2.342 . . . . 0.0 108.999 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.5 p -127.11 -21.16 4.0 Favored 'General case' 0 C--O 1.262 1.747 0 C-N-CA 127.395 2.278 . . . . 0.0 113.297 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 46.01 49.14 12.28 Favored 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 125.512 1.525 . . . . 0.0 108.597 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -97.8 -9.71 26.04 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 127.248 2.219 . . . . 0.0 110.158 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.303 2.1 mp 64.57 157.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.592 2.59 0 O-C-N 120.398 -1.439 . . . . 0.0 114.478 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 . . . . . 0 C--N 1.301 -1.52 0 CA-C-O 122.914 1.34 . . . . 0.0 107.394 169.177 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.6 tttt . . . . . 0 C--O 1.205 -1.284 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 56.1 40.31 30.22 Favored 'General case' 0 CA--C 1.583 2.232 1 CA-C-O 129.032 4.253 . . . . 0.0 116.367 167.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.61 165.38 13.33 Favored 'General case' 0 C--N 1.375 1.704 0 O-C-N 117.897 -3.002 . . . . 0.0 116.048 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.0 t -60.03 147.78 79.24 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 121.988 0.899 . . . . 0.0 112.367 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -53.56 132.65 49.98 Favored 'Trans proline' 0 C--N 1.408 3.68 1 C-N-CA 125.939 4.426 . . . . 0.0 115.18 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -94.53 171.71 8.64 Favored 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 125.882 1.673 . . . . 0.0 114.601 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -146.03 139.5 26.14 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 119.571 -1.955 . . . . 0.0 113.228 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -128.86 170.23 13.64 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.262 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -114.14 136.3 53.09 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 127.809 2.443 . . . . 0.0 114.664 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.69 144.14 48.98 Favored 'General case' 0 CA--C 1.603 2.997 0 C-N-CA 126.496 1.918 . . . . 0.0 111.277 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.68 167.92 13.45 Favored 'General case' 0 N--CA 1.515 2.786 0 CA-C-O 123.603 1.668 . . . . 0.0 107.83 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.65 137.32 57.75 Favored 'General case' 0 C--O 1.199 -1.59 0 CA-C-O 115.671 -2.109 . . . . 0.0 109.599 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.63 -13.7 60.0 Favored Glycine 0 CA--C 1.569 3.446 0 CA-C-O 126.399 3.222 . . . . 0.0 114.815 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -119.31 171.94 7.96 Favored 'General case' 0 C--O 1.196 -1.716 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.01 -168.75 37.61 Favored Glycine 0 CA--C 1.566 3.252 0 O-C-N 129.001 3.938 . . . . 0.0 111.227 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -59.57 -39.81 71.48 Favored 'Trans proline' 0 N--CA 1.515 2.744 0 C-N-CA 122.56 2.174 . . . . 0.0 112.854 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -95.58 42.14 1.09 Allowed 'General case' 0 CA--C 1.588 2.408 0 O-C-N 119.854 -1.779 . . . . 0.0 112.486 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.53 -25.75 18.15 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 129.438 3.095 . . . . 0.0 114.863 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -87.62 -15.63 61.41 Favored Glycine 0 N--CA 1.478 1.499 0 C-N-CA 126.184 1.849 . . . . 0.0 115.434 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.22 135.56 84.61 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 120.01 1.905 . . . . 0.0 113.773 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -89.16 156.81 5.67 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 124.438 1.757 . . . . 0.0 113.685 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.72 128.15 34.87 Favored 'General case' 0 C--O 1.273 2.342 0 CA-C-O 115.811 -2.042 . . . . 0.0 113.089 -169.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.82 21.05 66.82 Favored Glycine 0 N--CA 1.406 -3.306 0 CA-C-N 122.765 2.529 . . . . 0.0 118.791 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.88 155.34 38.65 Favored 'General case' 0 C--O 1.268 2.071 0 O-C-N 120.817 -1.402 . . . . 0.0 114.29 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.89 43.99 1.04 Allowed 'General case' 0 C--O 1.269 2.084 0 CA-C-N 121.881 2.128 . . . . 0.0 109.81 -174.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -59.45 137.32 58.04 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-N 122.606 2.457 . . . . 0.0 113.009 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.501 ' CG ' HH22 ' A' ' 89' ' ' ARG . 49.6 t0 -57.44 118.38 5.11 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 128.032 2.533 . . . . 0.0 113.422 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.09 19.17 54.17 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 126.351 2.282 . . . . 0.0 117.697 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.49 121.83 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 131.301 3.84 . . . . 0.0 106.79 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.97 119.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 O-C-N 125.726 1.891 . . . . 0.0 114.017 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -76.47 141.48 41.3 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.67 149.7 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 118.242 -2.786 . . . . 0.0 112.811 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.36 -179.48 6.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.786 -2.007 . . . . 0.0 115.64 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -144.37 160.06 41.68 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 127.496 2.318 . . . . 0.0 111.927 163.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -61.48 -51.55 68.21 Favored 'General case' 0 CA--C 1.561 1.383 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.72 -6.14 54.21 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.969 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.61 158.58 29.72 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 126.549 1.94 . . . . 0.0 115.602 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.48 134.89 39.1 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 122.263 2.301 . . . . 0.0 114.004 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -64.52 59.59 0.02 OUTLIER 'General case' 0 CA--C 1.593 2.602 0 C-N-CA 129.538 3.135 . . . . 0.0 109.658 170.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.5 p -150.39 153.16 34.29 Favored Pre-proline 0 N--CA 1.509 2.5 0 C-N-CA 125.061 1.344 . . . . 0.0 113.135 -170.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.45 146.43 50.07 Favored 'Trans proline' 0 CA--C 1.555 1.539 1 C-N-CA 125.416 4.077 . . . . 0.0 112.928 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -114.6 47.02 1.29 Allowed 'General case' 0 C--O 1.264 1.847 0 CA-C-O 125.614 2.626 . . . . 0.0 104.385 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -52.81 -29.63 28.71 Favored 'General case' 0 N--CA 1.489 1.494 1 O-C-N 116.189 -4.069 . . . . 0.0 114.145 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -60.89 -51.51 68.96 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 122.138 2.245 . . . . 0.0 111.115 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.63 -26.81 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 CA-C-O 123.753 1.74 . . . . 0.0 112.058 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -69.68 -12.13 66.77 Favored Glycine 1 CA--C 1.6 5.406 0 CA-C-N 112.676 -2.056 . . . . 0.0 114.041 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 66.9 p -148.29 -29.56 0.3 Allowed 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 123.787 3.794 . . . . 0.0 113.789 -159.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.81 168.14 19.45 Favored 'General case' 0 C--O 1.201 -1.448 1 O-C-N 116.111 -4.118 . . . . 0.0 112.157 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . 0.3 54.7 t-20 -75.44 110.5 10.62 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 128.746 3.779 . . . . 0.0 109.377 -156.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.53 -9.94 18.7 Favored 'Trans proline' 0 C--N 1.396 3.04 1 C-N-CA 128.909 6.406 . . . . 0.0 109.879 -164.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.9 44.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.324 -1.485 . . . . 0.0 114.174 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -68.41 -62.95 1.17 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.164 0.586 . . . . 0.0 110.89 155.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -81.96 153.86 26.04 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 117.17 -1.395 . . . . 0.0 112.461 160.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.29 160.24 22.1 Favored 'General case' 0 CA--C 1.595 2.697 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -36.84 125.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -75.57 134.59 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 O-C-N 126.104 2.128 . . . . 0.0 110.766 172.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.11 125.83 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 O-C-N 118.332 -2.73 . . . . 0.0 107.541 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.42 97.1 6.24 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.315 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -148.53 146.68 28.42 Favored 'General case' 0 C--N 1.375 1.717 0 CA-C-O 126.706 3.146 . . . . 0.0 108.041 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 92.9 mt -85.76 146.19 43.15 Favored Pre-proline 0 C--O 1.255 1.348 0 C-N-CA 128.705 2.802 . . . . 0.0 118.109 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -49.24 164.62 0.27 Allowed 'Trans proline' 0 CA--C 1.57 2.321 1 C-N-CA 125.92 4.413 . . . . 0.0 113.092 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 56.49 32.41 20.71 Favored 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 127.974 2.509 . . . . 0.0 112.949 166.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.45 44.97 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 117.053 -1.971 . . . . 0.0 116.471 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.5 m -59.8 131.02 49.62 Favored 'General case' 0 C--N 1.379 1.89 0 O-C-N 125.583 1.402 . . . . 0.0 108.875 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 94.1 m -90.96 141.86 28.39 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.085 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.5 154.57 93.3 Favored Pre-proline 0 C--O 1.276 2.485 0 CA-C-N 123.529 2.877 . . . . 0.0 110.203 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.22 130.6 28.95 Favored 'Trans proline' 0 C--N 1.402 3.387 0 C-N-CA 124.259 3.306 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -64.56 -4.64 4.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.243 1.817 . . . . 0.0 113.872 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.76 -11.39 49.54 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 116.442 -2.31 . . . . 0.0 113.899 164.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.43 143.38 43.66 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 128.826 2.851 . . . . 0.0 116.1 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.88 154.14 38.35 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 123.801 1.762 . . . . 0.0 113.191 148.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.0 -179.26 7.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 127.125 3.345 . . . . 0.0 108.447 -162.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 CA--C 1.567 1.625 1 O-C-N 114.135 -5.353 . . . . 0.0 111.531 154.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.514 2.731 0 CA-C-O 123.708 1.462 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -84.44 123.23 30.01 Favored 'General case' 0 C--O 1.272 2.276 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.239 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -70.25 -13.97 62.41 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 117.838 -3.039 . . . . 0.0 113.86 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m 58.53 -29.31 0.03 OUTLIER 'General case' 0 CA--C 1.588 2.406 0 N-CA-C 118.648 2.832 . . . . 0.0 118.648 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.422 ' HB3' ' HG2' ' A' ' 151' ' ' PRO . . . -87.53 150.04 23.98 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 126.224 1.809 . . . . 0.0 112.335 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -87.68 136.24 33.03 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 118.718 -2.489 . . . . 0.0 113.755 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -80.31 -2.18 44.13 Favored 'General case' 0 C--O 1.185 -2.303 0 C-N-CA 124.959 1.304 . . . . 0.0 109.136 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -123.16 156.42 35.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 119.433 -2.042 . . . . 0.0 113.169 -168.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.8 p -64.87 142.98 58.25 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.56 164.49 21.89 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 127.287 2.867 . . . . 0.0 114.518 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.37 153.06 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.201 0.938 . . . . 0.0 112.308 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -119.22 128.23 54.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.14 -2.85 . . . . 0.0 106.534 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.95 150.36 29.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 108.205 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -138.01 -19.79 1.13 Allowed 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 122.097 0.951 . . . . 0.0 111.881 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.0 -128.12 6.2 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 123.558 1.643 . . . . 0.0 112.392 166.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -142.04 -24.72 0.68 Allowed 'General case' 0 CA--C 1.588 2.407 0 C-N-CA 125.023 1.329 . . . . 0.0 113.572 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.295 25.4 tp10 -60.49 138.85 57.95 Favored 'General case' 0 CA--C 1.609 3.226 0 O-C-N 118.671 -2.518 . . . . 0.0 114.859 173.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.97 163.69 11.72 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 122.742 1.258 . . . . 0.0 114.288 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tp -73.82 54.75 0.51 Allowed 'General case' 0 C--O 1.288 3.112 0 CA-C-N 112.36 -2.2 . . . . 0.0 114.45 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -59.81 159.54 8.78 Favored 'General case' 0 N--CA 1.406 -2.628 0 C-N-CA 127.102 2.161 . . . . 0.0 116.327 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.464 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 77.1 m-85 -145.47 125.37 7.04 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -47.18 117.28 2.14 Favored 'Trans proline' 0 N--CA 1.452 -0.945 1 C-N-CA 125.492 4.128 . . . . 0.0 115.169 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 43.56 23.86 0.05 Allowed 'General case' 1 N--CA 1.557 4.92 1 C-N-CA 131.8 4.04 . . . . 0.0 110.898 -171.41 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.33 17.45 62.47 Favored Glycine 0 CA--C 1.551 2.326 0 O-C-N 117.444 -3.285 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -88.87 111.45 22.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 121.086 2.443 . . . . 0.0 109.796 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.15 38.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-O 116.634 -2.204 . . . . 0.0 118.118 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.35 126.75 92.61 Favored Pre-proline 0 CA--C 1.505 -0.753 0 O-C-N 127.583 2.578 . . . . 0.0 109.601 158.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.93 170.24 20.22 Favored 'Trans proline' 0 N--CA 1.516 2.794 0 C-N-CA 125.221 3.947 . . . . 0.0 113.102 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.4 mt -79.26 126.08 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 117.962 -2.961 . . . . 0.0 110.621 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -138.34 116.1 11.47 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 127.124 3.345 . . . . 0.0 106.82 163.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 m -74.24 -21.86 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 112.27 -2.241 . . . . 0.0 106.249 -168.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.96 39.19 1.51 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 127.669 2.388 . . . . 0.0 114.056 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.7 p -140.94 149.62 42.07 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 121.323 -0.861 . . . . 0.0 112.752 151.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.9 p -75.9 163.7 65.17 Favored Pre-proline 0 CA--C 1.581 2.165 0 CA-C-O 116.3 -1.809 . . . . 0.0 113.519 -170.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.35 -28.75 73.91 Favored 'Trans proline' 0 CA--C 1.569 2.263 0 CA-C-N 124.137 2.513 . . . . 0.0 112.627 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -69.58 -13.81 62.52 Favored 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.41 -10.57 34.71 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 127.795 2.438 . . . . 0.0 111.051 -163.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -86.01 64.7 8.73 Favored 'General case' 0 C--O 1.277 2.528 0 C-N-CA 127.131 2.172 . . . . 0.0 113.749 -160.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.5 tt -158.1 139.31 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-N 112.955 -1.929 . . . . 0.0 107.168 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.04 -165.53 39.0 Favored Glycine 0 CA--C 1.568 3.388 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -165.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -145.37 156.14 43.6 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 125.966 1.706 . . . . 0.0 115.43 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 14.9 m-85 -94.1 148.22 22.39 Favored 'General case' 0 C--O 1.277 2.53 0 C-N-CA 124.064 0.945 . . . . 0.0 109.285 157.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -122.78 138.77 54.54 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 126.22 1.808 . . . . 0.0 112.962 171.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -71.77 143.02 49.7 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 118.608 -2.557 . . . . 0.0 116.828 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . 0.252 . . -124.29 83.45 2.15 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.958 1.703 . . . . 0.0 111.498 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.9 p -80.57 -15.44 56.64 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 120.102 1.319 . . . . 0.0 113.294 -165.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 47.5 35.5 4.28 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -89.84 -9.68 48.19 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.262 1.7 mp 65.85 143.69 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.553 4.701 0 C-N-CA 130.283 3.433 . . . . 0.0 116.216 172.98 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 . . . . . 0 CA--C 1.58 2.126 0 C-N-CA 127.488 2.315 . . . . 0.0 111.901 172.623 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 CA--C 1.595 2.678 0 CA-C-O 122.713 1.244 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 50.16 31.33 4.94 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 116.771 2.138 . . . . 0.0 116.771 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.43 156.29 17.87 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 117.98 -2.95 . . . . 0.0 108.508 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.8 t -58.24 144.23 77.58 Favored Pre-proline 0 N--CA 1.52 3.072 0 C-N-CA 129.23 3.012 . . . . 0.0 108.616 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -47.1 139.47 15.22 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 124.681 3.587 . . . . 0.0 115.288 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -102.37 170.62 7.95 Favored 'General case' 0 CA--C 1.572 1.812 0 O-C-N 127.122 2.764 . . . . 0.0 106.659 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -155.91 144.02 19.86 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 118.537 -2.602 . . . . 0.0 109.176 -174.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.01 147.57 44.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 128.975 2.91 . . . . 0.0 117.186 -172.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -92.92 155.87 17.3 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -148.22 139.25 23.22 Favored 'General case' 0 N--CA 1.532 3.642 1 C-N-CA 132.652 4.381 . . . . 0.0 113.721 169.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -75.04 158.63 32.87 Favored 'General case' 0 CA--C 1.606 3.12 0 O-C-N 125.454 1.721 . . . . 0.0 114.186 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.5 tp -53.65 127.21 24.65 Favored 'General case' 0 CA--C 1.582 2.176 0 O-C-N 117.377 -3.327 . . . . 0.0 114.711 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.28 15.69 76.01 Favored Glycine 0 CA--C 1.552 2.381 0 C-N-CA 123.82 0.724 . . . . 0.0 111.98 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -151.66 163.38 39.24 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-O 124.63 2.157 . . . . 0.0 111.993 -166.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.98 -163.25 54.47 Favored Glycine 1 CA--C 1.581 4.167 0 O-C-N 118.384 -2.697 . . . . 0.0 111.558 -164.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -70.59 -26.8 23.27 Favored 'Trans proline' 1 CA--C 1.607 4.157 0 CA-C-O 117.975 -0.927 . . . . 0.0 111.981 -168.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.28 37.53 1.87 Allowed 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.257 1.389 . . . . 0.0 112.901 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -25.89 67.92 Favored 'General case' 0 C--N 1.373 1.623 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.33 -12.93 77.75 Favored Glycine 1 CA--C 1.587 4.559 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.8 mt -53.65 145.8 28.36 Favored Pre-proline 0 CA--C 1.584 2.256 0 CA-C-N 119.385 1.592 . . . . 0.0 110.992 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -85.23 169.02 10.1 Favored 'Trans proline' 0 N--CA 1.412 -3.273 0 O-C-N 123.689 1.362 . . . . 0.0 113.467 155.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -57.47 136.17 56.65 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 125.503 1.752 . . . . 0.0 115.28 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.99 -4.73 56.85 Favored Glycine 1 CA--C 1.582 4.221 0 CA-C-O 115.379 -2.901 . . . . 0.0 114.047 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.73 153.99 12.59 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -82.42 100.84 10.26 Favored 'General case' 0 C--O 1.276 2.492 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.718 -165.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.11 127.95 4.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 126.442 2.339 . . . . 0.0 109.658 167.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.05 155.99 36.64 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 125.994 1.718 . . . . 0.0 110.26 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.14 7.47 87.67 Favored Glycine 0 N--CA 1.488 2.165 0 O-C-N 125.79 1.931 . . . . 0.0 113.634 -165.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.7 132.59 62.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 C-N-CA 127.026 2.13 . . . . 0.0 109.525 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.3 mm -121.99 121.14 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 C-N-CA 126.422 1.889 . . . . 0.0 106.826 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -99.03 140.7 32.79 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.8 1.24 . . . . 0.0 109.56 -170.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.02 158.64 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-O 117.654 -1.165 . . . . 0.0 113.339 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -151.56 176.75 11.02 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 127.561 3.038 . . . . 0.0 111.508 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.8 p -123.17 158.49 30.66 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 128.916 2.887 . . . . 0.0 109.379 155.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -49.94 -44.43 50.52 Favored 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 128.521 2.728 . . . . 0.0 113.892 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.11 -17.11 75.46 Favored Glycine 1 CA--C 1.59 4.758 0 CA-C-N 111.91 -2.405 . . . . 0.0 114.169 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . 0.268 . . -76.73 136.3 39.04 Favored 'General case' 0 C--O 1.292 3.324 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.2 mt -84.94 152.3 23.61 Favored 'General case' 0 C--N 1.383 2.022 0 CA-C-N 113.063 -1.881 . . . . 0.0 106.412 170.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -72.66 6.81 2.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.013 -1.449 . . . . 0.0 113.204 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.3 p -70.81 140.47 86.44 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.25 134.24 26.5 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 121.429 1.419 . . . . 0.0 109.408 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . 0.259 49.7 mmtt -77.84 41.87 0.36 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 116.417 -1.754 . . . . 0.0 109.602 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -46.02 -29.12 1.35 Allowed 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 113.365 -3.207 . . . . 0.0 114.425 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -60.74 -46.56 89.98 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 123.684 2.947 . . . . 0.0 113.253 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.7 mt -81.93 -17.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 126.126 1.77 . . . . 0.0 108.698 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.37 -23.07 55.39 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 129.772 3.558 . . . . 0.0 113.427 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.7 p -127.33 -11.71 5.72 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-O 125.89 2.757 . . . . 0.0 116.238 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -81.25 154.74 26.44 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 111.469 -2.605 . . . . 0.0 106.156 166.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -92.07 124.45 59.91 Favored Pre-proline 0 CA--C 1.581 2.162 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.422 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 1.2 Cg_exo -52.94 -29.57 44.44 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.992 3.128 . . . . 0.0 115.642 169.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.4 -16.41 62.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -67.62 -17.45 64.62 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.929 3.059 . . . . 0.0 114.917 -170.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -135.04 178.01 7.36 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 122.696 1.236 . . . . 0.0 111.16 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.64 151.39 34.35 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 116.642 -1.647 . . . . 0.0 109.366 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.05 147.08 1.5 Allowed 'General case' 0 C--O 1.26 1.651 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.98 118.66 21.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 170.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.72 112.28 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 114.403 -2.713 . . . . 0.0 106.27 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 tt -80.1 137.82 36.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -156.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -157.02 145.95 20.02 Favored 'General case' 0 CA--C 1.611 3.31 0 C-N-CA 130.087 3.355 . . . . 0.0 107.956 -172.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.73 153.31 42.26 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 126.737 2.523 . . . . 0.0 111.744 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.72 171.77 12.73 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.398 3.398 . . . . 0.0 108.949 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.262 69.3 mt-30 64.69 12.78 7.87 Favored 'General case' 0 CA--C 1.589 2.455 0 C-N-CA 127.122 2.169 . . . . 0.0 112.419 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.99 19.32 44.34 Favored Glycine 0 CA--C 1.549 2.176 1 C-N-CA 132.881 5.038 . . . . 0.0 121.533 -163.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.0 m -61.43 137.74 58.25 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 124.068 0.947 . . . . 0.0 113.467 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 85.0 m -77.21 141.82 39.87 Favored 'General case' 0 CA--C 1.597 2.784 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.8 159.01 84.07 Favored Pre-proline 0 CA--C 1.572 1.794 0 C-N-CA 126.629 1.972 . . . . 0.0 113.273 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.13 136.96 25.47 Favored 'Trans proline' 0 CA--C 1.477 -2.333 0 CA-C-O 124.302 1.709 . . . . 0.0 112.392 -172.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -51.39 -19.92 1.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.254 166.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.43 17.26 44.74 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 125.006 3.548 . . . . 0.0 114.597 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -133.54 155.31 49.84 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-O 124.358 2.028 . . . . 0.0 110.537 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -100.57 143.38 30.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.591 -2.549 . . . . 0.0 107.369 160.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -155.42 -175.81 5.62 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 127.501 2.32 . . . . 0.0 112.641 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 . . . . . 0 N--CA 1.524 3.237 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 178.522 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 CA--C 1.561 1.837 0 N-CA-C 116.414 1.659 . . . . 0.0 116.414 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -62.42 126.58 27.81 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.209 -2.182 . . . . 0.0 113.104 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -79.7 -8.63 59.35 Favored 'General case' 0 CA--C 1.574 1.9 0 O-C-N 119.172 -2.205 . . . . 0.0 115.689 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m 57.94 -39.23 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 130.375 3.47 . . . . 0.0 119.322 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 165.47 25.09 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 110.788 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -89.79 139.51 30.51 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-N 113.767 -1.561 . . . . 0.0 115.001 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -78.92 -5.79 54.57 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 127.707 2.403 . . . . 0.0 110.866 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 156.4 48.96 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.323 1.535 . . . . 0.0 113.528 -165.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.0 p -56.6 163.06 1.95 Allowed 'General case' 0 CA--C 1.575 1.915 0 CA-C-O 124.253 1.978 . . . . 0.0 108.157 165.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.97 166.11 16.18 Favored 'General case' 0 CA--C 1.626 3.903 0 CA-C-N 110.562 -3.017 . . . . 0.0 117.643 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.53 168.83 10.45 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 144.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -126.93 132.53 50.84 Favored 'General case' 0 CA--C 1.579 2.059 0 C-N-CA 126.415 1.886 . . . . 0.0 111.728 158.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.27 128.7 26.01 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 119.521 -1.987 . . . . 0.0 109.101 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -124.16 -24.66 4.3 Favored 'General case' 0 C--O 1.278 2.585 0 O-C-N 128.194 3.434 . . . . 0.0 116.802 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.08 -133.53 4.31 Favored Glycine 0 CA--C 1.578 3.974 0 N-CA-C 119.755 2.662 . . . . 0.0 119.755 154.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -133.04 -29.58 1.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 CA-C-N 119.63 1.715 . . . . 0.0 114.728 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.72 139.28 51.11 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 125.384 1.678 . . . . 0.0 111.254 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -65.74 171.37 4.32 Favored 'General case' 0 CA--C 1.48 -1.747 0 C-N-CA 126.093 1.757 . . . . 0.0 112.759 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.18 37.83 0.17 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.091 -165.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -63.77 109.11 1.61 Allowed 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 127.845 2.458 . . . . 0.0 110.971 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.68 158.71 42.17 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 118.676 -2.515 . . . . 0.0 112.958 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.85 133.45 21.84 Favored 'Trans proline' 0 C--O 1.274 2.32 0 N-CA-C 107.401 -1.807 . . . . 0.0 107.401 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 61.56 7.24 1.76 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 130.055 3.342 . . . . 0.0 114.699 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.19 33.24 85.3 Favored Glycine 0 N--CA 1.492 2.431 0 CA-C-O 123.958 1.865 . . . . 0.0 112.835 -160.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -94.89 118.41 31.75 Favored 'General case' 0 CA--C 1.58 2.097 0 CA-C-N 113.762 -1.219 . . . . 0.0 109.934 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.19 28.93 0.02 OUTLIER Glycine 0 CA--C 1.57 3.494 0 O-C-N 116.882 -3.636 . . . . 0.0 114.329 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.73 128.44 88.28 Favored Pre-proline 0 C--O 1.26 1.654 0 CA-C-N 121.212 2.506 . . . . 0.0 114.62 167.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.44 171.25 18.49 Favored 'Trans proline' 0 N--CA 1.443 -1.487 1 C-N-CA 126.624 4.882 . . . . 0.0 114.477 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.28 135.7 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 128.354 2.662 . . . . 0.0 113.32 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -168.49 121.49 0.85 Allowed 'General case' 0 C--O 1.258 1.519 0 O-C-N 119.172 -2.205 . . . . 0.0 110.072 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.27 9.0 m -75.54 -24.18 56.71 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 118.434 -2.666 . . . . 0.0 112.095 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -75.43 5.58 5.63 Favored 'General case' 0 C--N 1.37 1.483 0 O-C-N 117.506 -3.246 . . . . 0.0 111.992 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -112.83 165.23 12.5 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.261 1.846 . . . . 0.0 112.235 158.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -120.27 175.84 2.11 Favored Pre-proline 0 C--O 1.281 2.74 0 C-N-CA 128.611 2.764 . . . . 0.0 113.506 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.37 -41.48 49.37 Favored 'Trans proline' 0 CA--C 1.591 3.365 0 C-N-CA 122.031 1.821 . . . . 0.0 114.077 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -52.2 -23.01 4.88 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 122.505 2.411 . . . . 0.0 112.414 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.13 -21.02 15.08 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 118.043 -2.911 . . . . 0.0 108.846 -161.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.01 73.8 0.04 OUTLIER 'General case' 0 CA--C 1.613 3.4 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.294 7.1 tt -158.1 137.34 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 C-N-CA 130.786 3.634 . . . . 0.0 104.702 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.36 -165.1 32.51 Favored Glycine 1 CA--C 1.588 4.611 0 CA-C-O 123.194 1.441 . . . . 0.0 111.717 -175.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -151.39 152.96 33.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 127.03 3.3 . . . . 0.0 116.446 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 110' ' ' PHE . 71.8 m-85 -92.88 147.3 22.96 Favored 'General case' 0 CA--C 1.606 3.11 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.179 164.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -125.68 136.79 53.61 Favored 'General case' 0 C--O 1.267 2.026 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -57.24 163.2 2.29 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.511 -1.368 . . . . 0.0 113.591 160.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.4 77.15 1.34 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.226 1.81 . . . . 0.0 111.209 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -71.25 -38.34 71.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.481 2.712 . . . . 0.0 112.538 -161.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 62.78 56.87 1.84 Allowed 'General case' 0 C--N 1.373 1.601 0 CA-C-O 126.988 3.28 . . . . 0.0 109.022 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 mtm180 -118.14 2.19 12.0 Favored 'General case' 0 CA--C 1.6 2.876 0 CA-C-O 113.493 -3.146 . . . . 0.0 107.681 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 mp 57.85 145.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 1 C-N-CA 132.23 4.212 . . . . 0.0 113.05 165.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 . . . . . 0 C--O 1.28 2.682 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 167.368 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.1 mttm . . . . . 0 CA--C 1.576 1.967 0 CA-C-O 115.623 -2.132 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.1 8.04 3.79 Favored 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 122.408 2.367 . . . . 0.0 116.596 -164.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.3 mt -101.37 167.23 10.3 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 123.415 1.579 . . . . 0.0 107.072 -171.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.9 m -72.9 159.77 84.52 Favored Pre-proline 0 C--N 1.368 1.393 0 CA-C-O 115.127 -2.368 . . . . 0.0 114.669 -171.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -49.18 134.86 30.78 Favored 'Trans proline' 0 CA--C 1.556 1.609 1 C-N-CA 130.636 7.557 . . . . 0.0 108.187 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -78.87 158.48 28.09 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.667 156.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -134.85 127.41 30.71 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 117.991 -2.943 . . . . 0.0 112.991 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.04 140.43 49.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.006 1.322 . . . . 0.0 113.652 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.451 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 65.1 t80 -92.45 151.57 20.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.698 3.592 . . . . 0.0 120.698 169.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.402 ' N ' ' CG ' ' A' ' 110' ' ' PHE . 24.6 m-85 -156.16 150.99 26.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.752 2.215 . . . . 0.0 108.455 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -71.08 150.03 45.91 Favored 'General case' 0 N--CA 1.524 3.266 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.796 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.4 tp -43.2 128.38 4.6 Favored 'General case' 0 C--O 1.257 1.49 0 CA-C-N 122.907 2.594 . . . . 0.0 117.161 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.42 18.54 75.4 Favored Glycine 0 CA--C 1.491 -1.462 0 CA-C-O 117.727 -1.596 . . . . 0.0 115.838 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 p -124.25 -164.14 1.22 Allowed 'General case' 0 C--O 1.282 2.773 0 CA-C-N 120.29 2.045 . . . . 0.0 112.428 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 -157.22 53.52 Favored Glycine 0 CA--C 1.547 2.088 0 CA-C-O 116.341 -2.366 . . . . 0.0 114.795 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.4 ' HD3' ' CE2' ' A' ' 111' ' ' TYR . 86.4 Cg_exo -65.47 -22.52 59.04 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 N-CA-C 117.771 2.181 . . . . 0.0 117.771 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -115.31 33.51 5.4 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.918 0.887 . . . . 0.0 110.419 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.59 -12.22 56.92 Favored 'General case' 1 C--O 1.307 4.083 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.895 -166.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.11 -35.8 37.34 Favored Glycine 0 C--N 1.347 1.144 1 CA-C-O 109.029 -6.428 . . . . 0.0 107.375 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.79 135.93 94.63 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-N 123.553 3.676 . . . . 0.0 115.176 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.17 162.77 41.44 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 N-CA-C 119.927 3.011 . . . . 0.0 119.927 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -62.42 134.9 57.09 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 117.657 -3.152 . . . . 0.0 115.106 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.32 71.51 Favored Glycine 0 N--CA 1.499 2.891 0 CA-C-O 115.995 -2.558 . . . . 0.0 110.416 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.69 140.42 41.59 Favored 'General case' 0 C--N 1.389 2.3 0 O-C-N 126.747 2.087 . . . . 0.0 114.283 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -104.98 41.72 1.31 Allowed 'General case' 0 C--O 1.268 2.034 0 CA-C-N 123.397 2.817 . . . . 0.0 111.193 -147.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -74.51 116.42 15.17 Favored 'General case' 0 N--CA 1.521 3.108 0 O-C-N 126.856 2.598 . . . . 0.0 112.166 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.66 152.38 3.76 Favored 'General case' 0 C--O 1.285 2.923 0 CA-C-O 125.414 2.53 . . . . 0.0 114.181 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.33 -10.7 58.1 Favored Glycine 0 CA--C 1.575 3.812 0 CA-C-N 111.953 -2.385 . . . . 0.0 115.952 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -101.62 143.33 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.806 2.442 . . . . 0.0 110.269 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.5 mm -126.18 111.03 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 127.134 2.174 . . . . 0.0 110.322 162.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -65.61 152.2 44.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.97 138.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 O-C-N 118.12 -2.862 . . . . 0.0 113.6 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.63 179.98 7.73 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 118.661 -2.524 . . . . 0.0 113.395 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.4 p -152.59 151.09 30.24 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.422 1.489 . . . . 0.0 108.903 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.79 -27.7 65.27 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 114.566 -2.635 . . . . 0.0 113.023 -170.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.88 -16.73 50.56 Favored Glycine 0 C--O 1.189 -2.664 1 O-C-N 130.369 4.793 . . . . 0.0 117.24 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.39 150.09 28.56 Favored 'General case' 0 C--N 1.409 3.158 0 CA-C-N 121.277 2.538 . . . . 0.0 108.263 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.86 146.48 23.61 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.66 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -76.07 7.89 3.71 Favored 'General case' 1 CA--C 1.648 4.742 0 O-C-N 117.766 -3.084 . . . . 0.0 113.974 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 p -70.57 145.54 92.77 Favored Pre-proline 0 N--CA 1.48 1.066 0 O-C-N 118.137 -2.852 . . . . 0.0 110.597 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.59 137.52 33.1 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 125.041 3.828 . . . . 0.0 112.995 160.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -101.52 67.0 1.11 Allowed 'General case' 0 C--O 1.263 1.784 0 C-N-CA 128.578 2.751 . . . . 0.0 108.987 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -73.22 -12.12 60.75 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.978 -161.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -82.45 -47.85 11.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 113.608 -3.091 . . . . 0.0 114.526 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.47 -32.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 O-C-N 126.641 2.463 . . . . 0.0 113.409 156.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.74 -15.53 62.27 Favored Glycine 0 CA--C 1.553 2.448 0 C-N-CA 126.468 1.985 . . . . 0.0 115.459 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 81.2 p -145.12 -30.08 0.44 Allowed 'General case' 1 CA--C 1.635 4.213 0 C-N-CA 130.105 3.362 . . . . 0.0 117.836 -160.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.97 149.6 46.94 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.042 1.737 . . . . 0.0 110.334 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -74.62 111.03 11.28 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.067 -170.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.31 -35.73 39.02 Favored 'Trans proline' 0 N--CA 1.51 2.494 0 CA-C-O 122.81 1.087 . . . . 0.0 109.488 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.26 2.52 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 117.114 -3.491 . . . . 0.0 114.498 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . 0.265 27.9 t-20 -69.51 -22.5 63.58 Favored 'General case' 0 CA--C 1.588 2.43 0 CA-C-N 120.264 1.393 . . . . 0.0 113.786 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -138.26 177.81 7.6 Favored 'General case' 0 C--O 1.177 -2.725 0 C-N-CA 127.669 2.388 . . . . 0.0 109.005 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.07 156.16 38.0 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 114.912 -2.471 . . . . 0.0 114.986 162.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.85 146.32 37.79 Favored 'General case' 0 C--O 1.175 -2.867 0 CA-C-N 121.837 2.108 . . . . 0.0 113.098 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.8 mt -61.11 143.69 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.612 1.096 . . . . 0.0 111.265 160.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.6 p -74.46 126.13 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.9 tp -58.46 118.91 6.1 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -138.27 141.49 39.87 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.7 154.79 50.66 Favored Pre-proline 0 C--O 1.198 -1.609 0 CA-C-N 122.889 2.586 . . . . 0.0 113.296 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -56.71 177.06 0.18 Allowed 'Trans proline' 0 CA--C 1.558 1.687 1 C-N-CA 130.404 7.403 . . . . 0.0 117.479 166.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 48.37 32.12 3.08 Favored 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 131.787 4.035 . . . . 0.0 114.502 172.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.48 11.9 54.41 Favored Glycine 0 CA--C 1.556 2.597 0 O-C-N 117.661 -3.149 . . . . 0.0 118.005 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . 0.253 5.9 m -63.13 119.81 10.26 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -161.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 46.9 m -63.69 131.22 47.26 Favored 'General case' 0 C--N 1.381 1.948 0 O-C-N 124.521 1.138 . . . . 0.0 108.436 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 44.2 mt -66.81 156.89 85.84 Favored Pre-proline 0 C--O 1.268 2.031 0 C-N-CA 127.162 2.185 . . . . 0.0 106.206 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -57.96 131.34 43.04 Favored 'Trans proline' 0 CA--C 1.571 2.333 0 C-N-CA 123.495 2.797 . . . . 0.0 113.905 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -60.77 -39.29 88.23 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.038 1.735 . . . . 0.0 109.992 -161.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.91 41.43 3.04 Favored Glycine 0 C--N 1.38 2.982 0 O-C-N 117.777 -3.077 . . . . 0.0 112.124 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.68 144.6 37.67 Favored 'General case' 0 C--O 1.204 -1.311 0 O-C-N 119.325 -2.279 . . . . 0.0 113.528 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -72.05 145.38 48.3 Favored 'General case' 0 C--O 1.284 2.884 0 CA-C-O 116.208 -1.853 . . . . 0.0 111.206 157.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -160.92 170.75 19.99 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 126.708 2.003 . . . . 0.0 110.297 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 . . . . . 0 CA--C 1.571 1.77 0 O-C-N 119.364 -2.085 . . . . 0.0 113.196 171.139 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 105.1 -3.2 . . . . 0.0 105.1 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.61 161.7 10.51 Favored Pre-proline 0 CA--C 1.613 3.369 0 CA-C-N 119.103 1.451 . . . . 0.0 112.801 162.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -78.13 166.53 24.59 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 O-C-N 124.275 1.671 . . . . 0.0 111.14 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -71.05 113.61 8.26 Favored 'General case' 0 C--O 1.275 2.408 0 CA-C-O 124.423 2.059 . . . . 0.0 112.772 -174.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -70.98 -9.14 57.43 Favored 'General case' 0 CA--C 1.614 3.413 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -167.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.1 m 58.49 -31.62 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 1 C-N-CA 132.1 4.16 . . . . 0.0 115.192 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.54 157.69 21.18 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.167 2.987 . . . . 0.0 113.11 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.0 t -79.53 136.89 37.0 Favored 'General case' 0 N--CA 1.422 -1.875 0 O-C-N 120.225 -1.547 . . . . 0.0 110.584 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.88 -29.35 70.69 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 115.849 -2.024 . . . . 0.0 113.952 169.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -100.38 162.68 12.79 Favored 'General case' 0 C--N 1.377 1.788 0 O-C-N 127.552 3.033 . . . . 0.0 113.611 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.307 35.2 p -59.45 140.35 56.27 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 125.183 2.421 . . . . 0.0 113.162 166.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.05 143.91 32.58 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 111.151 -2.749 . . . . 0.0 109.623 -171.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.31 152.38 21.06 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.578 -1.326 . . . . 0.0 108.004 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -116.64 134.15 55.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 118.29 -2.756 . . . . 0.0 110.637 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -68.76 139.89 55.32 Favored 'General case' 0 CA--C 1.607 3.139 0 C-N-CA 126.58 1.952 . . . . 0.0 115.856 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -115.72 -48.04 2.78 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.23 -135.62 5.61 Favored Glycine 0 N--CA 1.508 3.458 0 C-N-CA 127.063 2.268 . . . . 0.0 110.959 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -147.39 -29.04 0.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.277 2.038 . . . . 0.0 114.143 -164.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.79 129.47 37.74 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 127.819 2.448 . . . . 0.0 114.773 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.527 ' HB2' ' HE3' ' A' ' 65' ' ' LYS . 82.0 m-20 -56.91 155.57 7.83 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 128.384 2.674 . . . . 0.0 108.067 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.16 57.32 0.84 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.504 -2.623 . . . . 0.0 110.029 -170.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.527 ' HE3' ' HB2' ' A' ' 63' ' ' ASP . 82.8 mttt -87.61 101.81 14.0 Favored 'General case' 0 CA--C 1.576 1.957 1 O-C-N 115.776 -4.327 . . . . 0.0 106.86 -164.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -68.25 149.61 98.03 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -55.78 154.59 25.62 Favored 'Trans proline' 1 C--N 1.417 4.139 0 O-C-N 118.291 -1.479 . . . . 0.0 108.568 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 54.63 -5.95 0.02 OUTLIER 'General case' 0 N--CA 1.539 3.977 1 N-CA-C 122.123 4.12 . . . . 0.0 122.123 152.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.78 7.37 71.32 Favored Glycine 0 CA--C 1.564 3.154 1 O-C-N 115.285 -4.634 . . . . 0.0 113.861 -168.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -86.72 104.6 16.27 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 117.803 -1.094 . . . . 0.0 109.0 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.25 21.54 0.04 OUTLIER Glycine 0 C--N 1.356 1.694 0 CA-C-N 122.326 2.33 . . . . 0.0 113.212 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.254 97.9 t -73.29 117.6 61.67 Favored Pre-proline 0 C--O 1.268 2.031 0 O-C-N 119.535 -2.156 . . . . 0.0 116.087 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -68.64 170.18 15.77 Favored 'Trans proline' 0 CA--C 1.552 1.387 1 C-N-CA 129.287 6.658 . . . . 0.0 109.534 -169.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.8 mt -105.13 141.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 O-C-N 117.772 -3.08 . . . . 0.0 112.381 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 127.481 2.312 . . . . 0.0 111.778 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.4 m -57.49 -43.99 84.57 Favored 'General case' 0 C--O 1.192 -1.929 0 O-C-N 124.054 0.846 . . . . 0.0 112.124 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -77.14 39.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 128.0 2.52 . . . . 0.0 111.907 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.2 p -146.57 144.62 29.69 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 125.551 1.54 . . . . 0.0 111.88 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -83.16 168.01 25.45 Favored Pre-proline 0 C--O 1.271 2.215 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -62.89 -33.76 74.11 Favored 'Trans proline' 0 C--O 1.203 -1.241 0 CA-C-O 117.554 -1.102 . . . . 0.0 114.511 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -58.02 -29.12 65.07 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 128.698 2.799 . . . . 0.0 111.21 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.318 33.9 m-20 -74.16 -11.67 60.36 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 129.036 2.935 . . . . 0.0 114.104 -172.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -88.39 66.37 8.3 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 117.149 -1.405 . . . . 0.0 111.229 -157.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.8 tt -154.62 144.23 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.671 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 178.89 -167.49 37.8 Favored Glycine 1 CA--C 1.58 4.137 0 C-N-CA 116.873 -2.584 . . . . 0.0 114.925 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -153.57 147.18 25.1 Favored 'General case' 0 C--O 1.202 -1.432 0 O-C-N 118.247 -2.913 . . . . 0.0 112.985 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -92.91 139.48 30.49 Favored 'General case' 0 C--O 1.246 0.896 0 O-C-N 128.736 3.773 . . . . 0.0 117.34 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -140.69 164.0 31.37 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 121.813 2.097 . . . . 0.0 110.865 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -83.92 154.68 23.25 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 117.78 2.511 . . . . 0.0 117.78 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.23 88.69 2.11 Favored 'General case' 0 C--O 1.182 -2.453 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.635 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.7 p -67.6 -27.8 67.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 116.07 -1.919 . . . . 0.0 111.729 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 52.88 56.05 8.13 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-N 120.189 1.359 . . . . 0.0 109.252 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -122.91 -12.0 8.06 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 130.395 3.478 . . . . 0.0 114.476 -160.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 mp 61.27 124.88 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.549 4.495 1 C-N-CA 131.82 4.048 . . . . 0.0 108.521 166.684 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -86.08 -25.16 26.0 Favored 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 127.145 2.178 . . . . 0.0 107.368 169.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.6 127.56 1.45 Allowed Glycine 0 CA--C 1.553 2.417 0 C-N-CA 127.095 2.283 . . . . 0.0 109.344 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.15 139.24 1.38 Allowed Glycine 0 C--O 1.274 2.613 0 O-C-N 119.47 -2.194 . . . . 0.0 116.23 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.292 32.7 m-20 72.33 54.92 0.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 125.482 1.513 . . . . 0.0 111.331 162.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.43 155.55 10.03 Favored Glycine 0 CA--C 1.546 2.026 0 CA-C-O 115.905 -2.609 . . . . 0.0 113.46 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 100' ' ' LYS . 30.4 mmtm -116.65 114.76 24.53 Favored 'General case' 0 C--O 1.273 2.318 0 CA-C-N 123.152 3.476 . . . . 0.0 103.921 -171.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 84.8 mmm -47.86 137.02 10.31 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 125.79 2.709 . . . . 0.0 108.844 153.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -140.04 -4.63 1.34 Allowed 'General case' 0 CA--C 1.6 2.872 1 C-N-CA 133.607 4.763 . . . . 0.0 115.772 -176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 55.99 -0.34 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 131.667 3.987 . . . . 0.0 116.141 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -67.56 169.34 9.43 Favored 'General case' 0 N--CA 1.53 3.555 0 CA-C-N 123.844 3.02 . . . . 0.0 109.667 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.9 m -56.83 163.06 3.05 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 127.27 3.414 . . . . 0.0 111.61 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -71.57 168.05 24.7 Favored 'Trans proline' 0 N--CA 1.427 -2.402 0 CA-C-O 124.844 1.935 . . . . 0.0 115.228 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -113.74 164.54 13.58 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 116.767 -3.708 . . . . 0.0 107.167 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -134.25 122.56 22.91 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 129.775 3.23 . . . . 0.0 112.051 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -107.84 147.61 30.68 Favored 'General case' 0 CA--C 1.597 2.769 0 CA-C-N 113.438 -1.71 . . . . 0.0 112.508 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -101.82 148.88 24.77 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.834 2.454 . . . . 0.0 110.16 166.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -134.05 145.2 49.2 Favored 'General case' 0 C--O 1.255 1.394 0 C-N-CA 125.267 1.427 . . . . 0.0 111.884 168.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -57.73 157.05 7.75 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 160.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 114' ' ' GLY . 33.9 tp -66.25 138.03 57.38 Favored 'General case' 0 C--N 1.384 2.095 0 O-C-N 123.982 0.801 . . . . 0.0 111.068 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.456 ' H ' HD12 ' A' ' 113' ' ' LEU . . . 59.95 32.43 75.27 Favored Glycine 0 CA--C 1.564 3.129 0 CA-C-O 118.08 -1.4 . . . . 0.0 115.069 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -141.88 172.04 13.23 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 128.228 2.611 . . . . 0.0 112.206 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -163.98 45.93 Favored Glycine 1 C--O 1.298 4.126 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.879 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.57 -29.26 25.08 Favored 'Trans proline' 0 CA--C 1.578 2.708 1 C-N-CA 125.579 4.186 . . . . 0.0 111.378 -170.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -94.45 24.63 4.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.921 -2.362 . . . . 0.0 111.521 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 -29.59 41.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.062 1.745 . . . . 0.0 114.404 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.38 -10.38 84.66 Favored Glycine 0 C--N 1.388 3.42 0 CA-C-O 124.505 2.169 . . . . 0.0 117.668 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.9 mt -70.29 136.17 86.64 Favored Pre-proline 0 N--CA 1.522 3.155 1 O-C-N 115.776 -4.367 . . . . 0.0 110.179 168.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.18 174.26 13.11 Favored 'Trans proline' 0 C--N 1.376 1.986 0 O-C-N 123.689 1.363 . . . . 0.0 112.711 160.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.02 133.44 56.1 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 120.289 -1.507 . . . . 0.0 111.698 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.75 5.65 89.34 Favored Glycine 1 CA--C 1.621 6.663 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 168.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.98 151.37 4.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.596 1.665 . . . . 0.0 111.994 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -94.95 68.02 3.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -125.05 137.39 54.21 Favored 'General case' 0 C--O 1.258 1.542 0 C-N-CA 126.646 1.978 . . . . 0.0 113.745 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.259 3.2 t0 -57.39 124.05 17.57 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 112.194 -2.275 . . . . 0.0 112.296 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.84 -4.63 79.01 Favored Glycine 0 C--N 1.373 2.589 0 O-C-N 125.204 1.565 . . . . 0.0 114.115 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 mp -86.68 128.82 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.609 3.242 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 163.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.0 mm -109.75 109.62 29.09 Favored 'Isoleucine or valine' 0 C--O 1.254 1.332 1 O-C-N 129.179 4.049 . . . . 0.0 110.574 170.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.21 138.5 35.81 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.205 -0.935 . . . . 0.0 112.901 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.01 146.25 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 126.121 1.769 . . . . 0.0 114.029 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.85 153.57 35.62 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 130.153 3.381 . . . . 0.0 110.843 -175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.2 p -102.43 156.56 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 129.38 3.072 . . . . 0.0 105.096 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -52.7 -31.13 36.0 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.59 -27.31 10.68 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 127.892 2.663 . . . . 0.0 113.171 -163.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.53 157.98 8.28 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.302 1.441 . . . . 0.0 111.486 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.09 131.15 54.43 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 124.589 2.137 . . . . 0.0 110.939 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -64.53 24.42 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.369 0 O-C-N 117.971 -2.956 . . . . 0.0 118.272 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.3 p -87.36 150.76 49.82 Favored Pre-proline 0 C--N 1.362 1.119 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.31 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.4 148.77 49.28 Favored 'Trans proline' 0 CA--C 1.505 -0.949 0 CA-C-O 116.686 -1.464 . . . . 0.0 115.041 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -97.51 90.09 4.92 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 126.166 2.888 . . . . 0.0 109.868 -172.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -52.39 -59.54 4.3 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -64.44 -66.91 0.48 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.064 2.146 . . . . 0.0 106.758 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.0 mt -45.53 -27.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 119.223 -2.173 . . . . 0.0 116.394 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -92.9 -11.23 59.17 Favored Glycine 1 CA--C 1.579 4.035 0 O-C-N 117.785 -3.072 . . . . 0.0 115.834 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.3 p -125.56 -12.65 6.65 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 114.975 -2.441 . . . . 0.0 112.676 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -74.63 178.34 5.45 Favored 'General case' 0 CA--C 1.582 2.2 0 CA-C-O 113.115 -3.326 . . . . 0.0 115.733 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -109.6 97.47 27.82 Favored Pre-proline 0 N--CA 1.414 -2.262 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . 0.337 4.2 Cg_exo -57.86 -28.45 82.53 Favored 'Trans proline' 0 CA--C 1.581 2.827 0 C-N-CA 123.183 2.589 . . . . 0.0 113.882 171.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.7 -12.75 25.7 Favored 'General case' 0 CA--C 1.556 1.184 0 O-C-N 124.448 1.093 . . . . 0.0 113.195 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -61.81 -19.81 62.95 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -148.31 -176.55 5.34 Favored 'General case' 0 C--O 1.175 -2.831 0 CA-C-N 121.271 1.85 . . . . 0.0 110.345 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.24 156.24 0.6 Allowed 'General case' 0 C--N 1.386 2.153 0 CA-C-N 113.531 -1.668 . . . . 0.0 114.825 154.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.08 159.98 24.61 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.1 mt -81.46 130.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.722 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 p -63.35 121.2 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 124.497 2.094 . . . . 0.0 108.483 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 118.86 12.23 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 114.693 -5.005 . . . . 0.0 111.514 171.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -151.29 133.08 14.97 Favored 'General case' 0 C--O 1.251 1.136 0 O-C-N 126.87 2.606 . . . . 0.0 109.695 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.5 mt -75.21 165.63 52.2 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.52 145.97 92.68 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 119.509 0.86 . . . . 0.0 112.915 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 58.6 9.92 1.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.939 2.895 . . . . 0.0 113.098 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.29 30.17 73.45 Favored Glycine 0 CA--C 1.548 2.128 0 O-C-N 118.217 -2.802 . . . . 0.0 116.144 -168.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.7 m -55.0 125.65 21.31 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-N 112.737 -1.731 . . . . 0.0 111.889 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 87.0 m -69.51 125.82 27.86 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -164.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 mt -71.91 157.55 89.34 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 125.632 1.832 . . . . 0.0 106.168 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -44.02 124.84 5.04 Favored 'Trans proline' 0 N--CA 1.52 3.039 1 C-N-CA 129.195 6.597 . . . . 0.0 116.734 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -57.99 -25.41 61.03 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 128.579 2.751 . . . . 0.0 107.708 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.94 -15.25 9.38 Favored Glycine 1 CA--C 1.596 5.147 0 CA-C-N 120.781 1.628 . . . . 0.0 114.917 174.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -137.34 153.89 50.16 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 126.593 1.957 . . . . 0.0 113.188 -154.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -98.6 124.72 43.54 Favored 'General case' 0 C--O 1.199 -1.589 0 O-C-N 118.843 -2.411 . . . . 0.0 109.101 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -117.24 164.63 14.52 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 127.49 2.316 . . . . 0.0 113.988 168.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -62.63 -25.01 67.9 Favored 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 127.471 2.309 . . . . 0.0 116.108 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -90.22 179.87 43.86 Favored Glycine 0 CA--C 1.55 2.228 0 O-C-N 127.23 2.831 . . . . 0.0 114.326 170.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 51.0 m 53.67 53.16 11.87 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -96.15 159.13 15.12 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 126.565 1.946 . . . . 0.0 112.082 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.76 178.78 37.99 Favored Glycine 0 C--N 1.39 3.565 0 C-N-CA 126.134 1.826 . . . . 0.0 114.135 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -152.23 178.64 29.34 Favored Glycine 0 N--CA 1.475 1.271 0 O-C-N 117.148 -3.56 . . . . 0.0 111.63 -160.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . 0.255 16.2 m . . . . . 0 C--O 1.251 1.149 0 CA-C-O 125.273 2.463 . . . . 0.0 111.155 -10.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.352 -5.072 4 O4'-C1'-N19 114.42 6.22 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.651 5.762 2 C1'-O4'-C4' 105.051 -5.054 . 0.174 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C3'--C2' 1.605 7.311 0 C4'-C3'-C2' 99.313 -3.387 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 4 P--O3' 1.509 -8.184 2 O5'-C5'-C4' 121.59 8.136 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.45 -6.779 1 O4'-C1'-N19 112.254 4.054 . 0.498 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 3 O4'--C4' 1.352 -8.427 3 O4'-C1'-N19 114.791 6.591 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O3' 1.542 -5.437 4 O5'-C5'-C4' 116.88 4.772 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.415 " H2'" ' C5 ' ' B' ' 9' ' ' ' C' . . . . . . . . 2 C4'--C3' 1.454 -6.329 1 O5'-C5'-C4' 119.594 6.71 . 0.052 1a . 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ' C' . . . . . 0.415 ' C5 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 C3'--C2' 1.559 3.105 3 C3'-C2'-C1' 107.392 6.546 OUTLIER-DELTA 0.018 1a . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.658 6.499 2 P-O3'-C3' 129.596 8.247 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 3.524 0 CA-C-O 125.876 2.931 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 mt -87.74 142.86 32.89 Favored Pre-proline 0 C--N 1.369 1.455 0 O-C-N 117.897 -3.119 . . . . 0.0 112.9 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -56.02 154.1 29.13 Favored 'Trans proline' 0 C--O 1.252 1.176 1 C-N-CA 126.514 4.809 . . . . 0.0 118.687 169.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -71.04 111.93 6.79 Favored 'General case' 0 N--CA 1.403 -2.778 0 O-C-N 119.878 -1.764 . . . . 0.0 112.395 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 50' ' ' ALA 0.456 27.3 p30 -46.2 -32.8 3.22 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 119.72 -1.862 . . . . 0.0 115.742 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.3 m 64.96 -36.69 0.21 Allowed 'General case' 0 CA--C 1.609 3.219 0 C-N-CA 128.481 2.712 . . . . 0.0 106.974 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 48' ' ' ASN . . . -76.62 152.66 35.8 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 120.639 1.563 . . . . 0.0 113.766 -173.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -95.96 145.68 25.22 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 117.432 2.382 . . . . 0.0 117.432 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -83.03 -13.38 55.98 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -108.39 158.12 17.8 Favored 'General case' 0 N--CA 1.415 -2.18 0 O-C-N 127.965 3.291 . . . . 0.0 116.631 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.0 p -63.27 125.91 25.66 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.88 155.19 35.01 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 127.463 2.305 . . . . 0.0 111.783 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.97 164.09 12.5 Favored 'General case' 0 CA--C 1.593 2.63 0 C-N-CA 128.712 2.805 . . . . 0.0 109.043 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 67.4 m -132.51 130.65 40.7 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 118.878 -2.389 . . . . 0.0 110.616 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -67.49 137.4 55.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.269 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -125.58 -33.11 2.81 Favored 'General case' 0 CA--C 1.593 2.596 0 CA-C-N 120.874 1.67 . . . . 0.0 111.266 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.09 -134.66 0.65 Allowed Glycine 0 N--CA 1.514 3.842 0 N-CA-C 120.945 3.138 . . . . 0.0 120.945 170.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -133.82 -23.63 1.78 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 125.964 1.705 . . . . 0.0 113.444 167.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.92 146.96 25.97 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -72.21 159.47 34.04 Favored 'General case' 0 N--CA 1.409 -2.494 0 O-C-N 118.71 -2.494 . . . . 0.0 111.015 -168.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.1 tp -74.3 68.64 1.52 Allowed 'General case' 0 N--CA 1.534 3.73 0 CA-C-O 123.598 1.666 . . . . 0.0 111.543 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -91.87 158.99 16.0 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 125.114 2.387 . . . . 0.0 106.894 -168.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 61.8 m-85 -148.07 126.95 6.19 Favored Pre-proline 0 C--O 1.257 1.456 0 O-C-N 119.45 -2.031 . . . . 0.0 107.874 -167.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -57.96 106.95 0.28 Allowed 'Trans proline' 0 C--O 1.192 -1.779 1 C-N-CA 125.481 4.121 . . . . 0.0 113.117 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 38.77 36.34 0.14 Allowed 'General case' 0 C--N 1.387 2.235 0 C-N-CA 129.539 3.135 . . . . 0.0 115.244 -166.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.5 75.13 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 171.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.18 101.75 3.42 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.411 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.42 -1.26 0.04 OUTLIER Glycine 0 C--O 1.284 3.27 0 N-CA-C 122.952 3.941 . . . . 0.0 122.952 -167.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.76 144.26 68.55 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 121.797 -0.825 . . . . 0.0 113.138 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -82.95 163.67 15.68 Favored 'Trans proline' 0 CA--C 1.55 1.286 0 O-C-N 115.549 -2.921 . . . . 0.0 115.953 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.6 tt -78.55 144.35 11.29 Favored 'Isoleucine or valine' 0 C--O 1.277 2.534 0 CA-C-O 127.69 3.614 . . . . 0.0 112.026 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -150.06 144.46 25.77 Favored 'General case' 0 C--O 1.26 1.652 0 O-C-N 116.971 -3.58 . . . . 0.0 113.35 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.0 m -82.61 -36.29 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . 0.342 17.4 m120 -84.0 20.48 1.53 Allowed 'General case' 0 C--O 1.189 -2.084 0 C-N-CA 131.615 3.966 . . . . 0.0 116.124 -162.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 p -161.34 166.96 26.69 Favored 'General case' 0 C--N 1.388 2.248 0 C-N-CA 126.056 1.742 . . . . 0.0 112.538 171.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.0 p -94.44 169.6 9.47 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.131 0.972 . . . . 0.0 112.419 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 83' ' ' GLN . 49.5 Cg_exo -65.3 -23.69 58.87 Favored 'Trans proline' 0 CA--C 1.452 -3.589 0 O-C-N 116.908 -2.206 . . . . 0.0 116.908 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -68.01 -24.87 65.17 Favored 'General case' 0 C--O 1.274 2.348 0 C-N-CA 127.636 2.375 . . . . 0.0 107.751 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -78.64 -18.48 54.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 121.725 2.057 . . . . 0.0 115.205 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 80' ' ' PRO . 63.0 mm-40 -84.3 74.04 10.38 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 125.228 2.442 . . . . 0.0 112.104 -162.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -156.04 141.66 10.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.753 1 C-N-CA 133.29 4.636 . . . . 0.0 112.859 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.02 -173.41 40.79 Favored Glycine 1 CA--C 1.581 4.186 0 CA-C-O 124.394 2.108 . . . . 0.0 116.321 -168.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -136.44 156.13 49.04 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 109.36 -3.42 . . . . 0.0 111.736 168.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.408 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 36.1 m-85 -99.86 143.32 30.22 Favored 'General case' 0 N--CA 1.391 -3.399 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 162.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -123.04 143.34 50.01 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 126.097 1.759 . . . . 0.0 112.299 165.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.97 166.06 1.63 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 165.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 133.406 4.682 . . . . 0.0 112.875 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.1 p -137.26 -13.72 1.56 Allowed 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 59.48 41.16 19.72 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 124.342 2.02 . . . . 0.0 112.203 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -120.37 3.55 10.79 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 118.138 -2.851 . . . . 0.0 116.589 -161.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.8 mm 65.56 92.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.16 -3.63 0 C-N-CA 130.806 3.643 . . . . 0.0 116.579 149.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -74.44 135.17 42.32 Favored 'General case' 0 N--CA 1.418 -2.071 0 O-C-N 124.144 0.902 . . . . 0.0 109.981 161.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.12 -142.4 16.0 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 125.475 1.735 . . . . 0.0 110.58 -170.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -135.17 174.41 21.19 Favored Glycine 0 C--N 1.291 -1.923 0 CA-C-O 126.2 3.111 . . . . 0.0 110.01 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 56.63 48.98 15.4 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 129.736 3.214 . . . . 0.0 116.1 171.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -136.76 136.46 8.36 Favored Glycine 0 CA--C 1.564 3.128 0 CA-C-O 118.635 -1.091 . . . . 0.0 112.159 166.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -67.86 128.61 37.12 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 126.177 1.791 . . . . 0.0 111.354 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -87.47 163.04 16.92 Favored 'General case' 0 N--CA 1.527 3.403 0 CA-C-N 121.157 1.799 . . . . 0.0 108.127 167.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -111.78 -18.79 12.64 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 127.818 3.198 . . . . 0.0 110.86 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.27 27.24 15.42 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.235 1.834 . . . . 0.0 112.134 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.59 167.67 17.1 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 122.747 1.26 . . . . 0.0 107.872 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -65.67 146.22 98.99 Favored Pre-proline 0 C--N 1.405 2.983 0 CA-C-N 112.215 -2.266 . . . . 0.0 116.761 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.02 155.41 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 1 C-N-CA 127.993 5.795 . . . . 0.0 111.872 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -114.83 172.34 7.1 Favored 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -140.82 147.1 38.49 Favored 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 126.936 2.094 . . . . 0.0 113.237 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 55.6 m-85 -132.14 145.71 51.55 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 130.409 3.484 . . . . 0.0 116.717 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -98.83 141.25 31.85 Favored 'General case' 0 C--O 1.262 1.734 0 O-C-N 118.198 -2.814 . . . . 0.0 109.544 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -142.41 122.82 13.99 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 127.669 2.388 . . . . 0.0 110.09 172.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -45.82 151.54 0.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 111.082 171.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.305 69.1 tp -52.84 132.63 37.14 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 125.886 2.755 . . . . 0.0 112.456 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.34 42.18 98.74 Favored Glycine 0 C--O 1.263 1.94 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.898 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -149.55 173.01 14.09 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 114.14 -1.03 . . . . 0.0 112.03 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 54.71 -159.51 5.59 Favored Glycine 0 C--O 1.255 1.421 0 O-C-N 119.727 -1.858 . . . . 0.0 115.186 -163.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.1 -19.34 63.18 Favored 'Trans proline' 0 N--CA 1.5 1.9 1 C-N-CA 125.638 4.225 . . . . 0.0 117.794 -166.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -117.45 35.32 4.72 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 124.645 1.178 . . . . 0.0 111.547 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.59 -5.65 1.32 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 119.967 -1.708 . . . . 0.0 114.159 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.31 -36.66 44.23 Favored Glycine 0 N--CA 1.417 -2.622 0 CA-C-O 114.729 -3.262 . . . . 0.0 113.928 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.6 mt -69.22 125.65 92.13 Favored Pre-proline 0 C--O 1.262 1.737 0 CA-C-N 121.228 2.514 . . . . 0.0 116.768 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.57 171.93 2.34 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 121.868 1.712 . . . . 0.0 114.485 160.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -68.22 138.37 55.52 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.16 74.8 Favored Glycine 1 CA--C 1.585 4.459 0 C-N-CA 117.225 -2.417 . . . . 0.0 116.811 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.34 82.2 8.38 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 171.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.49 126.72 29.17 Favored 'General case' 0 C--O 1.207 -1.163 0 O-C-N 118.044 -2.91 . . . . 0.0 113.126 -167.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -148.1 159.2 44.17 Favored 'General case' 0 C--O 1.182 -2.495 0 C-N-CA 126.714 2.006 . . . . 0.0 110.558 -170.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.1 133.84 46.56 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.8 -2.31 72.59 Favored Glycine 1 CA--C 1.621 6.658 0 O-C-N 119.636 -1.915 . . . . 0.0 114.377 169.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.8 mt -131.3 142.08 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 1 C-N-CA 131.952 4.101 . . . . 0.0 104.62 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.9 mm -137.73 112.96 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.759 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -76.47 128.58 35.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.288 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 m -133.05 142.92 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 127.465 3.507 . . . . 0.0 114.889 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.18 173.57 12.1 Favored 'General case' 0 CA--C 1.478 -1.81 0 O-C-N 118.159 -2.838 . . . . 0.0 112.571 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 37.2 p -127.61 157.11 41.11 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 129.539 3.136 . . . . 0.0 109.916 173.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -64.67 -35.82 82.27 Favored 'General case' 0 CA--C 1.582 2.18 0 C-N-CA 123.964 0.906 . . . . 0.0 112.694 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.79 -22.19 72.65 Favored Glycine 1 CA--C 1.595 5.076 0 O-C-N 119.592 -1.943 . . . . 0.0 114.361 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.69 165.71 4.89 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-N 120.319 2.06 . . . . 0.0 113.197 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.3 mt -126.88 147.44 50.06 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.655 2.782 . . . . 0.0 112.424 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -75.51 -2.68 30.07 Favored 'General case' 1 CA--C 1.63 4.042 0 C-N-CA 126.926 2.091 . . . . 0.0 114.311 -175.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -71.62 148.48 92.85 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 126.22 1.808 . . . . 0.0 111.26 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.6 142.98 9.52 Favored 'Trans proline' 0 CA--C 1.467 -2.872 0 C-N-CA 123.929 3.086 . . . . 0.0 109.931 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -94.08 65.12 3.39 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 117.574 -3.204 . . . . 0.0 108.155 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.52 -34.35 75.72 Favored 'General case' 0 CA--C 1.61 3.254 0 CA-C-O 113.214 -3.279 . . . . 0.0 115.624 -161.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.268 41.0 m80 -62.05 -44.49 96.57 Favored 'General case' 1 CA--C 1.645 4.629 0 O-C-N 126.019 2.074 . . . . 0.0 110.292 171.698 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.4 mt -64.49 -31.87 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.02 -2.03 88.29 Favored Glycine 0 CA--C 1.496 -1.134 0 CA-C-O 116.392 -2.338 . . . . 0.0 117.185 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.5 p -128.88 -27.19 2.56 Favored 'General case' 0 CA--C 1.596 2.724 0 CA-C-N 122.141 2.97 . . . . 0.0 113.251 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -49.4 154.58 0.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 122.292 2.315 . . . . 0.0 111.18 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -67.02 121.0 76.19 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 129.284 3.034 . . . . 0.0 113.595 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -33.79 84.76 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 N-CA-C 118.293 2.382 . . . . 0.0 118.293 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.13 0.41 36.35 Favored 'General case' 0 C--O 1.254 1.341 0 C-N-CA 127.058 2.143 . . . . 0.0 114.579 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -72.93 -16.73 61.54 Favored 'General case' 0 C--O 1.172 -3.015 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -146.36 146.31 30.61 Favored 'General case' 0 CA--C 1.609 3.226 0 CA-C-N 113.074 -1.876 . . . . 0.0 113.363 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.77 152.89 44.64 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 118.706 -2.496 . . . . 0.0 117.135 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.27 116.02 6.18 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 119.747 -1.846 . . . . 0.0 114.771 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.49 120.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.62 0 C-N-CA 127.922 2.489 . . . . 0.0 108.596 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.3 109.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 166.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.6 116.93 6.69 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -172.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -153.52 142.47 21.19 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 116.432 -3.917 . . . . 0.0 108.406 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.54 140.29 22.1 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 116.511 -1.709 . . . . 0.0 114.633 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -37.72 169.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 123.205 2.604 . . . . 0.0 115.325 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 54.64 19.14 2.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.636 2.374 . . . . 0.0 112.318 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.14 13.65 60.25 Favored Glycine 0 CA--C 1.562 3.021 0 O-C-N 116.682 -3.761 . . . . 0.0 116.458 -169.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -60.82 116.22 4.27 Favored 'General case' 0 C--O 1.165 -3.39 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.995 -167.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 m -70.18 146.92 50.43 Favored 'General case' 1 N--CA 1.539 4.016 0 C-N-CA 125.611 1.564 . . . . 0.0 113.534 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.56 157.03 77.79 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 122.47 1.129 . . . . 0.0 111.773 175.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.95 120.42 7.88 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 125.038 3.825 . . . . 0.0 112.56 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -60.44 -20.32 59.44 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -168.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.13 4.12 Favored Glycine 0 CA--C 1.54 1.609 1 O-C-N 116.071 -4.143 . . . . 0.0 117.51 161.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.61 125.8 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 123.256 3.528 . . . . 0.0 115.528 171.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -66.71 131.04 45.12 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 115.583 -2.151 . . . . 0.0 109.085 167.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.51 141.86 37.31 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 123.459 2.845 . . . . 0.0 112.301 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -55.37 153.85 6.82 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 101.41 174.59 28.58 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 127.841 2.639 . . . . 0.0 108.43 163.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.3 m 55.72 36.0 26.4 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -71.17 -20.78 62.25 Favored 'General case' 0 N--CA 1.491 1.603 1 C-N-CA 131.832 4.053 . . . . 0.0 112.935 -167.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.46 177.76 51.28 Favored Glycine 0 C--N 1.361 1.918 0 O-C-N 116.391 -3.943 . . . . 0.0 112.197 -166.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.44 -154.97 52.07 Favored Glycine 0 CA--C 1.544 1.867 0 O-C-N 118.353 -2.851 . . . . 0.0 114.591 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 125.777 2.703 . . . . 0.0 117.415 -1.012 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.371 -4.3 5 C1'-O4'-C4' 102.656 -7.715 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O4'--C1' 1.474 5.023 4 C1'-O4'-C4' 99.503 -11.218 . 0.235 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.461 -5.729 2 O4'-C1'-N19 114.207 6.007 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.122 5 O4'-C1'-N19 116.586 8.386 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C2'--C1' 1.593 6.462 0 C4'-C3'-C2' 99.78 -2.92 . 0.03 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.614 7.976 2 C3'-C2'-C1' 107.376 6.528 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O3'--C3' 1.369 -3.843 3 C4'-C3'-C2' 93.359 -9.341 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O3' 1.55 -4.778 1 C1'-O4'-C4' 105.116 -4.982 . 0.114 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.461 3.895 3 C3'-C2'-C1' 107.584 6.76 . 0.187 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.547 -5.016 4 O4'-C1'-N19 115.891 7.691 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.072 0 N-CA-C 105.778 -2.929 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.1 mt -87.48 155.0 54.15 Favored Pre-proline 0 CA--C 1.58 2.131 0 CA-C-N 121.894 2.847 . . . . 0.0 114.629 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.69 166.38 29.63 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 CA-C-O 129.255 3.773 . . . . 0.0 106.663 172.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -54.99 141.61 33.27 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 109.953 -3.294 . . . . 0.0 113.548 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -96.47 -35.28 11.19 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 m 61.25 -21.82 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 129.985 3.314 . . . . 0.0 118.261 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.42 151.75 26.45 Favored 'General case' 0 CA--C 1.618 3.56 0 O-C-N 118.247 -2.783 . . . . 0.0 113.818 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -77.78 153.25 33.03 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 118.862 -2.399 . . . . 0.0 112.576 167.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -76.07 -27.34 57.19 Favored 'General case' 0 C--O 1.281 2.717 0 C-N-CA 125.616 1.567 . . . . 0.0 114.06 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.64 164.96 11.78 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 124.582 2.134 . . . . 0.0 111.171 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -67.0 159.62 28.22 Favored 'General case' 0 C--O 1.288 3.088 0 CA-C-N 111.206 -2.724 . . . . 0.0 111.02 167.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.0 147.13 28.14 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 127.284 3.421 . . . . 0.0 114.282 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -76.21 162.17 28.18 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.467 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.7 m -122.03 125.41 46.2 Favored 'General case' 0 C--N 1.38 1.916 0 C-N-CA 124.423 1.089 . . . . 0.0 109.047 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -69.41 129.36 39.54 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 125.95 1.7 . . . . 0.0 109.462 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -123.78 -7.29 7.92 Favored 'General case' 0 C--O 1.203 -1.381 0 C-N-CA 128.522 2.729 . . . . 0.0 110.475 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.8 -139.79 10.58 Favored Glycine 0 CA--C 1.566 3.269 0 O-C-N 119.333 -2.104 . . . . 0.0 109.463 159.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -147.98 -17.69 0.35 Allowed 'General case' 0 C--O 1.189 -2.116 0 C-N-CA 128.957 2.903 . . . . 0.0 109.952 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.06 132.72 49.94 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -60.19 161.57 6.88 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.048 1.739 . . . . 0.0 111.55 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.15 69.75 9.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 119.433 -2.042 . . . . 0.0 110.067 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -67.32 149.47 50.3 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.402 170.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.06 141.33 41.06 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 126.025 1.73 . . . . 0.0 113.146 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.48 129.69 24.55 Favored 'Trans proline' 0 C--N 1.381 2.271 0 N-CA-C 106.438 -2.178 . . . . 0.0 106.438 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 55.59 21.62 4.63 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 126.909 2.084 . . . . 0.0 115.583 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.01 27.81 72.73 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 124.573 1.082 . . . . 0.0 115.608 -170.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.258 20.1 tt0 -84.85 84.74 7.6 Favored 'General case' 1 CA--C 1.638 4.33 0 C-N-CA 128.463 2.705 . . . . 0.0 106.258 -175.241 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.11 0.08 OUTLIER Glycine 0 C--O 1.206 -1.648 2 CA-C-O 128.64 4.466 . . . . 0.0 123.615 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 133' ' ' VAL . 93.1 t -69.96 126.88 92.66 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.975 -3.662 . . . . 0.0 111.004 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.63 160.86 4.86 Favored 'Trans proline' 0 CA--C 1.58 2.782 1 C-N-CA 128.518 6.145 . . . . 0.0 114.582 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.3 tt -85.28 142.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 159.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -157.54 104.82 2.01 Favored 'General case' 0 C--O 1.272 2.266 0 C-N-CA 126.955 2.102 . . . . 0.0 110.898 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.6 m -59.17 -32.71 70.15 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 125.389 1.68 . . . . 0.0 113.434 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -83.43 2.7 35.31 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.8 p -114.63 147.66 39.23 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 129.549 3.139 . . . . 0.0 110.287 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.2 t -72.35 155.65 91.18 Favored Pre-proline 0 CA--C 1.609 3.247 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -36.3 -31.87 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.682 1 C-N-CA 126.769 4.979 . . . . 0.0 114.45 152.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -82.58 -22.2 34.94 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 120.043 1.292 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -83.89 -14.57 50.75 Favored 'General case' 0 C--O 1.213 -0.861 0 O-C-N 119.369 -2.082 . . . . 0.0 114.367 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -68.9 59.11 0.09 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -167.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 tt -156.25 139.59 7.45 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.06 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.72 -160.71 30.96 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.034 -1.425 . . . . 0.0 114.921 -172.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -148.85 145.67 27.6 Favored 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 119.63 1.715 . . . . 0.0 110.169 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 88.7 m-85 -85.4 161.22 19.53 Favored 'General case' 0 C--N 1.396 2.62 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 164.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -125.58 157.73 36.4 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 118.878 -2.389 . . . . 0.0 109.041 161.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.463 HH22 ' CG ' ' A' ' 128' ' ' ASP . 26.9 ptt180 -77.81 159.81 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.664 1.585 . . . . 0.0 107.815 169.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.04 136.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.449 1.9 . . . . 0.0 110.671 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -133.97 -16.22 2.25 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -168.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 55.26 60.03 3.63 Favored 'General case' 0 N--CA 1.538 3.944 0 O-C-N 119.568 -1.958 . . . . 0.0 107.051 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HB3' ' C2 ' ' B' ' 3' ' ' ' U' . 15.7 ttm180 -128.18 -8.61 5.34 Favored 'General case' 0 C--O 1.193 -1.914 0 O-C-N 119.408 -2.057 . . . . 0.0 109.125 -160.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.337 1.1 mp 68.39 136.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 171.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -145.54 -0.47 0.84 Allowed 'General case' 0 C--O 1.272 2.241 0 C-N-CA 127.503 2.321 . . . . 0.0 114.231 167.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -140.22 -149.07 5.26 Favored Glycine 0 C--N 1.39 3.531 0 C-N-CA 125.688 1.613 . . . . 0.0 113.701 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.43 -131.37 1.84 Allowed Glycine 0 N--CA 1.514 3.874 0 O-C-N 118.775 -2.603 . . . . 0.0 113.492 162.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 45.06 24.0 0.11 Allowed 'General case' 0 N--CA 1.502 2.151 1 C-N-CA 133.415 4.686 . . . . 0.0 116.145 168.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.67 166.81 34.88 Favored Glycine 0 N--CA 1.501 3.011 0 O-C-N 125.177 1.548 . . . . 0.0 115.613 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -128.7 134.57 48.52 Favored 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 114.642 -2.599 . . . . 0.0 114.192 -170.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 31.9 mtp -68.5 142.67 55.22 Favored 'General case' 0 N--CA 1.518 2.931 0 CA-C-N 122.381 2.355 . . . . 0.0 111.265 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.533 ' HE2' ' N3 ' ' B' ' 7' ' ' ' A' . 61.4 tttt -120.03 -4.15 10.09 Favored 'General case' 1 C--O 1.309 4.234 0 C-N-CA 129.644 3.178 . . . . 0.0 116.945 176.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.5 0.4 OUTLIER 73.68 -10.67 1.04 Allowed 'General case' 0 C--N 1.363 1.164 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 177.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.7 mt -68.91 153.73 43.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 129.395 3.078 . . . . 0.0 111.698 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.8 m -66.86 167.64 13.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 114.761 -2.542 . . . . 0.0 111.544 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.259 59.3 Cg_exo -65.28 164.72 24.55 Favored 'Trans proline' 0 CA--C 1.584 3.011 0 C-N-CA 124.504 3.469 . . . . 0.0 114.348 -176.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -131.53 168.63 17.33 Favored 'General case' 0 C--N 1.386 2.173 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -128.7 127.63 42.5 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 128.113 3.383 . . . . 0.0 112.283 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 60.6 m-85 -108.04 144.5 35.29 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 128.336 3.523 . . . . 0.0 111.194 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.6 144.1 31.88 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -140.36 151.34 44.91 Favored 'General case' 0 N--CA 1.514 2.765 0 O-C-N 118.635 -2.541 . . . . 0.0 109.83 176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.446 ' CD1' HG21 ' A' ' 146' ' ' ILE . 27.5 m-85 -90.46 161.29 15.6 Favored 'General case' 0 CA--C 1.595 2.708 0 CA-C-O 125.887 2.756 . . . . 0.0 112.586 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.3 tp -57.77 116.12 3.24 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 117.809 -3.057 . . . . 0.0 109.608 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.74 17.9 50.1 Favored Glycine 0 N--CA 1.501 3.0 0 O-C-N 118.584 -2.572 . . . . 0.0 115.259 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -133.55 165.37 25.05 Favored 'General case' 0 CA--C 1.504 -0.827 1 C-N-CA 132.841 4.456 . . . . 0.0 112.815 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.23 -165.69 52.09 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 125.683 1.611 . . . . 0.0 110.176 171.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.65 -28.54 52.41 Favored 'Trans proline' 0 N--CA 1.427 -2.393 1 C-N-CA 127.195 5.264 . . . . 0.0 111.422 -171.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -96.01 17.58 15.16 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 117.976 -2.952 . . . . 0.0 114.607 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.94 -12.21 0.3 Allowed 'General case' 0 C--N 1.39 2.366 0 O-C-N 118.869 -2.395 . . . . 0.0 116.095 -168.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.17 -34.63 57.99 Favored Glycine 0 C--N 1.287 -2.156 0 C-N-CA 128.461 2.934 . . . . 0.0 114.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.64 142.08 83.26 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.982 2.113 . . . . 0.0 115.044 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -77.4 163.91 29.36 Favored 'Trans proline' 0 C--N 1.397 3.111 1 C-N-CA 126.58 4.853 . . . . 0.0 115.118 161.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.42 151.18 41.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 117.374 -1.73 . . . . 0.0 115.124 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.91 8.12 5.49 Favored Glycine 0 CA--C 1.56 2.886 0 N-CA-C 120.903 3.121 . . . . 0.0 120.903 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.72 137.67 49.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 121.062 2.431 . . . . 0.0 113.458 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -78.89 142.79 36.49 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-O 116.307 -1.806 . . . . 0.0 114.227 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.06 142.41 7.35 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 129.672 3.189 . . . . 0.0 111.132 159.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.463 ' CG ' HH22 ' A' ' 89' ' ' ARG . 13.6 t0 -65.34 121.56 15.11 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 126.46 1.904 . . . . 0.0 115.222 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.94 74.72 Favored Glycine 0 CA--C 1.568 3.383 1 C-N-CA 130.957 4.122 . . . . 0.0 122.435 -169.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.1 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 O-C-N 128.199 2.941 . . . . 0.0 108.813 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.9 mm -120.9 119.89 60.77 Favored 'Isoleucine or valine' 0 C--N 1.385 2.112 0 CA-C-O 123.154 1.454 . . . . 0.0 112.491 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -73.63 138.99 45.16 Favored 'General case' 0 C--N 1.372 1.56 0 O-C-N 119.08 -2.262 . . . . 0.0 109.117 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 72' ' ' VAL . 3.0 m -134.95 147.51 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.577 0 C-N-CA 123.635 0.774 . . . . 0.0 111.998 159.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.71 169.78 17.81 Favored 'General case' 0 N--CA 1.395 -3.193 0 C-N-CA 126.848 2.059 . . . . 0.0 113.455 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.255 81.8 p -98.93 170.03 9.02 Favored 'General case' 0 C--O 1.248 0.994 0 O-C-N 120.242 -1.536 . . . . 0.0 113.631 152.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -60.05 -45.78 91.73 Favored 'General case' 0 C--O 1.283 2.863 0 CA-C-O 116.932 -1.508 . . . . 0.0 112.483 160.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.31 -34.45 67.86 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.89 153.78 41.08 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.967 1.365 . . . . 0.0 111.598 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.43 145.21 31.14 Favored 'General case' 0 C--O 1.259 1.581 0 C-N-CA 130.043 3.337 . . . . 0.0 113.792 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -65.49 4.37 0.56 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 p -85.74 142.51 36.99 Favored Pre-proline 0 CA--C 1.479 -1.761 0 C-N-CA 128.832 2.853 . . . . 0.0 109.934 -166.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -59.29 117.21 3.91 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 124.306 3.338 . . . . 0.0 109.845 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -68.17 52.86 0.07 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 126.385 1.874 . . . . 0.0 113.317 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.56 -24.35 67.48 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -171.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -74.14 -35.82 64.12 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.446 HG21 ' CD1' ' A' ' 112' ' ' TYR . 80.4 mt -67.72 -18.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 O-C-N 119.927 -1.733 . . . . 0.0 110.76 164.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.49 -11.7 65.97 Favored Glycine 0 CA--C 1.569 3.435 0 O-C-N 124.44 1.088 . . . . 0.0 115.738 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 24.7 p -130.5 -33.18 1.67 Allowed 'General case' 0 C--N 1.373 1.626 0 O-C-N 124.672 0.866 . . . . 0.0 111.441 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -66.2 142.05 57.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.642 1.564 . . . . 0.0 110.715 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -81.96 114.01 47.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 119.817 -1.802 . . . . 0.0 111.127 -149.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 -4.37 15.24 Favored 'Trans proline' 0 N--CA 1.425 -2.508 0 C-N-CA 124.069 3.179 . . . . 0.0 111.124 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.69 19.12 15.47 Favored 'General case' 0 C--O 1.193 -1.87 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -71.62 -54.95 8.75 Favored 'General case' 0 C--O 1.293 3.379 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.542 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.51 177.92 7.59 Favored 'General case' 0 CA--C 1.598 2.795 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.265 164.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.81 19.88 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 127.32 2.248 . . . . 0.0 107.206 170.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.24 136.55 58.0 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 113.973 -2.917 . . . . 0.0 117.775 169.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.5 mt -58.53 121.4 6.05 Favored 'Isoleucine or valine' 0 C--N 1.381 1.958 0 O-C-N 128.882 3.864 . . . . 0.0 108.242 165.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.19 103.8 2.0 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 O-C-N 120.086 -1.634 . . . . 0.0 110.664 172.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.52 106.74 0.58 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.551 1.941 . . . . 0.0 111.209 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -119.6 160.3 22.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-O 122.995 1.379 . . . . 0.0 109.773 156.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 83.7 mt -74.75 162.3 74.16 Favored Pre-proline 1 N--CA 1.54 4.042 0 C-N-CA 126.313 1.845 . . . . 0.0 110.528 163.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.27 164.39 10.73 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.182 1.921 . . . . 0.0 116.442 161.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 40.76 41.47 1.18 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 125.79 1.636 . . . . 0.0 113.472 -170.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.73 21.02 1.32 Allowed Glycine 0 CA--C 1.562 3.015 0 O-C-N 125.86 1.975 . . . . 0.0 117.076 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 84.9 m -58.17 131.72 51.4 Favored 'General case' 0 C--N 1.394 2.534 0 O-C-N 117.85 -3.147 . . . . 0.0 115.14 -165.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . 0.267 27.6 m -77.09 116.83 18.08 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 127.646 3.091 . . . . 0.0 114.161 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.36 154.63 83.0 Favored Pre-proline 0 CA--C 1.586 2.352 0 C-N-CA 130.804 3.642 . . . . 0.0 110.107 -169.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.96 149.44 7.98 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.673 2.249 . . . . 0.0 117.586 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.34 -16.66 62.45 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.319 1.448 . . . . 0.0 114.667 -163.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.18 -0.96 78.99 Favored Glycine 0 CA--C 1.572 3.621 0 CA-C-O 117.24 -1.867 . . . . 0.0 116.978 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -120.74 135.84 55.03 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.092 2.446 . . . . 0.0 111.368 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -83.89 154.3 23.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 127.266 2.854 . . . . 0.0 107.884 164.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . 0.292 . . -156.72 154.03 29.38 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 126.153 2.883 . . . . 0.0 112.649 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -62.97 140.11 58.83 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 112.348 -2.206 . . . . 0.0 112.134 159.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 177' ' ' ARG . . . 73.7 -166.82 54.61 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 127.876 2.655 . . . . 0.0 111.468 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m 47.64 35.08 4.09 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 124.023 0.929 . . . . 0.0 110.002 -162.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.439 ' HG2' ' HA2' ' A' ' 175' ' ' GLY . 0.7 OUTLIER -80.93 -10.44 59.72 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 129.395 3.078 . . . . 0.0 110.86 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.97 -118.34 5.93 Favored Glycine 0 C--O 1.268 2.251 0 O-C-N 118.973 -2.329 . . . . 0.0 110.154 169.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 68.56 -153.24 52.86 Favored Glycine 0 C--N 1.301 -1.413 0 O-C-N 119.238 -2.331 . . . . 0.0 118.819 167.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 1 N--CA 1.546 4.36 0 C-N-CA 125.418 1.487 . . . . 0.0 107.802 -7.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.515 -7.792 2 O4'-C1'-N19 114.073 5.873 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.465 -6.347 3 C3'-C2'-C1' 106.545 5.606 . 0.01 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.437 ' C2 ' ' HB3' ' A' ' 93' ' ' ARG . . . . . . . . 0 O4'--C4' 1.41 -3.543 1 C4'-C3'-C2' 98.366 -4.334 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.671 7.763 3 O4'-C1'-N19 115.965 7.765 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C5'--C4' 1.582 5.554 2 P-O3'-C3' 127.733 6.695 . 0.376 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.685 9.241 2 C5'-C4'-C3' 104.827 -7.115 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ' A' . . . . . 0.533 ' N3 ' ' HE2' ' A' ' 102' ' ' LYS . . . . . . . . 1 O4'--C4' 1.402 -4.26 1 O4'-C1'-N19 103.841 -4.359 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 4 3 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C2'--O2' 1.36 -4.095 3 C4'-C3'-C2' 95.779 -6.921 . 0.151 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O4'--C4' 1.391 -5.197 2 P-O3'-C3' 125.991 5.242 . 0.09 &a . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 P--O5' 1.55 -4.288 1 O3'-P-O5' 95.887 -4.27 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.217 0 N-CA-C 106.545 -2.622 . . . . 0.0 106.545 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.49 156.66 88.09 Favored Pre-proline 0 C--N 1.369 1.414 0 O-C-N 119.314 -2.286 . . . . 0.0 116.77 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.92 127.32 25.78 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 124.647 3.565 . . . . 0.0 111.389 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -71.49 133.73 46.05 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.55 -18.34 45.26 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -171.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m 59.27 -43.95 0.07 Allowed 'General case' 0 CA--C 1.589 2.445 0 C-N-CA 129.603 3.161 . . . . 0.0 118.295 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 39.19 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.976 2.11 . . . . 0.0 114.725 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.447 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 47.6 t -85.46 139.13 31.75 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 125.655 1.582 . . . . 0.0 113.429 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -79.86 -9.27 59.65 Favored 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 125.362 1.465 . . . . 0.0 113.892 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -109.85 157.09 19.56 Favored 'General case' 0 CA--C 1.581 2.163 0 CA-C-O 124.294 1.997 . . . . 0.0 110.717 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 p -68.2 165.37 18.48 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -111.61 136.92 50.16 Favored 'General case' 0 C--O 1.259 1.586 0 O-C-N 119.566 -1.959 . . . . 0.0 109.736 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.9 mt -75.08 160.86 29.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 126.634 1.973 . . . . 0.0 110.781 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.5 m -126.31 139.29 53.42 Favored 'General case' 0 N--CA 1.493 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 110.652 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.62 141.1 55.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.766 2.426 . . . . 0.0 109.055 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -125.59 -34.19 2.69 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 161.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.01 -126.85 0.02 OUTLIER Glycine 0 C--N 1.305 -1.15 1 CA-C-O 127.99 4.106 . . . . 0.0 113.948 168.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -154.45 -28.01 0.12 Allowed 'General case' 0 C--N 1.292 -1.911 2 O-C-N 114.434 -5.156 . . . . 0.0 111.381 163.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.35 145.89 53.77 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.71 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -54.23 167.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 117.534 -3.229 . . . . 0.0 112.349 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.1 tp -74.26 64.72 1.12 Allowed 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 125.31 2.481 . . . . 0.0 114.362 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -75.55 140.29 42.63 Favored 'General case' 0 C--O 1.287 3.027 0 O-C-N 119.166 -2.209 . . . . 0.0 111.043 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -127.06 156.81 73.79 Favored Pre-proline 0 C--N 1.397 2.658 0 O-C-N 119.256 -2.152 . . . . 0.0 111.319 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -79.86 141.18 14.97 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 42.92 16.46 0.01 OUTLIER 'General case' 0 CA--C 1.584 2.262 0 O-C-N 126.3 2.25 . . . . 0.0 116.207 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.49 73.24 Favored Glycine 0 CA--C 1.557 2.68 1 C-N-CA 130.95 4.119 . . . . 0.0 116.359 -164.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -85.42 108.23 17.77 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 117.39 -1.291 . . . . 0.0 110.319 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.91 10.85 0.03 OUTLIER Glycine 1 CA--C 1.601 5.431 0 CA-C-O 114.655 -3.303 . . . . 0.0 117.46 -170.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.18 125.81 59.0 Favored Pre-proline 0 CA--C 1.587 2.387 0 CA-C-N 122.752 3.276 . . . . 0.0 113.482 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.22 153.18 24.4 Favored 'Trans proline' 0 N--CA 1.421 -2.739 0 C-N-CA 122.762 2.308 . . . . 0.0 111.806 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -70.84 146.0 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 O-C-N 128.407 3.567 . . . . 0.0 109.972 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -145.91 111.05 5.3 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 118.291 -0.861 . . . . 0.0 109.695 162.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -67.17 -15.69 63.86 Favored 'General case' 0 C--N 1.378 1.833 0 CA-C-N 123.099 2.681 . . . . 0.0 111.604 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -89.43 12.16 17.2 Favored 'General case' 0 CA--C 1.608 3.2 0 C-N-CA 128.761 2.824 . . . . 0.0 110.719 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -120.93 163.23 18.55 Favored 'General case' 0 C--O 1.256 1.412 0 O-C-N 125.147 1.529 . . . . 0.0 111.407 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.8 p -101.76 163.25 18.17 Favored Pre-proline 0 C--O 1.256 1.403 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -59.37 -26.18 81.03 Favored 'Trans proline' 0 CA--C 1.563 1.954 0 CA-C-N 122.666 1.988 . . . . 0.0 110.485 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.47 -30.65 63.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 120.711 1.596 . . . . 0.0 113.91 173.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -79.99 -16.32 55.43 Favored 'General case' 0 C--O 1.186 -2.272 0 C-N-CA 127.643 2.377 . . . . 0.0 115.292 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -73.41 61.8 0.69 Allowed 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 129.32 3.048 . . . . 0.0 116.05 -167.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.264 13.3 tt -153.53 138.27 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 127.953 3.283 . . . . 0.0 108.363 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.46 -152.73 11.31 Favored Glycine 0 CA--C 1.489 -1.555 0 O-C-N 116.887 -3.633 . . . . 0.0 114.796 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -149.96 138.37 20.59 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 127.136 2.174 . . . . 0.0 110.493 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -89.35 155.71 19.18 Favored 'General case' 0 C--N 1.286 -2.18 0 O-C-N 127.85 3.219 . . . . 0.0 109.75 159.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -145.39 148.94 33.89 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.554 -1.341 . . . . 0.0 108.677 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.419 HH22 ' CG ' ' A' ' 128' ' ' ASP . 21.5 ptt180 -86.95 -177.72 6.13 Favored 'General case' 0 CA--C 1.61 3.263 0 CA-C-N 121.827 2.103 . . . . 0.0 114.906 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 136.9 9.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 118.878 -2.389 . . . . 0.0 110.592 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.9 p -145.4 -17.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 113.814 -2.993 . . . . 0.0 113.724 -164.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 47.47 48.72 16.54 Favored 'General case' 0 CA--C 1.602 2.956 0 O-C-N 125.39 1.681 . . . . 0.0 111.603 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -105.65 -9.57 17.27 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 119.939 -1.726 . . . . 0.0 112.444 170.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 mp 70.85 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.27 2.173 0 C-N-CA 127.051 2.14 . . . . 0.0 110.76 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.435 ' HG3' ' C4 ' ' B' ' 4' ' ' ' C' . 33.9 mtt-85 -123.35 -24.19 4.68 Favored 'General case' 0 CA--C 1.586 2.334 1 C-N-CA 133.205 4.602 . . . . 0.0 110.296 -179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.13 102.58 0.17 Allowed Glycine 0 C--O 1.2 -1.972 0 O-C-N 118.678 -2.514 . . . . 0.0 108.084 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.65 -155.39 51.09 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 124.459 2.144 . . . . 0.0 108.176 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 53.56 14.68 0.62 Allowed 'General case' 0 C--O 1.266 1.941 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.79 -172.49 45.07 Favored Glycine 0 C--N 1.285 -2.297 0 O-C-N 118.055 -2.903 . . . . 0.0 117.968 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -135.29 154.89 51.39 Favored 'General case' 0 N--CA 1.489 1.507 1 C-N-CA 133.374 4.669 . . . . 0.0 112.409 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -105.22 163.57 12.49 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 127.864 2.466 . . . . 0.0 111.795 -172.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -154.88 -7.27 0.14 Allowed 'General case' 0 C--O 1.239 0.509 0 O-C-N 120.908 -1.12 . . . . 0.0 112.244 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.95 37.85 22.13 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 126.101 1.76 . . . . 0.0 112.986 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.76 169.6 18.0 Favored 'General case' 0 C--O 1.289 3.144 0 C-N-CA 125.578 1.551 . . . . 0.0 110.621 167.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . 0.278 52.6 m -62.32 145.5 94.05 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 123.29 1.519 . . . . 0.0 114.992 170.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.263 15.1 Cg_exo -42.67 155.96 0.1 Allowed 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 121.709 1.606 . . . . 0.0 113.247 164.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -121.4 159.4 26.25 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.601 2.361 . . . . 0.0 115.545 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -129.92 139.94 51.03 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 126.72 2.512 . . . . 0.0 115.631 161.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -121.36 154.19 36.77 Favored 'General case' 0 CA--C 1.592 2.593 0 C-N-CA 126.464 1.905 . . . . 0.0 109.957 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -111.19 141.18 45.04 Favored 'General case' 0 N--CA 1.535 3.801 0 CA-C-N 122.929 2.604 . . . . 0.0 113.906 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.47 ' CD2' ' HA3' ' A' ' 116' ' ' GLY . 8.2 m-85 -141.66 150.92 42.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 125.021 2.343 . . . . 0.0 110.063 170.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -87.59 156.01 19.7 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-N 114.085 -1.416 . . . . 0.0 113.207 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.3 tp -51.47 127.62 20.55 Favored 'General case' 0 C--O 1.271 2.23 0 C-N-CA 124.072 0.949 . . . . 0.0 112.961 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.56 73.83 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.6 p -142.59 -178.51 5.81 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 119.709 1.754 . . . . 0.0 109.616 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 111' ' ' TYR . . . 63.38 -154.1 45.4 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -73.73 -43.08 0.67 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.325 2.017 . . . . 0.0 115.203 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.327 2.5 mm-40 -81.94 27.74 0.45 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 131.431 3.892 . . . . 0.0 110.481 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.76 -19.52 50.83 Favored 'General case' 0 C--O 1.159 -3.706 0 O-C-N 118.188 -2.82 . . . . 0.0 113.096 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.29 -34.5 54.65 Favored Glycine 0 C--O 1.253 1.337 0 O-C-N 124.752 1.282 . . . . 0.0 113.809 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 mt -65.36 139.29 97.34 Favored Pre-proline 0 CA--C 1.607 3.143 0 CA-C-N 120.772 2.286 . . . . 0.0 113.297 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -61.92 166.17 12.79 Favored 'Trans proline' 0 C--O 1.272 2.178 0 O-C-N 124.42 1.747 . . . . 0.0 113.983 155.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -65.09 123.43 19.49 Favored 'General case' 0 C--N 1.365 1.261 0 CA-C-N 110.27 -3.15 . . . . 0.0 116.6 170.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 20.22 62.86 Favored Glycine 0 CA--C 1.576 3.904 0 CA-C-O 124.128 1.96 . . . . 0.0 111.148 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.34 135.69 47.46 Favored 'General case' 0 C--O 1.25 1.094 0 O-C-N 117.534 -3.333 . . . . 0.0 108.793 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.73 11.94 1.5 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -161.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . 0.291 66.7 tttt -72.31 126.03 28.82 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 124.32 2.009 . . . . 0.0 111.238 -167.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.419 ' CG ' HH22 ' A' ' 89' ' ' ARG . 13.8 t0 -53.8 138.74 35.1 Favored 'General case' 0 C--O 1.271 2.226 0 O-C-N 117.588 -3.195 . . . . 0.0 108.038 -175.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.15 -11.42 63.81 Favored Glycine 0 N--CA 1.502 3.076 0 CA-C-O 116.147 -2.474 . . . . 0.0 117.367 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -108.97 134.7 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.616 3.517 0 C-N-CA 130.618 3.567 . . . . 0.0 110.91 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.88 124.11 71.63 Favored 'Isoleucine or valine' 0 C--O 1.291 3.28 0 O-C-N 125.694 1.871 . . . . 0.0 109.323 171.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.68 134.8 33.59 Favored 'General case' 0 CA--C 1.587 2.396 0 CA-C-O 125.418 2.532 . . . . 0.0 111.516 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.28 141.42 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 O-C-N 119.323 -2.11 . . . . 0.0 111.152 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.96 170.96 14.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 p -131.79 157.62 43.39 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 113.492 -1.685 . . . . 0.0 114.893 158.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -72.0 -27.24 62.61 Favored 'General case' 0 C--N 1.365 1.28 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.95 -18.25 63.64 Favored Glycine 0 CA--C 1.565 3.189 0 C-N-CA 127.792 2.615 . . . . 0.0 118.143 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.22 147.32 53.19 Favored 'General case' 0 C--O 1.286 3.017 0 C-N-CA 127.152 2.181 . . . . 0.0 110.202 162.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.88 142.1 30.05 Favored 'General case' 0 C--O 1.285 2.94 0 CA-C-O 125.122 2.391 . . . . 0.0 108.024 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -48.03 -12.46 0.03 OUTLIER 'General case' 0 CA--C 1.6 2.867 0 CA-C-O 114.014 -2.898 . . . . 0.0 116.012 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -55.34 139.42 66.21 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 130.841 3.656 . . . . 0.0 114.025 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -64.28 140.25 69.76 Favored 'Trans proline' 0 N--CA 1.528 3.503 0 C-N-CA 122.831 2.354 . . . . 0.0 106.369 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -91.53 60.84 4.17 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -23.12 66.09 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.816 -165.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -61.81 -55.51 29.22 Favored 'General case' 0 CA--C 1.61 3.287 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 6.4 mt -60.81 -25.26 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.623 0 C-N-CA 116.781 -1.968 . . . . 0.0 111.567 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.51 -12.03 83.44 Favored Glycine 1 CA--C 1.587 4.567 0 C-N-CA 128.696 3.046 . . . . 0.0 116.695 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.6 p -126.88 -24.96 3.41 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.3 158.71 28.78 Favored 'General case' 0 C--O 1.266 1.931 0 O-C-N 117.153 -3.467 . . . . 0.0 106.511 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.5 118.43 47.42 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.835 -2.507 . . . . 0.0 112.432 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -73.4 -25.31 15.51 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.95 2.433 . . . . 0.0 115.93 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.32 -4.27 35.24 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 120.699 -1.25 . . . . 0.0 109.705 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.82 -28.92 70.19 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 121.407 1.912 . . . . 0.0 113.64 -165.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.57 159.93 29.55 Favored 'General case' 0 C--O 1.25 1.119 1 C-N-CA 131.99 4.116 . . . . 0.0 110.847 160.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -53.94 160.74 1.37 Allowed 'General case' 1 N--CA 1.54 4.029 0 C-N-CA 128.441 2.696 . . . . 0.0 111.996 172.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.35 130.97 49.28 Favored 'General case' 0 CA--C 1.584 2.283 0 O-C-N 118.276 -2.765 . . . . 0.0 112.546 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.81 126.77 32.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 124.215 1.959 . . . . 0.0 107.193 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.0 126.8 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.608 0 O-C-N 120.157 -1.589 . . . . 0.0 111.827 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.73 116.7 7.21 Favored 'General case' 0 CA--C 1.604 3.035 0 O-C-N 126.589 2.431 . . . . 0.0 114.373 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -141.23 152.9 44.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 116.304 -3.997 . . . . 0.0 111.399 164.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -113.81 155.26 45.4 Favored Pre-proline 0 C--N 1.256 -3.498 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.469 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -48.92 159.67 0.88 Allowed 'Trans proline' 0 C--O 1.272 2.222 1 C-N-CA 132.108 8.539 . . . . 0.0 120.656 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.323 24.4 mt-30 46.52 31.72 1.42 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.62 72.28 Favored Glycine 0 CA--C 1.55 2.243 0 O-C-N 116.568 -3.832 . . . . 0.0 112.009 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.5 m -63.52 122.39 16.17 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-O 116.192 -1.861 . . . . 0.0 110.248 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 81.5 m -58.77 134.3 56.72 Favored 'General case' 0 C--N 1.382 2.015 0 CA-C-O 115.578 -2.154 . . . . 0.0 113.286 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.62 152.89 32.78 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 125.476 3.762 . . . . 0.0 111.344 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -62.94 145.09 94.31 Favored 'Trans proline' 1 CA--C 1.62 4.777 0 C-N-CA 125.06 3.84 . . . . 0.0 112.801 -161.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -69.11 -18.87 64.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 117.763 -3.086 . . . . 0.0 116.459 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.73 -17.95 10.07 Favored Glycine 0 CA--C 1.542 1.753 0 O-C-N 118.302 -2.749 . . . . 0.0 114.773 164.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.8 145.04 48.0 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 121.359 2.579 . . . . 0.0 115.829 -165.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -87.16 142.48 27.88 Favored 'General case' 0 CA--C 1.604 3.022 0 C-N-CA 131.006 3.722 . . . . 0.0 107.071 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.43 170.04 16.47 Favored 'General case' 0 CA--C 1.576 1.97 0 O-C-N 125.589 1.805 . . . . 0.0 113.517 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.0 162.65 14.63 Favored 'General case' 0 CA--C 1.555 1.147 0 O-C-N 124.556 1.16 . . . . 0.0 112.837 169.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 86.33 141.41 6.29 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-O 117.838 -1.534 . . . . 0.0 111.906 -170.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.7 m 60.46 41.94 15.16 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 125.215 1.185 . . . . 0.0 113.915 174.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -93.63 -1.58 55.14 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 -174.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 69.29 154.23 0.81 Allowed Glycine 0 N--CA 1.515 3.965 0 C-N-CA 128.224 2.821 . . . . 0.0 110.944 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.45 -168.42 38.81 Favored Glycine 0 CA--C 1.57 3.526 0 CA-C-O 116.411 -2.327 . . . . 0.0 114.056 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 CA--C 1.578 2.02 0 C-N-CA 128.372 2.669 . . . . 0.0 108.491 -9.055 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.611 4 C5'-C4'-C3' 106.693 -5.872 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.365 -4.716 2 P-O3'-C3' 124.79 4.241 . 0.642 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.624 3.107 2 O4'-C1'-N19 113.138 4.938 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 0.435 ' C4 ' ' HG3' ' A' ' 95' ' ' ARG . . . . . . . . 0 P--O3' 1.565 -3.5 4 O5'-C5'-C4' 119.717 6.798 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.452 " H3'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 2 P--O5' 1.515 -7.778 3 C4'-C3'-C2' 95.298 -7.402 . 0.114 1t . 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.452 H5'' " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 3 P--O5' 1.54 -5.288 5 C3'-C2'-C1' 108.328 7.587 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 5 4 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.469 -5.033 1 C5'-C4'-C3' 122.188 4.459 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.581 5.184 1 N19-C1'-C2' 120.003 4.127 . 0.199 &a . 0.0 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.623 8.684 5 C3'-C2'-C1' 107.36 6.511 . 0.067 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C4'--C3' 1.562 3.466 2 O4'-C1'-C2' 113.074 4.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt -115.8 141.6 27.76 Favored Pre-proline 0 C--O 1.281 2.72 0 O-C-N 118.234 -2.921 . . . . 0.0 105.827 166.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -67.83 154.45 73.0 Favored 'Trans proline' 0 N--CA 1.53 3.669 0 CA-C-O 114.172 -2.512 . . . . 0.0 112.479 -169.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -69.08 123.89 22.28 Favored 'General case' 0 CA--C 1.582 2.2 0 O-C-N 126.168 2.167 . . . . 0.0 110.51 161.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -80.7 -13.24 59.18 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 127.586 2.355 . . . . 0.0 114.869 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.3 m 57.24 -29.77 0.03 OUTLIER 'General case' 1 CA--C 1.644 4.561 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 171.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.326 . . -91.3 169.54 10.73 Favored 'General case' 0 C--O 1.188 -2.169 0 C-N-CA 127.011 2.125 . . . . 0.0 111.592 -174.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.1 t -84.81 130.4 34.68 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 128.325 2.65 . . . . 0.0 114.625 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -71.3 -15.01 62.39 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 127.627 2.371 . . . . 0.0 113.66 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 157' ' ' ILE . 15.5 m-85 -118.02 173.26 6.88 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 127.378 2.271 . . . . 0.0 116.403 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p -61.27 153.01 27.55 Favored 'General case' 0 C--O 1.287 3.068 0 O-C-N 128.831 3.832 . . . . 0.0 110.851 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.59 154.43 19.95 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 129.766 3.227 . . . . 0.0 112.408 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.09 156.32 20.73 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.744 1.218 . . . . 0.0 108.711 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 107' ' ' ARG . 57.4 m -139.46 121.9 16.12 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 131.486 3.914 . . . . 0.0 114.296 -168.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.262 4.5 tp-100 -77.42 142.32 39.3 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.244 1.497 . . . . 0.0 113.501 -167.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -135.77 -22.55 1.43 Allowed 'General case' 0 CA--C 1.601 2.93 0 CA-C-O 113.272 -3.251 . . . . 0.0 111.319 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.32 -130.92 0.61 Allowed Glycine 1 CA--C 1.61 6.012 0 O-C-N 126.47 2.356 . . . . 0.0 111.051 153.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -149.31 -20.93 0.29 Allowed 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 131.122 3.769 . . . . 0.0 113.053 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.94 147.84 48.32 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 124.893 1.371 . . . . 0.0 114.195 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.9 158.59 21.77 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.263 -2.148 . . . . 0.0 115.401 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.8 tp -75.36 51.52 0.56 Allowed 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 129.21 3.004 . . . . 0.0 111.818 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -76.44 139.26 40.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -129.7 88.01 50.8 Favored Pre-proline 0 CA--C 1.591 2.556 1 C-N-CA 132.611 4.365 . . . . 0.0 111.137 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.25 148.08 33.49 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.542 2.161 . . . . 0.0 115.978 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 45.34 20.68 0.05 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 131.119 3.768 . . . . 0.0 113.789 -165.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.7 22.25 69.8 Favored Glycine 0 N--CA 1.499 2.86 0 CA-C-O 116.351 -2.36 . . . . 0.0 108.43 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -84.08 106.37 15.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 128.091 2.877 . . . . 0.0 108.982 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.84 13.68 0.02 OUTLIER Glycine 0 CA--C 1.574 3.749 0 C-N-CA 128.702 3.049 . . . . 0.0 116.422 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.33 122.4 81.4 Favored Pre-proline 0 CA--C 1.56 1.351 0 O-C-N 117.96 -3.082 . . . . 0.0 112.537 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.401 ' HD2' ' CZ ' ' A' ' 110' ' ' PHE . 13.8 Cg_endo -75.16 177.36 8.71 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 121.69 1.593 . . . . 0.0 114.972 -168.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.99 129.89 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 112.378 -2.192 . . . . 0.0 111.016 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -167.38 104.4 0.53 Allowed 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 125.205 1.566 . . . . 0.0 114.312 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.9 m -70.06 -17.54 63.25 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-O 114.198 -2.81 . . . . 0.0 110.516 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -63.7 -11.96 30.43 Favored 'General case' 0 C--O 1.188 -2.136 0 CA-C-N 124.185 3.175 . . . . 0.0 112.536 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 p -125.37 136.88 53.9 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 126.994 2.118 . . . . 0.0 110.4 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 p -85.15 165.97 33.76 Favored Pre-proline 0 C--N 1.269 -2.935 0 C-N-CA 126.231 1.812 . . . . 0.0 112.328 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . 0.302 81.8 Cg_exo -52.87 -24.09 22.98 Favored 'Trans proline' 0 CA--C 1.574 2.521 1 C-N-CA 125.557 4.171 . . . . 0.0 115.684 168.388 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.05 -29.3 43.41 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 121.178 1.808 . . . . 0.0 112.636 171.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.75 -16.7 61.17 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -68.58 61.52 0.09 Allowed 'General case' 0 CA--C 1.595 2.697 0 C-N-CA 131.263 3.825 . . . . 0.0 110.367 -162.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 tt -156.05 138.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.906 0 C-N-CA 126.762 2.025 . . . . 0.0 113.383 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.4 -174.18 46.8 Favored Glycine 0 CA--C 1.557 2.68 0 O-C-N 119.829 -1.794 . . . . 0.0 114.13 -154.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -148.19 145.39 28.27 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 126.733 2.013 . . . . 0.0 112.21 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -92.63 137.15 32.62 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -126.74 139.78 52.87 Favored 'General case' 1 N--CA 1.548 4.457 0 C-N-CA 129.981 3.312 . . . . 0.0 112.555 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -71.51 166.96 20.69 Favored 'General case' 0 C--O 1.291 3.273 0 O-C-N 120.052 -1.655 . . . . 0.0 110.847 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.92 132.85 18.11 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 130.268 3.427 . . . . 0.0 108.182 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -140.8 -17.37 0.86 Allowed 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 130.018 3.327 . . . . 0.0 110.009 -163.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 47.58 60.92 3.19 Favored 'General case' 0 CA--C 1.589 2.447 0 O-C-N 125.909 2.005 . . . . 0.0 116.209 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -99.22 -23.69 15.12 Favored 'General case' 0 C--O 1.259 1.574 0 C-N-CA 129.201 3.0 . . . . 0.0 116.413 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 mp 60.18 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 CA-C-O 126.132 2.873 . . . . 0.0 111.805 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -82.65 55.42 2.98 Favored 'General case' 0 N--CA 1.511 2.598 1 O-C-N 115.34 -4.6 . . . . 0.0 107.619 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.87 117.45 0.02 OUTLIER Glycine 0 N--CA 1.422 -2.289 0 C-N-CA 124.746 1.165 . . . . 0.0 114.846 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.34 161.64 18.67 Favored Glycine 0 CA--C 1.574 3.732 0 C-N-CA 128.828 3.109 . . . . 0.0 116.505 165.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.447 0.0 OUTLIER 60.52 27.68 17.34 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 119.692 3.219 . . . . 0.0 119.692 -176.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.24 177.03 47.3 Favored Glycine 0 CA--C 1.56 2.859 0 CA-C-O 117.579 -1.678 . . . . 0.0 114.879 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -149.37 138.48 21.32 Favored 'General case' 0 C--N 1.399 2.757 0 C-N-CA 129.472 3.109 . . . . 0.0 109.07 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 45.3 mtm -67.97 149.49 49.68 Favored 'General case' 0 CA--C 1.58 2.119 0 C-N-CA 125.082 1.353 . . . . 0.0 113.251 171.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -114.42 -3.24 13.06 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 127.262 3.41 . . . . 0.0 114.218 -174.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 50.2 30.56 4.41 Favored 'General case' 0 C--N 1.39 2.328 0 O-C-N 117.745 -3.097 . . . . 0.0 117.888 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -122.07 170.37 9.91 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 126.72 2.512 . . . . 0.0 116.422 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.8 m -56.35 164.5 1.93 Allowed Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -49.5 164.03 0.38 Allowed 'Trans proline' 1 CA--C 1.622 4.91 1 C-N-CA 125.771 4.314 . . . . 0.0 112.178 166.48 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HG2' HG23 ' A' ' 57' ' ' THR . 79.3 mtp180 -141.78 168.57 19.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 110.851 -2.886 . . . . 0.0 109.028 174.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -140.66 149.87 42.8 Favored 'General case' 0 C--N 1.276 -2.601 0 O-C-N 118.926 -2.359 . . . . 0.0 108.925 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -130.63 162.8 28.57 Favored 'General case' 0 C--O 1.184 -2.361 0 C-N-CA 127.96 2.504 . . . . 0.0 108.217 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 73' ' ' PRO . 54.4 t80 -119.87 145.27 46.83 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 128.919 2.888 . . . . 0.0 113.96 173.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -147.61 141.59 25.92 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 127.218 2.207 . . . . 0.0 110.712 -171.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -70.45 163.8 25.99 Favored 'General case' 0 CA--C 1.605 3.08 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.18 127.73 32.61 Favored 'General case' 0 CA--C 1.573 1.86 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.839 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.13 20.77 79.01 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 117.979 -2.058 . . . . 0.0 118.151 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.281 3.8 p -134.66 167.63 20.47 Favored 'General case' 0 C--O 1.263 1.775 0 C-N-CA 127.046 2.138 . . . . 0.0 111.539 -174.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.18 -156.36 37.84 Favored Glycine 1 CA--C 1.585 4.407 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.945 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -71.53 -43.16 1.49 Allowed 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 124.036 3.157 . . . . 0.0 114.151 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -82.8 31.96 0.42 Allowed 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 116.802 -1.571 . . . . 0.0 110.599 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.23 -24.86 66.68 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 122.682 2.492 . . . . 0.0 112.37 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.35 -36.73 70.67 Favored Glycine 1 CA--C 1.582 4.225 0 O-C-N 125.242 1.589 . . . . 0.0 116.314 167.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.93 124.78 89.72 Favored Pre-proline 0 CA--C 1.586 2.353 0 CA-C-O 116.509 -1.71 . . . . 0.0 109.971 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -63.05 166.73 13.71 Favored 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 125.237 3.958 . . . . 0.0 113.107 161.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -65.57 127.45 31.93 Favored 'General case' 0 CA--C 1.549 0.907 1 O-C-N 115.481 -4.512 . . . . 0.0 114.241 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.98 -2.63 79.83 Favored Glycine 0 CA--C 1.554 2.469 0 CA-C-N 113.081 -1.872 . . . . 0.0 116.825 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.51 129.83 42.4 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 116.936 -3.685 . . . . 0.0 110.541 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -82.46 25.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.372 -3.33 . . . . 0.0 117.634 -154.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.82 126.97 30.15 Favored 'General case' 0 CA--C 1.593 2.601 0 O-C-N 117.29 -3.381 . . . . 0.0 110.238 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.26 147.35 46.51 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 113.01 -1.904 . . . . 0.0 111.642 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.57 -18.59 54.64 Favored Glycine 1 N--CA 1.525 4.606 0 O-C-N 119.11 -2.243 . . . . 0.0 116.55 -163.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 130' ' ' ILE . 1.5 mp -101.65 119.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 129.496 3.118 . . . . 0.0 109.189 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.87 102.46 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.152 0 C-N-CA 127.752 2.421 . . . . 0.0 106.092 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -71.97 129.81 39.46 Favored 'General case' 0 CA--C 1.588 2.412 0 C-N-CA 125.736 1.615 . . . . 0.0 113.04 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.77 150.12 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 C-N-CA 126.872 2.069 . . . . 0.0 108.623 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.89 19.36 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.415 -173.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.1 p -122.32 155.32 36.22 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 115.84 -2.029 . . . . 0.0 112.5 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.22 -47.71 62.26 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 124.869 3.486 . . . . 0.0 111.515 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.24 -2.61 90.63 Favored Glycine 2 CA--C 1.599 5.341 0 C-N-CA 129.549 3.452 . . . . 0.0 117.061 -172.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.27 33.49 Favored 'General case' 0 CA--C 1.614 3.408 0 CA-C-N 119.487 1.643 . . . . 0.0 111.961 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.3 mt -88.98 146.61 24.77 Favored 'General case' 0 CA--C 1.596 2.747 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 160.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -90.0 29.79 1.16 Allowed 'General case' 0 CA--C 1.6 2.873 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.419 ' O ' ' HE2' ' A' ' 143' ' ' LYS . 25.6 p -72.06 148.52 91.7 Favored Pre-proline 0 N--CA 1.508 2.464 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.825 168.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.43 136.07 35.64 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-O 116.875 -1.385 . . . . 0.0 112.862 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 141' ' ' THR . 53.3 mmtt -88.55 52.15 2.36 Favored 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 128.649 2.78 . . . . 0.0 110.565 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.41 -20.11 0.64 Allowed 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -81.01 -44.17 18.5 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 119.133 -2.23 . . . . 0.0 110.432 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.251 9.3 mt -55.84 -32.33 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-O 116.665 -1.636 . . . . 0.0 113.674 158.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.72 -14.62 81.22 Favored Glycine 0 N--CA 1.514 3.863 0 O-C-N 127.867 3.229 . . . . 0.0 119.352 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.4 p -133.43 -25.79 1.69 Allowed 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -54.91 142.64 28.87 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 125.979 1.712 . . . . 0.0 110.085 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -77.95 101.97 0.82 Allowed Pre-proline 0 CA--C 1.497 -1.08 0 O-C-N 124.343 1.027 . . . . 0.0 110.969 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.38 -21.81 71.48 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 125.136 3.891 . . . . 0.0 116.038 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.79 -9.76 55.85 Favored 'General case' 0 C--O 1.276 2.499 0 C-N-CA 128.279 2.632 . . . . 0.0 112.444 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -59.22 -27.09 65.42 Favored 'General case' 0 CA--C 1.568 1.662 1 N-CA-C 122.638 4.31 . . . . 0.0 122.638 166.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.04 157.76 45.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 118.699 -2.501 . . . . 0.0 114.441 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -32.53 150.34 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.733 1 C-N-CA 131.757 4.023 . . . . 0.0 111.69 160.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.5 137.29 50.1 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 125.563 2.601 . . . . 0.0 114.546 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.476 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 7.3 mt -73.14 129.02 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 118.746 -2.471 . . . . 0.0 111.58 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.15 116.26 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 126.866 2.604 . . . . 0.0 113.165 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.9 tt -88.04 119.48 28.46 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 124.27 1.028 . . . . 0.0 110.175 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.21 151.73 12.12 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 126.669 1.988 . . . . 0.0 105.869 -157.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.2 mt -110.44 145.35 32.05 Favored Pre-proline 0 CA--C 1.564 1.517 0 O-C-N 124.136 0.897 . . . . 0.0 112.666 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.56 167.07 13.97 Favored 'Trans proline' 1 CA--C 1.605 4.056 0 C-N-CA 121.961 1.774 . . . . 0.0 110.155 170.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 53.89 25.91 5.73 Favored 'General case' 0 N--CA 1.531 3.582 0 O-C-N 127.132 2.77 . . . . 0.0 111.874 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.88 29.56 6.34 Favored Glycine 1 N--CA 1.516 4.004 0 O-C-N 127.187 2.805 . . . . 0.0 111.272 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.2 m -58.99 141.99 52.36 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 122.36 3.08 . . . . 0.0 110.459 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m -106.07 119.53 39.46 Favored 'General case' 0 CA--C 1.587 2.395 0 O-C-N 119.596 -1.94 . . . . 0.0 108.75 -162.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.94 145.72 62.74 Favored Pre-proline 0 N--CA 1.389 -3.493 0 O-C-N 118.491 -2.63 . . . . 0.0 114.756 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -50.13 123.73 11.51 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 121.944 3.786 . . . . 0.0 121.944 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -50.13 -30.69 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 126.071 2.107 . . . . 0.0 116.569 -172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.4 -32.5 84.37 Favored Glycine 0 C--O 1.195 -2.296 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 171.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -91.48 127.92 37.11 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-N 118.323 1.062 . . . . 0.0 109.354 171.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -65.06 152.11 44.33 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 155.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -169.67 146.82 3.36 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 124.894 2.283 . . . . 0.0 107.687 -168.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.83 134.64 49.96 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 127.057 2.143 . . . . 0.0 112.814 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.15 -178.67 48.95 Favored Glycine 1 CA--C 1.587 4.546 0 CA-C-O 118.17 -1.35 . . . . 0.0 113.707 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.0 m 63.48 14.48 8.03 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 126.825 2.132 . . . . 0.0 113.711 -171.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -64.88 -6.14 7.65 Favored 'General case' 0 C--N 1.369 1.413 0 CA-C-N 125.406 3.73 . . . . 0.0 120.642 -169.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.61 177.52 45.48 Favored Glycine 0 C--N 1.273 -2.964 0 C-N-CA 127.744 2.592 . . . . 0.0 113.243 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.53 -146.92 5.58 Favored Glycine 0 CA--C 1.554 2.515 0 C-N-CA 124.18 0.895 . . . . 0.0 112.635 169.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.6 m . . . . . 0 C--N 1.383 2.043 0 O-C-N 117.564 -3.316 . . . . 0.0 113.368 -2.821 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.564 4.179 2 C3'-C2'-C1' 106.216 5.24 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C5'--C4' 1.58 5.405 4 O4'-C1'-N19 113.134 4.934 . 0.707 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C2'--C1' 1.593 6.525 3 C3'-C2'-C1' 93.468 -8.924 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 C3'--C2' 1.587 5.672 3 C1'-O4'-C4' 104.911 -5.21 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.399 -4.48 3 C1'-O4'-C4' 114.442 5.38 . 0.38 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.453 -7.52 0 O3'-P-O5' 97.504 -3.419 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.645 5.157 0 OP1-P-OP2 115.245 -2.903 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C3'--C2' 1.564 3.541 3 C5'-C4'-C3' 106.388 -6.075 . 0.588 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.346 -8.883 4 C3'-C2'-C1' 93.015 -9.428 . 0.123 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.516 -7.581 1 C1'-O4'-C4' 105.087 -5.014 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.599 0 N-CA-C 105.588 -3.005 . . . . 0.0 105.588 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -72.1 158.49 87.53 Favored Pre-proline 0 CA--C 1.572 1.8 0 O-C-N 124.047 0.498 . . . . 0.0 111.228 168.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.13 166.37 18.62 Favored 'Trans proline' 0 N--CA 1.503 2.08 1 C-N-CA 127.767 5.645 . . . . 0.0 112.14 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -67.68 100.98 0.96 Allowed 'General case' 0 CA--C 1.588 2.408 0 C-N-CA 130.706 3.602 . . . . 0.0 110.249 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.279 34.4 p30 -54.6 -22.5 13.57 Favored 'General case' 0 CA--C 1.591 2.546 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.1 m 64.84 -47.09 0.34 Allowed 'General case' 0 N--CA 1.517 2.892 0 C-N-CA 126.823 2.049 . . . . 0.0 114.495 165.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.26 143.47 52.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 128.08 3.8 . . . . 0.0 111.109 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.3 t -81.65 135.29 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 109.897 -3.319 . . . . 0.0 115.18 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -77.96 -3.21 40.78 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.004 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.23 147.48 51.07 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 129.013 2.925 . . . . 0.0 115.102 -163.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.261 79.8 p -61.21 135.86 57.87 Favored 'General case' 0 C--O 1.185 -2.293 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.256 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.77 129.91 34.7 Favored 'General case' 0 CA--C 1.613 3.385 0 CA-C-O 113.974 -2.917 . . . . 0.0 111.493 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.1 175.75 1.97 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 125.263 1.602 . . . . 0.0 109.671 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -146.79 128.2 14.94 Favored 'General case' 0 C--N 1.309 -1.19 1 O-C-N 114.03 -5.419 . . . . 0.0 106.616 170.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -61.27 121.54 12.83 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 125.716 1.607 . . . . 0.0 112.523 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -100.31 -54.66 2.81 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.02 -126.89 0.1 OUTLIER Glycine 0 C--N 1.37 2.419 0 O-C-N 124.764 1.29 . . . . 0.0 116.131 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -144.38 -28.79 0.49 Allowed 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.836 3.207 . . . . 0.0 112.555 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -72.28 131.43 42.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 130.976 3.71 . . . . 0.0 111.721 -171.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.92 160.94 5.36 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 123.85 1.786 . . . . 0.0 110.939 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -65.69 42.91 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 126.309 1.844 . . . . 0.0 113.506 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -61.51 137.58 58.25 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 121.473 1.942 . . . . 0.0 111.386 -164.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.11 107.47 17.91 Favored Pre-proline 0 CA--C 1.562 1.406 0 O-C-N 117.996 -2.94 . . . . 0.0 112.623 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . 0.268 14.9 Cg_exo -57.7 144.62 92.67 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.671 2.247 . . . . 0.0 113.284 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 40.83 37.03 0.46 Allowed 'General case' 0 N--CA 1.516 2.865 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.05 15.44 5.15 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 127.006 2.691 . . . . 0.0 119.086 -168.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -71.54 109.42 5.48 Favored 'General case' 0 N--CA 1.415 -2.188 1 CA-C-N 125.013 4.406 . . . . 0.0 114.287 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.11 34.96 0.03 OUTLIER Glycine 0 CA--C 1.54 1.615 1 O-C-N 113.725 -5.609 . . . . 0.0 116.877 167.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.0 t -70.99 133.75 85.88 Favored Pre-proline 0 CA--C 1.614 3.427 1 CA-C-N 124.559 4.18 . . . . 0.0 115.159 169.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.22 164.09 36.69 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.499 2.133 . . . . 0.0 116.256 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.68 151.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.18 0 O-C-N 125.903 2.002 . . . . 0.0 111.724 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -166.69 106.2 0.62 Allowed 'General case' 0 N--CA 1.529 3.524 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.017 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -60.66 -28.55 68.68 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -80.3 18.57 0.87 Allowed 'General case' 0 CA--C 1.589 2.45 0 C-N-CA 127.606 2.362 . . . . 0.0 114.377 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 87.6 p -141.51 143.89 34.04 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 127.298 2.239 . . . . 0.0 106.262 -171.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 p -72.39 158.19 87.89 Favored Pre-proline 0 CA--C 1.599 2.837 0 CA-C-N 120.974 1.715 . . . . 0.0 108.49 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.69 -28.24 65.2 Favored 'Trans proline' 0 N--CA 1.524 3.302 0 C-N-CA 124.985 3.79 . . . . 0.0 116.181 167.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.21 -18.38 62.47 Favored 'General case' 0 C--O 1.178 -2.668 0 C-N-CA 126.36 1.864 . . . . 0.0 110.994 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.479 ' HA ' ' HE3' ' A' ' 143' ' ' LYS 0.286 65.4 m-20 -73.86 -21.74 60.0 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 124.409 1.083 . . . . 0.0 111.807 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -79.66 60.55 3.38 Favored 'General case' 0 CA--C 1.599 2.831 0 O-C-N 125.23 1.581 . . . . 0.0 110.972 -153.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.03 139.24 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 126.544 1.938 . . . . 0.0 108.736 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.84 -167.24 40.25 Favored Glycine 0 N--CA 1.493 2.493 1 CA-C-O 127.831 4.017 . . . . 0.0 110.621 -163.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB3' ' CE3' ' A' ' 132' ' ' TRP . 9.5 p90 -144.04 138.82 28.6 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 111.113 -2.543 . . . . 0.0 113.524 -170.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.45 145.52 27.4 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.343 1.068 . . . . 0.0 111.21 153.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.454 ' CZ ' " H5'" ' B' ' 4' ' ' ' C' . 7.6 ttp180 -136.95 127.97 27.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 120.1 3.37 . . . . 0.0 120.1 170.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.465 HH22 ' CG ' ' A' ' 128' ' ' ASP . 11.4 ptt180 -50.34 161.06 0.33 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 129.47 3.108 . . . . 0.0 113.204 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.401 ' HA ' " H4'" ' B' ' 4' ' ' ' C' . . . -155.67 143.28 19.58 Favored 'General case' 0 C--N 1.394 2.525 0 O-C-N 117.426 -3.296 . . . . 0.0 113.89 169.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -145.75 -16.35 0.47 Allowed 'General case' 0 N--CA 1.535 3.822 0 C-N-CA 129.122 2.969 . . . . 0.0 112.433 -166.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 46.19 26.72 0.47 Allowed 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -69.78 -14.0 62.56 Favored 'General case' 0 C--O 1.169 -3.134 0 C-N-CA 129.709 3.204 . . . . 0.0 113.141 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.8 mt 70.52 144.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 C-N-CA 129.045 2.938 . . . . 0.0 110.509 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -118.74 -20.48 8.25 Favored 'General case' 1 N--CA 1.558 4.949 0 C-N-CA 128.173 2.589 . . . . 0.0 110.615 166.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.17 85.73 0.06 OUTLIER Glycine 0 N--CA 1.432 -1.617 0 CA-C-N 121.932 2.151 . . . . 0.0 113.723 174.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.73 -140.02 41.9 Favored Glycine 0 CA--C 1.553 2.425 0 C-N-CA 129.507 3.432 . . . . 0.0 109.501 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 55.33 10.63 0.47 Allowed 'General case' 0 N--CA 1.514 2.754 0 C-N-CA 129.177 2.991 . . . . 0.0 114.395 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.68 177.35 47.48 Favored Glycine 0 CA--C 1.476 -2.384 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -132.86 165.37 24.78 Favored 'General case' 0 CA--C 1.59 2.485 0 O-C-N 118.561 -2.729 . . . . 0.0 106.279 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.7 mtm -105.25 141.01 37.53 Favored 'General case' 0 C--O 1.197 -1.659 0 O-C-N 126.564 2.415 . . . . 0.0 106.315 -166.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -106.52 -16.69 14.46 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 115.719 -2.086 . . . . 0.0 111.756 165.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.34 0.3 OUTLIER 70.26 38.0 1.51 Allowed 'General case' 0 C--N 1.371 1.526 0 N-CA-C 118.798 2.888 . . . . 0.0 118.798 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.76 164.41 11.8 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.472 -1.392 . . . . 0.0 107.734 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.1 m -44.67 138.77 3.84 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 168.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.39 162.6 1.33 Allowed 'Trans proline' 0 C--O 1.303 3.728 0 C-N-CA 123.582 2.855 . . . . 0.0 114.222 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -135.05 163.1 30.65 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 128.676 2.791 . . . . 0.0 111.942 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -134.24 139.07 45.52 Favored 'General case' 0 C--O 1.272 2.255 0 O-C-N 117.842 -3.036 . . . . 0.0 108.747 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.55 150.15 41.32 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 126.778 2.031 . . . . 0.0 113.595 173.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -102.49 149.46 24.37 Favored 'General case' 0 C--N 1.364 1.228 0 O-C-N 119.686 -1.884 . . . . 0.0 111.889 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -153.01 147.3 25.74 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 118.823 -2.423 . . . . 0.0 110.945 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -65.51 160.35 22.49 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 127.171 3.367 . . . . 0.0 112.373 170.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.02 123.87 18.04 Favored 'General case' 0 N--CA 1.504 2.248 1 O-C-N 114.951 -4.843 . . . . 0.0 110.674 172.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.1 79.14 Favored Glycine 0 C--O 1.194 -2.387 0 C-N-CA 128.024 2.726 . . . . 0.0 115.853 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.2 p -131.78 160.16 36.37 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 129.325 3.603 . . . . 0.0 109.736 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.42 -167.3 53.97 Favored Glycine 0 CA--C 1.566 3.231 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.33 -38.79 34.75 Favored 'Trans proline' 0 CA--C 1.545 1.075 1 C-N-CA 127.595 5.53 . . . . 0.0 113.089 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -106.56 19.55 20.33 Favored 'General case' 0 C--O 1.276 2.45 0 O-C-N 118.398 -2.689 . . . . 0.0 112.425 -167.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.83 -17.79 2.71 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 116.962 -3.586 . . . . 0.0 115.332 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.77 -20.97 77.59 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 120.782 3.073 . . . . 0.0 120.782 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.55 151.69 68.86 Favored Pre-proline 0 C--O 1.181 -2.511 0 C-N-CA 129.225 3.01 . . . . 0.0 112.72 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -85.31 155.02 10.84 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 CA-C-O 124.569 1.82 . . . . 0.0 108.605 162.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -48.54 136.81 12.52 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 111.945 -2.389 . . . . 0.0 115.889 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.65 5.61 9.38 Favored Glycine 0 CA--C 1.568 3.351 0 C-N-CA 130.691 3.996 . . . . 0.0 118.877 -173.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -43.18 112.4 0.37 Allowed 'General case' 0 C--N 1.416 3.459 0 O-C-N 121.241 -1.152 . . . . 0.0 113.102 162.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -82.06 35.07 0.42 Allowed 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -157.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -71.07 142.92 50.83 Favored 'General case' 0 C--O 1.276 2.482 0 CA-C-N 113.298 -1.774 . . . . 0.0 115.092 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.465 ' CG ' HH22 ' A' ' 89' ' ' ARG . 18.9 t0 -63.28 134.15 55.36 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 127.332 2.253 . . . . 0.0 112.723 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.68 -1.31 88.94 Favored Glycine 0 C--N 1.302 -1.327 0 N-CA-C 119.492 2.557 . . . . 0.0 119.492 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.64 137.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 123.32 3.56 . . . . 0.0 114.518 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.52 116.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.414 ' CE3' ' HB3' ' A' ' 86' ' ' TYR . 83.3 m95 -87.66 138.52 31.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.734 1.73 . . . . 0.0 113.172 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.23 139.96 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 O-C-N 120.577 -1.327 . . . . 0.0 114.166 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -156.18 152.72 28.2 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 115.692 -2.099 . . . . 0.0 116.139 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.3 p -101.51 142.82 32.32 Favored 'General case' 0 C--O 1.28 2.686 0 C-N-CA 125.537 1.535 . . . . 0.0 110.85 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.88 -25.62 68.24 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.439 -2.038 . . . . 0.0 113.709 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.77 -31.12 30.27 Favored Glycine 0 N--CA 1.512 3.701 1 O-C-N 115.813 -4.305 . . . . 0.0 119.638 161.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.89 151.03 27.47 Favored 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 127.729 2.411 . . . . 0.0 111.346 -170.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.16 148.98 22.14 Favored 'General case' 0 CA--C 1.59 2.518 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -61.87 -18.2 59.27 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 114.973 -2.441 . . . . 0.0 114.361 -166.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.4 p -66.56 146.16 99.03 Favored Pre-proline 0 C--O 1.261 1.701 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.48 132.5 27.42 Favored 'Trans proline' 0 CA--C 1.584 2.995 0 CA-C-N 122.992 2.104 . . . . 0.0 110.995 165.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 57.6 mmtt -80.75 54.6 2.17 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.982 1.713 . . . . 0.0 112.637 -168.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.73 -18.76 56.53 Favored 'General case' 0 N--CA 1.53 3.526 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -58.02 -59.8 4.72 Favored 'General case' 0 C--N 1.377 1.785 0 O-C-N 117.394 -3.316 . . . . 0.0 114.638 160.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.4 -19.26 24.66 Favored 'Isoleucine or valine' 0 C--N 1.364 1.207 0 O-C-N 123.996 0.81 . . . . 0.0 112.562 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.19 -0.75 84.86 Favored Glycine 0 N--CA 1.497 2.717 1 CA-C-O 112.843 -4.309 . . . . 0.0 117.634 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.0 p -131.3 -18.55 2.87 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 122.571 3.186 . . . . 0.0 118.396 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -64.74 -176.32 0.25 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.372 0.987 . . . . 0.0 112.608 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -92.89 113.89 61.06 Favored Pre-proline 0 C--N 1.382 1.995 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.856 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -81.3 4.77 6.73 Favored 'Trans proline' 0 C--N 1.385 2.482 0 O-C-N 123.15 1.079 . . . . 0.0 113.908 -170.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.83 19.46 2.49 Favored 'General case' 0 CA--C 1.6 2.882 0 O-C-N 127.367 2.917 . . . . 0.0 113.286 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.15 -38.62 35.52 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 126.447 1.899 . . . . 0.0 107.93 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.1 152.83 24.0 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.295 -1.321 . . . . 0.0 114.416 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.92 140.93 56.49 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 125.549 1.539 . . . . 0.0 113.816 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.3 152.28 29.64 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 125.013 2.339 . . . . 0.0 115.568 -166.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.42 127.6 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.1 t -52.83 106.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.183 -2.399 0 O-C-N 118.634 -2.542 . . . . 0.0 112.574 151.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.99 118.51 9.87 Favored 'General case' 0 C--N 1.362 1.112 0 O-C-N 128.365 3.541 . . . . 0.0 116.376 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -146.56 164.06 33.8 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.018 1.727 . . . . 0.0 107.035 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.06 160.56 30.56 Favored Pre-proline 0 N--CA 1.505 2.291 0 C-N-CA 126.83 2.052 . . . . 0.0 112.478 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -68.37 166.08 26.68 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 118.1 2.308 . . . . 0.0 118.1 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 54.74 31.72 15.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.019 1.728 . . . . 0.0 112.053 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.01 10.86 78.48 Favored Glycine 1 C--N 1.401 4.191 0 CA-C-O 118.996 -0.891 . . . . 0.0 112.381 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.6 m -57.37 119.88 7.23 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 128.478 2.711 . . . . 0.0 109.52 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -81.47 142.43 32.94 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.412 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.93 171.62 2.35 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 128.913 2.885 . . . . 0.0 111.105 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.84 147.15 96.18 Favored 'Trans proline' 0 C--N 1.384 2.418 0 CA-C-O 113.849 -2.646 . . . . 0.0 115.526 172.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -72.36 -16.22 61.86 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 128.757 3.786 . . . . 0.0 114.933 158.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.49 -14.55 9.39 Favored Glycine 0 C--N 1.358 1.786 0 CA-C-O 117.518 -1.712 . . . . 0.0 115.804 160.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -136.97 108.08 6.76 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.084 1.942 . . . . 0.0 111.381 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -59.46 144.61 46.6 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.89 1.805 . . . . 0.0 114.241 164.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.05 175.63 11.56 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 128.483 3.992 . . . . 0.0 112.635 -167.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.48 139.72 51.75 Favored 'General case' 0 N--CA 1.408 -2.549 0 O-C-N 117.386 -3.321 . . . . 0.0 110.129 158.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 96.35 175.88 35.89 Favored Glycine 0 N--CA 1.509 3.556 0 C-N-CA 130.214 3.769 . . . . 0.0 113.23 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.3 m 49.16 39.71 16.0 Favored 'General case' 0 N--CA 1.517 2.897 0 O-C-N 121.059 -1.26 . . . . 0.0 112.646 -176.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.0 mmm-85 -85.73 -5.81 59.21 Favored 'General case' 1 CA--C 1.636 4.278 0 CA-C-N 121.312 1.869 . . . . 0.0 113.765 174.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.22 9.75 84.22 Favored Glycine 0 C--O 1.218 -0.884 0 C-N-CA 128.526 2.965 . . . . 0.0 117.948 169.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.03 -166.25 42.44 Favored Glycine 0 N--CA 1.504 3.225 0 O-C-N 116.948 -3.678 . . . . 0.0 108.808 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.499 2.007 0 CA-C-O 116.233 -1.842 . . . . 0.0 114.887 -0.16 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C2'--C1' 1.48 -4.811 1 OP1-P-OP2 108.609 -7.327 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.599 6.863 4 O4'-C1'-N19 118.131 9.931 . 0.855 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O4'--C1' 1.486 5.985 4 O4'-C1'-N19 121.626 13.426 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 0.454 " H5'" ' CZ ' ' A' ' 88' ' ' ARG . . . . . . . . 1 C2'--O2' 1.47 4.399 1 O4'-C1'-C2' 112.033 4.024 . 0.01 4n . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.466 -5.242 1 O4'-C1'-N19 114.93 6.73 . 0.417 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 3 O4'--C1' 1.501 7.263 1 O5'-C5'-C4' 116.806 4.718 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.567 4.383 0 C4'-C3'-C2' 98.77 -3.93 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.673 8.017 1 C5'-C4'-O4' 121.863 9.045 . 0.01 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 C2'--C1' 1.449 -7.88 0 O4'-C1'-N19 111.416 3.216 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 C2'--O2' 1.515 7.819 2 N19-C1'-C2' 106.498 -4.314 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.128 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.09 150.06 94.7 Favored Pre-proline 0 CA--C 1.592 2.593 0 O-C-N 119.036 -2.449 . . . . 0.0 113.11 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.96 -172.19 1.36 Allowed 'Trans proline' 0 N--CA 1.526 3.394 0 CA-C-O 123.319 1.299 . . . . 0.0 115.378 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.63 129.24 39.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 116.974 -1.488 . . . . 0.0 110.828 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -82.87 -15.74 50.3 Favored 'General case' 0 CA--C 1.604 3.029 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m 63.24 -52.8 0.2 Allowed 'General case' 0 C--O 1.251 1.139 0 C-N-CA 128.079 2.552 . . . . 0.0 113.619 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.0 170.29 3.67 Favored 'General case' 0 CA--C 1.592 2.588 0 CA-C-N 123.52 2.873 . . . . 0.0 111.469 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.3 t -77.55 144.55 37.52 Favored 'General case' 0 CA--C 1.58 2.105 0 CA-C-O 113.577 -3.106 . . . . 0.0 113.515 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -95.15 -4.41 46.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 125.76 3.891 . . . . 0.0 113.296 172.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -120.93 164.64 16.39 Favored 'General case' 0 N--CA 1.513 2.689 0 O-C-N 119.069 -2.27 . . . . 0.0 109.34 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.9 p -56.43 146.88 23.08 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 126.392 2.307 . . . . 0.0 110.244 157.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.04 162.56 24.28 Favored 'General case' 0 CA--C 1.567 1.61 0 O-C-N 116.308 -3.995 . . . . 0.0 112.914 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.37 107.32 18.16 Favored 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.028 2.131 . . . . 0.0 114.676 -153.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.4 m -65.2 118.74 9.68 Favored 'General case' 0 C--O 1.18 -2.57 0 O-C-N 126.554 2.409 . . . . 0.0 111.194 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -55.55 124.53 17.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 129.732 3.213 . . . . 0.0 115.627 165.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.19 -7.09 4.84 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 128.538 2.735 . . . . 0.0 111.885 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.43 -141.77 12.55 Favored Glycine 0 N--CA 1.507 3.411 0 O-C-N 120.024 -1.672 . . . . 0.0 112.801 165.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -137.61 -34.56 0.69 Allowed 'General case' 0 C--O 1.177 -2.712 0 O-C-N 116.68 -3.835 . . . . 0.0 110.041 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -58.27 138.0 56.68 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.72 2.408 . . . . 0.0 109.495 173.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -80.08 168.97 18.48 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 124.346 2.022 . . . . 0.0 111.309 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -72.62 61.88 0.53 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 118.677 -2.514 . . . . 0.0 112.281 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.43 149.26 36.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.549 -1.969 . . . . 0.0 114.032 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.08 91.65 23.42 Favored Pre-proline 0 CA--C 1.587 2.374 0 O-C-N 126.176 2.173 . . . . 0.0 110.479 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.09 148.17 18.28 Favored 'Trans proline' 0 C--O 1.195 -1.628 0 C-N-CA 123.697 2.931 . . . . 0.0 110.187 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 53.14 6.46 0.06 Allowed 'General case' 0 C--N 1.372 1.558 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.66 23.08 42.36 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 129.94 3.638 . . . . 0.0 113.589 -169.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -69.31 107.15 3.16 Favored 'General case' 0 CA--C 1.573 1.841 0 O-C-N 120.116 -1.814 . . . . 0.0 108.378 159.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.86 25.69 0.03 OUTLIER Glycine 0 C--N 1.385 3.277 0 C-N-CA 127.131 2.301 . . . . 0.0 113.626 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.49 123.25 78.95 Favored Pre-proline 0 C--N 1.374 1.674 1 O-C-N 114.518 -5.107 . . . . 0.0 110.775 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.63 173.47 12.19 Favored 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.84 2.36 . . . . 0.0 111.66 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -69.24 138.29 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 O-C-N 118.812 -2.43 . . . . 0.0 117.476 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.56 103.06 1.74 Allowed 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 116.938 -1.506 . . . . 0.0 111.144 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 m -71.95 -16.44 62.1 Favored 'General case' 0 CA--C 1.563 1.456 1 C-N-CA 133.009 4.524 . . . . 0.0 112.835 -175.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -83.84 17.08 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 115.139 -2.362 . . . . 0.0 113.137 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.8 p -146.79 176.7 9.67 Favored 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.291 22.0 p -130.18 -174.08 0.36 Allowed Pre-proline 0 C--N 1.289 -2.03 0 O-C-N 118.999 -2.313 . . . . 0.0 111.18 -166.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -73.25 -28.95 11.99 Favored 'Trans proline' 0 C--O 1.196 -1.585 0 CA-C-N 120.739 1.3 . . . . 0.0 113.428 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.45 -24.07 64.93 Favored 'General case' 0 CA--C 1.608 3.191 0 CA-C-O 123.141 1.448 . . . . 0.0 113.428 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.263 69.6 m-20 -92.12 -15.17 28.07 Favored 'General case' 0 C--O 1.187 -2.193 0 O-C-N 118.121 -2.862 . . . . 0.0 113.702 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -74.63 54.64 0.62 Allowed 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 118.144 2.646 . . . . 0.0 118.144 -169.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.07 148.3 17.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.4 -158.47 28.83 Favored Glycine 0 CA--C 1.543 1.82 0 O-C-N 118.558 -2.589 . . . . 0.0 111.585 -173.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -147.13 160.54 42.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.676 2.391 . . . . 0.0 116.981 -172.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -104.52 155.24 18.99 Favored 'General case' 0 CA--C 1.585 2.317 0 C-N-CA 130.327 3.451 . . . . 0.0 110.841 160.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.444 HH21 ' P ' ' B' ' 5' ' ' ' U' . 18.2 ttp180 -145.38 146.95 31.77 Favored 'General case' 0 C--O 1.191 -2.02 0 O-C-N 125.804 1.94 . . . . 0.0 109.49 171.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -62.35 154.69 27.25 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.081 1.752 . . . . 0.0 115.595 171.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.18 124.24 30.23 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 129.019 2.928 . . . . 0.0 111.606 158.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -110.36 -18.76 13.18 Favored 'General case' 0 N--CA 1.514 2.736 0 C-N-CA 128.56 2.744 . . . . 0.0 114.811 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 48.0 41.89 15.74 Favored 'General case' 0 C--N 1.382 2.021 0 C-N-CA 124.417 1.087 . . . . 0.0 112.368 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -91.09 -26.38 19.17 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 131.646 3.978 . . . . 0.0 107.652 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.282 1.7 mp 68.05 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 O-C-N 128.319 3.512 . . . . 0.0 114.084 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -136.31 81.77 1.9 Allowed 'General case' 0 C--O 1.276 2.482 0 C-N-CA 127.754 2.421 . . . . 0.0 107.507 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.21 47.63 43.55 Favored Glycine 0 N--CA 1.48 1.62 0 C-N-CA 126.771 2.129 . . . . 0.0 113.786 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.68 -155.95 47.35 Favored Glycine 1 CA--C 1.578 4.013 0 CA-C-N 113.889 -1.155 . . . . 0.0 112.165 -171.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 67.37 -1.48 1.52 Allowed 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 130.234 3.414 . . . . 0.0 114.387 -159.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.35 154.28 25.39 Favored Glycine 0 CA--C 1.571 3.564 0 O-C-N 118.103 -2.873 . . . . 0.0 118.681 170.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -71.91 128.63 36.34 Favored 'General case' 0 N--CA 1.52 3.056 0 O-C-N 119.503 -2.175 . . . . 0.0 114.606 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.3 mtp -84.57 127.72 34.21 Favored 'General case' 0 C--O 1.268 2.027 0 O-C-N 118.707 -2.496 . . . . 0.0 106.461 165.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -119.85 -6.94 10.05 Favored 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 127.637 2.375 . . . . 0.0 112.365 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 60.2 65.99 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.36 1.864 . . . . 0.0 107.22 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.49 HD21 " H1'" ' B' ' 7' ' ' ' A' . 24.3 mt -115.49 157.95 23.28 Favored 'General case' 0 C--O 1.278 2.598 0 C-N-CA 127.79 2.436 . . . . 0.0 112.027 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 t -60.35 158.59 27.83 Favored Pre-proline 0 C--O 1.263 1.804 0 O-C-N 125.891 1.994 . . . . 0.0 114.589 163.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.38 159.2 45.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 123.387 2.724 . . . . 0.0 114.494 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -135.56 152.03 50.89 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -126.08 136.09 52.5 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.358 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.81 130.94 53.49 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 127.763 3.165 . . . . 0.0 112.174 -164.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -102.36 147.18 27.02 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -145.57 153.06 40.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 127.42 2.95 . . . . 0.0 114.639 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -89.26 166.95 13.46 Favored 'General case' 0 CA--C 1.617 3.52 1 CA-C-N 126.64 4.291 . . . . 0.0 112.697 170.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -54.99 123.49 13.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.002 -1.454 . . . . 0.0 113.31 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.09 25.44 68.91 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 126.354 2.284 . . . . 0.0 111.558 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.6 p -132.56 169.39 16.68 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 118.757 -2.614 . . . . 0.0 107.049 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.06 -168.8 49.27 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 112.357 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.5 -26.12 12.29 Favored 'Trans proline' 0 N--CA 1.437 -1.848 1 C-N-CA 127.428 5.419 . . . . 0.0 112.675 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -101.04 31.99 3.4 Favored 'General case' 1 N--CA 1.561 5.117 0 C-N-CA 127.436 2.294 . . . . 0.0 109.47 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.28 -22.91 33.17 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.73 79.18 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.408 1.956 . . . . 0.0 115.281 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.59 125.96 81.62 Favored Pre-proline 0 CA--C 1.499 -1.007 0 CA-C-O 114.663 -2.589 . . . . 0.0 111.005 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 176.69 4.86 Favored 'Trans proline' 0 C--O 1.193 -1.755 0 CA-C-N 124.135 2.512 . . . . 0.0 109.367 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.97 137.17 55.94 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 125.051 1.34 . . . . 0.0 112.172 173.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.08 5.26 65.21 Favored Glycine 0 C--N 1.379 2.918 0 CA-C-O 125.028 2.46 . . . . 0.0 117.56 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.77 47.28 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 117.391 -3.417 . . . . 0.0 111.647 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -74.32 107.37 6.44 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 111.44 -2.618 . . . . 0.0 110.897 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -136.81 124.06 21.84 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.219 1.007 . . . . 0.0 110.175 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.26 107.76 0.7 Allowed 'General case' 0 CA--C 1.596 2.735 0 C-N-CA 128.108 2.563 . . . . 0.0 109.686 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.52 26.78 Favored Glycine 0 N--CA 1.503 3.123 0 C-N-CA 128.581 2.991 . . . . 0.0 111.175 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.25 119.03 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 124.184 0.994 . . . . 0.0 108.893 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.2 mm -101.39 120.54 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-O 124.261 1.981 . . . . 0.0 115.491 164.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -80.76 136.68 36.18 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 116.305 -3.997 . . . . 0.0 118.152 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -139.54 128.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.262 1.743 0 CA-C-N 123.813 3.006 . . . . 0.0 113.425 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.3 23.21 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 128.038 2.535 . . . . 0.0 109.54 -166.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.1 p -137.3 153.38 50.3 Favored 'General case' 0 C--O 1.277 2.504 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.42 -28.55 65.15 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 118.672 -2.517 . . . . 0.0 111.225 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.58 -0.28 89.86 Favored Glycine 1 N--CA 1.517 4.041 0 C-N-CA 128.412 2.911 . . . . 0.0 112.852 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.47 156.03 24.29 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 120.356 2.078 . . . . 0.0 109.009 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.3 mt -95.41 144.1 26.21 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 124.49 2.091 . . . . 0.0 109.054 167.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . 0.328 1.4 p-10 -75.73 26.9 0.11 Allowed 'General case' 0 C--N 1.389 2.283 0 O-C-N 117.934 -2.979 . . . . 0.0 113.601 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.0 p -91.62 158.92 39.66 Favored Pre-proline 0 CA--C 1.554 1.134 0 O-C-N 117.511 -3.243 . . . . 0.0 104.088 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -80.21 142.55 15.22 Favored 'Trans proline' 0 C--N 1.37 1.683 0 N-CA-C 105.087 -2.697 . . . . 0.0 105.087 173.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -88.19 74.64 8.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 117.0 -3.563 . . . . 0.0 107.419 -174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.12 -39.31 92.12 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 122.464 2.393 . . . . 0.0 114.436 -166.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -64.78 -59.32 4.36 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.2 mt -61.11 -23.93 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.088 0 C-N-CA 127.852 2.461 . . . . 0.0 115.633 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.57 -2.74 89.99 Favored Glycine 0 C--O 1.255 1.43 0 N-CA-C 120.163 2.825 . . . . 0.0 120.163 164.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.8 p -130.66 -35.18 1.49 Allowed 'General case' 0 C--O 1.179 -2.641 0 CA-C-N 122.803 3.301 . . . . 0.0 111.504 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -69.03 147.6 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 118.729 -2.482 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -44.21 121.15 3.89 Favored Pre-proline 1 N--CA 1.545 4.297 0 CA-C-O 115.197 -2.335 . . . . 0.0 111.562 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.56 -14.88 5.36 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 123.905 3.07 . . . . 0.0 116.504 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.22 9.8 9.88 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -163.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -69.31 -14.88 63.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 118.577 -2.577 . . . . 0.0 115.504 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.47 171.87 10.68 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 124.915 1.384 . . . . 0.0 108.367 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.13 143.85 5.53 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 118.279 -2.763 . . . . 0.0 114.191 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.51 109.11 1.85 Allowed 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 127.257 2.223 . . . . 0.0 110.529 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.67 132.23 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 128.137 2.575 . . . . 0.0 107.562 -160.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.51 97.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.7 114.79 12.37 Favored 'General case' 0 C--O 1.255 1.389 0 O-C-N 121.118 -0.989 . . . . 0.0 109.086 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -147.63 146.15 29.24 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 128.528 2.731 . . . . 0.0 107.56 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.16 153.01 53.82 Favored Pre-proline 0 CA--C 1.592 2.592 0 O-C-N 118.827 -2.421 . . . . 0.0 113.186 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -43.33 160.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.392 2.819 0 N-CA-C 119.029 2.665 . . . . 0.0 119.029 161.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 56.15 18.32 3.18 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 127.073 2.149 . . . . 0.0 109.733 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.21 19.35 70.19 Favored Glycine 0 C--O 1.187 -2.804 0 CA-C-N 119.764 1.165 . . . . 0.0 113.037 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.5 m -65.27 123.83 20.6 Favored 'General case' 0 C--O 1.262 1.729 0 CA-C-N 118.9 1.35 . . . . 0.0 108.005 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.6 m -74.86 138.26 42.36 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 124.463 2.078 . . . . 0.0 108.058 -165.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.5 mt -66.16 154.15 90.6 Favored Pre-proline 1 N--CA 1.553 4.716 1 CA-C-O 111.205 -4.236 . . . . 0.0 110.314 170.799 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -55.41 137.02 76.35 Favored 'Trans proline' 0 CA--C 1.559 1.752 1 C-N-CA 129.05 6.5 . . . . 0.0 113.718 -172.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -75.66 -16.64 60.17 Favored 'General case' 0 N--CA 1.481 1.117 1 O-C-N 115.67 -4.394 . . . . 0.0 112.688 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.46 -9.65 13.41 Favored Glycine 0 N--CA 1.512 3.701 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 166.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -119.39 157.54 27.97 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.141 2.97 . . . . 0.0 111.376 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -104.51 136.31 44.31 Favored 'General case' 0 CA--C 1.605 3.077 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.264 165.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.29 -173.17 4.3 Favored 'General case' 0 C--N 1.384 2.108 0 C-N-CA 127.964 2.506 . . . . 0.0 111.106 -158.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -73.99 152.34 40.07 Favored 'General case' 0 N--CA 1.519 3.021 0 C-N-CA 126.542 1.937 . . . . 0.0 109.891 158.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 71.55 174.85 21.53 Favored Glycine 0 CA--C 1.568 3.378 0 O-C-N 127.201 2.813 . . . . 0.0 116.567 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.9 m 57.66 37.74 27.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 125.291 2.472 . . . . 0.0 109.343 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -69.78 -17.27 63.41 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 54.78 -162.51 4.27 Favored Glycine 1 N--CA 1.527 4.742 1 C-N-CA 132.849 5.023 . . . . 0.0 110.522 -170.105 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.14 -164.12 25.82 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 118.471 -1.183 . . . . 0.0 112.922 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.27 2.156 2 CA-C-N 124.835 4.318 . . . . 0.0 112.401 -18.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C5'--C4' 1.627 8.969 2 OP1-P-OP2 110.472 -6.085 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 5 P--O3' 1.496 -9.285 1 O4'-C1'-N19 113.78 5.58 . 0.01 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O4'--C1' 1.476 5.13 1 O4'-C1'-N19 115.413 7.213 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.571 4.688 6 C5'-C4'-O4' 120.205 7.861 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.444 ' P ' HH21 ' A' ' 88' ' ' ARG . . . . . . . . 2 P--O3' 1.541 -5.518 3 O4'-C1'-N19 112.896 4.696 . 0.432 1t . 0.0 . . . . . . . . . . 3 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.39 -5.255 2 O4'-C1'-N19 113.238 5.038 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ' A' . . . . . 0.49 " H1'" HD21 ' A' ' 104' ' ' LEU . . . . . . . . 2 P--O5' 1.692 9.851 3 O4'-C1'-N19 116.088 7.888 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.452 3.188 3 C1'-O4'-C4' 104.814 -5.318 . 0.374 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 4 C2'--O2' 1.487 5.704 0 O5'-C5'-C4' 106.279 -2.801 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.395 4 O4'-C1'-N19 114.35 6.15 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.259 0 CA-C-O 123.283 1.491 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.83 159.36 54.69 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.78 151.8 74.21 Favored 'Trans proline' 0 N--CA 1.512 2.57 0 N-CA-C 118.439 2.438 . . . . 0.0 118.439 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.64 111.56 2.13 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 127.247 3.403 . . . . 0.0 109.553 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -58.81 -11.8 3.64 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 118.804 -2.435 . . . . 0.0 110.758 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m 46.22 -50.22 0.0 OUTLIER 'General case' 0 C--N 1.364 1.23 1 C-N-CA 133.036 4.534 . . . . 0.0 119.942 -170.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.18 154.24 23.87 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 131.808 4.043 . . . . 0.0 112.052 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.0 t -82.5 137.57 34.58 Favored 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 127.385 2.274 . . . . 0.0 115.64 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -76.13 -21.05 57.05 Favored 'General case' 0 CA--C 1.615 3.461 0 CA-C-O 122.797 1.284 . . . . 0.0 110.56 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -88.29 173.01 9.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 118.389 -2.695 . . . . 0.0 113.952 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p -71.98 172.23 10.38 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 119.25 -2.156 . . . . 0.0 110.84 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . 0.309 . . -117.18 132.73 56.58 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 119.666 -1.896 . . . . 0.0 114.764 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.7 mt -70.25 163.42 26.51 Favored 'General case' 0 N--CA 1.513 2.677 0 C-N-CA 129.74 3.216 . . . . 0.0 111.643 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.9 m -128.15 131.12 48.95 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 168.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -66.92 149.95 49.89 Favored 'General case' 0 CA--C 1.6 2.893 0 C-N-CA 124.259 1.024 . . . . 0.0 112.083 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -151.53 -19.81 0.2 Allowed 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.611 -1.931 . . . . 0.0 113.43 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.94 -125.65 0.83 Allowed Glycine 0 CA--C 1.548 2.153 0 C-N-CA 128.107 2.765 . . . . 0.0 113.748 160.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -156.68 -22.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -69.32 139.68 54.3 Favored 'General case' 0 C--O 1.279 2.654 0 C-N-CA 126.272 1.829 . . . . 0.0 115.638 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.77 164.72 9.51 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 128.507 2.723 . . . . 0.0 115.816 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.8 tp -82.7 52.34 2.09 Favored 'General case' 0 CA--C 1.569 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 113.823 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -55.23 138.47 44.93 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 118.984 -2.323 . . . . 0.0 109.604 -171.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 50.5 m-85 -128.47 129.29 23.57 Favored Pre-proline 0 C--O 1.187 -2.221 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -84.11 137.75 7.48 Favored 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.315 4.01 . . . . 0.0 109.477 -170.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 45.81 23.82 0.18 Allowed 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.88 7.38 65.9 Favored Glycine 0 CA--C 1.567 3.325 0 CA-C-O 117.242 -1.865 . . . . 0.0 112.044 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -65.42 72.37 0.05 OUTLIER 'General case' 0 C--O 1.19 -2.052 0 CA-C-N 119.847 1.824 . . . . 0.0 111.892 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.16 33.96 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.206 0 CA-C-N 122.968 2.622 . . . . 0.0 119.398 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -74.43 119.36 76.14 Favored Pre-proline 0 C--O 1.257 1.453 0 O-C-N 118.708 -2.642 . . . . 0.0 110.593 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.51 161.49 20.56 Favored 'Trans proline' 0 CA--C 1.601 3.835 0 N-CA-C 119.035 2.667 . . . . 0.0 119.035 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.19 131.17 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 O-C-N 126.139 2.149 . . . . 0.0 108.922 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -165.12 91.96 0.55 Allowed 'General case' 0 N--CA 1.536 3.84 0 C-N-CA 128.65 2.78 . . . . 0.0 106.031 172.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -67.61 -21.22 65.41 Favored 'General case' 0 C--O 1.185 -2.315 0 CA-C-O 123.676 1.703 . . . . 0.0 113.607 -174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -55.41 -50.25 70.27 Favored 'General case' 0 N--CA 1.421 -1.889 1 O-C-N 115.342 -4.599 . . . . 0.0 114.897 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.2 p -58.36 153.86 14.72 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 119.069 2.988 . . . . 0.0 119.069 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.2 t -78.31 145.73 69.02 Favored Pre-proline 0 C--O 1.17 -3.128 0 O-C-N 125.241 1.588 . . . . 0.0 108.767 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.91 -34.72 16.86 Favored 'Trans proline' 0 CA--C 1.587 3.139 1 C-N-CA 125.755 4.303 . . . . 0.0 113.086 162.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.31 -38.77 92.45 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.646 1.178 . . . . 0.0 108.954 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.25 -19.66 66.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-O 116.201 -1.857 . . . . 0.0 114.629 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -84.62 81.18 8.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 123.523 2.874 . . . . 0.0 114.094 -151.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 tt -163.52 130.83 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.926 0 C-N-CA 126.999 2.12 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 -157.7 15.51 Favored Glycine 0 CA--C 1.557 2.702 0 CA-C-O 124.289 2.049 . . . . 0.0 115.902 -166.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -161.05 146.85 14.46 Favored 'General case' 0 C--O 1.284 2.897 0 CA-C-O 122.624 1.202 . . . . 0.0 112.547 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 4.2 m-85 -97.78 141.33 30.91 Favored 'General case' 0 C--O 1.171 -3.061 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.221 162.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -125.47 143.45 50.99 Favored 'General case' 0 C--O 1.202 -1.407 0 C-N-CA 125.668 1.587 . . . . 0.0 108.016 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.501 HH22 ' CG ' ' A' ' 128' ' ' ASP . 1.2 ptt180 -54.8 174.19 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 126.015 2.072 . . . . 0.0 116.348 163.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.29 139.59 13.38 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 115.181 -2.342 . . . . 0.0 108.999 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.5 p -127.11 -21.16 4.0 Favored 'General case' 0 C--O 1.262 1.747 0 C-N-CA 127.395 2.278 . . . . 0.0 113.297 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 46.01 49.14 12.28 Favored 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 125.512 1.525 . . . . 0.0 108.597 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -97.8 -9.71 26.04 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 127.248 2.219 . . . . 0.0 110.158 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 96' ' ' GLY 0.303 2.1 mp 64.57 157.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.592 2.59 0 O-C-N 120.398 -1.439 . . . . 0.0 114.478 176.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HG3' ' H3 ' ' B' ' 3' ' ' ' U' . 49.4 mtt-85 -139.61 55.28 1.67 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.914 1.34 . . . . 0.0 107.394 169.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 94' ' ' ILE . . . 103.22 -3.12 47.31 Favored Glycine 0 C--N 1.349 1.285 0 C-N-CA 127.334 2.397 . . . . 0.0 116.034 166.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.35 -172.73 45.74 Favored Glycine 0 C--N 1.358 1.805 0 O-C-N 119.038 -2.448 . . . . 0.0 113.756 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 55.54 12.29 0.75 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 112.418 -1.891 . . . . 0.0 116.086 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.54 -178.66 42.82 Favored Glycine 0 N--CA 1.49 2.288 0 CA-C-N 114.302 -1.317 . . . . 0.0 114.037 172.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -116.46 146.71 42.35 Favored 'General case' 0 N--CA 1.503 2.189 1 CA-C-N 107.909 -4.146 . . . . 0.0 111.872 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 20.4 mtt -86.66 150.28 24.31 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 115.49 -2.195 . . . . 0.0 112.701 174.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -138.91 -7.01 1.42 Allowed 'General case' 0 C--O 1.205 -1.284 0 O-C-N 127.705 3.128 . . . . 0.0 115.593 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 56.1 40.31 30.22 Favored 'General case' 0 CA--C 1.583 2.232 1 CA-C-O 129.032 4.253 . . . . 0.0 116.367 167.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.61 165.38 13.33 Favored 'General case' 0 C--N 1.375 1.704 0 O-C-N 117.897 -3.002 . . . . 0.0 116.048 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.0 t -60.03 147.78 79.24 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 121.988 0.899 . . . . 0.0 112.367 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -53.56 132.65 49.98 Favored 'Trans proline' 0 C--N 1.408 3.68 1 C-N-CA 125.939 4.426 . . . . 0.0 115.18 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -94.53 171.71 8.64 Favored 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 125.882 1.673 . . . . 0.0 114.601 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -146.03 139.5 26.14 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 119.571 -1.955 . . . . 0.0 113.228 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -128.86 170.23 13.64 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.262 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -114.14 136.3 53.09 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 127.809 2.443 . . . . 0.0 114.664 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.69 144.14 48.98 Favored 'General case' 0 CA--C 1.603 2.997 0 C-N-CA 126.496 1.918 . . . . 0.0 111.277 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.68 167.92 13.45 Favored 'General case' 0 N--CA 1.515 2.786 0 CA-C-O 123.603 1.668 . . . . 0.0 107.83 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.65 137.32 57.75 Favored 'General case' 0 C--O 1.199 -1.59 0 CA-C-O 115.671 -2.109 . . . . 0.0 109.599 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.63 -13.7 60.0 Favored Glycine 0 CA--C 1.569 3.446 0 CA-C-O 126.399 3.222 . . . . 0.0 114.815 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -119.31 171.94 7.96 Favored 'General case' 0 C--O 1.196 -1.716 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.01 -168.75 37.61 Favored Glycine 0 CA--C 1.566 3.252 0 O-C-N 129.001 3.938 . . . . 0.0 111.227 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -59.57 -39.81 71.48 Favored 'Trans proline' 0 N--CA 1.515 2.744 0 C-N-CA 122.56 2.174 . . . . 0.0 112.854 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -95.58 42.14 1.09 Allowed 'General case' 0 CA--C 1.588 2.408 0 O-C-N 119.854 -1.779 . . . . 0.0 112.486 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.53 -25.75 18.15 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 129.438 3.095 . . . . 0.0 114.863 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -87.62 -15.63 61.41 Favored Glycine 0 N--CA 1.478 1.499 0 C-N-CA 126.184 1.849 . . . . 0.0 115.434 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.22 135.56 84.61 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 120.01 1.905 . . . . 0.0 113.773 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -89.16 156.81 5.67 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 124.438 1.757 . . . . 0.0 113.685 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.72 128.15 34.87 Favored 'General case' 0 C--O 1.273 2.342 0 CA-C-O 115.811 -2.042 . . . . 0.0 113.089 -169.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.82 21.05 66.82 Favored Glycine 0 N--CA 1.406 -3.306 0 CA-C-N 122.765 2.529 . . . . 0.0 118.791 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.88 155.34 38.65 Favored 'General case' 0 C--O 1.268 2.071 0 O-C-N 120.817 -1.402 . . . . 0.0 114.29 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.89 43.99 1.04 Allowed 'General case' 0 C--O 1.269 2.084 0 CA-C-N 121.881 2.128 . . . . 0.0 109.81 -174.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -59.45 137.32 58.04 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-N 122.606 2.457 . . . . 0.0 113.009 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.501 ' CG ' HH22 ' A' ' 89' ' ' ARG . 49.6 t0 -57.44 118.38 5.11 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 128.032 2.533 . . . . 0.0 113.422 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.09 19.17 54.17 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 126.351 2.282 . . . . 0.0 117.697 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.49 121.83 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 131.301 3.84 . . . . 0.0 106.79 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.97 119.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 O-C-N 125.726 1.891 . . . . 0.0 114.017 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -76.47 141.48 41.3 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.67 149.7 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 118.242 -2.786 . . . . 0.0 112.811 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.36 -179.48 6.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.786 -2.007 . . . . 0.0 115.64 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -144.37 160.06 41.68 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 127.496 2.318 . . . . 0.0 111.927 163.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -61.48 -51.55 68.21 Favored 'General case' 0 CA--C 1.561 1.383 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.72 -6.14 54.21 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.969 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.61 158.58 29.72 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 126.549 1.94 . . . . 0.0 115.602 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.48 134.89 39.1 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 122.263 2.301 . . . . 0.0 114.004 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -64.52 59.59 0.02 OUTLIER 'General case' 0 CA--C 1.593 2.602 0 C-N-CA 129.538 3.135 . . . . 0.0 109.658 170.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.5 p -150.39 153.16 34.29 Favored Pre-proline 0 N--CA 1.509 2.5 0 C-N-CA 125.061 1.344 . . . . 0.0 113.135 -170.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.45 146.43 50.07 Favored 'Trans proline' 0 CA--C 1.555 1.539 1 C-N-CA 125.416 4.077 . . . . 0.0 112.928 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -114.6 47.02 1.29 Allowed 'General case' 0 C--O 1.264 1.847 0 CA-C-O 125.614 2.626 . . . . 0.0 104.385 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -52.81 -29.63 28.71 Favored 'General case' 0 N--CA 1.489 1.494 1 O-C-N 116.189 -4.069 . . . . 0.0 114.145 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -60.89 -51.51 68.96 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 122.138 2.245 . . . . 0.0 111.115 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.63 -26.81 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 CA-C-O 123.753 1.74 . . . . 0.0 112.058 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -69.68 -12.13 66.77 Favored Glycine 1 CA--C 1.6 5.406 0 CA-C-N 112.676 -2.056 . . . . 0.0 114.041 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 66.9 p -148.29 -29.56 0.3 Allowed 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 123.787 3.794 . . . . 0.0 113.789 -159.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.81 168.14 19.45 Favored 'General case' 0 C--O 1.201 -1.448 1 O-C-N 116.111 -4.118 . . . . 0.0 112.157 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . 0.3 54.7 t-20 -75.44 110.5 10.62 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 128.746 3.779 . . . . 0.0 109.377 -156.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.53 -9.94 18.7 Favored 'Trans proline' 0 C--N 1.396 3.04 1 C-N-CA 128.909 6.406 . . . . 0.0 109.879 -164.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.9 44.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.324 -1.485 . . . . 0.0 114.174 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -68.41 -62.95 1.17 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.164 0.586 . . . . 0.0 110.89 155.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -81.96 153.86 26.04 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 117.17 -1.395 . . . . 0.0 112.461 160.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.29 160.24 22.1 Favored 'General case' 0 CA--C 1.595 2.697 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -36.84 125.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -75.57 134.59 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 O-C-N 126.104 2.128 . . . . 0.0 110.766 172.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.11 125.83 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 O-C-N 118.332 -2.73 . . . . 0.0 107.541 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.42 97.1 6.24 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.315 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -148.53 146.68 28.42 Favored 'General case' 0 C--N 1.375 1.717 0 CA-C-O 126.706 3.146 . . . . 0.0 108.041 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 92.9 mt -85.76 146.19 43.15 Favored Pre-proline 0 C--O 1.255 1.348 0 C-N-CA 128.705 2.802 . . . . 0.0 118.109 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -49.24 164.62 0.27 Allowed 'Trans proline' 0 CA--C 1.57 2.321 1 C-N-CA 125.92 4.413 . . . . 0.0 113.092 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 56.49 32.41 20.71 Favored 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 127.974 2.509 . . . . 0.0 112.949 166.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.45 44.97 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 117.053 -1.971 . . . . 0.0 116.471 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.5 m -59.8 131.02 49.62 Favored 'General case' 0 C--N 1.379 1.89 0 O-C-N 125.583 1.402 . . . . 0.0 108.875 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 94.1 m -90.96 141.86 28.39 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.085 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.5 154.57 93.3 Favored Pre-proline 0 C--O 1.276 2.485 0 CA-C-N 123.529 2.877 . . . . 0.0 110.203 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.22 130.6 28.95 Favored 'Trans proline' 0 C--N 1.402 3.387 0 C-N-CA 124.259 3.306 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -64.56 -4.64 4.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.243 1.817 . . . . 0.0 113.872 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.76 -11.39 49.54 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 116.442 -2.31 . . . . 0.0 113.899 164.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.43 143.38 43.66 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 128.826 2.851 . . . . 0.0 116.1 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.88 154.14 38.35 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 123.801 1.762 . . . . 0.0 113.191 148.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.0 -179.26 7.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 127.125 3.345 . . . . 0.0 108.447 -162.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.77 160.34 30.1 Favored 'General case' 0 CA--C 1.567 1.625 1 O-C-N 114.135 -5.353 . . . . 0.0 111.531 154.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.49 -173.28 46.9 Favored Glycine 0 C--O 1.258 1.645 0 C-N-CA 126.047 1.784 . . . . 0.0 112.72 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.451 ' HB2' " H2'" ' B' ' 10' ' ' ' G' . 17.5 m 62.73 34.09 14.97 Favored 'General case' 0 CA--C 1.603 3.012 0 C-N-CA 126.061 1.744 . . . . 0.0 113.041 174.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.522 HH22 ' P ' ' B' ' 9' ' ' ' C' . 3.6 mmm180 -94.2 -8.39 39.46 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 118.899 2.926 . . . . 0.0 118.899 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.92 -166.91 54.31 Favored Glycine 0 C--N 1.302 -1.36 0 O-C-N 126.971 2.67 . . . . 0.0 113.941 -157.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.25 176.02 37.57 Favored Glycine 0 CA--C 1.556 2.6 0 CA-C-N 117.802 0.801 . . . . 0.0 112.082 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 CA--C 1.579 2.069 1 O-C-N 115.588 -4.478 . . . . 0.0 110.801 3.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.549 3.003 1 O4'-C1'-N19 113.906 5.706 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O3'--C3' 1.471 3.409 2 O4'-C1'-N19 114.839 6.639 . 0.522 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.416 ' H3 ' ' HG3' ' A' ' 95' ' ' ARG . . . . . . . . 2 C3'--C2' 1.608 7.526 1 O3'-P-O5' 112.844 4.654 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--OP2 1.429 -3.284 5 O4'-C1'-N19 115.35 7.15 . 0.01 4n . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.586 5.765 4 O4'-C1'-N19 118.234 10.034 . 0.547 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.549 3.006 2 C3'-C2'-C1' 107.494 6.66 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.512 -8.103 2 C4'-C3'-C2' 94.958 -7.742 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.586 5.605 3 O4'-C1'-N19 116.227 8.027 . 0.01 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ' C' . . . . . 0.522 ' P ' HH22 ' A' ' 177' ' ' ARG . . . . . . . . 0 C2'--O2' 1.458 3.498 3 O4'-C1'-C2' 115.718 6.656 . 0.513 &a . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ' G' . . . . . 0.451 " H2'" ' HB2' ' A' ' 176' ' ' SER . . . . . . . . 1 O4'--C4' 1.404 -4.054 2 O4'-C1'-N19 117.082 8.882 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.882 0 N-CA-C 116.526 1.37 . . . . 0.0 116.526 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.0 mt -60.08 150.86 68.74 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 120.588 -1.536 . . . . 0.0 109.686 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.3 179.93 5.36 Favored 'Trans proline' 0 N--CA 1.514 2.731 0 CA-C-O 123.708 1.462 . . . . 0.0 110.402 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -84.44 123.23 30.01 Favored 'General case' 0 C--O 1.272 2.276 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.239 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -70.25 -13.97 62.41 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 117.838 -3.039 . . . . 0.0 113.86 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m 58.53 -29.31 0.03 OUTLIER 'General case' 0 CA--C 1.588 2.406 0 N-CA-C 118.648 2.832 . . . . 0.0 118.648 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.422 ' HB3' ' HG2' ' A' ' 151' ' ' PRO . . . -87.53 150.04 23.98 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 126.224 1.809 . . . . 0.0 112.335 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -87.68 136.24 33.03 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 118.718 -2.489 . . . . 0.0 113.755 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -80.31 -2.18 44.13 Favored 'General case' 0 C--O 1.185 -2.303 0 C-N-CA 124.959 1.304 . . . . 0.0 109.136 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -123.16 156.42 35.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 119.433 -2.042 . . . . 0.0 113.169 -168.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.8 p -64.87 142.98 58.25 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.56 164.49 21.89 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 127.287 2.867 . . . . 0.0 114.518 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.37 153.06 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.201 0.938 . . . . 0.0 112.308 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -119.22 128.23 54.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.14 -2.85 . . . . 0.0 106.534 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.95 150.36 29.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 108.205 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -138.01 -19.79 1.13 Allowed 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 122.097 0.951 . . . . 0.0 111.881 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.0 -128.12 6.2 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 123.558 1.643 . . . . 0.0 112.392 166.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -142.04 -24.72 0.68 Allowed 'General case' 0 CA--C 1.588 2.407 0 C-N-CA 125.023 1.329 . . . . 0.0 113.572 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.295 25.4 tp10 -60.49 138.85 57.95 Favored 'General case' 0 CA--C 1.609 3.226 0 O-C-N 118.671 -2.518 . . . . 0.0 114.859 173.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.97 163.69 11.72 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 122.742 1.258 . . . . 0.0 114.288 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tp -73.82 54.75 0.51 Allowed 'General case' 0 C--O 1.288 3.112 0 CA-C-N 112.36 -2.2 . . . . 0.0 114.45 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -59.81 159.54 8.78 Favored 'General case' 0 N--CA 1.406 -2.628 0 C-N-CA 127.102 2.161 . . . . 0.0 116.327 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.464 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 77.1 m-85 -145.47 125.37 7.04 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -47.18 117.28 2.14 Favored 'Trans proline' 0 N--CA 1.452 -0.945 1 C-N-CA 125.492 4.128 . . . . 0.0 115.169 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 43.56 23.86 0.05 Allowed 'General case' 1 N--CA 1.557 4.92 1 C-N-CA 131.8 4.04 . . . . 0.0 110.898 -171.41 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.33 17.45 62.47 Favored Glycine 0 CA--C 1.551 2.326 0 O-C-N 117.444 -3.285 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -88.87 111.45 22.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 121.086 2.443 . . . . 0.0 109.796 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.15 38.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-O 116.634 -2.204 . . . . 0.0 118.118 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.35 126.75 92.61 Favored Pre-proline 0 CA--C 1.505 -0.753 0 O-C-N 127.583 2.578 . . . . 0.0 109.601 158.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.93 170.24 20.22 Favored 'Trans proline' 0 N--CA 1.516 2.794 0 C-N-CA 125.221 3.947 . . . . 0.0 113.102 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.4 mt -79.26 126.08 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 117.962 -2.961 . . . . 0.0 110.621 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -138.34 116.1 11.47 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 127.124 3.345 . . . . 0.0 106.82 163.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 m -74.24 -21.86 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 112.27 -2.241 . . . . 0.0 106.249 -168.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.96 39.19 1.51 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 127.669 2.388 . . . . 0.0 114.056 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.7 p -140.94 149.62 42.07 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 121.323 -0.861 . . . . 0.0 112.752 151.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.9 p -75.9 163.7 65.17 Favored Pre-proline 0 CA--C 1.581 2.165 0 CA-C-O 116.3 -1.809 . . . . 0.0 113.519 -170.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.35 -28.75 73.91 Favored 'Trans proline' 0 CA--C 1.569 2.263 0 CA-C-N 124.137 2.513 . . . . 0.0 112.627 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -69.58 -13.81 62.52 Favored 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.41 -10.57 34.71 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 127.795 2.438 . . . . 0.0 111.051 -163.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -86.01 64.7 8.73 Favored 'General case' 0 C--O 1.277 2.528 0 C-N-CA 127.131 2.172 . . . . 0.0 113.749 -160.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.5 tt -158.1 139.31 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-N 112.955 -1.929 . . . . 0.0 107.168 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.04 -165.53 39.0 Favored Glycine 0 CA--C 1.568 3.388 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -165.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -145.37 156.14 43.6 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 125.966 1.706 . . . . 0.0 115.43 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 14.9 m-85 -94.1 148.22 22.39 Favored 'General case' 0 C--O 1.277 2.53 0 C-N-CA 124.064 0.945 . . . . 0.0 109.285 157.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -122.78 138.77 54.54 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 126.22 1.808 . . . . 0.0 112.962 171.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -71.77 143.02 49.7 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 118.608 -2.557 . . . . 0.0 116.828 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . 0.252 . . -124.29 83.45 2.15 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.958 1.703 . . . . 0.0 111.498 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.9 p -80.57 -15.44 56.64 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 120.102 1.319 . . . . 0.0 113.294 -165.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 47.5 35.5 4.28 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HB3' ' C2 ' ' B' ' 3' ' ' ' U' . 13.0 ttm180 -89.84 -9.68 48.19 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.262 1.7 mp 65.85 143.69 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.553 4.701 0 C-N-CA 130.283 3.433 . . . . 0.0 116.216 172.98 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -123.6 -9.1 7.94 Favored 'General case' 0 CA--C 1.58 2.126 0 C-N-CA 127.488 2.315 . . . . 0.0 111.901 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.27 -137.85 2.3 Favored Glycine 0 C--N 1.358 1.772 0 CA-C-O 114.676 -3.291 . . . . 0.0 113.289 -174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.77 -140.54 0.69 Allowed Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 120.56 2.18 . . . . 0.0 116.559 160.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 51.21 13.59 0.18 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 128.527 2.731 . . . . 0.0 117.804 -171.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 164.98 -171.23 40.32 Favored Glycine 0 C--O 1.191 -2.581 0 O-C-N 118.374 -2.704 . . . . 0.0 111.993 161.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -131.82 152.29 51.09 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 118.524 -2.75 . . . . 0.0 111.236 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 27.0 mtp -52.42 155.08 2.22 Favored 'General case' 0 CA--C 1.585 2.308 0 CA-C-N 119.349 0.977 . . . . 0.0 111.549 169.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -139.37 6.74 2.34 Favored 'General case' 0 CA--C 1.595 2.678 0 C-N-CA 128.658 2.783 . . . . 0.0 109.141 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 50.16 31.33 4.94 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 116.771 2.138 . . . . 0.0 116.771 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.43 156.29 17.87 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 117.98 -2.95 . . . . 0.0 108.508 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.8 t -58.24 144.23 77.58 Favored Pre-proline 0 N--CA 1.52 3.072 0 C-N-CA 129.23 3.012 . . . . 0.0 108.616 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -47.1 139.47 15.22 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 124.681 3.587 . . . . 0.0 115.288 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -102.37 170.62 7.95 Favored 'General case' 0 CA--C 1.572 1.812 0 O-C-N 127.122 2.764 . . . . 0.0 106.659 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -155.91 144.02 19.86 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 118.537 -2.602 . . . . 0.0 109.176 -174.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.01 147.57 44.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 128.975 2.91 . . . . 0.0 117.186 -172.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -92.92 155.87 17.3 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -148.22 139.25 23.22 Favored 'General case' 0 N--CA 1.532 3.642 1 C-N-CA 132.652 4.381 . . . . 0.0 113.721 169.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -75.04 158.63 32.87 Favored 'General case' 0 CA--C 1.606 3.12 0 O-C-N 125.454 1.721 . . . . 0.0 114.186 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.5 tp -53.65 127.21 24.65 Favored 'General case' 0 CA--C 1.582 2.176 0 O-C-N 117.377 -3.327 . . . . 0.0 114.711 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.28 15.69 76.01 Favored Glycine 0 CA--C 1.552 2.381 0 C-N-CA 123.82 0.724 . . . . 0.0 111.98 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -151.66 163.38 39.24 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-O 124.63 2.157 . . . . 0.0 111.993 -166.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.98 -163.25 54.47 Favored Glycine 1 CA--C 1.581 4.167 0 O-C-N 118.384 -2.697 . . . . 0.0 111.558 -164.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -70.59 -26.8 23.27 Favored 'Trans proline' 1 CA--C 1.607 4.157 0 CA-C-O 117.975 -0.927 . . . . 0.0 111.981 -168.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.28 37.53 1.87 Allowed 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.257 1.389 . . . . 0.0 112.901 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -25.89 67.92 Favored 'General case' 0 C--N 1.373 1.623 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.33 -12.93 77.75 Favored Glycine 1 CA--C 1.587 4.559 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.8 mt -53.65 145.8 28.36 Favored Pre-proline 0 CA--C 1.584 2.256 0 CA-C-N 119.385 1.592 . . . . 0.0 110.992 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -85.23 169.02 10.1 Favored 'Trans proline' 0 N--CA 1.412 -3.273 0 O-C-N 123.689 1.362 . . . . 0.0 113.467 155.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -57.47 136.17 56.65 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 125.503 1.752 . . . . 0.0 115.28 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.99 -4.73 56.85 Favored Glycine 1 CA--C 1.582 4.221 0 CA-C-O 115.379 -2.901 . . . . 0.0 114.047 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.73 153.99 12.59 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -82.42 100.84 10.26 Favored 'General case' 0 C--O 1.276 2.492 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.718 -165.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.11 127.95 4.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 126.442 2.339 . . . . 0.0 109.658 167.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.05 155.99 36.64 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 125.994 1.718 . . . . 0.0 110.26 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.14 7.47 87.67 Favored Glycine 0 N--CA 1.488 2.165 0 O-C-N 125.79 1.931 . . . . 0.0 113.634 -165.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.7 132.59 62.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 C-N-CA 127.026 2.13 . . . . 0.0 109.525 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.3 mm -121.99 121.14 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 C-N-CA 126.422 1.889 . . . . 0.0 106.826 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -99.03 140.7 32.79 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.8 1.24 . . . . 0.0 109.56 -170.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.02 158.64 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-O 117.654 -1.165 . . . . 0.0 113.339 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -151.56 176.75 11.02 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 127.561 3.038 . . . . 0.0 111.508 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.8 p -123.17 158.49 30.66 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 128.916 2.887 . . . . 0.0 109.379 155.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -49.94 -44.43 50.52 Favored 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 128.521 2.728 . . . . 0.0 113.892 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.11 -17.11 75.46 Favored Glycine 1 CA--C 1.59 4.758 0 CA-C-N 111.91 -2.405 . . . . 0.0 114.169 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . 0.268 . . -76.73 136.3 39.04 Favored 'General case' 0 C--O 1.292 3.324 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.2 mt -84.94 152.3 23.61 Favored 'General case' 0 C--N 1.383 2.022 0 CA-C-N 113.063 -1.881 . . . . 0.0 106.412 170.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -72.66 6.81 2.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.013 -1.449 . . . . 0.0 113.204 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.3 p -70.81 140.47 86.44 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.25 134.24 26.5 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 121.429 1.419 . . . . 0.0 109.408 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . 0.259 49.7 mmtt -77.84 41.87 0.36 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 116.417 -1.754 . . . . 0.0 109.602 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -46.02 -29.12 1.35 Allowed 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 113.365 -3.207 . . . . 0.0 114.425 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -60.74 -46.56 89.98 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 123.684 2.947 . . . . 0.0 113.253 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.7 mt -81.93 -17.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 126.126 1.77 . . . . 0.0 108.698 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.37 -23.07 55.39 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 129.772 3.558 . . . . 0.0 113.427 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.7 p -127.33 -11.71 5.72 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-O 125.89 2.757 . . . . 0.0 116.238 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -81.25 154.74 26.44 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 111.469 -2.605 . . . . 0.0 106.156 166.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -92.07 124.45 59.91 Favored Pre-proline 0 CA--C 1.581 2.162 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.422 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 1.2 Cg_exo -52.94 -29.57 44.44 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.992 3.128 . . . . 0.0 115.642 169.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.4 -16.41 62.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -67.62 -17.45 64.62 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.929 3.059 . . . . 0.0 114.917 -170.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -135.04 178.01 7.36 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 122.696 1.236 . . . . 0.0 111.16 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.64 151.39 34.35 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 116.642 -1.647 . . . . 0.0 109.366 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.05 147.08 1.5 Allowed 'General case' 0 C--O 1.26 1.651 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.98 118.66 21.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 170.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.72 112.28 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 114.403 -2.713 . . . . 0.0 106.27 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 tt -80.1 137.82 36.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -156.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -157.02 145.95 20.02 Favored 'General case' 0 CA--C 1.611 3.31 0 C-N-CA 130.087 3.355 . . . . 0.0 107.956 -172.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.73 153.31 42.26 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 126.737 2.523 . . . . 0.0 111.744 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.72 171.77 12.73 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.398 3.398 . . . . 0.0 108.949 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.262 69.3 mt-30 64.69 12.78 7.87 Favored 'General case' 0 CA--C 1.589 2.455 0 C-N-CA 127.122 2.169 . . . . 0.0 112.419 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.99 19.32 44.34 Favored Glycine 0 CA--C 1.549 2.176 1 C-N-CA 132.881 5.038 . . . . 0.0 121.533 -163.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.0 m -61.43 137.74 58.25 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 124.068 0.947 . . . . 0.0 113.467 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 85.0 m -77.21 141.82 39.87 Favored 'General case' 0 CA--C 1.597 2.784 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.8 159.01 84.07 Favored Pre-proline 0 CA--C 1.572 1.794 0 C-N-CA 126.629 1.972 . . . . 0.0 113.273 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.13 136.96 25.47 Favored 'Trans proline' 0 CA--C 1.477 -2.333 0 CA-C-O 124.302 1.709 . . . . 0.0 112.392 -172.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -51.39 -19.92 1.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.254 166.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.43 17.26 44.74 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 125.006 3.548 . . . . 0.0 114.597 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -133.54 155.31 49.84 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-O 124.358 2.028 . . . . 0.0 110.537 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.412 ' HA ' " H1'" ' B' ' 10' ' ' ' G' . 12.8 m-30 -100.57 143.38 30.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.591 -2.549 . . . . 0.0 107.369 160.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -155.42 -175.81 5.62 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 127.501 2.32 . . . . 0.0 112.641 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -88.2 -7.69 56.46 Favored 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -96.58 -171.13 34.55 Favored Glycine 0 CA--C 1.56 2.854 0 C-N-CA 130.533 3.921 . . . . 0.0 116.94 166.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . 0.265 3.4 m 56.07 14.47 1.47 Allowed 'General case' 0 CA--C 1.606 3.098 0 C-N-CA 130.743 3.617 . . . . 0.0 114.525 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -71.45 -34.61 70.39 Favored 'General case' 0 C--O 1.173 -2.968 0 C-N-CA 129.468 3.107 . . . . 0.0 117.69 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 68.1 -144.56 43.23 Favored Glycine 0 N--CA 1.413 -2.869 0 CA-C-O 113.567 -3.907 . . . . 0.0 109.958 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 62.96 -144.34 49.41 Favored Glycine 0 C--O 1.188 -2.774 0 CA-C-N 122.896 3.348 . . . . 0.0 117.014 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.255 1.369 0 C-N-CA 131.152 3.781 . . . . 0.0 110.077 -13.014 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 5 C2'--O2' 1.492 6.108 2 C5'-C4'-O4' 114.894 4.067 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.468 -5.073 5 C1'-O4'-C4' 102.326 -8.082 . 0.494 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.491 ' C2 ' ' HB3' ' A' ' 93' ' ' ARG . . . . . . . . 0 O4'--C1' 1.459 3.737 2 O4'-C1'-N19 118.685 10.485 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.359 -4.59 3 C5'-C4'-C3' 104.141 -7.572 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.381 -6.041 1 O4'-C1'-N19 114.368 6.168 . 0.58 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.583 5.598 3 N19-C1'-C2' 121.649 5.156 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.504 6.986 4 C5'-C4'-O4' 117.484 5.917 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 4 C5'--C4' 1.576 5.056 3 O4'-C1'-N19 114.444 6.244 . 0.082 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.496 -3.17 4 C5'-C4'-C3' 122.786 4.857 . 0.171 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ' G' . . . . . 0.412 " H1'" ' HA ' ' A' ' 172' ' ' TYR . . . . . . . . 2 O4'--C1' 1.499 7.049 8 C5'-C4'-O4' 98.595 -7.575 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.378 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.2 mt -69.49 170.92 7.91 Favored Pre-proline 0 C--O 1.193 -1.896 0 CA-C-O 121.815 0.817 . . . . 0.0 111.466 166.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -69.85 161.07 47.34 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 N-CA-C 116.414 1.659 . . . . 0.0 116.414 166.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -62.42 126.58 27.81 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.209 -2.182 . . . . 0.0 113.104 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -79.7 -8.63 59.35 Favored 'General case' 0 CA--C 1.574 1.9 0 O-C-N 119.172 -2.205 . . . . 0.0 115.689 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m 57.94 -39.23 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 130.375 3.47 . . . . 0.0 119.322 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 165.47 25.09 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 110.788 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -89.79 139.51 30.51 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-N 113.767 -1.561 . . . . 0.0 115.001 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -78.92 -5.79 54.57 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 127.707 2.403 . . . . 0.0 110.866 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 156.4 48.96 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.323 1.535 . . . . 0.0 113.528 -165.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.0 p -56.6 163.06 1.95 Allowed 'General case' 0 CA--C 1.575 1.915 0 CA-C-O 124.253 1.978 . . . . 0.0 108.157 165.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.97 166.11 16.18 Favored 'General case' 0 CA--C 1.626 3.903 0 CA-C-N 110.562 -3.017 . . . . 0.0 117.643 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.53 168.83 10.45 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 144.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -126.93 132.53 50.84 Favored 'General case' 0 CA--C 1.579 2.059 0 C-N-CA 126.415 1.886 . . . . 0.0 111.728 158.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.27 128.7 26.01 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 119.521 -1.987 . . . . 0.0 109.101 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -124.16 -24.66 4.3 Favored 'General case' 0 C--O 1.278 2.585 0 O-C-N 128.194 3.434 . . . . 0.0 116.802 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.08 -133.53 4.31 Favored Glycine 0 CA--C 1.578 3.974 0 N-CA-C 119.755 2.662 . . . . 0.0 119.755 154.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -133.04 -29.58 1.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 CA-C-N 119.63 1.715 . . . . 0.0 114.728 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.72 139.28 51.11 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 125.384 1.678 . . . . 0.0 111.254 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -65.74 171.37 4.32 Favored 'General case' 0 CA--C 1.48 -1.747 0 C-N-CA 126.093 1.757 . . . . 0.0 112.759 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.18 37.83 0.17 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.091 -165.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -63.77 109.11 1.61 Allowed 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 127.845 2.458 . . . . 0.0 110.971 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.68 158.71 42.17 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 118.676 -2.515 . . . . 0.0 112.958 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.85 133.45 21.84 Favored 'Trans proline' 0 C--O 1.274 2.32 0 N-CA-C 107.401 -1.807 . . . . 0.0 107.401 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 61.56 7.24 1.76 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 130.055 3.342 . . . . 0.0 114.699 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.19 33.24 85.3 Favored Glycine 0 N--CA 1.492 2.431 0 CA-C-O 123.958 1.865 . . . . 0.0 112.835 -160.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -94.89 118.41 31.75 Favored 'General case' 0 CA--C 1.58 2.097 0 CA-C-N 113.762 -1.219 . . . . 0.0 109.934 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.19 28.93 0.02 OUTLIER Glycine 0 CA--C 1.57 3.494 0 O-C-N 116.882 -3.636 . . . . 0.0 114.329 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.73 128.44 88.28 Favored Pre-proline 0 C--O 1.26 1.654 0 CA-C-N 121.212 2.506 . . . . 0.0 114.62 167.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.44 171.25 18.49 Favored 'Trans proline' 0 N--CA 1.443 -1.487 1 C-N-CA 126.624 4.882 . . . . 0.0 114.477 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.28 135.7 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 128.354 2.662 . . . . 0.0 113.32 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -168.49 121.49 0.85 Allowed 'General case' 0 C--O 1.258 1.519 0 O-C-N 119.172 -2.205 . . . . 0.0 110.072 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.27 9.0 m -75.54 -24.18 56.71 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 118.434 -2.666 . . . . 0.0 112.095 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -75.43 5.58 5.63 Favored 'General case' 0 C--N 1.37 1.483 0 O-C-N 117.506 -3.246 . . . . 0.0 111.992 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -112.83 165.23 12.5 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.261 1.846 . . . . 0.0 112.235 158.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -120.27 175.84 2.11 Favored Pre-proline 0 C--O 1.281 2.74 0 C-N-CA 128.611 2.764 . . . . 0.0 113.506 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.37 -41.48 49.37 Favored 'Trans proline' 0 CA--C 1.591 3.365 0 C-N-CA 122.031 1.821 . . . . 0.0 114.077 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -52.2 -23.01 4.88 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 122.505 2.411 . . . . 0.0 112.414 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.13 -21.02 15.08 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 118.043 -2.911 . . . . 0.0 108.846 -161.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.01 73.8 0.04 OUTLIER 'General case' 0 CA--C 1.613 3.4 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.294 7.1 tt -158.1 137.34 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 C-N-CA 130.786 3.634 . . . . 0.0 104.702 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.36 -165.1 32.51 Favored Glycine 1 CA--C 1.588 4.611 0 CA-C-O 123.194 1.441 . . . . 0.0 111.717 -175.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -151.39 152.96 33.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 127.03 3.3 . . . . 0.0 116.446 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 110' ' ' PHE . 71.8 m-85 -92.88 147.3 22.96 Favored 'General case' 0 CA--C 1.606 3.11 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.179 164.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -125.68 136.79 53.61 Favored 'General case' 0 C--O 1.267 2.026 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -57.24 163.2 2.29 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.511 -1.368 . . . . 0.0 113.591 160.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.4 77.15 1.34 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.226 1.81 . . . . 0.0 111.209 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -71.25 -38.34 71.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.481 2.712 . . . . 0.0 112.538 -161.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 62.78 56.87 1.84 Allowed 'General case' 0 C--N 1.373 1.601 0 CA-C-O 126.988 3.28 . . . . 0.0 109.022 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 mtm180 -118.14 2.19 12.0 Favored 'General case' 0 CA--C 1.6 2.876 0 CA-C-O 113.493 -3.146 . . . . 0.0 107.681 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 mp 57.85 145.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 1 C-N-CA 132.23 4.212 . . . . 0.0 113.05 165.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -92.26 -23.33 19.35 Favored 'General case' 0 C--O 1.28 2.682 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 167.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.54 124.7 1.6 Allowed Glycine 0 CA--C 1.54 1.604 0 O-C-N 125.356 1.66 . . . . 0.0 109.551 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.4 -162.09 54.22 Favored Glycine 0 CA--C 1.547 2.068 0 CA-C-O 127.644 3.914 . . . . 0.0 110.404 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.272 4.7 m-20 51.45 15.37 0.32 Allowed 'General case' 0 C--O 1.191 -2.02 0 O-C-N 116.53 -3.924 . . . . 0.0 119.705 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.52 173.62 39.91 Favored Glycine 0 N--CA 1.504 3.207 0 O-C-N 118.841 -2.412 . . . . 0.0 115.121 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -130.62 144.91 51.74 Favored 'General case' 0 N--CA 1.514 2.76 0 C-N-CA 128.216 2.606 . . . . 0.0 107.382 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.8 mtp -111.18 157.49 20.01 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 130.826 3.651 . . . . 0.0 111.526 -171.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.429 ' HD3' ' N3 ' ' B' ' 7' ' ' ' A' . 49.1 mttm -132.78 -12.72 2.94 Favored 'General case' 0 CA--C 1.576 1.967 0 CA-C-O 115.623 -2.132 . . . . 0.0 111.615 -165.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.1 8.04 3.79 Favored 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 122.408 2.367 . . . . 0.0 116.596 -164.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.3 mt -101.37 167.23 10.3 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 123.415 1.579 . . . . 0.0 107.072 -171.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.9 m -72.9 159.77 84.52 Favored Pre-proline 0 C--N 1.368 1.393 0 CA-C-O 115.127 -2.368 . . . . 0.0 114.669 -171.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -49.18 134.86 30.78 Favored 'Trans proline' 0 CA--C 1.556 1.609 1 C-N-CA 130.636 7.557 . . . . 0.0 108.187 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -78.87 158.48 28.09 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.667 156.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -134.85 127.41 30.71 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 117.991 -2.943 . . . . 0.0 112.991 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.04 140.43 49.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.006 1.322 . . . . 0.0 113.652 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.451 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 65.1 t80 -92.45 151.57 20.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.698 3.592 . . . . 0.0 120.698 169.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.402 ' N ' ' CG ' ' A' ' 110' ' ' PHE . 24.6 m-85 -156.16 150.99 26.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.752 2.215 . . . . 0.0 108.455 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -71.08 150.03 45.91 Favored 'General case' 0 N--CA 1.524 3.266 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.796 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.4 tp -43.2 128.38 4.6 Favored 'General case' 0 C--O 1.257 1.49 0 CA-C-N 122.907 2.594 . . . . 0.0 117.161 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.42 18.54 75.4 Favored Glycine 0 CA--C 1.491 -1.462 0 CA-C-O 117.727 -1.596 . . . . 0.0 115.838 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 p -124.25 -164.14 1.22 Allowed 'General case' 0 C--O 1.282 2.773 0 CA-C-N 120.29 2.045 . . . . 0.0 112.428 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 -157.22 53.52 Favored Glycine 0 CA--C 1.547 2.088 0 CA-C-O 116.341 -2.366 . . . . 0.0 114.795 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.4 ' HD3' ' CE2' ' A' ' 111' ' ' TYR . 86.4 Cg_exo -65.47 -22.52 59.04 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 N-CA-C 117.771 2.181 . . . . 0.0 117.771 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -115.31 33.51 5.4 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.918 0.887 . . . . 0.0 110.419 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.59 -12.22 56.92 Favored 'General case' 1 C--O 1.307 4.083 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.895 -166.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.11 -35.8 37.34 Favored Glycine 0 C--N 1.347 1.144 1 CA-C-O 109.029 -6.428 . . . . 0.0 107.375 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.79 135.93 94.63 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-N 123.553 3.676 . . . . 0.0 115.176 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.17 162.77 41.44 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 N-CA-C 119.927 3.011 . . . . 0.0 119.927 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -62.42 134.9 57.09 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 117.657 -3.152 . . . . 0.0 115.106 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.32 71.51 Favored Glycine 0 N--CA 1.499 2.891 0 CA-C-O 115.995 -2.558 . . . . 0.0 110.416 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.69 140.42 41.59 Favored 'General case' 0 C--N 1.389 2.3 0 O-C-N 126.747 2.087 . . . . 0.0 114.283 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -104.98 41.72 1.31 Allowed 'General case' 0 C--O 1.268 2.034 0 CA-C-N 123.397 2.817 . . . . 0.0 111.193 -147.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -74.51 116.42 15.17 Favored 'General case' 0 N--CA 1.521 3.108 0 O-C-N 126.856 2.598 . . . . 0.0 112.166 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.66 152.38 3.76 Favored 'General case' 0 C--O 1.285 2.923 0 CA-C-O 125.414 2.53 . . . . 0.0 114.181 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.33 -10.7 58.1 Favored Glycine 0 CA--C 1.575 3.812 0 CA-C-N 111.953 -2.385 . . . . 0.0 115.952 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -101.62 143.33 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.806 2.442 . . . . 0.0 110.269 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.5 mm -126.18 111.03 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 127.134 2.174 . . . . 0.0 110.322 162.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -65.61 152.2 44.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.97 138.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 O-C-N 118.12 -2.862 . . . . 0.0 113.6 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.63 179.98 7.73 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 118.661 -2.524 . . . . 0.0 113.395 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.4 p -152.59 151.09 30.24 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.422 1.489 . . . . 0.0 108.903 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.79 -27.7 65.27 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 114.566 -2.635 . . . . 0.0 113.023 -170.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.88 -16.73 50.56 Favored Glycine 0 C--O 1.189 -2.664 1 O-C-N 130.369 4.793 . . . . 0.0 117.24 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.39 150.09 28.56 Favored 'General case' 0 C--N 1.409 3.158 0 CA-C-N 121.277 2.538 . . . . 0.0 108.263 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.86 146.48 23.61 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.66 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -76.07 7.89 3.71 Favored 'General case' 1 CA--C 1.648 4.742 0 O-C-N 117.766 -3.084 . . . . 0.0 113.974 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 p -70.57 145.54 92.77 Favored Pre-proline 0 N--CA 1.48 1.066 0 O-C-N 118.137 -2.852 . . . . 0.0 110.597 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.59 137.52 33.1 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 125.041 3.828 . . . . 0.0 112.995 160.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -101.52 67.0 1.11 Allowed 'General case' 0 C--O 1.263 1.784 0 C-N-CA 128.578 2.751 . . . . 0.0 108.987 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -73.22 -12.12 60.75 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.978 -161.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -82.45 -47.85 11.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 113.608 -3.091 . . . . 0.0 114.526 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.47 -32.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 O-C-N 126.641 2.463 . . . . 0.0 113.409 156.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.74 -15.53 62.27 Favored Glycine 0 CA--C 1.553 2.448 0 C-N-CA 126.468 1.985 . . . . 0.0 115.459 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 81.2 p -145.12 -30.08 0.44 Allowed 'General case' 1 CA--C 1.635 4.213 0 C-N-CA 130.105 3.362 . . . . 0.0 117.836 -160.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.97 149.6 46.94 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.042 1.737 . . . . 0.0 110.334 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -74.62 111.03 11.28 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.067 -170.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.31 -35.73 39.02 Favored 'Trans proline' 0 N--CA 1.51 2.494 0 CA-C-O 122.81 1.087 . . . . 0.0 109.488 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.26 2.52 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 117.114 -3.491 . . . . 0.0 114.498 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . 0.265 27.9 t-20 -69.51 -22.5 63.58 Favored 'General case' 0 CA--C 1.588 2.43 0 CA-C-N 120.264 1.393 . . . . 0.0 113.786 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -138.26 177.81 7.6 Favored 'General case' 0 C--O 1.177 -2.725 0 C-N-CA 127.669 2.388 . . . . 0.0 109.005 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.07 156.16 38.0 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 114.912 -2.471 . . . . 0.0 114.986 162.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.85 146.32 37.79 Favored 'General case' 0 C--O 1.175 -2.867 0 CA-C-N 121.837 2.108 . . . . 0.0 113.098 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.8 mt -61.11 143.69 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.612 1.096 . . . . 0.0 111.265 160.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.6 p -74.46 126.13 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.9 tp -58.46 118.91 6.1 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -138.27 141.49 39.87 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.7 154.79 50.66 Favored Pre-proline 0 C--O 1.198 -1.609 0 CA-C-N 122.889 2.586 . . . . 0.0 113.296 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -56.71 177.06 0.18 Allowed 'Trans proline' 0 CA--C 1.558 1.687 1 C-N-CA 130.404 7.403 . . . . 0.0 117.479 166.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 48.37 32.12 3.08 Favored 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 131.787 4.035 . . . . 0.0 114.502 172.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.48 11.9 54.41 Favored Glycine 0 CA--C 1.556 2.597 0 O-C-N 117.661 -3.149 . . . . 0.0 118.005 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . 0.253 5.9 m -63.13 119.81 10.26 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -161.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 46.9 m -63.69 131.22 47.26 Favored 'General case' 0 C--N 1.381 1.948 0 O-C-N 124.521 1.138 . . . . 0.0 108.436 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 44.2 mt -66.81 156.89 85.84 Favored Pre-proline 0 C--O 1.268 2.031 0 C-N-CA 127.162 2.185 . . . . 0.0 106.206 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -57.96 131.34 43.04 Favored 'Trans proline' 0 CA--C 1.571 2.333 0 C-N-CA 123.495 2.797 . . . . 0.0 113.905 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -60.77 -39.29 88.23 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.038 1.735 . . . . 0.0 109.992 -161.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.91 41.43 3.04 Favored Glycine 0 C--N 1.38 2.982 0 O-C-N 117.777 -3.077 . . . . 0.0 112.124 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.68 144.6 37.67 Favored 'General case' 0 C--O 1.204 -1.311 0 O-C-N 119.325 -2.279 . . . . 0.0 113.528 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -72.05 145.38 48.3 Favored 'General case' 0 C--O 1.284 2.884 0 CA-C-O 116.208 -1.853 . . . . 0.0 111.206 157.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -160.92 170.75 19.99 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 126.708 2.003 . . . . 0.0 110.297 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -79.48 59.1 2.84 Favored 'General case' 0 CA--C 1.571 1.77 0 O-C-N 119.364 -2.085 . . . . 0.0 113.196 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -159.86 176.94 36.53 Favored Glycine 0 CA--C 1.575 3.812 0 C-N-CA 127.839 2.638 . . . . 0.0 109.638 -168.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . 0.26 64.2 m 41.2 35.82 0.43 Allowed 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 127.252 2.221 . . . . 0.0 113.974 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -91.43 -3.53 56.56 Favored 'General case' 0 CA--C 1.603 2.993 0 C-N-CA 127.8 2.44 . . . . 0.0 110.494 -174.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 71.51 -157.69 53.34 Favored Glycine 0 C--N 1.357 1.702 0 N-CA-C 116.898 1.519 . . . . 0.0 116.898 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.85 -166.9 36.37 Favored Glycine 0 C--N 1.377 2.835 0 CA-C-O 124.855 2.364 . . . . 0.0 117.978 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.273 2.314 1 O-C-N 113.781 -5.541 . . . . 0.0 115.075 -2.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.474 4 OP1-P-OP2 110.3 -6.2 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O4'--C1' 1.463 4.125 2 O3'-P-O5' 116.512 6.585 . 0.531 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.55 -4.713 4 O5'-C5'-C4' 120.909 7.65 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.559 3.12 3 C5'-C4'-C3' 107.527 -5.315 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O3'--C3' 1.466 3.079 1 C5'-C4'-C3' 108.744 -4.504 . 0.547 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.394 -4.892 2 O5'-C5'-C4' 117.895 5.496 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ' A' . . . . . 0.429 ' N3 ' ' HD3' ' A' ' 102' ' ' LYS . . . . . . . . 2 C2'--C1' 1.61 8.165 3 C1'-O4'-C4' 104.245 -5.95 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 3 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.582 5.202 3 C3'-C2'-C1' 108.812 8.124 . 0.46 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.798 2 C1'-O4'-C4' 104.205 -5.995 . 0.366 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.569 4.555 2 O4'-C1'-N19 118.024 9.824 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 N--CA 1.483 0.901 0 CA-C-O 118.651 -0.645 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -71.05 113.61 8.26 Favored 'General case' 0 C--O 1.275 2.408 0 CA-C-O 124.423 2.059 . . . . 0.0 112.772 -174.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -70.98 -9.14 57.43 Favored 'General case' 0 CA--C 1.614 3.413 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -167.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.1 m 58.49 -31.62 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 1 C-N-CA 132.1 4.16 . . . . 0.0 115.192 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.54 157.69 21.18 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.167 2.987 . . . . 0.0 113.11 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.0 t -79.53 136.89 37.0 Favored 'General case' 0 N--CA 1.422 -1.875 0 O-C-N 120.225 -1.547 . . . . 0.0 110.584 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.88 -29.35 70.69 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 115.849 -2.024 . . . . 0.0 113.952 169.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -100.38 162.68 12.79 Favored 'General case' 0 C--N 1.377 1.788 0 O-C-N 127.552 3.033 . . . . 0.0 113.611 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.307 35.2 p -59.45 140.35 56.27 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 125.183 2.421 . . . . 0.0 113.162 166.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.05 143.91 32.58 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 111.151 -2.749 . . . . 0.0 109.623 -171.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.31 152.38 21.06 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.578 -1.326 . . . . 0.0 108.004 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -116.64 134.15 55.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 118.29 -2.756 . . . . 0.0 110.637 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -68.76 139.89 55.32 Favored 'General case' 0 CA--C 1.607 3.139 0 C-N-CA 126.58 1.952 . . . . 0.0 115.856 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -115.72 -48.04 2.78 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.23 -135.62 5.61 Favored Glycine 0 N--CA 1.508 3.458 0 C-N-CA 127.063 2.268 . . . . 0.0 110.959 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -147.39 -29.04 0.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.277 2.038 . . . . 0.0 114.143 -164.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.79 129.47 37.74 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 127.819 2.448 . . . . 0.0 114.773 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.527 ' HB2' ' HE3' ' A' ' 65' ' ' LYS . 82.0 m-20 -56.91 155.57 7.83 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 128.384 2.674 . . . . 0.0 108.067 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.16 57.32 0.84 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.504 -2.623 . . . . 0.0 110.029 -170.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.527 ' HE3' ' HB2' ' A' ' 63' ' ' ASP . 82.8 mttt -87.61 101.81 14.0 Favored 'General case' 0 CA--C 1.576 1.957 1 O-C-N 115.776 -4.327 . . . . 0.0 106.86 -164.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -68.25 149.61 98.03 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -55.78 154.59 25.62 Favored 'Trans proline' 1 C--N 1.417 4.139 0 O-C-N 118.291 -1.479 . . . . 0.0 108.568 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 54.63 -5.95 0.02 OUTLIER 'General case' 0 N--CA 1.539 3.977 1 N-CA-C 122.123 4.12 . . . . 0.0 122.123 152.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.78 7.37 71.32 Favored Glycine 0 CA--C 1.564 3.154 1 O-C-N 115.285 -4.634 . . . . 0.0 113.861 -168.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -86.72 104.6 16.27 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 117.803 -1.094 . . . . 0.0 109.0 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.25 21.54 0.04 OUTLIER Glycine 0 C--N 1.356 1.694 0 CA-C-N 122.326 2.33 . . . . 0.0 113.212 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.254 97.9 t -73.29 117.6 61.67 Favored Pre-proline 0 C--O 1.268 2.031 0 O-C-N 119.535 -2.156 . . . . 0.0 116.087 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -68.64 170.18 15.77 Favored 'Trans proline' 0 CA--C 1.552 1.387 1 C-N-CA 129.287 6.658 . . . . 0.0 109.534 -169.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.8 mt -105.13 141.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 O-C-N 117.772 -3.08 . . . . 0.0 112.381 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 127.481 2.312 . . . . 0.0 111.778 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.4 m -57.49 -43.99 84.57 Favored 'General case' 0 C--O 1.192 -1.929 0 O-C-N 124.054 0.846 . . . . 0.0 112.124 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -77.14 39.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 128.0 2.52 . . . . 0.0 111.907 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.2 p -146.57 144.62 29.69 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 125.551 1.54 . . . . 0.0 111.88 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -83.16 168.01 25.45 Favored Pre-proline 0 C--O 1.271 2.215 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -62.89 -33.76 74.11 Favored 'Trans proline' 0 C--O 1.203 -1.241 0 CA-C-O 117.554 -1.102 . . . . 0.0 114.511 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -58.02 -29.12 65.07 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 128.698 2.799 . . . . 0.0 111.21 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.318 33.9 m-20 -74.16 -11.67 60.36 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 129.036 2.935 . . . . 0.0 114.104 -172.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -88.39 66.37 8.3 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 117.149 -1.405 . . . . 0.0 111.229 -157.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.8 tt -154.62 144.23 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.671 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 178.89 -167.49 37.8 Favored Glycine 1 CA--C 1.58 4.137 0 C-N-CA 116.873 -2.584 . . . . 0.0 114.925 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -153.57 147.18 25.1 Favored 'General case' 0 C--O 1.202 -1.432 0 O-C-N 118.247 -2.913 . . . . 0.0 112.985 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -92.91 139.48 30.49 Favored 'General case' 0 C--O 1.246 0.896 0 O-C-N 128.736 3.773 . . . . 0.0 117.34 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -140.69 164.0 31.37 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 121.813 2.097 . . . . 0.0 110.865 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -83.92 154.68 23.25 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 117.78 2.511 . . . . 0.0 117.78 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.23 88.69 2.11 Favored 'General case' 0 C--O 1.182 -2.453 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.635 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.7 p -67.6 -27.8 67.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 116.07 -1.919 . . . . 0.0 111.729 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 52.88 56.05 8.13 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-N 120.189 1.359 . . . . 0.0 109.252 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -122.91 -12.0 8.06 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 130.395 3.478 . . . . 0.0 114.476 -160.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 mp 61.27 124.88 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.549 4.495 1 C-N-CA 131.82 4.048 . . . . 0.0 108.521 166.684 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 . . . . . 0 N--CA 1.518 2.954 0 C-N-CA 127.145 2.178 . . . . 0.0 107.368 169.507 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.7 tttt . . . . . 0 CA--C 1.6 2.872 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 55.99 -0.34 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 131.667 3.987 . . . . 0.0 116.141 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -67.56 169.34 9.43 Favored 'General case' 0 N--CA 1.53 3.555 0 CA-C-N 123.844 3.02 . . . . 0.0 109.667 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.9 m -56.83 163.06 3.05 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 127.27 3.414 . . . . 0.0 111.61 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -71.57 168.05 24.7 Favored 'Trans proline' 0 N--CA 1.427 -2.402 0 CA-C-O 124.844 1.935 . . . . 0.0 115.228 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -113.74 164.54 13.58 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 116.767 -3.708 . . . . 0.0 107.167 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -134.25 122.56 22.91 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 129.775 3.23 . . . . 0.0 112.051 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -107.84 147.61 30.68 Favored 'General case' 0 CA--C 1.597 2.769 0 CA-C-N 113.438 -1.71 . . . . 0.0 112.508 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -101.82 148.88 24.77 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.834 2.454 . . . . 0.0 110.16 166.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -134.05 145.2 49.2 Favored 'General case' 0 C--O 1.255 1.394 0 C-N-CA 125.267 1.427 . . . . 0.0 111.884 168.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -57.73 157.05 7.75 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 160.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 114' ' ' GLY . 33.9 tp -66.25 138.03 57.38 Favored 'General case' 0 C--N 1.384 2.095 0 O-C-N 123.982 0.801 . . . . 0.0 111.068 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.456 ' H ' HD12 ' A' ' 113' ' ' LEU . . . 59.95 32.43 75.27 Favored Glycine 0 CA--C 1.564 3.129 0 CA-C-O 118.08 -1.4 . . . . 0.0 115.069 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -141.88 172.04 13.23 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 128.228 2.611 . . . . 0.0 112.206 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -163.98 45.93 Favored Glycine 1 C--O 1.298 4.126 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.879 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.57 -29.26 25.08 Favored 'Trans proline' 0 CA--C 1.578 2.708 1 C-N-CA 125.579 4.186 . . . . 0.0 111.378 -170.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -94.45 24.63 4.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.921 -2.362 . . . . 0.0 111.521 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 -29.59 41.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.062 1.745 . . . . 0.0 114.404 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.38 -10.38 84.66 Favored Glycine 0 C--N 1.388 3.42 0 CA-C-O 124.505 2.169 . . . . 0.0 117.668 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.9 mt -70.29 136.17 86.64 Favored Pre-proline 0 N--CA 1.522 3.155 1 O-C-N 115.776 -4.367 . . . . 0.0 110.179 168.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.18 174.26 13.11 Favored 'Trans proline' 0 C--N 1.376 1.986 0 O-C-N 123.689 1.363 . . . . 0.0 112.711 160.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.02 133.44 56.1 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 120.289 -1.507 . . . . 0.0 111.698 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.75 5.65 89.34 Favored Glycine 1 CA--C 1.621 6.663 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 168.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.98 151.37 4.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.596 1.665 . . . . 0.0 111.994 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -94.95 68.02 3.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -125.05 137.39 54.21 Favored 'General case' 0 C--O 1.258 1.542 0 C-N-CA 126.646 1.978 . . . . 0.0 113.745 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.259 3.2 t0 -57.39 124.05 17.57 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 112.194 -2.275 . . . . 0.0 112.296 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.84 -4.63 79.01 Favored Glycine 0 C--N 1.373 2.589 0 O-C-N 125.204 1.565 . . . . 0.0 114.115 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 mp -86.68 128.82 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.609 3.242 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 163.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.0 mm -109.75 109.62 29.09 Favored 'Isoleucine or valine' 0 C--O 1.254 1.332 1 O-C-N 129.179 4.049 . . . . 0.0 110.574 170.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.21 138.5 35.81 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.205 -0.935 . . . . 0.0 112.901 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.01 146.25 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 126.121 1.769 . . . . 0.0 114.029 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.85 153.57 35.62 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 130.153 3.381 . . . . 0.0 110.843 -175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.2 p -102.43 156.56 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 129.38 3.072 . . . . 0.0 105.096 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -52.7 -31.13 36.0 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.59 -27.31 10.68 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 127.892 2.663 . . . . 0.0 113.171 -163.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.53 157.98 8.28 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.302 1.441 . . . . 0.0 111.486 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.09 131.15 54.43 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 124.589 2.137 . . . . 0.0 110.939 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -64.53 24.42 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.369 0 O-C-N 117.971 -2.956 . . . . 0.0 118.272 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.3 p -87.36 150.76 49.82 Favored Pre-proline 0 C--N 1.362 1.119 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.31 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.4 148.77 49.28 Favored 'Trans proline' 0 CA--C 1.505 -0.949 0 CA-C-O 116.686 -1.464 . . . . 0.0 115.041 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -97.51 90.09 4.92 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 126.166 2.888 . . . . 0.0 109.868 -172.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -52.39 -59.54 4.3 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -64.44 -66.91 0.48 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.064 2.146 . . . . 0.0 106.758 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.0 mt -45.53 -27.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 119.223 -2.173 . . . . 0.0 116.394 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -92.9 -11.23 59.17 Favored Glycine 1 CA--C 1.579 4.035 0 O-C-N 117.785 -3.072 . . . . 0.0 115.834 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.3 p -125.56 -12.65 6.65 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 114.975 -2.441 . . . . 0.0 112.676 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -74.63 178.34 5.45 Favored 'General case' 0 CA--C 1.582 2.2 0 CA-C-O 113.115 -3.326 . . . . 0.0 115.733 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -109.6 97.47 27.82 Favored Pre-proline 0 N--CA 1.414 -2.262 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . 0.337 4.2 Cg_exo -57.86 -28.45 82.53 Favored 'Trans proline' 0 CA--C 1.581 2.827 0 C-N-CA 123.183 2.589 . . . . 0.0 113.882 171.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.7 -12.75 25.7 Favored 'General case' 0 CA--C 1.556 1.184 0 O-C-N 124.448 1.093 . . . . 0.0 113.195 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -61.81 -19.81 62.95 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -148.31 -176.55 5.34 Favored 'General case' 0 C--O 1.175 -2.831 0 CA-C-N 121.271 1.85 . . . . 0.0 110.345 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.24 156.24 0.6 Allowed 'General case' 0 C--N 1.386 2.153 0 CA-C-N 113.531 -1.668 . . . . 0.0 114.825 154.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.08 159.98 24.61 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.1 mt -81.46 130.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.722 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 p -63.35 121.2 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 124.497 2.094 . . . . 0.0 108.483 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 118.86 12.23 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 114.693 -5.005 . . . . 0.0 111.514 171.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -151.29 133.08 14.97 Favored 'General case' 0 C--O 1.251 1.136 0 O-C-N 126.87 2.606 . . . . 0.0 109.695 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.5 mt -75.21 165.63 52.2 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.52 145.97 92.68 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 119.509 0.86 . . . . 0.0 112.915 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 58.6 9.92 1.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.939 2.895 . . . . 0.0 113.098 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.29 30.17 73.45 Favored Glycine 0 CA--C 1.548 2.128 0 O-C-N 118.217 -2.802 . . . . 0.0 116.144 -168.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.7 m -55.0 125.65 21.31 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-N 112.737 -1.731 . . . . 0.0 111.889 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 87.0 m -69.51 125.82 27.86 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -164.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 mt -71.91 157.55 89.34 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 125.632 1.832 . . . . 0.0 106.168 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -44.02 124.84 5.04 Favored 'Trans proline' 0 N--CA 1.52 3.039 1 C-N-CA 129.195 6.597 . . . . 0.0 116.734 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -57.99 -25.41 61.03 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 128.579 2.751 . . . . 0.0 107.708 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.94 -15.25 9.38 Favored Glycine 1 CA--C 1.596 5.147 0 CA-C-N 120.781 1.628 . . . . 0.0 114.917 174.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -137.34 153.89 50.16 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 126.593 1.957 . . . . 0.0 113.188 -154.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -98.6 124.72 43.54 Favored 'General case' 0 C--O 1.199 -1.589 0 O-C-N 118.843 -2.411 . . . . 0.0 109.101 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -117.24 164.63 14.52 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 127.49 2.316 . . . . 0.0 113.988 168.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 CA--C 1.568 1.662 0 C-N-CA 127.471 2.309 . . . . 0.0 116.108 174.488 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo . . . . . 0 C--O 1.252 1.176 0 N-CA-C 118.687 2.534 . . . . 0.0 118.687 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -71.04 111.93 6.79 Favored 'General case' 0 N--CA 1.403 -2.778 0 O-C-N 119.878 -1.764 . . . . 0.0 112.395 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 50' ' ' ALA 0.456 27.3 p30 -46.2 -32.8 3.22 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 119.72 -1.862 . . . . 0.0 115.742 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.3 m 64.96 -36.69 0.21 Allowed 'General case' 0 CA--C 1.609 3.219 0 C-N-CA 128.481 2.712 . . . . 0.0 106.974 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 48' ' ' ASN . . . -76.62 152.66 35.8 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 120.639 1.563 . . . . 0.0 113.766 -173.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -95.96 145.68 25.22 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 117.432 2.382 . . . . 0.0 117.432 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -83.03 -13.38 55.98 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -108.39 158.12 17.8 Favored 'General case' 0 N--CA 1.415 -2.18 0 O-C-N 127.965 3.291 . . . . 0.0 116.631 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.0 p -63.27 125.91 25.66 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.88 155.19 35.01 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 127.463 2.305 . . . . 0.0 111.783 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.97 164.09 12.5 Favored 'General case' 0 CA--C 1.593 2.63 0 C-N-CA 128.712 2.805 . . . . 0.0 109.043 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 67.4 m -132.51 130.65 40.7 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 118.878 -2.389 . . . . 0.0 110.616 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -67.49 137.4 55.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.269 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -125.58 -33.11 2.81 Favored 'General case' 0 CA--C 1.593 2.596 0 CA-C-N 120.874 1.67 . . . . 0.0 111.266 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.09 -134.66 0.65 Allowed Glycine 0 N--CA 1.514 3.842 0 N-CA-C 120.945 3.138 . . . . 0.0 120.945 170.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -133.82 -23.63 1.78 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 125.964 1.705 . . . . 0.0 113.444 167.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.92 146.96 25.97 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -72.21 159.47 34.04 Favored 'General case' 0 N--CA 1.409 -2.494 0 O-C-N 118.71 -2.494 . . . . 0.0 111.015 -168.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.1 tp -74.3 68.64 1.52 Allowed 'General case' 0 N--CA 1.534 3.73 0 CA-C-O 123.598 1.666 . . . . 0.0 111.543 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -91.87 158.99 16.0 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 125.114 2.387 . . . . 0.0 106.894 -168.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 61.8 m-85 -148.07 126.95 6.19 Favored Pre-proline 0 C--O 1.257 1.456 0 O-C-N 119.45 -2.031 . . . . 0.0 107.874 -167.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -57.96 106.95 0.28 Allowed 'Trans proline' 0 C--O 1.192 -1.779 1 C-N-CA 125.481 4.121 . . . . 0.0 113.117 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 38.77 36.34 0.14 Allowed 'General case' 0 C--N 1.387 2.235 0 C-N-CA 129.539 3.135 . . . . 0.0 115.244 -166.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.5 75.13 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 171.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.18 101.75 3.42 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.411 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.42 -1.26 0.04 OUTLIER Glycine 0 C--O 1.284 3.27 0 N-CA-C 122.952 3.941 . . . . 0.0 122.952 -167.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.76 144.26 68.55 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 121.797 -0.825 . . . . 0.0 113.138 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -82.95 163.67 15.68 Favored 'Trans proline' 0 CA--C 1.55 1.286 0 O-C-N 115.549 -2.921 . . . . 0.0 115.953 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.6 tt -78.55 144.35 11.29 Favored 'Isoleucine or valine' 0 C--O 1.277 2.534 0 CA-C-O 127.69 3.614 . . . . 0.0 112.026 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -150.06 144.46 25.77 Favored 'General case' 0 C--O 1.26 1.652 0 O-C-N 116.971 -3.58 . . . . 0.0 113.35 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.0 m -82.61 -36.29 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . 0.342 17.4 m120 -84.0 20.48 1.53 Allowed 'General case' 0 C--O 1.189 -2.084 0 C-N-CA 131.615 3.966 . . . . 0.0 116.124 -162.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 p -161.34 166.96 26.69 Favored 'General case' 0 C--N 1.388 2.248 0 C-N-CA 126.056 1.742 . . . . 0.0 112.538 171.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.0 p -94.44 169.6 9.47 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.131 0.972 . . . . 0.0 112.419 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 83' ' ' GLN . 49.5 Cg_exo -65.3 -23.69 58.87 Favored 'Trans proline' 0 CA--C 1.452 -3.589 0 O-C-N 116.908 -2.206 . . . . 0.0 116.908 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -68.01 -24.87 65.17 Favored 'General case' 0 C--O 1.274 2.348 0 C-N-CA 127.636 2.375 . . . . 0.0 107.751 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -78.64 -18.48 54.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 121.725 2.057 . . . . 0.0 115.205 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 80' ' ' PRO . 63.0 mm-40 -84.3 74.04 10.38 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 125.228 2.442 . . . . 0.0 112.104 -162.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -156.04 141.66 10.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.753 1 C-N-CA 133.29 4.636 . . . . 0.0 112.859 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.02 -173.41 40.79 Favored Glycine 1 CA--C 1.581 4.186 0 CA-C-O 124.394 2.108 . . . . 0.0 116.321 -168.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -136.44 156.13 49.04 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 109.36 -3.42 . . . . 0.0 111.736 168.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.408 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 36.1 m-85 -99.86 143.32 30.22 Favored 'General case' 0 N--CA 1.391 -3.399 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 162.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -123.04 143.34 50.01 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 126.097 1.759 . . . . 0.0 112.299 165.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.97 166.06 1.63 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 165.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 133.406 4.682 . . . . 0.0 112.875 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.1 p -137.26 -13.72 1.56 Allowed 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 59.48 41.16 19.72 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 124.342 2.02 . . . . 0.0 112.203 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -120.37 3.55 10.79 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 118.138 -2.851 . . . . 0.0 116.589 -161.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.8 mm 65.56 92.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.16 -3.63 0 C-N-CA 130.806 3.643 . . . . 0.0 116.579 149.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 . . . . . 0 N--CA 1.418 -2.071 0 O-C-N 124.144 0.902 . . . . 0.0 109.981 161.916 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 CA--C 1.57 1.714 0 CA-C-O 114.258 -2.782 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.27 27.24 15.42 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.235 1.834 . . . . 0.0 112.134 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.59 167.67 17.1 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 122.747 1.26 . . . . 0.0 107.872 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -65.67 146.22 98.99 Favored Pre-proline 0 C--N 1.405 2.983 0 CA-C-N 112.215 -2.266 . . . . 0.0 116.761 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.02 155.41 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 1 C-N-CA 127.993 5.795 . . . . 0.0 111.872 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -114.83 172.34 7.1 Favored 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -140.82 147.1 38.49 Favored 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 126.936 2.094 . . . . 0.0 113.237 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 55.6 m-85 -132.14 145.71 51.55 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 130.409 3.484 . . . . 0.0 116.717 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -98.83 141.25 31.85 Favored 'General case' 0 C--O 1.262 1.734 0 O-C-N 118.198 -2.814 . . . . 0.0 109.544 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -142.41 122.82 13.99 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 127.669 2.388 . . . . 0.0 110.09 172.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -45.82 151.54 0.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 111.082 171.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.305 69.1 tp -52.84 132.63 37.14 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 125.886 2.755 . . . . 0.0 112.456 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.34 42.18 98.74 Favored Glycine 0 C--O 1.263 1.94 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.898 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -149.55 173.01 14.09 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 114.14 -1.03 . . . . 0.0 112.03 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 54.71 -159.51 5.59 Favored Glycine 0 C--O 1.255 1.421 0 O-C-N 119.727 -1.858 . . . . 0.0 115.186 -163.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.1 -19.34 63.18 Favored 'Trans proline' 0 N--CA 1.5 1.9 1 C-N-CA 125.638 4.225 . . . . 0.0 117.794 -166.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -117.45 35.32 4.72 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 124.645 1.178 . . . . 0.0 111.547 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.59 -5.65 1.32 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 119.967 -1.708 . . . . 0.0 114.159 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.31 -36.66 44.23 Favored Glycine 0 N--CA 1.417 -2.622 0 CA-C-O 114.729 -3.262 . . . . 0.0 113.928 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.6 mt -69.22 125.65 92.13 Favored Pre-proline 0 C--O 1.262 1.737 0 CA-C-N 121.228 2.514 . . . . 0.0 116.768 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.57 171.93 2.34 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 121.868 1.712 . . . . 0.0 114.485 160.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -68.22 138.37 55.52 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.16 74.8 Favored Glycine 1 CA--C 1.585 4.459 0 C-N-CA 117.225 -2.417 . . . . 0.0 116.811 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.34 82.2 8.38 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 171.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.49 126.72 29.17 Favored 'General case' 0 C--O 1.207 -1.163 0 O-C-N 118.044 -2.91 . . . . 0.0 113.126 -167.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -148.1 159.2 44.17 Favored 'General case' 0 C--O 1.182 -2.495 0 C-N-CA 126.714 2.006 . . . . 0.0 110.558 -170.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.1 133.84 46.56 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.8 -2.31 72.59 Favored Glycine 1 CA--C 1.621 6.658 0 O-C-N 119.636 -1.915 . . . . 0.0 114.377 169.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.8 mt -131.3 142.08 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 1 C-N-CA 131.952 4.101 . . . . 0.0 104.62 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.9 mm -137.73 112.96 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.759 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -76.47 128.58 35.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.288 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 m -133.05 142.92 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 127.465 3.507 . . . . 0.0 114.889 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.18 173.57 12.1 Favored 'General case' 0 CA--C 1.478 -1.81 0 O-C-N 118.159 -2.838 . . . . 0.0 112.571 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 37.2 p -127.61 157.11 41.11 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 129.539 3.136 . . . . 0.0 109.916 173.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -64.67 -35.82 82.27 Favored 'General case' 0 CA--C 1.582 2.18 0 C-N-CA 123.964 0.906 . . . . 0.0 112.694 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.79 -22.19 72.65 Favored Glycine 1 CA--C 1.595 5.076 0 O-C-N 119.592 -1.943 . . . . 0.0 114.361 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.69 165.71 4.89 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-N 120.319 2.06 . . . . 0.0 113.197 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.3 mt -126.88 147.44 50.06 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.655 2.782 . . . . 0.0 112.424 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -75.51 -2.68 30.07 Favored 'General case' 1 CA--C 1.63 4.042 0 C-N-CA 126.926 2.091 . . . . 0.0 114.311 -175.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -71.62 148.48 92.85 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 126.22 1.808 . . . . 0.0 111.26 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.6 142.98 9.52 Favored 'Trans proline' 0 CA--C 1.467 -2.872 0 C-N-CA 123.929 3.086 . . . . 0.0 109.931 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -94.08 65.12 3.39 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 117.574 -3.204 . . . . 0.0 108.155 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.52 -34.35 75.72 Favored 'General case' 0 CA--C 1.61 3.254 0 CA-C-O 113.214 -3.279 . . . . 0.0 115.624 -161.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.268 41.0 m80 -62.05 -44.49 96.57 Favored 'General case' 1 CA--C 1.645 4.629 0 O-C-N 126.019 2.074 . . . . 0.0 110.292 171.698 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.4 mt -64.49 -31.87 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.02 -2.03 88.29 Favored Glycine 0 CA--C 1.496 -1.134 0 CA-C-O 116.392 -2.338 . . . . 0.0 117.185 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.5 p -128.88 -27.19 2.56 Favored 'General case' 0 CA--C 1.596 2.724 0 CA-C-N 122.141 2.97 . . . . 0.0 113.251 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -49.4 154.58 0.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 122.292 2.315 . . . . 0.0 111.18 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -67.02 121.0 76.19 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 129.284 3.034 . . . . 0.0 113.595 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -33.79 84.76 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 N-CA-C 118.293 2.382 . . . . 0.0 118.293 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.13 0.41 36.35 Favored 'General case' 0 C--O 1.254 1.341 0 C-N-CA 127.058 2.143 . . . . 0.0 114.579 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -72.93 -16.73 61.54 Favored 'General case' 0 C--O 1.172 -3.015 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -146.36 146.31 30.61 Favored 'General case' 0 CA--C 1.609 3.226 0 CA-C-N 113.074 -1.876 . . . . 0.0 113.363 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.77 152.89 44.64 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 118.706 -2.496 . . . . 0.0 117.135 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.27 116.02 6.18 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 119.747 -1.846 . . . . 0.0 114.771 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.49 120.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.62 0 C-N-CA 127.922 2.489 . . . . 0.0 108.596 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.3 109.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 166.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.6 116.93 6.69 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -172.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -153.52 142.47 21.19 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 116.432 -3.917 . . . . 0.0 108.406 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.54 140.29 22.1 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 116.511 -1.709 . . . . 0.0 114.633 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -37.72 169.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 123.205 2.604 . . . . 0.0 115.325 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 54.64 19.14 2.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.636 2.374 . . . . 0.0 112.318 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.14 13.65 60.25 Favored Glycine 0 CA--C 1.562 3.021 0 O-C-N 116.682 -3.761 . . . . 0.0 116.458 -169.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -60.82 116.22 4.27 Favored 'General case' 0 C--O 1.165 -3.39 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.995 -167.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 m -70.18 146.92 50.43 Favored 'General case' 1 N--CA 1.539 4.016 0 C-N-CA 125.611 1.564 . . . . 0.0 113.534 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.56 157.03 77.79 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 122.47 1.129 . . . . 0.0 111.773 175.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.95 120.42 7.88 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 125.038 3.825 . . . . 0.0 112.56 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -60.44 -20.32 59.44 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -168.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.13 4.12 Favored Glycine 0 CA--C 1.54 1.609 1 O-C-N 116.071 -4.143 . . . . 0.0 117.51 161.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.61 125.8 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 123.256 3.528 . . . . 0.0 115.528 171.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -66.71 131.04 45.12 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 115.583 -2.151 . . . . 0.0 109.085 167.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.51 141.86 37.31 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 123.459 2.845 . . . . 0.0 112.301 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 . . . . . 0 CA--C 1.577 2.01 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -171.333 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 N--CA 1.501 1.962 0 CA-C-O 129.255 3.773 . . . . 0.0 106.663 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -54.99 141.61 33.27 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 109.953 -3.294 . . . . 0.0 113.548 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -96.47 -35.28 11.19 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 m 61.25 -21.82 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 129.985 3.314 . . . . 0.0 118.261 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.42 151.75 26.45 Favored 'General case' 0 CA--C 1.618 3.56 0 O-C-N 118.247 -2.783 . . . . 0.0 113.818 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -77.78 153.25 33.03 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 118.862 -2.399 . . . . 0.0 112.576 167.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -76.07 -27.34 57.19 Favored 'General case' 0 C--O 1.281 2.717 0 C-N-CA 125.616 1.567 . . . . 0.0 114.06 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.64 164.96 11.78 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 124.582 2.134 . . . . 0.0 111.171 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -67.0 159.62 28.22 Favored 'General case' 0 C--O 1.288 3.088 0 CA-C-N 111.206 -2.724 . . . . 0.0 111.02 167.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.0 147.13 28.14 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 127.284 3.421 . . . . 0.0 114.282 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -76.21 162.17 28.18 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.467 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.7 m -122.03 125.41 46.2 Favored 'General case' 0 C--N 1.38 1.916 0 C-N-CA 124.423 1.089 . . . . 0.0 109.047 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -69.41 129.36 39.54 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 125.95 1.7 . . . . 0.0 109.462 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -123.78 -7.29 7.92 Favored 'General case' 0 C--O 1.203 -1.381 0 C-N-CA 128.522 2.729 . . . . 0.0 110.475 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.8 -139.79 10.58 Favored Glycine 0 CA--C 1.566 3.269 0 O-C-N 119.333 -2.104 . . . . 0.0 109.463 159.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -147.98 -17.69 0.35 Allowed 'General case' 0 C--O 1.189 -2.116 0 C-N-CA 128.957 2.903 . . . . 0.0 109.952 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.06 132.72 49.94 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -60.19 161.57 6.88 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.048 1.739 . . . . 0.0 111.55 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.15 69.75 9.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 119.433 -2.042 . . . . 0.0 110.067 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -67.32 149.47 50.3 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.402 170.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.06 141.33 41.06 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 126.025 1.73 . . . . 0.0 113.146 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.48 129.69 24.55 Favored 'Trans proline' 0 C--N 1.381 2.271 0 N-CA-C 106.438 -2.178 . . . . 0.0 106.438 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 55.59 21.62 4.63 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 126.909 2.084 . . . . 0.0 115.583 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.01 27.81 72.73 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 124.573 1.082 . . . . 0.0 115.608 -170.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.258 20.1 tt0 -84.85 84.74 7.6 Favored 'General case' 1 CA--C 1.638 4.33 0 C-N-CA 128.463 2.705 . . . . 0.0 106.258 -175.241 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.11 0.08 OUTLIER Glycine 0 C--O 1.206 -1.648 2 CA-C-O 128.64 4.466 . . . . 0.0 123.615 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 133' ' ' VAL . 93.1 t -69.96 126.88 92.66 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.975 -3.662 . . . . 0.0 111.004 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.63 160.86 4.86 Favored 'Trans proline' 0 CA--C 1.58 2.782 1 C-N-CA 128.518 6.145 . . . . 0.0 114.582 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.3 tt -85.28 142.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 159.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -157.54 104.82 2.01 Favored 'General case' 0 C--O 1.272 2.266 0 C-N-CA 126.955 2.102 . . . . 0.0 110.898 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.6 m -59.17 -32.71 70.15 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 125.389 1.68 . . . . 0.0 113.434 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -83.43 2.7 35.31 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.8 p -114.63 147.66 39.23 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 129.549 3.139 . . . . 0.0 110.287 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.2 t -72.35 155.65 91.18 Favored Pre-proline 0 CA--C 1.609 3.247 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -36.3 -31.87 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.682 1 C-N-CA 126.769 4.979 . . . . 0.0 114.45 152.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -82.58 -22.2 34.94 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 120.043 1.292 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -83.89 -14.57 50.75 Favored 'General case' 0 C--O 1.213 -0.861 0 O-C-N 119.369 -2.082 . . . . 0.0 114.367 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -68.9 59.11 0.09 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -167.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 tt -156.25 139.59 7.45 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.06 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.72 -160.71 30.96 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.034 -1.425 . . . . 0.0 114.921 -172.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -148.85 145.67 27.6 Favored 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 119.63 1.715 . . . . 0.0 110.169 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 88.7 m-85 -85.4 161.22 19.53 Favored 'General case' 0 C--N 1.396 2.62 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 164.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -125.58 157.73 36.4 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 118.878 -2.389 . . . . 0.0 109.041 161.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.463 HH22 ' CG ' ' A' ' 128' ' ' ASP . 26.9 ptt180 -77.81 159.81 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.664 1.585 . . . . 0.0 107.815 169.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.04 136.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.449 1.9 . . . . 0.0 110.671 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -133.97 -16.22 2.25 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -168.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 55.26 60.03 3.63 Favored 'General case' 0 N--CA 1.538 3.944 0 O-C-N 119.568 -1.958 . . . . 0.0 107.051 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -128.18 -8.61 5.34 Favored 'General case' 0 C--O 1.193 -1.914 0 O-C-N 119.408 -2.057 . . . . 0.0 109.125 -160.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.337 1.1 mp 68.39 136.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 171.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 . . . . . 0 C--O 1.272 2.241 0 C-N-CA 127.503 2.321 . . . . 0.0 114.231 167.13 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.4 tttt . . . . . 1 C--O 1.309 4.234 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.5 0.4 OUTLIER 73.68 -10.67 1.04 Allowed 'General case' 0 C--N 1.363 1.164 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 177.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.7 mt -68.91 153.73 43.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 129.395 3.078 . . . . 0.0 111.698 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.8 m -66.86 167.64 13.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 114.761 -2.542 . . . . 0.0 111.544 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.259 59.3 Cg_exo -65.28 164.72 24.55 Favored 'Trans proline' 0 CA--C 1.584 3.011 0 C-N-CA 124.504 3.469 . . . . 0.0 114.348 -176.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -131.53 168.63 17.33 Favored 'General case' 0 C--N 1.386 2.173 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -128.7 127.63 42.5 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 128.113 3.383 . . . . 0.0 112.283 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 60.6 m-85 -108.04 144.5 35.29 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 128.336 3.523 . . . . 0.0 111.194 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.6 144.1 31.88 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -140.36 151.34 44.91 Favored 'General case' 0 N--CA 1.514 2.765 0 O-C-N 118.635 -2.541 . . . . 0.0 109.83 176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.446 ' CD1' HG21 ' A' ' 146' ' ' ILE . 27.5 m-85 -90.46 161.29 15.6 Favored 'General case' 0 CA--C 1.595 2.708 0 CA-C-O 125.887 2.756 . . . . 0.0 112.586 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.3 tp -57.77 116.12 3.24 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 117.809 -3.057 . . . . 0.0 109.608 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.74 17.9 50.1 Favored Glycine 0 N--CA 1.501 3.0 0 O-C-N 118.584 -2.572 . . . . 0.0 115.259 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -133.55 165.37 25.05 Favored 'General case' 0 CA--C 1.504 -0.827 1 C-N-CA 132.841 4.456 . . . . 0.0 112.815 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.23 -165.69 52.09 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 125.683 1.611 . . . . 0.0 110.176 171.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.65 -28.54 52.41 Favored 'Trans proline' 0 N--CA 1.427 -2.393 1 C-N-CA 127.195 5.264 . . . . 0.0 111.422 -171.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -96.01 17.58 15.16 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 117.976 -2.952 . . . . 0.0 114.607 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.94 -12.21 0.3 Allowed 'General case' 0 C--N 1.39 2.366 0 O-C-N 118.869 -2.395 . . . . 0.0 116.095 -168.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.17 -34.63 57.99 Favored Glycine 0 C--N 1.287 -2.156 0 C-N-CA 128.461 2.934 . . . . 0.0 114.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.64 142.08 83.26 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.982 2.113 . . . . 0.0 115.044 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -77.4 163.91 29.36 Favored 'Trans proline' 0 C--N 1.397 3.111 1 C-N-CA 126.58 4.853 . . . . 0.0 115.118 161.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.42 151.18 41.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 117.374 -1.73 . . . . 0.0 115.124 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.91 8.12 5.49 Favored Glycine 0 CA--C 1.56 2.886 0 N-CA-C 120.903 3.121 . . . . 0.0 120.903 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.72 137.67 49.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 121.062 2.431 . . . . 0.0 113.458 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -78.89 142.79 36.49 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-O 116.307 -1.806 . . . . 0.0 114.227 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.06 142.41 7.35 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 129.672 3.189 . . . . 0.0 111.132 159.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.463 ' CG ' HH22 ' A' ' 89' ' ' ARG . 13.6 t0 -65.34 121.56 15.11 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 126.46 1.904 . . . . 0.0 115.222 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.94 74.72 Favored Glycine 0 CA--C 1.568 3.383 1 C-N-CA 130.957 4.122 . . . . 0.0 122.435 -169.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.1 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 O-C-N 128.199 2.941 . . . . 0.0 108.813 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.9 mm -120.9 119.89 60.77 Favored 'Isoleucine or valine' 0 C--N 1.385 2.112 0 CA-C-O 123.154 1.454 . . . . 0.0 112.491 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -73.63 138.99 45.16 Favored 'General case' 0 C--N 1.372 1.56 0 O-C-N 119.08 -2.262 . . . . 0.0 109.117 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 72' ' ' VAL . 3.0 m -134.95 147.51 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.577 0 C-N-CA 123.635 0.774 . . . . 0.0 111.998 159.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.71 169.78 17.81 Favored 'General case' 0 N--CA 1.395 -3.193 0 C-N-CA 126.848 2.059 . . . . 0.0 113.455 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.255 81.8 p -98.93 170.03 9.02 Favored 'General case' 0 C--O 1.248 0.994 0 O-C-N 120.242 -1.536 . . . . 0.0 113.631 152.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -60.05 -45.78 91.73 Favored 'General case' 0 C--O 1.283 2.863 0 CA-C-O 116.932 -1.508 . . . . 0.0 112.483 160.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.31 -34.45 67.86 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.89 153.78 41.08 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.967 1.365 . . . . 0.0 111.598 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.43 145.21 31.14 Favored 'General case' 0 C--O 1.259 1.581 0 C-N-CA 130.043 3.337 . . . . 0.0 113.792 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -65.49 4.37 0.56 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 p -85.74 142.51 36.99 Favored Pre-proline 0 CA--C 1.479 -1.761 0 C-N-CA 128.832 2.853 . . . . 0.0 109.934 -166.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -59.29 117.21 3.91 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 124.306 3.338 . . . . 0.0 109.845 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -68.17 52.86 0.07 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 126.385 1.874 . . . . 0.0 113.317 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.56 -24.35 67.48 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -171.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -74.14 -35.82 64.12 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.446 HG21 ' CD1' ' A' ' 112' ' ' TYR . 80.4 mt -67.72 -18.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 O-C-N 119.927 -1.733 . . . . 0.0 110.76 164.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.49 -11.7 65.97 Favored Glycine 0 CA--C 1.569 3.435 0 O-C-N 124.44 1.088 . . . . 0.0 115.738 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 24.7 p -130.5 -33.18 1.67 Allowed 'General case' 0 C--N 1.373 1.626 0 O-C-N 124.672 0.866 . . . . 0.0 111.441 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -66.2 142.05 57.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.642 1.564 . . . . 0.0 110.715 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -81.96 114.01 47.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 119.817 -1.802 . . . . 0.0 111.127 -149.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 -4.37 15.24 Favored 'Trans proline' 0 N--CA 1.425 -2.508 0 C-N-CA 124.069 3.179 . . . . 0.0 111.124 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.69 19.12 15.47 Favored 'General case' 0 C--O 1.193 -1.87 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -71.62 -54.95 8.75 Favored 'General case' 0 C--O 1.293 3.379 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.542 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.51 177.92 7.59 Favored 'General case' 0 CA--C 1.598 2.795 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.265 164.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.81 19.88 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 127.32 2.248 . . . . 0.0 107.206 170.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.24 136.55 58.0 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 113.973 -2.917 . . . . 0.0 117.775 169.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.5 mt -58.53 121.4 6.05 Favored 'Isoleucine or valine' 0 C--N 1.381 1.958 0 O-C-N 128.882 3.864 . . . . 0.0 108.242 165.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.19 103.8 2.0 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 O-C-N 120.086 -1.634 . . . . 0.0 110.664 172.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.52 106.74 0.58 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.551 1.941 . . . . 0.0 111.209 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -119.6 160.3 22.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-O 122.995 1.379 . . . . 0.0 109.773 156.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 83.7 mt -74.75 162.3 74.16 Favored Pre-proline 1 N--CA 1.54 4.042 0 C-N-CA 126.313 1.845 . . . . 0.0 110.528 163.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.27 164.39 10.73 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.182 1.921 . . . . 0.0 116.442 161.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 40.76 41.47 1.18 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 125.79 1.636 . . . . 0.0 113.472 -170.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.73 21.02 1.32 Allowed Glycine 0 CA--C 1.562 3.015 0 O-C-N 125.86 1.975 . . . . 0.0 117.076 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 84.9 m -58.17 131.72 51.4 Favored 'General case' 0 C--N 1.394 2.534 0 O-C-N 117.85 -3.147 . . . . 0.0 115.14 -165.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . 0.267 27.6 m -77.09 116.83 18.08 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 127.646 3.091 . . . . 0.0 114.161 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.36 154.63 83.0 Favored Pre-proline 0 CA--C 1.586 2.352 0 C-N-CA 130.804 3.642 . . . . 0.0 110.107 -169.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.96 149.44 7.98 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.673 2.249 . . . . 0.0 117.586 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.34 -16.66 62.45 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.319 1.448 . . . . 0.0 114.667 -163.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.18 -0.96 78.99 Favored Glycine 0 CA--C 1.572 3.621 0 CA-C-O 117.24 -1.867 . . . . 0.0 116.978 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -120.74 135.84 55.03 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.092 2.446 . . . . 0.0 111.368 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -83.89 154.3 23.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 127.266 2.854 . . . . 0.0 107.884 164.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . 0.292 . . -156.72 154.03 29.38 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 126.153 2.883 . . . . 0.0 112.649 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 . . . . . 0 N--CA 1.43 -1.427 0 CA-C-N 112.348 -2.206 . . . . 0.0 112.134 159.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 CA--C 1.574 2.508 0 CA-C-O 122.91 1.129 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -71.49 133.73 46.05 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.55 -18.34 45.26 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -171.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m 59.27 -43.95 0.07 Allowed 'General case' 0 CA--C 1.589 2.445 0 C-N-CA 129.603 3.161 . . . . 0.0 118.295 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 39.19 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.976 2.11 . . . . 0.0 114.725 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.447 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 47.6 t -85.46 139.13 31.75 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 125.655 1.582 . . . . 0.0 113.429 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -79.86 -9.27 59.65 Favored 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 125.362 1.465 . . . . 0.0 113.892 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -109.85 157.09 19.56 Favored 'General case' 0 CA--C 1.581 2.163 0 CA-C-O 124.294 1.997 . . . . 0.0 110.717 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 p -68.2 165.37 18.48 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -111.61 136.92 50.16 Favored 'General case' 0 C--O 1.259 1.586 0 O-C-N 119.566 -1.959 . . . . 0.0 109.736 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.9 mt -75.08 160.86 29.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 126.634 1.973 . . . . 0.0 110.781 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.5 m -126.31 139.29 53.42 Favored 'General case' 0 N--CA 1.493 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 110.652 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.62 141.1 55.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.766 2.426 . . . . 0.0 109.055 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -125.59 -34.19 2.69 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 161.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.01 -126.85 0.02 OUTLIER Glycine 0 C--N 1.305 -1.15 1 CA-C-O 127.99 4.106 . . . . 0.0 113.948 168.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -154.45 -28.01 0.12 Allowed 'General case' 0 C--N 1.292 -1.911 2 O-C-N 114.434 -5.156 . . . . 0.0 111.381 163.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.35 145.89 53.77 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.71 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -54.23 167.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 117.534 -3.229 . . . . 0.0 112.349 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.1 tp -74.26 64.72 1.12 Allowed 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 125.31 2.481 . . . . 0.0 114.362 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -75.55 140.29 42.63 Favored 'General case' 0 C--O 1.287 3.027 0 O-C-N 119.166 -2.209 . . . . 0.0 111.043 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -127.06 156.81 73.79 Favored Pre-proline 0 C--N 1.397 2.658 0 O-C-N 119.256 -2.152 . . . . 0.0 111.319 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -79.86 141.18 14.97 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 42.92 16.46 0.01 OUTLIER 'General case' 0 CA--C 1.584 2.262 0 O-C-N 126.3 2.25 . . . . 0.0 116.207 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.49 73.24 Favored Glycine 0 CA--C 1.557 2.68 1 C-N-CA 130.95 4.119 . . . . 0.0 116.359 -164.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -85.42 108.23 17.77 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 117.39 -1.291 . . . . 0.0 110.319 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.91 10.85 0.03 OUTLIER Glycine 1 CA--C 1.601 5.431 0 CA-C-O 114.655 -3.303 . . . . 0.0 117.46 -170.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.18 125.81 59.0 Favored Pre-proline 0 CA--C 1.587 2.387 0 CA-C-N 122.752 3.276 . . . . 0.0 113.482 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.22 153.18 24.4 Favored 'Trans proline' 0 N--CA 1.421 -2.739 0 C-N-CA 122.762 2.308 . . . . 0.0 111.806 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -70.84 146.0 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 O-C-N 128.407 3.567 . . . . 0.0 109.972 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -145.91 111.05 5.3 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 118.291 -0.861 . . . . 0.0 109.695 162.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -67.17 -15.69 63.86 Favored 'General case' 0 C--N 1.378 1.833 0 CA-C-N 123.099 2.681 . . . . 0.0 111.604 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -89.43 12.16 17.2 Favored 'General case' 0 CA--C 1.608 3.2 0 C-N-CA 128.761 2.824 . . . . 0.0 110.719 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -120.93 163.23 18.55 Favored 'General case' 0 C--O 1.256 1.412 0 O-C-N 125.147 1.529 . . . . 0.0 111.407 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.8 p -101.76 163.25 18.17 Favored Pre-proline 0 C--O 1.256 1.403 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -59.37 -26.18 81.03 Favored 'Trans proline' 0 CA--C 1.563 1.954 0 CA-C-N 122.666 1.988 . . . . 0.0 110.485 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.47 -30.65 63.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 120.711 1.596 . . . . 0.0 113.91 173.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -79.99 -16.32 55.43 Favored 'General case' 0 C--O 1.186 -2.272 0 C-N-CA 127.643 2.377 . . . . 0.0 115.292 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -73.41 61.8 0.69 Allowed 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 129.32 3.048 . . . . 0.0 116.05 -167.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.264 13.3 tt -153.53 138.27 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 127.953 3.283 . . . . 0.0 108.363 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.46 -152.73 11.31 Favored Glycine 0 CA--C 1.489 -1.555 0 O-C-N 116.887 -3.633 . . . . 0.0 114.796 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -149.96 138.37 20.59 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 127.136 2.174 . . . . 0.0 110.493 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -89.35 155.71 19.18 Favored 'General case' 0 C--N 1.286 -2.18 0 O-C-N 127.85 3.219 . . . . 0.0 109.75 159.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -145.39 148.94 33.89 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.554 -1.341 . . . . 0.0 108.677 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.419 HH22 ' CG ' ' A' ' 128' ' ' ASP . 21.5 ptt180 -86.95 -177.72 6.13 Favored 'General case' 0 CA--C 1.61 3.263 0 CA-C-N 121.827 2.103 . . . . 0.0 114.906 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 136.9 9.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 118.878 -2.389 . . . . 0.0 110.592 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.9 p -145.4 -17.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 113.814 -2.993 . . . . 0.0 113.724 -164.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 47.47 48.72 16.54 Favored 'General case' 0 CA--C 1.602 2.956 0 O-C-N 125.39 1.681 . . . . 0.0 111.603 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -105.65 -9.57 17.27 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 119.939 -1.726 . . . . 0.0 112.444 170.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 mp 70.85 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.27 2.173 0 C-N-CA 127.051 2.14 . . . . 0.0 110.76 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 . . . . . 0 CA--C 1.586 2.334 1 C-N-CA 133.205 4.602 . . . . 0.0 110.296 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.239 0.509 0 CA-C-O 118.218 -0.896 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.95 37.85 22.13 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 126.101 1.76 . . . . 0.0 112.986 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.76 169.6 18.0 Favored 'General case' 0 C--O 1.289 3.144 0 C-N-CA 125.578 1.551 . . . . 0.0 110.621 167.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . 0.278 52.6 m -62.32 145.5 94.05 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 123.29 1.519 . . . . 0.0 114.992 170.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.263 15.1 Cg_exo -42.67 155.96 0.1 Allowed 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 121.709 1.606 . . . . 0.0 113.247 164.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -121.4 159.4 26.25 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.601 2.361 . . . . 0.0 115.545 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -129.92 139.94 51.03 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 126.72 2.512 . . . . 0.0 115.631 161.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -121.36 154.19 36.77 Favored 'General case' 0 CA--C 1.592 2.593 0 C-N-CA 126.464 1.905 . . . . 0.0 109.957 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -111.19 141.18 45.04 Favored 'General case' 0 N--CA 1.535 3.801 0 CA-C-N 122.929 2.604 . . . . 0.0 113.906 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.47 ' CD2' ' HA3' ' A' ' 116' ' ' GLY . 8.2 m-85 -141.66 150.92 42.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 125.021 2.343 . . . . 0.0 110.063 170.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -87.59 156.01 19.7 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-N 114.085 -1.416 . . . . 0.0 113.207 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.3 tp -51.47 127.62 20.55 Favored 'General case' 0 C--O 1.271 2.23 0 C-N-CA 124.072 0.949 . . . . 0.0 112.961 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.56 73.83 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.6 p -142.59 -178.51 5.81 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 119.709 1.754 . . . . 0.0 109.616 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 111' ' ' TYR . . . 63.38 -154.1 45.4 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -73.73 -43.08 0.67 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.325 2.017 . . . . 0.0 115.203 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.327 2.5 mm-40 -81.94 27.74 0.45 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 131.431 3.892 . . . . 0.0 110.481 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.76 -19.52 50.83 Favored 'General case' 0 C--O 1.159 -3.706 0 O-C-N 118.188 -2.82 . . . . 0.0 113.096 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.29 -34.5 54.65 Favored Glycine 0 C--O 1.253 1.337 0 O-C-N 124.752 1.282 . . . . 0.0 113.809 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 mt -65.36 139.29 97.34 Favored Pre-proline 0 CA--C 1.607 3.143 0 CA-C-N 120.772 2.286 . . . . 0.0 113.297 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -61.92 166.17 12.79 Favored 'Trans proline' 0 C--O 1.272 2.178 0 O-C-N 124.42 1.747 . . . . 0.0 113.983 155.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -65.09 123.43 19.49 Favored 'General case' 0 C--N 1.365 1.261 0 CA-C-N 110.27 -3.15 . . . . 0.0 116.6 170.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 20.22 62.86 Favored Glycine 0 CA--C 1.576 3.904 0 CA-C-O 124.128 1.96 . . . . 0.0 111.148 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.34 135.69 47.46 Favored 'General case' 0 C--O 1.25 1.094 0 O-C-N 117.534 -3.333 . . . . 0.0 108.793 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.73 11.94 1.5 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -161.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . 0.291 66.7 tttt -72.31 126.03 28.82 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 124.32 2.009 . . . . 0.0 111.238 -167.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.419 ' CG ' HH22 ' A' ' 89' ' ' ARG . 13.8 t0 -53.8 138.74 35.1 Favored 'General case' 0 C--O 1.271 2.226 0 O-C-N 117.588 -3.195 . . . . 0.0 108.038 -175.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.15 -11.42 63.81 Favored Glycine 0 N--CA 1.502 3.076 0 CA-C-O 116.147 -2.474 . . . . 0.0 117.367 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -108.97 134.7 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.616 3.517 0 C-N-CA 130.618 3.567 . . . . 0.0 110.91 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.88 124.11 71.63 Favored 'Isoleucine or valine' 0 C--O 1.291 3.28 0 O-C-N 125.694 1.871 . . . . 0.0 109.323 171.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.68 134.8 33.59 Favored 'General case' 0 CA--C 1.587 2.396 0 CA-C-O 125.418 2.532 . . . . 0.0 111.516 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.28 141.42 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 O-C-N 119.323 -2.11 . . . . 0.0 111.152 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.96 170.96 14.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 p -131.79 157.62 43.39 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 113.492 -1.685 . . . . 0.0 114.893 158.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -72.0 -27.24 62.61 Favored 'General case' 0 C--N 1.365 1.28 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.95 -18.25 63.64 Favored Glycine 0 CA--C 1.565 3.189 0 C-N-CA 127.792 2.615 . . . . 0.0 118.143 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.22 147.32 53.19 Favored 'General case' 0 C--O 1.286 3.017 0 C-N-CA 127.152 2.181 . . . . 0.0 110.202 162.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.88 142.1 30.05 Favored 'General case' 0 C--O 1.285 2.94 0 CA-C-O 125.122 2.391 . . . . 0.0 108.024 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -48.03 -12.46 0.03 OUTLIER 'General case' 0 CA--C 1.6 2.867 0 CA-C-O 114.014 -2.898 . . . . 0.0 116.012 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -55.34 139.42 66.21 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 130.841 3.656 . . . . 0.0 114.025 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -64.28 140.25 69.76 Favored 'Trans proline' 0 N--CA 1.528 3.503 0 C-N-CA 122.831 2.354 . . . . 0.0 106.369 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -91.53 60.84 4.17 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -23.12 66.09 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.816 -165.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -61.81 -55.51 29.22 Favored 'General case' 0 CA--C 1.61 3.287 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 6.4 mt -60.81 -25.26 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.623 0 C-N-CA 116.781 -1.968 . . . . 0.0 111.567 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.51 -12.03 83.44 Favored Glycine 1 CA--C 1.587 4.567 0 C-N-CA 128.696 3.046 . . . . 0.0 116.695 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.6 p -126.88 -24.96 3.41 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.3 158.71 28.78 Favored 'General case' 0 C--O 1.266 1.931 0 O-C-N 117.153 -3.467 . . . . 0.0 106.511 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.5 118.43 47.42 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.835 -2.507 . . . . 0.0 112.432 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -73.4 -25.31 15.51 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.95 2.433 . . . . 0.0 115.93 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.32 -4.27 35.24 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 120.699 -1.25 . . . . 0.0 109.705 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.82 -28.92 70.19 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 121.407 1.912 . . . . 0.0 113.64 -165.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.57 159.93 29.55 Favored 'General case' 0 C--O 1.25 1.119 1 C-N-CA 131.99 4.116 . . . . 0.0 110.847 160.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -53.94 160.74 1.37 Allowed 'General case' 1 N--CA 1.54 4.029 0 C-N-CA 128.441 2.696 . . . . 0.0 111.996 172.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.35 130.97 49.28 Favored 'General case' 0 CA--C 1.584 2.283 0 O-C-N 118.276 -2.765 . . . . 0.0 112.546 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.81 126.77 32.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 124.215 1.959 . . . . 0.0 107.193 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.0 126.8 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.608 0 O-C-N 120.157 -1.589 . . . . 0.0 111.827 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.73 116.7 7.21 Favored 'General case' 0 CA--C 1.604 3.035 0 O-C-N 126.589 2.431 . . . . 0.0 114.373 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -141.23 152.9 44.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 116.304 -3.997 . . . . 0.0 111.399 164.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -113.81 155.26 45.4 Favored Pre-proline 0 C--N 1.256 -3.498 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.469 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -48.92 159.67 0.88 Allowed 'Trans proline' 0 C--O 1.272 2.222 1 C-N-CA 132.108 8.539 . . . . 0.0 120.656 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.323 24.4 mt-30 46.52 31.72 1.42 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.62 72.28 Favored Glycine 0 CA--C 1.55 2.243 0 O-C-N 116.568 -3.832 . . . . 0.0 112.009 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.5 m -63.52 122.39 16.17 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-O 116.192 -1.861 . . . . 0.0 110.248 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 81.5 m -58.77 134.3 56.72 Favored 'General case' 0 C--N 1.382 2.015 0 CA-C-O 115.578 -2.154 . . . . 0.0 113.286 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.62 152.89 32.78 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 125.476 3.762 . . . . 0.0 111.344 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -62.94 145.09 94.31 Favored 'Trans proline' 1 CA--C 1.62 4.777 0 C-N-CA 125.06 3.84 . . . . 0.0 112.801 -161.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -69.11 -18.87 64.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 117.763 -3.086 . . . . 0.0 116.459 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.73 -17.95 10.07 Favored Glycine 0 CA--C 1.542 1.753 0 O-C-N 118.302 -2.749 . . . . 0.0 114.773 164.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.8 145.04 48.0 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 121.359 2.579 . . . . 0.0 115.829 -165.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -87.16 142.48 27.88 Favored 'General case' 0 CA--C 1.604 3.022 0 C-N-CA 131.006 3.722 . . . . 0.0 107.071 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.43 170.04 16.47 Favored 'General case' 0 CA--C 1.576 1.97 0 O-C-N 125.589 1.805 . . . . 0.0 113.517 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.555 1.147 0 O-C-N 124.556 1.16 . . . . 0.0 112.837 169.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 N--CA 1.53 3.669 0 CA-C-O 114.172 -2.512 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -69.08 123.89 22.28 Favored 'General case' 0 CA--C 1.582 2.2 0 O-C-N 126.168 2.167 . . . . 0.0 110.51 161.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -80.7 -13.24 59.18 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 127.586 2.355 . . . . 0.0 114.869 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.3 m 57.24 -29.77 0.03 OUTLIER 'General case' 1 CA--C 1.644 4.561 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 171.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.326 . . -91.3 169.54 10.73 Favored 'General case' 0 C--O 1.188 -2.169 0 C-N-CA 127.011 2.125 . . . . 0.0 111.592 -174.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.1 t -84.81 130.4 34.68 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 128.325 2.65 . . . . 0.0 114.625 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -71.3 -15.01 62.39 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 127.627 2.371 . . . . 0.0 113.66 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 157' ' ' ILE . 15.5 m-85 -118.02 173.26 6.88 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 127.378 2.271 . . . . 0.0 116.403 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p -61.27 153.01 27.55 Favored 'General case' 0 C--O 1.287 3.068 0 O-C-N 128.831 3.832 . . . . 0.0 110.851 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.59 154.43 19.95 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 129.766 3.227 . . . . 0.0 112.408 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.09 156.32 20.73 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.744 1.218 . . . . 0.0 108.711 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 107' ' ' ARG . 57.4 m -139.46 121.9 16.12 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 131.486 3.914 . . . . 0.0 114.296 -168.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.262 4.5 tp-100 -77.42 142.32 39.3 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.244 1.497 . . . . 0.0 113.501 -167.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -135.77 -22.55 1.43 Allowed 'General case' 0 CA--C 1.601 2.93 0 CA-C-O 113.272 -3.251 . . . . 0.0 111.319 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.32 -130.92 0.61 Allowed Glycine 1 CA--C 1.61 6.012 0 O-C-N 126.47 2.356 . . . . 0.0 111.051 153.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -149.31 -20.93 0.29 Allowed 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 131.122 3.769 . . . . 0.0 113.053 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.94 147.84 48.32 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 124.893 1.371 . . . . 0.0 114.195 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.9 158.59 21.77 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.263 -2.148 . . . . 0.0 115.401 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.8 tp -75.36 51.52 0.56 Allowed 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 129.21 3.004 . . . . 0.0 111.818 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -76.44 139.26 40.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -129.7 88.01 50.8 Favored Pre-proline 0 CA--C 1.591 2.556 1 C-N-CA 132.611 4.365 . . . . 0.0 111.137 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.25 148.08 33.49 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.542 2.161 . . . . 0.0 115.978 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 45.34 20.68 0.05 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 131.119 3.768 . . . . 0.0 113.789 -165.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.7 22.25 69.8 Favored Glycine 0 N--CA 1.499 2.86 0 CA-C-O 116.351 -2.36 . . . . 0.0 108.43 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -84.08 106.37 15.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 128.091 2.877 . . . . 0.0 108.982 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.84 13.68 0.02 OUTLIER Glycine 0 CA--C 1.574 3.749 0 C-N-CA 128.702 3.049 . . . . 0.0 116.422 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.33 122.4 81.4 Favored Pre-proline 0 CA--C 1.56 1.351 0 O-C-N 117.96 -3.082 . . . . 0.0 112.537 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.401 ' HD2' ' CZ ' ' A' ' 110' ' ' PHE . 13.8 Cg_endo -75.16 177.36 8.71 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 121.69 1.593 . . . . 0.0 114.972 -168.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.99 129.89 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 112.378 -2.192 . . . . 0.0 111.016 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -167.38 104.4 0.53 Allowed 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 125.205 1.566 . . . . 0.0 114.312 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.9 m -70.06 -17.54 63.25 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-O 114.198 -2.81 . . . . 0.0 110.516 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -63.7 -11.96 30.43 Favored 'General case' 0 C--O 1.188 -2.136 0 CA-C-N 124.185 3.175 . . . . 0.0 112.536 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 p -125.37 136.88 53.9 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 126.994 2.118 . . . . 0.0 110.4 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 p -85.15 165.97 33.76 Favored Pre-proline 0 C--N 1.269 -2.935 0 C-N-CA 126.231 1.812 . . . . 0.0 112.328 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . 0.302 81.8 Cg_exo -52.87 -24.09 22.98 Favored 'Trans proline' 0 CA--C 1.574 2.521 1 C-N-CA 125.557 4.171 . . . . 0.0 115.684 168.388 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.05 -29.3 43.41 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 121.178 1.808 . . . . 0.0 112.636 171.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.75 -16.7 61.17 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -68.58 61.52 0.09 Allowed 'General case' 0 CA--C 1.595 2.697 0 C-N-CA 131.263 3.825 . . . . 0.0 110.367 -162.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 tt -156.05 138.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.906 0 C-N-CA 126.762 2.025 . . . . 0.0 113.383 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.4 -174.18 46.8 Favored Glycine 0 CA--C 1.557 2.68 0 O-C-N 119.829 -1.794 . . . . 0.0 114.13 -154.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -148.19 145.39 28.27 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 126.733 2.013 . . . . 0.0 112.21 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -92.63 137.15 32.62 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -126.74 139.78 52.87 Favored 'General case' 1 N--CA 1.548 4.457 0 C-N-CA 129.981 3.312 . . . . 0.0 112.555 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -71.51 166.96 20.69 Favored 'General case' 0 C--O 1.291 3.273 0 O-C-N 120.052 -1.655 . . . . 0.0 110.847 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.92 132.85 18.11 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 130.268 3.427 . . . . 0.0 108.182 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -140.8 -17.37 0.86 Allowed 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 130.018 3.327 . . . . 0.0 110.009 -163.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 47.58 60.92 3.19 Favored 'General case' 0 CA--C 1.589 2.447 0 O-C-N 125.909 2.005 . . . . 0.0 116.209 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -99.22 -23.69 15.12 Favored 'General case' 0 C--O 1.259 1.574 0 C-N-CA 129.201 3.0 . . . . 0.0 116.413 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 mp 60.18 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 CA-C-O 126.132 2.873 . . . . 0.0 111.805 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 . . . . . 0 N--CA 1.511 2.598 1 O-C-N 115.34 -4.6 . . . . 0.0 107.619 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt . . . . . 0 N--CA 1.508 2.437 0 CA-C-O 127.262 3.41 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 50.2 30.56 4.41 Favored 'General case' 0 C--N 1.39 2.328 0 O-C-N 117.745 -3.097 . . . . 0.0 117.888 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -122.07 170.37 9.91 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 126.72 2.512 . . . . 0.0 116.422 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.8 m -56.35 164.5 1.93 Allowed Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -49.5 164.03 0.38 Allowed 'Trans proline' 1 CA--C 1.622 4.91 1 C-N-CA 125.771 4.314 . . . . 0.0 112.178 166.48 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HG2' HG23 ' A' ' 57' ' ' THR . 79.3 mtp180 -141.78 168.57 19.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 110.851 -2.886 . . . . 0.0 109.028 174.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -140.66 149.87 42.8 Favored 'General case' 0 C--N 1.276 -2.601 0 O-C-N 118.926 -2.359 . . . . 0.0 108.925 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -130.63 162.8 28.57 Favored 'General case' 0 C--O 1.184 -2.361 0 C-N-CA 127.96 2.504 . . . . 0.0 108.217 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 73' ' ' PRO . 54.4 t80 -119.87 145.27 46.83 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 128.919 2.888 . . . . 0.0 113.96 173.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -147.61 141.59 25.92 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 127.218 2.207 . . . . 0.0 110.712 -171.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -70.45 163.8 25.99 Favored 'General case' 0 CA--C 1.605 3.08 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.18 127.73 32.61 Favored 'General case' 0 CA--C 1.573 1.86 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.839 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.13 20.77 79.01 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 117.979 -2.058 . . . . 0.0 118.151 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.281 3.8 p -134.66 167.63 20.47 Favored 'General case' 0 C--O 1.263 1.775 0 C-N-CA 127.046 2.138 . . . . 0.0 111.539 -174.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.18 -156.36 37.84 Favored Glycine 1 CA--C 1.585 4.407 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.945 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -71.53 -43.16 1.49 Allowed 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 124.036 3.157 . . . . 0.0 114.151 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -82.8 31.96 0.42 Allowed 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 116.802 -1.571 . . . . 0.0 110.599 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.23 -24.86 66.68 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 122.682 2.492 . . . . 0.0 112.37 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.35 -36.73 70.67 Favored Glycine 1 CA--C 1.582 4.225 0 O-C-N 125.242 1.589 . . . . 0.0 116.314 167.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.93 124.78 89.72 Favored Pre-proline 0 CA--C 1.586 2.353 0 CA-C-O 116.509 -1.71 . . . . 0.0 109.971 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -63.05 166.73 13.71 Favored 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 125.237 3.958 . . . . 0.0 113.107 161.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -65.57 127.45 31.93 Favored 'General case' 0 CA--C 1.549 0.907 1 O-C-N 115.481 -4.512 . . . . 0.0 114.241 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.98 -2.63 79.83 Favored Glycine 0 CA--C 1.554 2.469 0 CA-C-N 113.081 -1.872 . . . . 0.0 116.825 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.51 129.83 42.4 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 116.936 -3.685 . . . . 0.0 110.541 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -82.46 25.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.372 -3.33 . . . . 0.0 117.634 -154.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.82 126.97 30.15 Favored 'General case' 0 CA--C 1.593 2.601 0 O-C-N 117.29 -3.381 . . . . 0.0 110.238 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.26 147.35 46.51 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 113.01 -1.904 . . . . 0.0 111.642 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.57 -18.59 54.64 Favored Glycine 1 N--CA 1.525 4.606 0 O-C-N 119.11 -2.243 . . . . 0.0 116.55 -163.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 130' ' ' ILE . 1.5 mp -101.65 119.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 129.496 3.118 . . . . 0.0 109.189 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.87 102.46 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.152 0 C-N-CA 127.752 2.421 . . . . 0.0 106.092 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -71.97 129.81 39.46 Favored 'General case' 0 CA--C 1.588 2.412 0 C-N-CA 125.736 1.615 . . . . 0.0 113.04 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.77 150.12 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 C-N-CA 126.872 2.069 . . . . 0.0 108.623 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.89 19.36 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.415 -173.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.1 p -122.32 155.32 36.22 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 115.84 -2.029 . . . . 0.0 112.5 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.22 -47.71 62.26 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 124.869 3.486 . . . . 0.0 111.515 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.24 -2.61 90.63 Favored Glycine 2 CA--C 1.599 5.341 0 C-N-CA 129.549 3.452 . . . . 0.0 117.061 -172.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.27 33.49 Favored 'General case' 0 CA--C 1.614 3.408 0 CA-C-N 119.487 1.643 . . . . 0.0 111.961 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.3 mt -88.98 146.61 24.77 Favored 'General case' 0 CA--C 1.596 2.747 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 160.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -90.0 29.79 1.16 Allowed 'General case' 0 CA--C 1.6 2.873 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.419 ' O ' ' HE2' ' A' ' 143' ' ' LYS . 25.6 p -72.06 148.52 91.7 Favored Pre-proline 0 N--CA 1.508 2.464 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.825 168.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.43 136.07 35.64 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-O 116.875 -1.385 . . . . 0.0 112.862 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 141' ' ' THR . 53.3 mmtt -88.55 52.15 2.36 Favored 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 128.649 2.78 . . . . 0.0 110.565 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.41 -20.11 0.64 Allowed 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -81.01 -44.17 18.5 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 119.133 -2.23 . . . . 0.0 110.432 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.251 9.3 mt -55.84 -32.33 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-O 116.665 -1.636 . . . . 0.0 113.674 158.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.72 -14.62 81.22 Favored Glycine 0 N--CA 1.514 3.863 0 O-C-N 127.867 3.229 . . . . 0.0 119.352 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.4 p -133.43 -25.79 1.69 Allowed 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -54.91 142.64 28.87 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 125.979 1.712 . . . . 0.0 110.085 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -77.95 101.97 0.82 Allowed Pre-proline 0 CA--C 1.497 -1.08 0 O-C-N 124.343 1.027 . . . . 0.0 110.969 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.38 -21.81 71.48 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 125.136 3.891 . . . . 0.0 116.038 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.79 -9.76 55.85 Favored 'General case' 0 C--O 1.276 2.499 0 C-N-CA 128.279 2.632 . . . . 0.0 112.444 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -59.22 -27.09 65.42 Favored 'General case' 0 CA--C 1.568 1.662 1 N-CA-C 122.638 4.31 . . . . 0.0 122.638 166.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.04 157.76 45.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 118.699 -2.501 . . . . 0.0 114.441 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -32.53 150.34 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.733 1 C-N-CA 131.757 4.023 . . . . 0.0 111.69 160.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.5 137.29 50.1 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 125.563 2.601 . . . . 0.0 114.546 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.476 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 7.3 mt -73.14 129.02 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 118.746 -2.471 . . . . 0.0 111.58 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.15 116.26 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 126.866 2.604 . . . . 0.0 113.165 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.9 tt -88.04 119.48 28.46 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 124.27 1.028 . . . . 0.0 110.175 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.21 151.73 12.12 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 126.669 1.988 . . . . 0.0 105.869 -157.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.2 mt -110.44 145.35 32.05 Favored Pre-proline 0 CA--C 1.564 1.517 0 O-C-N 124.136 0.897 . . . . 0.0 112.666 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.56 167.07 13.97 Favored 'Trans proline' 1 CA--C 1.605 4.056 0 C-N-CA 121.961 1.774 . . . . 0.0 110.155 170.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 53.89 25.91 5.73 Favored 'General case' 0 N--CA 1.531 3.582 0 O-C-N 127.132 2.77 . . . . 0.0 111.874 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.88 29.56 6.34 Favored Glycine 1 N--CA 1.516 4.004 0 O-C-N 127.187 2.805 . . . . 0.0 111.272 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.2 m -58.99 141.99 52.36 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 122.36 3.08 . . . . 0.0 110.459 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m -106.07 119.53 39.46 Favored 'General case' 0 CA--C 1.587 2.395 0 O-C-N 119.596 -1.94 . . . . 0.0 108.75 -162.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.94 145.72 62.74 Favored Pre-proline 0 N--CA 1.389 -3.493 0 O-C-N 118.491 -2.63 . . . . 0.0 114.756 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -50.13 123.73 11.51 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 121.944 3.786 . . . . 0.0 121.944 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -50.13 -30.69 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 126.071 2.107 . . . . 0.0 116.569 -172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.4 -32.5 84.37 Favored Glycine 0 C--O 1.195 -2.296 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 171.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -91.48 127.92 37.11 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-N 118.323 1.062 . . . . 0.0 109.354 171.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -65.06 152.11 44.33 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 155.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -169.67 146.82 3.36 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 124.894 2.283 . . . . 0.0 107.687 -168.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.057 2.143 . . . . 0.0 112.814 -178.365 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 N--CA 1.503 2.08 0 CA-C-O 121.655 0.606 . . . . 0.0 112.14 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -67.68 100.98 0.96 Allowed 'General case' 0 CA--C 1.588 2.408 0 C-N-CA 130.706 3.602 . . . . 0.0 110.249 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.279 34.4 p30 -54.6 -22.5 13.57 Favored 'General case' 0 CA--C 1.591 2.546 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.1 m 64.84 -47.09 0.34 Allowed 'General case' 0 N--CA 1.517 2.892 0 C-N-CA 126.823 2.049 . . . . 0.0 114.495 165.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.26 143.47 52.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 128.08 3.8 . . . . 0.0 111.109 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.3 t -81.65 135.29 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 109.897 -3.319 . . . . 0.0 115.18 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -77.96 -3.21 40.78 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.004 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.23 147.48 51.07 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 129.013 2.925 . . . . 0.0 115.102 -163.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.261 79.8 p -61.21 135.86 57.87 Favored 'General case' 0 C--O 1.185 -2.293 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.256 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.77 129.91 34.7 Favored 'General case' 0 CA--C 1.613 3.385 0 CA-C-O 113.974 -2.917 . . . . 0.0 111.493 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.1 175.75 1.97 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 125.263 1.602 . . . . 0.0 109.671 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -146.79 128.2 14.94 Favored 'General case' 0 C--N 1.309 -1.19 1 O-C-N 114.03 -5.419 . . . . 0.0 106.616 170.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -61.27 121.54 12.83 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 125.716 1.607 . . . . 0.0 112.523 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -100.31 -54.66 2.81 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.02 -126.89 0.1 OUTLIER Glycine 0 C--N 1.37 2.419 0 O-C-N 124.764 1.29 . . . . 0.0 116.131 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -144.38 -28.79 0.49 Allowed 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.836 3.207 . . . . 0.0 112.555 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -72.28 131.43 42.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 130.976 3.71 . . . . 0.0 111.721 -171.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.92 160.94 5.36 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 123.85 1.786 . . . . 0.0 110.939 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -65.69 42.91 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 126.309 1.844 . . . . 0.0 113.506 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -61.51 137.58 58.25 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 121.473 1.942 . . . . 0.0 111.386 -164.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.11 107.47 17.91 Favored Pre-proline 0 CA--C 1.562 1.406 0 O-C-N 117.996 -2.94 . . . . 0.0 112.623 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . 0.268 14.9 Cg_exo -57.7 144.62 92.67 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.671 2.247 . . . . 0.0 113.284 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 40.83 37.03 0.46 Allowed 'General case' 0 N--CA 1.516 2.865 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.05 15.44 5.15 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 127.006 2.691 . . . . 0.0 119.086 -168.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -71.54 109.42 5.48 Favored 'General case' 0 N--CA 1.415 -2.188 1 CA-C-N 125.013 4.406 . . . . 0.0 114.287 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.11 34.96 0.03 OUTLIER Glycine 0 CA--C 1.54 1.615 1 O-C-N 113.725 -5.609 . . . . 0.0 116.877 167.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.0 t -70.99 133.75 85.88 Favored Pre-proline 0 CA--C 1.614 3.427 1 CA-C-N 124.559 4.18 . . . . 0.0 115.159 169.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.22 164.09 36.69 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.499 2.133 . . . . 0.0 116.256 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.68 151.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.18 0 O-C-N 125.903 2.002 . . . . 0.0 111.724 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -166.69 106.2 0.62 Allowed 'General case' 0 N--CA 1.529 3.524 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.017 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -60.66 -28.55 68.68 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -80.3 18.57 0.87 Allowed 'General case' 0 CA--C 1.589 2.45 0 C-N-CA 127.606 2.362 . . . . 0.0 114.377 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 87.6 p -141.51 143.89 34.04 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 127.298 2.239 . . . . 0.0 106.262 -171.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 p -72.39 158.19 87.89 Favored Pre-proline 0 CA--C 1.599 2.837 0 CA-C-N 120.974 1.715 . . . . 0.0 108.49 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.69 -28.24 65.2 Favored 'Trans proline' 0 N--CA 1.524 3.302 0 C-N-CA 124.985 3.79 . . . . 0.0 116.181 167.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.21 -18.38 62.47 Favored 'General case' 0 C--O 1.178 -2.668 0 C-N-CA 126.36 1.864 . . . . 0.0 110.994 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.479 ' HA ' ' HE3' ' A' ' 143' ' ' LYS 0.286 65.4 m-20 -73.86 -21.74 60.0 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 124.409 1.083 . . . . 0.0 111.807 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -79.66 60.55 3.38 Favored 'General case' 0 CA--C 1.599 2.831 0 O-C-N 125.23 1.581 . . . . 0.0 110.972 -153.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.03 139.24 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 126.544 1.938 . . . . 0.0 108.736 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.84 -167.24 40.25 Favored Glycine 0 N--CA 1.493 2.493 1 CA-C-O 127.831 4.017 . . . . 0.0 110.621 -163.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB3' ' CE3' ' A' ' 132' ' ' TRP . 9.5 p90 -144.04 138.82 28.6 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 111.113 -2.543 . . . . 0.0 113.524 -170.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.45 145.52 27.4 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.343 1.068 . . . . 0.0 111.21 153.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -136.95 127.97 27.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 120.1 3.37 . . . . 0.0 120.1 170.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.465 HH22 ' CG ' ' A' ' 128' ' ' ASP . 11.4 ptt180 -50.34 161.06 0.33 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 129.47 3.108 . . . . 0.0 113.204 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.67 143.28 19.58 Favored 'General case' 0 C--N 1.394 2.525 0 O-C-N 117.426 -3.296 . . . . 0.0 113.89 169.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -145.75 -16.35 0.47 Allowed 'General case' 0 N--CA 1.535 3.822 0 C-N-CA 129.122 2.969 . . . . 0.0 112.433 -166.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 46.19 26.72 0.47 Allowed 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -69.78 -14.0 62.56 Favored 'General case' 0 C--O 1.169 -3.134 0 C-N-CA 129.709 3.204 . . . . 0.0 113.141 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.8 mt 70.52 144.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 C-N-CA 129.045 2.938 . . . . 0.0 110.509 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 . . . . . 1 N--CA 1.558 4.949 0 C-N-CA 128.173 2.589 . . . . 0.0 110.615 166.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt . . . . . 0 CA--C 1.566 1.561 0 CA-C-O 115.719 -2.086 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.34 0.3 OUTLIER 70.26 38.0 1.51 Allowed 'General case' 0 C--N 1.371 1.526 0 N-CA-C 118.798 2.888 . . . . 0.0 118.798 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.76 164.41 11.8 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.472 -1.392 . . . . 0.0 107.734 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.1 m -44.67 138.77 3.84 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 168.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.39 162.6 1.33 Allowed 'Trans proline' 0 C--O 1.303 3.728 0 C-N-CA 123.582 2.855 . . . . 0.0 114.222 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -135.05 163.1 30.65 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 128.676 2.791 . . . . 0.0 111.942 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -134.24 139.07 45.52 Favored 'General case' 0 C--O 1.272 2.255 0 O-C-N 117.842 -3.036 . . . . 0.0 108.747 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.55 150.15 41.32 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 126.778 2.031 . . . . 0.0 113.595 173.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -102.49 149.46 24.37 Favored 'General case' 0 C--N 1.364 1.228 0 O-C-N 119.686 -1.884 . . . . 0.0 111.889 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -153.01 147.3 25.74 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 118.823 -2.423 . . . . 0.0 110.945 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -65.51 160.35 22.49 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 127.171 3.367 . . . . 0.0 112.373 170.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.02 123.87 18.04 Favored 'General case' 0 N--CA 1.504 2.248 1 O-C-N 114.951 -4.843 . . . . 0.0 110.674 172.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.1 79.14 Favored Glycine 0 C--O 1.194 -2.387 0 C-N-CA 128.024 2.726 . . . . 0.0 115.853 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.2 p -131.78 160.16 36.37 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 129.325 3.603 . . . . 0.0 109.736 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.42 -167.3 53.97 Favored Glycine 0 CA--C 1.566 3.231 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.33 -38.79 34.75 Favored 'Trans proline' 0 CA--C 1.545 1.075 1 C-N-CA 127.595 5.53 . . . . 0.0 113.089 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -106.56 19.55 20.33 Favored 'General case' 0 C--O 1.276 2.45 0 O-C-N 118.398 -2.689 . . . . 0.0 112.425 -167.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.83 -17.79 2.71 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 116.962 -3.586 . . . . 0.0 115.332 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.77 -20.97 77.59 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 120.782 3.073 . . . . 0.0 120.782 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.55 151.69 68.86 Favored Pre-proline 0 C--O 1.181 -2.511 0 C-N-CA 129.225 3.01 . . . . 0.0 112.72 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -85.31 155.02 10.84 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 CA-C-O 124.569 1.82 . . . . 0.0 108.605 162.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -48.54 136.81 12.52 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 111.945 -2.389 . . . . 0.0 115.889 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.65 5.61 9.38 Favored Glycine 0 CA--C 1.568 3.351 0 C-N-CA 130.691 3.996 . . . . 0.0 118.877 -173.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -43.18 112.4 0.37 Allowed 'General case' 0 C--N 1.416 3.459 0 O-C-N 121.241 -1.152 . . . . 0.0 113.102 162.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -82.06 35.07 0.42 Allowed 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -157.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -71.07 142.92 50.83 Favored 'General case' 0 C--O 1.276 2.482 0 CA-C-N 113.298 -1.774 . . . . 0.0 115.092 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.465 ' CG ' HH22 ' A' ' 89' ' ' ARG . 18.9 t0 -63.28 134.15 55.36 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 127.332 2.253 . . . . 0.0 112.723 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.68 -1.31 88.94 Favored Glycine 0 C--N 1.302 -1.327 0 N-CA-C 119.492 2.557 . . . . 0.0 119.492 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.64 137.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 123.32 3.56 . . . . 0.0 114.518 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.52 116.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.414 ' CE3' ' HB3' ' A' ' 86' ' ' TYR . 83.3 m95 -87.66 138.52 31.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.734 1.73 . . . . 0.0 113.172 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.23 139.96 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 O-C-N 120.577 -1.327 . . . . 0.0 114.166 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -156.18 152.72 28.2 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 115.692 -2.099 . . . . 0.0 116.139 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.3 p -101.51 142.82 32.32 Favored 'General case' 0 C--O 1.28 2.686 0 C-N-CA 125.537 1.535 . . . . 0.0 110.85 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.88 -25.62 68.24 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.439 -2.038 . . . . 0.0 113.709 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.77 -31.12 30.27 Favored Glycine 0 N--CA 1.512 3.701 1 O-C-N 115.813 -4.305 . . . . 0.0 119.638 161.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.89 151.03 27.47 Favored 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 127.729 2.411 . . . . 0.0 111.346 -170.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.16 148.98 22.14 Favored 'General case' 0 CA--C 1.59 2.518 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -61.87 -18.2 59.27 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 114.973 -2.441 . . . . 0.0 114.361 -166.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.4 p -66.56 146.16 99.03 Favored Pre-proline 0 C--O 1.261 1.701 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.48 132.5 27.42 Favored 'Trans proline' 0 CA--C 1.584 2.995 0 CA-C-N 122.992 2.104 . . . . 0.0 110.995 165.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 57.6 mmtt -80.75 54.6 2.17 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.982 1.713 . . . . 0.0 112.637 -168.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.73 -18.76 56.53 Favored 'General case' 0 N--CA 1.53 3.526 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -58.02 -59.8 4.72 Favored 'General case' 0 C--N 1.377 1.785 0 O-C-N 117.394 -3.316 . . . . 0.0 114.638 160.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.4 -19.26 24.66 Favored 'Isoleucine or valine' 0 C--N 1.364 1.207 0 O-C-N 123.996 0.81 . . . . 0.0 112.562 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.19 -0.75 84.86 Favored Glycine 0 N--CA 1.497 2.717 1 CA-C-O 112.843 -4.309 . . . . 0.0 117.634 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.0 p -131.3 -18.55 2.87 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 122.571 3.186 . . . . 0.0 118.396 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -64.74 -176.32 0.25 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.372 0.987 . . . . 0.0 112.608 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -92.89 113.89 61.06 Favored Pre-proline 0 C--N 1.382 1.995 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.856 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -81.3 4.77 6.73 Favored 'Trans proline' 0 C--N 1.385 2.482 0 O-C-N 123.15 1.079 . . . . 0.0 113.908 -170.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.83 19.46 2.49 Favored 'General case' 0 CA--C 1.6 2.882 0 O-C-N 127.367 2.917 . . . . 0.0 113.286 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.15 -38.62 35.52 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 126.447 1.899 . . . . 0.0 107.93 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.1 152.83 24.0 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.295 -1.321 . . . . 0.0 114.416 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.92 140.93 56.49 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 125.549 1.539 . . . . 0.0 113.816 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.3 152.28 29.64 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 125.013 2.339 . . . . 0.0 115.568 -166.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.42 127.6 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.1 t -52.83 106.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.183 -2.399 0 O-C-N 118.634 -2.542 . . . . 0.0 112.574 151.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.99 118.51 9.87 Favored 'General case' 0 C--N 1.362 1.112 0 O-C-N 128.365 3.541 . . . . 0.0 116.376 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -146.56 164.06 33.8 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.018 1.727 . . . . 0.0 107.035 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.06 160.56 30.56 Favored Pre-proline 0 N--CA 1.505 2.291 0 C-N-CA 126.83 2.052 . . . . 0.0 112.478 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -68.37 166.08 26.68 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 118.1 2.308 . . . . 0.0 118.1 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 54.74 31.72 15.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.019 1.728 . . . . 0.0 112.053 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.01 10.86 78.48 Favored Glycine 1 C--N 1.401 4.191 0 CA-C-O 118.996 -0.891 . . . . 0.0 112.381 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.6 m -57.37 119.88 7.23 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 128.478 2.711 . . . . 0.0 109.52 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -81.47 142.43 32.94 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.412 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.93 171.62 2.35 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 128.913 2.885 . . . . 0.0 111.105 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.84 147.15 96.18 Favored 'Trans proline' 0 C--N 1.384 2.418 0 CA-C-O 113.849 -2.646 . . . . 0.0 115.526 172.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -72.36 -16.22 61.86 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 128.757 3.786 . . . . 0.0 114.933 158.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.49 -14.55 9.39 Favored Glycine 0 C--N 1.358 1.786 0 CA-C-O 117.518 -1.712 . . . . 0.0 115.804 160.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -136.97 108.08 6.76 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.084 1.942 . . . . 0.0 111.381 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -59.46 144.61 46.6 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.89 1.805 . . . . 0.0 114.241 164.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.05 175.63 11.56 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 128.483 3.992 . . . . 0.0 112.635 -167.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.408 -2.549 0 O-C-N 117.386 -3.321 . . . . 0.0 110.129 158.248 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.526 3.394 0 CA-C-O 123.319 1.299 . . . . 0.0 115.378 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.63 129.24 39.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 116.974 -1.488 . . . . 0.0 110.828 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -82.87 -15.74 50.3 Favored 'General case' 0 CA--C 1.604 3.029 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m 63.24 -52.8 0.2 Allowed 'General case' 0 C--O 1.251 1.139 0 C-N-CA 128.079 2.552 . . . . 0.0 113.619 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.0 170.29 3.67 Favored 'General case' 0 CA--C 1.592 2.588 0 CA-C-N 123.52 2.873 . . . . 0.0 111.469 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.3 t -77.55 144.55 37.52 Favored 'General case' 0 CA--C 1.58 2.105 0 CA-C-O 113.577 -3.106 . . . . 0.0 113.515 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -95.15 -4.41 46.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 125.76 3.891 . . . . 0.0 113.296 172.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -120.93 164.64 16.39 Favored 'General case' 0 N--CA 1.513 2.689 0 O-C-N 119.069 -2.27 . . . . 0.0 109.34 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.9 p -56.43 146.88 23.08 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 126.392 2.307 . . . . 0.0 110.244 157.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.04 162.56 24.28 Favored 'General case' 0 CA--C 1.567 1.61 0 O-C-N 116.308 -3.995 . . . . 0.0 112.914 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.37 107.32 18.16 Favored 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.028 2.131 . . . . 0.0 114.676 -153.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.4 m -65.2 118.74 9.68 Favored 'General case' 0 C--O 1.18 -2.57 0 O-C-N 126.554 2.409 . . . . 0.0 111.194 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -55.55 124.53 17.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 129.732 3.213 . . . . 0.0 115.627 165.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.19 -7.09 4.84 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 128.538 2.735 . . . . 0.0 111.885 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.43 -141.77 12.55 Favored Glycine 0 N--CA 1.507 3.411 0 O-C-N 120.024 -1.672 . . . . 0.0 112.801 165.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -137.61 -34.56 0.69 Allowed 'General case' 0 C--O 1.177 -2.712 0 O-C-N 116.68 -3.835 . . . . 0.0 110.041 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -58.27 138.0 56.68 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.72 2.408 . . . . 0.0 109.495 173.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -80.08 168.97 18.48 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 124.346 2.022 . . . . 0.0 111.309 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -72.62 61.88 0.53 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 118.677 -2.514 . . . . 0.0 112.281 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.43 149.26 36.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.549 -1.969 . . . . 0.0 114.032 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.08 91.65 23.42 Favored Pre-proline 0 CA--C 1.587 2.374 0 O-C-N 126.176 2.173 . . . . 0.0 110.479 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.09 148.17 18.28 Favored 'Trans proline' 0 C--O 1.195 -1.628 0 C-N-CA 123.697 2.931 . . . . 0.0 110.187 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 53.14 6.46 0.06 Allowed 'General case' 0 C--N 1.372 1.558 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.66 23.08 42.36 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 129.94 3.638 . . . . 0.0 113.589 -169.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -69.31 107.15 3.16 Favored 'General case' 0 CA--C 1.573 1.841 0 O-C-N 120.116 -1.814 . . . . 0.0 108.378 159.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.86 25.69 0.03 OUTLIER Glycine 0 C--N 1.385 3.277 0 C-N-CA 127.131 2.301 . . . . 0.0 113.626 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.49 123.25 78.95 Favored Pre-proline 0 C--N 1.374 1.674 1 O-C-N 114.518 -5.107 . . . . 0.0 110.775 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.63 173.47 12.19 Favored 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.84 2.36 . . . . 0.0 111.66 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -69.24 138.29 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 O-C-N 118.812 -2.43 . . . . 0.0 117.476 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.56 103.06 1.74 Allowed 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 116.938 -1.506 . . . . 0.0 111.144 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 m -71.95 -16.44 62.1 Favored 'General case' 0 CA--C 1.563 1.456 1 C-N-CA 133.009 4.524 . . . . 0.0 112.835 -175.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -83.84 17.08 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 115.139 -2.362 . . . . 0.0 113.137 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.8 p -146.79 176.7 9.67 Favored 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.291 22.0 p -130.18 -174.08 0.36 Allowed Pre-proline 0 C--N 1.289 -2.03 0 O-C-N 118.999 -2.313 . . . . 0.0 111.18 -166.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -73.25 -28.95 11.99 Favored 'Trans proline' 0 C--O 1.196 -1.585 0 CA-C-N 120.739 1.3 . . . . 0.0 113.428 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.45 -24.07 64.93 Favored 'General case' 0 CA--C 1.608 3.191 0 CA-C-O 123.141 1.448 . . . . 0.0 113.428 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.263 69.6 m-20 -92.12 -15.17 28.07 Favored 'General case' 0 C--O 1.187 -2.193 0 O-C-N 118.121 -2.862 . . . . 0.0 113.702 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -74.63 54.64 0.62 Allowed 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 118.144 2.646 . . . . 0.0 118.144 -169.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.07 148.3 17.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.4 -158.47 28.83 Favored Glycine 0 CA--C 1.543 1.82 0 O-C-N 118.558 -2.589 . . . . 0.0 111.585 -173.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -147.13 160.54 42.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.676 2.391 . . . . 0.0 116.981 -172.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -104.52 155.24 18.99 Favored 'General case' 0 CA--C 1.585 2.317 0 C-N-CA 130.327 3.451 . . . . 0.0 110.841 160.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -145.38 146.95 31.77 Favored 'General case' 0 C--O 1.191 -2.02 0 O-C-N 125.804 1.94 . . . . 0.0 109.49 171.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -62.35 154.69 27.25 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.081 1.752 . . . . 0.0 115.595 171.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.18 124.24 30.23 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 129.019 2.928 . . . . 0.0 111.606 158.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -110.36 -18.76 13.18 Favored 'General case' 0 N--CA 1.514 2.736 0 C-N-CA 128.56 2.744 . . . . 0.0 114.811 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 48.0 41.89 15.74 Favored 'General case' 0 C--N 1.382 2.021 0 C-N-CA 124.417 1.087 . . . . 0.0 112.368 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -91.09 -26.38 19.17 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 131.646 3.978 . . . . 0.0 107.652 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.282 1.7 mp 68.05 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 O-C-N 128.319 3.512 . . . . 0.0 114.084 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 . . . . . 0 C--O 1.276 2.482 0 C-N-CA 127.754 2.421 . . . . 0.0 107.507 -179.258 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mttt . . . . . 0 N--CA 1.522 3.14 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 60.2 65.99 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.36 1.864 . . . . 0.0 107.22 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -115.49 157.95 23.28 Favored 'General case' 0 C--O 1.278 2.598 0 C-N-CA 127.79 2.436 . . . . 0.0 112.027 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 t -60.35 158.59 27.83 Favored Pre-proline 0 C--O 1.263 1.804 0 O-C-N 125.891 1.994 . . . . 0.0 114.589 163.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.38 159.2 45.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 123.387 2.724 . . . . 0.0 114.494 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -135.56 152.03 50.89 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -126.08 136.09 52.5 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.358 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.81 130.94 53.49 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 127.763 3.165 . . . . 0.0 112.174 -164.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -102.36 147.18 27.02 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -145.57 153.06 40.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 127.42 2.95 . . . . 0.0 114.639 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -89.26 166.95 13.46 Favored 'General case' 0 CA--C 1.617 3.52 1 CA-C-N 126.64 4.291 . . . . 0.0 112.697 170.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -54.99 123.49 13.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.002 -1.454 . . . . 0.0 113.31 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.09 25.44 68.91 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 126.354 2.284 . . . . 0.0 111.558 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.6 p -132.56 169.39 16.68 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 118.757 -2.614 . . . . 0.0 107.049 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.06 -168.8 49.27 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 112.357 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.5 -26.12 12.29 Favored 'Trans proline' 0 N--CA 1.437 -1.848 1 C-N-CA 127.428 5.419 . . . . 0.0 112.675 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -101.04 31.99 3.4 Favored 'General case' 1 N--CA 1.561 5.117 0 C-N-CA 127.436 2.294 . . . . 0.0 109.47 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.28 -22.91 33.17 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.73 79.18 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.408 1.956 . . . . 0.0 115.281 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.59 125.96 81.62 Favored Pre-proline 0 CA--C 1.499 -1.007 0 CA-C-O 114.663 -2.589 . . . . 0.0 111.005 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 176.69 4.86 Favored 'Trans proline' 0 C--O 1.193 -1.755 0 CA-C-N 124.135 2.512 . . . . 0.0 109.367 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.97 137.17 55.94 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 125.051 1.34 . . . . 0.0 112.172 173.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.08 5.26 65.21 Favored Glycine 0 C--N 1.379 2.918 0 CA-C-O 125.028 2.46 . . . . 0.0 117.56 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.77 47.28 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 117.391 -3.417 . . . . 0.0 111.647 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -74.32 107.37 6.44 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 111.44 -2.618 . . . . 0.0 110.897 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -136.81 124.06 21.84 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.219 1.007 . . . . 0.0 110.175 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.26 107.76 0.7 Allowed 'General case' 0 CA--C 1.596 2.735 0 C-N-CA 128.108 2.563 . . . . 0.0 109.686 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.52 26.78 Favored Glycine 0 N--CA 1.503 3.123 0 C-N-CA 128.581 2.991 . . . . 0.0 111.175 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.25 119.03 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 124.184 0.994 . . . . 0.0 108.893 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.2 mm -101.39 120.54 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-O 124.261 1.981 . . . . 0.0 115.491 164.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -80.76 136.68 36.18 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 116.305 -3.997 . . . . 0.0 118.152 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -139.54 128.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.262 1.743 0 CA-C-N 123.813 3.006 . . . . 0.0 113.425 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.3 23.21 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 128.038 2.535 . . . . 0.0 109.54 -166.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.1 p -137.3 153.38 50.3 Favored 'General case' 0 C--O 1.277 2.504 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.42 -28.55 65.15 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 118.672 -2.517 . . . . 0.0 111.225 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.58 -0.28 89.86 Favored Glycine 1 N--CA 1.517 4.041 0 C-N-CA 128.412 2.911 . . . . 0.0 112.852 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.47 156.03 24.29 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 120.356 2.078 . . . . 0.0 109.009 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.3 mt -95.41 144.1 26.21 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 124.49 2.091 . . . . 0.0 109.054 167.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . 0.328 1.4 p-10 -75.73 26.9 0.11 Allowed 'General case' 0 C--N 1.389 2.283 0 O-C-N 117.934 -2.979 . . . . 0.0 113.601 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.0 p -91.62 158.92 39.66 Favored Pre-proline 0 CA--C 1.554 1.134 0 O-C-N 117.511 -3.243 . . . . 0.0 104.088 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -80.21 142.55 15.22 Favored 'Trans proline' 0 C--N 1.37 1.683 0 N-CA-C 105.087 -2.697 . . . . 0.0 105.087 173.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -88.19 74.64 8.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 117.0 -3.563 . . . . 0.0 107.419 -174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.12 -39.31 92.12 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 122.464 2.393 . . . . 0.0 114.436 -166.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -64.78 -59.32 4.36 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.2 mt -61.11 -23.93 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.088 0 C-N-CA 127.852 2.461 . . . . 0.0 115.633 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.57 -2.74 89.99 Favored Glycine 0 C--O 1.255 1.43 0 N-CA-C 120.163 2.825 . . . . 0.0 120.163 164.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.8 p -130.66 -35.18 1.49 Allowed 'General case' 0 C--O 1.179 -2.641 0 CA-C-N 122.803 3.301 . . . . 0.0 111.504 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -69.03 147.6 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 118.729 -2.482 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -44.21 121.15 3.89 Favored Pre-proline 1 N--CA 1.545 4.297 0 CA-C-O 115.197 -2.335 . . . . 0.0 111.562 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.56 -14.88 5.36 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 123.905 3.07 . . . . 0.0 116.504 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.22 9.8 9.88 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -163.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -69.31 -14.88 63.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 118.577 -2.577 . . . . 0.0 115.504 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.47 171.87 10.68 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 124.915 1.384 . . . . 0.0 108.367 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.13 143.85 5.53 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 118.279 -2.763 . . . . 0.0 114.191 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.51 109.11 1.85 Allowed 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 127.257 2.223 . . . . 0.0 110.529 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.67 132.23 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 128.137 2.575 . . . . 0.0 107.562 -160.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.51 97.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.7 114.79 12.37 Favored 'General case' 0 C--O 1.255 1.389 0 O-C-N 121.118 -0.989 . . . . 0.0 109.086 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -147.63 146.15 29.24 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 128.528 2.731 . . . . 0.0 107.56 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.16 153.01 53.82 Favored Pre-proline 0 CA--C 1.592 2.592 0 O-C-N 118.827 -2.421 . . . . 0.0 113.186 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -43.33 160.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.392 2.819 0 N-CA-C 119.029 2.665 . . . . 0.0 119.029 161.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 56.15 18.32 3.18 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 127.073 2.149 . . . . 0.0 109.733 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.21 19.35 70.19 Favored Glycine 0 C--O 1.187 -2.804 0 CA-C-N 119.764 1.165 . . . . 0.0 113.037 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.5 m -65.27 123.83 20.6 Favored 'General case' 0 C--O 1.262 1.729 0 CA-C-N 118.9 1.35 . . . . 0.0 108.005 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.6 m -74.86 138.26 42.36 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 124.463 2.078 . . . . 0.0 108.058 -165.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.5 mt -66.16 154.15 90.6 Favored Pre-proline 1 N--CA 1.553 4.716 1 CA-C-O 111.205 -4.236 . . . . 0.0 110.314 170.799 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -55.41 137.02 76.35 Favored 'Trans proline' 0 CA--C 1.559 1.752 1 C-N-CA 129.05 6.5 . . . . 0.0 113.718 -172.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -75.66 -16.64 60.17 Favored 'General case' 0 N--CA 1.481 1.117 1 O-C-N 115.67 -4.394 . . . . 0.0 112.688 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.46 -9.65 13.41 Favored Glycine 0 N--CA 1.512 3.701 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 166.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -119.39 157.54 27.97 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.141 2.97 . . . . 0.0 111.376 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -104.51 136.31 44.31 Favored 'General case' 0 CA--C 1.605 3.077 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.264 165.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.29 -173.17 4.3 Favored 'General case' 0 C--N 1.384 2.108 0 C-N-CA 127.964 2.506 . . . . 0.0 111.106 -158.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.519 3.021 0 C-N-CA 126.542 1.937 . . . . 0.0 109.891 158.542 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 N--CA 1.512 2.57 0 N-CA-C 118.439 2.438 . . . . 0.0 118.439 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.64 111.56 2.13 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 127.247 3.403 . . . . 0.0 109.553 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -58.81 -11.8 3.64 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 118.804 -2.435 . . . . 0.0 110.758 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m 46.22 -50.22 0.0 OUTLIER 'General case' 0 C--N 1.364 1.23 1 C-N-CA 133.036 4.534 . . . . 0.0 119.942 -170.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.18 154.24 23.87 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 131.808 4.043 . . . . 0.0 112.052 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.0 t -82.5 137.57 34.58 Favored 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 127.385 2.274 . . . . 0.0 115.64 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -76.13 -21.05 57.05 Favored 'General case' 0 CA--C 1.615 3.461 0 CA-C-O 122.797 1.284 . . . . 0.0 110.56 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -88.29 173.01 9.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 118.389 -2.695 . . . . 0.0 113.952 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p -71.98 172.23 10.38 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 119.25 -2.156 . . . . 0.0 110.84 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . 0.309 . . -117.18 132.73 56.58 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 119.666 -1.896 . . . . 0.0 114.764 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.7 mt -70.25 163.42 26.51 Favored 'General case' 0 N--CA 1.513 2.677 0 C-N-CA 129.74 3.216 . . . . 0.0 111.643 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.9 m -128.15 131.12 48.95 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 168.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -66.92 149.95 49.89 Favored 'General case' 0 CA--C 1.6 2.893 0 C-N-CA 124.259 1.024 . . . . 0.0 112.083 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -151.53 -19.81 0.2 Allowed 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.611 -1.931 . . . . 0.0 113.43 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.94 -125.65 0.83 Allowed Glycine 0 CA--C 1.548 2.153 0 C-N-CA 128.107 2.765 . . . . 0.0 113.748 160.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -156.68 -22.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -69.32 139.68 54.3 Favored 'General case' 0 C--O 1.279 2.654 0 C-N-CA 126.272 1.829 . . . . 0.0 115.638 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.77 164.72 9.51 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 128.507 2.723 . . . . 0.0 115.816 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.8 tp -82.7 52.34 2.09 Favored 'General case' 0 CA--C 1.569 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 113.823 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -55.23 138.47 44.93 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 118.984 -2.323 . . . . 0.0 109.604 -171.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 50.5 m-85 -128.47 129.29 23.57 Favored Pre-proline 0 C--O 1.187 -2.221 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -84.11 137.75 7.48 Favored 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.315 4.01 . . . . 0.0 109.477 -170.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 45.81 23.82 0.18 Allowed 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.88 7.38 65.9 Favored Glycine 0 CA--C 1.567 3.325 0 CA-C-O 117.242 -1.865 . . . . 0.0 112.044 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -65.42 72.37 0.05 OUTLIER 'General case' 0 C--O 1.19 -2.052 0 CA-C-N 119.847 1.824 . . . . 0.0 111.892 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.16 33.96 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.206 0 CA-C-N 122.968 2.622 . . . . 0.0 119.398 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -74.43 119.36 76.14 Favored Pre-proline 0 C--O 1.257 1.453 0 O-C-N 118.708 -2.642 . . . . 0.0 110.593 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.51 161.49 20.56 Favored 'Trans proline' 0 CA--C 1.601 3.835 0 N-CA-C 119.035 2.667 . . . . 0.0 119.035 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.19 131.17 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 O-C-N 126.139 2.149 . . . . 0.0 108.922 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -165.12 91.96 0.55 Allowed 'General case' 0 N--CA 1.536 3.84 0 C-N-CA 128.65 2.78 . . . . 0.0 106.031 172.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -67.61 -21.22 65.41 Favored 'General case' 0 C--O 1.185 -2.315 0 CA-C-O 123.676 1.703 . . . . 0.0 113.607 -174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -55.41 -50.25 70.27 Favored 'General case' 0 N--CA 1.421 -1.889 1 O-C-N 115.342 -4.599 . . . . 0.0 114.897 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.2 p -58.36 153.86 14.72 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 119.069 2.988 . . . . 0.0 119.069 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.2 t -78.31 145.73 69.02 Favored Pre-proline 0 C--O 1.17 -3.128 0 O-C-N 125.241 1.588 . . . . 0.0 108.767 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.91 -34.72 16.86 Favored 'Trans proline' 0 CA--C 1.587 3.139 1 C-N-CA 125.755 4.303 . . . . 0.0 113.086 162.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.31 -38.77 92.45 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.646 1.178 . . . . 0.0 108.954 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.25 -19.66 66.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-O 116.201 -1.857 . . . . 0.0 114.629 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -84.62 81.18 8.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 123.523 2.874 . . . . 0.0 114.094 -151.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 tt -163.52 130.83 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.926 0 C-N-CA 126.999 2.12 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 -157.7 15.51 Favored Glycine 0 CA--C 1.557 2.702 0 CA-C-O 124.289 2.049 . . . . 0.0 115.902 -166.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -161.05 146.85 14.46 Favored 'General case' 0 C--O 1.284 2.897 0 CA-C-O 122.624 1.202 . . . . 0.0 112.547 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 4.2 m-85 -97.78 141.33 30.91 Favored 'General case' 0 C--O 1.171 -3.061 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.221 162.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -125.47 143.45 50.99 Favored 'General case' 0 C--O 1.202 -1.407 0 C-N-CA 125.668 1.587 . . . . 0.0 108.016 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.501 HH22 ' CG ' ' A' ' 128' ' ' ASP . 1.2 ptt180 -54.8 174.19 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 126.015 2.072 . . . . 0.0 116.348 163.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.29 139.59 13.38 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 115.181 -2.342 . . . . 0.0 108.999 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.5 p -127.11 -21.16 4.0 Favored 'General case' 0 C--O 1.262 1.747 0 C-N-CA 127.395 2.278 . . . . 0.0 113.297 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 46.01 49.14 12.28 Favored 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 125.512 1.525 . . . . 0.0 108.597 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -97.8 -9.71 26.04 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 127.248 2.219 . . . . 0.0 110.158 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.303 2.1 mp 64.57 157.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.592 2.59 0 O-C-N 120.398 -1.439 . . . . 0.0 114.478 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 . . . . . 0 C--N 1.301 -1.52 0 CA-C-O 122.914 1.34 . . . . 0.0 107.394 169.177 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.6 tttt . . . . . 0 C--O 1.205 -1.284 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 56.1 40.31 30.22 Favored 'General case' 0 CA--C 1.583 2.232 1 CA-C-O 129.032 4.253 . . . . 0.0 116.367 167.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.61 165.38 13.33 Favored 'General case' 0 C--N 1.375 1.704 0 O-C-N 117.897 -3.002 . . . . 0.0 116.048 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.0 t -60.03 147.78 79.24 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 121.988 0.899 . . . . 0.0 112.367 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -53.56 132.65 49.98 Favored 'Trans proline' 0 C--N 1.408 3.68 1 C-N-CA 125.939 4.426 . . . . 0.0 115.18 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -94.53 171.71 8.64 Favored 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 125.882 1.673 . . . . 0.0 114.601 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -146.03 139.5 26.14 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 119.571 -1.955 . . . . 0.0 113.228 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -128.86 170.23 13.64 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.262 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -114.14 136.3 53.09 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 127.809 2.443 . . . . 0.0 114.664 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.69 144.14 48.98 Favored 'General case' 0 CA--C 1.603 2.997 0 C-N-CA 126.496 1.918 . . . . 0.0 111.277 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.68 167.92 13.45 Favored 'General case' 0 N--CA 1.515 2.786 0 CA-C-O 123.603 1.668 . . . . 0.0 107.83 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.65 137.32 57.75 Favored 'General case' 0 C--O 1.199 -1.59 0 CA-C-O 115.671 -2.109 . . . . 0.0 109.599 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.63 -13.7 60.0 Favored Glycine 0 CA--C 1.569 3.446 0 CA-C-O 126.399 3.222 . . . . 0.0 114.815 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -119.31 171.94 7.96 Favored 'General case' 0 C--O 1.196 -1.716 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.01 -168.75 37.61 Favored Glycine 0 CA--C 1.566 3.252 0 O-C-N 129.001 3.938 . . . . 0.0 111.227 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -59.57 -39.81 71.48 Favored 'Trans proline' 0 N--CA 1.515 2.744 0 C-N-CA 122.56 2.174 . . . . 0.0 112.854 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -95.58 42.14 1.09 Allowed 'General case' 0 CA--C 1.588 2.408 0 O-C-N 119.854 -1.779 . . . . 0.0 112.486 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.53 -25.75 18.15 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 129.438 3.095 . . . . 0.0 114.863 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -87.62 -15.63 61.41 Favored Glycine 0 N--CA 1.478 1.499 0 C-N-CA 126.184 1.849 . . . . 0.0 115.434 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.22 135.56 84.61 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 120.01 1.905 . . . . 0.0 113.773 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -89.16 156.81 5.67 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 124.438 1.757 . . . . 0.0 113.685 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.72 128.15 34.87 Favored 'General case' 0 C--O 1.273 2.342 0 CA-C-O 115.811 -2.042 . . . . 0.0 113.089 -169.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.82 21.05 66.82 Favored Glycine 0 N--CA 1.406 -3.306 0 CA-C-N 122.765 2.529 . . . . 0.0 118.791 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.88 155.34 38.65 Favored 'General case' 0 C--O 1.268 2.071 0 O-C-N 120.817 -1.402 . . . . 0.0 114.29 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.89 43.99 1.04 Allowed 'General case' 0 C--O 1.269 2.084 0 CA-C-N 121.881 2.128 . . . . 0.0 109.81 -174.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -59.45 137.32 58.04 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-N 122.606 2.457 . . . . 0.0 113.009 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.501 ' CG ' HH22 ' A' ' 89' ' ' ARG . 49.6 t0 -57.44 118.38 5.11 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 128.032 2.533 . . . . 0.0 113.422 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.09 19.17 54.17 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 126.351 2.282 . . . . 0.0 117.697 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.49 121.83 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 131.301 3.84 . . . . 0.0 106.79 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.97 119.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 O-C-N 125.726 1.891 . . . . 0.0 114.017 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -76.47 141.48 41.3 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.67 149.7 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 118.242 -2.786 . . . . 0.0 112.811 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.36 -179.48 6.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.786 -2.007 . . . . 0.0 115.64 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -144.37 160.06 41.68 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 127.496 2.318 . . . . 0.0 111.927 163.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -61.48 -51.55 68.21 Favored 'General case' 0 CA--C 1.561 1.383 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.72 -6.14 54.21 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.969 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.61 158.58 29.72 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 126.549 1.94 . . . . 0.0 115.602 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.48 134.89 39.1 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 122.263 2.301 . . . . 0.0 114.004 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -64.52 59.59 0.02 OUTLIER 'General case' 0 CA--C 1.593 2.602 0 C-N-CA 129.538 3.135 . . . . 0.0 109.658 170.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.5 p -150.39 153.16 34.29 Favored Pre-proline 0 N--CA 1.509 2.5 0 C-N-CA 125.061 1.344 . . . . 0.0 113.135 -170.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.45 146.43 50.07 Favored 'Trans proline' 0 CA--C 1.555 1.539 1 C-N-CA 125.416 4.077 . . . . 0.0 112.928 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -114.6 47.02 1.29 Allowed 'General case' 0 C--O 1.264 1.847 0 CA-C-O 125.614 2.626 . . . . 0.0 104.385 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -52.81 -29.63 28.71 Favored 'General case' 0 N--CA 1.489 1.494 1 O-C-N 116.189 -4.069 . . . . 0.0 114.145 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -60.89 -51.51 68.96 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 122.138 2.245 . . . . 0.0 111.115 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.63 -26.81 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 CA-C-O 123.753 1.74 . . . . 0.0 112.058 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -69.68 -12.13 66.77 Favored Glycine 1 CA--C 1.6 5.406 0 CA-C-N 112.676 -2.056 . . . . 0.0 114.041 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 66.9 p -148.29 -29.56 0.3 Allowed 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 123.787 3.794 . . . . 0.0 113.789 -159.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.81 168.14 19.45 Favored 'General case' 0 C--O 1.201 -1.448 1 O-C-N 116.111 -4.118 . . . . 0.0 112.157 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . 0.3 54.7 t-20 -75.44 110.5 10.62 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 128.746 3.779 . . . . 0.0 109.377 -156.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.53 -9.94 18.7 Favored 'Trans proline' 0 C--N 1.396 3.04 1 C-N-CA 128.909 6.406 . . . . 0.0 109.879 -164.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.9 44.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.324 -1.485 . . . . 0.0 114.174 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -68.41 -62.95 1.17 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.164 0.586 . . . . 0.0 110.89 155.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -81.96 153.86 26.04 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 117.17 -1.395 . . . . 0.0 112.461 160.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.29 160.24 22.1 Favored 'General case' 0 CA--C 1.595 2.697 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -36.84 125.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -75.57 134.59 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 O-C-N 126.104 2.128 . . . . 0.0 110.766 172.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.11 125.83 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 O-C-N 118.332 -2.73 . . . . 0.0 107.541 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.42 97.1 6.24 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.315 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -148.53 146.68 28.42 Favored 'General case' 0 C--N 1.375 1.717 0 CA-C-O 126.706 3.146 . . . . 0.0 108.041 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 92.9 mt -85.76 146.19 43.15 Favored Pre-proline 0 C--O 1.255 1.348 0 C-N-CA 128.705 2.802 . . . . 0.0 118.109 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -49.24 164.62 0.27 Allowed 'Trans proline' 0 CA--C 1.57 2.321 1 C-N-CA 125.92 4.413 . . . . 0.0 113.092 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 56.49 32.41 20.71 Favored 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 127.974 2.509 . . . . 0.0 112.949 166.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.45 44.97 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 117.053 -1.971 . . . . 0.0 116.471 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.5 m -59.8 131.02 49.62 Favored 'General case' 0 C--N 1.379 1.89 0 O-C-N 125.583 1.402 . . . . 0.0 108.875 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 94.1 m -90.96 141.86 28.39 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.085 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.5 154.57 93.3 Favored Pre-proline 0 C--O 1.276 2.485 0 CA-C-N 123.529 2.877 . . . . 0.0 110.203 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.22 130.6 28.95 Favored 'Trans proline' 0 C--N 1.402 3.387 0 C-N-CA 124.259 3.306 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -64.56 -4.64 4.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.243 1.817 . . . . 0.0 113.872 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.76 -11.39 49.54 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 116.442 -2.31 . . . . 0.0 113.899 164.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.43 143.38 43.66 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 128.826 2.851 . . . . 0.0 116.1 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.88 154.14 38.35 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 123.801 1.762 . . . . 0.0 113.191 148.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.0 -179.26 7.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 127.125 3.345 . . . . 0.0 108.447 -162.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 CA--C 1.567 1.625 1 O-C-N 114.135 -5.353 . . . . 0.0 111.531 154.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.514 2.731 0 CA-C-O 123.708 1.462 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -84.44 123.23 30.01 Favored 'General case' 0 C--O 1.272 2.276 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.239 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -70.25 -13.97 62.41 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 117.838 -3.039 . . . . 0.0 113.86 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m 58.53 -29.31 0.03 OUTLIER 'General case' 0 CA--C 1.588 2.406 0 N-CA-C 118.648 2.832 . . . . 0.0 118.648 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.422 ' HB3' ' HG2' ' A' ' 151' ' ' PRO . . . -87.53 150.04 23.98 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 126.224 1.809 . . . . 0.0 112.335 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -87.68 136.24 33.03 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 118.718 -2.489 . . . . 0.0 113.755 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -80.31 -2.18 44.13 Favored 'General case' 0 C--O 1.185 -2.303 0 C-N-CA 124.959 1.304 . . . . 0.0 109.136 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -123.16 156.42 35.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 119.433 -2.042 . . . . 0.0 113.169 -168.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.8 p -64.87 142.98 58.25 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.56 164.49 21.89 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 127.287 2.867 . . . . 0.0 114.518 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.37 153.06 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.201 0.938 . . . . 0.0 112.308 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -119.22 128.23 54.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.14 -2.85 . . . . 0.0 106.534 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.95 150.36 29.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 108.205 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -138.01 -19.79 1.13 Allowed 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 122.097 0.951 . . . . 0.0 111.881 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.0 -128.12 6.2 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 123.558 1.643 . . . . 0.0 112.392 166.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -142.04 -24.72 0.68 Allowed 'General case' 0 CA--C 1.588 2.407 0 C-N-CA 125.023 1.329 . . . . 0.0 113.572 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.295 25.4 tp10 -60.49 138.85 57.95 Favored 'General case' 0 CA--C 1.609 3.226 0 O-C-N 118.671 -2.518 . . . . 0.0 114.859 173.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.97 163.69 11.72 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 122.742 1.258 . . . . 0.0 114.288 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tp -73.82 54.75 0.51 Allowed 'General case' 0 C--O 1.288 3.112 0 CA-C-N 112.36 -2.2 . . . . 0.0 114.45 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -59.81 159.54 8.78 Favored 'General case' 0 N--CA 1.406 -2.628 0 C-N-CA 127.102 2.161 . . . . 0.0 116.327 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.464 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 77.1 m-85 -145.47 125.37 7.04 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -47.18 117.28 2.14 Favored 'Trans proline' 0 N--CA 1.452 -0.945 1 C-N-CA 125.492 4.128 . . . . 0.0 115.169 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 43.56 23.86 0.05 Allowed 'General case' 1 N--CA 1.557 4.92 1 C-N-CA 131.8 4.04 . . . . 0.0 110.898 -171.41 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.33 17.45 62.47 Favored Glycine 0 CA--C 1.551 2.326 0 O-C-N 117.444 -3.285 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -88.87 111.45 22.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 121.086 2.443 . . . . 0.0 109.796 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.15 38.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-O 116.634 -2.204 . . . . 0.0 118.118 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.35 126.75 92.61 Favored Pre-proline 0 CA--C 1.505 -0.753 0 O-C-N 127.583 2.578 . . . . 0.0 109.601 158.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.93 170.24 20.22 Favored 'Trans proline' 0 N--CA 1.516 2.794 0 C-N-CA 125.221 3.947 . . . . 0.0 113.102 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.4 mt -79.26 126.08 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 117.962 -2.961 . . . . 0.0 110.621 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -138.34 116.1 11.47 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 127.124 3.345 . . . . 0.0 106.82 163.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 m -74.24 -21.86 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 112.27 -2.241 . . . . 0.0 106.249 -168.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.96 39.19 1.51 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 127.669 2.388 . . . . 0.0 114.056 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.7 p -140.94 149.62 42.07 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 121.323 -0.861 . . . . 0.0 112.752 151.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.9 p -75.9 163.7 65.17 Favored Pre-proline 0 CA--C 1.581 2.165 0 CA-C-O 116.3 -1.809 . . . . 0.0 113.519 -170.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.35 -28.75 73.91 Favored 'Trans proline' 0 CA--C 1.569 2.263 0 CA-C-N 124.137 2.513 . . . . 0.0 112.627 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -69.58 -13.81 62.52 Favored 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.41 -10.57 34.71 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 127.795 2.438 . . . . 0.0 111.051 -163.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -86.01 64.7 8.73 Favored 'General case' 0 C--O 1.277 2.528 0 C-N-CA 127.131 2.172 . . . . 0.0 113.749 -160.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.5 tt -158.1 139.31 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-N 112.955 -1.929 . . . . 0.0 107.168 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.04 -165.53 39.0 Favored Glycine 0 CA--C 1.568 3.388 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -165.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -145.37 156.14 43.6 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 125.966 1.706 . . . . 0.0 115.43 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 14.9 m-85 -94.1 148.22 22.39 Favored 'General case' 0 C--O 1.277 2.53 0 C-N-CA 124.064 0.945 . . . . 0.0 109.285 157.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -122.78 138.77 54.54 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 126.22 1.808 . . . . 0.0 112.962 171.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -71.77 143.02 49.7 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 118.608 -2.557 . . . . 0.0 116.828 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . 0.252 . . -124.29 83.45 2.15 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.958 1.703 . . . . 0.0 111.498 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.9 p -80.57 -15.44 56.64 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 120.102 1.319 . . . . 0.0 113.294 -165.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 47.5 35.5 4.28 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -89.84 -9.68 48.19 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.262 1.7 mp 65.85 143.69 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.553 4.701 0 C-N-CA 130.283 3.433 . . . . 0.0 116.216 172.98 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 . . . . . 0 CA--C 1.58 2.126 0 C-N-CA 127.488 2.315 . . . . 0.0 111.901 172.623 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 CA--C 1.595 2.678 0 CA-C-O 122.713 1.244 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 50.16 31.33 4.94 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 116.771 2.138 . . . . 0.0 116.771 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.43 156.29 17.87 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 117.98 -2.95 . . . . 0.0 108.508 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.8 t -58.24 144.23 77.58 Favored Pre-proline 0 N--CA 1.52 3.072 0 C-N-CA 129.23 3.012 . . . . 0.0 108.616 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -47.1 139.47 15.22 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 124.681 3.587 . . . . 0.0 115.288 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -102.37 170.62 7.95 Favored 'General case' 0 CA--C 1.572 1.812 0 O-C-N 127.122 2.764 . . . . 0.0 106.659 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -155.91 144.02 19.86 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 118.537 -2.602 . . . . 0.0 109.176 -174.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.01 147.57 44.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 128.975 2.91 . . . . 0.0 117.186 -172.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -92.92 155.87 17.3 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -148.22 139.25 23.22 Favored 'General case' 0 N--CA 1.532 3.642 1 C-N-CA 132.652 4.381 . . . . 0.0 113.721 169.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -75.04 158.63 32.87 Favored 'General case' 0 CA--C 1.606 3.12 0 O-C-N 125.454 1.721 . . . . 0.0 114.186 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.5 tp -53.65 127.21 24.65 Favored 'General case' 0 CA--C 1.582 2.176 0 O-C-N 117.377 -3.327 . . . . 0.0 114.711 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.28 15.69 76.01 Favored Glycine 0 CA--C 1.552 2.381 0 C-N-CA 123.82 0.724 . . . . 0.0 111.98 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -151.66 163.38 39.24 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-O 124.63 2.157 . . . . 0.0 111.993 -166.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.98 -163.25 54.47 Favored Glycine 1 CA--C 1.581 4.167 0 O-C-N 118.384 -2.697 . . . . 0.0 111.558 -164.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -70.59 -26.8 23.27 Favored 'Trans proline' 1 CA--C 1.607 4.157 0 CA-C-O 117.975 -0.927 . . . . 0.0 111.981 -168.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.28 37.53 1.87 Allowed 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.257 1.389 . . . . 0.0 112.901 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -25.89 67.92 Favored 'General case' 0 C--N 1.373 1.623 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.33 -12.93 77.75 Favored Glycine 1 CA--C 1.587 4.559 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.8 mt -53.65 145.8 28.36 Favored Pre-proline 0 CA--C 1.584 2.256 0 CA-C-N 119.385 1.592 . . . . 0.0 110.992 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -85.23 169.02 10.1 Favored 'Trans proline' 0 N--CA 1.412 -3.273 0 O-C-N 123.689 1.362 . . . . 0.0 113.467 155.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -57.47 136.17 56.65 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 125.503 1.752 . . . . 0.0 115.28 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.99 -4.73 56.85 Favored Glycine 1 CA--C 1.582 4.221 0 CA-C-O 115.379 -2.901 . . . . 0.0 114.047 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.73 153.99 12.59 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -82.42 100.84 10.26 Favored 'General case' 0 C--O 1.276 2.492 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.718 -165.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.11 127.95 4.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 126.442 2.339 . . . . 0.0 109.658 167.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.05 155.99 36.64 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 125.994 1.718 . . . . 0.0 110.26 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.14 7.47 87.67 Favored Glycine 0 N--CA 1.488 2.165 0 O-C-N 125.79 1.931 . . . . 0.0 113.634 -165.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.7 132.59 62.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 C-N-CA 127.026 2.13 . . . . 0.0 109.525 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.3 mm -121.99 121.14 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 C-N-CA 126.422 1.889 . . . . 0.0 106.826 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -99.03 140.7 32.79 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.8 1.24 . . . . 0.0 109.56 -170.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.02 158.64 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-O 117.654 -1.165 . . . . 0.0 113.339 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -151.56 176.75 11.02 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 127.561 3.038 . . . . 0.0 111.508 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.8 p -123.17 158.49 30.66 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 128.916 2.887 . . . . 0.0 109.379 155.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -49.94 -44.43 50.52 Favored 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 128.521 2.728 . . . . 0.0 113.892 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.11 -17.11 75.46 Favored Glycine 1 CA--C 1.59 4.758 0 CA-C-N 111.91 -2.405 . . . . 0.0 114.169 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . 0.268 . . -76.73 136.3 39.04 Favored 'General case' 0 C--O 1.292 3.324 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.2 mt -84.94 152.3 23.61 Favored 'General case' 0 C--N 1.383 2.022 0 CA-C-N 113.063 -1.881 . . . . 0.0 106.412 170.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -72.66 6.81 2.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.013 -1.449 . . . . 0.0 113.204 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.3 p -70.81 140.47 86.44 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.25 134.24 26.5 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 121.429 1.419 . . . . 0.0 109.408 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . 0.259 49.7 mmtt -77.84 41.87 0.36 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 116.417 -1.754 . . . . 0.0 109.602 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -46.02 -29.12 1.35 Allowed 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 113.365 -3.207 . . . . 0.0 114.425 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -60.74 -46.56 89.98 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 123.684 2.947 . . . . 0.0 113.253 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.7 mt -81.93 -17.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 126.126 1.77 . . . . 0.0 108.698 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.37 -23.07 55.39 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 129.772 3.558 . . . . 0.0 113.427 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.7 p -127.33 -11.71 5.72 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-O 125.89 2.757 . . . . 0.0 116.238 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -81.25 154.74 26.44 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 111.469 -2.605 . . . . 0.0 106.156 166.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -92.07 124.45 59.91 Favored Pre-proline 0 CA--C 1.581 2.162 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.422 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 1.2 Cg_exo -52.94 -29.57 44.44 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.992 3.128 . . . . 0.0 115.642 169.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.4 -16.41 62.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -67.62 -17.45 64.62 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.929 3.059 . . . . 0.0 114.917 -170.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -135.04 178.01 7.36 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 122.696 1.236 . . . . 0.0 111.16 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.64 151.39 34.35 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 116.642 -1.647 . . . . 0.0 109.366 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.05 147.08 1.5 Allowed 'General case' 0 C--O 1.26 1.651 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.98 118.66 21.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 170.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.72 112.28 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 114.403 -2.713 . . . . 0.0 106.27 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 tt -80.1 137.82 36.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -156.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -157.02 145.95 20.02 Favored 'General case' 0 CA--C 1.611 3.31 0 C-N-CA 130.087 3.355 . . . . 0.0 107.956 -172.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.73 153.31 42.26 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 126.737 2.523 . . . . 0.0 111.744 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.72 171.77 12.73 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.398 3.398 . . . . 0.0 108.949 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.262 69.3 mt-30 64.69 12.78 7.87 Favored 'General case' 0 CA--C 1.589 2.455 0 C-N-CA 127.122 2.169 . . . . 0.0 112.419 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.99 19.32 44.34 Favored Glycine 0 CA--C 1.549 2.176 1 C-N-CA 132.881 5.038 . . . . 0.0 121.533 -163.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.0 m -61.43 137.74 58.25 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 124.068 0.947 . . . . 0.0 113.467 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 85.0 m -77.21 141.82 39.87 Favored 'General case' 0 CA--C 1.597 2.784 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.8 159.01 84.07 Favored Pre-proline 0 CA--C 1.572 1.794 0 C-N-CA 126.629 1.972 . . . . 0.0 113.273 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.13 136.96 25.47 Favored 'Trans proline' 0 CA--C 1.477 -2.333 0 CA-C-O 124.302 1.709 . . . . 0.0 112.392 -172.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -51.39 -19.92 1.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.254 166.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.43 17.26 44.74 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 125.006 3.548 . . . . 0.0 114.597 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -133.54 155.31 49.84 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-O 124.358 2.028 . . . . 0.0 110.537 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -100.57 143.38 30.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.591 -2.549 . . . . 0.0 107.369 160.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -155.42 -175.81 5.62 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 127.501 2.32 . . . . 0.0 112.641 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 . . . . . 0 N--CA 1.524 3.237 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 178.522 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 CA--C 1.561 1.837 0 N-CA-C 116.414 1.659 . . . . 0.0 116.414 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -62.42 126.58 27.81 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.209 -2.182 . . . . 0.0 113.104 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -79.7 -8.63 59.35 Favored 'General case' 0 CA--C 1.574 1.9 0 O-C-N 119.172 -2.205 . . . . 0.0 115.689 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m 57.94 -39.23 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 130.375 3.47 . . . . 0.0 119.322 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 165.47 25.09 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 110.788 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -89.79 139.51 30.51 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-N 113.767 -1.561 . . . . 0.0 115.001 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -78.92 -5.79 54.57 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 127.707 2.403 . . . . 0.0 110.866 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 156.4 48.96 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.323 1.535 . . . . 0.0 113.528 -165.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.0 p -56.6 163.06 1.95 Allowed 'General case' 0 CA--C 1.575 1.915 0 CA-C-O 124.253 1.978 . . . . 0.0 108.157 165.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.97 166.11 16.18 Favored 'General case' 0 CA--C 1.626 3.903 0 CA-C-N 110.562 -3.017 . . . . 0.0 117.643 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.53 168.83 10.45 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 144.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -126.93 132.53 50.84 Favored 'General case' 0 CA--C 1.579 2.059 0 C-N-CA 126.415 1.886 . . . . 0.0 111.728 158.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.27 128.7 26.01 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 119.521 -1.987 . . . . 0.0 109.101 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -124.16 -24.66 4.3 Favored 'General case' 0 C--O 1.278 2.585 0 O-C-N 128.194 3.434 . . . . 0.0 116.802 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.08 -133.53 4.31 Favored Glycine 0 CA--C 1.578 3.974 0 N-CA-C 119.755 2.662 . . . . 0.0 119.755 154.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -133.04 -29.58 1.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 CA-C-N 119.63 1.715 . . . . 0.0 114.728 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.72 139.28 51.11 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 125.384 1.678 . . . . 0.0 111.254 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -65.74 171.37 4.32 Favored 'General case' 0 CA--C 1.48 -1.747 0 C-N-CA 126.093 1.757 . . . . 0.0 112.759 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.18 37.83 0.17 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.091 -165.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -63.77 109.11 1.61 Allowed 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 127.845 2.458 . . . . 0.0 110.971 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.68 158.71 42.17 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 118.676 -2.515 . . . . 0.0 112.958 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.85 133.45 21.84 Favored 'Trans proline' 0 C--O 1.274 2.32 0 N-CA-C 107.401 -1.807 . . . . 0.0 107.401 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 61.56 7.24 1.76 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 130.055 3.342 . . . . 0.0 114.699 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.19 33.24 85.3 Favored Glycine 0 N--CA 1.492 2.431 0 CA-C-O 123.958 1.865 . . . . 0.0 112.835 -160.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -94.89 118.41 31.75 Favored 'General case' 0 CA--C 1.58 2.097 0 CA-C-N 113.762 -1.219 . . . . 0.0 109.934 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.19 28.93 0.02 OUTLIER Glycine 0 CA--C 1.57 3.494 0 O-C-N 116.882 -3.636 . . . . 0.0 114.329 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.73 128.44 88.28 Favored Pre-proline 0 C--O 1.26 1.654 0 CA-C-N 121.212 2.506 . . . . 0.0 114.62 167.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.44 171.25 18.49 Favored 'Trans proline' 0 N--CA 1.443 -1.487 1 C-N-CA 126.624 4.882 . . . . 0.0 114.477 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.28 135.7 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 128.354 2.662 . . . . 0.0 113.32 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -168.49 121.49 0.85 Allowed 'General case' 0 C--O 1.258 1.519 0 O-C-N 119.172 -2.205 . . . . 0.0 110.072 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.27 9.0 m -75.54 -24.18 56.71 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 118.434 -2.666 . . . . 0.0 112.095 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -75.43 5.58 5.63 Favored 'General case' 0 C--N 1.37 1.483 0 O-C-N 117.506 -3.246 . . . . 0.0 111.992 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -112.83 165.23 12.5 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.261 1.846 . . . . 0.0 112.235 158.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -120.27 175.84 2.11 Favored Pre-proline 0 C--O 1.281 2.74 0 C-N-CA 128.611 2.764 . . . . 0.0 113.506 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.37 -41.48 49.37 Favored 'Trans proline' 0 CA--C 1.591 3.365 0 C-N-CA 122.031 1.821 . . . . 0.0 114.077 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -52.2 -23.01 4.88 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 122.505 2.411 . . . . 0.0 112.414 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.13 -21.02 15.08 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 118.043 -2.911 . . . . 0.0 108.846 -161.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.01 73.8 0.04 OUTLIER 'General case' 0 CA--C 1.613 3.4 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.294 7.1 tt -158.1 137.34 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 C-N-CA 130.786 3.634 . . . . 0.0 104.702 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.36 -165.1 32.51 Favored Glycine 1 CA--C 1.588 4.611 0 CA-C-O 123.194 1.441 . . . . 0.0 111.717 -175.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -151.39 152.96 33.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 127.03 3.3 . . . . 0.0 116.446 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 110' ' ' PHE . 71.8 m-85 -92.88 147.3 22.96 Favored 'General case' 0 CA--C 1.606 3.11 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.179 164.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -125.68 136.79 53.61 Favored 'General case' 0 C--O 1.267 2.026 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -57.24 163.2 2.29 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.511 -1.368 . . . . 0.0 113.591 160.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.4 77.15 1.34 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.226 1.81 . . . . 0.0 111.209 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -71.25 -38.34 71.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.481 2.712 . . . . 0.0 112.538 -161.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 62.78 56.87 1.84 Allowed 'General case' 0 C--N 1.373 1.601 0 CA-C-O 126.988 3.28 . . . . 0.0 109.022 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 mtm180 -118.14 2.19 12.0 Favored 'General case' 0 CA--C 1.6 2.876 0 CA-C-O 113.493 -3.146 . . . . 0.0 107.681 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 mp 57.85 145.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 1 C-N-CA 132.23 4.212 . . . . 0.0 113.05 165.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 . . . . . 0 C--O 1.28 2.682 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 167.368 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.1 mttm . . . . . 0 CA--C 1.576 1.967 0 CA-C-O 115.623 -2.132 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.1 8.04 3.79 Favored 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 122.408 2.367 . . . . 0.0 116.596 -164.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.3 mt -101.37 167.23 10.3 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 123.415 1.579 . . . . 0.0 107.072 -171.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.9 m -72.9 159.77 84.52 Favored Pre-proline 0 C--N 1.368 1.393 0 CA-C-O 115.127 -2.368 . . . . 0.0 114.669 -171.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -49.18 134.86 30.78 Favored 'Trans proline' 0 CA--C 1.556 1.609 1 C-N-CA 130.636 7.557 . . . . 0.0 108.187 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -78.87 158.48 28.09 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.667 156.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -134.85 127.41 30.71 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 117.991 -2.943 . . . . 0.0 112.991 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.04 140.43 49.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.006 1.322 . . . . 0.0 113.652 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.451 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 65.1 t80 -92.45 151.57 20.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.698 3.592 . . . . 0.0 120.698 169.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.402 ' N ' ' CG ' ' A' ' 110' ' ' PHE . 24.6 m-85 -156.16 150.99 26.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.752 2.215 . . . . 0.0 108.455 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -71.08 150.03 45.91 Favored 'General case' 0 N--CA 1.524 3.266 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.796 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.4 tp -43.2 128.38 4.6 Favored 'General case' 0 C--O 1.257 1.49 0 CA-C-N 122.907 2.594 . . . . 0.0 117.161 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.42 18.54 75.4 Favored Glycine 0 CA--C 1.491 -1.462 0 CA-C-O 117.727 -1.596 . . . . 0.0 115.838 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 p -124.25 -164.14 1.22 Allowed 'General case' 0 C--O 1.282 2.773 0 CA-C-N 120.29 2.045 . . . . 0.0 112.428 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 -157.22 53.52 Favored Glycine 0 CA--C 1.547 2.088 0 CA-C-O 116.341 -2.366 . . . . 0.0 114.795 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.4 ' HD3' ' CE2' ' A' ' 111' ' ' TYR . 86.4 Cg_exo -65.47 -22.52 59.04 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 N-CA-C 117.771 2.181 . . . . 0.0 117.771 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -115.31 33.51 5.4 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.918 0.887 . . . . 0.0 110.419 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.59 -12.22 56.92 Favored 'General case' 1 C--O 1.307 4.083 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.895 -166.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.11 -35.8 37.34 Favored Glycine 0 C--N 1.347 1.144 1 CA-C-O 109.029 -6.428 . . . . 0.0 107.375 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.79 135.93 94.63 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-N 123.553 3.676 . . . . 0.0 115.176 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.17 162.77 41.44 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 N-CA-C 119.927 3.011 . . . . 0.0 119.927 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -62.42 134.9 57.09 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 117.657 -3.152 . . . . 0.0 115.106 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.32 71.51 Favored Glycine 0 N--CA 1.499 2.891 0 CA-C-O 115.995 -2.558 . . . . 0.0 110.416 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.69 140.42 41.59 Favored 'General case' 0 C--N 1.389 2.3 0 O-C-N 126.747 2.087 . . . . 0.0 114.283 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -104.98 41.72 1.31 Allowed 'General case' 0 C--O 1.268 2.034 0 CA-C-N 123.397 2.817 . . . . 0.0 111.193 -147.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -74.51 116.42 15.17 Favored 'General case' 0 N--CA 1.521 3.108 0 O-C-N 126.856 2.598 . . . . 0.0 112.166 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.66 152.38 3.76 Favored 'General case' 0 C--O 1.285 2.923 0 CA-C-O 125.414 2.53 . . . . 0.0 114.181 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.33 -10.7 58.1 Favored Glycine 0 CA--C 1.575 3.812 0 CA-C-N 111.953 -2.385 . . . . 0.0 115.952 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -101.62 143.33 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.806 2.442 . . . . 0.0 110.269 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.5 mm -126.18 111.03 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 127.134 2.174 . . . . 0.0 110.322 162.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -65.61 152.2 44.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.97 138.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 O-C-N 118.12 -2.862 . . . . 0.0 113.6 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.63 179.98 7.73 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 118.661 -2.524 . . . . 0.0 113.395 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.4 p -152.59 151.09 30.24 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.422 1.489 . . . . 0.0 108.903 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.79 -27.7 65.27 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 114.566 -2.635 . . . . 0.0 113.023 -170.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.88 -16.73 50.56 Favored Glycine 0 C--O 1.189 -2.664 1 O-C-N 130.369 4.793 . . . . 0.0 117.24 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.39 150.09 28.56 Favored 'General case' 0 C--N 1.409 3.158 0 CA-C-N 121.277 2.538 . . . . 0.0 108.263 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.86 146.48 23.61 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.66 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -76.07 7.89 3.71 Favored 'General case' 1 CA--C 1.648 4.742 0 O-C-N 117.766 -3.084 . . . . 0.0 113.974 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 p -70.57 145.54 92.77 Favored Pre-proline 0 N--CA 1.48 1.066 0 O-C-N 118.137 -2.852 . . . . 0.0 110.597 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.59 137.52 33.1 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 125.041 3.828 . . . . 0.0 112.995 160.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -101.52 67.0 1.11 Allowed 'General case' 0 C--O 1.263 1.784 0 C-N-CA 128.578 2.751 . . . . 0.0 108.987 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -73.22 -12.12 60.75 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.978 -161.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -82.45 -47.85 11.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 113.608 -3.091 . . . . 0.0 114.526 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.47 -32.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 O-C-N 126.641 2.463 . . . . 0.0 113.409 156.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.74 -15.53 62.27 Favored Glycine 0 CA--C 1.553 2.448 0 C-N-CA 126.468 1.985 . . . . 0.0 115.459 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 81.2 p -145.12 -30.08 0.44 Allowed 'General case' 1 CA--C 1.635 4.213 0 C-N-CA 130.105 3.362 . . . . 0.0 117.836 -160.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.97 149.6 46.94 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.042 1.737 . . . . 0.0 110.334 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -74.62 111.03 11.28 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.067 -170.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.31 -35.73 39.02 Favored 'Trans proline' 0 N--CA 1.51 2.494 0 CA-C-O 122.81 1.087 . . . . 0.0 109.488 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.26 2.52 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 117.114 -3.491 . . . . 0.0 114.498 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . 0.265 27.9 t-20 -69.51 -22.5 63.58 Favored 'General case' 0 CA--C 1.588 2.43 0 CA-C-N 120.264 1.393 . . . . 0.0 113.786 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -138.26 177.81 7.6 Favored 'General case' 0 C--O 1.177 -2.725 0 C-N-CA 127.669 2.388 . . . . 0.0 109.005 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.07 156.16 38.0 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 114.912 -2.471 . . . . 0.0 114.986 162.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.85 146.32 37.79 Favored 'General case' 0 C--O 1.175 -2.867 0 CA-C-N 121.837 2.108 . . . . 0.0 113.098 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.8 mt -61.11 143.69 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.612 1.096 . . . . 0.0 111.265 160.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.6 p -74.46 126.13 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.9 tp -58.46 118.91 6.1 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -138.27 141.49 39.87 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.7 154.79 50.66 Favored Pre-proline 0 C--O 1.198 -1.609 0 CA-C-N 122.889 2.586 . . . . 0.0 113.296 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -56.71 177.06 0.18 Allowed 'Trans proline' 0 CA--C 1.558 1.687 1 C-N-CA 130.404 7.403 . . . . 0.0 117.479 166.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 48.37 32.12 3.08 Favored 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 131.787 4.035 . . . . 0.0 114.502 172.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.48 11.9 54.41 Favored Glycine 0 CA--C 1.556 2.597 0 O-C-N 117.661 -3.149 . . . . 0.0 118.005 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . 0.253 5.9 m -63.13 119.81 10.26 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -161.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 46.9 m -63.69 131.22 47.26 Favored 'General case' 0 C--N 1.381 1.948 0 O-C-N 124.521 1.138 . . . . 0.0 108.436 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 44.2 mt -66.81 156.89 85.84 Favored Pre-proline 0 C--O 1.268 2.031 0 C-N-CA 127.162 2.185 . . . . 0.0 106.206 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -57.96 131.34 43.04 Favored 'Trans proline' 0 CA--C 1.571 2.333 0 C-N-CA 123.495 2.797 . . . . 0.0 113.905 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -60.77 -39.29 88.23 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.038 1.735 . . . . 0.0 109.992 -161.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.91 41.43 3.04 Favored Glycine 0 C--N 1.38 2.982 0 O-C-N 117.777 -3.077 . . . . 0.0 112.124 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.68 144.6 37.67 Favored 'General case' 0 C--O 1.204 -1.311 0 O-C-N 119.325 -2.279 . . . . 0.0 113.528 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -72.05 145.38 48.3 Favored 'General case' 0 C--O 1.284 2.884 0 CA-C-O 116.208 -1.853 . . . . 0.0 111.206 157.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -160.92 170.75 19.99 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 126.708 2.003 . . . . 0.0 110.297 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 . . . . . 0 CA--C 1.571 1.77 0 O-C-N 119.364 -2.085 . . . . 0.0 113.196 171.139 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 105.1 -3.2 . . . . 0.0 105.1 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.61 161.7 10.51 Favored Pre-proline 0 CA--C 1.613 3.369 0 CA-C-N 119.103 1.451 . . . . 0.0 112.801 162.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -78.13 166.53 24.59 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 O-C-N 124.275 1.671 . . . . 0.0 111.14 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -71.05 113.61 8.26 Favored 'General case' 0 C--O 1.275 2.408 0 CA-C-O 124.423 2.059 . . . . 0.0 112.772 -174.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -70.98 -9.14 57.43 Favored 'General case' 0 CA--C 1.614 3.413 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -167.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.1 m 58.49 -31.62 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 1 C-N-CA 132.1 4.16 . . . . 0.0 115.192 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.54 157.69 21.18 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.167 2.987 . . . . 0.0 113.11 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.0 t -79.53 136.89 37.0 Favored 'General case' 0 N--CA 1.422 -1.875 0 O-C-N 120.225 -1.547 . . . . 0.0 110.584 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.88 -29.35 70.69 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 115.849 -2.024 . . . . 0.0 113.952 169.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -100.38 162.68 12.79 Favored 'General case' 0 C--N 1.377 1.788 0 O-C-N 127.552 3.033 . . . . 0.0 113.611 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.307 35.2 p -59.45 140.35 56.27 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 125.183 2.421 . . . . 0.0 113.162 166.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.05 143.91 32.58 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 111.151 -2.749 . . . . 0.0 109.623 -171.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.31 152.38 21.06 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.578 -1.326 . . . . 0.0 108.004 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -116.64 134.15 55.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 118.29 -2.756 . . . . 0.0 110.637 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -68.76 139.89 55.32 Favored 'General case' 0 CA--C 1.607 3.139 0 C-N-CA 126.58 1.952 . . . . 0.0 115.856 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -115.72 -48.04 2.78 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.23 -135.62 5.61 Favored Glycine 0 N--CA 1.508 3.458 0 C-N-CA 127.063 2.268 . . . . 0.0 110.959 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -147.39 -29.04 0.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.277 2.038 . . . . 0.0 114.143 -164.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.79 129.47 37.74 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 127.819 2.448 . . . . 0.0 114.773 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.527 ' HB2' ' HE3' ' A' ' 65' ' ' LYS . 82.0 m-20 -56.91 155.57 7.83 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 128.384 2.674 . . . . 0.0 108.067 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.16 57.32 0.84 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.504 -2.623 . . . . 0.0 110.029 -170.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.527 ' HE3' ' HB2' ' A' ' 63' ' ' ASP . 82.8 mttt -87.61 101.81 14.0 Favored 'General case' 0 CA--C 1.576 1.957 1 O-C-N 115.776 -4.327 . . . . 0.0 106.86 -164.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -68.25 149.61 98.03 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -55.78 154.59 25.62 Favored 'Trans proline' 1 C--N 1.417 4.139 0 O-C-N 118.291 -1.479 . . . . 0.0 108.568 158.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 54.63 -5.95 0.02 OUTLIER 'General case' 0 N--CA 1.539 3.977 1 N-CA-C 122.123 4.12 . . . . 0.0 122.123 152.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.78 7.37 71.32 Favored Glycine 0 CA--C 1.564 3.154 1 O-C-N 115.285 -4.634 . . . . 0.0 113.861 -168.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -86.72 104.6 16.27 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 117.803 -1.094 . . . . 0.0 109.0 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.25 21.54 0.04 OUTLIER Glycine 0 C--N 1.356 1.694 0 CA-C-N 122.326 2.33 . . . . 0.0 113.212 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.254 97.9 t -73.29 117.6 61.67 Favored Pre-proline 0 C--O 1.268 2.031 0 O-C-N 119.535 -2.156 . . . . 0.0 116.087 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -68.64 170.18 15.77 Favored 'Trans proline' 0 CA--C 1.552 1.387 1 C-N-CA 129.287 6.658 . . . . 0.0 109.534 -169.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.8 mt -105.13 141.32 20.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 O-C-N 117.772 -3.08 . . . . 0.0 112.381 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 127.481 2.312 . . . . 0.0 111.778 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.4 m -57.49 -43.99 84.57 Favored 'General case' 0 C--O 1.192 -1.929 0 O-C-N 124.054 0.846 . . . . 0.0 112.124 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -77.14 39.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 128.0 2.52 . . . . 0.0 111.907 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.2 p -146.57 144.62 29.69 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 125.551 1.54 . . . . 0.0 111.88 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 p -83.16 168.01 25.45 Favored Pre-proline 0 C--O 1.271 2.215 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -62.89 -33.76 74.11 Favored 'Trans proline' 0 C--O 1.203 -1.241 0 CA-C-O 117.554 -1.102 . . . . 0.0 114.511 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -58.02 -29.12 65.07 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 128.698 2.799 . . . . 0.0 111.21 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.318 33.9 m-20 -74.16 -11.67 60.36 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 129.036 2.935 . . . . 0.0 114.104 -172.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -88.39 66.37 8.3 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 117.149 -1.405 . . . . 0.0 111.229 -157.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.8 tt -154.62 144.23 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.671 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 178.89 -167.49 37.8 Favored Glycine 1 CA--C 1.58 4.137 0 C-N-CA 116.873 -2.584 . . . . 0.0 114.925 -166.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -153.57 147.18 25.1 Favored 'General case' 0 C--O 1.202 -1.432 0 O-C-N 118.247 -2.913 . . . . 0.0 112.985 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -92.91 139.48 30.49 Favored 'General case' 0 C--O 1.246 0.896 0 O-C-N 128.736 3.773 . . . . 0.0 117.34 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -140.69 164.0 31.37 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 121.813 2.097 . . . . 0.0 110.865 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -83.92 154.68 23.25 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 117.78 2.511 . . . . 0.0 117.78 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.23 88.69 2.11 Favored 'General case' 0 C--O 1.182 -2.453 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.635 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.7 p -67.6 -27.8 67.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 116.07 -1.919 . . . . 0.0 111.729 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 52.88 56.05 8.13 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-N 120.189 1.359 . . . . 0.0 109.252 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -122.91 -12.0 8.06 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 130.395 3.478 . . . . 0.0 114.476 -160.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 mp 61.27 124.88 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.549 4.495 1 C-N-CA 131.82 4.048 . . . . 0.0 108.521 166.684 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -86.08 -25.16 26.0 Favored 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 127.145 2.178 . . . . 0.0 107.368 169.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.6 127.56 1.45 Allowed Glycine 0 CA--C 1.553 2.417 0 C-N-CA 127.095 2.283 . . . . 0.0 109.344 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.15 139.24 1.38 Allowed Glycine 0 C--O 1.274 2.613 0 O-C-N 119.47 -2.194 . . . . 0.0 116.23 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.292 32.7 m-20 72.33 54.92 0.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 125.482 1.513 . . . . 0.0 111.331 162.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.43 155.55 10.03 Favored Glycine 0 CA--C 1.546 2.026 0 CA-C-O 115.905 -2.609 . . . . 0.0 113.46 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 100' ' ' LYS . 30.4 mmtm -116.65 114.76 24.53 Favored 'General case' 0 C--O 1.273 2.318 0 CA-C-N 123.152 3.476 . . . . 0.0 103.921 -171.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 84.8 mmm -47.86 137.02 10.31 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 125.79 2.709 . . . . 0.0 108.844 153.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -140.04 -4.63 1.34 Allowed 'General case' 0 CA--C 1.6 2.872 1 C-N-CA 133.607 4.763 . . . . 0.0 115.772 -176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 55.99 -0.34 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 131.667 3.987 . . . . 0.0 116.141 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -67.56 169.34 9.43 Favored 'General case' 0 N--CA 1.53 3.555 0 CA-C-N 123.844 3.02 . . . . 0.0 109.667 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.9 m -56.83 163.06 3.05 Favored Pre-proline 0 C--O 1.211 -0.923 0 CA-C-O 127.27 3.414 . . . . 0.0 111.61 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -71.57 168.05 24.7 Favored 'Trans proline' 0 N--CA 1.427 -2.402 0 CA-C-O 124.844 1.935 . . . . 0.0 115.228 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -113.74 164.54 13.58 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 116.767 -3.708 . . . . 0.0 107.167 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -134.25 122.56 22.91 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 129.775 3.23 . . . . 0.0 112.051 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -107.84 147.61 30.68 Favored 'General case' 0 CA--C 1.597 2.769 0 CA-C-N 113.438 -1.71 . . . . 0.0 112.508 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -101.82 148.88 24.77 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.834 2.454 . . . . 0.0 110.16 166.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -134.05 145.2 49.2 Favored 'General case' 0 C--O 1.255 1.394 0 C-N-CA 125.267 1.427 . . . . 0.0 111.884 168.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -57.73 157.05 7.75 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 160.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 114' ' ' GLY . 33.9 tp -66.25 138.03 57.38 Favored 'General case' 0 C--N 1.384 2.095 0 O-C-N 123.982 0.801 . . . . 0.0 111.068 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.456 ' H ' HD12 ' A' ' 113' ' ' LEU . . . 59.95 32.43 75.27 Favored Glycine 0 CA--C 1.564 3.129 0 CA-C-O 118.08 -1.4 . . . . 0.0 115.069 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -141.88 172.04 13.23 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 128.228 2.611 . . . . 0.0 112.206 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -163.98 45.93 Favored Glycine 1 C--O 1.298 4.126 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.879 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.57 -29.26 25.08 Favored 'Trans proline' 0 CA--C 1.578 2.708 1 C-N-CA 125.579 4.186 . . . . 0.0 111.378 -170.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -94.45 24.63 4.39 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.921 -2.362 . . . . 0.0 111.521 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 -29.59 41.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.062 1.745 . . . . 0.0 114.404 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.38 -10.38 84.66 Favored Glycine 0 C--N 1.388 3.42 0 CA-C-O 124.505 2.169 . . . . 0.0 117.668 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.9 mt -70.29 136.17 86.64 Favored Pre-proline 0 N--CA 1.522 3.155 1 O-C-N 115.776 -4.367 . . . . 0.0 110.179 168.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.18 174.26 13.11 Favored 'Trans proline' 0 C--N 1.376 1.986 0 O-C-N 123.689 1.363 . . . . 0.0 112.711 160.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.02 133.44 56.1 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 120.289 -1.507 . . . . 0.0 111.698 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.75 5.65 89.34 Favored Glycine 1 CA--C 1.621 6.663 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 168.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.98 151.37 4.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.596 1.665 . . . . 0.0 111.994 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -94.95 68.02 3.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -125.05 137.39 54.21 Favored 'General case' 0 C--O 1.258 1.542 0 C-N-CA 126.646 1.978 . . . . 0.0 113.745 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.259 3.2 t0 -57.39 124.05 17.57 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 112.194 -2.275 . . . . 0.0 112.296 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.84 -4.63 79.01 Favored Glycine 0 C--N 1.373 2.589 0 O-C-N 125.204 1.565 . . . . 0.0 114.115 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 mp -86.68 128.82 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.609 3.242 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 163.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.0 mm -109.75 109.62 29.09 Favored 'Isoleucine or valine' 0 C--O 1.254 1.332 1 O-C-N 129.179 4.049 . . . . 0.0 110.574 170.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.21 138.5 35.81 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.205 -0.935 . . . . 0.0 112.901 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.01 146.25 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 126.121 1.769 . . . . 0.0 114.029 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.85 153.57 35.62 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 130.153 3.381 . . . . 0.0 110.843 -175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.2 p -102.43 156.56 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 129.38 3.072 . . . . 0.0 105.096 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -52.7 -31.13 36.0 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.59 -27.31 10.68 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 127.892 2.663 . . . . 0.0 113.171 -163.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.53 157.98 8.28 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.302 1.441 . . . . 0.0 111.486 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.09 131.15 54.43 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 124.589 2.137 . . . . 0.0 110.939 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -64.53 24.42 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.369 0 O-C-N 117.971 -2.956 . . . . 0.0 118.272 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.3 p -87.36 150.76 49.82 Favored Pre-proline 0 C--N 1.362 1.119 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.31 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.4 148.77 49.28 Favored 'Trans proline' 0 CA--C 1.505 -0.949 0 CA-C-O 116.686 -1.464 . . . . 0.0 115.041 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -97.51 90.09 4.92 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 126.166 2.888 . . . . 0.0 109.868 -172.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -52.39 -59.54 4.3 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -64.44 -66.91 0.48 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.064 2.146 . . . . 0.0 106.758 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.0 mt -45.53 -27.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 119.223 -2.173 . . . . 0.0 116.394 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -92.9 -11.23 59.17 Favored Glycine 1 CA--C 1.579 4.035 0 O-C-N 117.785 -3.072 . . . . 0.0 115.834 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.3 p -125.56 -12.65 6.65 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 114.975 -2.441 . . . . 0.0 112.676 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -74.63 178.34 5.45 Favored 'General case' 0 CA--C 1.582 2.2 0 CA-C-O 113.115 -3.326 . . . . 0.0 115.733 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -109.6 97.47 27.82 Favored Pre-proline 0 N--CA 1.414 -2.262 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . 0.337 4.2 Cg_exo -57.86 -28.45 82.53 Favored 'Trans proline' 0 CA--C 1.581 2.827 0 C-N-CA 123.183 2.589 . . . . 0.0 113.882 171.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.7 -12.75 25.7 Favored 'General case' 0 CA--C 1.556 1.184 0 O-C-N 124.448 1.093 . . . . 0.0 113.195 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -61.81 -19.81 62.95 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -148.31 -176.55 5.34 Favored 'General case' 0 C--O 1.175 -2.831 0 CA-C-N 121.271 1.85 . . . . 0.0 110.345 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.24 156.24 0.6 Allowed 'General case' 0 C--N 1.386 2.153 0 CA-C-N 113.531 -1.668 . . . . 0.0 114.825 154.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.08 159.98 24.61 Favored 'General case' 0 C--O 1.259 1.56 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.1 mt -81.46 130.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.722 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 p -63.35 121.2 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 124.497 2.094 . . . . 0.0 108.483 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 118.86 12.23 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 114.693 -5.005 . . . . 0.0 111.514 171.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -151.29 133.08 14.97 Favored 'General case' 0 C--O 1.251 1.136 0 O-C-N 126.87 2.606 . . . . 0.0 109.695 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.5 mt -75.21 165.63 52.2 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.52 145.97 92.68 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 CA-C-N 119.509 0.86 . . . . 0.0 112.915 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 58.6 9.92 1.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.939 2.895 . . . . 0.0 113.098 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.29 30.17 73.45 Favored Glycine 0 CA--C 1.548 2.128 0 O-C-N 118.217 -2.802 . . . . 0.0 116.144 -168.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.7 m -55.0 125.65 21.31 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-N 112.737 -1.731 . . . . 0.0 111.889 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 87.0 m -69.51 125.82 27.86 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -164.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 mt -71.91 157.55 89.34 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 125.632 1.832 . . . . 0.0 106.168 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -44.02 124.84 5.04 Favored 'Trans proline' 0 N--CA 1.52 3.039 1 C-N-CA 129.195 6.597 . . . . 0.0 116.734 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -57.99 -25.41 61.03 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 128.579 2.751 . . . . 0.0 107.708 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.94 -15.25 9.38 Favored Glycine 1 CA--C 1.596 5.147 0 CA-C-N 120.781 1.628 . . . . 0.0 114.917 174.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -137.34 153.89 50.16 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 126.593 1.957 . . . . 0.0 113.188 -154.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -98.6 124.72 43.54 Favored 'General case' 0 C--O 1.199 -1.589 0 O-C-N 118.843 -2.411 . . . . 0.0 109.101 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -117.24 164.63 14.52 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 127.49 2.316 . . . . 0.0 113.988 168.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -62.63 -25.01 67.9 Favored 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 127.471 2.309 . . . . 0.0 116.108 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -90.22 179.87 43.86 Favored Glycine 0 CA--C 1.55 2.228 0 O-C-N 127.23 2.831 . . . . 0.0 114.326 170.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 51.0 m 53.67 53.16 11.87 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -96.15 159.13 15.12 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 126.565 1.946 . . . . 0.0 112.082 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.76 178.78 37.99 Favored Glycine 0 C--N 1.39 3.565 0 C-N-CA 126.134 1.826 . . . . 0.0 114.135 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -152.23 178.64 29.34 Favored Glycine 0 N--CA 1.475 1.271 0 O-C-N 117.148 -3.56 . . . . 0.0 111.63 -160.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . 0.255 16.2 m . . . . . 0 C--O 1.251 1.149 0 CA-C-O 125.273 2.463 . . . . 0.0 111.155 -10.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.352 -5.072 4 O4'-C1'-N19 114.42 6.22 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.651 5.762 2 C1'-O4'-C4' 105.051 -5.054 . 0.174 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C3'--C2' 1.605 7.311 0 C4'-C3'-C2' 99.313 -3.387 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 4 P--O3' 1.509 -8.184 2 O5'-C5'-C4' 121.59 8.136 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.45 -6.779 1 O4'-C1'-N19 112.254 4.054 . 0.498 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 3 O4'--C4' 1.352 -8.427 3 O4'-C1'-N19 114.791 6.591 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O3' 1.542 -5.437 4 O5'-C5'-C4' 116.88 4.772 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.415 " H2'" ' C5 ' ' B' ' 9' ' ' ' C' . . . . . . . . 2 C4'--C3' 1.454 -6.329 1 O5'-C5'-C4' 119.594 6.71 . 0.052 1a . 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ' C' . . . . . 0.415 ' C5 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 C3'--C2' 1.559 3.105 3 C3'-C2'-C1' 107.392 6.546 OUTLIER-DELTA 0.018 1a . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.658 6.499 2 P-O3'-C3' 129.596 8.247 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 3.524 0 CA-C-O 125.876 2.931 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 mt -87.74 142.86 32.89 Favored Pre-proline 0 C--N 1.369 1.455 0 O-C-N 117.897 -3.119 . . . . 0.0 112.9 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -56.02 154.1 29.13 Favored 'Trans proline' 0 C--O 1.252 1.176 1 C-N-CA 126.514 4.809 . . . . 0.0 118.687 169.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -71.04 111.93 6.79 Favored 'General case' 0 N--CA 1.403 -2.778 0 O-C-N 119.878 -1.764 . . . . 0.0 112.395 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 50' ' ' ALA 0.456 27.3 p30 -46.2 -32.8 3.22 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 119.72 -1.862 . . . . 0.0 115.742 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.3 m 64.96 -36.69 0.21 Allowed 'General case' 0 CA--C 1.609 3.219 0 C-N-CA 128.481 2.712 . . . . 0.0 106.974 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 48' ' ' ASN . . . -76.62 152.66 35.8 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 120.639 1.563 . . . . 0.0 113.766 -173.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -95.96 145.68 25.22 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 117.432 2.382 . . . . 0.0 117.432 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -83.03 -13.38 55.98 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -108.39 158.12 17.8 Favored 'General case' 0 N--CA 1.415 -2.18 0 O-C-N 127.965 3.291 . . . . 0.0 116.631 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.0 p -63.27 125.91 25.66 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.88 155.19 35.01 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 127.463 2.305 . . . . 0.0 111.783 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.97 164.09 12.5 Favored 'General case' 0 CA--C 1.593 2.63 0 C-N-CA 128.712 2.805 . . . . 0.0 109.043 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 67.4 m -132.51 130.65 40.7 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 118.878 -2.389 . . . . 0.0 110.616 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -67.49 137.4 55.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.269 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -125.58 -33.11 2.81 Favored 'General case' 0 CA--C 1.593 2.596 0 CA-C-N 120.874 1.67 . . . . 0.0 111.266 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.09 -134.66 0.65 Allowed Glycine 0 N--CA 1.514 3.842 0 N-CA-C 120.945 3.138 . . . . 0.0 120.945 170.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -133.82 -23.63 1.78 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 125.964 1.705 . . . . 0.0 113.444 167.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.92 146.96 25.97 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -72.21 159.47 34.04 Favored 'General case' 0 N--CA 1.409 -2.494 0 O-C-N 118.71 -2.494 . . . . 0.0 111.015 -168.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.1 tp -74.3 68.64 1.52 Allowed 'General case' 0 N--CA 1.534 3.73 0 CA-C-O 123.598 1.666 . . . . 0.0 111.543 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -91.87 158.99 16.0 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 125.114 2.387 . . . . 0.0 106.894 -168.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 61.8 m-85 -148.07 126.95 6.19 Favored Pre-proline 0 C--O 1.257 1.456 0 O-C-N 119.45 -2.031 . . . . 0.0 107.874 -167.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -57.96 106.95 0.28 Allowed 'Trans proline' 0 C--O 1.192 -1.779 1 C-N-CA 125.481 4.121 . . . . 0.0 113.117 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 38.77 36.34 0.14 Allowed 'General case' 0 C--N 1.387 2.235 0 C-N-CA 129.539 3.135 . . . . 0.0 115.244 -166.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.5 75.13 Favored Glycine 0 CA--C 1.541 1.697 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 171.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.18 101.75 3.42 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.411 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.42 -1.26 0.04 OUTLIER Glycine 0 C--O 1.284 3.27 0 N-CA-C 122.952 3.941 . . . . 0.0 122.952 -167.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.76 144.26 68.55 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 121.797 -0.825 . . . . 0.0 113.138 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -82.95 163.67 15.68 Favored 'Trans proline' 0 CA--C 1.55 1.286 0 O-C-N 115.549 -2.921 . . . . 0.0 115.953 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.6 tt -78.55 144.35 11.29 Favored 'Isoleucine or valine' 0 C--O 1.277 2.534 0 CA-C-O 127.69 3.614 . . . . 0.0 112.026 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -150.06 144.46 25.77 Favored 'General case' 0 C--O 1.26 1.652 0 O-C-N 116.971 -3.58 . . . . 0.0 113.35 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.0 m -82.61 -36.29 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . 0.342 17.4 m120 -84.0 20.48 1.53 Allowed 'General case' 0 C--O 1.189 -2.084 0 C-N-CA 131.615 3.966 . . . . 0.0 116.124 -162.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 p -161.34 166.96 26.69 Favored 'General case' 0 C--N 1.388 2.248 0 C-N-CA 126.056 1.742 . . . . 0.0 112.538 171.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.0 p -94.44 169.6 9.47 Favored Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.131 0.972 . . . . 0.0 112.419 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 83' ' ' GLN . 49.5 Cg_exo -65.3 -23.69 58.87 Favored 'Trans proline' 0 CA--C 1.452 -3.589 0 O-C-N 116.908 -2.206 . . . . 0.0 116.908 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -68.01 -24.87 65.17 Favored 'General case' 0 C--O 1.274 2.348 0 C-N-CA 127.636 2.375 . . . . 0.0 107.751 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -78.64 -18.48 54.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 121.725 2.057 . . . . 0.0 115.205 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 80' ' ' PRO . 63.0 mm-40 -84.3 74.04 10.38 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 125.228 2.442 . . . . 0.0 112.104 -162.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tt -156.04 141.66 10.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.753 1 C-N-CA 133.29 4.636 . . . . 0.0 112.859 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.02 -173.41 40.79 Favored Glycine 1 CA--C 1.581 4.186 0 CA-C-O 124.394 2.108 . . . . 0.0 116.321 -168.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -136.44 156.13 49.04 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 109.36 -3.42 . . . . 0.0 111.736 168.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.408 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 36.1 m-85 -99.86 143.32 30.22 Favored 'General case' 0 N--CA 1.391 -3.399 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 162.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -123.04 143.34 50.01 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 126.097 1.759 . . . . 0.0 112.299 165.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.97 166.06 1.63 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 165.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 133.406 4.682 . . . . 0.0 112.875 172.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.1 p -137.26 -13.72 1.56 Allowed 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 59.48 41.16 19.72 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 124.342 2.02 . . . . 0.0 112.203 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -120.37 3.55 10.79 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 118.138 -2.851 . . . . 0.0 116.589 -161.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.8 mm 65.56 92.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.16 -3.63 0 C-N-CA 130.806 3.643 . . . . 0.0 116.579 149.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -74.44 135.17 42.32 Favored 'General case' 0 N--CA 1.418 -2.071 0 O-C-N 124.144 0.902 . . . . 0.0 109.981 161.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.12 -142.4 16.0 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 125.475 1.735 . . . . 0.0 110.58 -170.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -135.17 174.41 21.19 Favored Glycine 0 C--N 1.291 -1.923 0 CA-C-O 126.2 3.111 . . . . 0.0 110.01 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 56.63 48.98 15.4 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 129.736 3.214 . . . . 0.0 116.1 171.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -136.76 136.46 8.36 Favored Glycine 0 CA--C 1.564 3.128 0 CA-C-O 118.635 -1.091 . . . . 0.0 112.159 166.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -67.86 128.61 37.12 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 126.177 1.791 . . . . 0.0 111.354 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -87.47 163.04 16.92 Favored 'General case' 0 N--CA 1.527 3.403 0 CA-C-N 121.157 1.799 . . . . 0.0 108.127 167.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -111.78 -18.79 12.64 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 127.818 3.198 . . . . 0.0 110.86 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.27 27.24 15.42 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.235 1.834 . . . . 0.0 112.134 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.59 167.67 17.1 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 122.747 1.26 . . . . 0.0 107.872 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -65.67 146.22 98.99 Favored Pre-proline 0 C--N 1.405 2.983 0 CA-C-N 112.215 -2.266 . . . . 0.0 116.761 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.02 155.41 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 1 C-N-CA 127.993 5.795 . . . . 0.0 111.872 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -114.83 172.34 7.1 Favored 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -140.82 147.1 38.49 Favored 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 126.936 2.094 . . . . 0.0 113.237 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 55.6 m-85 -132.14 145.71 51.55 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 130.409 3.484 . . . . 0.0 116.717 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -98.83 141.25 31.85 Favored 'General case' 0 C--O 1.262 1.734 0 O-C-N 118.198 -2.814 . . . . 0.0 109.544 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -142.41 122.82 13.99 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 127.669 2.388 . . . . 0.0 110.09 172.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -45.82 151.54 0.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 O-C-N 120.72 -1.238 . . . . 0.0 111.082 171.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.305 69.1 tp -52.84 132.63 37.14 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 125.886 2.755 . . . . 0.0 112.456 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.34 42.18 98.74 Favored Glycine 0 C--O 1.263 1.94 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.898 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -149.55 173.01 14.09 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 114.14 -1.03 . . . . 0.0 112.03 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 54.71 -159.51 5.59 Favored Glycine 0 C--O 1.255 1.421 0 O-C-N 119.727 -1.858 . . . . 0.0 115.186 -163.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.1 -19.34 63.18 Favored 'Trans proline' 0 N--CA 1.5 1.9 1 C-N-CA 125.638 4.225 . . . . 0.0 117.794 -166.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -117.45 35.32 4.72 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 124.645 1.178 . . . . 0.0 111.547 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.59 -5.65 1.32 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 119.967 -1.708 . . . . 0.0 114.159 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.31 -36.66 44.23 Favored Glycine 0 N--CA 1.417 -2.622 0 CA-C-O 114.729 -3.262 . . . . 0.0 113.928 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.6 mt -69.22 125.65 92.13 Favored Pre-proline 0 C--O 1.262 1.737 0 CA-C-N 121.228 2.514 . . . . 0.0 116.768 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.57 171.93 2.34 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 121.868 1.712 . . . . 0.0 114.485 160.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -68.22 138.37 55.52 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.16 74.8 Favored Glycine 1 CA--C 1.585 4.459 0 C-N-CA 117.225 -2.417 . . . . 0.0 116.811 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.34 82.2 8.38 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 171.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.49 126.72 29.17 Favored 'General case' 0 C--O 1.207 -1.163 0 O-C-N 118.044 -2.91 . . . . 0.0 113.126 -167.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -148.1 159.2 44.17 Favored 'General case' 0 C--O 1.182 -2.495 0 C-N-CA 126.714 2.006 . . . . 0.0 110.558 -170.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.1 133.84 46.56 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.8 -2.31 72.59 Favored Glycine 1 CA--C 1.621 6.658 0 O-C-N 119.636 -1.915 . . . . 0.0 114.377 169.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.8 mt -131.3 142.08 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 1 C-N-CA 131.952 4.101 . . . . 0.0 104.62 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.9 mm -137.73 112.96 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.759 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -76.47 128.58 35.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.288 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 m -133.05 142.92 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 127.465 3.507 . . . . 0.0 114.889 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.18 173.57 12.1 Favored 'General case' 0 CA--C 1.478 -1.81 0 O-C-N 118.159 -2.838 . . . . 0.0 112.571 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 37.2 p -127.61 157.11 41.11 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 129.539 3.136 . . . . 0.0 109.916 173.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -64.67 -35.82 82.27 Favored 'General case' 0 CA--C 1.582 2.18 0 C-N-CA 123.964 0.906 . . . . 0.0 112.694 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.79 -22.19 72.65 Favored Glycine 1 CA--C 1.595 5.076 0 O-C-N 119.592 -1.943 . . . . 0.0 114.361 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.69 165.71 4.89 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-N 120.319 2.06 . . . . 0.0 113.197 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.3 mt -126.88 147.44 50.06 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.655 2.782 . . . . 0.0 112.424 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -75.51 -2.68 30.07 Favored 'General case' 1 CA--C 1.63 4.042 0 C-N-CA 126.926 2.091 . . . . 0.0 114.311 -175.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -71.62 148.48 92.85 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 126.22 1.808 . . . . 0.0 111.26 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.6 142.98 9.52 Favored 'Trans proline' 0 CA--C 1.467 -2.872 0 C-N-CA 123.929 3.086 . . . . 0.0 109.931 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -94.08 65.12 3.39 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 117.574 -3.204 . . . . 0.0 108.155 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.52 -34.35 75.72 Favored 'General case' 0 CA--C 1.61 3.254 0 CA-C-O 113.214 -3.279 . . . . 0.0 115.624 -161.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.268 41.0 m80 -62.05 -44.49 96.57 Favored 'General case' 1 CA--C 1.645 4.629 0 O-C-N 126.019 2.074 . . . . 0.0 110.292 171.698 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.4 mt -64.49 -31.87 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.02 -2.03 88.29 Favored Glycine 0 CA--C 1.496 -1.134 0 CA-C-O 116.392 -2.338 . . . . 0.0 117.185 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.5 p -128.88 -27.19 2.56 Favored 'General case' 0 CA--C 1.596 2.724 0 CA-C-N 122.141 2.97 . . . . 0.0 113.251 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -49.4 154.58 0.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 122.292 2.315 . . . . 0.0 111.18 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -67.02 121.0 76.19 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 129.284 3.034 . . . . 0.0 113.595 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -33.79 84.76 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 N-CA-C 118.293 2.382 . . . . 0.0 118.293 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.13 0.41 36.35 Favored 'General case' 0 C--O 1.254 1.341 0 C-N-CA 127.058 2.143 . . . . 0.0 114.579 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -72.93 -16.73 61.54 Favored 'General case' 0 C--O 1.172 -3.015 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -146.36 146.31 30.61 Favored 'General case' 0 CA--C 1.609 3.226 0 CA-C-N 113.074 -1.876 . . . . 0.0 113.363 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.77 152.89 44.64 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 118.706 -2.496 . . . . 0.0 117.135 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.27 116.02 6.18 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 119.747 -1.846 . . . . 0.0 114.771 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.49 120.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.62 0 C-N-CA 127.922 2.489 . . . . 0.0 108.596 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.3 109.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 166.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.6 116.93 6.69 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -172.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -153.52 142.47 21.19 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 116.432 -3.917 . . . . 0.0 108.406 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.54 140.29 22.1 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 116.511 -1.709 . . . . 0.0 114.633 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -37.72 169.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 123.205 2.604 . . . . 0.0 115.325 170.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 54.64 19.14 2.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.636 2.374 . . . . 0.0 112.318 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.14 13.65 60.25 Favored Glycine 0 CA--C 1.562 3.021 0 O-C-N 116.682 -3.761 . . . . 0.0 116.458 -169.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -60.82 116.22 4.27 Favored 'General case' 0 C--O 1.165 -3.39 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.995 -167.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 m -70.18 146.92 50.43 Favored 'General case' 1 N--CA 1.539 4.016 0 C-N-CA 125.611 1.564 . . . . 0.0 113.534 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.56 157.03 77.79 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 122.47 1.129 . . . . 0.0 111.773 175.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.95 120.42 7.88 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 125.038 3.825 . . . . 0.0 112.56 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -60.44 -20.32 59.44 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -168.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.13 4.12 Favored Glycine 0 CA--C 1.54 1.609 1 O-C-N 116.071 -4.143 . . . . 0.0 117.51 161.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.61 125.8 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 123.256 3.528 . . . . 0.0 115.528 171.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -66.71 131.04 45.12 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 115.583 -2.151 . . . . 0.0 109.085 167.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.51 141.86 37.31 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 123.459 2.845 . . . . 0.0 112.301 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -55.37 153.85 6.82 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 101.41 174.59 28.58 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 127.841 2.639 . . . . 0.0 108.43 163.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.3 m 55.72 36.0 26.4 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -71.17 -20.78 62.25 Favored 'General case' 0 N--CA 1.491 1.603 1 C-N-CA 131.832 4.053 . . . . 0.0 112.935 -167.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.46 177.76 51.28 Favored Glycine 0 C--N 1.361 1.918 0 O-C-N 116.391 -3.943 . . . . 0.0 112.197 -166.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.44 -154.97 52.07 Favored Glycine 0 CA--C 1.544 1.867 0 O-C-N 118.353 -2.851 . . . . 0.0 114.591 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 125.777 2.703 . . . . 0.0 117.415 -1.012 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.371 -4.3 5 C1'-O4'-C4' 102.656 -7.715 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O4'--C1' 1.474 5.023 4 C1'-O4'-C4' 99.503 -11.218 . 0.235 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.461 -5.729 2 O4'-C1'-N19 114.207 6.007 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.122 5 O4'-C1'-N19 116.586 8.386 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C2'--C1' 1.593 6.462 0 C4'-C3'-C2' 99.78 -2.92 . 0.03 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.614 7.976 2 C3'-C2'-C1' 107.376 6.528 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O3'--C3' 1.369 -3.843 3 C4'-C3'-C2' 93.359 -9.341 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O3' 1.55 -4.778 1 C1'-O4'-C4' 105.116 -4.982 . 0.114 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.461 3.895 3 C3'-C2'-C1' 107.584 6.76 . 0.187 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.547 -5.016 4 O4'-C1'-N19 115.891 7.691 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.072 0 N-CA-C 105.778 -2.929 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.1 mt -87.48 155.0 54.15 Favored Pre-proline 0 CA--C 1.58 2.131 0 CA-C-N 121.894 2.847 . . . . 0.0 114.629 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.69 166.38 29.63 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 CA-C-O 129.255 3.773 . . . . 0.0 106.663 172.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -54.99 141.61 33.27 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 109.953 -3.294 . . . . 0.0 113.548 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -96.47 -35.28 11.19 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 118.889 2.922 . . . . 0.0 118.889 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 m 61.25 -21.82 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 129.985 3.314 . . . . 0.0 118.261 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.42 151.75 26.45 Favored 'General case' 0 CA--C 1.618 3.56 0 O-C-N 118.247 -2.783 . . . . 0.0 113.818 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 t -77.78 153.25 33.03 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 118.862 -2.399 . . . . 0.0 112.576 167.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -76.07 -27.34 57.19 Favored 'General case' 0 C--O 1.281 2.717 0 C-N-CA 125.616 1.567 . . . . 0.0 114.06 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.64 164.96 11.78 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 124.582 2.134 . . . . 0.0 111.171 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -67.0 159.62 28.22 Favored 'General case' 0 C--O 1.288 3.088 0 CA-C-N 111.206 -2.724 . . . . 0.0 111.02 167.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.0 147.13 28.14 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 127.284 3.421 . . . . 0.0 114.282 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -76.21 162.17 28.18 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 111.713 -2.494 . . . . 0.0 109.467 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.7 m -122.03 125.41 46.2 Favored 'General case' 0 C--N 1.38 1.916 0 C-N-CA 124.423 1.089 . . . . 0.0 109.047 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -69.41 129.36 39.54 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 125.95 1.7 . . . . 0.0 109.462 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -123.78 -7.29 7.92 Favored 'General case' 0 C--O 1.203 -1.381 0 C-N-CA 128.522 2.729 . . . . 0.0 110.475 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.8 -139.79 10.58 Favored Glycine 0 CA--C 1.566 3.269 0 O-C-N 119.333 -2.104 . . . . 0.0 109.463 159.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -147.98 -17.69 0.35 Allowed 'General case' 0 C--O 1.189 -2.116 0 C-N-CA 128.957 2.903 . . . . 0.0 109.952 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.06 132.72 49.94 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -60.19 161.57 6.88 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.048 1.739 . . . . 0.0 111.55 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.15 69.75 9.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 119.433 -2.042 . . . . 0.0 110.067 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -67.32 149.47 50.3 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.402 170.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.06 141.33 41.06 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 126.025 1.73 . . . . 0.0 113.146 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.48 129.69 24.55 Favored 'Trans proline' 0 C--N 1.381 2.271 0 N-CA-C 106.438 -2.178 . . . . 0.0 106.438 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 55.59 21.62 4.63 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 126.909 2.084 . . . . 0.0 115.583 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.01 27.81 72.73 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 124.573 1.082 . . . . 0.0 115.608 -170.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.258 20.1 tt0 -84.85 84.74 7.6 Favored 'General case' 1 CA--C 1.638 4.33 0 C-N-CA 128.463 2.705 . . . . 0.0 106.258 -175.241 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.11 0.08 OUTLIER Glycine 0 C--O 1.206 -1.648 2 CA-C-O 128.64 4.466 . . . . 0.0 123.615 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 133' ' ' VAL . 93.1 t -69.96 126.88 92.66 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.975 -3.662 . . . . 0.0 111.004 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.63 160.86 4.86 Favored 'Trans proline' 0 CA--C 1.58 2.782 1 C-N-CA 128.518 6.145 . . . . 0.0 114.582 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.3 tt -85.28 142.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 159.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -157.54 104.82 2.01 Favored 'General case' 0 C--O 1.272 2.266 0 C-N-CA 126.955 2.102 . . . . 0.0 110.898 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.6 m -59.17 -32.71 70.15 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 125.389 1.68 . . . . 0.0 113.434 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -83.43 2.7 35.31 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.8 p -114.63 147.66 39.23 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 129.549 3.139 . . . . 0.0 110.287 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.2 t -72.35 155.65 91.18 Favored Pre-proline 0 CA--C 1.609 3.247 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -36.3 -31.87 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.682 1 C-N-CA 126.769 4.979 . . . . 0.0 114.45 152.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -82.58 -22.2 34.94 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 120.043 1.292 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -83.89 -14.57 50.75 Favored 'General case' 0 C--O 1.213 -0.861 0 O-C-N 119.369 -2.082 . . . . 0.0 114.367 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -68.9 59.11 0.09 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -167.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 tt -156.25 139.59 7.45 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.06 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.72 -160.71 30.96 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.034 -1.425 . . . . 0.0 114.921 -172.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -148.85 145.67 27.6 Favored 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 119.63 1.715 . . . . 0.0 110.169 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 88.7 m-85 -85.4 161.22 19.53 Favored 'General case' 0 C--N 1.396 2.62 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 164.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -125.58 157.73 36.4 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 118.878 -2.389 . . . . 0.0 109.041 161.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.463 HH22 ' CG ' ' A' ' 128' ' ' ASP . 26.9 ptt180 -77.81 159.81 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.664 1.585 . . . . 0.0 107.815 169.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.04 136.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.449 1.9 . . . . 0.0 110.671 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -133.97 -16.22 2.25 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -168.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 55.26 60.03 3.63 Favored 'General case' 0 N--CA 1.538 3.944 0 O-C-N 119.568 -1.958 . . . . 0.0 107.051 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HB3' ' C2 ' ' B' ' 3' ' ' ' U' . 15.7 ttm180 -128.18 -8.61 5.34 Favored 'General case' 0 C--O 1.193 -1.914 0 O-C-N 119.408 -2.057 . . . . 0.0 109.125 -160.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.337 1.1 mp 68.39 136.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 171.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -145.54 -0.47 0.84 Allowed 'General case' 0 C--O 1.272 2.241 0 C-N-CA 127.503 2.321 . . . . 0.0 114.231 167.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -140.22 -149.07 5.26 Favored Glycine 0 C--N 1.39 3.531 0 C-N-CA 125.688 1.613 . . . . 0.0 113.701 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.43 -131.37 1.84 Allowed Glycine 0 N--CA 1.514 3.874 0 O-C-N 118.775 -2.603 . . . . 0.0 113.492 162.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 45.06 24.0 0.11 Allowed 'General case' 0 N--CA 1.502 2.151 1 C-N-CA 133.415 4.686 . . . . 0.0 116.145 168.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.67 166.81 34.88 Favored Glycine 0 N--CA 1.501 3.011 0 O-C-N 125.177 1.548 . . . . 0.0 115.613 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -128.7 134.57 48.52 Favored 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 114.642 -2.599 . . . . 0.0 114.192 -170.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 31.9 mtp -68.5 142.67 55.22 Favored 'General case' 0 N--CA 1.518 2.931 0 CA-C-N 122.381 2.355 . . . . 0.0 111.265 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.533 ' HE2' ' N3 ' ' B' ' 7' ' ' ' A' . 61.4 tttt -120.03 -4.15 10.09 Favored 'General case' 1 C--O 1.309 4.234 0 C-N-CA 129.644 3.178 . . . . 0.0 116.945 176.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.5 0.4 OUTLIER 73.68 -10.67 1.04 Allowed 'General case' 0 C--N 1.363 1.164 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 177.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.7 mt -68.91 153.73 43.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 129.395 3.078 . . . . 0.0 111.698 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.8 m -66.86 167.64 13.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 114.761 -2.542 . . . . 0.0 111.544 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.259 59.3 Cg_exo -65.28 164.72 24.55 Favored 'Trans proline' 0 CA--C 1.584 3.011 0 C-N-CA 124.504 3.469 . . . . 0.0 114.348 -176.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -131.53 168.63 17.33 Favored 'General case' 0 C--N 1.386 2.173 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -128.7 127.63 42.5 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 128.113 3.383 . . . . 0.0 112.283 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 60.6 m-85 -108.04 144.5 35.29 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 128.336 3.523 . . . . 0.0 111.194 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.6 144.1 31.88 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -140.36 151.34 44.91 Favored 'General case' 0 N--CA 1.514 2.765 0 O-C-N 118.635 -2.541 . . . . 0.0 109.83 176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.446 ' CD1' HG21 ' A' ' 146' ' ' ILE . 27.5 m-85 -90.46 161.29 15.6 Favored 'General case' 0 CA--C 1.595 2.708 0 CA-C-O 125.887 2.756 . . . . 0.0 112.586 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.3 tp -57.77 116.12 3.24 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 117.809 -3.057 . . . . 0.0 109.608 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.74 17.9 50.1 Favored Glycine 0 N--CA 1.501 3.0 0 O-C-N 118.584 -2.572 . . . . 0.0 115.259 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -133.55 165.37 25.05 Favored 'General case' 0 CA--C 1.504 -0.827 1 C-N-CA 132.841 4.456 . . . . 0.0 112.815 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.23 -165.69 52.09 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 125.683 1.611 . . . . 0.0 110.176 171.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -65.65 -28.54 52.41 Favored 'Trans proline' 0 N--CA 1.427 -2.393 1 C-N-CA 127.195 5.264 . . . . 0.0 111.422 -171.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -96.01 17.58 15.16 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 117.976 -2.952 . . . . 0.0 114.607 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.94 -12.21 0.3 Allowed 'General case' 0 C--N 1.39 2.366 0 O-C-N 118.869 -2.395 . . . . 0.0 116.095 -168.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.17 -34.63 57.99 Favored Glycine 0 C--N 1.287 -2.156 0 C-N-CA 128.461 2.934 . . . . 0.0 114.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.64 142.08 83.26 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.982 2.113 . . . . 0.0 115.044 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -77.4 163.91 29.36 Favored 'Trans proline' 0 C--N 1.397 3.111 1 C-N-CA 126.58 4.853 . . . . 0.0 115.118 161.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.42 151.18 41.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 117.374 -1.73 . . . . 0.0 115.124 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.91 8.12 5.49 Favored Glycine 0 CA--C 1.56 2.886 0 N-CA-C 120.903 3.121 . . . . 0.0 120.903 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.72 137.67 49.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 121.062 2.431 . . . . 0.0 113.458 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -78.89 142.79 36.49 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-O 116.307 -1.806 . . . . 0.0 114.227 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.06 142.41 7.35 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 129.672 3.189 . . . . 0.0 111.132 159.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.463 ' CG ' HH22 ' A' ' 89' ' ' ARG . 13.6 t0 -65.34 121.56 15.11 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 126.46 1.904 . . . . 0.0 115.222 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.94 74.72 Favored Glycine 0 CA--C 1.568 3.383 1 C-N-CA 130.957 4.122 . . . . 0.0 122.435 -169.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.1 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 O-C-N 128.199 2.941 . . . . 0.0 108.813 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.9 mm -120.9 119.89 60.77 Favored 'Isoleucine or valine' 0 C--N 1.385 2.112 0 CA-C-O 123.154 1.454 . . . . 0.0 112.491 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -73.63 138.99 45.16 Favored 'General case' 0 C--N 1.372 1.56 0 O-C-N 119.08 -2.262 . . . . 0.0 109.117 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 72' ' ' VAL . 3.0 m -134.95 147.51 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.577 0 C-N-CA 123.635 0.774 . . . . 0.0 111.998 159.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.71 169.78 17.81 Favored 'General case' 0 N--CA 1.395 -3.193 0 C-N-CA 126.848 2.059 . . . . 0.0 113.455 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . 0.255 81.8 p -98.93 170.03 9.02 Favored 'General case' 0 C--O 1.248 0.994 0 O-C-N 120.242 -1.536 . . . . 0.0 113.631 152.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -60.05 -45.78 91.73 Favored 'General case' 0 C--O 1.283 2.863 0 CA-C-O 116.932 -1.508 . . . . 0.0 112.483 160.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.31 -34.45 67.86 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.89 153.78 41.08 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.967 1.365 . . . . 0.0 111.598 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.43 145.21 31.14 Favored 'General case' 0 C--O 1.259 1.581 0 C-N-CA 130.043 3.337 . . . . 0.0 113.792 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -65.49 4.37 0.56 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 p -85.74 142.51 36.99 Favored Pre-proline 0 CA--C 1.479 -1.761 0 C-N-CA 128.832 2.853 . . . . 0.0 109.934 -166.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -59.29 117.21 3.91 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 124.306 3.338 . . . . 0.0 109.845 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -68.17 52.86 0.07 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 126.385 1.874 . . . . 0.0 113.317 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.56 -24.35 67.48 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -171.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -74.14 -35.82 64.12 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.446 HG21 ' CD1' ' A' ' 112' ' ' TYR . 80.4 mt -67.72 -18.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 O-C-N 119.927 -1.733 . . . . 0.0 110.76 164.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.49 -11.7 65.97 Favored Glycine 0 CA--C 1.569 3.435 0 O-C-N 124.44 1.088 . . . . 0.0 115.738 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 24.7 p -130.5 -33.18 1.67 Allowed 'General case' 0 C--N 1.373 1.626 0 O-C-N 124.672 0.866 . . . . 0.0 111.441 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -66.2 142.05 57.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.642 1.564 . . . . 0.0 110.715 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -81.96 114.01 47.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 119.817 -1.802 . . . . 0.0 111.127 -149.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 -4.37 15.24 Favored 'Trans proline' 0 N--CA 1.425 -2.508 0 C-N-CA 124.069 3.179 . . . . 0.0 111.124 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.69 19.12 15.47 Favored 'General case' 0 C--O 1.193 -1.87 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -71.62 -54.95 8.75 Favored 'General case' 0 C--O 1.293 3.379 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.542 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.51 177.92 7.59 Favored 'General case' 0 CA--C 1.598 2.795 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.265 164.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.81 19.88 Favored 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 127.32 2.248 . . . . 0.0 107.206 170.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.24 136.55 58.0 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 113.973 -2.917 . . . . 0.0 117.775 169.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.5 mt -58.53 121.4 6.05 Favored 'Isoleucine or valine' 0 C--N 1.381 1.958 0 O-C-N 128.882 3.864 . . . . 0.0 108.242 165.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.19 103.8 2.0 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 O-C-N 120.086 -1.634 . . . . 0.0 110.664 172.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.52 106.74 0.58 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.551 1.941 . . . . 0.0 111.209 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -119.6 160.3 22.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-O 122.995 1.379 . . . . 0.0 109.773 156.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 83.7 mt -74.75 162.3 74.16 Favored Pre-proline 1 N--CA 1.54 4.042 0 C-N-CA 126.313 1.845 . . . . 0.0 110.528 163.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.27 164.39 10.73 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.182 1.921 . . . . 0.0 116.442 161.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 40.76 41.47 1.18 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 125.79 1.636 . . . . 0.0 113.472 -170.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.73 21.02 1.32 Allowed Glycine 0 CA--C 1.562 3.015 0 O-C-N 125.86 1.975 . . . . 0.0 117.076 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 84.9 m -58.17 131.72 51.4 Favored 'General case' 0 C--N 1.394 2.534 0 O-C-N 117.85 -3.147 . . . . 0.0 115.14 -165.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . 0.267 27.6 m -77.09 116.83 18.08 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 127.646 3.091 . . . . 0.0 114.161 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.36 154.63 83.0 Favored Pre-proline 0 CA--C 1.586 2.352 0 C-N-CA 130.804 3.642 . . . . 0.0 110.107 -169.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.96 149.44 7.98 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 122.673 2.249 . . . . 0.0 117.586 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.34 -16.66 62.45 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.319 1.448 . . . . 0.0 114.667 -163.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.18 -0.96 78.99 Favored Glycine 0 CA--C 1.572 3.621 0 CA-C-O 117.24 -1.867 . . . . 0.0 116.978 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -120.74 135.84 55.03 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.092 2.446 . . . . 0.0 111.368 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -83.89 154.3 23.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 127.266 2.854 . . . . 0.0 107.884 164.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . 0.292 . . -156.72 154.03 29.38 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 126.153 2.883 . . . . 0.0 112.649 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -62.97 140.11 58.83 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 112.348 -2.206 . . . . 0.0 112.134 159.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 177' ' ' ARG . . . 73.7 -166.82 54.61 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 127.876 2.655 . . . . 0.0 111.468 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m 47.64 35.08 4.09 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 124.023 0.929 . . . . 0.0 110.002 -162.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.439 ' HG2' ' HA2' ' A' ' 175' ' ' GLY . 0.7 OUTLIER -80.93 -10.44 59.72 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 129.395 3.078 . . . . 0.0 110.86 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 95.97 -118.34 5.93 Favored Glycine 0 C--O 1.268 2.251 0 O-C-N 118.973 -2.329 . . . . 0.0 110.154 169.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 68.56 -153.24 52.86 Favored Glycine 0 C--N 1.301 -1.413 0 O-C-N 119.238 -2.331 . . . . 0.0 118.819 167.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 1 N--CA 1.546 4.36 0 C-N-CA 125.418 1.487 . . . . 0.0 107.802 -7.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.515 -7.792 2 O4'-C1'-N19 114.073 5.873 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.465 -6.347 3 C3'-C2'-C1' 106.545 5.606 . 0.01 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.437 ' C2 ' ' HB3' ' A' ' 93' ' ' ARG . . . . . . . . 0 O4'--C4' 1.41 -3.543 1 C4'-C3'-C2' 98.366 -4.334 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.671 7.763 3 O4'-C1'-N19 115.965 7.765 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C5'--C4' 1.582 5.554 2 P-O3'-C3' 127.733 6.695 . 0.376 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.685 9.241 2 C5'-C4'-C3' 104.827 -7.115 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ' A' . . . . . 0.533 ' N3 ' ' HE2' ' A' ' 102' ' ' LYS . . . . . . . . 1 O4'--C4' 1.402 -4.26 1 O4'-C1'-N19 103.841 -4.359 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C2'--O2' 1.36 -4.095 3 C4'-C3'-C2' 95.779 -6.921 . 0.151 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O4'--C4' 1.391 -5.197 2 P-O3'-C3' 125.991 5.242 . 0.09 &a . 0.0 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 P--O5' 1.55 -4.288 1 O3'-P-O5' 95.887 -4.27 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.217 0 N-CA-C 106.545 -2.622 . . . . 0.0 106.545 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.49 156.66 88.09 Favored Pre-proline 0 C--N 1.369 1.414 0 O-C-N 119.314 -2.286 . . . . 0.0 116.77 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.92 127.32 25.78 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 124.647 3.565 . . . . 0.0 111.389 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -71.49 133.73 46.05 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.55 -18.34 45.26 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -171.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m 59.27 -43.95 0.07 Allowed 'General case' 0 CA--C 1.589 2.445 0 C-N-CA 129.603 3.161 . . . . 0.0 118.295 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 39.19 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 126.976 2.11 . . . . 0.0 114.725 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.447 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 47.6 t -85.46 139.13 31.75 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 125.655 1.582 . . . . 0.0 113.429 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -79.86 -9.27 59.65 Favored 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 125.362 1.465 . . . . 0.0 113.892 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -109.85 157.09 19.56 Favored 'General case' 0 CA--C 1.581 2.163 0 CA-C-O 124.294 1.997 . . . . 0.0 110.717 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 p -68.2 165.37 18.48 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -111.61 136.92 50.16 Favored 'General case' 0 C--O 1.259 1.586 0 O-C-N 119.566 -1.959 . . . . 0.0 109.736 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.9 mt -75.08 160.86 29.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 126.634 1.973 . . . . 0.0 110.781 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.5 m -126.31 139.29 53.42 Favored 'General case' 0 N--CA 1.493 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 110.652 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.62 141.1 55.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.766 2.426 . . . . 0.0 109.055 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -125.59 -34.19 2.69 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 161.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.01 -126.85 0.02 OUTLIER Glycine 0 C--N 1.305 -1.15 1 CA-C-O 127.99 4.106 . . . . 0.0 113.948 168.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -154.45 -28.01 0.12 Allowed 'General case' 0 C--N 1.292 -1.911 2 O-C-N 114.434 -5.156 . . . . 0.0 111.381 163.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.35 145.89 53.77 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.71 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -54.23 167.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 117.534 -3.229 . . . . 0.0 112.349 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.1 tp -74.26 64.72 1.12 Allowed 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 125.31 2.481 . . . . 0.0 114.362 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -75.55 140.29 42.63 Favored 'General case' 0 C--O 1.287 3.027 0 O-C-N 119.166 -2.209 . . . . 0.0 111.043 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -127.06 156.81 73.79 Favored Pre-proline 0 C--N 1.397 2.658 0 O-C-N 119.256 -2.152 . . . . 0.0 111.319 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -79.86 141.18 14.97 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 42.92 16.46 0.01 OUTLIER 'General case' 0 CA--C 1.584 2.262 0 O-C-N 126.3 2.25 . . . . 0.0 116.207 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.49 73.24 Favored Glycine 0 CA--C 1.557 2.68 1 C-N-CA 130.95 4.119 . . . . 0.0 116.359 -164.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -85.42 108.23 17.77 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 117.39 -1.291 . . . . 0.0 110.319 173.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.91 10.85 0.03 OUTLIER Glycine 1 CA--C 1.601 5.431 0 CA-C-O 114.655 -3.303 . . . . 0.0 117.46 -170.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.18 125.81 59.0 Favored Pre-proline 0 CA--C 1.587 2.387 0 CA-C-N 122.752 3.276 . . . . 0.0 113.482 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.22 153.18 24.4 Favored 'Trans proline' 0 N--CA 1.421 -2.739 0 C-N-CA 122.762 2.308 . . . . 0.0 111.806 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.0 mt -70.84 146.0 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 O-C-N 128.407 3.567 . . . . 0.0 109.972 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -145.91 111.05 5.3 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 118.291 -0.861 . . . . 0.0 109.695 162.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -67.17 -15.69 63.86 Favored 'General case' 0 C--N 1.378 1.833 0 CA-C-N 123.099 2.681 . . . . 0.0 111.604 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -89.43 12.16 17.2 Favored 'General case' 0 CA--C 1.608 3.2 0 C-N-CA 128.761 2.824 . . . . 0.0 110.719 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -120.93 163.23 18.55 Favored 'General case' 0 C--O 1.256 1.412 0 O-C-N 125.147 1.529 . . . . 0.0 111.407 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.8 p -101.76 163.25 18.17 Favored Pre-proline 0 C--O 1.256 1.403 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -59.37 -26.18 81.03 Favored 'Trans proline' 0 CA--C 1.563 1.954 0 CA-C-N 122.666 1.988 . . . . 0.0 110.485 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -56.47 -30.65 63.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 120.711 1.596 . . . . 0.0 113.91 173.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -79.99 -16.32 55.43 Favored 'General case' 0 C--O 1.186 -2.272 0 C-N-CA 127.643 2.377 . . . . 0.0 115.292 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -73.41 61.8 0.69 Allowed 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 129.32 3.048 . . . . 0.0 116.05 -167.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.264 13.3 tt -153.53 138.27 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 127.953 3.283 . . . . 0.0 108.363 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.46 -152.73 11.31 Favored Glycine 0 CA--C 1.489 -1.555 0 O-C-N 116.887 -3.633 . . . . 0.0 114.796 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -149.96 138.37 20.59 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 127.136 2.174 . . . . 0.0 110.493 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -89.35 155.71 19.18 Favored 'General case' 0 C--N 1.286 -2.18 0 O-C-N 127.85 3.219 . . . . 0.0 109.75 159.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -145.39 148.94 33.89 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.554 -1.341 . . . . 0.0 108.677 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.419 HH22 ' CG ' ' A' ' 128' ' ' ASP . 21.5 ptt180 -86.95 -177.72 6.13 Favored 'General case' 0 CA--C 1.61 3.263 0 CA-C-N 121.827 2.103 . . . . 0.0 114.906 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 136.9 9.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 118.878 -2.389 . . . . 0.0 110.592 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.9 p -145.4 -17.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 113.814 -2.993 . . . . 0.0 113.724 -164.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 47.47 48.72 16.54 Favored 'General case' 0 CA--C 1.602 2.956 0 O-C-N 125.39 1.681 . . . . 0.0 111.603 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -105.65 -9.57 17.27 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 119.939 -1.726 . . . . 0.0 112.444 170.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 mp 70.85 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.27 2.173 0 C-N-CA 127.051 2.14 . . . . 0.0 110.76 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.435 ' HG3' ' C4 ' ' B' ' 4' ' ' ' C' . 33.9 mtt-85 -123.35 -24.19 4.68 Favored 'General case' 0 CA--C 1.586 2.334 1 C-N-CA 133.205 4.602 . . . . 0.0 110.296 -179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.13 102.58 0.17 Allowed Glycine 0 C--O 1.2 -1.972 0 O-C-N 118.678 -2.514 . . . . 0.0 108.084 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.65 -155.39 51.09 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 124.459 2.144 . . . . 0.0 108.176 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 53.56 14.68 0.62 Allowed 'General case' 0 C--O 1.266 1.941 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.79 -172.49 45.07 Favored Glycine 0 C--N 1.285 -2.297 0 O-C-N 118.055 -2.903 . . . . 0.0 117.968 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -135.29 154.89 51.39 Favored 'General case' 0 N--CA 1.489 1.507 1 C-N-CA 133.374 4.669 . . . . 0.0 112.409 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -105.22 163.57 12.49 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 127.864 2.466 . . . . 0.0 111.795 -172.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -154.88 -7.27 0.14 Allowed 'General case' 0 C--O 1.239 0.509 0 O-C-N 120.908 -1.12 . . . . 0.0 112.244 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.95 37.85 22.13 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 126.101 1.76 . . . . 0.0 112.986 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.76 169.6 18.0 Favored 'General case' 0 C--O 1.289 3.144 0 C-N-CA 125.578 1.551 . . . . 0.0 110.621 167.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . 0.278 52.6 m -62.32 145.5 94.05 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 123.29 1.519 . . . . 0.0 114.992 170.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . 0.263 15.1 Cg_exo -42.67 155.96 0.1 Allowed 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 121.709 1.606 . . . . 0.0 113.247 164.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -121.4 159.4 26.25 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.601 2.361 . . . . 0.0 115.545 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -129.92 139.94 51.03 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 126.72 2.512 . . . . 0.0 115.631 161.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -121.36 154.19 36.77 Favored 'General case' 0 CA--C 1.592 2.593 0 C-N-CA 126.464 1.905 . . . . 0.0 109.957 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -111.19 141.18 45.04 Favored 'General case' 0 N--CA 1.535 3.801 0 CA-C-N 122.929 2.604 . . . . 0.0 113.906 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.47 ' CD2' ' HA3' ' A' ' 116' ' ' GLY . 8.2 m-85 -141.66 150.92 42.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 125.021 2.343 . . . . 0.0 110.063 170.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -87.59 156.01 19.7 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-N 114.085 -1.416 . . . . 0.0 113.207 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.3 tp -51.47 127.62 20.55 Favored 'General case' 0 C--O 1.271 2.23 0 C-N-CA 124.072 0.949 . . . . 0.0 112.961 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.56 73.83 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.6 p -142.59 -178.51 5.81 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 119.709 1.754 . . . . 0.0 109.616 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 111' ' ' TYR . . . 63.38 -154.1 45.4 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -73.73 -43.08 0.67 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.325 2.017 . . . . 0.0 115.203 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.327 2.5 mm-40 -81.94 27.74 0.45 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 131.431 3.892 . . . . 0.0 110.481 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.76 -19.52 50.83 Favored 'General case' 0 C--O 1.159 -3.706 0 O-C-N 118.188 -2.82 . . . . 0.0 113.096 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.29 -34.5 54.65 Favored Glycine 0 C--O 1.253 1.337 0 O-C-N 124.752 1.282 . . . . 0.0 113.809 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 mt -65.36 139.29 97.34 Favored Pre-proline 0 CA--C 1.607 3.143 0 CA-C-N 120.772 2.286 . . . . 0.0 113.297 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -61.92 166.17 12.79 Favored 'Trans proline' 0 C--O 1.272 2.178 0 O-C-N 124.42 1.747 . . . . 0.0 113.983 155.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -65.09 123.43 19.49 Favored 'General case' 0 C--N 1.365 1.261 0 CA-C-N 110.27 -3.15 . . . . 0.0 116.6 170.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 20.22 62.86 Favored Glycine 0 CA--C 1.576 3.904 0 CA-C-O 124.128 1.96 . . . . 0.0 111.148 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.34 135.69 47.46 Favored 'General case' 0 C--O 1.25 1.094 0 O-C-N 117.534 -3.333 . . . . 0.0 108.793 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.73 11.94 1.5 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -161.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . 0.291 66.7 tttt -72.31 126.03 28.82 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 124.32 2.009 . . . . 0.0 111.238 -167.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.419 ' CG ' HH22 ' A' ' 89' ' ' ARG . 13.8 t0 -53.8 138.74 35.1 Favored 'General case' 0 C--O 1.271 2.226 0 O-C-N 117.588 -3.195 . . . . 0.0 108.038 -175.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.15 -11.42 63.81 Favored Glycine 0 N--CA 1.502 3.076 0 CA-C-O 116.147 -2.474 . . . . 0.0 117.367 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -108.97 134.7 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.616 3.517 0 C-N-CA 130.618 3.567 . . . . 0.0 110.91 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.88 124.11 71.63 Favored 'Isoleucine or valine' 0 C--O 1.291 3.28 0 O-C-N 125.694 1.871 . . . . 0.0 109.323 171.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.68 134.8 33.59 Favored 'General case' 0 CA--C 1.587 2.396 0 CA-C-O 125.418 2.532 . . . . 0.0 111.516 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.28 141.42 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 O-C-N 119.323 -2.11 . . . . 0.0 111.152 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.96 170.96 14.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.8 p -131.79 157.62 43.39 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 113.492 -1.685 . . . . 0.0 114.893 158.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -72.0 -27.24 62.61 Favored 'General case' 0 C--N 1.365 1.28 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.95 -18.25 63.64 Favored Glycine 0 CA--C 1.565 3.189 0 C-N-CA 127.792 2.615 . . . . 0.0 118.143 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.22 147.32 53.19 Favored 'General case' 0 C--O 1.286 3.017 0 C-N-CA 127.152 2.181 . . . . 0.0 110.202 162.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -97.88 142.1 30.05 Favored 'General case' 0 C--O 1.285 2.94 0 CA-C-O 125.122 2.391 . . . . 0.0 108.024 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -48.03 -12.46 0.03 OUTLIER 'General case' 0 CA--C 1.6 2.867 0 CA-C-O 114.014 -2.898 . . . . 0.0 116.012 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -55.34 139.42 66.21 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 130.841 3.656 . . . . 0.0 114.025 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -64.28 140.25 69.76 Favored 'Trans proline' 0 N--CA 1.528 3.503 0 C-N-CA 122.831 2.354 . . . . 0.0 106.369 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -91.53 60.84 4.17 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -23.12 66.09 Favored 'General case' 0 C--O 1.174 -2.87 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.816 -165.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -61.81 -55.51 29.22 Favored 'General case' 0 CA--C 1.61 3.287 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 6.4 mt -60.81 -25.26 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.623 0 C-N-CA 116.781 -1.968 . . . . 0.0 111.567 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.51 -12.03 83.44 Favored Glycine 1 CA--C 1.587 4.567 0 C-N-CA 128.696 3.046 . . . . 0.0 116.695 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 64.6 p -126.88 -24.96 3.41 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.3 158.71 28.78 Favored 'General case' 0 C--O 1.266 1.931 0 O-C-N 117.153 -3.467 . . . . 0.0 106.511 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.5 118.43 47.42 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.835 -2.507 . . . . 0.0 112.432 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -73.4 -25.31 15.51 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.95 2.433 . . . . 0.0 115.93 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.32 -4.27 35.24 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 120.699 -1.25 . . . . 0.0 109.705 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.82 -28.92 70.19 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 121.407 1.912 . . . . 0.0 113.64 -165.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.57 159.93 29.55 Favored 'General case' 0 C--O 1.25 1.119 1 C-N-CA 131.99 4.116 . . . . 0.0 110.847 160.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -53.94 160.74 1.37 Allowed 'General case' 1 N--CA 1.54 4.029 0 C-N-CA 128.441 2.696 . . . . 0.0 111.996 172.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.35 130.97 49.28 Favored 'General case' 0 CA--C 1.584 2.283 0 O-C-N 118.276 -2.765 . . . . 0.0 112.546 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.81 126.77 32.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 124.215 1.959 . . . . 0.0 107.193 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.0 126.8 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.608 0 O-C-N 120.157 -1.589 . . . . 0.0 111.827 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.73 116.7 7.21 Favored 'General case' 0 CA--C 1.604 3.035 0 O-C-N 126.589 2.431 . . . . 0.0 114.373 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -141.23 152.9 44.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 116.304 -3.997 . . . . 0.0 111.399 164.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -113.81 155.26 45.4 Favored Pre-proline 0 C--N 1.256 -3.498 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.469 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -48.92 159.67 0.88 Allowed 'Trans proline' 0 C--O 1.272 2.222 1 C-N-CA 132.108 8.539 . . . . 0.0 120.656 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.323 24.4 mt-30 46.52 31.72 1.42 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.62 72.28 Favored Glycine 0 CA--C 1.55 2.243 0 O-C-N 116.568 -3.832 . . . . 0.0 112.009 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.5 m -63.52 122.39 16.17 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-O 116.192 -1.861 . . . . 0.0 110.248 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 81.5 m -58.77 134.3 56.72 Favored 'General case' 0 C--N 1.382 2.015 0 CA-C-O 115.578 -2.154 . . . . 0.0 113.286 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.62 152.89 32.78 Favored Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 125.476 3.762 . . . . 0.0 111.344 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -62.94 145.09 94.31 Favored 'Trans proline' 1 CA--C 1.62 4.777 0 C-N-CA 125.06 3.84 . . . . 0.0 112.801 -161.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -69.11 -18.87 64.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 117.763 -3.086 . . . . 0.0 116.459 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.73 -17.95 10.07 Favored Glycine 0 CA--C 1.542 1.753 0 O-C-N 118.302 -2.749 . . . . 0.0 114.773 164.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.8 145.04 48.0 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 121.359 2.579 . . . . 0.0 115.829 -165.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -87.16 142.48 27.88 Favored 'General case' 0 CA--C 1.604 3.022 0 C-N-CA 131.006 3.722 . . . . 0.0 107.071 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.43 170.04 16.47 Favored 'General case' 0 CA--C 1.576 1.97 0 O-C-N 125.589 1.805 . . . . 0.0 113.517 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.0 162.65 14.63 Favored 'General case' 0 CA--C 1.555 1.147 0 O-C-N 124.556 1.16 . . . . 0.0 112.837 169.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 86.33 141.41 6.29 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-O 117.838 -1.534 . . . . 0.0 111.906 -170.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.7 m 60.46 41.94 15.16 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 125.215 1.185 . . . . 0.0 113.915 174.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -93.63 -1.58 55.14 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 -174.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 69.29 154.23 0.81 Allowed Glycine 0 N--CA 1.515 3.965 0 C-N-CA 128.224 2.821 . . . . 0.0 110.944 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.45 -168.42 38.81 Favored Glycine 0 CA--C 1.57 3.526 0 CA-C-O 116.411 -2.327 . . . . 0.0 114.056 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 CA--C 1.578 2.02 0 C-N-CA 128.372 2.669 . . . . 0.0 108.491 -9.055 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.611 4 C5'-C4'-C3' 106.693 -5.872 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.365 -4.716 2 P-O3'-C3' 124.79 4.241 . 0.642 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.624 3.107 2 O4'-C1'-N19 113.138 4.938 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.435 ' C4 ' ' HG3' ' A' ' 95' ' ' ARG . . . . . . . . 0 P--O3' 1.565 -3.5 4 O5'-C5'-C4' 119.717 6.798 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.452 " H3'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 2 P--O5' 1.515 -7.778 3 C4'-C3'-C2' 95.298 -7.402 . 0.114 1t . 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.452 H5'' " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 3 P--O5' 1.54 -5.288 5 C3'-C2'-C1' 108.328 7.587 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 5 4 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.469 -5.033 1 C5'-C4'-C3' 122.188 4.459 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.581 5.184 1 N19-C1'-C2' 120.003 4.127 . 0.199 &a . 0.0 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.623 8.684 5 C3'-C2'-C1' 107.36 6.511 . 0.067 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C4'--C3' 1.562 3.466 2 O4'-C1'-C2' 113.074 4.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt -115.8 141.6 27.76 Favored Pre-proline 0 C--O 1.281 2.72 0 O-C-N 118.234 -2.921 . . . . 0.0 105.827 166.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -67.83 154.45 73.0 Favored 'Trans proline' 0 N--CA 1.53 3.669 0 CA-C-O 114.172 -2.512 . . . . 0.0 112.479 -169.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -69.08 123.89 22.28 Favored 'General case' 0 CA--C 1.582 2.2 0 O-C-N 126.168 2.167 . . . . 0.0 110.51 161.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -80.7 -13.24 59.18 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 127.586 2.355 . . . . 0.0 114.869 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.3 m 57.24 -29.77 0.03 OUTLIER 'General case' 1 CA--C 1.644 4.561 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 171.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.326 . . -91.3 169.54 10.73 Favored 'General case' 0 C--O 1.188 -2.169 0 C-N-CA 127.011 2.125 . . . . 0.0 111.592 -174.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.1 t -84.81 130.4 34.68 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 128.325 2.65 . . . . 0.0 114.625 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -71.3 -15.01 62.39 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 127.627 2.371 . . . . 0.0 113.66 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 157' ' ' ILE . 15.5 m-85 -118.02 173.26 6.88 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 127.378 2.271 . . . . 0.0 116.403 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.2 p -61.27 153.01 27.55 Favored 'General case' 0 C--O 1.287 3.068 0 O-C-N 128.831 3.832 . . . . 0.0 110.851 168.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.59 154.43 19.95 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 129.766 3.227 . . . . 0.0 112.408 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.09 156.32 20.73 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.744 1.218 . . . . 0.0 108.711 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 107' ' ' ARG . 57.4 m -139.46 121.9 16.12 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 131.486 3.914 . . . . 0.0 114.296 -168.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.262 4.5 tp-100 -77.42 142.32 39.3 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.244 1.497 . . . . 0.0 113.501 -167.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -135.77 -22.55 1.43 Allowed 'General case' 0 CA--C 1.601 2.93 0 CA-C-O 113.272 -3.251 . . . . 0.0 111.319 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.32 -130.92 0.61 Allowed Glycine 1 CA--C 1.61 6.012 0 O-C-N 126.47 2.356 . . . . 0.0 111.051 153.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -149.31 -20.93 0.29 Allowed 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 131.122 3.769 . . . . 0.0 113.053 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.94 147.84 48.32 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 124.893 1.371 . . . . 0.0 114.195 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.9 158.59 21.77 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 119.263 -2.148 . . . . 0.0 115.401 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.8 tp -75.36 51.52 0.56 Allowed 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 129.21 3.004 . . . . 0.0 111.818 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -76.44 139.26 40.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -129.7 88.01 50.8 Favored Pre-proline 0 CA--C 1.591 2.556 1 C-N-CA 132.611 4.365 . . . . 0.0 111.137 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.25 148.08 33.49 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.542 2.161 . . . . 0.0 115.978 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 45.34 20.68 0.05 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 131.119 3.768 . . . . 0.0 113.789 -165.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.7 22.25 69.8 Favored Glycine 0 N--CA 1.499 2.86 0 CA-C-O 116.351 -2.36 . . . . 0.0 108.43 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -84.08 106.37 15.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 128.091 2.877 . . . . 0.0 108.982 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.84 13.68 0.02 OUTLIER Glycine 0 CA--C 1.574 3.749 0 C-N-CA 128.702 3.049 . . . . 0.0 116.422 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.33 122.4 81.4 Favored Pre-proline 0 CA--C 1.56 1.351 0 O-C-N 117.96 -3.082 . . . . 0.0 112.537 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.401 ' HD2' ' CZ ' ' A' ' 110' ' ' PHE . 13.8 Cg_endo -75.16 177.36 8.71 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 121.69 1.593 . . . . 0.0 114.972 -168.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.99 129.89 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 112.378 -2.192 . . . . 0.0 111.016 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -167.38 104.4 0.53 Allowed 'General case' 0 N--CA 1.427 -1.582 0 O-C-N 125.205 1.566 . . . . 0.0 114.312 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.9 m -70.06 -17.54 63.25 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-O 114.198 -2.81 . . . . 0.0 110.516 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -63.7 -11.96 30.43 Favored 'General case' 0 C--O 1.188 -2.136 0 CA-C-N 124.185 3.175 . . . . 0.0 112.536 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 p -125.37 136.88 53.9 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 126.994 2.118 . . . . 0.0 110.4 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 p -85.15 165.97 33.76 Favored Pre-proline 0 C--N 1.269 -2.935 0 C-N-CA 126.231 1.812 . . . . 0.0 112.328 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . 0.302 81.8 Cg_exo -52.87 -24.09 22.98 Favored 'Trans proline' 0 CA--C 1.574 2.521 1 C-N-CA 125.557 4.171 . . . . 0.0 115.684 168.388 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -79.05 -29.3 43.41 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 121.178 1.808 . . . . 0.0 112.636 171.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.75 -16.7 61.17 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -68.58 61.52 0.09 Allowed 'General case' 0 CA--C 1.595 2.697 0 C-N-CA 131.263 3.825 . . . . 0.0 110.367 -162.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 tt -156.05 138.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.906 0 C-N-CA 126.762 2.025 . . . . 0.0 113.383 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.4 -174.18 46.8 Favored Glycine 0 CA--C 1.557 2.68 0 O-C-N 119.829 -1.794 . . . . 0.0 114.13 -154.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -148.19 145.39 28.27 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 126.733 2.013 . . . . 0.0 112.21 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -92.63 137.15 32.62 Favored 'General case' 0 C--O 1.198 -1.619 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -126.74 139.78 52.87 Favored 'General case' 1 N--CA 1.548 4.457 0 C-N-CA 129.981 3.312 . . . . 0.0 112.555 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -71.51 166.96 20.69 Favored 'General case' 0 C--O 1.291 3.273 0 O-C-N 120.052 -1.655 . . . . 0.0 110.847 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.92 132.85 18.11 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 130.268 3.427 . . . . 0.0 108.182 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -140.8 -17.37 0.86 Allowed 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 130.018 3.327 . . . . 0.0 110.009 -163.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 47.58 60.92 3.19 Favored 'General case' 0 CA--C 1.589 2.447 0 O-C-N 125.909 2.005 . . . . 0.0 116.209 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -99.22 -23.69 15.12 Favored 'General case' 0 C--O 1.259 1.574 0 C-N-CA 129.201 3.0 . . . . 0.0 116.413 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 mp 60.18 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 CA-C-O 126.132 2.873 . . . . 0.0 111.805 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -82.65 55.42 2.98 Favored 'General case' 0 N--CA 1.511 2.598 1 O-C-N 115.34 -4.6 . . . . 0.0 107.619 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.87 117.45 0.02 OUTLIER Glycine 0 N--CA 1.422 -2.289 0 C-N-CA 124.746 1.165 . . . . 0.0 114.846 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.34 161.64 18.67 Favored Glycine 0 CA--C 1.574 3.732 0 C-N-CA 128.828 3.109 . . . . 0.0 116.505 165.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.447 0.0 OUTLIER 60.52 27.68 17.34 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 119.692 3.219 . . . . 0.0 119.692 -176.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.24 177.03 47.3 Favored Glycine 0 CA--C 1.56 2.859 0 CA-C-O 117.579 -1.678 . . . . 0.0 114.879 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -149.37 138.48 21.32 Favored 'General case' 0 C--N 1.399 2.757 0 C-N-CA 129.472 3.109 . . . . 0.0 109.07 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 45.3 mtm -67.97 149.49 49.68 Favored 'General case' 0 CA--C 1.58 2.119 0 C-N-CA 125.082 1.353 . . . . 0.0 113.251 171.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -114.42 -3.24 13.06 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 127.262 3.41 . . . . 0.0 114.218 -174.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 50.2 30.56 4.41 Favored 'General case' 0 C--N 1.39 2.328 0 O-C-N 117.745 -3.097 . . . . 0.0 117.888 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -122.07 170.37 9.91 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 126.72 2.512 . . . . 0.0 116.422 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.8 m -56.35 164.5 1.93 Allowed Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -49.5 164.03 0.38 Allowed 'Trans proline' 1 CA--C 1.622 4.91 1 C-N-CA 125.771 4.314 . . . . 0.0 112.178 166.48 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HG2' HG23 ' A' ' 57' ' ' THR . 79.3 mtp180 -141.78 168.57 19.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 110.851 -2.886 . . . . 0.0 109.028 174.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -140.66 149.87 42.8 Favored 'General case' 0 C--N 1.276 -2.601 0 O-C-N 118.926 -2.359 . . . . 0.0 108.925 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -130.63 162.8 28.57 Favored 'General case' 0 C--O 1.184 -2.361 0 C-N-CA 127.96 2.504 . . . . 0.0 108.217 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 73' ' ' PRO . 54.4 t80 -119.87 145.27 46.83 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 128.919 2.888 . . . . 0.0 113.96 173.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -147.61 141.59 25.92 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 127.218 2.207 . . . . 0.0 110.712 -171.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -70.45 163.8 25.99 Favored 'General case' 0 CA--C 1.605 3.08 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 tp -63.18 127.73 32.61 Favored 'General case' 0 CA--C 1.573 1.86 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.839 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.13 20.77 79.01 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 117.979 -2.058 . . . . 0.0 118.151 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.281 3.8 p -134.66 167.63 20.47 Favored 'General case' 0 C--O 1.263 1.775 0 C-N-CA 127.046 2.138 . . . . 0.0 111.539 -174.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.18 -156.36 37.84 Favored Glycine 1 CA--C 1.585 4.407 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.945 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -71.53 -43.16 1.49 Allowed 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 124.036 3.157 . . . . 0.0 114.151 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -82.8 31.96 0.42 Allowed 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 116.802 -1.571 . . . . 0.0 110.599 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.23 -24.86 66.68 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 122.682 2.492 . . . . 0.0 112.37 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.35 -36.73 70.67 Favored Glycine 1 CA--C 1.582 4.225 0 O-C-N 125.242 1.589 . . . . 0.0 116.314 167.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.93 124.78 89.72 Favored Pre-proline 0 CA--C 1.586 2.353 0 CA-C-O 116.509 -1.71 . . . . 0.0 109.971 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -63.05 166.73 13.71 Favored 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 125.237 3.958 . . . . 0.0 113.107 161.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -65.57 127.45 31.93 Favored 'General case' 0 CA--C 1.549 0.907 1 O-C-N 115.481 -4.512 . . . . 0.0 114.241 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.98 -2.63 79.83 Favored Glycine 0 CA--C 1.554 2.469 0 CA-C-N 113.081 -1.872 . . . . 0.0 116.825 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.51 129.83 42.4 Favored 'General case' 0 C--O 1.271 2.217 0 O-C-N 116.936 -3.685 . . . . 0.0 110.541 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -82.46 25.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.372 -3.33 . . . . 0.0 117.634 -154.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.82 126.97 30.15 Favored 'General case' 0 CA--C 1.593 2.601 0 O-C-N 117.29 -3.381 . . . . 0.0 110.238 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.26 147.35 46.51 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 113.01 -1.904 . . . . 0.0 111.642 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.57 -18.59 54.64 Favored Glycine 1 N--CA 1.525 4.606 0 O-C-N 119.11 -2.243 . . . . 0.0 116.55 -163.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 130' ' ' ILE . 1.5 mp -101.65 119.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 129.496 3.118 . . . . 0.0 109.189 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.87 102.46 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.152 0 C-N-CA 127.752 2.421 . . . . 0.0 106.092 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -71.97 129.81 39.46 Favored 'General case' 0 CA--C 1.588 2.412 0 C-N-CA 125.736 1.615 . . . . 0.0 113.04 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.77 150.12 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 C-N-CA 126.872 2.069 . . . . 0.0 108.623 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -158.27 171.89 19.36 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.415 -173.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.1 p -122.32 155.32 36.22 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 115.84 -2.029 . . . . 0.0 112.5 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.22 -47.71 62.26 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 124.869 3.486 . . . . 0.0 111.515 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.24 -2.61 90.63 Favored Glycine 2 CA--C 1.599 5.341 0 C-N-CA 129.549 3.452 . . . . 0.0 117.061 -172.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.27 33.49 Favored 'General case' 0 CA--C 1.614 3.408 0 CA-C-N 119.487 1.643 . . . . 0.0 111.961 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.3 mt -88.98 146.61 24.77 Favored 'General case' 0 CA--C 1.596 2.747 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 160.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -90.0 29.79 1.16 Allowed 'General case' 0 CA--C 1.6 2.873 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.419 ' O ' ' HE2' ' A' ' 143' ' ' LYS . 25.6 p -72.06 148.52 91.7 Favored Pre-proline 0 N--CA 1.508 2.464 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.825 168.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.43 136.07 35.64 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-O 116.875 -1.385 . . . . 0.0 112.862 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 141' ' ' THR . 53.3 mmtt -88.55 52.15 2.36 Favored 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 128.649 2.78 . . . . 0.0 110.565 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.41 -20.11 0.64 Allowed 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -81.01 -44.17 18.5 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 119.133 -2.23 . . . . 0.0 110.432 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.251 9.3 mt -55.84 -32.33 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-O 116.665 -1.636 . . . . 0.0 113.674 158.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.72 -14.62 81.22 Favored Glycine 0 N--CA 1.514 3.863 0 O-C-N 127.867 3.229 . . . . 0.0 119.352 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.4 p -133.43 -25.79 1.69 Allowed 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -54.91 142.64 28.87 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 125.979 1.712 . . . . 0.0 110.085 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -77.95 101.97 0.82 Allowed Pre-proline 0 CA--C 1.497 -1.08 0 O-C-N 124.343 1.027 . . . . 0.0 110.969 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.38 -21.81 71.48 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 125.136 3.891 . . . . 0.0 116.038 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.79 -9.76 55.85 Favored 'General case' 0 C--O 1.276 2.499 0 C-N-CA 128.279 2.632 . . . . 0.0 112.444 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -59.22 -27.09 65.42 Favored 'General case' 0 CA--C 1.568 1.662 1 N-CA-C 122.638 4.31 . . . . 0.0 122.638 166.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.04 157.76 45.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 118.699 -2.501 . . . . 0.0 114.441 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -32.53 150.34 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.733 1 C-N-CA 131.757 4.023 . . . . 0.0 111.69 160.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.5 137.29 50.1 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 125.563 2.601 . . . . 0.0 114.546 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.476 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 7.3 mt -73.14 129.02 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 118.746 -2.471 . . . . 0.0 111.58 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.15 116.26 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 126.866 2.604 . . . . 0.0 113.165 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.9 tt -88.04 119.48 28.46 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 124.27 1.028 . . . . 0.0 110.175 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.21 151.73 12.12 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 126.669 1.988 . . . . 0.0 105.869 -157.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.2 mt -110.44 145.35 32.05 Favored Pre-proline 0 CA--C 1.564 1.517 0 O-C-N 124.136 0.897 . . . . 0.0 112.666 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.56 167.07 13.97 Favored 'Trans proline' 1 CA--C 1.605 4.056 0 C-N-CA 121.961 1.774 . . . . 0.0 110.155 170.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 53.89 25.91 5.73 Favored 'General case' 0 N--CA 1.531 3.582 0 O-C-N 127.132 2.77 . . . . 0.0 111.874 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 47.88 29.56 6.34 Favored Glycine 1 N--CA 1.516 4.004 0 O-C-N 127.187 2.805 . . . . 0.0 111.272 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.2 m -58.99 141.99 52.36 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 122.36 3.08 . . . . 0.0 110.459 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m -106.07 119.53 39.46 Favored 'General case' 0 CA--C 1.587 2.395 0 O-C-N 119.596 -1.94 . . . . 0.0 108.75 -162.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.94 145.72 62.74 Favored Pre-proline 0 N--CA 1.389 -3.493 0 O-C-N 118.491 -2.63 . . . . 0.0 114.756 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -50.13 123.73 11.51 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 121.944 3.786 . . . . 0.0 121.944 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -50.13 -30.69 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 126.071 2.107 . . . . 0.0 116.569 -172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.4 -32.5 84.37 Favored Glycine 0 C--O 1.195 -2.296 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 171.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -91.48 127.92 37.11 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-N 118.323 1.062 . . . . 0.0 109.354 171.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -65.06 152.11 44.33 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 155.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -169.67 146.82 3.36 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 124.894 2.283 . . . . 0.0 107.687 -168.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.83 134.64 49.96 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 127.057 2.143 . . . . 0.0 112.814 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.15 -178.67 48.95 Favored Glycine 1 CA--C 1.587 4.546 0 CA-C-O 118.17 -1.35 . . . . 0.0 113.707 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.0 m 63.48 14.48 8.03 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 126.825 2.132 . . . . 0.0 113.711 -171.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -64.88 -6.14 7.65 Favored 'General case' 0 C--N 1.369 1.413 0 CA-C-N 125.406 3.73 . . . . 0.0 120.642 -169.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.61 177.52 45.48 Favored Glycine 0 C--N 1.273 -2.964 0 C-N-CA 127.744 2.592 . . . . 0.0 113.243 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.53 -146.92 5.58 Favored Glycine 0 CA--C 1.554 2.515 0 C-N-CA 124.18 0.895 . . . . 0.0 112.635 169.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.6 m . . . . . 0 C--N 1.383 2.043 0 O-C-N 117.564 -3.316 . . . . 0.0 113.368 -2.821 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.564 4.179 2 C3'-C2'-C1' 106.216 5.24 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C5'--C4' 1.58 5.405 4 O4'-C1'-N19 113.134 4.934 . 0.707 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C2'--C1' 1.593 6.525 3 C3'-C2'-C1' 93.468 -8.924 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 C3'--C2' 1.587 5.672 3 C1'-O4'-C4' 104.911 -5.21 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.399 -4.48 3 C1'-O4'-C4' 114.442 5.38 . 0.38 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.453 -7.52 0 O3'-P-O5' 97.504 -3.419 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.645 5.157 0 OP1-P-OP2 115.245 -2.903 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C3'--C2' 1.564 3.541 3 C5'-C4'-C3' 106.388 -6.075 . 0.588 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.346 -8.883 4 C3'-C2'-C1' 93.015 -9.428 . 0.123 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.516 -7.581 1 C1'-O4'-C4' 105.087 -5.014 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.599 0 N-CA-C 105.588 -3.005 . . . . 0.0 105.588 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -72.1 158.49 87.53 Favored Pre-proline 0 CA--C 1.572 1.8 0 O-C-N 124.047 0.498 . . . . 0.0 111.228 168.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.13 166.37 18.62 Favored 'Trans proline' 0 N--CA 1.503 2.08 1 C-N-CA 127.767 5.645 . . . . 0.0 112.14 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -67.68 100.98 0.96 Allowed 'General case' 0 CA--C 1.588 2.408 0 C-N-CA 130.706 3.602 . . . . 0.0 110.249 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.279 34.4 p30 -54.6 -22.5 13.57 Favored 'General case' 0 CA--C 1.591 2.546 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.1 m 64.84 -47.09 0.34 Allowed 'General case' 0 N--CA 1.517 2.892 0 C-N-CA 126.823 2.049 . . . . 0.0 114.495 165.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.26 143.47 52.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 128.08 3.8 . . . . 0.0 111.109 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.3 t -81.65 135.29 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 109.897 -3.319 . . . . 0.0 115.18 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -77.96 -3.21 40.78 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.004 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.23 147.48 51.07 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 129.013 2.925 . . . . 0.0 115.102 -163.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . 0.261 79.8 p -61.21 135.86 57.87 Favored 'General case' 0 C--O 1.185 -2.293 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.256 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.77 129.91 34.7 Favored 'General case' 0 CA--C 1.613 3.385 0 CA-C-O 113.974 -2.917 . . . . 0.0 111.493 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.1 175.75 1.97 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 125.263 1.602 . . . . 0.0 109.671 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -146.79 128.2 14.94 Favored 'General case' 0 C--N 1.309 -1.19 1 O-C-N 114.03 -5.419 . . . . 0.0 106.616 170.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -61.27 121.54 12.83 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 125.716 1.607 . . . . 0.0 112.523 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -100.31 -54.66 2.81 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.02 -126.89 0.1 OUTLIER Glycine 0 C--N 1.37 2.419 0 O-C-N 124.764 1.29 . . . . 0.0 116.131 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -144.38 -28.79 0.49 Allowed 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.836 3.207 . . . . 0.0 112.555 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -72.28 131.43 42.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 130.976 3.71 . . . . 0.0 111.721 -171.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.92 160.94 5.36 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 123.85 1.786 . . . . 0.0 110.939 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -65.69 42.91 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 126.309 1.844 . . . . 0.0 113.506 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -61.51 137.58 58.25 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 121.473 1.942 . . . . 0.0 111.386 -164.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.11 107.47 17.91 Favored Pre-proline 0 CA--C 1.562 1.406 0 O-C-N 117.996 -2.94 . . . . 0.0 112.623 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . 0.268 14.9 Cg_exo -57.7 144.62 92.67 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.671 2.247 . . . . 0.0 113.284 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 40.83 37.03 0.46 Allowed 'General case' 0 N--CA 1.516 2.865 0 C-N-CA 129.627 3.171 . . . . 0.0 112.954 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.05 15.44 5.15 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 127.006 2.691 . . . . 0.0 119.086 -168.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -71.54 109.42 5.48 Favored 'General case' 0 N--CA 1.415 -2.188 1 CA-C-N 125.013 4.406 . . . . 0.0 114.287 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.11 34.96 0.03 OUTLIER Glycine 0 CA--C 1.54 1.615 1 O-C-N 113.725 -5.609 . . . . 0.0 116.877 167.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.0 t -70.99 133.75 85.88 Favored Pre-proline 0 CA--C 1.614 3.427 1 CA-C-N 124.559 4.18 . . . . 0.0 115.159 169.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.22 164.09 36.69 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.499 2.133 . . . . 0.0 116.256 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.6 mt -74.68 151.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.18 0 O-C-N 125.903 2.002 . . . . 0.0 111.724 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -166.69 106.2 0.62 Allowed 'General case' 0 N--CA 1.529 3.524 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.017 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -60.66 -28.55 68.68 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -80.3 18.57 0.87 Allowed 'General case' 0 CA--C 1.589 2.45 0 C-N-CA 127.606 2.362 . . . . 0.0 114.377 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 87.6 p -141.51 143.89 34.04 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 127.298 2.239 . . . . 0.0 106.262 -171.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 p -72.39 158.19 87.89 Favored Pre-proline 0 CA--C 1.599 2.837 0 CA-C-N 120.974 1.715 . . . . 0.0 108.49 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.69 -28.24 65.2 Favored 'Trans proline' 0 N--CA 1.524 3.302 0 C-N-CA 124.985 3.79 . . . . 0.0 116.181 167.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.21 -18.38 62.47 Favored 'General case' 0 C--O 1.178 -2.668 0 C-N-CA 126.36 1.864 . . . . 0.0 110.994 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.479 ' HA ' ' HE3' ' A' ' 143' ' ' LYS 0.286 65.4 m-20 -73.86 -21.74 60.0 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 124.409 1.083 . . . . 0.0 111.807 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -79.66 60.55 3.38 Favored 'General case' 0 CA--C 1.599 2.831 0 O-C-N 125.23 1.581 . . . . 0.0 110.972 -153.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.03 139.24 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 126.544 1.938 . . . . 0.0 108.736 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.84 -167.24 40.25 Favored Glycine 0 N--CA 1.493 2.493 1 CA-C-O 127.831 4.017 . . . . 0.0 110.621 -163.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB3' ' CE3' ' A' ' 132' ' ' TRP . 9.5 p90 -144.04 138.82 28.6 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 111.113 -2.543 . . . . 0.0 113.524 -170.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.45 145.52 27.4 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.343 1.068 . . . . 0.0 111.21 153.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.454 ' CZ ' " H5'" ' B' ' 4' ' ' ' C' . 7.6 ttp180 -136.95 127.97 27.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 120.1 3.37 . . . . 0.0 120.1 170.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.465 HH22 ' CG ' ' A' ' 128' ' ' ASP . 11.4 ptt180 -50.34 161.06 0.33 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 129.47 3.108 . . . . 0.0 113.204 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.401 ' HA ' " H4'" ' B' ' 4' ' ' ' C' . . . -155.67 143.28 19.58 Favored 'General case' 0 C--N 1.394 2.525 0 O-C-N 117.426 -3.296 . . . . 0.0 113.89 169.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.5 p -145.75 -16.35 0.47 Allowed 'General case' 0 N--CA 1.535 3.822 0 C-N-CA 129.122 2.969 . . . . 0.0 112.433 -166.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 46.19 26.72 0.47 Allowed 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -69.78 -14.0 62.56 Favored 'General case' 0 C--O 1.169 -3.134 0 C-N-CA 129.709 3.204 . . . . 0.0 113.141 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.8 mt 70.52 144.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 C-N-CA 129.045 2.938 . . . . 0.0 110.509 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -118.74 -20.48 8.25 Favored 'General case' 1 N--CA 1.558 4.949 0 C-N-CA 128.173 2.589 . . . . 0.0 110.615 166.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.17 85.73 0.06 OUTLIER Glycine 0 N--CA 1.432 -1.617 0 CA-C-N 121.932 2.151 . . . . 0.0 113.723 174.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.73 -140.02 41.9 Favored Glycine 0 CA--C 1.553 2.425 0 C-N-CA 129.507 3.432 . . . . 0.0 109.501 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 55.33 10.63 0.47 Allowed 'General case' 0 N--CA 1.514 2.754 0 C-N-CA 129.177 2.991 . . . . 0.0 114.395 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.68 177.35 47.48 Favored Glycine 0 CA--C 1.476 -2.384 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -132.86 165.37 24.78 Favored 'General case' 0 CA--C 1.59 2.485 0 O-C-N 118.561 -2.729 . . . . 0.0 106.279 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.7 mtm -105.25 141.01 37.53 Favored 'General case' 0 C--O 1.197 -1.659 0 O-C-N 126.564 2.415 . . . . 0.0 106.315 -166.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -106.52 -16.69 14.46 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 115.719 -2.086 . . . . 0.0 111.756 165.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.34 0.3 OUTLIER 70.26 38.0 1.51 Allowed 'General case' 0 C--N 1.371 1.526 0 N-CA-C 118.798 2.888 . . . . 0.0 118.798 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.76 164.41 11.8 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 120.472 -1.392 . . . . 0.0 107.734 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.1 m -44.67 138.77 3.84 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 168.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.39 162.6 1.33 Allowed 'Trans proline' 0 C--O 1.303 3.728 0 C-N-CA 123.582 2.855 . . . . 0.0 114.222 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -135.05 163.1 30.65 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 128.676 2.791 . . . . 0.0 111.942 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -134.24 139.07 45.52 Favored 'General case' 0 C--O 1.272 2.255 0 O-C-N 117.842 -3.036 . . . . 0.0 108.747 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.55 150.15 41.32 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 126.778 2.031 . . . . 0.0 113.595 173.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -102.49 149.46 24.37 Favored 'General case' 0 C--N 1.364 1.228 0 O-C-N 119.686 -1.884 . . . . 0.0 111.889 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -153.01 147.3 25.74 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 118.823 -2.423 . . . . 0.0 110.945 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -65.51 160.35 22.49 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 127.171 3.367 . . . . 0.0 112.373 170.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.02 123.87 18.04 Favored 'General case' 0 N--CA 1.504 2.248 1 O-C-N 114.951 -4.843 . . . . 0.0 110.674 172.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.1 79.14 Favored Glycine 0 C--O 1.194 -2.387 0 C-N-CA 128.024 2.726 . . . . 0.0 115.853 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.2 p -131.78 160.16 36.37 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 129.325 3.603 . . . . 0.0 109.736 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.42 -167.3 53.97 Favored Glycine 0 CA--C 1.566 3.231 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.33 -38.79 34.75 Favored 'Trans proline' 0 CA--C 1.545 1.075 1 C-N-CA 127.595 5.53 . . . . 0.0 113.089 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -106.56 19.55 20.33 Favored 'General case' 0 C--O 1.276 2.45 0 O-C-N 118.398 -2.689 . . . . 0.0 112.425 -167.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.83 -17.79 2.71 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 116.962 -3.586 . . . . 0.0 115.332 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.77 -20.97 77.59 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 120.782 3.073 . . . . 0.0 120.782 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.55 151.69 68.86 Favored Pre-proline 0 C--O 1.181 -2.511 0 C-N-CA 129.225 3.01 . . . . 0.0 112.72 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -85.31 155.02 10.84 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 CA-C-O 124.569 1.82 . . . . 0.0 108.605 162.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -48.54 136.81 12.52 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 111.945 -2.389 . . . . 0.0 115.889 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.65 5.61 9.38 Favored Glycine 0 CA--C 1.568 3.351 0 C-N-CA 130.691 3.996 . . . . 0.0 118.877 -173.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -43.18 112.4 0.37 Allowed 'General case' 0 C--N 1.416 3.459 0 O-C-N 121.241 -1.152 . . . . 0.0 113.102 162.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -82.06 35.07 0.42 Allowed 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -157.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -71.07 142.92 50.83 Favored 'General case' 0 C--O 1.276 2.482 0 CA-C-N 113.298 -1.774 . . . . 0.0 115.092 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.465 ' CG ' HH22 ' A' ' 89' ' ' ARG . 18.9 t0 -63.28 134.15 55.36 Favored 'General case' 0 C--N 1.281 -2.389 0 C-N-CA 127.332 2.253 . . . . 0.0 112.723 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.68 -1.31 88.94 Favored Glycine 0 C--N 1.302 -1.327 0 N-CA-C 119.492 2.557 . . . . 0.0 119.492 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.64 137.03 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 123.32 3.56 . . . . 0.0 114.518 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.3 mm -122.52 116.43 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.414 ' CE3' ' HB3' ' A' ' 86' ' ' TYR . 83.3 m95 -87.66 138.52 31.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 123.734 1.73 . . . . 0.0 113.172 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.23 139.96 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 O-C-N 120.577 -1.327 . . . . 0.0 114.166 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -156.18 152.72 28.2 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 115.692 -2.099 . . . . 0.0 116.139 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.3 p -101.51 142.82 32.32 Favored 'General case' 0 C--O 1.28 2.686 0 C-N-CA 125.537 1.535 . . . . 0.0 110.85 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.88 -25.62 68.24 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 119.439 -2.038 . . . . 0.0 113.709 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.77 -31.12 30.27 Favored Glycine 0 N--CA 1.512 3.701 1 O-C-N 115.813 -4.305 . . . . 0.0 119.638 161.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.89 151.03 27.47 Favored 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 127.729 2.411 . . . . 0.0 111.346 -170.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.16 148.98 22.14 Favored 'General case' 0 CA--C 1.59 2.518 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -61.87 -18.2 59.27 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 114.973 -2.441 . . . . 0.0 114.361 -166.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.4 p -66.56 146.16 99.03 Favored Pre-proline 0 C--O 1.261 1.701 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.48 132.5 27.42 Favored 'Trans proline' 0 CA--C 1.584 2.995 0 CA-C-N 122.992 2.104 . . . . 0.0 110.995 165.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 57.6 mmtt -80.75 54.6 2.17 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.982 1.713 . . . . 0.0 112.637 -168.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.73 -18.76 56.53 Favored 'General case' 0 N--CA 1.53 3.526 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -58.02 -59.8 4.72 Favored 'General case' 0 C--N 1.377 1.785 0 O-C-N 117.394 -3.316 . . . . 0.0 114.638 160.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.4 -19.26 24.66 Favored 'Isoleucine or valine' 0 C--N 1.364 1.207 0 O-C-N 123.996 0.81 . . . . 0.0 112.562 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.19 -0.75 84.86 Favored Glycine 0 N--CA 1.497 2.717 1 CA-C-O 112.843 -4.309 . . . . 0.0 117.634 172.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.0 p -131.3 -18.55 2.87 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 122.571 3.186 . . . . 0.0 118.396 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -64.74 -176.32 0.25 Allowed 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.372 0.987 . . . . 0.0 112.608 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -92.89 113.89 61.06 Favored Pre-proline 0 C--N 1.382 1.995 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.856 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -81.3 4.77 6.73 Favored 'Trans proline' 0 C--N 1.385 2.482 0 O-C-N 123.15 1.079 . . . . 0.0 113.908 -170.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.83 19.46 2.49 Favored 'General case' 0 CA--C 1.6 2.882 0 O-C-N 127.367 2.917 . . . . 0.0 113.286 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.15 -38.62 35.52 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 126.447 1.899 . . . . 0.0 107.93 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.1 152.83 24.0 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.295 -1.321 . . . . 0.0 114.416 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.92 140.93 56.49 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 125.549 1.539 . . . . 0.0 113.816 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.3 152.28 29.64 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 125.013 2.339 . . . . 0.0 115.568 -166.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.42 127.6 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 101.904 -3.369 . . . . 0.0 101.904 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 26.1 t -52.83 106.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.183 -2.399 0 O-C-N 118.634 -2.542 . . . . 0.0 112.574 151.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.2 tt -65.99 118.51 9.87 Favored 'General case' 0 C--N 1.362 1.112 0 O-C-N 128.365 3.541 . . . . 0.0 116.376 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -146.56 164.06 33.8 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.018 1.727 . . . . 0.0 107.035 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.06 160.56 30.56 Favored Pre-proline 0 N--CA 1.505 2.291 0 C-N-CA 126.83 2.052 . . . . 0.0 112.478 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -68.37 166.08 26.68 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 118.1 2.308 . . . . 0.0 118.1 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 54.74 31.72 15.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.019 1.728 . . . . 0.0 112.053 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.01 10.86 78.48 Favored Glycine 1 C--N 1.401 4.191 0 CA-C-O 118.996 -0.891 . . . . 0.0 112.381 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.6 m -57.37 119.88 7.23 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 128.478 2.711 . . . . 0.0 109.52 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -81.47 142.43 32.94 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.412 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.93 171.62 2.35 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 128.913 2.885 . . . . 0.0 111.105 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.84 147.15 96.18 Favored 'Trans proline' 0 C--N 1.384 2.418 0 CA-C-O 113.849 -2.646 . . . . 0.0 115.526 172.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -72.36 -16.22 61.86 Favored 'General case' 0 N--CA 1.419 -1.994 0 O-C-N 128.757 3.786 . . . . 0.0 114.933 158.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.49 -14.55 9.39 Favored Glycine 0 C--N 1.358 1.786 0 CA-C-O 117.518 -1.712 . . . . 0.0 115.804 160.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -136.97 108.08 6.76 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.084 1.942 . . . . 0.0 111.381 -173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -59.46 144.61 46.6 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.89 1.805 . . . . 0.0 114.241 164.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.05 175.63 11.56 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 128.483 3.992 . . . . 0.0 112.635 -167.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.48 139.72 51.75 Favored 'General case' 0 N--CA 1.408 -2.549 0 O-C-N 117.386 -3.321 . . . . 0.0 110.129 158.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 96.35 175.88 35.89 Favored Glycine 0 N--CA 1.509 3.556 0 C-N-CA 130.214 3.769 . . . . 0.0 113.23 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.3 m 49.16 39.71 16.0 Favored 'General case' 0 N--CA 1.517 2.897 0 O-C-N 121.059 -1.26 . . . . 0.0 112.646 -176.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.0 mmm-85 -85.73 -5.81 59.21 Favored 'General case' 1 CA--C 1.636 4.278 0 CA-C-N 121.312 1.869 . . . . 0.0 113.765 174.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.22 9.75 84.22 Favored Glycine 0 C--O 1.218 -0.884 0 C-N-CA 128.526 2.965 . . . . 0.0 117.948 169.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.03 -166.25 42.44 Favored Glycine 0 N--CA 1.504 3.225 0 O-C-N 116.948 -3.678 . . . . 0.0 108.808 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.499 2.007 0 CA-C-O 116.233 -1.842 . . . . 0.0 114.887 -0.16 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 C2'--C1' 1.48 -4.811 1 OP1-P-OP2 108.609 -7.327 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.599 6.863 4 O4'-C1'-N19 118.131 9.931 . 0.855 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O4'--C1' 1.486 5.985 4 O4'-C1'-N19 121.626 13.426 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.454 " H5'" ' CZ ' ' A' ' 88' ' ' ARG . . . . . . . . 1 C2'--O2' 1.47 4.399 1 O4'-C1'-C2' 112.033 4.024 . 0.01 4n . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.466 -5.242 1 O4'-C1'-N19 114.93 6.73 . 0.417 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 3 O4'--C1' 1.501 7.263 1 O5'-C5'-C4' 116.806 4.718 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.567 4.383 0 C4'-C3'-C2' 98.77 -3.93 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.673 8.017 1 C5'-C4'-O4' 121.863 9.045 . 0.01 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 C2'--C1' 1.449 -7.88 0 O4'-C1'-N19 111.416 3.216 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 C2'--O2' 1.515 7.819 2 N19-C1'-C2' 106.498 -4.314 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.128 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.09 150.06 94.7 Favored Pre-proline 0 CA--C 1.592 2.593 0 O-C-N 119.036 -2.449 . . . . 0.0 113.11 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.96 -172.19 1.36 Allowed 'Trans proline' 0 N--CA 1.526 3.394 0 CA-C-O 123.319 1.299 . . . . 0.0 115.378 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.63 129.24 39.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 116.974 -1.488 . . . . 0.0 110.828 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -82.87 -15.74 50.3 Favored 'General case' 0 CA--C 1.604 3.029 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m 63.24 -52.8 0.2 Allowed 'General case' 0 C--O 1.251 1.139 0 C-N-CA 128.079 2.552 . . . . 0.0 113.619 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.0 170.29 3.67 Favored 'General case' 0 CA--C 1.592 2.588 0 CA-C-N 123.52 2.873 . . . . 0.0 111.469 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.3 t -77.55 144.55 37.52 Favored 'General case' 0 CA--C 1.58 2.105 0 CA-C-O 113.577 -3.106 . . . . 0.0 113.515 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -95.15 -4.41 46.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 125.76 3.891 . . . . 0.0 113.296 172.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -120.93 164.64 16.39 Favored 'General case' 0 N--CA 1.513 2.689 0 O-C-N 119.069 -2.27 . . . . 0.0 109.34 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.9 p -56.43 146.88 23.08 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 126.392 2.307 . . . . 0.0 110.244 157.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.04 162.56 24.28 Favored 'General case' 0 CA--C 1.567 1.61 0 O-C-N 116.308 -3.995 . . . . 0.0 112.914 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.37 107.32 18.16 Favored 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.028 2.131 . . . . 0.0 114.676 -153.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.4 m -65.2 118.74 9.68 Favored 'General case' 0 C--O 1.18 -2.57 0 O-C-N 126.554 2.409 . . . . 0.0 111.194 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -55.55 124.53 17.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 129.732 3.213 . . . . 0.0 115.627 165.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.19 -7.09 4.84 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 128.538 2.735 . . . . 0.0 111.885 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.43 -141.77 12.55 Favored Glycine 0 N--CA 1.507 3.411 0 O-C-N 120.024 -1.672 . . . . 0.0 112.801 165.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -137.61 -34.56 0.69 Allowed 'General case' 0 C--O 1.177 -2.712 0 O-C-N 116.68 -3.835 . . . . 0.0 110.041 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -58.27 138.0 56.68 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.72 2.408 . . . . 0.0 109.495 173.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -80.08 168.97 18.48 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 124.346 2.022 . . . . 0.0 111.309 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -72.62 61.88 0.53 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 118.677 -2.514 . . . . 0.0 112.281 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.43 149.26 36.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.549 -1.969 . . . . 0.0 114.032 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.08 91.65 23.42 Favored Pre-proline 0 CA--C 1.587 2.374 0 O-C-N 126.176 2.173 . . . . 0.0 110.479 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -51.09 148.17 18.28 Favored 'Trans proline' 0 C--O 1.195 -1.628 0 C-N-CA 123.697 2.931 . . . . 0.0 110.187 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 53.14 6.46 0.06 Allowed 'General case' 0 C--N 1.372 1.558 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.66 23.08 42.36 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 129.94 3.638 . . . . 0.0 113.589 -169.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -69.31 107.15 3.16 Favored 'General case' 0 CA--C 1.573 1.841 0 O-C-N 120.116 -1.814 . . . . 0.0 108.378 159.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.86 25.69 0.03 OUTLIER Glycine 0 C--N 1.385 3.277 0 C-N-CA 127.131 2.301 . . . . 0.0 113.626 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.49 123.25 78.95 Favored Pre-proline 0 C--N 1.374 1.674 1 O-C-N 114.518 -5.107 . . . . 0.0 110.775 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.63 173.47 12.19 Favored 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.84 2.36 . . . . 0.0 111.66 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -69.24 138.29 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 O-C-N 118.812 -2.43 . . . . 0.0 117.476 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.56 103.06 1.74 Allowed 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 116.938 -1.506 . . . . 0.0 111.144 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 m -71.95 -16.44 62.1 Favored 'General case' 0 CA--C 1.563 1.456 1 C-N-CA 133.009 4.524 . . . . 0.0 112.835 -175.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -83.84 17.08 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 115.139 -2.362 . . . . 0.0 113.137 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.8 p -146.79 176.7 9.67 Favored 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.291 22.0 p -130.18 -174.08 0.36 Allowed Pre-proline 0 C--N 1.289 -2.03 0 O-C-N 118.999 -2.313 . . . . 0.0 111.18 -166.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -73.25 -28.95 11.99 Favored 'Trans proline' 0 C--O 1.196 -1.585 0 CA-C-N 120.739 1.3 . . . . 0.0 113.428 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.45 -24.07 64.93 Favored 'General case' 0 CA--C 1.608 3.191 0 CA-C-O 123.141 1.448 . . . . 0.0 113.428 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.263 69.6 m-20 -92.12 -15.17 28.07 Favored 'General case' 0 C--O 1.187 -2.193 0 O-C-N 118.121 -2.862 . . . . 0.0 113.702 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -74.63 54.64 0.62 Allowed 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 118.144 2.646 . . . . 0.0 118.144 -169.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.07 148.3 17.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.4 -158.47 28.83 Favored Glycine 0 CA--C 1.543 1.82 0 O-C-N 118.558 -2.589 . . . . 0.0 111.585 -173.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -147.13 160.54 42.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.676 2.391 . . . . 0.0 116.981 -172.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -104.52 155.24 18.99 Favored 'General case' 0 CA--C 1.585 2.317 0 C-N-CA 130.327 3.451 . . . . 0.0 110.841 160.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.444 HH21 ' P ' ' B' ' 5' ' ' ' U' . 18.2 ttp180 -145.38 146.95 31.77 Favored 'General case' 0 C--O 1.191 -2.02 0 O-C-N 125.804 1.94 . . . . 0.0 109.49 171.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -62.35 154.69 27.25 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.081 1.752 . . . . 0.0 115.595 171.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.18 124.24 30.23 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 129.019 2.928 . . . . 0.0 111.606 158.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -110.36 -18.76 13.18 Favored 'General case' 0 N--CA 1.514 2.736 0 C-N-CA 128.56 2.744 . . . . 0.0 114.811 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 48.0 41.89 15.74 Favored 'General case' 0 C--N 1.382 2.021 0 C-N-CA 124.417 1.087 . . . . 0.0 112.368 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -91.09 -26.38 19.17 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 131.646 3.978 . . . . 0.0 107.652 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.282 1.7 mp 68.05 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 O-C-N 128.319 3.512 . . . . 0.0 114.084 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -136.31 81.77 1.9 Allowed 'General case' 0 C--O 1.276 2.482 0 C-N-CA 127.754 2.421 . . . . 0.0 107.507 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.21 47.63 43.55 Favored Glycine 0 N--CA 1.48 1.62 0 C-N-CA 126.771 2.129 . . . . 0.0 113.786 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.68 -155.95 47.35 Favored Glycine 1 CA--C 1.578 4.013 0 CA-C-N 113.889 -1.155 . . . . 0.0 112.165 -171.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 67.37 -1.48 1.52 Allowed 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 130.234 3.414 . . . . 0.0 114.387 -159.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.35 154.28 25.39 Favored Glycine 0 CA--C 1.571 3.564 0 O-C-N 118.103 -2.873 . . . . 0.0 118.681 170.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -71.91 128.63 36.34 Favored 'General case' 0 N--CA 1.52 3.056 0 O-C-N 119.503 -2.175 . . . . 0.0 114.606 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.3 mtp -84.57 127.72 34.21 Favored 'General case' 0 C--O 1.268 2.027 0 O-C-N 118.707 -2.496 . . . . 0.0 106.461 165.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -119.85 -6.94 10.05 Favored 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 127.637 2.375 . . . . 0.0 112.365 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 60.2 65.99 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.36 1.864 . . . . 0.0 107.22 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.49 HD21 " H1'" ' B' ' 7' ' ' ' A' . 24.3 mt -115.49 157.95 23.28 Favored 'General case' 0 C--O 1.278 2.598 0 C-N-CA 127.79 2.436 . . . . 0.0 112.027 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 t -60.35 158.59 27.83 Favored Pre-proline 0 C--O 1.263 1.804 0 O-C-N 125.891 1.994 . . . . 0.0 114.589 163.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.38 159.2 45.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 123.387 2.724 . . . . 0.0 114.494 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -135.56 152.03 50.89 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -126.08 136.09 52.5 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.358 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.81 130.94 53.49 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 127.763 3.165 . . . . 0.0 112.174 -164.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -102.36 147.18 27.02 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -145.57 153.06 40.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 127.42 2.95 . . . . 0.0 114.639 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -89.26 166.95 13.46 Favored 'General case' 0 CA--C 1.617 3.52 1 CA-C-N 126.64 4.291 . . . . 0.0 112.697 170.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.1 tp -54.99 123.49 13.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.002 -1.454 . . . . 0.0 113.31 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.09 25.44 68.91 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 126.354 2.284 . . . . 0.0 111.558 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.6 p -132.56 169.39 16.68 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 118.757 -2.614 . . . . 0.0 107.049 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.06 -168.8 49.27 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 112.357 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.5 -26.12 12.29 Favored 'Trans proline' 0 N--CA 1.437 -1.848 1 C-N-CA 127.428 5.419 . . . . 0.0 112.675 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -101.04 31.99 3.4 Favored 'General case' 1 N--CA 1.561 5.117 0 C-N-CA 127.436 2.294 . . . . 0.0 109.47 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.28 -22.91 33.17 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.58 -15.73 79.18 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.408 1.956 . . . . 0.0 115.281 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.59 125.96 81.62 Favored Pre-proline 0 CA--C 1.499 -1.007 0 CA-C-O 114.663 -2.589 . . . . 0.0 111.005 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 176.69 4.86 Favored 'Trans proline' 0 C--O 1.193 -1.755 0 CA-C-N 124.135 2.512 . . . . 0.0 109.367 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.97 137.17 55.94 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 125.051 1.34 . . . . 0.0 112.172 173.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.08 5.26 65.21 Favored Glycine 0 C--N 1.379 2.918 0 CA-C-O 125.028 2.46 . . . . 0.0 117.56 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.77 47.28 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 117.391 -3.417 . . . . 0.0 111.647 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -74.32 107.37 6.44 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 111.44 -2.618 . . . . 0.0 110.897 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -136.81 124.06 21.84 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.219 1.007 . . . . 0.0 110.175 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.26 107.76 0.7 Allowed 'General case' 0 CA--C 1.596 2.735 0 C-N-CA 128.108 2.563 . . . . 0.0 109.686 -171.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.83 14.52 26.78 Favored Glycine 0 N--CA 1.503 3.123 0 C-N-CA 128.581 2.991 . . . . 0.0 111.175 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.25 119.03 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 124.184 0.994 . . . . 0.0 108.893 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.2 mm -101.39 120.54 51.12 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 CA-C-O 124.261 1.981 . . . . 0.0 115.491 164.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -80.76 136.68 36.18 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 116.305 -3.997 . . . . 0.0 118.152 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -139.54 128.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.262 1.743 0 CA-C-N 123.813 3.006 . . . . 0.0 113.425 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.3 23.21 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 128.038 2.535 . . . . 0.0 109.54 -166.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.1 p -137.3 153.38 50.3 Favored 'General case' 0 C--O 1.277 2.504 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.42 -28.55 65.15 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 118.672 -2.517 . . . . 0.0 111.225 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.58 -0.28 89.86 Favored Glycine 1 N--CA 1.517 4.041 0 C-N-CA 128.412 2.911 . . . . 0.0 112.852 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.47 156.03 24.29 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 120.356 2.078 . . . . 0.0 109.009 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.3 mt -95.41 144.1 26.21 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 124.49 2.091 . . . . 0.0 109.054 167.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . 0.328 1.4 p-10 -75.73 26.9 0.11 Allowed 'General case' 0 C--N 1.389 2.283 0 O-C-N 117.934 -2.979 . . . . 0.0 113.601 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.0 p -91.62 158.92 39.66 Favored Pre-proline 0 CA--C 1.554 1.134 0 O-C-N 117.511 -3.243 . . . . 0.0 104.088 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -80.21 142.55 15.22 Favored 'Trans proline' 0 C--N 1.37 1.683 0 N-CA-C 105.087 -2.697 . . . . 0.0 105.087 173.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -88.19 74.64 8.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 117.0 -3.563 . . . . 0.0 107.419 -174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.12 -39.31 92.12 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 122.464 2.393 . . . . 0.0 114.436 -166.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -64.78 -59.32 4.36 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.2 mt -61.11 -23.93 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.088 0 C-N-CA 127.852 2.461 . . . . 0.0 115.633 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.57 -2.74 89.99 Favored Glycine 0 C--O 1.255 1.43 0 N-CA-C 120.163 2.825 . . . . 0.0 120.163 164.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.8 p -130.66 -35.18 1.49 Allowed 'General case' 0 C--O 1.179 -2.641 0 CA-C-N 122.803 3.301 . . . . 0.0 111.504 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -69.03 147.6 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 118.729 -2.482 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -44.21 121.15 3.89 Favored Pre-proline 1 N--CA 1.545 4.297 0 CA-C-O 115.197 -2.335 . . . . 0.0 111.562 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.56 -14.88 5.36 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 123.905 3.07 . . . . 0.0 116.504 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.22 9.8 9.88 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -163.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -69.31 -14.88 63.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 118.577 -2.577 . . . . 0.0 115.504 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -126.47 171.87 10.68 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 124.915 1.384 . . . . 0.0 108.367 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.13 143.85 5.53 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 118.279 -2.763 . . . . 0.0 114.191 170.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.51 109.11 1.85 Allowed 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 127.257 2.223 . . . . 0.0 110.529 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.67 132.23 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 128.137 2.575 . . . . 0.0 107.562 -160.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.51 97.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.7 114.79 12.37 Favored 'General case' 0 C--O 1.255 1.389 0 O-C-N 121.118 -0.989 . . . . 0.0 109.086 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -147.63 146.15 29.24 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 128.528 2.731 . . . . 0.0 107.56 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.16 153.01 53.82 Favored Pre-proline 0 CA--C 1.592 2.592 0 O-C-N 118.827 -2.421 . . . . 0.0 113.186 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -43.33 160.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.392 2.819 0 N-CA-C 119.029 2.665 . . . . 0.0 119.029 161.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 56.15 18.32 3.18 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 127.073 2.149 . . . . 0.0 109.733 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.21 19.35 70.19 Favored Glycine 0 C--O 1.187 -2.804 0 CA-C-N 119.764 1.165 . . . . 0.0 113.037 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.5 m -65.27 123.83 20.6 Favored 'General case' 0 C--O 1.262 1.729 0 CA-C-N 118.9 1.35 . . . . 0.0 108.005 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.6 m -74.86 138.26 42.36 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 124.463 2.078 . . . . 0.0 108.058 -165.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.5 mt -66.16 154.15 90.6 Favored Pre-proline 1 N--CA 1.553 4.716 1 CA-C-O 111.205 -4.236 . . . . 0.0 110.314 170.799 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -55.41 137.02 76.35 Favored 'Trans proline' 0 CA--C 1.559 1.752 1 C-N-CA 129.05 6.5 . . . . 0.0 113.718 -172.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -75.66 -16.64 60.17 Favored 'General case' 0 N--CA 1.481 1.117 1 O-C-N 115.67 -4.394 . . . . 0.0 112.688 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.46 -9.65 13.41 Favored Glycine 0 N--CA 1.512 3.701 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 166.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -119.39 157.54 27.97 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.141 2.97 . . . . 0.0 111.376 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -104.51 136.31 44.31 Favored 'General case' 0 CA--C 1.605 3.077 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.264 165.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.29 -173.17 4.3 Favored 'General case' 0 C--N 1.384 2.108 0 C-N-CA 127.964 2.506 . . . . 0.0 111.106 -158.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -73.99 152.34 40.07 Favored 'General case' 0 N--CA 1.519 3.021 0 C-N-CA 126.542 1.937 . . . . 0.0 109.891 158.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 71.55 174.85 21.53 Favored Glycine 0 CA--C 1.568 3.378 0 O-C-N 127.201 2.813 . . . . 0.0 116.567 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.9 m 57.66 37.74 27.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 125.291 2.472 . . . . 0.0 109.343 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -69.78 -17.27 63.41 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 54.78 -162.51 4.27 Favored Glycine 1 N--CA 1.527 4.742 1 C-N-CA 132.849 5.023 . . . . 0.0 110.522 -170.105 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.14 -164.12 25.82 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 118.471 -1.183 . . . . 0.0 112.922 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.27 2.156 2 CA-C-N 124.835 4.318 . . . . 0.0 112.401 -18.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C5'--C4' 1.627 8.969 2 OP1-P-OP2 110.472 -6.085 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 5 P--O3' 1.496 -9.285 1 O4'-C1'-N19 113.78 5.58 . 0.01 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O4'--C1' 1.476 5.13 1 O4'-C1'-N19 115.413 7.213 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.571 4.688 6 C5'-C4'-O4' 120.205 7.861 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.444 ' P ' HH21 ' A' ' 88' ' ' ARG . . . . . . . . 2 P--O3' 1.541 -5.518 3 O4'-C1'-N19 112.896 4.696 . 0.432 1t . 0.0 . . . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.39 -5.255 2 O4'-C1'-N19 113.238 5.038 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ' A' . . . . . 0.49 " H1'" HD21 ' A' ' 104' ' ' LEU . . . . . . . . 2 P--O5' 1.692 9.851 3 O4'-C1'-N19 116.088 7.888 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.452 3.188 3 C1'-O4'-C4' 104.814 -5.318 . 0.374 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 4 C2'--O2' 1.487 5.704 0 O5'-C5'-C4' 106.279 -2.801 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.395 4 O4'-C1'-N19 114.35 6.15 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.259 0 CA-C-O 123.283 1.491 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.83 159.36 54.69 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.78 151.8 74.21 Favored 'Trans proline' 0 N--CA 1.512 2.57 0 N-CA-C 118.439 2.438 . . . . 0.0 118.439 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.64 111.56 2.13 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 127.247 3.403 . . . . 0.0 109.553 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -58.81 -11.8 3.64 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 118.804 -2.435 . . . . 0.0 110.758 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m 46.22 -50.22 0.0 OUTLIER 'General case' 0 C--N 1.364 1.23 1 C-N-CA 133.036 4.534 . . . . 0.0 119.942 -170.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.18 154.24 23.87 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 131.808 4.043 . . . . 0.0 112.052 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.0 t -82.5 137.57 34.58 Favored 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 127.385 2.274 . . . . 0.0 115.64 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -76.13 -21.05 57.05 Favored 'General case' 0 CA--C 1.615 3.461 0 CA-C-O 122.797 1.284 . . . . 0.0 110.56 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -88.29 173.01 9.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 118.389 -2.695 . . . . 0.0 113.952 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.3 p -71.98 172.23 10.38 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 119.25 -2.156 . . . . 0.0 110.84 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . 0.309 . . -117.18 132.73 56.58 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 119.666 -1.896 . . . . 0.0 114.764 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.7 mt -70.25 163.42 26.51 Favored 'General case' 0 N--CA 1.513 2.677 0 C-N-CA 129.74 3.216 . . . . 0.0 111.643 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.9 m -128.15 131.12 48.95 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 168.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -66.92 149.95 49.89 Favored 'General case' 0 CA--C 1.6 2.893 0 C-N-CA 124.259 1.024 . . . . 0.0 112.083 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -151.53 -19.81 0.2 Allowed 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.611 -1.931 . . . . 0.0 113.43 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.94 -125.65 0.83 Allowed Glycine 0 CA--C 1.548 2.153 0 C-N-CA 128.107 2.765 . . . . 0.0 113.748 160.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -156.68 -22.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -69.32 139.68 54.3 Favored 'General case' 0 C--O 1.279 2.654 0 C-N-CA 126.272 1.829 . . . . 0.0 115.638 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.77 164.72 9.51 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 128.507 2.723 . . . . 0.0 115.816 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.8 tp -82.7 52.34 2.09 Favored 'General case' 0 CA--C 1.569 1.676 1 O-C-N 116.045 -4.159 . . . . 0.0 113.823 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -55.23 138.47 44.93 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 118.984 -2.323 . . . . 0.0 109.604 -171.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 50.5 m-85 -128.47 129.29 23.57 Favored Pre-proline 0 C--O 1.187 -2.221 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -84.11 137.75 7.48 Favored 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.315 4.01 . . . . 0.0 109.477 -170.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 45.81 23.82 0.18 Allowed 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.88 7.38 65.9 Favored Glycine 0 CA--C 1.567 3.325 0 CA-C-O 117.242 -1.865 . . . . 0.0 112.044 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -65.42 72.37 0.05 OUTLIER 'General case' 0 C--O 1.19 -2.052 0 CA-C-N 119.847 1.824 . . . . 0.0 111.892 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -175.16 33.96 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.206 0 CA-C-N 122.968 2.622 . . . . 0.0 119.398 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -74.43 119.36 76.14 Favored Pre-proline 0 C--O 1.257 1.453 0 O-C-N 118.708 -2.642 . . . . 0.0 110.593 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.51 161.49 20.56 Favored 'Trans proline' 0 CA--C 1.601 3.835 0 N-CA-C 119.035 2.667 . . . . 0.0 119.035 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.19 131.17 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 O-C-N 126.139 2.149 . . . . 0.0 108.922 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -165.12 91.96 0.55 Allowed 'General case' 0 N--CA 1.536 3.84 0 C-N-CA 128.65 2.78 . . . . 0.0 106.031 172.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -67.61 -21.22 65.41 Favored 'General case' 0 C--O 1.185 -2.315 0 CA-C-O 123.676 1.703 . . . . 0.0 113.607 -174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -55.41 -50.25 70.27 Favored 'General case' 0 N--CA 1.421 -1.889 1 O-C-N 115.342 -4.599 . . . . 0.0 114.897 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.2 p -58.36 153.86 14.72 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 119.069 2.988 . . . . 0.0 119.069 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.2 t -78.31 145.73 69.02 Favored Pre-proline 0 C--O 1.17 -3.128 0 O-C-N 125.241 1.588 . . . . 0.0 108.767 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.91 -34.72 16.86 Favored 'Trans proline' 0 CA--C 1.587 3.139 1 C-N-CA 125.755 4.303 . . . . 0.0 113.086 162.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.31 -38.77 92.45 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.646 1.178 . . . . 0.0 108.954 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.25 -19.66 66.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-O 116.201 -1.857 . . . . 0.0 114.629 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -84.62 81.18 8.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 123.523 2.874 . . . . 0.0 114.094 -151.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 tt -163.52 130.83 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.926 0 C-N-CA 126.999 2.12 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 -157.7 15.51 Favored Glycine 0 CA--C 1.557 2.702 0 CA-C-O 124.289 2.049 . . . . 0.0 115.902 -166.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -161.05 146.85 14.46 Favored 'General case' 0 C--O 1.284 2.897 0 CA-C-O 122.624 1.202 . . . . 0.0 112.547 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 4.2 m-85 -97.78 141.33 30.91 Favored 'General case' 0 C--O 1.171 -3.061 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.221 162.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -125.47 143.45 50.99 Favored 'General case' 0 C--O 1.202 -1.407 0 C-N-CA 125.668 1.587 . . . . 0.0 108.016 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.501 HH22 ' CG ' ' A' ' 128' ' ' ASP . 1.2 ptt180 -54.8 174.19 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 126.015 2.072 . . . . 0.0 116.348 163.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.29 139.59 13.38 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 115.181 -2.342 . . . . 0.0 108.999 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.5 p -127.11 -21.16 4.0 Favored 'General case' 0 C--O 1.262 1.747 0 C-N-CA 127.395 2.278 . . . . 0.0 113.297 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 46.01 49.14 12.28 Favored 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 125.512 1.525 . . . . 0.0 108.597 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -97.8 -9.71 26.04 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 127.248 2.219 . . . . 0.0 110.158 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 96' ' ' GLY 0.303 2.1 mp 64.57 157.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.592 2.59 0 O-C-N 120.398 -1.439 . . . . 0.0 114.478 176.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HG3' ' H3 ' ' B' ' 3' ' ' ' U' . 49.4 mtt-85 -139.61 55.28 1.67 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.914 1.34 . . . . 0.0 107.394 169.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 94' ' ' ILE . . . 103.22 -3.12 47.31 Favored Glycine 0 C--N 1.349 1.285 0 C-N-CA 127.334 2.397 . . . . 0.0 116.034 166.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.35 -172.73 45.74 Favored Glycine 0 C--N 1.358 1.805 0 O-C-N 119.038 -2.448 . . . . 0.0 113.756 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 55.54 12.29 0.75 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 112.418 -1.891 . . . . 0.0 116.086 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.54 -178.66 42.82 Favored Glycine 0 N--CA 1.49 2.288 0 CA-C-N 114.302 -1.317 . . . . 0.0 114.037 172.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -116.46 146.71 42.35 Favored 'General case' 0 N--CA 1.503 2.189 1 CA-C-N 107.909 -4.146 . . . . 0.0 111.872 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 20.4 mtt -86.66 150.28 24.31 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 115.49 -2.195 . . . . 0.0 112.701 174.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -138.91 -7.01 1.42 Allowed 'General case' 0 C--O 1.205 -1.284 0 O-C-N 127.705 3.128 . . . . 0.0 115.593 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 56.1 40.31 30.22 Favored 'General case' 0 CA--C 1.583 2.232 1 CA-C-O 129.032 4.253 . . . . 0.0 116.367 167.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.61 165.38 13.33 Favored 'General case' 0 C--N 1.375 1.704 0 O-C-N 117.897 -3.002 . . . . 0.0 116.048 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.0 t -60.03 147.78 79.24 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 121.988 0.899 . . . . 0.0 112.367 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -53.56 132.65 49.98 Favored 'Trans proline' 0 C--N 1.408 3.68 1 C-N-CA 125.939 4.426 . . . . 0.0 115.18 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -94.53 171.71 8.64 Favored 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 125.882 1.673 . . . . 0.0 114.601 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -146.03 139.5 26.14 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 119.571 -1.955 . . . . 0.0 113.228 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -128.86 170.23 13.64 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.262 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -114.14 136.3 53.09 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 127.809 2.443 . . . . 0.0 114.664 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.69 144.14 48.98 Favored 'General case' 0 CA--C 1.603 2.997 0 C-N-CA 126.496 1.918 . . . . 0.0 111.277 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.68 167.92 13.45 Favored 'General case' 0 N--CA 1.515 2.786 0 CA-C-O 123.603 1.668 . . . . 0.0 107.83 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.65 137.32 57.75 Favored 'General case' 0 C--O 1.199 -1.59 0 CA-C-O 115.671 -2.109 . . . . 0.0 109.599 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.63 -13.7 60.0 Favored Glycine 0 CA--C 1.569 3.446 0 CA-C-O 126.399 3.222 . . . . 0.0 114.815 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 p -119.31 171.94 7.96 Favored 'General case' 0 C--O 1.196 -1.716 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.01 -168.75 37.61 Favored Glycine 0 CA--C 1.566 3.252 0 O-C-N 129.001 3.938 . . . . 0.0 111.227 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -59.57 -39.81 71.48 Favored 'Trans proline' 0 N--CA 1.515 2.744 0 C-N-CA 122.56 2.174 . . . . 0.0 112.854 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -95.58 42.14 1.09 Allowed 'General case' 0 CA--C 1.588 2.408 0 O-C-N 119.854 -1.779 . . . . 0.0 112.486 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.53 -25.75 18.15 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 129.438 3.095 . . . . 0.0 114.863 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -87.62 -15.63 61.41 Favored Glycine 0 N--CA 1.478 1.499 0 C-N-CA 126.184 1.849 . . . . 0.0 115.434 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.22 135.56 84.61 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 120.01 1.905 . . . . 0.0 113.773 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -89.16 156.81 5.67 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 124.438 1.757 . . . . 0.0 113.685 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.72 128.15 34.87 Favored 'General case' 0 C--O 1.273 2.342 0 CA-C-O 115.811 -2.042 . . . . 0.0 113.089 -169.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.82 21.05 66.82 Favored Glycine 0 N--CA 1.406 -3.306 0 CA-C-N 122.765 2.529 . . . . 0.0 118.791 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.88 155.34 38.65 Favored 'General case' 0 C--O 1.268 2.071 0 O-C-N 120.817 -1.402 . . . . 0.0 114.29 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.89 43.99 1.04 Allowed 'General case' 0 C--O 1.269 2.084 0 CA-C-N 121.881 2.128 . . . . 0.0 109.81 -174.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -59.45 137.32 58.04 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-N 122.606 2.457 . . . . 0.0 113.009 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.501 ' CG ' HH22 ' A' ' 89' ' ' ARG . 49.6 t0 -57.44 118.38 5.11 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 128.032 2.533 . . . . 0.0 113.422 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.09 19.17 54.17 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 126.351 2.282 . . . . 0.0 117.697 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.49 121.83 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 131.301 3.84 . . . . 0.0 106.79 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.97 119.04 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 O-C-N 125.726 1.891 . . . . 0.0 114.017 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -76.47 141.48 41.3 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.67 149.7 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 118.242 -2.786 . . . . 0.0 112.811 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.36 -179.48 6.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.786 -2.007 . . . . 0.0 115.64 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -144.37 160.06 41.68 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 127.496 2.318 . . . . 0.0 111.927 163.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -61.48 -51.55 68.21 Favored 'General case' 0 CA--C 1.561 1.383 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.72 -6.14 54.21 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.969 -169.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.61 158.58 29.72 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 126.549 1.94 . . . . 0.0 115.602 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.48 134.89 39.1 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 122.263 2.301 . . . . 0.0 114.004 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -64.52 59.59 0.02 OUTLIER 'General case' 0 CA--C 1.593 2.602 0 C-N-CA 129.538 3.135 . . . . 0.0 109.658 170.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.5 p -150.39 153.16 34.29 Favored Pre-proline 0 N--CA 1.509 2.5 0 C-N-CA 125.061 1.344 . . . . 0.0 113.135 -170.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.45 146.43 50.07 Favored 'Trans proline' 0 CA--C 1.555 1.539 1 C-N-CA 125.416 4.077 . . . . 0.0 112.928 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -114.6 47.02 1.29 Allowed 'General case' 0 C--O 1.264 1.847 0 CA-C-O 125.614 2.626 . . . . 0.0 104.385 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -52.81 -29.63 28.71 Favored 'General case' 0 N--CA 1.489 1.494 1 O-C-N 116.189 -4.069 . . . . 0.0 114.145 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -60.89 -51.51 68.96 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 122.138 2.245 . . . . 0.0 111.115 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.63 -26.81 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 CA-C-O 123.753 1.74 . . . . 0.0 112.058 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -69.68 -12.13 66.77 Favored Glycine 1 CA--C 1.6 5.406 0 CA-C-N 112.676 -2.056 . . . . 0.0 114.041 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 66.9 p -148.29 -29.56 0.3 Allowed 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 123.787 3.794 . . . . 0.0 113.789 -159.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -72.81 168.14 19.45 Favored 'General case' 0 C--O 1.201 -1.448 1 O-C-N 116.111 -4.118 . . . . 0.0 112.157 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . 0.3 54.7 t-20 -75.44 110.5 10.62 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 128.746 3.779 . . . . 0.0 109.377 -156.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.53 -9.94 18.7 Favored 'Trans proline' 0 C--N 1.396 3.04 1 C-N-CA 128.909 6.406 . . . . 0.0 109.879 -164.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.9 44.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.324 -1.485 . . . . 0.0 114.174 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -68.41 -62.95 1.17 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.164 0.586 . . . . 0.0 110.89 155.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -81.96 153.86 26.04 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 117.17 -1.395 . . . . 0.0 112.461 160.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.29 160.24 22.1 Favored 'General case' 0 CA--C 1.595 2.697 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -36.84 125.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -75.57 134.59 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 O-C-N 126.104 2.128 . . . . 0.0 110.766 172.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.11 125.83 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 O-C-N 118.332 -2.73 . . . . 0.0 107.541 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.42 97.1 6.24 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.315 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -148.53 146.68 28.42 Favored 'General case' 0 C--N 1.375 1.717 0 CA-C-O 126.706 3.146 . . . . 0.0 108.041 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 92.9 mt -85.76 146.19 43.15 Favored Pre-proline 0 C--O 1.255 1.348 0 C-N-CA 128.705 2.802 . . . . 0.0 118.109 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -49.24 164.62 0.27 Allowed 'Trans proline' 0 CA--C 1.57 2.321 1 C-N-CA 125.92 4.413 . . . . 0.0 113.092 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 56.49 32.41 20.71 Favored 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 127.974 2.509 . . . . 0.0 112.949 166.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.45 44.97 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 117.053 -1.971 . . . . 0.0 116.471 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.5 m -59.8 131.02 49.62 Favored 'General case' 0 C--N 1.379 1.89 0 O-C-N 125.583 1.402 . . . . 0.0 108.875 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 94.1 m -90.96 141.86 28.39 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.085 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.5 154.57 93.3 Favored Pre-proline 0 C--O 1.276 2.485 0 CA-C-N 123.529 2.877 . . . . 0.0 110.203 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.22 130.6 28.95 Favored 'Trans proline' 0 C--N 1.402 3.387 0 C-N-CA 124.259 3.306 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -64.56 -4.64 4.29 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.243 1.817 . . . . 0.0 113.872 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.76 -11.39 49.54 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 116.442 -2.31 . . . . 0.0 113.899 164.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.43 143.38 43.66 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 128.826 2.851 . . . . 0.0 116.1 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.88 154.14 38.35 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 123.801 1.762 . . . . 0.0 113.191 148.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.0 -179.26 7.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 127.125 3.345 . . . . 0.0 108.447 -162.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.77 160.34 30.1 Favored 'General case' 0 CA--C 1.567 1.625 1 O-C-N 114.135 -5.353 . . . . 0.0 111.531 154.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.49 -173.28 46.9 Favored Glycine 0 C--O 1.258 1.645 0 C-N-CA 126.047 1.784 . . . . 0.0 112.72 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.451 ' HB2' " H2'" ' B' ' 10' ' ' ' G' . 17.5 m 62.73 34.09 14.97 Favored 'General case' 0 CA--C 1.603 3.012 0 C-N-CA 126.061 1.744 . . . . 0.0 113.041 174.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.522 HH22 ' P ' ' B' ' 9' ' ' ' C' . 3.6 mmm180 -94.2 -8.39 39.46 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 118.899 2.926 . . . . 0.0 118.899 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.92 -166.91 54.31 Favored Glycine 0 C--N 1.302 -1.36 0 O-C-N 126.971 2.67 . . . . 0.0 113.941 -157.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.25 176.02 37.57 Favored Glycine 0 CA--C 1.556 2.6 0 CA-C-N 117.802 0.801 . . . . 0.0 112.082 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 CA--C 1.579 2.069 1 O-C-N 115.588 -4.478 . . . . 0.0 110.801 3.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.549 3.003 1 O4'-C1'-N19 113.906 5.706 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O3'--C3' 1.471 3.409 2 O4'-C1'-N19 114.839 6.639 . 0.522 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.416 ' H3 ' ' HG3' ' A' ' 95' ' ' ARG . . . . . . . . 2 C3'--C2' 1.608 7.526 1 O3'-P-O5' 112.844 4.654 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--OP2 1.429 -3.284 5 O4'-C1'-N19 115.35 7.15 . 0.01 4n . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.586 5.765 4 O4'-C1'-N19 118.234 10.034 . 0.547 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.549 3.006 2 C3'-C2'-C1' 107.494 6.66 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.512 -8.103 2 C4'-C3'-C2' 94.958 -7.742 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.586 5.605 3 O4'-C1'-N19 116.227 8.027 . 0.01 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ' C' . . . . . 0.522 ' P ' HH22 ' A' ' 177' ' ' ARG . . . . . . . . 0 C2'--O2' 1.458 3.498 3 O4'-C1'-C2' 115.718 6.656 . 0.513 &a . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ' G' . . . . . 0.451 " H2'" ' HB2' ' A' ' 176' ' ' SER . . . . . . . . 1 O4'--C4' 1.404 -4.054 2 O4'-C1'-N19 117.082 8.882 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.882 0 N-CA-C 116.526 1.37 . . . . 0.0 116.526 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.0 mt -60.08 150.86 68.74 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 120.588 -1.536 . . . . 0.0 109.686 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.3 179.93 5.36 Favored 'Trans proline' 0 N--CA 1.514 2.731 0 CA-C-O 123.708 1.462 . . . . 0.0 110.402 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -84.44 123.23 30.01 Favored 'General case' 0 C--O 1.272 2.276 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.239 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -70.25 -13.97 62.41 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 117.838 -3.039 . . . . 0.0 113.86 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m 58.53 -29.31 0.03 OUTLIER 'General case' 0 CA--C 1.588 2.406 0 N-CA-C 118.648 2.832 . . . . 0.0 118.648 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.422 ' HB3' ' HG2' ' A' ' 151' ' ' PRO . . . -87.53 150.04 23.98 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 126.224 1.809 . . . . 0.0 112.335 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -87.68 136.24 33.03 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 118.718 -2.489 . . . . 0.0 113.755 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -80.31 -2.18 44.13 Favored 'General case' 0 C--O 1.185 -2.303 0 C-N-CA 124.959 1.304 . . . . 0.0 109.136 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -123.16 156.42 35.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 119.433 -2.042 . . . . 0.0 113.169 -168.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.8 p -64.87 142.98 58.25 Favored 'General case' 0 CA--C 1.592 2.559 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.56 164.49 21.89 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 127.287 2.867 . . . . 0.0 114.518 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.37 153.06 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.201 0.938 . . . . 0.0 112.308 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -119.22 128.23 54.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.14 -2.85 . . . . 0.0 106.534 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.95 150.36 29.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 108.205 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -138.01 -19.79 1.13 Allowed 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 122.097 0.951 . . . . 0.0 111.881 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.0 -128.12 6.2 Favored Glycine 0 C--N 1.361 1.951 0 CA-C-O 123.558 1.643 . . . . 0.0 112.392 166.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -142.04 -24.72 0.68 Allowed 'General case' 0 CA--C 1.588 2.407 0 C-N-CA 125.023 1.329 . . . . 0.0 113.572 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.295 25.4 tp10 -60.49 138.85 57.95 Favored 'General case' 0 CA--C 1.609 3.226 0 O-C-N 118.671 -2.518 . . . . 0.0 114.859 173.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.97 163.69 11.72 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 122.742 1.258 . . . . 0.0 114.288 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tp -73.82 54.75 0.51 Allowed 'General case' 0 C--O 1.288 3.112 0 CA-C-N 112.36 -2.2 . . . . 0.0 114.45 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -59.81 159.54 8.78 Favored 'General case' 0 N--CA 1.406 -2.628 0 C-N-CA 127.102 2.161 . . . . 0.0 116.327 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.464 ' CE2' ' CE2' ' A' ' 87' ' ' TYR . 77.1 m-85 -145.47 125.37 7.04 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -47.18 117.28 2.14 Favored 'Trans proline' 0 N--CA 1.452 -0.945 1 C-N-CA 125.492 4.128 . . . . 0.0 115.169 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 43.56 23.86 0.05 Allowed 'General case' 1 N--CA 1.557 4.92 1 C-N-CA 131.8 4.04 . . . . 0.0 110.898 -171.41 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.33 17.45 62.47 Favored Glycine 0 CA--C 1.551 2.326 0 O-C-N 117.444 -3.285 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -88.87 111.45 22.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 121.086 2.443 . . . . 0.0 109.796 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.15 38.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 CA-C-O 116.634 -2.204 . . . . 0.0 118.118 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.35 126.75 92.61 Favored Pre-proline 0 CA--C 1.505 -0.753 0 O-C-N 127.583 2.578 . . . . 0.0 109.601 158.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.93 170.24 20.22 Favored 'Trans proline' 0 N--CA 1.516 2.794 0 C-N-CA 125.221 3.947 . . . . 0.0 113.102 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.4 mt -79.26 126.08 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 117.962 -2.961 . . . . 0.0 110.621 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -138.34 116.1 11.47 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 127.124 3.345 . . . . 0.0 106.82 163.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 m -74.24 -21.86 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 112.27 -2.241 . . . . 0.0 106.249 -168.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.96 39.19 1.51 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 127.669 2.388 . . . . 0.0 114.056 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.7 p -140.94 149.62 42.07 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 121.323 -0.861 . . . . 0.0 112.752 151.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.9 p -75.9 163.7 65.17 Favored Pre-proline 0 CA--C 1.581 2.165 0 CA-C-O 116.3 -1.809 . . . . 0.0 113.519 -170.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.35 -28.75 73.91 Favored 'Trans proline' 0 CA--C 1.569 2.263 0 CA-C-N 124.137 2.513 . . . . 0.0 112.627 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -69.58 -13.81 62.52 Favored 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.41 -10.57 34.71 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 127.795 2.438 . . . . 0.0 111.051 -163.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -86.01 64.7 8.73 Favored 'General case' 0 C--O 1.277 2.528 0 C-N-CA 127.131 2.172 . . . . 0.0 113.749 -160.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.5 tt -158.1 139.31 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-N 112.955 -1.929 . . . . 0.0 107.168 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.04 -165.53 39.0 Favored Glycine 0 CA--C 1.568 3.388 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -165.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -145.37 156.14 43.6 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 125.966 1.706 . . . . 0.0 115.43 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CE2' ' CE2' ' A' ' 66' ' ' PHE . 14.9 m-85 -94.1 148.22 22.39 Favored 'General case' 0 C--O 1.277 2.53 0 C-N-CA 124.064 0.945 . . . . 0.0 109.285 157.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -122.78 138.77 54.54 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 126.22 1.808 . . . . 0.0 112.962 171.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -71.77 143.02 49.7 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 118.608 -2.557 . . . . 0.0 116.828 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . 0.252 . . -124.29 83.45 2.15 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 125.958 1.703 . . . . 0.0 111.498 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.9 p -80.57 -15.44 56.64 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 120.102 1.319 . . . . 0.0 113.294 -165.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 47.5 35.5 4.28 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HB3' ' C2 ' ' B' ' 3' ' ' ' U' . 13.0 ttm180 -89.84 -9.68 48.19 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.262 1.7 mp 65.85 143.69 0.01 OUTLIER 'Isoleucine or valine' 1 N--CA 1.553 4.701 0 C-N-CA 130.283 3.433 . . . . 0.0 116.216 172.98 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -123.6 -9.1 7.94 Favored 'General case' 0 CA--C 1.58 2.126 0 C-N-CA 127.488 2.315 . . . . 0.0 111.901 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.27 -137.85 2.3 Favored Glycine 0 C--N 1.358 1.772 0 CA-C-O 114.676 -3.291 . . . . 0.0 113.289 -174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.77 -140.54 0.69 Allowed Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 120.56 2.18 . . . . 0.0 116.559 160.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 51.21 13.59 0.18 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 128.527 2.731 . . . . 0.0 117.804 -171.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 164.98 -171.23 40.32 Favored Glycine 0 C--O 1.191 -2.581 0 O-C-N 118.374 -2.704 . . . . 0.0 111.993 161.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -131.82 152.29 51.09 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 118.524 -2.75 . . . . 0.0 111.236 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 27.0 mtp -52.42 155.08 2.22 Favored 'General case' 0 CA--C 1.585 2.308 0 CA-C-N 119.349 0.977 . . . . 0.0 111.549 169.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -139.37 6.74 2.34 Favored 'General case' 0 CA--C 1.595 2.678 0 C-N-CA 128.658 2.783 . . . . 0.0 109.141 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 50.16 31.33 4.94 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 116.771 2.138 . . . . 0.0 116.771 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.43 156.29 17.87 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 117.98 -2.95 . . . . 0.0 108.508 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.8 t -58.24 144.23 77.58 Favored Pre-proline 0 N--CA 1.52 3.072 0 C-N-CA 129.23 3.012 . . . . 0.0 108.616 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -47.1 139.47 15.22 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 124.681 3.587 . . . . 0.0 115.288 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -102.37 170.62 7.95 Favored 'General case' 0 CA--C 1.572 1.812 0 O-C-N 127.122 2.764 . . . . 0.0 106.659 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -155.91 144.02 19.86 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 118.537 -2.602 . . . . 0.0 109.176 -174.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.01 147.57 44.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 128.975 2.91 . . . . 0.0 117.186 -172.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -92.92 155.87 17.3 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -148.22 139.25 23.22 Favored 'General case' 0 N--CA 1.532 3.642 1 C-N-CA 132.652 4.381 . . . . 0.0 113.721 169.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -75.04 158.63 32.87 Favored 'General case' 0 CA--C 1.606 3.12 0 O-C-N 125.454 1.721 . . . . 0.0 114.186 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.5 tp -53.65 127.21 24.65 Favored 'General case' 0 CA--C 1.582 2.176 0 O-C-N 117.377 -3.327 . . . . 0.0 114.711 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.28 15.69 76.01 Favored Glycine 0 CA--C 1.552 2.381 0 C-N-CA 123.82 0.724 . . . . 0.0 111.98 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -151.66 163.38 39.24 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-O 124.63 2.157 . . . . 0.0 111.993 -166.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.98 -163.25 54.47 Favored Glycine 1 CA--C 1.581 4.167 0 O-C-N 118.384 -2.697 . . . . 0.0 111.558 -164.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -70.59 -26.8 23.27 Favored 'Trans proline' 1 CA--C 1.607 4.157 0 CA-C-O 117.975 -0.927 . . . . 0.0 111.981 -168.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.28 37.53 1.87 Allowed 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.257 1.389 . . . . 0.0 112.901 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -25.89 67.92 Favored 'General case' 0 C--N 1.373 1.623 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.33 -12.93 77.75 Favored Glycine 1 CA--C 1.587 4.559 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.8 mt -53.65 145.8 28.36 Favored Pre-proline 0 CA--C 1.584 2.256 0 CA-C-N 119.385 1.592 . . . . 0.0 110.992 161.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -85.23 169.02 10.1 Favored 'Trans proline' 0 N--CA 1.412 -3.273 0 O-C-N 123.689 1.362 . . . . 0.0 113.467 155.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -57.47 136.17 56.65 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 125.503 1.752 . . . . 0.0 115.28 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.99 -4.73 56.85 Favored Glycine 1 CA--C 1.582 4.221 0 CA-C-O 115.379 -2.901 . . . . 0.0 114.047 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.73 153.99 12.59 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -82.42 100.84 10.26 Favored 'General case' 0 C--O 1.276 2.492 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.718 -165.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.11 127.95 4.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 126.442 2.339 . . . . 0.0 109.658 167.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.05 155.99 36.64 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 125.994 1.718 . . . . 0.0 110.26 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.14 7.47 87.67 Favored Glycine 0 N--CA 1.488 2.165 0 O-C-N 125.79 1.931 . . . . 0.0 113.634 -165.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.7 132.59 62.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 C-N-CA 127.026 2.13 . . . . 0.0 109.525 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.3 mm -121.99 121.14 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 C-N-CA 126.422 1.889 . . . . 0.0 106.826 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -99.03 140.7 32.79 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.8 1.24 . . . . 0.0 109.56 -170.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.02 158.64 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-O 117.654 -1.165 . . . . 0.0 113.339 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -151.56 176.75 11.02 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 127.561 3.038 . . . . 0.0 111.508 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.8 p -123.17 158.49 30.66 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 128.916 2.887 . . . . 0.0 109.379 155.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -49.94 -44.43 50.52 Favored 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 128.521 2.728 . . . . 0.0 113.892 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.11 -17.11 75.46 Favored Glycine 1 CA--C 1.59 4.758 0 CA-C-N 111.91 -2.405 . . . . 0.0 114.169 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . 0.268 . . -76.73 136.3 39.04 Favored 'General case' 0 C--O 1.292 3.324 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.2 mt -84.94 152.3 23.61 Favored 'General case' 0 C--N 1.383 2.022 0 CA-C-N 113.063 -1.881 . . . . 0.0 106.412 170.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -72.66 6.81 2.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.013 -1.449 . . . . 0.0 113.204 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.3 p -70.81 140.47 86.44 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.25 134.24 26.5 Favored 'Trans proline' 0 C--O 1.205 -1.17 0 C-N-CA 121.429 1.419 . . . . 0.0 109.408 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . 0.259 49.7 mmtt -77.84 41.87 0.36 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 116.417 -1.754 . . . . 0.0 109.602 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -46.02 -29.12 1.35 Allowed 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 113.365 -3.207 . . . . 0.0 114.425 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -60.74 -46.56 89.98 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 123.684 2.947 . . . . 0.0 113.253 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.7 mt -81.93 -17.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 126.126 1.77 . . . . 0.0 108.698 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.37 -23.07 55.39 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 129.772 3.558 . . . . 0.0 113.427 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.7 p -127.33 -11.71 5.72 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-O 125.89 2.757 . . . . 0.0 116.238 -172.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -81.25 154.74 26.44 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 111.469 -2.605 . . . . 0.0 106.156 166.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -92.07 124.45 59.91 Favored Pre-proline 0 CA--C 1.581 2.162 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.422 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 1.2 Cg_exo -52.94 -29.57 44.44 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.992 3.128 . . . . 0.0 115.642 169.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.4 -16.41 62.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -67.62 -17.45 64.62 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.929 3.059 . . . . 0.0 114.917 -170.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -135.04 178.01 7.36 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 122.696 1.236 . . . . 0.0 111.16 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.64 151.39 34.35 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 116.642 -1.647 . . . . 0.0 109.366 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.05 147.08 1.5 Allowed 'General case' 0 C--O 1.26 1.651 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.98 118.66 21.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 170.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.72 112.28 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 114.403 -2.713 . . . . 0.0 106.27 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 tt -80.1 137.82 36.83 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -156.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -157.02 145.95 20.02 Favored 'General case' 0 CA--C 1.611 3.31 0 C-N-CA 130.087 3.355 . . . . 0.0 107.956 -172.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.73 153.31 42.26 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 126.737 2.523 . . . . 0.0 111.744 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.72 171.77 12.73 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.398 3.398 . . . . 0.0 108.949 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . 0.262 69.3 mt-30 64.69 12.78 7.87 Favored 'General case' 0 CA--C 1.589 2.455 0 C-N-CA 127.122 2.169 . . . . 0.0 112.419 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.99 19.32 44.34 Favored Glycine 0 CA--C 1.549 2.176 1 C-N-CA 132.881 5.038 . . . . 0.0 121.533 -163.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.0 m -61.43 137.74 58.25 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 124.068 0.947 . . . . 0.0 113.467 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 85.0 m -77.21 141.82 39.87 Favored 'General case' 0 CA--C 1.597 2.784 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.8 159.01 84.07 Favored Pre-proline 0 CA--C 1.572 1.794 0 C-N-CA 126.629 1.972 . . . . 0.0 113.273 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.13 136.96 25.47 Favored 'Trans proline' 0 CA--C 1.477 -2.333 0 CA-C-O 124.302 1.709 . . . . 0.0 112.392 -172.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -51.39 -19.92 1.55 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.254 166.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.43 17.26 44.74 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-N 125.006 3.548 . . . . 0.0 114.597 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -133.54 155.31 49.84 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-O 124.358 2.028 . . . . 0.0 110.537 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.412 ' HA ' " H1'" ' B' ' 10' ' ' ' G' . 12.8 m-30 -100.57 143.38 30.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.591 -2.549 . . . . 0.0 107.369 160.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -155.42 -175.81 5.62 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 127.501 2.32 . . . . 0.0 112.641 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -88.2 -7.69 56.46 Favored 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -96.58 -171.13 34.55 Favored Glycine 0 CA--C 1.56 2.854 0 C-N-CA 130.533 3.921 . . . . 0.0 116.94 166.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . 0.265 3.4 m 56.07 14.47 1.47 Allowed 'General case' 0 CA--C 1.606 3.098 0 C-N-CA 130.743 3.617 . . . . 0.0 114.525 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -71.45 -34.61 70.39 Favored 'General case' 0 C--O 1.173 -2.968 0 C-N-CA 129.468 3.107 . . . . 0.0 117.69 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 68.1 -144.56 43.23 Favored Glycine 0 N--CA 1.413 -2.869 0 CA-C-O 113.567 -3.907 . . . . 0.0 109.958 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 62.96 -144.34 49.41 Favored Glycine 0 C--O 1.188 -2.774 0 CA-C-N 122.896 3.348 . . . . 0.0 117.014 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.255 1.369 0 C-N-CA 131.152 3.781 . . . . 0.0 110.077 -13.014 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 5 C2'--O2' 1.492 6.108 2 C5'-C4'-O4' 114.894 4.067 . 0.0 '__' . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.468 -5.073 5 C1'-O4'-C4' 102.326 -8.082 . 0.494 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.491 ' C2 ' ' HB3' ' A' ' 93' ' ' ARG . . . . . . . . 0 O4'--C1' 1.459 3.737 2 O4'-C1'-N19 118.685 10.485 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.359 -4.59 3 C5'-C4'-C3' 104.141 -7.572 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.381 -6.041 1 O4'-C1'-N19 114.368 6.168 . 0.58 1t . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.583 5.598 3 N19-C1'-C2' 121.649 5.156 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.504 6.986 4 C5'-C4'-O4' 117.484 5.917 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 4 C5'--C4' 1.576 5.056 3 O4'-C1'-N19 114.444 6.244 . 0.082 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.496 -3.17 4 C5'-C4'-C3' 122.786 4.857 . 0.171 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ' G' . . . . . 0.412 " H1'" ' HA ' ' A' ' 172' ' ' TYR . . . . . . . . 2 O4'--C1' 1.499 7.049 8 C5'-C4'-O4' 98.595 -7.575 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.378 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.2 mt -69.49 170.92 7.91 Favored Pre-proline 0 C--O 1.193 -1.896 0 CA-C-O 121.815 0.817 . . . . 0.0 111.466 166.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -69.85 161.07 47.34 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 N-CA-C 116.414 1.659 . . . . 0.0 116.414 166.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -62.42 126.58 27.81 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.209 -2.182 . . . . 0.0 113.104 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -79.7 -8.63 59.35 Favored 'General case' 0 CA--C 1.574 1.9 0 O-C-N 119.172 -2.205 . . . . 0.0 115.689 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m 57.94 -39.23 0.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 130.375 3.47 . . . . 0.0 119.322 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 165.47 25.09 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 110.788 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -89.79 139.51 30.51 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-N 113.767 -1.561 . . . . 0.0 115.001 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -78.92 -5.79 54.57 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 127.707 2.403 . . . . 0.0 110.866 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 156.4 48.96 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.323 1.535 . . . . 0.0 113.528 -165.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.0 p -56.6 163.06 1.95 Allowed 'General case' 0 CA--C 1.575 1.915 0 CA-C-O 124.253 1.978 . . . . 0.0 108.157 165.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.97 166.11 16.18 Favored 'General case' 0 CA--C 1.626 3.903 0 CA-C-N 110.562 -3.017 . . . . 0.0 117.643 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.53 168.83 10.45 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 144.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -126.93 132.53 50.84 Favored 'General case' 0 CA--C 1.579 2.059 0 C-N-CA 126.415 1.886 . . . . 0.0 111.728 158.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.27 128.7 26.01 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 119.521 -1.987 . . . . 0.0 109.101 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -124.16 -24.66 4.3 Favored 'General case' 0 C--O 1.278 2.585 0 O-C-N 128.194 3.434 . . . . 0.0 116.802 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.08 -133.53 4.31 Favored Glycine 0 CA--C 1.578 3.974 0 N-CA-C 119.755 2.662 . . . . 0.0 119.755 154.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -133.04 -29.58 1.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 CA-C-N 119.63 1.715 . . . . 0.0 114.728 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.72 139.28 51.11 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 125.384 1.678 . . . . 0.0 111.254 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -65.74 171.37 4.32 Favored 'General case' 0 CA--C 1.48 -1.747 0 C-N-CA 126.093 1.757 . . . . 0.0 112.759 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.18 37.83 0.17 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.091 -165.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -63.77 109.11 1.61 Allowed 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 127.845 2.458 . . . . 0.0 110.971 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.68 158.71 42.17 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 118.676 -2.515 . . . . 0.0 112.958 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.85 133.45 21.84 Favored 'Trans proline' 0 C--O 1.274 2.32 0 N-CA-C 107.401 -1.807 . . . . 0.0 107.401 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 61.56 7.24 1.76 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 130.055 3.342 . . . . 0.0 114.699 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.19 33.24 85.3 Favored Glycine 0 N--CA 1.492 2.431 0 CA-C-O 123.958 1.865 . . . . 0.0 112.835 -160.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -94.89 118.41 31.75 Favored 'General case' 0 CA--C 1.58 2.097 0 CA-C-N 113.762 -1.219 . . . . 0.0 109.934 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.19 28.93 0.02 OUTLIER Glycine 0 CA--C 1.57 3.494 0 O-C-N 116.882 -3.636 . . . . 0.0 114.329 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.73 128.44 88.28 Favored Pre-proline 0 C--O 1.26 1.654 0 CA-C-N 121.212 2.506 . . . . 0.0 114.62 167.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.44 171.25 18.49 Favored 'Trans proline' 0 N--CA 1.443 -1.487 1 C-N-CA 126.624 4.882 . . . . 0.0 114.477 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.28 135.7 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 128.354 2.662 . . . . 0.0 113.32 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -168.49 121.49 0.85 Allowed 'General case' 0 C--O 1.258 1.519 0 O-C-N 119.172 -2.205 . . . . 0.0 110.072 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.27 9.0 m -75.54 -24.18 56.71 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 118.434 -2.666 . . . . 0.0 112.095 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -75.43 5.58 5.63 Favored 'General case' 0 C--N 1.37 1.483 0 O-C-N 117.506 -3.246 . . . . 0.0 111.992 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -112.83 165.23 12.5 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.261 1.846 . . . . 0.0 112.235 158.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -120.27 175.84 2.11 Favored Pre-proline 0 C--O 1.281 2.74 0 C-N-CA 128.611 2.764 . . . . 0.0 113.506 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.37 -41.48 49.37 Favored 'Trans proline' 0 CA--C 1.591 3.365 0 C-N-CA 122.031 1.821 . . . . 0.0 114.077 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -52.2 -23.01 4.88 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 122.505 2.411 . . . . 0.0 112.414 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.13 -21.02 15.08 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 118.043 -2.911 . . . . 0.0 108.846 -161.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.01 73.8 0.04 OUTLIER 'General case' 0 CA--C 1.613 3.4 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.294 7.1 tt -158.1 137.34 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 C-N-CA 130.786 3.634 . . . . 0.0 104.702 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.36 -165.1 32.51 Favored Glycine 1 CA--C 1.588 4.611 0 CA-C-O 123.194 1.441 . . . . 0.0 111.717 -175.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -151.39 152.96 33.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 127.03 3.3 . . . . 0.0 116.446 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 110' ' ' PHE . 71.8 m-85 -92.88 147.3 22.96 Favored 'General case' 0 CA--C 1.606 3.11 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.179 164.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -125.68 136.79 53.61 Favored 'General case' 0 C--O 1.267 2.026 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -57.24 163.2 2.29 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.511 -1.368 . . . . 0.0 113.591 160.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.4 77.15 1.34 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.226 1.81 . . . . 0.0 111.209 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -71.25 -38.34 71.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.481 2.712 . . . . 0.0 112.538 -161.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 62.78 56.87 1.84 Allowed 'General case' 0 C--N 1.373 1.601 0 CA-C-O 126.988 3.28 . . . . 0.0 109.022 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 mtm180 -118.14 2.19 12.0 Favored 'General case' 0 CA--C 1.6 2.876 0 CA-C-O 113.493 -3.146 . . . . 0.0 107.681 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 mp 57.85 145.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 1 C-N-CA 132.23 4.212 . . . . 0.0 113.05 165.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -92.26 -23.33 19.35 Favored 'General case' 0 C--O 1.28 2.682 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 167.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.54 124.7 1.6 Allowed Glycine 0 CA--C 1.54 1.604 0 O-C-N 125.356 1.66 . . . . 0.0 109.551 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.4 -162.09 54.22 Favored Glycine 0 CA--C 1.547 2.068 0 CA-C-O 127.644 3.914 . . . . 0.0 110.404 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.272 4.7 m-20 51.45 15.37 0.32 Allowed 'General case' 0 C--O 1.191 -2.02 0 O-C-N 116.53 -3.924 . . . . 0.0 119.705 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.52 173.62 39.91 Favored Glycine 0 N--CA 1.504 3.207 0 O-C-N 118.841 -2.412 . . . . 0.0 115.121 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -130.62 144.91 51.74 Favored 'General case' 0 N--CA 1.514 2.76 0 C-N-CA 128.216 2.606 . . . . 0.0 107.382 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.8 mtp -111.18 157.49 20.01 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 130.826 3.651 . . . . 0.0 111.526 -171.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.429 ' HD3' ' N3 ' ' B' ' 7' ' ' ' A' . 49.1 mttm -132.78 -12.72 2.94 Favored 'General case' 0 CA--C 1.576 1.967 0 CA-C-O 115.623 -2.132 . . . . 0.0 111.615 -165.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.1 8.04 3.79 Favored 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 122.408 2.367 . . . . 0.0 116.596 -164.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.3 mt -101.37 167.23 10.3 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 123.415 1.579 . . . . 0.0 107.072 -171.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.9 m -72.9 159.77 84.52 Favored Pre-proline 0 C--N 1.368 1.393 0 CA-C-O 115.127 -2.368 . . . . 0.0 114.669 -171.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -49.18 134.86 30.78 Favored 'Trans proline' 0 CA--C 1.556 1.609 1 C-N-CA 130.636 7.557 . . . . 0.0 108.187 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -78.87 158.48 28.09 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-N 113.937 -1.483 . . . . 0.0 112.667 156.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -134.85 127.41 30.71 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 117.991 -2.943 . . . . 0.0 112.991 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.04 140.43 49.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.006 1.322 . . . . 0.0 113.652 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.451 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 65.1 t80 -92.45 151.57 20.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.698 3.592 . . . . 0.0 120.698 169.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.402 ' N ' ' CG ' ' A' ' 110' ' ' PHE . 24.6 m-85 -156.16 150.99 26.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.752 2.215 . . . . 0.0 108.455 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -71.08 150.03 45.91 Favored 'General case' 0 N--CA 1.524 3.266 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.796 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.4 tp -43.2 128.38 4.6 Favored 'General case' 0 C--O 1.257 1.49 0 CA-C-N 122.907 2.594 . . . . 0.0 117.161 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.42 18.54 75.4 Favored Glycine 0 CA--C 1.491 -1.462 0 CA-C-O 117.727 -1.596 . . . . 0.0 115.838 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 p -124.25 -164.14 1.22 Allowed 'General case' 0 C--O 1.282 2.773 0 CA-C-N 120.29 2.045 . . . . 0.0 112.428 171.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 -157.22 53.52 Favored Glycine 0 CA--C 1.547 2.088 0 CA-C-O 116.341 -2.366 . . . . 0.0 114.795 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.4 ' HD3' ' CE2' ' A' ' 111' ' ' TYR . 86.4 Cg_exo -65.47 -22.52 59.04 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 N-CA-C 117.771 2.181 . . . . 0.0 117.771 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -115.31 33.51 5.4 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.918 0.887 . . . . 0.0 110.419 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.59 -12.22 56.92 Favored 'General case' 1 C--O 1.307 4.083 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.895 -166.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.11 -35.8 37.34 Favored Glycine 0 C--N 1.347 1.144 1 CA-C-O 109.029 -6.428 . . . . 0.0 107.375 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.79 135.93 94.63 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-N 123.553 3.676 . . . . 0.0 115.176 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.17 162.77 41.44 Favored 'Trans proline' 0 CA--C 1.554 1.48 0 N-CA-C 119.927 3.011 . . . . 0.0 119.927 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -62.42 134.9 57.09 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 117.657 -3.152 . . . . 0.0 115.106 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.32 71.51 Favored Glycine 0 N--CA 1.499 2.891 0 CA-C-O 115.995 -2.558 . . . . 0.0 110.416 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.69 140.42 41.59 Favored 'General case' 0 C--N 1.389 2.3 0 O-C-N 126.747 2.087 . . . . 0.0 114.283 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -104.98 41.72 1.31 Allowed 'General case' 0 C--O 1.268 2.034 0 CA-C-N 123.397 2.817 . . . . 0.0 111.193 -147.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -74.51 116.42 15.17 Favored 'General case' 0 N--CA 1.521 3.108 0 O-C-N 126.856 2.598 . . . . 0.0 112.166 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.66 152.38 3.76 Favored 'General case' 0 C--O 1.285 2.923 0 CA-C-O 125.414 2.53 . . . . 0.0 114.181 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.33 -10.7 58.1 Favored Glycine 0 CA--C 1.575 3.812 0 CA-C-N 111.953 -2.385 . . . . 0.0 115.952 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -101.62 143.33 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.806 2.442 . . . . 0.0 110.269 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.5 mm -126.18 111.03 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 127.134 2.174 . . . . 0.0 110.322 162.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -65.61 152.2 44.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.97 138.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 O-C-N 118.12 -2.862 . . . . 0.0 113.6 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.63 179.98 7.73 Favored 'General case' 0 C--O 1.252 1.235 0 O-C-N 118.661 -2.524 . . . . 0.0 113.395 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.4 p -152.59 151.09 30.24 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.422 1.489 . . . . 0.0 108.903 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.79 -27.7 65.27 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 114.566 -2.635 . . . . 0.0 113.023 -170.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.88 -16.73 50.56 Favored Glycine 0 C--O 1.189 -2.664 1 O-C-N 130.369 4.793 . . . . 0.0 117.24 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.39 150.09 28.56 Favored 'General case' 0 C--N 1.409 3.158 0 CA-C-N 121.277 2.538 . . . . 0.0 108.263 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.86 146.48 23.61 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.66 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -76.07 7.89 3.71 Favored 'General case' 1 CA--C 1.648 4.742 0 O-C-N 117.766 -3.084 . . . . 0.0 113.974 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 p -70.57 145.54 92.77 Favored Pre-proline 0 N--CA 1.48 1.066 0 O-C-N 118.137 -2.852 . . . . 0.0 110.597 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.59 137.52 33.1 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 125.041 3.828 . . . . 0.0 112.995 160.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -101.52 67.0 1.11 Allowed 'General case' 0 C--O 1.263 1.784 0 C-N-CA 128.578 2.751 . . . . 0.0 108.987 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -73.22 -12.12 60.75 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.978 -161.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -82.45 -47.85 11.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 113.608 -3.091 . . . . 0.0 114.526 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.47 -32.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 O-C-N 126.641 2.463 . . . . 0.0 113.409 156.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.74 -15.53 62.27 Favored Glycine 0 CA--C 1.553 2.448 0 C-N-CA 126.468 1.985 . . . . 0.0 115.459 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 81.2 p -145.12 -30.08 0.44 Allowed 'General case' 1 CA--C 1.635 4.213 0 C-N-CA 130.105 3.362 . . . . 0.0 117.836 -160.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.97 149.6 46.94 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.042 1.737 . . . . 0.0 110.334 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -74.62 111.03 11.28 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.067 -170.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.31 -35.73 39.02 Favored 'Trans proline' 0 N--CA 1.51 2.494 0 CA-C-O 122.81 1.087 . . . . 0.0 109.488 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.26 2.52 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 117.114 -3.491 . . . . 0.0 114.498 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . 0.265 27.9 t-20 -69.51 -22.5 63.58 Favored 'General case' 0 CA--C 1.588 2.43 0 CA-C-N 120.264 1.393 . . . . 0.0 113.786 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -138.26 177.81 7.6 Favored 'General case' 0 C--O 1.177 -2.725 0 C-N-CA 127.669 2.388 . . . . 0.0 109.005 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.07 156.16 38.0 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 114.912 -2.471 . . . . 0.0 114.986 162.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.85 146.32 37.79 Favored 'General case' 0 C--O 1.175 -2.867 0 CA-C-N 121.837 2.108 . . . . 0.0 113.098 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.8 mt -61.11 143.69 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.612 1.096 . . . . 0.0 111.265 160.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.6 p -74.46 126.13 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.9 tp -58.46 118.91 6.1 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -138.27 141.49 39.87 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.7 154.79 50.66 Favored Pre-proline 0 C--O 1.198 -1.609 0 CA-C-N 122.889 2.586 . . . . 0.0 113.296 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -56.71 177.06 0.18 Allowed 'Trans proline' 0 CA--C 1.558 1.687 1 C-N-CA 130.404 7.403 . . . . 0.0 117.479 166.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 48.37 32.12 3.08 Favored 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 131.787 4.035 . . . . 0.0 114.502 172.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.48 11.9 54.41 Favored Glycine 0 CA--C 1.556 2.597 0 O-C-N 117.661 -3.149 . . . . 0.0 118.005 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . 0.253 5.9 m -63.13 119.81 10.26 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -161.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 46.9 m -63.69 131.22 47.26 Favored 'General case' 0 C--N 1.381 1.948 0 O-C-N 124.521 1.138 . . . . 0.0 108.436 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 44.2 mt -66.81 156.89 85.84 Favored Pre-proline 0 C--O 1.268 2.031 0 C-N-CA 127.162 2.185 . . . . 0.0 106.206 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -57.96 131.34 43.04 Favored 'Trans proline' 0 CA--C 1.571 2.333 0 C-N-CA 123.495 2.797 . . . . 0.0 113.905 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -60.77 -39.29 88.23 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.038 1.735 . . . . 0.0 109.992 -161.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.91 41.43 3.04 Favored Glycine 0 C--N 1.38 2.982 0 O-C-N 117.777 -3.077 . . . . 0.0 112.124 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.68 144.6 37.67 Favored 'General case' 0 C--O 1.204 -1.311 0 O-C-N 119.325 -2.279 . . . . 0.0 113.528 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -72.05 145.38 48.3 Favored 'General case' 0 C--O 1.284 2.884 0 CA-C-O 116.208 -1.853 . . . . 0.0 111.206 157.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -160.92 170.75 19.99 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 126.708 2.003 . . . . 0.0 110.297 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -79.48 59.1 2.84 Favored 'General case' 0 CA--C 1.571 1.77 0 O-C-N 119.364 -2.085 . . . . 0.0 113.196 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -159.86 176.94 36.53 Favored Glycine 0 CA--C 1.575 3.812 0 C-N-CA 127.839 2.638 . . . . 0.0 109.638 -168.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . 0.26 64.2 m 41.2 35.82 0.43 Allowed 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 127.252 2.221 . . . . 0.0 113.974 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -91.43 -3.53 56.56 Favored 'General case' 0 CA--C 1.603 2.993 0 C-N-CA 127.8 2.44 . . . . 0.0 110.494 -174.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 71.51 -157.69 53.34 Favored Glycine 0 C--N 1.357 1.702 0 N-CA-C 116.898 1.519 . . . . 0.0 116.898 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.85 -166.9 36.37 Favored Glycine 0 C--N 1.377 2.835 0 CA-C-O 124.855 2.364 . . . . 0.0 117.978 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.273 2.314 1 O-C-N 113.781 -5.541 . . . . 0.0 115.075 -2.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.474 4 OP1-P-OP2 110.3 -6.2 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O4'--C1' 1.463 4.125 2 O3'-P-O5' 116.512 6.585 . 0.531 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.55 -4.713 4 O5'-C5'-C4' 120.909 7.65 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.559 3.12 3 C5'-C4'-C3' 107.527 -5.315 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O3'--C3' 1.466 3.079 1 C5'-C4'-C3' 108.744 -4.504 . 0.547 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.394 -4.892 2 O5'-C5'-C4' 117.895 5.496 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ' A' . . . . . 0.429 ' N3 ' ' HD3' ' A' ' 102' ' ' LYS . . . . . . . . 2 C2'--C1' 1.61 8.165 3 C1'-O4'-C4' 104.245 -5.95 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.582 5.202 3 C3'-C2'-C1' 108.812 8.124 . 0.46 1a . 0.0 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.798 2 C1'-O4'-C4' 104.205 -5.995 . 0.366 1b . 0.0 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C5'--C4' 1.569 4.555 2 O4'-C1'-N19 118.024 9.824 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 2 . 1 stop_ save_